
<html lang="en"     class="pb-page"  data-request-id="43a9e3c6-591d-4a83-acd0-cfa56ea002f0"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";article:article:10.1021/acs.jmedchem.8b00124;requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;issue:issue:10.1021/jmcmar.2018.61.issue-16;wgroup:string:ACHS website Group;website:website:acspubs;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="citation_journal_title" content="Journal of Medicinal Chemistry" /></meta><meta name="dc.Title" content="NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer" /></meta><meta name="dc.Creator" content="Kuojun  Zhang" /></meta><meta name="dc.Creator" content="Dong  Chen" /></meta><meta name="dc.Creator" content="Kun  Ma" /></meta><meta name="dc.Creator" content="Xiaoxing  Wu" /></meta><meta name="dc.Creator" content="Haiping  Hao" /></meta><meta name="dc.Creator" content="Sheng  Jiang" /></meta><meta name="dc.Description" content="NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase responsible for detoxification of quinones and also bioactivation of certain quinones. It is abnormally overexpressed in many tum..." /></meta><meta name="Description" content="NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase responsible for detoxification of quinones and also bioactivation of certain quinones. It is abnormally overexpressed in many tum..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="April 30, 2018" /></meta><meta name="dc.Type" content="review-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/acs.jmedchem.8b00124" /></meta><meta name="dc.Language" content="en" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="Copyright © 2018 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00124" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Facs.jmedchem.8b00124" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Facs.jmedchem.8b00124" /></link>
        
    
    

<title>NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/acs.jmedchem.8b00124" /></meta><meta property="og:title" content="NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0016.jpeg" /></meta><meta property="og:description" content="NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase responsible for detoxification of quinones and also bioactivation of certain quinones. It is abnormally overexpressed in many tumors and intimately linked with multiple carcinogenic processes. NQO1 is considered to be a cancer-specific target for therapy but currently available NQO1 inhibitors have not yet led to chemotherapeutic success. Utilization of NOQ1’s ability to bioactivate chemotherapeutic quinones, however, has emerged as a promising selective anticancer therapy. On the basis of the different levels of NQO1 between cancer and normal cells, the catalytic property of NQO1 has recently been exploited to develop effective probes for cancer detection. This article summarizes the most significant advances concerning the discovery and development of NQO1 inhibitors, NQO1-directed chemotherapeutic quinones, and NQO1-activated optical probes, along with the prospects and potential obstacles in this research area." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/acs.jmedchem.8b00124"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/acs.jmedchem.8b00124">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Facs.jmedchem.8b00124&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Facs.jmedchem.8b00124&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/acs.jmedchem.8b00124&amp;href=/doi/10.1021/acs.jmedchem.8b00124" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2018</span><span class="cit-fg-volume">, 61</span><span class="cit-fg-issue">, 16</span><span class="cit-fg-pageRange">, 6983-7003</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/61/16" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/acs.jmedchem.7b01686" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Perspective</span><a href="/doi/10.1021/acs.jmedchem.8b00260" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer</span></h1><ul class="loa"><li><span><span class="hlFld-ContribAuthor">Kuojun Zhang</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kuojun Zhang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kuojun++Zhang">Kuojun Zhang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath1">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Dong Chen</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Dong Chen</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Dong++Chen">Dong Chen</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath2">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Kun Ma</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Kun Ma</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">Center for Drug Evaluation, China Food and Drug Administration, Beijing 100038, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Kun++Ma">Kun Ma</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath3">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Xiaoxing Wu</span><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Xiaoxing Wu</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China</div></div><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Xiaoxing++Wu">Xiaoxing Wu</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath4">View Biography</a></span></div></div></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor">Haiping Hao</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Haiping Hao</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>For J.H.: E-mail, <a href="/cdn-cgi/l/email-protection#29414159761e1e191c191c6941465d44484045074a4644"><span class="__cf_email__" data-cfemail="9cf4f4ecc3ababaca9aca9dcf4f3e8f1fdf5f0b2fff3f1">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Haiping++Hao">Haiping Hao</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath5">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5142-1134" title="Orcid link">http://orcid.org/0000-0002-5142-1134</a></div></div></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor">Sheng Jiang</span><strong>*</strong><div class="loa-info hlFld-Affiliation"><div class="loa-info-name">Sheng Jiang</div><div class="loa-info-affiliations"><div class="loa-info-affiliations-info">State Key Laboratory of Natural Medicines and Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, Nanjing, 210009, China</div></div><span class="conrtib-corresp"><strong>*</strong>For S.J.: phone, 86-18688888237; E-mail, <a href="/cdn-cgi/l/email-protection#fb91929a959c8893c2bb9c969a9297d5989496"><span class="__cf_email__" data-cfemail="d4bebdb5bab3a7bced94b3b9b5bdb8fab7bbb9">[email protected]</span></a></span><span class="conrtib-corresp"></span><div class="loa-info-scifinder"><span>More by <a href="/action/doSearch?field1=Contrib&amp;text1=Sheng++Jiang">Sheng Jiang</a></span></div><div class="loa-info-bio"><span><a class="internalNav" href="#ath6">View Biography</a></span></div><div class="loa-info-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4550-5024" title="Orcid link">http://orcid.org/0000-0002-4550-5024</a></div></div></span></li><span class="comma-separator"></span></ul><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00124&amp;href=/doi/10.1021%2Facs.jmedchem.8b00124" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2018</span></span><span class="cit-volume">, 61</span><span class="cit-issue">, 16</span><span class="cit-pageRange">, 6983–7003</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">April 30, 2018</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>23 January 2018</li><li><span class="item_label"><b>Published</b> online</span>30 April 2018</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 23 August 2018</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/acs.jmedchem.8b00124" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00124</a></div><div class="article_header-article-copyright"><strong>Copyright © 2018 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D6983%26pageCount%3D21%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DKuojun%2BZhang%252C%2BDong%2BChen%252C%2BKun%2BMa%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D61%26issueNum%3D16%26contentID%3Dacs.jmedchem.8b00124%26title%3DNAD%2528P%2529H%253AQuinone%2BOxidoreductase%2B1%2B%2528NQO1%2529%2Bas%2Ba%2BTherapeutic%2Band%2BDiagnostic%2BTarget%2Bin%2BCancer%26numPages%3D21%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D7003%26publicationDate%3DAugust%2B2018">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/acs.jmedchem.8b00124"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3363</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">54</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/acs.jmedchem.8b00124" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;NAD(P)H:Quinone Oxidoreductase 1 (NQO1) as a Therapeutic and Diagnostic Target in Cancer&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Kuojun&quot;,&quot;last_name&quot;:&quot;Zhang&quot;},{&quot;first_name&quot;:&quot;Dong&quot;,&quot;last_name&quot;:&quot;Chen&quot;},{&quot;first_name&quot;:&quot;Kun&quot;,&quot;last_name&quot;:&quot;Ma&quot;},{&quot;first_name&quot;:&quot;Xiaoxing&quot;,&quot;last_name&quot;:&quot;Wu&quot;},{&quot;first_name&quot;:&quot;Haiping&quot;,&quot;last_name&quot;:&quot;Hao&quot;},{&quot;first_name&quot;:&quot;Sheng&quot;,&quot;last_name&quot;:&quot;Jiang&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2018&quot;,&quot;month&quot;:&quot;04&quot;,&quot;day&quot;:&quot;30&quot;,&quot;issue&quot;:&quot;16&quot;,&quot;volume&quot;:&quot;61&quot;,&quot;pages&quot;:&quot;6983-7003&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/acs.jmedchem.8b00124&quot;},&quot;abstract&quot;:&quot;NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase responsible for detoxification of quinones and also bioactivation of certain quinones. It is abnormally overexpressed in many tumors and intimately linked with multiple carcinogenic processes. NQO1 is considered to be a cancer-specific target for therapy but currently available NQO1 inhibitors have not yet led to chemotherapeutic success. Utilization of NOQ1’s ability to bioactivate chemotherapeutic quinones, however, has emerged as a promising selective anticancer therapy. On the basis of the different levels of NQO1 between cancer and normal cells, the catalytic property of NQO1 has recently been exploited to develop effective probes for cancer detection. This article summarizes the most significant advances concerning the discovery and development of NQO1 inhibitors, NQO1-directed chemotherapeutic quinones, and NQO1-activated optical probes, along with the prospects and potential obstacles in this research area.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00124&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00124" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00124&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00124" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Facs.jmedchem.8b00124&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00124" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Facs.jmedchem.8b00124&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=acs.jmedchem.8b00124&amp;href=/doi/10.1021/acs.jmedchem.8b00124" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/acs.jmedchem.8b00124" /></input><a href="/doi/pdf/10.1021/acs.jmedchem.8b00124" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (5 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00124&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Facs.jmedchem.8b00124%26sid%3Dliteratum%253Aachs%26pmid%3D29712428%26genre%3Darticle%26aulast%3DZhang%26date%3D2018%26atitle%3DNAD%2528P%2529H%253AQuinone%2BOxidoreductase%2B1%2B%2528NQO1%2529%2Bas%2Ba%2BTherapeutic%2Band%2BDiagnostic%2BTarget%2Bin%2BCancer%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D61%26issue%3D16%26spage%3D6983%26epage%3D7003%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290896" title="Cells">Cells</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=292258" title="Cancer">Cancer</a>,</li><li><a href="/action/doSearch?ConceptID=292524" title="Peptides and proteins">Peptides and proteins</a>,</li><li><a href="/action/doSearch?ConceptID=292601" title="Probes">Probes</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/61/16" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/jmcmar.2018.61.issue-16/20180823/jmcmar.2018.61.issue-16.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="_i1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">NAD(P)H:quinone oxidoreductase 1 (NQO1) is a two-electron reductase responsible for detoxification of quinones and also bioactivation of certain quinones. It is abnormally overexpressed in many tumors and intimately linked with multiple carcinogenic processes. NQO1 is considered to be a cancer-specific target for therapy but currently available NQO1 inhibitors have not yet led to chemotherapeutic success. Utilization of NOQ1’s ability to bioactivate chemotherapeutic quinones, however, has emerged as a promising selective anticancer therapy. On the basis of the different levels of NQO1 between cancer and normal cells, the catalytic property of NQO1 has recently been exploited to develop effective probes for cancer detection. This article summarizes the most significant advances concerning the discovery and development of NQO1 inhibitors, NQO1-directed chemotherapeutic quinones, and NQO1-activated optical probes, along with the prospects and potential obstacles in this research area.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">1.  Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_84546" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_84546" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Cancer remains one of the leading causes of death worldwide. According to the American Cancer Society, 1.6 million new cancer cases and 600920 cancer deaths were estimated to have occurred in the United States in 2017.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> Despite enormous efforts in past decades, conquering this devastating disease still poses huge challenges. One major hurdle is the difficulty of securing early diagnosis, thereby perhaps missing the best time for treatment. Nonselective chemotherapy has a central role in cancer therapy regimens and produces undesirable toxic effects and additional challenges, such as acquired chemoresistance and high rates of recurrence, which further diminish the odds of therapeutic success. Thus, early detection of cancer biomarkers and development of innovative therapeutics are urgently needed for effective cancer control and management. Targeting enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1, EC 1.6.99.2) may improve these aspects of cancer treatment.</div><div class="NLM_p">NQO1 was isolated in the late 1950s, characterized from the soluble fraction of rat liver homogenates by Ernster and Navazio,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and named DT-diaphorase (DTD). In subsequent years, the functional importance of NQO1 has been an active area of research. It is well-known that NQO1 is a flavoenzyme capable of catalyzing obligatory two-electron reductions of a wide range of quinones to the hydroquinones in an NAD(P)H-dependent manner. Depending on the chemical reactivities of the hydroquinones formed, this reaction is either a detoxification or bioactivation process.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Generation of stable hydroquinones by NQO1 is believed to be a detoxification mechanism because this process can avoid one-electron reductions that can produce toxic semiquinone radicals and reactive oxygen species (ROS) and direct reactions with intracellular sulfhydryl groups.<a onclick="showRef(event, 'ref4 ref5'); return false;" href="javascript:void(0);" class="ref ref4 ref5">(4,5)</a> Rather than detoxifying, NQO1-directed reduction in some cases can bioactivate certain antitumor quinones into potent cytotoxic compounds through the formation of an unstable hydroquinone that can alkylate DNA or rapidly produce amounts of ROS via redox cycling.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Moreover, NQO1 can reduce the drug-derived quinone-like species such as quinone-imine metabolites that are formed by cytochromes P450 (CYP), thereby playing an important role in relieving the adverse drug reactions (ADRs) and mediating a protective mechanism for detoxification.<a onclick="showRef(event, 'ref7 ref8'); return false;" href="javascript:void(0);" class="ref ref7 ref8">(7,8)</a> In addition to its enzymatic activity, NQO1 has been found to be involved in other biological processes such as antioxidant activity and the recently recognized stabilization of key regulatory proteins under stress.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a></div><div class="NLM_p last">Interest in NQO1 has been largely sparked by the findings that it is expressed in many human solid tumors at levels of 5–200-fold above that in normal tissue, such as breast,<a onclick="showRef(event, 'ref10 ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref10 ref11 ref12">(10−12)</a> lung,<a onclick="showRef(event, 'ref13 ref14 ref15'); return false;" href="javascript:void(0);" class="ref ref13 ref14 ref15">(13−15)</a> prostate,<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> stomach,<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> colon,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> pancreatic<a onclick="showRef(event, 'ref19 ref20'); return false;" href="javascript:void(0);" class="ref ref19 ref20">(19,20)</a> and head and neck cancer,<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> and cholangiocarcinoma<a onclick="showRef(event, 'ref22 ref23'); return false;" href="javascript:void(0);" class="ref ref22 ref23">(22,23)</a> among others.<a onclick="showRef(event, 'ref24 ref25 ref26'); return false;" href="javascript:void(0);" class="ref ref24 ref25 ref26">(24−26)</a> Further, its elevated activity is closely associated with tumor progression, aggressiveness, resistance to chemotherapy, and poor patient prognosis. Some effort has been made to explore small-molecule NQO1 inhibitors as an anticancer strategy but little success has been achieved. Considering the different levels of NQO1 in tumors compared to that in normal tissues, the compounds containing a quinone pharmacophore that are bioactivated by NQO1 should show remarkable tumor-selectivity, leaving normal cells intact. This constitutes an explicit example of “enzyme-directed bioreductive drug development” and has led to the development of NQO1-directed antitumor agents. To date, numerous NQO1 substrates have been reported and a few are in clinical development.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> For example, indolequinone apaziquone is now being evaluated in phase III trials as an intravesical therapeutic agent in the treatment of nonmuscle invasive bladder cancer (NMIBC).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Such reports have aroused further interest in the development of more efficient NQO1 substrates as bioreductive drugs. The catalytic properties of NQO1 together with the fact that NQO1 is overexpressed early in the carcinogenic process has prompted the design of various NQO1-activated optical probes for cancer cell imaging. Such probes are invaluable for accurate and early cancer diagnosis and optimization of surgical and personalized chemotherapeutic treatments.<a onclick="showRef(event, 'ref28 ref29 ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref28 ref29 ref30 ref31">(28−31)</a> Thus, NQO1 is an attractive target for selective anticancer therapy and accurate cancer detection. In this report, we review advances with NQO1 as an anticancer target. Potential obstacles and future directions in this research area are also presented.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i3">2.  An Overview of NQO1</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_08736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_08736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">NQO1 is considered to be a ubiquitous soluble enzyme present in nearly all animal species. With the development of detection technology, its distribution across tissues and localization in cells has been assessed in several animal species, including humans. NQO1 is distributed at various levels in almost all normal human tissues. In general, it is expressed at high levels in adipocytes, vascular endothelium, and epithelial cells and at lower levels in human hepatocytes and myocardia.<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> Because NQO1 expression is both inducible and genetically determined,<a onclick="showRef(event, 'ref8 ref33 ref34'); return false;" href="javascript:void(0);" class="ref ref8 ref33 ref34">(8,33,34)</a> significant intra- and interindividual variability has been found in NQO1 levels. For example, despite low levels in normal hepatic tissues, NQO1 can be highly inducible in preneoplastic lesions and liver cancers.<a onclick="showRef(event, 'ref35 ref36'); return false;" href="javascript:void(0);" class="ref ref35 ref36">(35,36)</a> Several lines of evidence also suggest that some factors such as obesity and ethnicity may result in different hepatic NQO1 levels in different individuals.<a onclick="showRef(event, 'ref8 ref33 ref34 ref37'); return false;" href="javascript:void(0);" class="ref ref8 ref33 ref34 ref37">(8,33,34,37)</a> In terms of cellular localization, more than 90% of NQO1 is found to be in cytosol with much lower levels being detected in the Golgi complex, mitochondria, endoplasmic reticulum, cellular membrane, nucleus, mitotic spindle, and extracellular components.<a onclick="showRef(event, 'ref32 ref38 ref39'); return false;" href="javascript:void(0);" class="ref ref32 ref38 ref39">(32,38,39)</a></div><div class="NLM_p">The X-ray crystallographic structures of rat, mouse, and human NQO1 alone, and of complexes in which these enzymes are bound to cofactors, inhibitors, and substrates, have been determined.<a onclick="showRef(event, 'ref40 ref41 ref42 ref43 ref44'); return false;" href="javascript:void(0);" class="ref ref40 ref41 ref42 ref43 ref44">(40−44)</a> Analysis of these crystal structures revealed high homology between samples from rat, mouse, or humans.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a> The structures of the <i>apo</i> recombinant human NQO1 (hNQO1) containing only the FAD and the complex with the substrate duroquinone (2,3,5,6-tetramethyl-1,2-benzoquinone (<b>1</b>) are shown in <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figures <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a> and <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, respectively. hNQO1 is a ∼60 kDa protein consisting of two highly identical subunits intertwined antiparallel to one another, each consisting of 274 amino acids with one noncovalently bound FAD. Each subunit has two separate domains, in which residues 1–220 constitute a major catalytic domain and residues 221–273 are a small C-terminal domain. The catalytic domain consists a central parallel β-sheet surrounded by helices, while the C-terminal domain is composed of an antiparallel hairpin motif, an α-helix and several loops (<a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a></a>B). Each catalytic domain contains three binding sites: (i) the FAD binding site, (ii) a hydrophilic adenine-ribose portion of a NAD(P)H binding site, and (iii) a hydride donor/acceptor binding site, which is a catalytic pocket that binds either the nicotinamide portion of NAD(P)H, the hydride donor, or a hydride acceptor substrate.<a onclick="showRef(event, 'ref5 ref44'); return false;" href="javascript:void(0);" class="ref ref5 ref44">(5,44)</a> The NQO1-catalyzed reaction proceeds via a ping-pong, enzyme-substituted mechanism in which NAD(P)H and the substrate alternately occupy the same binding site. It involves a double hydride transfer in which one hydride is transferred from NAD(P)H to N5 of the FAD and is followed by the release of NAD(P)<sup>+</sup> from the catalytic site; the other hydride is transferred across a 4 Å distance<a onclick="showRef(event, 'ref45'); return false;" href="javascript:void(0);" class="ref ref45">(45)</a> from the N5 of FADH2 to the quinone substrate, and this is followed by the release of the hydroquinone formed from the catalytic binding pocket.<a onclick="showRef(event, 'ref41 ref42'); return false;" href="javascript:void(0);" class="ref ref41 ref42">(41,42)</a></div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of human NQO1 in complex with FAD (apoenzyme) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1D4A">1D4A</a>). (A) Overall structure of NQO1 apoenzyme. One monomer is shown in green and the other in orange. Carbon atoms of FAD are shown in purple. (B) One monomer of NQO1 apoenzyme. The catalytic domain is shown in purple and the C-terminal domain in blue. Carbon atoms of FAD are shown in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of NQO1 apoenzyme with <b>1</b> bound to the active site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DXO">1DXO</a>). (A) Binding surface of <b>1</b> to the active site. (B) Detailed binding mode of <b>1</b>. (C) Chemical structure of <b>1</b>. Carbon atoms of FAD are shown in purple and <b>1</b> in yellow. Hydrogen bonds are represented by green dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The two independent but almost identical active sites formed by residues from each subunit are positioned at opposite ends of the dimer interface. The FAD moiety in the catalytic domain of one of the monomers forms one wall of the catalytic pocket.<a onclick="showRef(event, 'ref42 ref46'); return false;" href="javascript:void(0);" class="ref ref42 ref46">(42,46)</a> The major molecular interactions of duroquinone (<b>1</b>) with the enzyme are shown in <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a></a>. Duroquinone binds to the NQO1 active site in a position similar to that adopted by the nicotinamide ring of NADP<sup>+</sup> by interacting with FAD and several hydrophobic and hydrophilic residues. It aligns with the isoalloxazine ring of FAD, the distance between the two rings being 3.4 Å, and with five aromatic residues (Trp-105′, Phe-106′, Phe-178, Tyr-126, and Tyr-128) and Gly-149′ and enjoys H-bond interactions with the hydroxyl groups of Tyr128 and Tyr-126.<a onclick="showRef(event, 'ref42'); return false;" href="javascript:void(0);" class="ref ref42">(42)</a> Together with the data from the cocrystal structures with other quinone substrates, it can be concluded that the active site of NQO1 is a flexible and changeable hydrophobic pocket with three potential hydrogen-bonding residues (i.e., Tyr-126, Tyr-128, and His-161) that can accommodate consecutive binding of NAD(P)H and ligands of different sizes and shapes, adopting a variety of binding modes and interactions.<a onclick="showRef(event, 'ref42 ref44'); return false;" href="javascript:void(0);" class="ref ref42 ref44">(42,44)</a> Such high plasticity may provide significant advantages in the design of NQO1-directed antitumor agents by tolerating different sizes and diversified chemical properties. However, caution needs to be exercised because quinone substrates can bind to the active site in more than one orientation, and analogue compounds with different substituents may bind to the enzyme in different orientations. NQO1 crystal structure-based molecular modeling studies have been applied in structure-based design efforts for the optimization of several groups of inhibitors and substrates.<a onclick="showRef(event, 'ref45 ref47 ref48 ref49'); return false;" href="javascript:void(0);" class="ref ref45 ref47 ref48 ref49">(45,47−49)</a></div><div class="NLM_p last">An isoenzyme of NQO1 is NRH:quinone oxidoreductase 2 (NQO2) that, at its C-terminus, is 43 residues shorter than NQO1. NQO2 has a 54% and 49% identity with NQO1 in cDNA and protein sequence, respectively. NQO1 and NQO2 have significant structural similarity, particularly in the conserved features of the active sites observed in X-ray crystallographic studies.<a onclick="showRef(event, 'ref5 ref50'); return false;" href="javascript:void(0);" class="ref ref5 ref50">(5,50)</a> NQO2 is also able to reduce a quinone to hydroquinone, but it cannot use NAD(P)H as reducing cofactor unless the pH is substantially lower. Instead, NQO2 utilizes dihydronicotinamide riboside (NRH) to develop its enzymatic activity. Furthermore, in contrast to NQO1, which is overexpressed in solid tumors, NQO2 is highly expressed in red blood cells and in leukemias.<a onclick="showRef(event, 'ref51'); return false;" href="javascript:void(0);" class="ref ref51">(51)</a> In addition, typical NQO1 inhibitors such as dicoumarol (DIC, <b>2</b>) and ES936 (<b>6</b>) are poor inhibitors of NQO2, while potent NQO2 inhibitors such as resveratrol and quercetin only weakly inhibit NQO1.<a onclick="showRef(event, 'ref5 ref8 ref50'); return false;" href="javascript:void(0);" class="ref ref5 ref8 ref50">(5,8,50)</a> Although NQO1 and NQO2 share overlapping substrate specificity, remarkable differences have been found in terms of affinities toward various substrates.<a onclick="showRef(event, 'ref52'); return false;" href="javascript:void(0);" class="ref ref52">(52)</a> Due to its biological significance, there is growing interest in NQO2, and a great deal of information about this quinone reductase is accumulating. Because this subject is outside of the scope of this review, a brief overview of NQO2 will suffice here.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i4">3.  Role Of NQO1 in Cancer</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_18637" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_18637" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A great deal of evidence has been published suggesting a “Janus” effect of NQO1 in cancer biology, where it behaves as either a tumor suppressor or a tumor promotor (<a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a></a>). NQO1 is constitutively expressed at relatively low levels in various normal tissues under physiological conditions. Under oxidative or electrophilic stress, it can be transcriptionally induced in concert with a battery of defensive genes under the control of NF-E2 p45-related factor 2 (Nrf2)/Kelch-like ECH-associated protein 1(Keap1)/– antioxidant response element (ARE) signaling pathway, providing cells with multiple layers of protection against carcinogenesis. These include detoxification of quinones, instant scavenging of superoxides, maintenance of lipid-soluble antioxidants in their reduced forms, and serving as a gatekeeper of the 20S proteasome which can stabilize key regulatory proteins.<a onclick="showRef(event, 'ref53'); return false;" href="javascript:void(0);" class="ref ref53">(53)</a> Cancer chemoprevention by dietary phytochemicals that can induce the expression of NQO1 has been considered as a practical and economic approach to cancer control and management. However, NQO1 has been found to be abnormally up-regulated in numerous human solid tumors and high levels of NQO1 correlate with poorer patient prognosis. Moreover, NQO1 appears to be overexpressed very early in carcinogenesis, even in precancerous lesions, and it is a potentially useful clinical cancer diagnostic biomarker.<a onclick="showRef(event, 'ref54'); return false;" href="javascript:void(0);" class="ref ref54">(54)</a> Cancer cells are known to have an apparent increase in their ROS production relative to normal cells. In this context, high levels of NQO1 in cancers are postulated to assist cancer cells in dealing with elevated oxidative stress, as they do in normal cells.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This hypothesis has been confirmed, to some extent, from studies of Nrf2, the transcription factor controlling NQO1 expression. In many cancers, including cancers of the lung, liver, gall bladder, pancreas, and ovarian, Nrf2 is constantly overactivated by gain-of-function mutations of itself or loss-of-function mutations of Keap1.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> Hyperactivation of Nrf2 helps transformed or malignant cells to evade extreme oxidative stress through the induction of cytoprotective genes, e.g., the overexpression of NQO1.<a onclick="showRef(event, 'ref56'); return false;" href="javascript:void(0);" class="ref ref56">(56)</a> The mechanism by which NQO1 is overexpressed through Nrf2 may vary among different types of solid tumors. For example, mutations of Keap1 in gall bladder cancer lead to the decreased binding with Nrf2 and drive the expression of NQO1,<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> while in pancreatic cancer, K-ras mutations promote the dimerization of c-Jun with Nrf2 independently of Keap1 to drive NQO1 induction.<a onclick="showRef(event, 'ref58'); return false;" href="javascript:void(0);" class="ref ref58">(58)</a> Besides, Nrf2-induced overexpression of NQO1 may play a role in the disappointing outcomes of chemotherapy, where it may be an adaptive response to oxidative stress and cytotoxicity and may confer protective effects on cancer cells.<a onclick="showRef(event, 'ref56 ref57'); return false;" href="javascript:void(0);" class="ref ref56 ref57">(56,57)</a> In this regard, inhibition of NQO1 would prevent cancer cell growth and malignant transformation as such inhibition could result in toxic oxidative stress levels.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0003.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. NQO1’s biological role in cancer. NQO1 can provide normal cells with multiple layers of protection to resist carcinogenesis. On the other hand, NQO1 is overexpressed in cancer cells, where it promotes cell proliferation, malignant transformation, and drug resistance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">The crosstalk between NQO1 and signaling networks integrating their activity ultimately determines the fate of cells. Li et al.<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> demonstrated that NQO1 was up-regulated with respect to melanocytes in most melanoma cell lines. This overexpression significantly induces cell cycle progression by up-regulation of cyclins A2, B1, and D1. Furthermore, it was found that NQO1 binds to and stabilizes trans-activator BCL3, which in turn up-regulates NF-κB p50, promoting the proliferation of melanoma cells. A study by Ahn et al.<a onclick="showRef(event, 'ref59'); return false;" href="javascript:void(0);" class="ref ref59">(59)</a> reported that NQO1 was required for the tumor necrosis factor (TNF) and other inflammatory stimuli-induced activation of IKK, NF-κB, JNK, p38 MAPK, p44/p42 MAPK, and Akt. Moreover, TNF-induced expressions of NF-κB-targeted gene implicated in cell proliferation, antiapoptosis, and invasion were also correlated with the level of NQO1, and these results were further validated in NQO1-null mice. In addition, it has been demonstrated that NQO1 can act as a chaperone, preventing the proteasome-mediated degradation of hypoxia inducible factor α (HIF-1α) and indicating that its tumor-promoting effects are in part associated with HIF-1α.<a onclick="showRef(event, 'ref60'); return false;" href="javascript:void(0);" class="ref ref60">(60)</a> Indeed, RNAi-mediated knockdown of NQO1 has been found to suppress HIF-1α signaling and tumor growth of human colorectal and breast cancer cells.</div><div class="NLM_p">Madajewski and co-workers have determined that NQO1 is critical for tumor growth at both primary and secondary nonsmall cell lung cancer sites because depletion of NQO1 expression in vitro causes an increase in ROS formation, inhibits anchorage-independent growth, increases anoikis sensitization, and decreases cell invasion.<a onclick="showRef(event, 'ref55'); return false;" href="javascript:void(0);" class="ref ref55">(55)</a> This result was confirmed in a lung tumor xenograft model. It is important to note that NQO1 overexpression is linked to cancer stem cell phenotypes, as depletion of NQO1 significantly diminishes the proportion of aldehyde dehydrogenase (ALDH)<sup>high</sup> cancer cells within the tumor population.</div><div class="NLM_p">In cholangiocarcinoma (CCA), a rare type of liver cancer, inhibition of NQO1 with DIC (<b>2</b>), a potent NQO1 inhibitor, was reported by Prawan et al.<a onclick="showRef(event, 'ref61'); return false;" href="javascript:void(0);" class="ref ref61">(61)</a> to markedly potentiate the cytotoxicity of gemcitabine to CCA. Further, RNAi knockdown and NQO1 knock-in cell lines were used to validate the role of NQO1 in chemotherapy resistance.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> The results shown that knockdown of NQO1 sensitizes CCA to an array of commonly used chemotherapeutic agents, including 5-fluorouracil (5-FU), doxorubicin, and gemcitabine, while overexpressed NQO1 on the other hand, protects CCA cells from these chemotherapeutic agents, indicating the possibility for combination therapy using wide-ranging traditional cytotoxic agents.<a onclick="showRef(event, 'ref62'); return false;" href="javascript:void(0);" class="ref ref62">(62)</a> Inhibition of NQO1 by RNAi significantly inhibits the colony formation capacity of CCA and arrested cells at the G1 phase, causing inhibition of cell proliferation by up-regulation of p21 and down-regulation of cyclin D1.<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Significantly, knockdown of NQO1 also suppresses the metastasis of CCA by up-regulation of tissue inhibitors of metalloproteinases 1 (TIMP1) and down-regulation of matrix metalloproteinase 9 (MMP9).<a onclick="showRef(event, 'ref63'); return false;" href="javascript:void(0);" class="ref ref63">(63)</a> Thus, NQO1 plays an important role in cancer cell survival, proliferation, invasion, metastasis, and angiogenesis, as well as chemosensitivity, via interaction with various oncogenic signaling pathways.</div><div class="NLM_p last">There are two common single nucleotide polymorphisms (SNPs) in NQO1 with defined phenotypes and population frequencies. These are NQO1*2 (ID, rs180056; NQO1 609C>T; NQO1 P187S; allelic frequency, 0.22–0.47) and NQO1*3 (ID, rs1131341; NQO1 465C>T; NQO1 R139W; allelic frequency, 0.00–0.05).<a onclick="showRef(event, 'ref64'); return false;" href="javascript:void(0);" class="ref ref64">(64)</a> NQO1*2 is known to have a profound effect on cellular NQO1 activity by highly decreasing its stability, as the mutant form of protein is rapidly ubiquitinated and degraded by the proteasome.<a onclick="showRef(event, 'ref65'); return false;" href="javascript:void(0);" class="ref ref65">(65)</a> Individuals homozygous for the NQO1*2 polymorphism have negligible NQO1 enzymatic activity, whereas individuals genotyped as heterozygous have decreased levels of NQO1 activity. While many recently performed meta-analyses have suggested a correlation between NQO1*2 polymorphism and increased cancer risk, other studies question its significance.<a onclick="showRef(event, 'ref66'); return false;" href="javascript:void(0);" class="ref ref66">(66)</a> Individuals with this polymorphism who have cancer would obviously not benefit from a therapy that targets overexpression of NQO1. NQO1*3 polymorphism is rarely found in homozygosis, but such polymorphism in heterozygosis has been shown to be correlated with increased risk of pediatric acute lymphoblastic leukemia.<a onclick="showRef(event, 'ref67'); return false;" href="javascript:void(0);" class="ref ref67">(67)</a> The phenotypical implications of NQO1*3 vary according to the substrate, showing native activity using dichlorophenol indophenols as substrates but reduced activity toward mitomycin C (MMC, <b>14</b>).</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i5">4.  NQO1 Inhibitors</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25235" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25235" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Preliminary validation of NQO1 as a therapeutic target has been achieved mainly through RNAi knockdown experiments. RNAi-based studies, however, do not necessarily recapitulate the effects observed with small molecule inhibitors. This has led to interest in the development of NQO1 inhibitors, but studies with currently available NQO1 inhibitors show no correlation between NQO1 inhibition and anticancer activity. Further study is still required to determine if the inhibition of NQO1 by small molecules can be leveraged for therapeutic applications. Some inhibitors exhibit excellent anticancer activity, especially in combination with other chemotherapeutics, and in addition, efficient and selective NQO1 inhibitors can serve as tools with which to study the biology of NQO1 beyond RNAi knockdown experiments. <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a></a> summarizes the most studied NQO1 inhibitors, which are generally classified into two types based on the mechanism of action, namely competitive (reversible) inhibitors and mechanism-based (irreversible) inhibitors.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0004.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the most studied NQO1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec4_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i6" class="anchor-spacer"></div><h3 class="article-section__title" id="_i6">4.1.  Typical Competitive Inhibitors</h3><div class="NLM_p">A range of structurally diverse NQO1 competitive inhibitors have been reported. These compete with NAD(P)H for binding to NQO1, thus preventing the hydride transfer to FAD. Among known inhibitors, DIC (<b>2</b>), an anticoagulant isolated from sweet clover (<i>Melilotusalba</i>), is the most potent competitive inhibitor with <i>K</i><sub>i</sub> = 1–10 nM.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> The cocrystal structure reported by Asher et al.<a onclick="showRef(event, 'ref43'); return false;" href="javascript:void(0);" class="ref ref43">(43)</a> showed that <b>2</b> binds to the active site through a series of hydrophobic and hydrogen bonds with residues of enzyme and the cofactor FAD. One coumarin ring of <b>2</b> lies parallel to the isoalloxazine ring of the FAD and forms two hydrogen bonds, between O-5 of DIC and Tyr 128 and between O-17 and His 161′ (<a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a></a>). DIC has been frequently used as a pharmacological tool with which to study the cellular function of NQO1, and considerable research has focused on the ability of <b>2</b> to inhibit the malignant phenotype of pancreatic cancer cells. However, substantial evidence reveals that DIC’s growth inhibitory effects on pancreatic cancer cells were due to other properties of DIC, such as mitochondrial uncoupling, rather than inhibition of NQO1.<a onclick="showRef(event, 'ref68 ref69'); return false;" href="javascript:void(0);" class="ref ref68 ref69">(68,69)</a></div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0005.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Co-crystal structure of NQO1 apoenzyme with <b>2</b> bound to the active site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F1O">2F1O</a>). (A) Binding surface of <b>2</b> to the active site. (B) Detailed binding mode of <b>2</b>. Carbon atoms of FAD are shown in purple and <b>2</b> in yellow. Hydrogen bonds are represented by green dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The lack of selectivity of <b>2</b> has prompted searches for structurally novel NQO1 inhibitors. Virtual screening of the National Cancer Institute (NCI) database identified <b>3</b> as a potent competitive NQO1 inhibitor. This compound displays potency comparable to that of <b>2</b> and, more importantly, has “off-target” effects remarkably reduced from those of <b>2</b>.<a onclick="showRef(event, 'ref68'); return false;" href="javascript:void(0);" class="ref ref68">(68)</a> Subsequently, a wide investigation of inhibitors structurally related to <b>2</b> led to the discovery of several NQO1 inhibitors that are endowed with equal or greater potency and improved selectivity toward NQO1. These include the symmetric analogues such as <b>4</b> and asymmetric analogues such as <b>5</b>.<a onclick="showRef(event, 'ref69'); return false;" href="javascript:void(0);" class="ref ref69">(69)</a> Unfortunately, it was finally concluded that the growth inhibitory effects of newly synthesized coumarin-based NQO1 inhibitors, similar to <b>2</b>, were independent of the extent of NQO1 inhibition. This fact did not favor NQO1 as a druggable target. Nevertheless, the improved selectivity profiles of these compounds allow them to serve as pharmacological probes with which to study other biological functions of NQO1, particularly the ability to regulate oncoprotein stability.</div></div><div id="sec4_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i7" class="anchor-spacer"></div><h3 class="article-section__title" id="_i7">4.2.  Irreversible Inhibitors</h3><div class="NLM_p">As described above, a number of well-established “‘off-target”’ effects limit the use of compound <b>2</b> in exploration of NQO1 function. The nature of competitive inhibition and ping-pong catalytic mechanism of NQO1 associated with other DIC derivatives also impedes their use in the evaluation of the activating or detoxifying properties of NQO1.</div><div class="NLM_p">To overcome these hurdles, an alternative approach was adopted to develop mechanism-based (suicide) inhibitors exemplified by indolequinone ES936 (<b>6</b>), whose <i>K</i><sub>i</sub> = 0.45 ± 0.7 μM and <i>k</i><sub>inact</sub> = 0.78 ± 0.12 min<sup>–1</sup>.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> The partition ratio (the number of inhibitor molecules released from the active site in relation to the number which remain to inactivate the enzyme) is a more significant parameter describing the mechanism-based inhibitor. The partition ratio for ES936 is 1.40 ± 0.03, suggesting that ES936 is a potent inhibitor of NQO1.<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a> Compound <b>6</b> was discovered serendipitously during the process of characterization of NQO1 substrates in the indolequinone series. In the mechanism of action, this compound irreversibly alkylates either Tyr126 or Tyr128 within the NQO1 active site after it undergoes reduction by NQO1 followed by loss of the 4-nitrophenoxy group, generating a reactive iminium intermediate (<a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a></a>).<a onclick="showRef(event, 'ref71'); return false;" href="javascript:void(0);" class="ref ref71">(71)</a> The plane of ES936 is parallel to the isoallozaxine ring of the FAD. Together, the 1- and 2-methyl and the bulky group at the indole 3-position support its deep insertion into the catalytic site. Enzyme–ES936 interactions are mostly hydrophobic contacts, with only one hydrogen bond formed between the O-7 of ES396 and Tyr 127′ (<a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a></a>).<a onclick="showRef(event, 'ref70'); return false;" href="javascript:void(0);" class="ref ref70">(70)</a></div><figure id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0006.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proposed mechanism for irreversible inhibition of NQO1 by ES936.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0007.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cocrystal structure of NQO1 apoenzyme with <b>6</b> bound to the active site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KBQ">1KBQ</a>). (A) Binding surface of <b>6</b> to the active site. (B) Detailed binding mode of <b>6</b>. Carbon atoms of FAD are shown in purple and <b>2</b> in yellow. Hydrogen bonds are represented by green dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>6</b> shows potent NQO1 inhibition and a growth inhibitory effect in the low nanomolar range in the human pancreatic cancer cell line MIA PaCa-2, implying a positive correlation between inhibition of NQO1 activity and anticancer activity.<a onclick="showRef(event, 'ref72'); return false;" href="javascript:void(0);" class="ref ref72">(72)</a> However, when a series of ES936-based indolequinones was synthesized and their structure–activity relationships (SAR) explored, no correlation was observed between the two variants in identical cancer cell lines. In fact, some analogues that are potent inhibitors of NQO1 are relatively ineffective inhibitors of cell proliferation, whereas those compounds that are poor inhibitors of NQO1 exhibit robust growth inhibitory effects.<a onclick="showRef(event, 'ref71 ref73'); return false;" href="javascript:void(0);" class="ref ref71 ref73">(71,73)</a> This suggests that other targets apart from NQO1, such as thioredoxin reductase need to be considered in order to understand the potent efficiency of this series of indolequinones in human pancreatic cancer cells.<a onclick="showRef(event, 'ref74'); return false;" href="javascript:void(0);" class="ref ref74">(74)</a></div><div class="NLM_p last">In addition to the indolequinones, 7-aminoquinoline-5,8-dione antibiotics (<b>7</b>, <b>8</b>) have been identified as NQO1 inhibitors. As with ES936 (<b>6</b>), <b>7</b> and <b>8</b> may irreversibly inhibit NQO1 activity due to the presence of effective leaving groups at the (quinoline-3-yl)methyl position that can be eliminated upon reduction of the quinone moiety by NQO1 followed by the formation of a iminium intermediate.<a onclick="showRef(event, 'ref75'); return false;" href="javascript:void(0);" class="ref ref75">(75)</a></div></div><div id="sec4_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8">4.3.  New Scaffolds of Competitive Inhibitors</h3><div class="NLM_p last">In the case of DIC (<b>2</b>) and ES936 (<b>6</b>), a better understanding of NQO1’s biological functions requires some new scaffolds for NQO1 inhibitors. Using compounds <b>2</b> and <b>6</b> for reference, Bian et al.<a onclick="showRef(event, 'ref76'); return false;" href="javascript:void(0);" class="ref ref76">(76)</a> recently identified compounds <b>9</b>–<b>11</b> with different chemical scaffolds as NQO1 inhibitors with IC<sub>50</sub> values of 0.92, 2.04, and 1.47 μM, respectively, through a shape-based similarity search and a second cascade docking filtering. By comparing the docked pose of <b>9</b> within the NQO1 active site to that of <b>2</b>, it was found that the general molecular orientation and the spatial location of <b>2</b> and <b>9</b> are very similar, and the modifications of fragments A and C in <b>9</b> possibly increased its affinity toward NQO1.<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a> Accordingly, SAR studies of <b>9</b> led to the discovery of several potent NQO1 inhibitors. In particular, <b>12</b> and <b>13</b> show more potent activity than <b>9</b> with inhibition rates of 89.2%, 99.6%, and 81.2% at 10 μM, respectively. Due to the superior aqueous solubility than that of <b>13</b>, compound <b>12</b> was selected for the design of an affinity-based probe (see <a class="ref internalNav" href="#sec6_2" aria-label="section 6.2">section 6.2</a>, below).</div></div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i9">5.  Bioreductive Substrates for NQO1</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_32154" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_32154" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Hydroquinones generated from the NQO1-mediated two-electron reduction of quinones are much more stable and readily conjugate with endogenous ligands, such as GSH and glucuronic acid, thereby facilitating their elimination. However, hydroquinones are not necessarily an innocuous species and in some cases can induce cancer cell death by any of three mechanisms: (i) chemical rearrangement leading to alkylation of DNA, (ii) oxidization back to parent quinones with production of significant amount of reactive oxygen species (ROS) which can directly cause DNA damage, and (iii) inhibition of heat shock protein (Hsp90) (<a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a></a>).<a onclick="showRef(event, 'ref77'); return false;" href="javascript:void(0);" class="ref ref77">(77)</a> In principle, NQO1-bioactivated anticancer agents can be classified into two types: (i) typical quinone substrates and (ii) quinone-containing prodrugs, where the quinone serves as the moiety for the targeted delivery of cytotoxic agents to prescribed sites.</div><figure id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0008.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Detoxification and activation pathways of quinones upon reduction by NQO1. ROS = reactive oxygen species; Hsp90 = heat shock protein 90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i10" class="anchor-spacer"></div><h3 class="article-section__title" id="_i10">5.1.  Typical Quinone Substrates</h3><div class="NLM_p">Numerous naturally occurring and synthetic quinone substrates have been reported and reviewed previously elsewhere.<a onclick="showRef(event, 'ref6 ref46'); return false;" href="javascript:void(0);" class="ref ref6 ref46">(6,46)</a> They are in different classes based on their structural skeletons and the most relevant compounds of each class are enumerated, followed by a summary of the mode of action, substrate specificity, and reported clinical data. On the basis of mechanism of action, they can be classified as DNA alkylators (<a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a></a>), protein inhibitors (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>), or redox cyclers (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>).</div><figure id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0009.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of NQO1-bioreductive agents that are converted into DNA alkylators upon reduction by NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec5_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11">5.1.1.  Indolequinones</h4><div class="NLM_p">MMC (<b>14</b>), isolated from <i>Streptomyces caespitosus</i> and considered to be an archetypical bioreductive alkylating agent, was produced commercially in Japan in 1958 but not approved for clinical use in the USA until 1974.<a onclick="showRef(event, 'ref78'); return false;" href="javascript:void(0);" class="ref ref78">(78)</a> Its cytotoxic mechanism is initiated by enzymatic reduction of the quinone moiety, followed by generation of electrophilic centers at C1 and C10 that can alkylate DNA causing the damage.<a onclick="showRef(event, 'ref79'); return false;" href="javascript:void(0);" class="ref ref79">(79)</a> Although it is clear that NQO1 is capable of activating <b>14</b>, the tumor response to <b>14</b> cannot be simply related to NQO1 levels, and many studies have failed to identify an association between the two variables.<a onclick="showRef(event, 'ref80'); return false;" href="javascript:void(0);" class="ref ref80">(80)</a> MMC has been shown to undergo activation by other enzymes, including NADPH:cytochrome P450 reductase (P-450R), xanthine oxidase (XO), NADPH:cytochrome b5 reductase (b-5R) and NAD(P)H:quinone oxidoreductase 2 (NQO2). This, together with the fact that the reduction of <b>14</b> by NQO1 is pH-dependent, suggests that <b>14</b> is a poor substrate for NQO1.<a onclick="showRef(event, 'ref81'); return false;" href="javascript:void(0);" class="ref ref81">(81)</a></div><div class="NLM_p">Despite a wide antitumor scope with effectiveness in many solid tumors, including gastric, pancreatic, breast, bladder, cervical, and bladder, the clinical application of <b>14</b> has been limited by its rapid clearance and cumulative and unpredictable toxic effects. Systemic use of <b>14</b> has decreased in the past decades, with the exception of its treatment of anal squamous cell carcinoma in combination with radiotherapy and 5-FU.<a onclick="showRef(event, 'ref82'); return false;" href="javascript:void(0);" class="ref ref82">(82)</a> Because <b>14</b> is generally not associated with multidrug resistance, extensive efforts in recent years have been focused on reducing its toxicity. In particular, a lipid-based prodrug of <b>14</b> (MLP) was prepared and formulated in long-circulating pegylated liposomes (PL-MLP, Promitil). Notably, this formulation demonstrates increased efficacy, improved pharmacokinetic profiles, and reduced toxicity in various tumor types when compared to the parent compound (<b>14</b>) and has recently entered into phase I study for advanced solid tumor patients (NCT01705002).<a onclick="showRef(event, 'ref83'); return false;" href="javascript:void(0);" class="ref ref83">(83)</a></div><div class="NLM_p">Apaziquone (<b>15</b>), originally known as EO9, was developed in the mid-1980s in a project sponsored by the Dutch Cancer Society (KWF Kankerbestrijding) at the University of Amsterdam.<a onclick="showRef(event, 'ref84'); return false;" href="javascript:void(0);" class="ref ref84">(84)</a> It is a simpler synthetic analogue of <b>14</b> with an aziridine directly attached to the indolequinone. Although <b>15</b> is structurally related to <b>14</b>, it exhibits better antitumor activity than <b>14</b> and no significant bone marrow toxicity was detected in animal toxicology studies.<a onclick="showRef(event, 'ref85'); return false;" href="javascript:void(0);" class="ref ref85">(85)</a></div><div class="NLM_p last">The mechanism of <b>15</b> has been extensively studied and is believed to involve three main pathways: (i) generation of ROS via redox cycling to cause DNA strand breaks following the reduction of quinone moiety of apaziquone by one-electron reductases, (ii) alkylation of DNA by electrophilic centers at the (indol-3-yl)methyl and the (indol-2-yl)methyl upon the reduction of quinone moiety by one-electron or two-electron reductases, and (iii) alkylation of DNA by opening of the aziridine ring after protonation.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Under aerobic conditions, NQO1-rich tumors are sensitive to <b>15</b> and a good correlation exists between NQO1 level and tumor sensitivity. However, under hypoxic conditions, one-electron reductases such as P-450R play a prominent role and tumors with low NQO1 level are sensitive to <b>15</b>. Compound <b>15</b> is therefore a unique bioreductive agent because it is able to target either the aerobic fraction of NQO1-rich tumors or the hypoxic fraction of NQO1-deficient tumors. Significantly, the capacity of <b>15</b> to target hypoxic cells suggests its potential utility in combination with radiotherapy.<a onclick="showRef(event, 'ref86'); return false;" href="javascript:void(0);" class="ref ref86">(86)</a> This compound has a chequered history progressing from the clinic to the laboratory and back again.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> Due to its outstanding antitumor profile and ability to avoid myelosuppression, <b>15</b> soon proceeded into clinical evaluation, but it was found that intravenous administration of <b>15</b> for advanced breast, gastric, pancreatic, colorectal, and nonsmall lung cancers in phase II studies failed to generate the desired response.<a onclick="showRef(event, 'ref87 ref88'); return false;" href="javascript:void(0);" class="ref ref87 ref88">(87,88)</a> This was ascribed to poor delivery to tumors caused by short half-life in circulation and poor penetration through avascular tissue. While these properties represent a serious problem in the treatment of systemic disease, there are, paradoxically, significant advantages in local therapies required for nonmuscle invasive bladder cancer (NMIBC). EOquin, a new formulation of <b>15</b> specially developed for intravesical administration, has entered clinical studies. Significant activity against NMIBC and no systemic side effects are observed when <b>15</b> is administered intravesically to marker lesions in multiple phase I/II studies.<a onclick="showRef(event, 'ref89 ref90 ref91'); return false;" href="javascript:void(0);" class="ref ref89 ref90 ref91">(89−91)</a> Spectrum Pharmaceuticals Inc. has recently completed two phase III clinical trials (NCT00461591 and NCT00598806) with <b>15</b>.<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a> These two trials did not reach statistically significant goals in the two-year recurrence rate between treatment and placebo arms when analyzed individually. When the results of the two trials were combined, however,<a onclick="showRef(event, 'ref92 ref93'); return false;" href="javascript:void(0);" class="ref ref92 ref93">(92,93)</a> statistical significance was obtained in both the two-year recurrence rate and time to recurrence. Posthoc analysis of the pooled data exhibits significant efficacy of <b>15</b>, especially when the administration of <b>15</b> is completed 30 min or more after surgery.<a onclick="showRef(event, 'ref92'); return false;" href="javascript:void(0);" class="ref ref92">(92)</a> The FDA’s Oncologic Drugs Advisory Committee questioned the validity of this statistical analysis and requested a further phase III trial to test the hypotheses arising from the completed studies.<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></div></div><div id="sec5_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12">5.1.2.  Diaziridinylbenzoquinones</h4><div class="NLM_p">Aziridine-substituted benzoquinones were among the earliest quinone-containing alkylating agents evaluated as potential anticancer drugs. The early representative compounds containing aziridine include triaziquone (<b>16</b>), carbazilquinone (<b>17</b>), and diaziquone (AZQ, <b>18</b>) that are NQO1 substrates and have been clinically evaluated. However, their clinical use was precluded for various reasons, including severe toxic side effects, undesirable pharmacokinetic properties, and lack of efficacy superior to that of existing chemotherapeutic agents.<a onclick="showRef(event, 'ref94'); return false;" href="javascript:void(0);" class="ref ref94">(94)</a></div><div class="NLM_p last">Studies of a large number of AZQ analogues led to the identification of MeDZQ (<b>19</b>), which has greater cytotoxicity to NQO1-rich tumors and a faster reduction rate by NQO1 than AZQ (<b>18</b>).<a onclick="showRef(event, 'ref95'); return false;" href="javascript:void(0);" class="ref ref95">(95)</a> However, <b>19</b> has not been clinically evaluated due to its low solubility. A more soluble diaziridinylbenzoquinone, RH1 (<b>20</b>), is rapidly taken up by cancer cells and induces preferential DNA cross-linking, cell cycle disturbance, and apoptosis in an NQO1-dependent manner.<a onclick="showRef(event, 'ref96'); return false;" href="javascript:void(0);" class="ref ref96">(96)</a> A study conducted using established isogenic cell line pairs demonstrated that RH1 can be effectively bioactivated by NQO1 both in vitro and in vivo.<a onclick="showRef(event, 'ref97'); return false;" href="javascript:void(0);" class="ref ref97">(97)</a> Preclinical studies demonstrated significant efficacy of RH1 in breast, colorectal, ovarian, and nonsmall cell lung cancer, Ewing’s sarcoma, and osteosarcoma xenograft models.<a onclick="showRef(event, 'ref98 ref99'); return false;" href="javascript:void(0);" class="ref ref98 ref99">(98,99)</a> Compound <b>20</b>, formulated in 20% cyclodextrin, was selected by Cancer Research UK (CR-UK) and NCI (NCT00558727) for a dose-escalation phase I clinical study in patients with advanced solid tumors, and it was found to be well tolerated with a maximum tolerated dose (MTD) of 1430 μg/m<sup>2</sup>/day.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> However, the paired tumor biopsy data show that DNA cross-linking can occur in the presence of relatively low levels of NQO1 activity and, conversely, that higher tumor NQO1 activity can be associated with relatively lower tumor DNA cross-linking.<a onclick="showRef(event, 'ref100'); return false;" href="javascript:void(0);" class="ref ref100">(100)</a> It is plausible that RH1 activation in vivo occurs at nontumor sites or that RH1 can be activated by non-NQO1 mechanisms such as p-450R<a onclick="showRef(event, 'ref101'); return false;" href="javascript:void(0);" class="ref ref101">(101)</a> and NQO2.<a onclick="showRef(event, 'ref102'); return false;" href="javascript:void(0);" class="ref ref102">(102)</a></div></div><div id="sec5_1_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13">5.1.3.  Benzoquinones Ansamycins</h4><div class="NLM_p">Heat shock protein 90 (Hsp90) is a molecular chaperone responsible for the ATP-dependent folding, maturation, stability, and function of a number of client proteins implicated in cancer progression. As a consequence, Hsp90 is an attractive drug target for cancer therapy because its inhibition has the potential for simultaneous interference of multiple oncogenic signaling proteins (<a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a></a>).<a onclick="showRef(event, 'ref103'); return false;" href="javascript:void(0);" class="ref ref103">(103)</a> Benzoquinone ansamycins including the quinone-containing polyketide antibiotics geldanamycin (GA, <b>21</b>), 17-(allylamino)-17-demethoxygeldanamycin (17-AAG, <b>22</b>), and 17-(dimethyl-aminoethylamino)-17-demethoxygeldanamycin (17-DMAG, <b>23</b>), represent the first-generation of Hsp90 inhibitors. This type of Hsp90 inhibitor competitively binds to the N-terminal ATP binding pocket of Hsp90, abolishing the ATPase activity, leading to the destabilization of oncogenic clients and the inhibition of tumor growth. As reported, the hydroquinone forms of benzoquinone ansamycins, formed by the metabolism of NQO1, are relatively stable and are more potent Hsp90 inhibitors than the parent compounds.<a onclick="showRef(event, 'ref104 ref105 ref106 ref107'); return false;" href="javascript:void(0);" class="ref ref104 ref105 ref106 ref107">(104−107)</a> Molecular modeling studies suggest that a number of hydrogen bond interactions are formed between the hydroquinone and the key residues within the ATP binding pocket of Hsp90, resulting in enhanced binding affinity for Hsp90 compared to the parent quinones.<a onclick="showRef(event, 'ref104 ref105'); return false;" href="javascript:void(0);" class="ref ref104 ref105">(104,105)</a> The benzoquinone ansamycins can also be reduced by one-electron reductases and can interact with glutathione (GSH). These reactions are correlated with toxicity, especially liver toxicity, because the liver contains high levels of one-electron reductases.<a onclick="showRef(event, 'ref108 ref109'); return false;" href="javascript:void(0);" class="ref ref108 ref109">(108,109)</a></div><figure id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0010.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Chemical structures of NQO1-bioreductive agents that are converted into Hsp90 inhibitors more potent than the parent compounds upon reduction by NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Compound <b>21</b> was first isolated from the mycelia and broth of <i>Streptomyces geldanus</i> in 1970 and is a prototypical benzoquinone ansamycin. This Hsp90 inhibitor acted as an important chemical probe with which to validate the druggability of Hsp90, with potent and broad anticancer properties. Despite its promise in preclinical studies, its use in clinical settings was terminated because of unacceptable hepatotoxicity.<a onclick="showRef(event, 'ref110'); return false;" href="javascript:void(0);" class="ref ref110">(110)</a></div><div class="NLM_p">17-AAG (tanespimycin, KOS953, <b>22</b>) shows good activity against a wide range of solid and hematologic malignancies in preclinical models and is the first Hsp90 inhibitor to enter clinical evaluation. It displays a decreased hepatotoxicity that is mediated by one-electron reductases and lower reactivity than <b>21</b> toward GSH at the C-19 position of the ansa ring.<a onclick="showRef(event, 'ref109'); return false;" href="javascript:void(0);" class="ref ref109">(109)</a> Compound <b>22</b> has completed multiple phase I/II clinical studies for various malignancies as a monotherapy and a combination therapy. The phase III clinical studies for patients with relapsed and refractory multiple myeloma (NCT00546780 and NCT00514371) have been reviewed elsewhere.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> However, <b>22</b> suffers from P-glycoprotein mediated multidrug resistance and formulation problems stemming from poor solubility and low bioavailability.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a></div><div class="NLM_p">In an attempt to simplify formulation, further efforts were undertaken by the NCI and led to the identification of 17-DMAG (alvespimycin, KOS-1022, <b>23</b>). Compound <b>23</b> has superior preclinical activities and displays reduced metabolic liability on NQO1 and improved formulation and pharmacokinetic properties.<a onclick="showRef(event, 'ref112'); return false;" href="javascript:void(0);" class="ref ref112">(112)</a> Significantly, this molecule is orally available, facilitating administration and probably increasing patient compliance during treatment. Thus, <b>23</b> has been investigated in multiple phase I clinical trials for many malignancies, as well as in phase II studies for patients with advanced leukemia.<a onclick="showRef(event, 'ref111'); return false;" href="javascript:void(0);" class="ref ref111">(111)</a> However, researchers at Kosan Biosciences discontinued the development of <b>23</b> due to its toxicity profile.</div><div class="NLM_p last">Infinity Pharmaceuticals, Inc., has published two more soluble GM analogues, IPI-504 (retaspimycin hydrochloride, <b>24</b>) and IPI-493 (<b>25</b>). Compound <b>24</b> is a highly soluble hydroquinone hydrochloride derivative of 17-AAG (<b>22</b>), and <b>22</b> and <b>24</b> can rapidly interconvert under redox conditions.<a onclick="showRef(event, 'ref107'); return false;" href="javascript:void(0);" class="ref ref107">(107)</a> There is evidence that NQO1 does not determine the activity of <b>24</b>.<a onclick="showRef(event, 'ref113'); return false;" href="javascript:void(0);" class="ref ref113">(113)</a> A phase III study of <b>24</b> for the treatment of nonsmall cell lung cancer and other solid tumors is currently in progress.<a onclick="showRef(event, 'ref114'); return false;" href="javascript:void(0);" class="ref ref114">(114)</a> Compound <b>25</b>, a metabolite of 17-AAG (<b>22</b>), is less sensitive and dependent on NQO1. Phase I clinical trials of <b>25</b> in patients for solid tumors were initiated in 2009,<a onclick="showRef(event, 'ref115'); return false;" href="javascript:void(0);" class="ref ref115">(115)</a> but no further developments have been reported.</div></div><div id="sec5_1_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14">5.1.4.  Quinolinequinones</h4><div class="NLM_p">Streptonigrin (STN, <b>26</b>) is a naturally occurring quinolinequinone antibiotic that was first isolated from the broth of <i>Streptomyces flocculus</i> by Rao and Cullen in 1959.<a onclick="showRef(event, 'ref116'); return false;" href="javascript:void(0);" class="ref ref116">(116)</a> This is a moderate NQO1 substrate, causing DNA and chromosome damage via a redox cycling process.<a onclick="showRef(event, 'ref47'); return false;" href="javascript:void(0);" class="ref ref47">(47)</a> Structurally, the 5,8-quinolinedione moiety in <b>26</b> is essential for its cytotoxicity and can be reduced by NQO1<a onclick="showRef(event, 'ref117'); return false;" href="javascript:void(0);" class="ref ref117">(117)</a> and/or one-electron reductases<a onclick="showRef(event, 'ref118'); return false;" href="javascript:void(0);" class="ref ref118">(118)</a> to a hydroquinone or semiquinone intermediate, respectively. Either form spontaneously reverts back to the parent compound in the presence of molecular oxygen accompanied by generation of superoxide anions (O<sub>2</sub><sup>•–</sup>), which can be converted to hydrogen peroxide (H<sub>2</sub>O<sub>2</sub>). Hydrogen peroxide can be reduced to hydroxyl radical (·OH) via a metal-catalyzed Fenton reaction. The hydroxyl radical is ultimately responsible for the DNA degradation. Compound <b>26</b> was studied in clinical trials in the 1960s and 1970s but was discontinued due to severe and prolonged myelosuppression.<a onclick="showRef(event, 'ref119'); return false;" href="javascript:void(0);" class="ref ref119">(119)</a></div><div class="NLM_p">Lavendamycin (<b>27</b>), originally isolated in 1982 from <i>Streptomyces lavendulae</i> by Balitz et al.<a onclick="showRef(event, 'ref120'); return false;" href="javascript:void(0);" class="ref ref120">(120)</a> is structurally and biosynthetically similar to <b>26</b> (<a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a></a>). While <b>27</b> is not suitable for clinical development due to its low aqueous solubility and high degree of toxicity, its analogues with less toxicity and improved solubility should have potential as anticancer agents. Some of these, e.g., compounds <b>28</b>–<b>30</b>, can be metabolized quickly by recombinant human NQO1 in vitro and show more toxicity toward the BE-NQ human colon adenocarcinoma cell lines that are transfected with NQO1 than to the BE-WT (NQO1-deficient) cell lines.<a onclick="showRef(event, 'ref45 ref48 ref121'); return false;" href="javascript:void(0);" class="ref ref45 ref48 ref121">(45,48,121)</a></div><figure id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0011.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of NQO1-bioreductive agents that are converted into redox cyclers upon reduction by NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec5_1_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15">5.1.5.  Naphthoquinones</h4><div class="NLM_p">Structurally, the NQO1 substrates discussed above are all <i>p</i>-quinones. The known <i>o</i>-quinone substrates for NQO1 are limited to three natural naphthoquinones, β-lapachone (β-lap, <b>31</b>), tanshinone IIA (Tan IIA, <b>32</b>), and dunnione (<b>33</b>), and their synthetic analogues.</div><div class="NLM_p">β-Lapachone (<b>31</b>), a tetrahydropyran-fused <i>o</i>-naphthoquinone first isolated from the bark of the Lapacho tree (genus <i>Tabebuia</i>) native to South America, has received considerable attention due to its wide variety of pharmacological properties, which include anti-infective, anti-inflammatory, and particularly outstanding anticancer effects.<a onclick="showRef(event, 'ref122'); return false;" href="javascript:void(0);" class="ref ref122">(122)</a> The cytotoxicity of <b>31</b> was originally hypothesized to impede DNA damage repair due to inhibition of topoisomerases.<a onclick="showRef(event, 'ref123'); return false;" href="javascript:void(0);" class="ref ref123">(123)</a> It is now known that it is a specific NQO1 substrate, and many valuable models have been utilized to research its cytotoxic mechanism. In isogenic cell line pairs, isogenically matched NQO1-deficient cancer cells were resistant to <b>31</b>, while NQO1-containing cells were sensitive to <b>31</b>.<a onclick="showRef(event, 'ref122 ref124 ref125'); return false;" href="javascript:void(0);" class="ref ref122 ref124 ref125">(122,124,125)</a> Heat and radiation upregulate the NQO1 level, enhancing the anticancer activity of <b>31</b> in both cultured and xenografted tumors.<a onclick="showRef(event, 'ref126 ref127 ref128'); return false;" href="javascript:void(0);" class="ref ref126 ref127 ref128">(126−128)</a> Furthermore, lethality induced by <b>31</b> could be significantly inhibited by NQO1 inhibitor <b>2</b> or be limited by knockdown of NQO1 via siRNA. Together, the cytotoxicity of <b>31</b> is predominately determined by the metabolic activation of NQO1.</div><div class="NLM_p"><b>31</b> is reduced by NQO1 to the corresponding hydroquinone and rapidly autoxidized back to the parent quinone through the semiquinone intermediate, allowing for a futile redox cycle which consumes ∼60 mol equivalents of NAD(P)H and produces ∼120 mol equivalents of O<sub>2</sub><sup>–•</sup>, which are rapidly transformed into H<sub>2</sub>O<sub>2</sub> by superoxide dismutase (SOD).<a onclick="showRef(event, 'ref124 ref129'); return false;" href="javascript:void(0);" class="ref ref124 ref129">(124,129)</a> Most solid tumors have a higher NQO1 expression than surrounding normal tissues, particularly >85% of nonsmall cell lung cancer, have NQO1 at levels of 10–50-fold above normal tissues, ∼85% pancreatic cancer at levels of 10–100-fold, ∼60% prostate and breast cancer at levels of 5–100-fold, but with a low level of catalase (CAT), the reverse of normal tissues.<a onclick="showRef(event, 'ref15 ref16 ref130 ref131 ref132'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref130 ref131 ref132">(15,16,130−132)</a> As a consequence, the resulting H<sub>2</sub>O<sub>2</sub> is long-lived and rapidly diffuses into the nucleus, leading to oxidative base and DNA single-strand breaks (SSB), intracellular Ca<sup>2+</sup> increase,<a onclick="showRef(event, 'ref133 ref134'); return false;" href="javascript:void(0);" class="ref ref133 ref134">(133,134)</a> poly(ADP-ribose)polymerase-1 (PARP-1) hyperactivation, NAD+/ATP depletion, and ultimately cell death as a form of programmed necrosis, known as NAD<sup>+</sup>-Keresis.<a onclick="showRef(event, 'ref15 ref130 ref135 ref136 ref137 ref138'); return false;" href="javascript:void(0);" class="ref ref15 ref130 ref135 ref136 ref137 ref138">(15,130,135−138)</a> It is important to note that cell death mediated by <b>31</b> is driven by nuclear translocation of apoptosis-inducing factor (AIF),<a onclick="showRef(event, 'ref139'); return false;" href="javascript:void(0);" class="ref ref139">(139)</a> and activation of μ-calpain,<a onclick="showRef(event, 'ref15 ref124 ref140'); return false;" href="javascript:void(0);" class="ref ref15 ref124 ref140">(15,124,140)</a> as well as inhibition of glyceraldehyde 3-phosphate dehydrogenase (GAPDH)/glycolysis and oxidative phosphorylation (OXPHOS),<a onclick="showRef(event, 'ref136 ref137 ref141'); return false;" href="javascript:void(0);" class="ref ref136 ref137 ref141">(136,137,141)</a> which is independent of p53, caspase, cell cycle status, oncogenic driver, and pro- or antiapoptotic proteins, implying great potential for circumvention of drug resistance.<a onclick="showRef(event, 'ref130 ref131 ref136 ref137 ref141 ref142'); return false;" href="javascript:void(0);" class="ref ref130 ref131 ref136 ref137 ref141 ref142">(130,131,136,137,141,142)</a> Few drugs can harness such cell death responses in a tumor-specific manner at clinically achievable doses, while cancer cells with >100 units of NQO1 catalytic activity are extremely sensitive to <b>31</b> with normal tissues intact.<a onclick="showRef(event, 'ref143'); return false;" href="javascript:void(0);" class="ref ref143">(143)</a></div><div class="NLM_p"><b>31</b> takes advantage of the elevated NQO1:CAT ratios to elicit selective killing toward many solid tumors, especially refractory pancreatic, prostate, breast, and nonsmall cell lung cancer.<a onclick="showRef(event, 'ref15 ref16 ref130 ref132 ref137 ref141'); return false;" href="javascript:void(0);" class="ref ref15 ref16 ref130 ref132 ref137 ref141">(15,16,130,132,137,141)</a> Importantly, in drug-resistant triple-negative breast cancers, Cao et al.<a onclick="showRef(event, 'ref130'); return false;" href="javascript:void(0);" class="ref ref130">(130)</a> found that <b>31</b>-mediated bystander effects could accomplish higher efficacy via killing both NQO1-rich and adjacent heterogeneous NQO1-deficient tumors, while normal tissues are protected by their low NQO1:CAT ratio. On the other hand, <b>31</b> can also induce NQO1-independent cytotoxicity in NQO1-null or NQO1-rich cancer cells treated with DIC (<b>2</b>) at higher concentrations and with prolonged exposure. This may be related to the elevated oxidative stress arising from one-electron reduction by other enzymes, such as P-450R and b-5R,<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> or from nonenzymatic catalyzed two-electron reduction.<a onclick="showRef(event, 'ref144'); return false;" href="javascript:void(0);" class="ref ref144">(144)</a></div><div class="NLM_p">Despite its therapeutic promise, the (pre)clinical evaluation of <b>31</b> has been largely hampered by its poor solubility (0.038 mg/mL), short half-life in vivo (blood <i>t</i><sub>1/2</sub> = 24 min), and narrow therapeutic window resulting from methemoglobinemia.<a onclick="showRef(event, 'ref145 ref146 ref147'); return false;" href="javascript:void(0);" class="ref ref145 ref146 ref147">(145−147)</a> In an effort to overcome these undesirable properties, active research has been directed to the prodrug strategy combined with specific types of delivery systems.<a onclick="showRef(event, 'ref148'); return false;" href="javascript:void(0);" class="ref ref148">(148)</a> In the design of β-lap prodrugs, a Schiff’s base leaving group was engineered, leading to a series of nontoxic and inactive mono(arylimino) derivatives of β-lap such as <b>34</b>, which undergoes hydrolysis to release active β-lap under acidic conditions.<a onclick="showRef(event, 'ref149'); return false;" href="javascript:void(0);" class="ref ref149">(149)</a> The hydroquinone analogue of <b>31</b> complexed with hydroxypropyl β-cyclodextrin (HPβ-CD), i.e., the clinical forms ARQ501 and ARQ761, have entered into multiple phase I/II clinical trials as monotherapies for patients with various cancer types and also in combination with other cytotoxic drugs.<a onclick="showRef(event, 'ref150 ref151 ref152 ref153'); return false;" href="javascript:void(0);" class="ref ref150 ref151 ref152 ref153">(150−153)</a> While increased aqueous solubility and tumor response were observed, these studies were limited due to hemolytic anemia and rapid clearance caused by the HPβ-CD carrier and the dose-limiting methemoglobinemia and nonspecific distribution. Further efforts have employed nanotherapeutic delivery vehicles, such as poly(ethylene glycol)-<i>block</i>-poly(D,<span class="smallcaps smallerCapital">l</span>-lactide) (PEG–PLA) polymer micelles,<a onclick="showRef(event, 'ref145 ref154 ref155'); return false;" href="javascript:void(0);" class="ref ref145 ref154 ref155">(145,154,155)</a> gold nanoparticles,<a onclick="showRef(event, 'ref156'); return false;" href="javascript:void(0);" class="ref ref156">(156)</a> polymer millirods,<a onclick="showRef(event, 'ref157'); return false;" href="javascript:void(0);" class="ref ref157">(157)</a> and superparamagnetic iron oxide nanoparticles.<a onclick="showRef(event, 'ref158'); return false;" href="javascript:void(0);" class="ref ref158">(158)</a> On the basis of the unique mechanism associated with <b>31</b>, strategies were carried out combining radiotherapy<a onclick="showRef(event, 'ref15 ref16'); return false;" href="javascript:void(0);" class="ref ref15 ref16">(15,16)</a> or other anticancer drugs that act on cancer-specific NADPH-biogenesis pathways but lack tumor selectivity and adequate efficiency when serving as a single agent.<a onclick="showRef(event, 'ref138 ref159'); return false;" href="javascript:void(0);" class="ref ref138 ref159">(138,159)</a> These include various PARP inhibitors,<a onclick="showRef(event, 'ref137'); return false;" href="javascript:void(0);" class="ref ref137">(137)</a> base excision repair (BER) inhibitor methoxyamine,<a onclick="showRef(event, 'ref135'); return false;" href="javascript:void(0);" class="ref ref135">(135)</a> nicotinamidephospho-ribosyltransferase (NAMPT) inhibitor FK866,<a onclick="showRef(event, 'ref136 ref160'); return false;" href="javascript:void(0);" class="ref ref136 ref160">(136,160)</a> and mitochondrial glutaminase 1 (GLS1) inhibitor CB839.<a onclick="showRef(event, 'ref161'); return false;" href="javascript:void(0);" class="ref ref161">(161)</a> These agents share a distinct but highly complementary mechanism of action with <b>31</b>, affording a synergistic effect which reduces required doses and treatment times for both agents, enhances their efficacy, and expands the therapeutic window.</div><div class="NLM_p">Tan IIA (<b>32</b>) is a natural <i>o</i>-naphthoquinone occurring abundantly in the rhizome of the Chinese herb <i>Salvia miltiorrhiza Bunge</i> (Danshen). It exhibits significant cytotoxicity against a wide range of human cancers in a broad concentration range from submicromolar to high micromolar. Recently, it has been found to be a specific NQO1 substrate with a metabolic activation mechanism similar to that of <b>31</b> that initiates a p53-independent but caspase-dependent mitochondrial apoptotic pathway relying on NQO1-mediated ROS production.<a onclick="showRef(event, 'ref162'); return false;" href="javascript:void(0);" class="ref ref162">(162)</a></div><div class="NLM_p last">You et al.<a onclick="showRef(event, 'ref163'); return false;" href="javascript:void(0);" class="ref ref163">(163)</a> first hybridized <b>32</b> and <b>31</b>, generating the scaffold of 3-methylnaphtho[1,2-<i>b</i>]furan-4,5-dione. By analysis of the binding mode with NQO1, a series of L-shaped <i>o</i>-quinone analogues derived from this hybrid scaffold have been prepared and could occupy the side binding pocket by interacting with residues Tyr128, Phe232, Phe236, and His194. Compound (<b>35)</b> was found to be an efficient substrate for NQO1 and to exert cytotoxicity through NQO1-driven ROS production with tumor selectivity and safety better than that of <b>31</b>. Unfortunately, <b>35</b> is even less soluble than <b>31</b> (0.021 and 0.038 mg/mL, respectively). To identify more drug-like molecules, another new scaffold of naphtho[2,1-<i>d</i>]oxazole-4,5-dione with improved solubility was produced by incorporating a variety of water-soluble side chains.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> The most soluble and promising compound in this series, <b>36</b>, displays significant activity in NQO1-expressing cancer cells and in tumor xenograft mouse models.<a onclick="showRef(event, 'ref164'); return false;" href="javascript:void(0);" class="ref ref164">(164)</a> As mentioned above, the NQO1 specific activity of <b>31</b> is limited to a relatively narrow concentration range and exposure time, possibly because it is metabolized by one-electron reductases, especially P-450R.<a onclick="showRef(event, 'ref140'); return false;" href="javascript:void(0);" class="ref ref140">(140)</a> The same group yielded diversified β-lap-inspired scaffolds in an attempt to obtain novel quinone compounds and reduce the nonspecific ROS production by P-450R.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> A specific substrate (<b>37</b>) was identified, affording a much higher selectivity toward NQO1 versus P-450 than that of <b>31</b> with selectivity ratios of 6.37 and 1.36, respectively, indicating a superior safety profile. Docking analysis has suggested that aside from the π-stacking of the isoalloxazine moiety of FAD, other factors contribute to its excellent performance. These include hydrogen bonding interactions between two carbonyl groups and Tyr126 and Tyr128 residues that were similar to hydrogen bonds in <b>31</b>, and additional C–H···π interactions formed by the 7,8-dimethyl groups of <b>37</b> with Trp105 and Phe178 residues.<a onclick="showRef(event, 'ref165'); return false;" href="javascript:void(0);" class="ref ref165">(165)</a> An L-shape type of nitrogen-containing chain was attached to the C2 position of <b>37</b>, resulting in the more effective and selective NQO1 substrate <b>38</b>.<a onclick="showRef(event, 'ref166'); return false;" href="javascript:void(0);" class="ref ref166">(166)</a> The naturally occurring tetrahydrofuran fused <i>o</i>-naphthoquinone(±)-dunnione (<b>33</b>) has been recently identified by the same group as an efficient NQO1 substrate, and the mechanism of action of the cytotoxicity was found to involve NQO1-dependent ROS production.<a onclick="showRef(event, 'ref167'); return false;" href="javascript:void(0);" class="ref ref167">(167)</a></div></div><div id="sec5_1_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16">5.1.6.  Diazaanthraquinones</h4><div class="NLM_p">Deoxynyboquinone (DNQ, <b>39</b>) was originally synthesized in 1961 during a study of the natural antibiotic nybomycin and more recently was found to be a natural product present in a deep-sea <i>Actinomycete Pseudonocardia</i> sp. SCSIO 01299 in 2011.<a onclick="showRef(event, 'ref168'); return false;" href="javascript:void(0);" class="ref ref168">(168)</a> Compound <b>39</b> was found to possess potent antitumor activity in vitro and in vivo, which is dependent on quantities of toxic ROS produced by NQO1-catalyzed redox cycling.<a onclick="showRef(event, 'ref47 ref77'); return false;" href="javascript:void(0);" class="ref ref47 ref77">(47,77)</a> While DNQ <b>39</b> killed cancer cells by inducing a PARP-1 hyperactivation-mediated programmed necrosis pathway identical to that produced by <b>31</b>, <b>39</b> is about 20–100-fold more potent than <b>31</b>, with a dramatically expanded therapeutic window, longer in vivo half-life, and enhanced metabolic stability in intact hepatocytes in vitro, albeit with more severe dose-limiting methemaglobinemia than <b>31</b>.<a onclick="showRef(event, 'ref169'); return false;" href="javascript:void(0);" class="ref ref169">(169)</a></div><div class="NLM_p last">According to the documented cocrystal structure, a good relationship exists between the NQO1 processing activity and the distance between the N5 of FAD and carbon α to the quinone carbonyl in the substrate, with compounds that have a shorter predicted “hydride donor–acceptor distance” in computational docking proving to be better NQO1 substrates.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Guided by this rule, a diverse set of DNQ derivatives with a range of NQO1 processing activities were reported by Parkinson et al.<a onclick="showRef(event, 'ref47 ref77'); return false;" href="javascript:void(0);" class="ref ref47 ref77">(47,77)</a> Results show that the anticancer activity of these DNQ derivatives was strongly correlated with NQO1 processing ability. The compounds that behave as excellent NQO1 substrates are also potent cancer cell death inducers. In the presence of DIC (<b>2</b>), the cell death induced by compounds that are better NQO1 substrates diminishes to a greater extent. In particular, the pharmacokinetic and toxicological data of isobutyldeoxy-nyboquinone (IB-DNQ, <b>40</b>) in the domestic felid species are promising and support further development of IB-DNQ as an anticancer agent targeting NQO1-expressing cancers.<a onclick="showRef(event, 'ref170'); return false;" href="javascript:void(0);" class="ref ref170">(170)</a> Significantly, DNQs serving as model compounds clearly show that there is a strong correlation between NQO1 processing ability and anticancer activity.</div></div><div id="sec5_1_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17">5.2.2.  Quinone-Containing Prodrugs</h4><div class="NLM_p">Indolequinone-based prodrugs have received considerable attention because they can avoid the toxic effects of the parent drugs and indolequinone moieties can efficiently detach parent drugs from the (indol-3-yl)methyl position upon reduction by NQO1. The indolequinone structure itself can be converted to an electrophilic iminium intermediate, which can also induce cytotoxicity to cancer cells, thereby triggering a synergistic effect with the parent drug. Representative indolequinone-based prodrugs are shown in <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a></a>.</div><figure id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0012.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. NQO1-activated prodrugs. The trigger group that can be activated by NQO1 is shown in red, the linker in blue, and the parent drug in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">Camptothecin (CPT) attached at the C3 position of the indolequinone nucleus through an <i>N</i>,<i>N</i>′-dimethyl-1-aminoethylcarbamate linker affords the water-soluble prodrug <b>41</b>.<a onclick="showRef(event, 'ref171'); return false;" href="javascript:void(0);" class="ref ref171">(171)</a> This CPT prodrug is an efficient substrate for NQO1 and exhibits much lower toxic effects and higher hypoxia selectivity than the parent drug. Molecule <b>42</b> with oridonin attached at the indolequinone nucleus via an ester linkage exhibits potent anticancer activity in NQO1-rich tumor cells and in a liver cancer xenograft mouse model.<a onclick="showRef(event, 'ref172'); return false;" href="javascript:void(0);" class="ref ref172">(172)</a> This induced NQO1-dependent apoptosis proceeds through a ROS-triggered mitochondrial apoptotic pathway. An indolequinone-diazeniumdiolate (<b>43</b>) was reported to release NO upon metabolism by NQO1 and shows significant antiproliferative activity in NQO1-expressing cancer cells.<a onclick="showRef(event, 'ref173'); return false;" href="javascript:void(0);" class="ref ref173">(173)</a> Huang et al.<a onclick="showRef(event, 'ref174'); return false;" href="javascript:void(0);" class="ref ref174">(174)</a> reported a highly cancer-targeting prodrug (<b>44</b>) containing moieties of a therapeutic drug SN38 (7-ethyl-10- hydroxycamptothecin), an indolequinone structure, and an α<sub>v</sub>β<sub>3</sub> integrin-targeting cyclic peptide RGDyK. Compound <b>44</b> was found to target α<sub>v</sub>β<sub>3</sub> integrins, releasing the drug SN38 in the presence of NQO1.</div></div></div></div><div id="sec6" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i18">6.  NQO1 and Cancer Detection</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_65022" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_65022" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Achieving highly selective and sensitive detection or visualization of cancer-associated events and targets is invaluable for reliable early cancer diagnosis, the collection of temporal and spatial information about tumor microenvironment, exploration of cellular machinery of the disease, and optimization of surgical and personalized chemotherapeutic treatments. Despite its great significance, it remains a challenging task. First, it is necessary to identify a cancer specific trait, a biomarker that is stable and dependable and not shared with normal cells. Second, development of rapid and highly sensitive reporter systems or probes is required to specifically monitor the trait. Enzyme NQO1 is such a biomarker, given the fact that it is upregulated in many solid tumors relative to the normal counterparts and its activity is strongly affected by the life cycle of cancer cells. To date, a number of NQO1 activity-based and affinity-based optical probes have been successfully developed for detection and cellular imaging of NQO1.</div><div id="sec6_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19">6.1.  Activity-Based Probes</h3><div class="NLM_p">Enzyme-activated, or “turn-on” probes can generate rapid, highly sensitive, and selective signals associated with cancer cells, and this type of probe has seen growing interest. In the case of NQO1, the explored probes are commonly composed of a quinone-based enzyme substrate as a trigger group and a dye as a reporter, two moieties directly bonded or bridged by a linker. The intense fluorescent reporter signature of these probes is unveiled upon the specific activation of the quinone moiety by NQO1, as described below (<a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig13" id="" class=" internalNav">13</a></a>).</div><figure id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0013.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. NQO1-activated fluorescent probes. The trigger group is present in red, the linker in blue, and the dye in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div id="sec6_1_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20">6.1.1.  Fluorescent Probes</h4><div class="NLM_p">The trimethyl-locked quinone propionic acid (Q3PA) has been extensively used as the trigger group because of its rapid and highly selective reduction by NQO1 and the subsequent facile intramolecular lactonization which releases the reporter group rapidly.<a onclick="showRef(event, 'ref38'); return false;" href="javascript:void(0);" class="ref ref38">(38)</a> Rhodamines have been a favored choice in fluorescent probe-based applications. McCarley et al.<a onclick="showRef(event, 'ref175'); return false;" href="javascript:void(0);" class="ref ref175">(175)</a> reported an activatable probe (<b>45</b>) consisting of a Q3PA trigger group and an <i>N</i>-morpholino-capped rhodamine, named MorphR110. The intense fluorescence of <b>45</b> is not revealed until the Q3PA is reduced by hNQO1, followed by the lactonize-and-release sequence. While <b>45</b> is very sensitive to the presence of purified hNQO1 in solution under physiological conditions, it fails to image NQO1-positive cancer cells. This is possibly due to the remarkable decrease in the fluorescence and absorbance of the reporter (MorphR110) upon its reaction with NADH. The same group discovered a seminaphthorhodamine compound (MJSNR) with excellent photophysical properties and stability in the presence of NADH.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a> They constructed the turn-on probe (<b>46</b>) in which MJSNR is attached to Q3PA. Although the positive-to-negative ratios (PNR) upon exposure to cancer cells is not high, <b>46</b> possesses some desirable characteristics, including rapid uptake and turn-on and high selectivity with respect to potential chemical or enzymatic interference.<a onclick="showRef(event, 'ref176'); return false;" href="javascript:void(0);" class="ref ref176">(176)</a></div><div class="NLM_p">Such pioneering work has inspired extensive efforts for the development of a variety of NQO1-responsive, turn-on fluorescence probes. McCarley et al.<a onclick="showRef(event, 'ref28 ref177'); return false;" href="javascript:void(0);" class="ref ref28 ref177">(28,177)</a> developed two quenched probes (<b>47</b>, <b>48</b>) based on naphthalimide, whose fluorescence is efficiently masked by photoinduced electron transfer (PeT) quenching arising from the covalently attached Q3PA, a quencher subunit. Upon activation of Q3PA and subsequent detachment, the reporter naphthalimide can be dequenched and exhibits highly intense and Stokes-shifted emission due to the push–pull internal charge-transfer (ICT) mechanism of the naphthalimide scaffold. The difference in chemical structural between the two probes lies only in the linker between Q3PA and fluorescent dye. The probe (<b>48</b>) contains a shorter electron-donating linker in contrast to the electron-drawing carbamate-based linking unit in probe <b>47</b>. For probe <b>48</b>, this produces a greater increase in brightness for reporter versus a probe that achieves a higher PNR value upon exposure to cancer cells and a more efficient NQO1 catalytic efficiency, which in turn results in a faster release of free reporter.<a onclick="showRef(event, 'ref177'); return false;" href="javascript:void(0);" class="ref ref177">(177)</a> More importantly, these two probes, especially probe <b>48</b>, which generates a green energy-range reporter upon activation, can readily penetrate the membrane of human cancer cells and allow discrimination between NQO1-positive and NQO1-negative cancer cell lines by the naked eye without influence on cell viability in the longer-term cellular studies. This highlights the feasibility of the application to living-cell imaging.<a onclick="showRef(event, 'ref28 ref177'); return false;" href="javascript:void(0);" class="ref ref28 ref177">(28,177)</a> A self-eliminating linker <i>N</i>-methyl-<i>p</i>-aminobenzyl alcohol (NMPABA) was used by the McCarley group to generate a tripartite quenched fluorophore Q3PA-naphthalimide (<b>49</b>).<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> Interestingly, reduced Q3PA is rapidly detached from the linker NMPABA, which subsequently undergoes degradation to release naphthalimide. This reporter possesses highly intense, red-shifted fluorescence emission, and NQO1-positive cancer cells can be imaged and identified with a PNR value of 500:1.</div><div class="NLM_p">Near-infrared (NIR) probes are ideal tools for in vivo imaging as this type of probe offers deep tissue penetration and low background fluorescence. McCarley et al.<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> reported an NIR triggerable probe (<b>50</b>) in which Q3PA was attached to tricarbocyanine (TCy) by a self-degrading linker, 2-mercaptoethanol, through a carbamate to the amine of TCy. The fluorescence of <b>50</b> is greatly increased after the activation of Q3PA and the linker self-cleavage with unprecedented, catalytically efficient formation of a fluorescent reporter. Significantly, although it requires a special camera,<a onclick="showRef(event, 'ref30 ref31'); return false;" href="javascript:void(0);" class="ref ref30 ref31">(30,31)</a> this probe provides high-fidelity detection and visualization of endogenous intracellular NQO1 activity in 2D or 3D cancer cell cultures and in a preclinical in vivo model of peritoneally disseminated ovarian cancer.</div><div class="NLM_p last">Fei et al.<a onclick="showRef(event, 'ref178'); return false;" href="javascript:void(0);" class="ref ref178">(178)</a> synthesized another profluorophore (<b>51</b>) by conjugating Q3PA with a red fluorescent dye OH-BODIPY via a self-degrading linker, <i>p</i>-aminobenzyl alcohol. A polymeric micelle assembly was employed to encapsulate this profluorophore (<b>51</b>), leading to a nanoprobe with enhanced solubility, photostability, and biocompatibility. More importantly, this nanoprobe has been successfully utilized for discriminative imaging of NQO1-positive cells via favorable ratiometric measurement of NQO1 activity.</div></div><div id="sec6_1_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21">6.1.2.  Theranostic Prodrug</h4><div class="NLM_p">Theranostic prodrugs, as the name suggests, possess the dual-function of diagnosis and therapy. This type of drug has emerged as an invaluable technology in biomedicine. An NQO1-activable theranostic prodrug (<b>52</b>) was constructed by Liu et al.<a onclick="showRef(event, 'ref179'); return false;" href="javascript:void(0);" class="ref ref179">(179)</a> The trigger group and fluorescence quencher Q3PA is conjugated via a self-cleavable linker <i>p</i>-aminobenzyl alcohol to an anticancer drug CPT that also serves as a fluorescent dye. Free CPT was released, and its fluorescence was recovered by dequenching from Q3PA. In this way, this prodrug can not only detect NQO1 activity and provide the feedback in real-time on quinone reduction and drug release but also selectively kill cancer cells with overexpressed NQO1. In an effort to further enhance the cancer-targeting property, Shin et al.<a onclick="showRef(event, 'ref180'); return false;" href="javascript:void(0);" class="ref ref180">(180)</a> disclosed a tumor-targeting enzyme-triggered theranostic prodrug (<b>53</b>) that is composed of three moieties, a therapeutic drug SN38, Q3PA, and a cancer-targeting unit, biotin. Upon preferential uptake by cancer cells with the aid of biotin, <b>53</b> is cleaved by NQO1 accompanied by the release of SN38, inducing cancer cell apoptosis (<a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig14" id="" class=" internalNav">14</a></a>). Simultaneously, the drug release and apoptosis of cancer cells expressing both biotin receptors and high levels of NQO1 was imaged and monitored via the native fluorescence of the free SN38. This type of enzyme-triggered targeted prodrug therapy is a promising approach for future cancer treatment.</div><figure id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0014.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. NQO1-activated theranostic prodrugs. The trigger group is present in red, the linker in blue, and the dye in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec6_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22">6.2.  Affinity-Based Probes</h3><div class="NLM_p">An affinity-based small-molecule probe <b>54</b> was developed by linking the NQO1 inhibitor (<b>12</b>) as the recognition group and fluorescein isothiocyanate (FITC) with an aliphatic amine. This probe demonstrates good inhibitory activity against NQO1 and has been successfully exploited to label the enzyme in lung adenocarcinoma A549 cells that have robust expression of NQO1 at micromolar concentrations (<a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">Figure <a data-tab="pane-pcw-Figures" href="#fig15" id="" class=" internalNav">15</a></a>).<a onclick="showRef(event, 'ref49'); return false;" href="javascript:void(0);" class="ref ref49">(49)</a></div><figure id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0015.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. An affinity-based probe. The trigger group is present in red, the linker in blue and the dye in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div></div><div id="sec7" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i23">7.  Conclusion and Outlook</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_80736" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_80736" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">A major goal in current cancer therapy is to improve selectivity for cancer cells over that of normal cells. One approach to achieve this is targeting a specific trait peculiar to cancer cells. Due to its well-documented overexpression in many human cancers together with its bioactivation of certain quinone substrates, NQO1 is considered as a desirable target for cancer therapy. To date, NQO1 inhibitors and chemotherapeutic quinones with different chemotypes are available for further exploration of NQO1 as a therapeutic target for cancer therapy. However, some critical issues remain to be resolved. While RNAi-mediated silencing of NQO1 has provided strong evidence to support the promotional effect of NQO1 in cancer development, studies with the currently available NQO1 inhibitors have been unsuccessful and translating this approach into clinical trials is currently problematic. It is unknown whether this is just due to the ineffectiveness of the NQO1 inhibitors utilized. To date, only a limited number of NQO1 inhibitors have been reported. Most of them suffer some limitations such as selectivity issues and the high concentrations required for inhibition. Many important aspects of NQO1 function in cancer are not completely understood. For example, why NQO1 is overexpressed in tumors and whether NQO1 is the main driver of the cancer are still questions. Therefore, there is an urgent need for the development of highly potent and selective NQO1 inhibitors in order to further probe the NQO1 biology and validate the druggability of NQO1, proceeding beyond RNAi knockdown studies.</div><div class="NLM_p">Personalized medicine means more efficient and effective disease diagnosis and treatment because this strategy enables the preselection of cancer patients based on molecular biomarkers and utilization of drugs whose therapeutic efficiency can be predicted. NQO1 is an ideal target in this regard, given its overexpression in many solid tumors coupled with existing diagnostic tests for NQO1 polymorphism and overexpression. However, the development of NQO1 substrates has encountered some challenges. A few of the bioreductive agents developed to date have been specific for a single enzyme, NQO1. Hence, the separate NQO1 level may not be a suitable indicator to predict clinical response to the therapy of these bioreductive agents. Again, most of the reported NQO1 substrates, such as MMC (<b>14</b>), apaziquone (<b>15</b>), AZQ (<b>18</b>), and RH1 (<b>20</b>), are DNA alkylators. Their clinical efficacy may be limited due to resistance originating in the DNA repair machinery. The head-to-head assays conducted in vitro and cultured cell systems convincingly demonstrate that only two classes of compounds, β-lap (<b>31</b>) and DNQ (<b>39</b>), induce cancer cell death through NQO1-mediated activation.<a onclick="showRef(event, 'ref47 ref77'); return false;" href="javascript:void(0);" class="ref ref47 ref77">(47,77)</a> While β-lap (<b>31</b>), a redox cycler, elicits tumor-selective programmed necrosis, it has modest potency in vitro and has other drawbacks such as poor solubility and a narrow therapeutic window. The combination of <b>31</b> with other drugs that target cancer-specific NADPH-biogenesis pathways have distinct but complementary mechanisms with <b>31</b> shows immense promise to enhance efficacy and expand the therapeutic window. For example, <b>31</b> (depletion of NAD<sup>+</sup>) and NAMPT inhibitor FK866 (inhibition of NAD<sup>+</sup> production) together can induce a more remarkable depletion of NAD<sup>+</sup>, exerting a synergistic effect to induce cancer cell death. Encouragingly, DNQ (<b>39</b>) is an excellent NQO1 substrate and its anticancer activity is strictly dependent on the bioactivation of NQO1, indicating promise as a personalized anticancer therapy. <b>39</b> and its analogues have been used as model compounds to elucidate a key question regarding the relationship between the ability of substrates to be processed by NQO1 and their anticancer activity. This provides a design criterion for new NQO1-activated bioreductive agents. DNQ analogues like <b>40</b> are also excellent substrates for NQO1 with high efficacy, cancer selectivity, and desirable pharmacokinetic properties in in vivo models. These profiles make them attractive for translational development.</div><div class="NLM_p last">The early detection of cancer is critical to successful treatment. Enzyme-activated probes have emerged as a promising tool for accurate early cancer detection. Currently, there have been a number of NQO1-activated fluorescence probes published, and some of them can effectively distinguish cancer cells from healthy cells. For example, the NIR probe (<b>50</b>) has achieved in vitro and in vivo imaging of NQO1 and is capable of sensitively detecting peritoneal ovarian cancer metastases in an animal model. Of great significance, theranostic prodrugs are highly desirable for both precise diagnosis and cancer treatment. NQO1-based theranostic prodrugs provide not only real-time monitoring of the reduction of quinone moiety and parent drug release but also elicit selective cytotoxicity toward cancer cells, two birds with one stone. We anticipate that more effective, sensitive, and targeted optical probes and theranostic prodrugs will be developed to improve cancer detection and treatment.</div></div><div class="NLM_back"><div class="article_supporting-info" id=""></div><div class="testing" data-doi="10.1021/acs.jmedchem.8b00124" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_01006" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_01006" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Haiping Hao</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-5142-1134" title="Orcid link">http://orcid.org/0000-0002-5142-1134</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#305858406f07070005000570585f445d51595c1e535f5d"><span class="__cf_email__" data-cfemail="c1a9a9b19ef6f6f1f4f1f481a9aeb5aca0a8adefa2aeac">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sheng Jiang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing, 210009, China</span>; 
    <span class="author-orcid"><img src="/products/achs/releasedAssets/images/orchid.png" alt="Orcid" /></img><a href="http://orcid.org/0000-0002-4550-5024" title="Orcid link">http://orcid.org/0000-0002-4550-5024</a>; 
    </span><span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#6b01020a050c1803522b0c060a020745080406"><span class="__cf_email__" data-cfemail="28424149464f5b4011684f45494144064b4745">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kuojun Zhang</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing, 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Dong Chen</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing, 210009, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kun Ma</span> - <span class="hlFld-Affiliation affiliation">Center
for Drug Evaluation, China Food and Drug
Administration, Beijing 100038, China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xiaoxing Wu</span> - <span class="hlFld-Affiliation affiliation">State
Key Laboratory of Natural Medicines and Department of Medicinal Chemistry,
School of Pharmacy, China Pharmaceutical
University, Nanjing, 210009, China</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div class="bio" rid="ath1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="biographies">Biographies</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_47132" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_47132" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><figure id="ath1" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Kuojun Zhang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=BIO-d7e2060-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kuojun Zhang</b> received her Master’s degree at China Pharmaceutical University. Currently, she is pursuing her Ph.D. under the supervision of Professor Sheng Jiang. Her research topics are focused on the discovery of effective inhibitors of NQO1.</p></figure></div><div class="bio" rid="ath2"><figure id="ath2" data-index="17" class="article__inlineFigure"><h2 class="fig-label">Dong Chen</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=BIO-d7e2065-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Dong Chen</b> received his Bachelor’s degree from China Pharmaceutical University and earned his Ph.D. in Medicinal Chemistry from Kunming Institute of Botany, Chinese Academy of Sciences. He is currently a member of the Department of Medicinal Chemistry, School of Pharmacy, China Pharmaceutical University, and spends much of his time on synthesis of natural products.</p></figure></div><div class="bio" rid="ath3"><figure id="ath3" data-index="18" class="article__inlineFigure"><h2 class="fig-label">Kun Ma</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=BIO-d7e2070-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Kun Ma</b> received his Bachelor’s degree from China Pharmaceutical University and earned his Master’s degree from Shenyang Pharmaceutical University. He is currently a member of the Centre for Drug Evaluation, China Food and Drug Administration.</p></figure></div><div class="bio" rid="ath4"><figure id="ath4" data-index="19" class="article__inlineFigure"><h2 class="fig-label">Xiaoxing Wu</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=BIO-d7e2075-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Xiaoxing Wu</b> received his Ph.D. from Brandeis University in 2009 and continued his postdoctoral research at the Massachusetts Institute of Technology. After two years of working in academia and four years in top pharmaceutical companies, he joined in faculty at China Pharmaceutical University as a Principal Investigator in 2017. His current research interests are in the discovery of small-molecule drugs for treatment of metabolic diseases or immuno-oncology.</p></figure></div><div class="bio" rid="ath5"><figure id="ath5" data-index="20" class="article__inlineFigure"><h2 class="fig-label">Haiping Hao</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=BIO-d7e2080-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Haiping Hao</b> received his Ph.D. from China Pharmaceutical University in 2006 and was a visiting scholar at the National Cancer Institute (USA) during 2012–2013. Professor Hao is the Dean of College of Pharmacy and the Associate Director of the State Key Laboratory of Natural Medicines at China Pharmaceutical University. His major scientific interests focus on the elucidation of metabolic regulation in the pathogenesis of chronic diseases such as tumor and atherosclerosis and the translational link to target discovery and drug development.</p></figure></div><div class="bio" rid="ath6"><figure id="ath6" data-index="21" class="article__inlineFigure"><h2 class="fig-label">Sheng Jiang</h2><div class="figure-bottom-links"><div class="download-hi-res-img"></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=BIO-d7e2085-autogenerated"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><b>Sheng Jiang</b> received his Ph.D. degree from Shanghai Institute of Organic Chemistry (China) in 2003. After four years of postdoctoral training, he started his independent career in 2008 at Guangzhou Biomedicine and Health, CAS. In 2017, Professor Jiang moved his research group to the China Pharmaceutical University. His scientific interest is mainly focused on development of novel small drug-like molecules and peptidomimetic derivatives acting on targets of epigenetics and immuno-oncology.</p></figure></div><div class="ack" id="ACK-d7e2090-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i30">Acknowledgments</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88504" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88504" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">This work was supported by the National Natural Science Foundation (21472191, 81773559), the National Major Scientific and Technological Program for Drug Discovery Grant (2018ZX09301045002), the International Cooperation Special Grant (2016A050502036) from the Science and Technology Development Project of Guangdong Province, the International Cooperation Grant (201704030099) of Guangzhou, and the Science and Technology Planning Project of Guangdong Province (2013A022100019) and Chinese Pharmaceutical Association—Yiling Biopharmaceutical Innovation Foundation.</p></div><table summary="" class="NLM_def-list" id="dl1"><tr><td colspan="2" class="NLM_title">Abbreviations Used</td></tr><tr><td class="NLM_term">NQO1</td><td class="NLM_def"><p class="first last">NAD(P)H:quinone oxidoreductase 1</p></td></tr><tr><td class="NLM_term">DTD</td><td class="NLM_def"><p class="first last">DT-diaphorase</p></td></tr><tr><td class="NLM_term">Nrf2</td><td class="NLM_def"><p class="first last">NF-E2 p45-related factor 2</p></td></tr><tr><td class="NLM_term">Keap1</td><td class="NLM_def"><p class="first last">Kelch-like ECH-associated protein 1</p></td></tr><tr><td class="NLM_term">ARE</td><td class="NLM_def"><p class="first last">antioxidant response element</p></td></tr><tr><td class="NLM_term">TNF</td><td class="NLM_def"><p class="first last">tumor necrosis factor</p></td></tr><tr><td class="NLM_term">HIF-1α</td><td class="NLM_def"><p class="first last">hypoxia inducible factor α</p></td></tr><tr><td class="NLM_term">ALDH</td><td class="NLM_def"><p class="first last">aldehyde dehydrogenase</p></td></tr><tr><td class="NLM_term">CCA</td><td class="NLM_def"><p class="first last">cholangiocarcinoma</p></td></tr><tr><td class="NLM_term">DIC</td><td class="NLM_def"><p class="first last">dicumarol</p></td></tr><tr><td class="NLM_term">5-FU</td><td class="NLM_def"><p class="first last">5-fluorouracil</p></td></tr><tr><td class="NLM_term">TIMP1</td><td class="NLM_def"><p class="first last">tissue inhibitors of metalloproteinases 1</p></td></tr><tr><td class="NLM_term">MMP9</td><td class="NLM_def"><p class="first last">matrix metalloproteinase 9</p></td></tr><tr><td class="NLM_term">SNPs</td><td class="NLM_def"><p class="first last">single nucleotide polymorphisms</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">MMC</td><td class="NLM_def"><p class="first last">mitomycin C</p></td></tr><tr><td class="NLM_term">ROS</td><td class="NLM_def"><p class="first last">reactive oxygen species</p></td></tr><tr><td class="NLM_term">Hsp90</td><td class="NLM_def"><p class="first last">heat shock protein</p></td></tr><tr><td class="NLM_term">P-450R</td><td class="NLM_def"><p class="first last">NADPH:cytochrome P450 reductase</p></td></tr><tr><td class="NLM_term">XO</td><td class="NLM_def"><p class="first last">xanthine oxidase</p></td></tr><tr><td class="NLM_term">b-5R</td><td class="NLM_def"><p class="first last">NADPH:cytochrome b5 reductase</p></td></tr><tr><td class="NLM_term">NMIBC</td><td class="NLM_def"><p class="first last">nonmuscle invasive bladder cancer</p></td></tr><tr><td class="NLM_term">AZQ</td><td class="NLM_def"><p class="first last">diaziquione</p></td></tr><tr><td class="NLM_term">STN</td><td class="NLM_def"><p class="first last">streptonigrin</p></td></tr><tr><td class="NLM_term">β-lap</td><td class="NLM_def"><p class="first last">β-lapachone</p></td></tr><tr><td class="NLM_term">Tan IIA</td><td class="NLM_def"><p class="first last">tanshinone IIA</p></td></tr><tr><td class="NLM_term">PARP-1</td><td class="NLM_def"><p class="first last">poly(ADP-ribose)polymerase-1</p></td></tr><tr><td class="NLM_term">HPβ-CD</td><td class="NLM_def"><p class="first last">hydroxylpropyl β-cyclodextrin</p></td></tr><tr><td class="NLM_term">PEG–PLA</td><td class="NLM_def"><p class="first last">poly(ethylene glycol)-<i>block</i>-poly(<span class="smallcaps smallerCapital">d</span>,<span class="smallcaps smallerCapital">l</span>-lactide)</p></td></tr><tr><td class="NLM_term">BER</td><td class="NLM_def"><p class="first last">base excision repair</p></td></tr><tr><td class="NLM_term">NAMPT</td><td class="NLM_def"><p class="first last">nicotinamidephosphoribosyltransferase</p></td></tr><tr><td class="NLM_term">GLS1</td><td class="NLM_def"><p class="first last">glutaminase 1</p></td></tr><tr><td class="NLM_term">DNQ</td><td class="NLM_def"><p class="first last">deoxynyboquinone</p></td></tr><tr><td class="NLM_term">CPT</td><td class="NLM_def"><p class="first last">camptothecin</p></td></tr><tr><td class="NLM_term">PeT</td><td class="NLM_def"><p class="first last">photoinduced electron transfer</p></td></tr><tr><td class="NLM_term">ICT</td><td class="NLM_def"><p class="first last">push–pull internal charge transfer</p></td></tr><tr><td class="NLM_term">NIR</td><td class="NLM_def"><p class="first last">near-infrared</p></td></tr><tr><td class="NLM_term">FITC</td><td class="NLM_def"><p class="first last">fluorescein isothiocyanate</p></td></tr></table><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_10133" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_10133" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 180 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2017</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3322%2Fcaac.21387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28055103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2017&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2017&doi=10.3322%2Fcaac.21387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Statistics, 2017</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States.  For all sites combined, the cancer incidence rate is 20% higher in men than in women, while the cancer death rate is 40% higher.  However, sex disparities vary by cancer type.  For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the "epidemic of diagnosis." Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2005-2014) declined by about 1.5% annually in both men and women.  From 1991 to 2014, the overall cancer death rate dropped 25%, translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.  Although the cancer death rate was 15% higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21% to 11%, as it did for Hispanics (31% to 16%).  Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population.  CA Cancer J Clin 2017;67:7-30. © 2017 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB4oj7vNRTIb5oR8RchjrrfW6udTcc2eZzm8OcCjioOrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D&md5=e439f3424d5a773e4ae289c392236ad6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21387%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202017%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2017%26volume%3D67%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eranster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navazio, F.</span></span> <span> </span><span class="NLM_article-title">Soluble diaphorase in animal tissues</span>. <i>Acta Chem. Scand.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.3891/acta.chem.scand.12-0595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3891%2Facta.chem.scand.12-0595" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1958&pages=595-602&author=L.+Eransterauthor=F.+Navazio&title=Soluble+diaphorase+in+animal+tissues&doi=10.3891%2Facta.chem.scand.12-0595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.12-0595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.12-0595%26sid%3Dliteratum%253Aachs%26aulast%3DEranster%26aufirst%3DL.%26aulast%3DNavazio%26aufirst%3DF.%26atitle%3DSoluble%2520diaphorase%2520in%2520animal%2520tissues%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1958%26volume%3D12%26spage%3D595%26epage%3D602%26doi%3D10.3891%2Facta.chem.scand.12-0595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/S0009-2797(00)00199-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0009-2797%2800%2900199-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11154736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=77-97&author=D.+Rossauthor=J.+K.+Kepaauthor=S.+L.+Winskiauthor=H.+D.+Beallauthor=A.+Anwarauthor=D.+Siegel&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29%3A+chemoprotection%2C+bioactivation%2C+gene+regulation+and+genetic+polymorphisms&doi=10.1016%2FS0009-2797%2800%2900199-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span></div><div class="casAuthors">Ross, D.; Kepa, J. K.; Winski, S. L.; Beall, H. D.; Anwar, A.; Siegel, D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">77-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review, with 155 refs.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones.  This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E.  Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed.  NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized.  An overview of genetic polymorphisms in NQO1 is presented and biol. significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXdLgkTvlewbVg90H21EOLACvtfcHk0lgZ8ZbKgWBdIg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D&md5=800e91c28ad691db2ab9cd749011f8c2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900199-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900199-X%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%253A%2520chemoprotection%252C%2520bioactivation%252C%2520gene%2520regulation%2520and%2520genetic%2520polymorphisms%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D77%26epage%3D97%26doi%3D10.1016%2FS0009-2797%2800%2900199-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(04)82019-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0076-6879%2804%2982019-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2004&pages=355-364&author=P.+Talalayauthor=A.+T.+Dinkova-Kostova&title=Role+of+nicotinamide+quinone+oxidoreductase+1+%28NQO1%29+in+protection+against+toxicity+of+electrophiles+and+reactive+oxygen+intermediates&doi=10.1016%2FS0076-6879%2804%2982019-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2804%2982019-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252804%252982019-6%26sid%3Dliteratum%253Aachs%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520nicotinamide%2520quinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520in%2520protection%2520against%2520toxicity%2520of%2520electrophiles%2520and%2520reactive%2520oxygen%2520intermediates%26jtitle%3DMethods%2520Enzymol.%26date%3D2004%26volume%3D382%26spage%3D355%26epage%3D364%26doi%3D10.1016%2FS0076-6879%2804%2982019-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdemli, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structure, function, and mechanism of cytosolic quinone reductases</span>. <i>Vitam. Horm.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/S0083-6729(07)00004-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0083-6729%2807%2900004-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=18374190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltVKnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2008&pages=63-84&author=M.+A.+Bianchetauthor=S.+B.+Erdemliauthor=L.+M.+Amzel&title=Structure%2C+function%2C+and+mechanism+of+cytosolic+quinone+reductases&doi=10.1016%2FS0083-6729%2807%2900004-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, function, and mechanism of cytosolic quinone reductases</span></div><div class="casAuthors">Bianchet, Mario A.; Erdemli, Sabri Bora; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Vitamin K</span>),
    <span class="NLM_cas:pages">63-84, 453-455, (color plates)</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Quinone reductases type 1 (QR1) are FAD-contg. enzymes that catalyze the redn. of many quinones, including menadione (vitamin K3), to hydroquinones using reducing equiv. provided by NAD(P)H.  The reaction proceeds with a ping-pong mechanism in which the NAD(P)H and the substrate occupy alternatively overlapping regions of the same binding site and participate in a double hydride transfer: one from NAD(P)H to the FAD of the enzyme, and one from the FADH2 of the enzyme to the quinone substrate.  The main function of QR1 is probably the detoxification of dietary quinones but it may also contribute to the redn. of vitamin K for its involvement in blood coagulation.  In addn., the same reaction that QR1 uses in the detoxification of quinones, activates some compds. making them cytotoxic.  Since QR1 is elevated in many tumors, this property has encouraged the development of chemotherapeutic compds. that become cytotoxic after redn. by QR1.  The structures of QR1 alone, and in complexes with substrates, inhibitors, and chemotherapeutic prodrugs, combined with biochem. and mechanistic studies have provided invaluable insight into the mechanism of the enzyme as well as suggestions for the improvements of the chemotherapeutic prodrugs.  Similar information is beginning to accumulate about another related enzyme, QR2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonlqRfBgGYELVg90H21EOLACvtfcHk0ljNho_LuFotWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltVKnu70%253D&md5=7dda6283158c91a092ef2d4f18f7057a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2807%2900004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252807%252900004-0%26sid%3Dliteratum%253Aachs%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DErdemli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructure%252C%2520function%252C%2520and%2520mechanism%2520of%2520cytosolic%2520quinone%2520reductases%26jtitle%3DVitam.%2520Horm.%26date%3D2008%26volume%3D78%26spage%3D63%26epage%3D84%26doi%3D10.1016%2FS0083-6729%2807%2900004-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bcp.2011.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=22209713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFOhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1033-1040&author=D.+Siegelauthor=C.+Yanauthor=D.+Ross&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+in+the+sensitivity+and+resistance+to+antitumor+quinones&doi=10.1016%2Fj.bcp.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones</span></div><div class="casAuthors">Siegel, David; Yan, Chao; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1033-1040</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Quinones represent a large and diverse class of antitumor drugs and many quinones are approved for clin. use or are currently undergoing evaluation in clin. trials.  For many quinones redn. to the hydroquinone has been shown to play a key role in their antitumor activity.  The two-electron redn. of quinones by NQO1 has been shown to be an efficient pathway to hydroquinone formation.  NQO1 is expressed at high levels in many human solid tumors making this enzyme ideally suited for intracellular drug activation.  Cellular levels of NQO1 are influenced by the NQO1*2 polymorphism.  Individuals homozygous for the NQO1*2 allele are NQO1 null and homozygous NQO1*2*2 cell lines have been shown to be more resistant to antitumor quinones when compared to isogenic cell lines overexpressing NQO1.  In this review we will discuss the role of NQO1 in the sensitivity and resistance of human cancers to the quinone antitumor drugs mitomycin C, β-lapachone and the benzoquinone ansamycin class of Hsp90 inhibitors including 17-AAG.  The role of NQO1 in the bioreductive activation of mitomycin C remains controversial but pre-clin. data strongly suggests a role for NQO1 in the activation of β-lapachone and the benzoquinone ansamycin class of Hsp90 inhibitors.  Despite a large vol. of preclin. data demonstrating that NQO1 is an important determinant of sensitivity to these antitumor quinones there is little information on whether the clin. response to these agents is influenced by the NQO1*2 polymorphism.  The availability of simple assays for the detn. of the NQO1*2 polymorphism should facilitate clin. testing of this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAHcbPaHFBbVg90H21EOLACvtfcHk0ljNho_LuFotWA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFOhsbk%253D&md5=076c2caa6ec32484de8451218d5fa199</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520in%2520the%2520sensitivity%2520and%2520resistance%2520to%2520antitumor%2520quinones%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1033%26epage%3D1040%26doi%3D10.1016%2Fj.bcp.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vredenburg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, J. C.</span></span> <span> </span><span class="NLM_article-title">Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1021/tx400431k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400431k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=576-586&author=G.+Vredenburgauthor=N.+S.+Eliasauthor=H.+Venkataramanauthor=D.+F.+Hendriksauthor=N.+P.+Vermeulenauthor=J.+N.+Commandeurauthor=J.+C.+Vos&title=Human+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29-mediated+inactivation+of+reactive+quinoneimine+metabolites+of+diclofenac+and+mefenamic+acid&doi=10.1021%2Ftx400431k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Ftx400431k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400431k%26sid%3Dliteratum%253Aachs%26aulast%3DVredenburg%26aufirst%3DG.%26aulast%3DElias%26aufirst%3DN.%2BS.%26aulast%3DVenkataraman%26aufirst%3DH.%26aulast%3DHendriks%26aufirst%3DD.%2BF.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%26aulast%3DVos%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529-mediated%2520inactivation%2520of%2520reactive%2520quinoneimine%2520metabolites%2520of%2520diclofenac%2520and%2520mefenamic%2520acid%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D576%26epage%3D586%26doi%3D10.1021%2Ftx400431k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">den
Braver-Sewradj, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Braver, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toorneman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leeuwen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, J. C.</span></span> <span> </span><span class="NLM_article-title">Reduction and scavenging of chemically reactive drug metabolites by NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 and variability in hepatic concentrations</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.7b00289</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.7b00289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=116-126&author=S.+P.+den%0ABraver-Sewradjauthor=M.+W.+den+Braverauthor=R.+M.+Toornemanauthor=S.+van+Leeuwenauthor=Y.+Zhangauthor=S.+J.+Dekkerauthor=N.+P.+E.+Vermeulenauthor=J.+N.+M.+Commandeurauthor=J.+C.+Vos&title=Reduction+and+scavenging+of+chemically+reactive+drug+metabolites+by+NAD%28P%29H%3Aquinone+oxidoreductase+1+and+NRH%3Aquinone+oxidoreductase+2+and+variability+in+hepatic+concentrations&doi=10.1021%2Facs.chemrestox.7b00289"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.7b00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.7b00289%26sid%3Dliteratum%253Aachs%26aulast%3Dden%2BBraver-Sewradj%26aufirst%3DS.%2BP.%26aulast%3Dden%2BBraver%26aufirst%3DM.%2BW.%26aulast%3DToorneman%26aufirst%3DR.%2BM.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDekker%26aufirst%3DS.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%2BM.%26aulast%3DVos%26aufirst%3DJ.%2BC.%26atitle%3DReduction%2520and%2520scavenging%2520of%2520chemically%2520reactive%2520drug%2520metabolites%2520by%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520and%2520NRH%253Aquinone%2520oxidoreductase%25202%2520and%2520variability%2520in%2520hepatic%2520concentrations%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26spage%3D116%26epage%3D126%26doi%3D10.1021%2Facs.chemrestox.7b00289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>501</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.abb.2010.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20361926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2010&pages=116-123&author=A.+T.+Dinkova-Kostovaauthor=P.+Talalay&title=NAD%28P%29H%3Aquinone+acceptor+oxidoreductase+1+%28NQO1%29%2C+a+multifunctional+antioxidant+enzyme+and+exceptionally+versatile+cytoprotector&doi=10.1016%2Fj.abb.2010.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1) is a widely-distributed FAD-dependent flavoprotein that promotes obligatory 2-electron redns. of quinones, quinoneimines, nitroaroms., and azo dyes, at rates that are comparable with NADH or NADPH.  These redns. depress quinone levels and thereby minimize opportunities for generation of reactive oxygen intermediates by redox cycling, and for depletion of intracellular thiol pools.  NQO1 is a highly-inducible enzyme that is regulated by the Keap1/Nrf2/ARE pathway.  Evidence for the importance of the antioxidant functions of NQO1 in combating oxidative stress is provided by demonstrations that induction of NQO1 levels or their depletion (knockout, or knockdown) are assocd. with decreased and increased susceptibilities to oxidative stress, resp.  Furthermore, benzene genotoxicity is markedly enhanced when NQO1 activity is compromised.  Not surprisingly, human polymorphisms that suppress NQO1 activities are assocd. with increased predisposition to disease.  Recent studies have uncovered protective roles for NQO1 that apparently are unrelated to its enzymic activities.  NQO1 binds to and thereby stabilizes the important tumor suppressor p53 against proteasomal degrdn.  Indeed, NQO1 appears to regulate the degradative fate of other proteins.  These findings suggest that NQO1 may exercise a selective gatekeeping role in regulating the proteasomal degrdn. of specific proteins, thereby broadening the cytoprotective role of NQO1 far beyond its highly effective antioxidant functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSJ6D5dmXsrVg90H21EOLACvtfcHk0liTwcEyiDY-MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jur7L&md5=fdca92a7699b006532ac6334ee79e709</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520acceptor%2520oxidoreductase%25201%2520%2528NQO1%2529%252C%2520a%2520multifunctional%2520antioxidant%2520enzyme%2520and%2520exceptionally%2520versatile%2520cytoprotector%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D501%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.abb.2010.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Clinical implications of high NQO1 expression in breast cancers</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1186/1756-9966-33-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2F1756-9966-33-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24499631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtl2gtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=14-14&author=Y.+Yangauthor=Y.+Zhangauthor=Q.+Wuauthor=X.+Cuiauthor=Z.+Linauthor=S.+Liuauthor=L.+Chen&title=Clinical+implications+of+high+NQO1+expression+in+breast+cancers&doi=10.1186%2F1756-9966-33-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical implications of high NQO1 expression in breast cancers</span></div><div class="casAuthors">Yang, Yang; Zhang, Yan; Wu, Qunying; Cui, Xuelian; Lin, Zhenhua; Liu, Shuangping; Chen, Liyan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14/1-14/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: NAD (P) H: quinone oxidoreductase 1 (NQO1) is a xenobiotic metabolizing enzyme that detoxifies chem. stressors and antioxidants, providing cytoprotection in normal tissues.  However, high-level expression of NQO1 has been correlated with numerous human malignancies, suggesting a role in carcinogenesis and tumor progression.  This study aimed to explore the clinicopathol. significance of NQO1 and as a prognostic determinant in breast cancer.  Methods: A total of 176 breast cancer patients with strict follow-up, 45 ductal carcinoma in situ (DCIS), 22 hyperplasia and 52 adjacent non-tumor breast tissues were selected for immunohistochem. staining of NQO1 protein.  Immunofluorescence staining was also performed to detect the subcellular localization of NQO1 protein in MCF-7 breast cancer cells.  Eight fresh breast cancers paired with adjacent non-tumor tissues were quantified using real time RT-PCR (qRT-PCR) and western blot.  The correlations between NQO1 overexpression and the clin. features of breast cancer were evaluated using chi-square test and Fisher's exact tests.  The survival rate was calcd. using the Kaplan-Meier method, and the relationship between prognostic factors and patient survival was also analyzed by the Cox proportional hazards models.  Results: NQO1 protein showed a mainly cytoplasmic staining pattern in breast cancer.  The strongly pos. rate of NQO1 protein was 61.9% (109/176) in breast cancer, and was significantly higher than in DCIS (31.1%, 14/45), hyperplasia tissues (13.6%, 3/22) and adjacent non-tumor tissues (13.5%, 7/52).  High-level expression of NQO1 protein was correlated with late clin. stage, poor differentiation, lymph node metastasis, Her2 expression and disease-free and 10-yr overall survival rates in breast cancer.  Moreover, multivariate anal. suggested that NQO1 emerged as a significant independent prognostic factor along with clin. stage nd Her2 expression status in patients with breast cancer.  Conclusions: High-level expression of NQO1 appears to be assocd. with breast cancer progression, and may be a potential biomarker for poor prognostic evaluation of breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ZR_Aw-dUrrVg90H21EOLACvtfcHk0liTwcEyiDY-MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtl2gtrc%253D&md5=deb02775d7dd7c50017839c92e00a463</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-33-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-33-14%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DClinical%2520implications%2520of%2520high%2520NQO1%2520expression%2520in%2520breast%2520cancers%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D33%26spage%3D14%26epage%3D14%26doi%3D10.1186%2F1756-9966-33-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez de Cerain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Penuela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idoate, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, J.</span></span> <span> </span><span class="NLM_article-title">DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1038/bjc.1997.485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fbjc.1997.485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=9328153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVGqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1997&pages=923-929&author=A.+Marinauthor=A.+Lopez+de+Cerainauthor=E.+Hamiltonauthor=A.+D.+Lewisauthor=J.+M.+Martinez-Penuelaauthor=M.+A.+Idoateauthor=J.+Bello&title=DT-diaphorase+and+cytochrome+B5+reductase+in+human+lung+and+breast+tumours&doi=10.1038%2Fbjc.1997.485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase and cytochrome b5 reductase in human lung and breast tumors</span></div><div class="casAuthors">Marin, A.; De Cerain, A. Lopez; Hamilton, E.; Lewis, A. D.; Martinez-Penuela, J. M.; Idoate, M. A.; Bello, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">The level of expression of enzymes that can activate or detoxify bioreductive agents within tumors has emerged as an important feature in the development of these anti-tumor compds.  The levels of two such reductase enzymes have been detd. in 19 human non-small-cell lung tumors and 20 human breast tumors, together with the corresponding normal tissue.  DT-diaphorase (DTD) enzyme levels (both expression and activity) were detd. in these samples.  Cytochrome b5 reductase (Cytb5R) activity was also assessed.  With the exception of six patients, the levels of DTD activity were below 45 nmol min-1 mg-1 in the normal tissues assayed.  DTD tumor activity was extremely variable, distinguishing two different groups of patients, one with DTD activity above 79 nmol min-1 mg-1 and the other with levels that were in the same range as found for the normal tissues.  In 53% of the lung tumor samples, DTD activity was increased with respect to the normal tissue by a factor of 2.4-90.3 (range 79-965 nmol min-1 mg-1).  In 70% of the breast tumor samples, DTD activity was over 80 nmol min-1 mg-1 (range 83-267 nmol min-1 mg-1).  DTD expression measured by Western blot correlated well with the enzyme activity measured in both tumor and normal tissues.  The levels of the other reductase enzyme, Cytb5R, were not as variable as those for DTD, being in the same range in both tumor and normal tissue or slightly higher in the normal tissues.  The heterogeneous nature of DTD activity and expression reinforces the need to measure enzyme levels in individual patients before therapy with DTD-activated bioreductive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdxUZUHFex87Vg90H21EOLACvtfcHk0liTwcEyiDY-MQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVGqur8%253D&md5=e23411ec0a602243217380212f109117</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1997.485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1997.485%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DA.%26aulast%3DLopez%2Bde%2BCerain%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DE.%26aulast%3DLewis%26aufirst%3DA.%2BD.%26aulast%3DMartinez-Penuela%26aufirst%3DJ.%2BM.%26aulast%3DIdoate%26aufirst%3DM.%2BA.%26aulast%3DBello%26aufirst%3DJ.%26atitle%3DDT-diaphorase%2520and%2520cytochrome%2520B5%2520reductase%2520in%2520human%2520lung%2520and%2520breast%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1997%26volume%3D76%26spage%3D923%26epage%3D929%26doi%3D10.1038%2Fbjc.1997.485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6936</span>– <span class="NLM_lpage">6945</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-0935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-07-0935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6936-6945&author=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=Y.+Dongauthor=E.+A.+Beyauthor=D.+A.+Boothman&title=Nonhomologous+end+joining+is+essential+for+cellular+resistance+to+the+novel+antitumor+agent%2C+beta-lapachone&doi=10.1158%2F0008-5472.CAN-07-0935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0935%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNonhomologous%2520end%2520joining%2520is%2520essential%2520for%2520cellular%2520resistance%2520to%2520the%2520novel%2520antitumor%2520agent%252C%2520beta-lapachone%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6936%26epage%3D6945%26doi%3D10.1158%2F0008-5472.CAN-07-0935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2595</span>, <span class="refDoi"> DOI: 10.3892/or.2014.3494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3892%2For.2014.3494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25231218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=2589-2595&author=X.+Cuiauthor=T.+Jinauthor=X.+Wangauthor=G.+Jinauthor=Z.+Liauthor=L.+Lin&title=NAD%28P%29H%3Aquinone+oxidoreductase-1+overexpression+predicts+poor+prognosis+in+small+cell+lung+cancer&doi=10.3892%2For.2014.3494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer</span></div><div class="casAuthors">Cui, Xuelian; Jin, Tiefeng; Wang, Xiaoyan; Jin, Guang; Li, Zhuhu; Lin, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2589-2595</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">NAD(P)H:quinone oxidoreductase-1 (NQO1) is commonly elevated in various types of human cancers, including pancreatic, breast and thyroid cancer, as well as others.  However, little is known concerning the status of NQO1 in small cell lung cancer (SCLC).  To investigate the clinicopathol. significance of NQO1 expression and evaluate its role as a potential prognostic marker in SCLC, protein and mRNA expression levels of NQO1 were detd. in four fresh tissue samples of SCLC and paired adjacent non-cancerous tissues using western blotting and real-time qRT-PCR, resp., and 115 cases of SCLC with strict follow-up were selected for immunohistochem. (IHC) staining of NQO1 protein.  The correlation between NQO1 expression and the clinicopathol. features of SCLC was evaluated using the Chi-square (χ2) and Fisher's exact tests, survival rates were calcd. using the Kaplan-Meier method, and univariate and multivariate analyses were performed using the Cox proportional hazards regression model.  In regards to the results, levels of NQO1 protein and mRNA were significantly elevated in the four fresh tissue samples of SCLC compared with levels in the paired adjacent non-cancerous tissues, resp.  IHC anal. showed that the rate of strong pos. NQO1 protein expression was significantly higher (48.70%) in SCLC when compared with the rate in either adjacent non-cancerous or normal lung tissues (both P<0.001).  The rate of strong pos. NQO1 protein expression was correlated with large tumor size (P = 0.019), late pathol. stage (P = 0.001) and the presence of lymph node metastasis (P = 0.001).  Moreover, high-level expression of NQO1 protein was significantly correlated with lower disease-free survival (P = 0.001) and 5-yr survival rates (P<0.001) in SCLC patients, particularly early-stage patients (P = 0.045 and P = 0.033, resp.).  Further Cox anal. revealed that NQO1 expression emerged as a significantly independent hazard factor for the 5-yr survival rate of patients with SCLC (P = 0.042).  In conclusion, NQO1 plays an important role in the progression of SCLC, and it may potentially be used as a biomarker and therapeutic target of SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfTZv2w1bkkbVg90H21EOLACvtfcHk0lgadyrOGJfXXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGktL7F&md5=6f70a1c514fac8b8ebfac85dea7a7981</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3892%2For.2014.3494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2014.3494%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DL.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase-1%2520overexpression%2520predicts%2520poor%2520prognosis%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2014%26volume%3D32%26spage%3D2589%26epage%3D2595%26doi%3D10.3892%2For.2014.3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Men, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span> <span> </span><span class="NLM_article-title">NQO1 protein expression predicts poor prognosis of non-small cell lung cancers</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">207</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1227-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2Fs12885-015-1227-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=207&author=Z.+Liauthor=Y.+Zhangauthor=T.+Jinauthor=J.+Menauthor=Z.+Linauthor=P.+Qiauthor=Y.+Piaoauthor=G.+Yan&title=NQO1+protein+expression+predicts+poor+prognosis+of+non-small+cell+lung+cancers&doi=10.1186%2Fs12885-015-1227-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1227-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1227-8%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DMen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DP.%26aulast%3DPiao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DG.%26atitle%3DNQO1%2520protein%2520expression%2520predicts%2520poor%2520prognosis%2520of%2520non-small%2520cell%2520lung%2520cancers%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D207%26doi%3D10.1186%2Fs12885-015-1227-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">11832</span>– <span class="NLM_lpage">11837</span>, <span class="refDoi"> DOI: 10.1073/pnas.0702176104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1073%2Fpnas.0702176104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=17609380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVakt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=11832-11837&author=E.+A.+Beyauthor=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=Y.+Dongauthor=C.+R.+Yangauthor=L.+Girardauthor=J.+D.+Minnaauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=D.+A.+Boothman&title=An+NQO1-+and+PARP-1-mediated+cell+death+pathway+induced+in+non-small-cell+lung+cancer+cells+by+beta-lapachone&doi=10.1073%2Fpnas.0702176104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone</span></div><div class="casAuthors">Bey, Erik A.; Bentle, Melissa S.; Reinicke, Kathryn E.; Dong, Ying; Yang, Chin-Rang; Girard, Luc; Minna, John D.; Bornmann, William G.; Gao, Jinming; Boothman, Avid A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11832-11837, S11832/1-S11832/17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancer is the no. one cause of cancer-related deaths in the world.  Patients treated with current chemotherapies for non-small-cell lung cancers (NSCLCs) have a survival rate of ≈15% after 5 years.  Novel approaches are needed to treat this disease.  We show elevated NAD(P)H:quinone oxidoreductase-1 (NQO1) levels in tumors from NSCLC patients.  β-Lapachone, an effective chemotherapeutic and radiosensitizing agent, selectively killed NSCLC cells that expressed high levels of NQO1.  Isogenic H596 NSCLC cells that lacked or expressed NQO1 along with A549 NSCLC cells treated with or without dicoumarol, were used to elucidate the mechanism of action and optimal therapeutic window of P3-lapachone.  NSCLC cells were killed in an NQO1-dependent manner by 3-lapachone (LD50, ≈4 μM) with a min. 2-h exposure.  Kinetically, β-lapachone-induced cell death was characterized by the following: (i) dramatic reactive oxygen species (ROS) formation, eliciting extensive DNA damage; (ii) hyperactivation of poly(ADP-ribose)polymerase-1 (PARP-1); (iii) depletion of NAD+/ATP levels; and (iv) proteolytic cleavage of p53/PARP-1, indicating μ-calpain activation and apoptosis.  β-Lapachone-induced PARP-1 hyperactivation, nucleotide depletion, and apoptosis were blocked by 3-aminobenzamide, a PARP-1 inhibitor, and BAPTA acetoxymethyl ester (BAPTA-AM), a Ca2+ chelator.  NQO1- cells (H596, IMR-90) or dicoumarol-exposed NQO1 + A549 cells were resistant (LD50, > 40 μM) to ROS formation and all cytotoxic effects of /-lapachone.  Our data indicate that the most efficacious strategy using β-lapachone in chemotherapy was to deliver the drug in short pulses, greatly reducing cytotoxicity to NQO1- "normal" cells.  β-Lapachone killed cells in a tumor-selective manner and is indicated for use against NQO1+ NSCLC cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot6pYpTh-Qp7Vg90H21EOLACvtfcHk0lgadyrOGJfXXg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVakt74%253D&md5=3468a6d9a091d4379eec7f362099ee47</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0702176104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0702176104%26sid%3Dliteratum%253Aachs%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%2BR.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DAn%2520NQO1-%2520and%2520PARP-1-mediated%2520cell%2520death%2520pathway%2520induced%2520in%2520non-small-cell%2520lung%2520cancer%2520cells%2520by%2520beta-lapachone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D11832%26epage%3D11837%26doi%3D10.1073%2Fpnas.0702176104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabbani, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8096</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-10-1418" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8088-8096&author=Y.+Dongauthor=E.+A.+Beyauthor=L.+S.+Liauthor=W.+Kabbaniauthor=J.+Yanauthor=X.+J.+Xieauthor=J.+T.+Hsiehauthor=J.+Gaoauthor=D.+A.+Boothman&title=Prostate+cancer+radiosensitization+through+poly%28ADP-Ribose%29+polymerase-1+hyperactivation&doi=10.1158%2F0008-5472.CAN-10-1418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1418%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DKabbani%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DHsieh%26aufirst%3DJ.%2BT.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DProstate%2520cancer%2520radiosensitization%2520through%2520poly%2528ADP-Ribose%2529%2520polymerase-1%2520hyperactivation%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8088%26epage%3D8096%26doi%3D10.1158%2F0008-5472.CAN-10-1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span> <span> </span><span class="NLM_article-title">Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma</span>. <i>Exp. Mol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1016/j.yexmp.2013.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.yexmp.2013.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24384455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVWnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2014&pages=200-205&author=L.+Linauthor=Y.+Qinauthor=T.+Jinauthor=S.+Liuauthor=S.+Zhangauthor=X.+Shenauthor=Z.+Lin&title=Significance+of+NQO1+overexpression+for+prognostic+evaluation+of+gastric+adenocarcinoma&doi=10.1016%2Fj.yexmp.2013.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma</span></div><div class="casAuthors">Lin, Lijuan; Qin, Yunzhi; Jin, Tiefeng; Liu, Shuangping; Zhang, Songnan; Shen, Xionghu; Lin, Zhenhua</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">EXMPA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4800</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">NQO1 (NAD(P)H: quinone oxidoreductase, also known as DT-diaphorase) plays a prominent role in maintaining cellular homeostasis.  NQO1 is abnormally elevated in many solid cancer types, including those of the adrenal gland, breast, colon, lung, ovary, and thyroid.  However, little is known about the status of NQO1 in gastric adenocarcinoma (GAC).  To investigate the clinicopathol. significance of NQO1 expression in GAC, and thus evaluate its role as a potential prognostic marker, 203 cases of primary GAC, 31 of gastric dysplasia, and 53 of adjacent non-tumor tissues were selected for immunohistochem. staining of NQO1 protein.  Correlations between NQO1 overexpression and clinicopathol. characteristics were evaluated by χ2 test and Fisher's exact test, while survival rates were calcd. by Kaplan-Meier method.  The relationship between prognostic factors and patient survival was analyzed by Cox proportional hazards model.  Through these analyses it was found that the strongly pos. rate of NQO1 protein in GAC was significantly higher than that in gastric dysplasia and adjacent non-tumor tissues.  Anal. by qRT-PCR also confirmed that NQO1 mRNA levels were increased in GAC compared with those detected in either adjacent non-tumor tissues or normal gastric mucosa.  Addnl., the NQO1 expression rate was pos. correlated with tumor size, serosal invasion, tumor stage, and both disease-free survival and 5-yr survival rates.  Further anal. showed that although NQO1 was not an independent predictor of GAC, elevated expression of NQO1 could predict lower disease-free survival and 5-yr survival times in late-stage patients.  In conclusion, NQO1 plays an important role in the progression of GAC, and might be a potential, but not an independent, poor prognostic biomarker and therapeutic target of GAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOezXLNrgOI7Vg90H21EOLACvtfcHk0lhpyoO4yCk_jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVWnsL4%253D&md5=b0477890872ddbce9d0a556f3f1eb004</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.yexmp.2013.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexmp.2013.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DZ.%26atitle%3DSignificance%2520of%2520NQO1%2520overexpression%2520for%2520prognostic%2520evaluation%2520of%2520gastric%2520adenocarcinoma%26jtitle%3DExp.%2520Mol.%2520Pathol.%26date%3D2014%26volume%3D96%26spage%3D200%26epage%3D205%26doi%3D10.1016%2Fj.yexmp.2013.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24695690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC2cngtFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1124-1131&author=L.+Jiauthor=Y.+Weiauthor=T.+Jiangauthor=S.+Wang&title=Correlation+of+Nrf2%2C+NQO1%2C+MRP1%2C+cmyc+and+p53+in+colorectal+cancer+and+their+relationships+to+clinicopathologic+features+and+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival</span></div><div class="casAuthors">Ji Lili; Wei Yingze; Wang Shuyang; Jiang Tao</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Due to emergence of resistant tumor populations, prognosis for metastatic colorectal cancer (CRC) patients remains poor and five-year survival rate is still very low.  To guide clinicians in selecting treatment option for CRC patients, reliable markers predictive of poor clinical outcome are desirable.  This study analyzed the correlation of NF-E2-related factor 2 (Nrf2), NAD(P)H quinine oxidoreductase 1 (NQO1), multidrug resistant protein 1 (MRP1), cmyc and p53 in CRC and their relationships to Duke's stage and clinical prognosis. 76 specimens of CRC tissues were immunohistochemically investigated using Nrf2, NQO1, MRP1, cmyc and p53 antibodies.  IHC stain showed that Nrf2, NQO1, MRP1, cmyc and p53 were highly expressed in CRC tissues compared with adjacent non-tumor tissues.  Significant positive correlations were found between the expression of Nrf2 and that of NQO1, MRP1, cmyc and p53.  Moreover, there was significant correlation between the high level of Nrf2, NQO1, MRP1, p53 expression and Duke's stage, as well as poor clinical prognosis.  We confirmed that Nrf2, NQO1, MRP1, and p53 expression exhibits considerable heterogeneity according to CRC clinical stage and prognosis.  Nrf2 is the most promising biomarker in identifying a poor prognostic group of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzJ6OiEeVF0e2qxNLjzXe8fW6udTcc2eYBd_-7zTJEebntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cngtFGruw%253D%253D&md5=135cdebf7b8d1304e274cba8ebb58eb8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DCorrelation%2520of%2520Nrf2%252C%2520NQO1%252C%2520MRP1%252C%2520cmyc%2520and%2520p53%2520in%2520colorectal%2520cancer%2520and%2520their%2520relationships%2520to%2520clinicopathologic%2520features%2520and%2520survival%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2014%26volume%3D7%26spage%3D1124%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ough, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberley, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, J. J.</span></span> <span> </span><span class="NLM_article-title">Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.4161/cbt.4.1.1382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.4161%2Fcbt.4.1.1382" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=102-109&author=M.+Oughauthor=A.+Lewisauthor=E.+A.+Beyauthor=J.+Gaoauthor=J.+M.+Ritchieauthor=W.+Bornmannauthor=D.+A.+Boothmanauthor=L.+W.+Oberleyauthor=J.+J.+Cullen&title=Efficacy+of+beta-lapachone+in+pancreatic+cancer+treatment%3A+exploiting+the+novel%2C+therapeutic+target+NQO1&doi=10.4161%2Fcbt.4.1.1382"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4161%2Fcbt.4.1.1382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.4.1.1382%26sid%3Dliteratum%253Aachs%26aulast%3DOugh%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DRitchie%26aufirst%3DJ.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DOberley%26aufirst%3DL.%2BW.%26aulast%3DCullen%26aufirst%3DJ.%2BJ.%26atitle%3DEfficacy%2520of%2520beta-lapachone%2520in%2520pancreatic%2520cancer%2520treatment%253A%2520exploiting%2520the%2520novel%252C%2520therapeutic%2520target%2520NQO1%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D102%26epage%3D109%26doi%3D10.4161%2Fcbt.4.1.1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ough, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberley, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1834</span>, <span class="refDoi"> DOI: 10.1002/mc.20199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fmc.20199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28639725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=1825-1834&author=A.+M.+Lewisauthor=M.+Oughauthor=J.+Duauthor=M.+S.+Tsaoauthor=L.+W.+Oberleyauthor=J.+J.+Cullen&title=Targeting+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29+in+pancreatic+cancer&doi=10.1002%2Fmc.20199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NAD(P)H:Quinone Oxidoreductase (NQO1) in Pancreatic Cancer</span></div><div class="casAuthors">Lewis, Anne M.; Ough, Matthew; Du, Juan; Tsao, Ming-Sound; Oberley, Larry W.; Cullen, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1825-1834</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NAD(P)H:Quinone oxidoreductase (NQO1) functions as an important part of cellular antioxidant defense by detoxifying quinones, thus preventing the formation of reactive oxygen species.  The aims of our study were to det. if NQO1 is elevated in pancreatic cancer specimens and pancreatic cancer cell lines and if so, would compds. previously demonstrated to redox cycle with NQO1 be effective in killing pancreatic cancer cells.  Immunohistochem. of resected pancreatic specimens demonstrated an increased immunoreactivity for NQO1 in pancreatic cancer and pancreatic intraepithelial neoplasia (PanIN) specimens vs. normal human pancreas.  Immunocytochem. and Western immunoblots demonstrated inceased immunoreactivity in pancreatic cancer cells when compared to a near normal immortalized human pancreatic ductal epithelial cell line and a colonic epithelial cell line.  Streptonigrin, a compd. known to cause redox cycling in the presence of NQO1, decreased clonogenic survival and decreased anchorage-independent growth in soft agar.  Streptonigrin had little effect on cell lines with absent or reduced levels of NQO1.  The effects of streptonigrin were reversed in pancreatic cancer cells pretreated with dicumarol, a known inhibitor of NQO1.  NQO1 may be a therapeutic target in pancreatic cancer where survival is measured in months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3VRHeDUDUa7Vg90H21EOLACvtfcHk0lgI7YxL_NPHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7rK&md5=6d49f7cbc682ebca05b1fe5b4767f791</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fmc.20199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20199%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DOugh%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26aulast%3DOberley%26aufirst%3DL.%2BW.%26aulast%3DCullen%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D1825%26epage%3D1834%26doi%3D10.1002%2Fmc.20199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibodeaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordy, J. S.</span></span> <span> </span><span class="NLM_article-title">NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1767</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-15-0765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27196777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1757-1767&author=L.+S.+Liauthor=S.+Reddyauthor=Z.+H.+Linauthor=S.+Liuauthor=H.+Parkauthor=S.+G.+Chunauthor=W.+G.+Bornmannauthor=J.+Thibodeauxauthor=J.+Yanauthor=G.+Chakrabartiauthor=X.+J.+Xieauthor=B.+D.+Sumerauthor=D.+A.+Boothmanauthor=J.+S.+Yordy&title=NQO1-mediated+tumor-selective+lethality+and+radiosensitization+for+head+and+neck+cancer&doi=10.1158%2F1535-7163.MCT-15-0765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer</span></div><div class="casAuthors">Li, Long-Shan; Reddy, Srilakshmi; Lin, Zhen-Hua; Liu, Shuangping; Park, Hyunsil; Chun, Stephen G.; Bornmann, William G.; Thibodeaux, Joel; Yan, Jingsheng; Chakrabarti, Gaurab; Xie, Xian-Jin; Sumer, Baran D.; Boothman, David A.; Yordy, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1757-1767</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ionizing radiation (IR) is a key therapeutic regimen for many head and neck cancers (HNC).  However, the 5-yr overall survival rate for locally advanced HNCs is approx. 50% and better therapeutic efficacy is needed.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is overexpressed in many cancers, and β-lapachone (β-lap), a unique NQO1 bioactivatable drug, exploits this enzyme to release massive reactive oxygen species (ROS) that synergize with IR to kill by programmed necrosis. β-Lap represents a novel therapeutic opportunity in HNC leading to tumor-selective lethality that will enhance the efficacy of IR.  Immunohistochem. staining and Western blot assays were used to assess the expression levels of NQO1 in HNC cells and tumors.  Forty-five percent of endogenous HNCs expressed elevated NQO1 levels.  In addn., multiple HNC cell lines and tumors demonstrated elevated levels of NQO1 expression and activity and were tested for anticancer lethality and radiosensitization by β-lap using long-term survival assays.  The combination of nontoxic β-lap doses and IR significantly enhanced NQO1-dependent tumor cell lethality, increased ROS, TUNEL-pos. cells, DNA damage, NAD+, and ATP consumption, and resulted in significant antitumor efficacy and prolonged survival in two xenograft murine HNC models, demonstrating β-lap radiosensitization of HNCs through a NQO1-dependent mechanism.  This translational study offers a potential biomarker-driven strategy using NQO1 expression to select tumors susceptible to β-lap-induced radiosensitization.  Mol Cancer Ther; 15(7); 1757-67. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRs3bMowb77LVg90H21EOLACvtfcHk0lgI7YxL_NPHsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrur%252FN&md5=34a4232d03e6dee61e8074f3c918e521</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0765%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DZ.%2BH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DChun%26aufirst%3DS.%2BG.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DThibodeaux%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DSumer%26aufirst%3DB.%2BD.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DYordy%26aufirst%3DJ.%2BS.%26atitle%3DNQO1-mediated%2520tumor-selective%2520lethality%2520and%2520radiosensitization%2520for%2520head%2520and%2520neck%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D1757%26epage%3D1767%26doi%3D10.1158%2F1535-7163.MCT-15-0765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korita, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatakeyama, K.</span></span> <span> </span><span class="NLM_article-title">Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21577322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC3Mrhs1KqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=363-370&author=T.+Wakaiauthor=Y.+Shiraiauthor=J.+Sakataauthor=Y.+Matsudaauthor=P.+V.+Koritaauthor=M.+Takamuraauthor=Y.+Ajiokaauthor=K.+Hatakeyama&title=Prognostic+significance+of+NQO1+expression+in+intrahepatic+cholangiocarcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma</span></div><div class="casAuthors">Wakai Toshifumi; Shirai Yoshio; Sakata Jun; Matsuda Yasunobu; Korita Pavel V; Takamura Masaaki; Ajioka Yoichi; Hatakeyama Katsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">363-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This study aimed to evaluate the association between the immunohistochemical expression of NAD(P) H:quinone oxidoreductase-1 (NQO1) and nuclear factor erythroid 2-related factor 2 (Nrf2) in resected specimens of intrahepatic cholangiocarcinoma (ICC) and to elucidate the prognostic value of NQO1 and Nrf2 expression.  A retrospective analysis was conducted of 34 consecutive patients who underwent surgical resection for ICC.  Immunohistochemistry of the resected specimens was conducted using each of the following primary monoclonal antibodies against NQO1 and Nrf2.  Of the 34 patients, 23 were classified as having tumors with NQO1-positive expression and 11 had tumors with loss of NQO1 expression, whereas 22 patients had tumors with Nrf2-positive expression and 12 had tumors with loss of Nrf2 expression.  NQO1 expression showed a positive association with Nrf2 expression (p=0.005).  Loss of NQO1 expression was more frequent in tumor specimens that were moderately or poorly differentiated (11/26; 42%) than in well-differentiated tumors (0/8; 0%; p=0.034).  Post-resection survival was significantly worse in patients with tumors with loss of NQO1 expression than in patients with NQO1-positive tumors (cumulative 5 -year survival rate of 0% and 51%, respectively; p=0.005).  Nrf2 expression was not associated with survival after resection (p=0.287).  The Cox proportional hazards regression analysis revealed that lymph node involvement (p<0.001) and loss of NQO1 expression (p<0.001) had an independent adverse effect on survival.  Loss of NQO1 expression reflects dedifferentiation and thus indicates a poor prognosis for patients undergoing resection for ICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlyqtZJd_lev3jf77P2BG3fW6udTcc2eYNt3hCQwZZ67ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mrhs1KqtA%253D%253D&md5=833ec78d5f395c8f361dc0d168f11295</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakai%26aufirst%3DT.%26aulast%3DShirai%26aufirst%3DY.%26aulast%3DSakata%26aufirst%3DJ.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DKorita%26aufirst%3DP.%2BV.%26aulast%3DTakamura%26aufirst%3DM.%26aulast%3DAjioka%26aufirst%3DY.%26aulast%3DHatakeyama%26aufirst%3DK.%26atitle%3DPrognostic%2520significance%2520of%2520NQO1%2520expression%2520in%2520intrahepatic%2520cholangiocarcinoma%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2011%26volume%3D4%26spage%3D363%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buranrat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau-in, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puapairoj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeekpudsa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span> <span> </span><span class="NLM_article-title">NQO1 expression correlates with cholangiocarcinoma prognosis</span>. <i>Asian Pac. J. Cancer Prev</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">Suppl</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23480754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC3svps1Gmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=131-136&issue=Suppl&author=B.+Buranratauthor=S.+Chau-inauthor=A.+Prawanauthor=A.+Puapairojauthor=P.+Zeekpudsaauthor=V.+Kukongviriyapan&title=NQO1+expression+correlates+with+cholangiocarcinoma+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1 expression correlates with cholangiocarcinoma prognosis</span></div><div class="casAuthors">Buranrat Benjaporn; Chau-in Siri; Prawan Auemduan; Puapairoj Anucha; Zeekpudsa Pornsilp; Kukongviriyapan Veerapol</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13 Suppl</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cholangiocarcinoma (CCA) is a rare type of liver cancer with a very poor prognosis.  The prevalence of CCA is markedly variable with the highest incidence in the northeast Thailand, followed by other parts of Southeast Asia and China.  Currently, there is still no reliable biomarker for diagnosis or treatment.  NADPH-quinone oxidoreductase 1 (NQO1) is a xenobiotic metabolizing enzyme detoxifying chemical stressors and antioxidants, thereby providing cytoprotection in normal tissues.  However, NQO1 is over-expressed in some cancers, suggesting roles in carcinogenesis and tumor progression.  In this study, we examined NQO1 activity in surgical specimens from CCA patients and found much higher values than in the adjacent normal tissues.  Immunohistochemical analysis revealed strong staining in tumor epithelial elements, whereas the non-tumor bile ducts and liver parenchyma were weakly stained.  NQO1 mRNA expression in tumor tissues was widely varied among 43 patients.  A significant association was observed between high level of NQO1 expression and short overall survival time by the Cox proportional hazard ratio of 2.40, p<0.05.  By histological classification, non-papillary adenocarcinoma was an independent predictor for poor prognosis with the hazard ratio of 2.79, p<0.05.  NQO1 expression may serve as a prognostic biomarker for the CCA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNfoZsjPp4hv6BottYdIAWfW6udTcc2eYTMzzUTjzVyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svps1Gmtw%253D%253D&md5=c8691b8b6dbb5aa3b0e096b344374fac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuranrat%26aufirst%3DB.%26aulast%3DChau-in%26aufirst%3DS.%26aulast%3DPrawan%26aufirst%3DA.%26aulast%3DPuapairoj%26aufirst%3DA.%26aulast%3DZeekpudsa%26aufirst%3DP.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26atitle%3DNQO1%2520expression%2520correlates%2520with%2520cholangiocarcinoma%2520prognosis%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev%26date%3D2012%26volume%3D13%26issue%3DSuppl%26spage%3D131%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garate, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">The NAD(P)H:quinone qxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.freeradbiomed.2010.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20226854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVeitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1601-1609&author=M.+Garateauthor=A.+A.+Waniauthor=G.+Li&title=The+NAD%28P%29H%3Aquinone+qxidoreductase+1+induces+cell+cycle+progression+and+proliferation+of+melanoma+cells&doi=10.1016%2Fj.freeradbiomed.2010.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells</span></div><div class="casAuthors">Garate, Marco; Wani, Aijaz A.; Li, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1601-1609</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The oxidoreductase NQO1 plays a prominent role in maintaining the cellular homeostasis.  NQO1 is mainly a cytosolic enzyme which catalyzes the metab. of quinones and is present in almost all tissue types providing protection against different stresses including xenobiotics, oxidants, UV light, and ionizing radiation.  This enzyme is overexpressed in many cancerous tissues and its function in carcinogenesis remains unclear.  Due to the relative lack of information on the role of NQO1 in melanoma pathogenesis, we attempted to det. the expression and basic function of NQO1 in melanoma cell proliferation.  We found that NQO1 is overexpressed in most melanoma cell lines with respect to melanocytes.  Furthermore, the expression of this oxidoreductase significantly induces cell cycle progression by upregulating the expression of cyclins A2, B1 and D1, leading to the proliferation of melanoma cells.  Our results also indicate that NQO1 is an upstream regulator of NF-κB p50, a factor linked to melanoma progression and poor patient prognosis.  Interestingly, we found that NQO1 stabilizes the transactivator BCL3, which in turn upregulates NF-κB p50.  More importantly, our results also indicate that NF-κB p50 correlates with the expression of NQO1 and mediates its role in the proliferation of melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN76lpLZ-knrVg90H21EOLACvtfcHk0liUcHphrR3bbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVeitrc%253D&md5=c9c6157ed02494427ea6c2fce2ab1866</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DGarate%26aufirst%3DM.%26aulast%3DWani%26aufirst%3DA.%2BA.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DThe%2520NAD%2528P%2529H%253Aquinone%2520qxidoreductase%25201%2520induces%2520cell%2520cycle%2520progression%2520and%2520proliferation%2520of%2520melanoma%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1601%26epage%3D1609%26doi%3D10.1016%2Fj.freeradbiomed.2010.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="NLM_citation" id="cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">244</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1271-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2Fs12885-015-1271-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25885439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjls1WjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=244&author=X.+Cuiauthor=L.+Liauthor=G.+Yanauthor=K.+Mengauthor=Z.+Linauthor=Y.+Nanauthor=G.+Jinauthor=C.+Li&title=High+expression+of+NQO1+is+associated+with+poor+prognosis+in+serous+ovarian+carcinoma&doi=10.1186%2Fs12885-015-1271-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma</span></div><div class="casAuthors">Cui Xuelian; Lin Zhenhua; Jin Guang; Cui Xuelian; Yan Guanghai; Meng Kai; Lin Zhenhua; Li Chunyu; Li Lianhua; Nan Yunze</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">244</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  NAD(P)H:  quinone oxidoreductase (NQO1) is a flavoprotein that catalyzes two-electron reduction and detoxification of quinones and its derivatives.  NQO1 catalyzes reactions that have a protective effect against redox cycling, oxidative stress and neoplasia.  High expression of NQO1 is associated with many solid tumors including those affecting the colon, breast and pancreas; however, its role in the progression of ovarian carcinoma is largely undefined.  This study aimed to investigate the clinicopathological significance of high NQO1 expression in serous ovarian carcinoma.  METHODS:  NQO1 protein expression was assessed using immunohistochemical (IHC) staining in 160 patients with serous ovarian carcinoma, 62 patients with ovarian borderline tumors and 53 patients with benign ovarian tumors.  Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect NQO1 mRNA expression levels.  The correlation between high NQO1 expression and clinicopathological features of ovarian carcinoma was evaluated by Chi-square and Fisher's exact test.  Overall survival (OS) rates of all of ovarian carcinoma patients were calculated using the Kaplan-Meier method, and univariate and multivariate analyses were performed using the Cox proportional hazards regression model.  RESULTS:  NQO1 protein expression in ovarian carcinoma cells was predominantly cytoplasmic.  Strong, positive expression of NQO1 protein was observed in 63.8% (102/160) of ovarian carcinomas, which was significantly higher than in borderline serous tumors (32.3%, 20/62) or benign serous tumors (11.3%, 6/53).  Importantly, the rate of strong, positive NQO1 expression in borderline serous tumors was also higher than in benign serous tumors.  High expression of NQO1 protein was closely associated with higher histological grade, advanced clinical stage and lower OS rates in ovarian carcinomas.  Moreover, multivariate analysis indicated that NQO1 was a significant independent prognostic factor, in addition to clinical stage, in patients with ovarian carcinoma.  CONCLUSIONS:  NQO1 is frequently upregulated in ovarian carcinoma.  High expressin of NQO1 protein may be an effective biomarker for poor prognostic evaluation of patients with serous ovarian carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWO10RlPN5-u2mnZh2OgS0fW6udTcc2eYTMzzUTjzVyLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjls1WjsA%253D%253D&md5=8356b0110e8b153176db8ea8095238fa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1271-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1271-4%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DNan%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DHigh%2520expression%2520of%2520NQO1%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520serous%2520ovarian%2520carcinoma%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D244%26doi%3D10.1186%2Fs12885-015-1271-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span> <span> </span><span class="NLM_article-title">NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">414</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-14-414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2F1471-2407-14-414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=414&author=Y.+Maauthor=J.+Kongauthor=G.+Yanauthor=X.+Renauthor=D.+Jinauthor=T.+Jinauthor=L.+Linauthor=Z.+Lin&title=NQO1+overexpression+is+associated+with+poor+prognosis+in+squamous+cell+carcinoma+of+the+uterine+cervix&doi=10.1186%2F1471-2407-14-414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-14-414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-14-414%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DZ.%26atitle%3DNQO1%2520overexpression%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520uterine%2520cervix%26jtitle%3DBMC%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D414%26doi%3D10.1186%2F1471-2407-14-414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="NLM_citation" id="cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1341490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1080%2F17425255.2017.1341490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28637373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKiu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=783-791&author=R.+M.+Phillipsauthor=H.+R.+Hendriksauthor=J.+B.+Sweeneyauthor=G.+Reddyauthor=G.+J.+Peters&title=Efficacy%2C+pharmacokinetic+and+pharmacodynamic+evaluation+of+apaziquone+in+the+treatment+of+non-muscle+invasive+bladder+cancer&doi=10.1080%2F17425255.2017.1341490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer</span></div><div class="casAuthors">Phillips, R. M.; Hendriks, H. R.; Sweeney, J. B.; Reddy, G.; Peters, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">783-791</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Apaziquone (also known as EO9 and QapzolaTM) is a prodrug that is activated to DNA damaging species by oxidoreductases (particularly NQO1) and has the ability to kill aerobic and/or hypoxic cancer cells.: While its poor pharmacokinetic properties contributed to its failure in phase II clin. trials when administered i.v., these properties were ideal for loco-regional therapies.  Apaziquone demonstrated good anti-cancer activity against non-muscle invasive bladder cancer (NMIBC) when administered intravesically to marker lesions and was well tolerated with no systemic side effects.  However, phase III clin. trials did not reach statistical significance for the primary endpoint of 2-yr recurrence in apaziquone over placebo although improvements were obsd.  Post-hoc anal. of the combined study data did indicate a significant benefit for patients treated with apaziquone, esp. when the instillation of apaziquone was given 30 min or more after surgery.  A further phase III study is ongoing to test the hypotheses generated in the unsuccessful phase III studies conducted to date.: Because of its specific pharmacol. properties, Apaziquone is excellently suited for local therapy such as NMIBC.  Future studies should include proper biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxlj4YY60Ej7Vg90H21EOLACvtfcHk0ljoXovFRa5n8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKiu7vP&md5=27956c11232190cdbf7a8847427c0ed4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1341490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1341490%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DHendriks%26aufirst%3DH.%2BR.%26aulast%3DSweeney%26aufirst%3DJ.%2BB.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DEfficacy%252C%2520pharmacokinetic%2520and%2520pharmacodynamic%2520evaluation%2520of%2520apaziquone%2520in%2520the%2520treatment%2520of%2520non-muscle%2520invasive%2520bladder%2520cancer%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D783%26epage%3D791%26doi%3D10.1080%2F17425255.2017.1341490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Pro-fluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1021/ja309346f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja309346f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=309-314&author=W.+C.+Silversauthor=B.+Prasaiauthor=D.+H.+Burkauthor=M.+L.+Brownauthor=R.+L.+McCarley&title=Pro-fluorogenic+reductase+substrate+for+rapid%2C+selective%2C+and+sensitive+visualization+and+detection+of+human+cancer+cells+that+overexpress+NQO1&doi=10.1021%2Fja309346f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja309346f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja309346f%26sid%3Dliteratum%253Aachs%26aulast%3DSilvers%26aufirst%3DW.%2BC.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DBurk%26aufirst%3DD.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DPro-fluorogenic%2520reductase%2520substrate%2520for%2520rapid%252C%2520selective%252C%2520and%2520sensitive%2520visualization%2520and%2520detection%2520of%2520human%2520cancer%2520cells%2520that%2520overexpress%2520NQO1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D309%26epage%3D314%26doi%3D10.1021%2Fja309346f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative Profluorophore</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">7575</span>– <span class="NLM_lpage">7578</span>, <span class="refDoi"> DOI: 10.1021/ja5030707</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5030707" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=7575-7578&author=S.+U.+Hettiarachchiauthor=B.+Prasaiauthor=R.+L.+McCarley&title=Detection+and+cellular+imaging+of+human+cancer+enzyme+using+a+turn-on%2C+wavelength-shiftable%2C+self-immolative+Profluorophore&doi=10.1021%2Fja5030707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and Cellular Imaging of Human Cancer Enzyme Using a Turn-On, Wavelength-Shiftable, Self-Immolative Profluorophore</span></div><div class="casAuthors">Hettiarachchi, Suraj U.; Prasai, Bijeta; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7575-7578</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A frontier area in the development of activatable (turn-on) fluorescence-based probes is concerned with rapid and selective stimulus triggering of probe activation so as to allow biomarker identification and cellular imaging.  The work here is concerned with a cloaked fluorophore composed of a reporter whose fluorescence is efficiently quenched by its attachment to an activatable trigger group via a novel self-immolative linker.  Highly selective and rapid activation of the trigger group is achieved by chem. and enzymic means that result in activated trigger group detachment from the self-immolative linker, with the latter subsequently cleaved from the reporter autonomously, thereby unmasking intense, red-shifted fluorescence emission.  To achieve this success, we used a tripartite probe comprised of a trimethyl-locked quinone propionic acid (Q3PA) trigger group and a fluorescently-masked naphthalimide reporter connected by an N-methyl-p-aminobenzyl alc. (NMPABA) self-immolative linker.  Delineated here are the synthesis and characterization of this cloaked fluorophore and the evaluation of its triggered turning on in the presence of an up-regulated enzyme in human cancer cells, NAD(P)H:quinone oxidoreductase-1 (NQO1, DT-diaphorase, EC 1.6.99.2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQG-vT5UnaibVg90H21EOLACvtfcHk0ljoXovFRa5n8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSnsLk%253D&md5=a3777b5e4faf5a78d8edaba98be794c4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja5030707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5030707%26sid%3Dliteratum%253Aachs%26aulast%3DHettiarachchi%26aufirst%3DS.%2BU.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DDetection%2520and%2520cellular%2520imaging%2520of%2520human%2520cancer%2520enzyme%2520using%2520a%2520turn-on%252C%2520wavelength-shiftable%252C%2520self-immolative%2520Profluorophore%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D7575%26epage%3D7578%26doi%3D10.1021%2Fja5030707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">A near-infrared, wavelength-shiftable, turn-on fluorescent probe for the detection and imaging of cancer tumor cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b01094</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b01094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlyjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1121-1132&author=Z.+Shenauthor=B.+Prasaiauthor=Y.+Nakamuraauthor=H.+Kobayashiauthor=M.+S.+Jacksonauthor=R.+L.+McCarley&title=A+near-infrared%2C+wavelength-shiftable%2C+turn-on+fluorescent+probe+for+the+detection+and+imaging+of+cancer+tumor+cells&doi=10.1021%2Facschembio.6b01094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A Near-Infrared, Wavelength-Shiftable, Turn-on Fluorescent Probe for the Detection and Imaging of Cancer Tumor Cells</span></div><div class="casAuthors">Shen, Zhenhua; Prasai, Bijeta; Nakamura, Yuko; Kobayashi, Hisataka; Jackson, Milcah S.; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1121-1132</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fast, selective, and noninvasive reporting of intracellular cancer-assocd. events and species will lead to a better understanding of tumorigenesis at the mol. level and development of precision medicine approaches in oncol.  Overexpressed reductase presence in solid tumor cells is key to cancer progression and protection of those diseased cells from the oxidative effects of therapeutics meant to kill them.  Human NAD(P)H:quinone oxidoreductase isoenzyme I (hNQO1), a cytoprotective 2-electron-specific reductase found at unusually high activity levels in cancer cells of multiple origins, has attracted significant attention due to its major role in metastatic pathways and its link to low survival rates in patients, as well as its ability to effectively activate quinone-based, anticancer drugs.  Accurate assessment of hNQO1 activities in living tumor models and ready differentiation of metastases from healthy tissue by fluorescent light-based protocols requires creation of hNQO1-responsive, near-IR probes that offer deep tissue penetration and low background fluorescence.  Herein, we disclose a quinone-trigger-based, near-IR probe whose fluorescence is effectively turned on several hundred-fold through highly selective redn. of the quinone trigger group by hNQO1, with unprecedented, catalytically efficient formation of a fluorescent reporter. hNQO1 activity-specific prodn. of a fluorescence signal in two-dimensional cultures of respiring human cancer cells that harbor the reductase enzyme allows for their quick (30 min) high-integrity recognition.  The characteristics of the near-IR probe make possible the imaging of clin. relevant three-dimensional colorectal tumor models possessing spatially heterogeneous hNQO1 activities and provide for fluorescence-assisted identification of submillimeter dimension metastases in a preclin. mouse model of human ovarian serous adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEPpZS_DxlpLVg90H21EOLACvtfcHk0ljoXovFRa5n8A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlyjur8%253D&md5=180febd56039c1d2ed43fc9410563a7c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b01094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b01094%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DJackson%26aufirst%3DM.%2BS.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DA%2520near-infrared%252C%2520wavelength-shiftable%252C%2520turn-on%2520fluorescent%2520probe%2520for%2520the%2520detection%2520and%2520imaging%2520of%2520cancer%2520tumor%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D1121%26epage%3D1132%26doi%3D10.1021%2Facschembio.6b01094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choyke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span> <span> </span><span class="NLM_article-title">Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD (P) H: quinone oxidoreductase isozyme 1 (hNQO1)</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">61181</span>– <span class="NLM_lpage">61192</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.18044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.18632%2Foncotarget.18044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=61181-61192&author=Y.+Nakamuraauthor=Z.+Shenauthor=T.+Haradaauthor=T.+Nagayaauthor=K.+Satoauthor=S.+Okuyamaauthor=F.+Ogataauthor=P.+Choykeauthor=R.+McCarleyauthor=H.+Kobayashi&title=Characteristics+of+ovarian+cancer+detection+by+a+near-infrared+fluorescent+probe+activated+by+human+NAD+%28P%29+H%3A+quinone+oxidoreductase+isozyme+1+%28hNQO1%29&doi=10.18632%2Foncotarget.18044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.18044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.18044%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DNagaya%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DS.%26aulast%3DOgata%26aufirst%3DF.%26aulast%3DChoyke%26aufirst%3DP.%26aulast%3DMcCarley%26aufirst%3DR.%26aulast%3DKobayashi%26aufirst%3DH.%26atitle%3DCharacteristics%2520of%2520ovarian%2520cancer%2520detection%2520by%2520a%2520near-infrared%2520fluorescent%2520probe%2520activated%2520by%2520human%2520NAD%2520%2528P%2529%2520H%253A%2520quinone%2520oxidoreductase%2520isozyme%25201%2520%2528hNQO1%2529%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D61181%26epage%3D61192%26doi%3D10.18632%2Foncotarget.18044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(00)00310-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0891-5849%2800%2900310-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11035253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=246-253&author=D.+Siegelauthor=D.+Ross&title=Immunodetection+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+in+human+tissues&doi=10.1016%2FS0891-5849%2800%2900310-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues</span></div><div class="casAuthors">Siegel, David; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">246-253</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Despite the extensive interest in NADPH:quinone oxidoreductase (NQO1, DT-diaphorase), there is little immunohistochem. information regarding its distribution in either normal human tissues or in human tumors.  Using immunohistochem. (IHC), we have examd. cell-specific expression of NQO1 in many normal tissues and tumors as a step toward defining the distribution of NQO1 in humans.  NQO1 was detected by IHC in respiratory, breast duct, thyroid follicle, and colonic epithelium, as well as in the corneal and lens epithelium of the eye.  NQO1 was also detected by IHC in vascular endothelium in all tissues examd.  NQO1 could also readily be detected in the endothelial lining of the aorta but was not detected using immunoblot anal. in the myocardium.  Adipocytes stained pos. for NQO1, and the enzyme was also detected by both IHC and immunoblot anal. in parasympathetic ganglia in the small intestine and in the optic nerve and nerve fibers.  NQO1 was not highly expressed in five different human liver samples using immunoblot anal., whereas studies using IHC demonstrated only trace NQO1 staining in isolated bile duct epithelium.  NQO1 expression was also examd. by IHC in a variety of solid tumors.  Marked NQO1 staining was detected in solid tumors from thyroid, adrenal, breast, ovarian, colon, and cornea and in non-small cell lung cancers.  The NQO1 content of many solid tumors supports the use of NQO1-directed anticancer agents for therapeutic purposes, but the distribution of NQO1 in normal tissues suggests that potential adverse effects of such agents need to be carefully monitored in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYni1QJFl4J7Vg90H21EOLACvtfcHk0lj5L8SXytkbAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrk%253D&md5=e990cc91825486b72d24c848b5d4a819</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900310-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900310-5%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DImmunodetection%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520in%2520human%2520tissues%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D246%26epage%3D253%26doi%3D10.1016%2FS0891-5849%2800%2900310-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Braver-Sewradj, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Braver, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dijk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N. M.</span></span> <span> </span><span class="NLM_article-title">Inter-individual variability in activity of the major drug metabolizing enzymes in liver homogenates of 20 individuals</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.2174/1389200219666180108160046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2174%2F1389200219666180108160046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=29318967" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+C.+Vosauthor=S.+P.+den+Braver-Sewradjauthor=M.+W.+den+Braverauthor=M.+van+Dijkauthor=Y.+Zhangauthor=S.+J.+Dekkerauthor=L.+Wijayaauthor=N.+P.+E.+Vermeulenauthor=L.+Richertauthor=J.+N.+M.+Commandeur&title=Inter-individual+variability+in+activity+of+the+major+drug+metabolizing+enzymes+in+liver+homogenates+of+20+individuals&doi=10.2174%2F1389200219666180108160046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F1389200219666180108160046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200219666180108160046%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DJ.%2BC.%26aulast%3Dden%2BBraver-Sewradj%26aufirst%3DS.%2BP.%26aulast%3Dden%2BBraver%26aufirst%3DM.%2BW.%26aulast%3Dvan%2BDijk%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDekker%26aufirst%3DS.%2BJ.%26aulast%3DWijaya%26aufirst%3DL.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26aulast%3DRichert%26aufirst%3DL.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%2BM.%26atitle%3DInter-individual%2520variability%2520in%2520activity%2520of%2520the%2520major%2520drug%2520metabolizing%2520enzymes%2520in%2520liver%2520homogenates%2520of%252020%2520individuals%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2018%26doi%3D10.2174%2F1389200219666180108160046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref34"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref34'); return false;" data-citation="" class="refNumLink">34</a></strong><div class="NLM_citation" id="cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rougee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riches, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, A. C.</span></span> <span> </span><span class="NLM_article-title">The ontogeny and population variability of human hepatic NADPH dehydrogenase quinone oxido-reductase 1 (NQO1)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.068650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fdmd.115.068650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=967-974&author=L.+R.+Rougeeauthor=Z.+Richesauthor=J.+M.+Bermanauthor=A.+C.+Collier&title=The+ontogeny+and+population+variability+of+human+hepatic+NADPH+dehydrogenase+quinone+oxido-reductase+1+%28NQO1%29&doi=10.1124%2Fdmd.115.068650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068650%26sid%3Dliteratum%253Aachs%26aulast%3DRougee%26aufirst%3DL.%2BR.%26aulast%3DRiches%26aufirst%3DZ.%26aulast%3DBerman%26aufirst%3DJ.%2BM.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26atitle%3DThe%2520ontogeny%2520and%2520population%2520variability%2520of%2520human%2520hepatic%2520NADPH%2520dehydrogenase%2520quinone%2520oxido-reductase%25201%2520%2528NQO1%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D967%26epage%3D974%26doi%3D10.1124%2Fdmd.115.068650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref35"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref35'); return false;" data-citation="" class="refNumLink">35</a></strong><div class="NLM_citation" id="cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleksunes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manautou, J. E.</span></span> <span> </span><span class="NLM_article-title">Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.3748/wjg.v12.i12.1937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3748%2Fwjg.v12.i12.1937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16610002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28Xksl2ntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1937-1940&author=L.+M.+Aleksunesauthor=M.+Goedkenauthor=J.+E.+Manautou&title=Up-regulation+of+NAD%28P%29H+quinone+oxidoreductase+1+during+human+liver+injury&doi=10.3748%2Fwjg.v12.i12.1937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury</span></div><div class="casAuthors">Aleksunes, Lauren M.; Goedken, Michael; Manautou, Jose E.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1937-1940</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">AIM: To investigate the expression and activity of NAD(P)H quinone oxidoreductase 1 (NQO1) in human liver specimens obtained from patients with liver damage due to acetaminophen (APAP) overdose or primary biliary cirrhosis (PBC).  METHODS: NQO1 activity was detd. in cytosol from normal, APAP and PBC liver specimens.  Western blot and immunohistochem. staining were used to det. patterns of NQO1 expression using a specific antibody against NQO1.  RESULTS: NQO1 protein was very low in normal human livers.  In both APAP and PBC livers, there was strong induction of NQO1 protein levels on Western blot.  Correspondingly, significant up-regulation of enzyme activity (16- and 22-fold, P < 0.05) was also obsd. in APAP and PBC livers, resp.  Immunohistochem. anal. highlighted injury-specific patterns of NQO1 staining in both APAP and PBC livers.  CONCLUSION: These data demonstrate that NQO1 protein and activity are markedly induced in human livers during both APAP overdose and PBC.  Up-regulation of this cytoprotective enzyme may represent an adaptive stress response to limit further disease progression by detoxifying reactive species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMZN7WGnnwLLVg90H21EOLACvtfcHk0lj5L8SXytkbAg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xksl2ntbk%253D&md5=518fff81404a13bab637fc25cbdeaea2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v12.i12.1937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v12.i12.1937%26sid%3Dliteratum%253Aachs%26aulast%3DAleksunes%26aufirst%3DL.%2BM.%26aulast%3DGoedken%26aufirst%3DM.%26aulast%3DManautou%26aufirst%3DJ.%2BE.%26atitle%3DUp-regulation%2520of%2520NAD%2528P%2529H%2520quinone%2520oxidoreductase%25201%2520during%2520human%2520liver%2520injury%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2006%26volume%3D12%26spage%3D1937%26epage%3D1940%26doi%3D10.3748%2Fwjg.v12.i12.1937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref36"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref36'); return false;" data-citation="" class="refNumLink">36</a></strong><div class="NLM_citation" id="cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strassburg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassburg, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manns, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukey, R. H.</span></span> <span> </span><span class="NLM_article-title">Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1124/mol.61.2.320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.61.2.320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=320-325&author=A.+Strassburgauthor=C.+P.+Strassburgauthor=M.+P.+Mannsauthor=R.+H.+Tukey&title=Differential+gene+expression+of+NAD%28P%29H%3Aquinone+oxidoreductase+and+NRH%3Aquinone+oxidoreductase+in+human+hepatocellular+and+biliary+tissue&doi=10.1124%2Fmol.61.2.320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fmol.61.2.320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.61.2.320%26sid%3Dliteratum%253Aachs%26aulast%3DStrassburg%26aufirst%3DA.%26aulast%3DStrassburg%26aufirst%3DC.%2BP.%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DTukey%26aufirst%3DR.%2BH.%26atitle%3DDifferential%2520gene%2520expression%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520and%2520NRH%253Aquinone%2520oxidoreductase%2520in%2520human%2520hepatocellular%2520and%2520biliary%2520tissue%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D320%26epage%3D325%26doi%3D10.1124%2Fmol.61.2.320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref37"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref37'); return false;" data-citation="" class="refNumLink">37</a></strong><div class="NLM_citation" id="cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covarrubias, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakhman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relling, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, J. G.</span></span> <span> </span><span class="NLM_article-title">Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2006.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.toxlet.2006.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16478651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XltFOrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2006&pages=249-258&author=V.+G.+Covarrubiasauthor=S.+S.+Lakhmanauthor=A.+Forrestauthor=M.+V.+Rellingauthor=J.+G.+Blanco&title=Higher+activity+of+polymorphic+NAD%28P%29H%3Aquinone+oxidoreductase+in+liver+cytosols+from+blacks+compared+to+whites&doi=10.1016%2Fj.toxlet.2006.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites</span></div><div class="casAuthors">Covarrubias, Vanessa Gonzalez; Lakhman, Sukhwinder S.; Forrest, Alan; Relling, Mary V.; Blanco, Javier G.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-258</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In human liver, the 2-electron redn. of quinone compds., such as menadione is catalyzed by cytosolic carbonyl reductase (CBR) and NAD(P)H:quinone oxidoreductase (NQO1) activities.  We assessed the relative contributions of CBR and NQO1 activities to the total menadione reducing capacity in liver cytosols from black (n = 31) and white donors (n = 63).  Maximal menadione reductase activities did not differ between black (13.0 ± 5.0 nmol/min mg), and white donors (11.4 ± 6.6 nmol/min mg; p = 0.208).  In addn., both groups presented similar levels of CBR activities (CBRblacks = 10.9 ± 4.1 nmol/min mg vs. CBRwhites = 10.5 ± 5.8 nmol/min mg; p = 0.708).  In contrast, blacks showed higher NQO1 activities (2-fold) than whites (NQO1blacks = 2.1 ± 3.0 nmol/min mg vs. NQO1whites = 0.9 ± 1.6 nmol/min mg, p < 0.01).  To further explore this disparity, we tested whether NQO1 activity was assocd. with the common NQO1 * 2 genetic polymorphism by paired DNA samples for genotyping.  Cytosolic NQO1 activities differed significantly by NQO1 genotype status in whites (NQO1whites[NQO1*1/*1] = 1.3 ± 1.7 nmol/min mg vs. NQO1whites[NQO1*1/*2+NQO1*2/*2] = 0.5 ± 0.7 nmol/min mg, p < 0.01), but not in blacks (NQO1blacks[NQO1*1/*1] = 2.6 ± 3.4 nmol/min mg vs. NQO1blacks[NQO1*1/*2] = 1.1 ± 1.2 nmol/min mg, p = 0.134).  Our findings pinpoint the presence of significant interethnic differences in polymorphic hepatic NQO1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5L7Zq1ydGWLVg90H21EOLACvtfcHk0lizyUOe_irqGg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltFOrtL4%253D&md5=4e2793398368040c75dd0c8d42652d45</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2006.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2006.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DCovarrubias%26aufirst%3DV.%2BG.%26aulast%3DLakhman%26aufirst%3DS.%2BS.%26aulast%3DForrest%26aufirst%3DA.%26aulast%3DRelling%26aufirst%3DM.%2BV.%26aulast%3DBlanco%26aufirst%3DJ.%2BG.%26atitle%3DHigher%2520activity%2520of%2520polymorphic%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520in%2520liver%2520cytosols%2520from%2520blacks%2520compared%2520to%2520whites%26jtitle%3DToxicol.%2520Lett.%26date%3D2006%26volume%3D164%26spage%3D249%26epage%3D258%26doi%3D10.1016%2Fj.toxlet.2006.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref38"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref38'); return false;" data-citation="" class="refNumLink">38</a></strong><div class="NLM_citation" id="cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollabaugh, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8014</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/bi300760u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300760u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8014-8026&author=M.+F.+Mendozaauthor=N.+M.+Hollabaughauthor=S.+U.+Hettiarachchiauthor=R.+L.+McCarley&title=Human+NAD%28P%29H%3Aquinone+oxidoreductase+type+I+%28hNQO1%29+activation+of+quinone+propionic+acid+trigger+groups&doi=10.1021%2Fbi300760u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi300760u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300760u%26sid%3Dliteratum%253Aachs%26aulast%3DMendoza%26aufirst%3DM.%2BF.%26aulast%3DHollabaugh%26aufirst%3DN.%2BM.%26aulast%3DHettiarachchi%26aufirst%3DS.%2BU.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DHuman%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520type%2520I%2520%2528hNQO1%2529%2520activation%2520of%2520quinone%2520propionic%2520acid%2520trigger%2520groups%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D8014%26epage%3D8026%26doi%3D10.1021%2Fbi300760u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref39"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref39'); return false;" data-citation="" class="refNumLink">39</a></strong><div class="NLM_citation" id="cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e44861</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0044861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1371%2Fjournal.pone.0044861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e44861&author=D.+Siegelauthor=J.+K.+Kepaauthor=D.+Ross&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+localizes+to+the+mitotic+spindle+in+human+cells&doi=10.1371%2Fjournal.pone.0044861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0044861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0044861%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520localizes%2520to%2520the%2520mitotic%2520spindle%2520in%2520human%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De44861%26doi%3D10.1371%2Fjournal.pone.0044861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref40"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref40'); return false;" data-citation="" class="refNumLink">40</a></strong><div class="NLM_citation" id="cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skelly, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suter, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Preliminary crystallographic data for NAD(P)H quinone reductase isolated from the Walker 256 rat carcinoma cell line</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1016/0022-2836(89)90233-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2F0022-2836%2889%2990233-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1989&pages=623-624&author=J.+V.+Skellyauthor=D.+A.+Suterauthor=R.+J.+Knoxauthor=E.+Garmanauthor=D.+I.+Stuartauthor=M.+R.+Sandersonauthor=J.+J.+Robertsauthor=S.+Neidle&title=Preliminary+crystallographic+data+for+NAD%28P%29H+quinone+reductase+isolated+from+the+Walker+256+rat+carcinoma+cell+line&doi=10.1016%2F0022-2836%2889%2990233-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2889%2990233-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252889%252990233-7%26sid%3Dliteratum%253Aachs%26aulast%3DSkelly%26aufirst%3DJ.%2BV.%26aulast%3DSuter%26aufirst%3DD.%2BA.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26aulast%3DRoberts%26aufirst%3DJ.%2BJ.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DPreliminary%2520crystallographic%2520data%2520for%2520NAD%2528P%2529H%2520quinone%2520reductase%2520isolated%2520from%2520the%2520Walker%2520256%2520rat%2520carcinoma%2520cell%2520line%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1989%26volume%3D205%26spage%3D623%26epage%3D624%26doi%3D10.1016%2F0022-2836%2889%2990233-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref41"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref41'); return false;" data-citation="" class="refNumLink">41</a></strong><div class="NLM_citation" id="cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">8846</span>– <span class="NLM_lpage">8850</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.19.8846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1073%2Fpnas.92.19.8846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=7568029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADyaK2MXotVGqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=8846-8850&author=R.+Liauthor=M.+A.+Bianchetauthor=P.+Talalayauthor=L.+M.+Amzel&title=The+three-dimensional+structure+of+NAD%28P%29H%3Aquinone+reductase%2C+a+flavoprotein+involved+in+cancer+chemoprotection+and+chemotherapy%3A+mechanism+of+the+two-electron+reduction&doi=10.1073%2Fpnas.92.19.8846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction</span></div><div class="casAuthors">Li, Rongbao; Bianchet, Mario A.; Talalay, Paul; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8846-50</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">NAD(P)H-quinone reductase (EC 1.6.99.2; DT-diaphorase) (I) is a homodimeric FAD-contg. enzyme that catalyzes obligatory NAD(P)H-dependent 2-electron redns. of quinones and protects cells against the toxic and neoplastic effects of free radicals and reactive O species arising from 1-electron redns.  These 2-electron redns. participate in the reductive bioactivation of cancer chemotherapeutic agents, such as mitomycin C, in tumor cells.  Thus, surprisingly, the same enzymic reaction that protects normal cells activates cytotoxic drugs used in cancer chemotherapy.  The 2.1-Å crystal structure of rat liver I reveals that the folding of a portion of each monomer is similar to that of flavodoxin, a bacterial FMN-contg. protein.  Two addnl. portions of the polypeptide chains are involved in dimerization and in formation of the 2 identical catalytic sites to which both monomers contribute.  The crystallog. structures of 2 FAD-contg. enzyme complexes (one contg. NADP, the other contg. duroquinone) suggest that direct hydride transfers from NAD(P)H to FAD and from FADH2 to the quinone [which occupies the site vacated by NAD(P)H] provide a simple rationale for the obligatory 2-electron redns. involving a ping-pong mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8odSAC4zmXrVg90H21EOLACvtfcHk0liCAXRCmGqhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotVGqsb4%253D&md5=02011e74bffe95b5148f3edcf8c5255f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.19.8846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.19.8846%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520three-dimensional%2520structure%2520of%2520NAD%2528P%2529H%253Aquinone%2520reductase%252C%2520a%2520flavoprotein%2520involved%2520in%2520cancer%2520chemoprotection%2520and%2520chemotherapy%253A%2520mechanism%2520of%2520the%2520two-electron%2520reduction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D8846%26epage%3D8850%26doi%3D10.1073%2Fpnas.92.19.8846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref42"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref42'); return false;" data-citation="" class="refNumLink">42</a></strong><div class="NLM_citation" id="cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3177</span>– <span class="NLM_lpage">3182</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.7.3177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1073%2Fpnas.97.7.3177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10706635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlWqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3177-3182&author=M.+Faigauthor=M.+A.+Bianchetauthor=P.+Talalayauthor=S.+Chenauthor=S.+Winskiauthor=D.+Rossauthor=L.+M.+Amzel&title=Structures+of+recombinant+human+and+mouse+NAD%28P%29H%3Aquinone+oxidoreductases%3A+species+comparison+and+structural+changes+with+substrate+binding+and+release&doi=10.1073%2Fpnas.97.7.3177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release</span></div><div class="casAuthors">Faig, Margarita; Bianchet, Mario A.; Talalay, Paul; Chen, Shiuan; Winski, Shannon; Ross, David; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3177-3182</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">NAD(P)H/quinone acceptor oxidoreductase (QR1, NQO1, formerly DT-diaphorase; EC 1.6.99.2) protects animal cells from the deleterious and carcinogenic effects of quinones and other electrophiles.  In this paper we report the apoenzyme structures of human (at 1.7-Å resoln.) and mouse (2.8 Å) QR1 and the complex of the human enzyme with the substrate duroquinone (2.5 Å) (2,3,5,6-tetramethyl-p-benzoquinone).  In addn. to providing a description and rationale of the structural and catalytic differences among several species, these structures reveal the changes that accompany substrate or cofactor (NAD) binding and release.  Tyrosine-128 and the loop spanning residues 232-236 close the binding site, partially occupying the space left vacant by the departing mol. (substrate or cofactor).  These changes highlight the exquisite control of access to the catalytic site that is required by the ping-pong mechanism in which, after reducing the flavin, NAD(P)+ leaves the catalytic site and allows substrate to bind at the vacated position.  In the human QR1-duroquinone structure one ring carbon is significantly closer to the flavin N5, suggesting a direct hydride transfer to this atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNsGZ7S3xBmbVg90H21EOLACvtfcHk0liCAXRCmGqhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlWqsrc%253D&md5=ea05115386364d758bc56f4cb248df86</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.7.3177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.7.3177%26sid%3Dliteratum%253Aachs%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWinski%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructures%2520of%2520recombinant%2520human%2520and%2520mouse%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductases%253A%2520species%2520comparison%2520and%2520structural%2520changes%2520with%2520substrate%2520binding%2520and%2520release%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D3177%26epage%3D3182%26doi%3D10.1073%2Fpnas.97.7.3177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref43"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref43'); return false;" data-citation="" class="refNumLink">43</a></strong><div class="NLM_citation" id="cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dym, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsvetkov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaul, Y.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">6372</span>– <span class="NLM_lpage">6378</span>, <span class="refDoi"> DOI: 10.1021/bi0600087</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0600087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=6372-6378&author=G.+Asherauthor=O.+Dymauthor=P.+Tsvetkovauthor=J.+Adlerauthor=Y.+Shaul&title=The+crystal+structure+of+NAD%28P%29H+quinone+oxidoreductase+1+in+complex+with+its+potent+inhibitor+dicoumarol&doi=10.1021%2Fbi0600087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol</span></div><div class="casAuthors">Asher, Gad; Dym, Orly; Tsvetkov, Peter; Adler, Julia; Shaul, Yosef</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6372-6378</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NAD(P)H-quinone oxidoreductase 1 (NQO1) is a ubiquitous flavoenzyme that catalyzes 2-electron redn. of quinones to hydroquinones utilizing NAD(P)H as an electron donor.  NQO1 binds and stabilizes several short-lived proteins including tumor suppressors p53 and p73 and the enzyme, ornithine decarboxylase (ODC).  Dicoumarol (I) is a widely used potent competitive inhibitor of NQO1 activity, which competes with NAD(P)H for binding to NQO1.  I also disrupts the binding of NQO1 to p53, p73, and ODC, and induces their ubiquitin-independent proteasomal degrdn.  Here, the authors report the crystal structure of human NQO1 in complex with I at 2.75 Å resoln.  The authors identified the interactions of I with different residues of NQO1 and the conformational changes imposed upon I binding.  The most prominent conformational changes that occurred in the presence of I involved Tyr-128 and Phe-232 that were present on the surface of the NQO1 catalytic pocket.  On the basis of the comparison of the NQO1 structure in complex with different NQO1 inhibitors and the authors' previous anal. of NQO1 mutants, it was proposed that the specific conformations of Tyr-128 and Phe-232 are important for NQO1 interaction with p53 and other client proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkSa4EYFO7G7Vg90H21EOLACvtfcHk0liCAXRCmGqhOA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVSnsbw%253D&md5=518fc56112b1093246f8d41ff6bbcc9e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi0600087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0600087%26sid%3Dliteratum%253Aachs%26aulast%3DAsher%26aufirst%3DG.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DTsvetkov%26aufirst%3DP.%26aulast%3DAdler%26aufirst%3DJ.%26aulast%3DShaul%26aufirst%3DY.%26atitle%3DThe%2520crystal%2520structure%2520of%2520NAD%2528P%2529H%2520quinone%2520oxidoreductase%25201%2520in%2520complex%2520with%2520its%2520potent%2520inhibitor%2520dicoumarol%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D6372%26epage%3D6378%26doi%3D10.1021%2Fbi0600087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref44"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref44'); return false;" data-citation="" class="refNumLink">44</a></strong><div class="NLM_citation" id="cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudnott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(01)00636-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0969-2126%2801%2900636-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=659-667&author=M.+Faigauthor=M.+A.+Bianchetauthor=S.+Winskiauthor=R.+Hargreavesauthor=C.+J.+Moodyauthor=A.+R.+Hudnottauthor=D.+Rossauthor=L.+M.+Amzel&title=Structure-based+development+of+anticancer+drugs%3A+complexes+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+with+chemotherapeutic+quinones&doi=10.1016%2FS0969-2126%2801%2900636-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2801%2900636-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252801%252900636-0%26sid%3Dliteratum%253Aachs%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DWinski%26aufirst%3DS.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DHudnott%26aufirst%3DA.%2BR.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructure-based%2520development%2520of%2520anticancer%2520drugs%253A%2520complexes%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520with%2520chemotherapeutic%2520quinones%26jtitle%3DStructure%26date%3D2001%26volume%3D9%26spage%3D659%26epage%3D667%26doi%3D10.1016%2FS0969-2126%2801%2900636-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref45"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref45'); return false;" data-citation="" class="refNumLink">45</a></strong><div class="NLM_citation" id="cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharjan, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimian, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seradj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocksdale, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span> <span> </span><span class="NLM_article-title">Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7733</span>– <span class="NLM_lpage">774946</span>, <span class="refDoi"> DOI: 10.1021/jm050758z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050758z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7733-774946&author=M.+Hassaniauthor=W.+Caiauthor=D.+C.+Holleyauthor=J.+P.+Lineswalaauthor=B.+R.+Maharjanauthor=G.+R.+Ebrahimianauthor=H.+Seradjauthor=M.+G.+Stocksdaleauthor=F.+Mohammadiauthor=C.+C.+Marvinauthor=J.+M.+Gerdesauthor=H.+D.+Beallauthor=M.+Behforouz&title=Novel+lavendamycin+analogues+as+antitumor+agents%3A+synthesis%2C+in+vitro+cytotoxicity%2C+structure-metabolism%2C+and+computational+molecular+modeling+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1021%2Fjm050758z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050758z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050758z%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DMaharjan%26aufirst%3DB.%2BR.%26aulast%3DEbrahimian%26aufirst%3DG.%2BR.%26aulast%3DSeradj%26aufirst%3DH.%26aulast%3DStocksdale%26aufirst%3DM.%2BG.%26aulast%3DMohammadi%26aufirst%3DF.%26aulast%3DMarvin%26aufirst%3DC.%2BC.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DBehforouz%26aufirst%3DM.%26atitle%3DNovel%2520lavendamycin%2520analogues%2520as%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520cytotoxicity%252C%2520structure-metabolism%252C%2520and%2520computational%2520molecular%2520modeling%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7733%26epage%3D774946%26doi%3D10.1021%2Fjm050758z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref46"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref46'); return false;" data-citation="" class="refNumLink">46</a></strong><div class="NLM_citation" id="cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcaín, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, J. M.</span></span> <span> </span><span class="NLM_article-title">NQO1-directed antitumour quinones</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1517/13543776.17.6.649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1517%2F13543776.17.6.649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFWqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=649-665&author=F.+J.+Alca%C3%ADnauthor=J.+M.+Villalba&title=NQO1-directed+antitumour+quinones&doi=10.1517%2F13543776.17.6.649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1-directed antitumour quinones</span></div><div class="casAuthors">Alcain, Francisco J.; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">649-665</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  NAD(P)H:(quinone acceptor) oxidoreductase 1 (NQO1) is a cytosolic flavoenzyme that catalyzes the obligatory two-electron redn. of several quinones to their corresponding hydroquinones by using both NADH and NADPH.  NQO1 has relevance in chemotherapy because bioreductive drugs require enzymic activation prior to conversion into cytotoxic compds.  Because levels of NQO1 are elevated in some tumors, the enzyme provides an opportunity to develop improved new chemotherapeutic drugs that are bioactivated by this enzyme.  The classical NQO1-directed drugs are quinone-contg. alkylating agents, such as the prototypical bioreductive agent mitomycin C, and different azirinidylbenzoquinones, such as 2,5 bis-[1-aziridyl]-1,4 benzoquinone, that target DNA crosslinks and strand breaks after redn.  New analogs of those quinones, such as EO9 and RH1, have been developed to overcome the poor substrate specificity and poor soly. in aq. soln. to improve its therapeutic utilization.  Also, NQO1 is implied in the activation of new drugs that act as inhibitors of different proteins. β-Lapachone is not a DNA damaging agent and preclin. studies have shown very promising results.  The benzoquinone ansamycins, 17-allylamino,17-demethoxygeldanamycin and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin, which exhibit anticancer activity by binding to heat-shock protein 90 (Hsp90), are also in clin. trials.  NQO1 activity needs a threshold value to induce cytotoxicity.  As a polymorphism in NQO1, known as NQO1*2, results in dramatically decreased NQO1 enzyme activity, NQO1 polymorphism should be carefully monitored in the patients before the use of NQO1-directed drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqsFzr5qNvbVg90H21EOLACvtfcHk0liafndV7OsnvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFWqt78%253D&md5=62fa440c64accbd447a61dc504721e5e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.6.649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.6.649%26sid%3Dliteratum%253Aachs%26aulast%3DAlca%25C3%25ADn%26aufirst%3DF.%2BJ.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DNQO1-directed%2520antitumour%2520quinones%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D649%26epage%3D665%26doi%3D10.1517%2F13543776.17.6.649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref47"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref47'); return false;" data-citation="" class="refNumLink">47</a></strong><div class="NLM_citation" id="cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cismesia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Efficient NQO1 substrates are potent and selective anticancer agents</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2183</span>, <span class="refDoi"> DOI: 10.1021/cb4005832</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4005832" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cqtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2173-2183&author=E.+I.+Parkinsonauthor=J.+S.+Bairauthor=M.+Cismesiaauthor=P.+J.+Hergenrother&title=Efficient+NQO1+substrates+are+potent+and+selective+anticancer+agents&doi=10.1021%2Fcb4005832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient NQO1 Substrates are Potent and Selective Anticancer Agents</span></div><div class="casAuthors">Parkinson, Elizabeth I.; Bair, Joseph S.; Cismesia, Megan; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2173-2183</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major goal of personalized medicine in oncol. is the identification of drugs with predictable efficacy based on a specific trait of the cancer cell, as has been demonstrated with gleevec (presence of Bcr-Abl protein), herceptin (Her2 overexpression), and iressa (presence of a specific EGFR mutation).  This is a challenging task, as it requires identifying a cellular component that is altered in cancer, but not normal cells, and discovering a compd. that specifically interacts with it.  The enzyme NQO1 is a potential target for personalized medicine, as it is overexpressed in many solid tumors.  In normal cells NQO1 is inducibly expressed, and its major role is to detoxify quinones via bioredn.; however, certain quinones become more toxic after redn. by NQO1, and these compds. have potential as selective anticancer agents.  Several quinones of this type have been reported, including mitomycin C, RH1, EO9, streptonigrin, β-lapachone, and deoxynyboquinone (DNQ, I).  However, no unified picture has emerged from these studies, and the key question regarding the relationship between NQO1 processing and anticancer activity remains unanswered.  Here, we directly compare these quinones as substrates for NQO1 in vitro, and for their ability to kill cancer cells in culture in an NQO1-dependent manner.  We show that DNQ is a superior NQO1 substrate, and we use computationally guided design to create DNQ analogs that have a spectrum of activities with NQO1.  Assessment of these compds. definitively establishes a strong relationship between in vitro NQO1 processing and induction of cancer cell death and suggests these compds. are outstanding candidates for selective anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1kk91zQCbDrVg90H21EOLACvtfcHk0liafndV7OsnvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cqtb7M&md5=589e4483d77ac0534e4098ae8c9c4760</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcb4005832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4005832%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DCismesia%26aufirst%3DM.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DEfficient%2520NQO1%2520substrates%2520are%2520potent%2520and%2520selective%2520anticancer%2520agents%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2173%26epage%3D2183%26doi%3D10.1021%2Fcb4005832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref48"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref48'); return false;" data-citation="" class="refNumLink">48</a></strong><div class="NLM_citation" id="cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span> <span> </span><span class="NLM_article-title">Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3104</span>– <span class="NLM_lpage">3115</span>, <span class="refDoi"> DOI: 10.1021/jm701066a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVKmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3104-3115&author=M.+Hassaniauthor=W.+Caiauthor=K.+H.+Koelschauthor=D.+C.+Holleyauthor=A.+S.+Roseauthor=F.+Olangauthor=J.+P.+Lineswalaauthor=W.+G.+Hollowayauthor=J.+M.+Gerdesauthor=M.+Behforouzauthor=H.+D.+Beall&title=Lavendamycin+antitumor+agents%3A+structure-based+design%2C+synthesis%2C+and+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+model+validation+with+molecular+docking+and+biological+studies&doi=10.1021%2Fjm701066a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Lavendamycin Antitumor Agents: Structure-Based Design, Synthesis, and NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Model Validation with Molecular Docking and Biological Studies</span></div><div class="casAuthors">Hassani, Mary; Cai, Wen; Koelsch, Katherine H.; Holley, David C.; Rose, Anthony S.; Olang, Fatemeh; Lineswala, Jayana P.; Holloway, William G.; Gerdes, John M.; Behforouz, Mohammad; Beall, Howard D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3104-3115</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A 1H69 crystal structure-based in silico model of the NAD(P)H:quinone oxidoreductase 1 (NQO1) active site has been developed to facilitate NQO1-directed lavendamycin antitumor agent development.  Lavendamycin analogs, e.g. I, were designed as NQO1 substrates utilizing structure-based design criteria.  Computational docking studies were performed using the model to predict NQO1 substrate specificity.  Designed N-acyllavendamycin esters and amides were synthesized by Pictet-Spengler condensation.  Metab. and cytotoxicity studies were performed on the analogs with recombinant human NQO1 and human colon adenocarcinoma cells (NQO1-deficient BE and NQO1-rich BE-NQ).  Docking and biol. data were found to be correlated where analogs were categorized as good, poor, poor, poor, and good NQO1 substrates, resp.  Our results demonstrated that the ligand design criteria were valid, resulting in the discovery of two good NQO1 substrates.  The obsd. consistency between the docking and biol. data suggests that the model possesses practical predictive power.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUcaMyIPjnRrVg90H21EOLACvtfcHk0liafndV7OsnvA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVKmur4%253D&md5=993bc0a63b2e61cc7a190788c655eb7e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm701066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701066a%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DKoelsch%26aufirst%3DK.%2BH.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DRose%26aufirst%3DA.%2BS.%26aulast%3DOlang%26aufirst%3DF.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DW.%2BG.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBehforouz%26aufirst%3DM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26atitle%3DLavendamycin%2520antitumor%2520agents%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520and%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520model%2520validation%2520with%2520molecular%2520docking%2520and%2520biological%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3104%26epage%3D3115%26doi%3D10.1021%2Fjm701066a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref49"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref49'); return false;" data-citation="" class="refNumLink">49</a></strong><div class="NLM_citation" id="cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">839</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2016.10.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=828-839&author=J.+Bianauthor=X.+Liauthor=L.+Xuauthor=N.+Wangauthor=X.+Qianauthor=Q.+Youauthor=X.+Zhang&title=Affinity-based+small+fluorescent+probe+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29.+Design%2C+synthesis+and+pharmacological+evaluation&doi=10.1016%2Fj.ejmech.2016.10.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DAffinity-based%2520small%2520fluorescent%2520probe%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529.%2520Design%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D828%26epage%3D839%26doi%3D10.1016%2Fj.ejmech.2016.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref50"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref50'); return false;" data-citation="" class="refNumLink">50</a></strong><div class="NLM_citation" id="cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structures of mammalian cytosolic quinone reductases</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(00)00299-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0891-5849%2800%2900299-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11035252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=241-245&author=C.+E.+Fosterauthor=M.+A.+Bianchetauthor=P.+Talalayauthor=M.+Faigauthor=L.+M.+Amzel&title=Structures+of+mammalian+cytosolic+quinone+reductases&doi=10.1016%2FS0891-5849%2800%2900299-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of mammalian cytosolic quinone reductases</span></div><div class="casAuthors">Foster, Christine E.; Bianchet, Mario A.; Talalay, Paul; Faig, Margarita; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">241-245</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 14 refs.  The metab. of quinone compds. presents one source of oxidative stress in mammals, as many pathways proceed by mechanisms that generate reactive oxygen species as byproducts.  One defense against quinone toxicity is the enzyme NAD(P)H:quinone oxidoreductase type 1 (QR1), which metabolizes quinones by a two-electron redn. mechanism, thus averting prodn. of radicals.  QR1 is expressed in the cytoplasm of many tissues, and is highly inducible.  A closely related homolog, quinone reductase type 2 (QR2), has been identified in several mammalian species.  QR2 is also capable of reducing quinones to hydroquinones, but unlike QR1, cannot use NAD(P)H.  X-ray crystallog. studies of QR1 and QR2 illustrate that despite their different biochem. properties, these enzymes have very similar three-dimensional structures.  In particular, conserved features of the active sites point to the close relationship between these two enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqv8qE1WvdS7Vg90H21EOLACvtfcHk0ljwQ7B9cLTHYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrg%253D&md5=dec7a440e344046491917934f56f5313</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900299-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900299-9%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DC.%2BE.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructures%2520of%2520mammalian%2520cytosolic%2520quinone%2520reductases%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D241%26epage%3D245%26doi%3D10.1016%2FS0891-5849%2800%2900299-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref51"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref51'); return false;" data-citation="" class="refNumLink">51</a></strong><div class="NLM_citation" id="cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6688</span>, <span class="refDoi"> DOI: 10.1021/bi2002967</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2002967" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6678-6688&author=C.+Yanauthor=M.+Dufourauthor=D.+Siegelauthor=P.+Reiganauthor=J.+Gomezauthor=B.+Shiehauthor=C.+J.+Moodyauthor=D.+Ross&title=Indolequinone+inhibitors+of+NRH%3Aquinone+oxidoreductase+2.+Characterization+of+the+mechanism+of+inhibition+in+both+cell-free+and+cellular+systems&doi=10.1021%2Fbi2002967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi2002967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2002967%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%26aulast%3DDufour%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DGomez%26aufirst%3DJ.%26aulast%3DShieh%26aufirst%3DB.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DIndolequinone%2520inhibitors%2520of%2520NRH%253Aquinone%2520oxidoreductase%25202.%2520Characterization%2520of%2520the%2520mechanism%2520of%2520inhibition%2520in%2520both%2520cell-free%2520and%2520cellular%2520systems%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6678%26epage%3D6688%26doi%3D10.1021%2Fbi2002967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref52"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref52'); return false;" data-citation="" class="refNumLink">52</a></strong><div class="NLM_citation" id="cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, D. J.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, A. K.</span></span> <span> </span><span class="NLM_article-title">NRH:quinone oxidoreductase2 (NQO2)</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/S0009-2797(00)00200-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0009-2797%2800%2900200-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11154737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=99-112&author=D.+J.+Longauthor=A.+K.+Jaiswal&title=NRH%3Aquinone+oxidoreductase2+%28NQO2%29&doi=10.1016%2FS0009-2797%2800%2900200-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">NRH:quinone oxidoreductase2 (NQO2)</span></div><div class="casAuthors">Long, D. J.; Jaiswal, A. K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">99-112</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review, with 73 refs.  The quinone oxidoreductases [NAD(P)H:quinone oxidoreductase1 (NQO1) and NRH:quinone oxidoreductase2 (NQO2)] are flavoproteins.  NQO1 is known to catalyze metabolic detoxification of quinones and protect cells from redox cycling, oxidative stress and neoplasia.  NQO2 is a 231 amino acid protein (25956 mw) that is 43 amino acids shorter than NQO1 at its C-terminus.  The human NQO2 cDNA and protein are 54 and 49% similar to the human liver cytosolic NQO1 cDNA and protein.  Recent studies have revealed that NQO2 differs from NQO1 in its cofactor requirement.  NQO2 uses dihydronicotinamide riboside (NRH) rather than NAD(P)H as an electron donor.  Another difference between NQO1 and NQO2 is that NQO2 is resistant to typical inhibitors of NQO1, such as dicoumarol, Cibacron blue and phenindone.  Flavones, including quercetin and benzo(a)pyrene, are known inhibitors of NQO2.  Even though overlapping substrate specificities have been obsd. for NQO1 and NQO2, significant differences exist in relative affinities for the various substrates.  Anal. of the crystal structure of NQO2 revealed that NQO2 contains a specific metal binding site, which is not present in NQO1.  The human NQO2 gene has been precisely localized to chromosome 6p25.  The human NQO2 gene locus is highly polymorphic.  The NQO2 gene is ubiquitously expressed and induced in response to TCDD.  Nucleotide sequence anal. of the NQO2 gene promoter revealed the presence of several cis-elements, including SP1 binding sites, CCAAT box, xenobiotic response element (XRE) and an antioxidant response element (ARE).  The complement of these elements regulates tissue specific expression and induction of the NQO2 gene in response to xenobiotics and antioxidants.  The in vivo role of NQO2 and its role in quinone detoxification remains unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-3DSF4CJxcLVg90H21EOLACvtfcHk0ljwQ7B9cLTHYw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOnug%253D%253D&md5=6180e990aec3b7754653993364e52159</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900200-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900200-3%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DD.%2BJ.%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26atitle%3DNRH%253Aquinone%2520oxidoreductase2%2520%2528NQO2%2529%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D99%26epage%3D112%26doi%3D10.1016%2FS0009-2797%2800%2900200-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref53"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref53'); return false;" data-citation="" class="refNumLink">53</a></strong><div class="NLM_citation" id="cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nioi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors</span>. <i>Mutat. Res., Fundam. Mol. Mech. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.mrfmmm.2004.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.mrfmmm.2004.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15476858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot12gs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2004&pages=149-171&author=P.+Nioiauthor=J.+D.+Hayes&title=Contribution+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+to+protection+against+carcinogenesis%2C+and+regulation+of+its+gene+by+the+Nrf2+basic-region+leucine+zipper+and+the+arylhydrocarbon+receptor+basic+helix-loop-helix+transcription+factors&doi=10.1016%2Fj.mrfmmm.2004.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors</span></div><div class="casAuthors">Nioi, Paul; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">149-171</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is a key enzyme involved in defense against reactive forms of oxygen and inhibition of neoplasia.  Under conditions of oxidative stress, expression of NQO1 is induced, and the resulting increase in oxidoreductase protein provides the cell with multiple layers of protection against environmental insults.  Firstly, the catalytic activity of NQO1 is directed towards the complete redn. and detoxication of highly reactive quinones.  Secondly, the oxidoreductase maintains the endogenous lipid-sol. antioxidants, α-tocopherol-hydroquinone and ubiquinol in their reduced and active forms.  Thirdly, NQO1 is required for the stabilization of p53 protein in response to DNA-damaging stimuli, and it thereby influences cell fate decisions.  In view of the anticarcinogenic actions of NQO1, an understanding of the mechanisms that govern its expression is desirable.  The redox sensitivity of NQO1 transcription occurs through a cis-acting antioxidant response element (ARE) located within the regulatory region of the mouse, rat and human genes.  This element recruits the pos. acting basic leucine zipper (bZip) transcription factor NF-E2 p45-related factor 2 (Nrf2).  Under normal constitutive conditions, Nrf2 assocs. with the cytoskeletal-binding protein Keap1, which regulates the subcellular distribution of the bZip factor and also targets it for proteasome-dependent degrdn.  Oxidative stress inhibits the Nrf2-Keap1 interaction, thus promoting nuclear accumulation of the transcription factor and transactivation of NQO1 and other ARE-driven genes.  Mouse, rat and human NQO1 can also be induced by planar arom. hydrocarbons through a cis-acting xenobiotic response element (XRE) located in their gene promoters.  The XRE recruits the arylhydrocarbon receptor (AhR) and AhR nuclear translocator.  Cross-talk may occur between Nrf2 and AhR, but the details of this process remain to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7W-E8vNF8ALVg90H21EOLACvtfcHk0lhZYEdgmzk2pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot12gs7w%253D&md5=e57ca8beda945db8d929c3bfbb9472a0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2004.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2004.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DNioi%26aufirst%3DP.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DContribution%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520to%2520protection%2520against%2520carcinogenesis%252C%2520and%2520regulation%2520of%2520its%2520gene%2520by%2520the%2520Nrf2%2520basic-region%2520leucine%2520zipper%2520and%2520the%2520arylhydrocarbon%2520receptor%2520basic%2520helix-loop-helix%2520transcription%2520factors%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2004%26volume%3D555%26spage%3D149%26epage%3D171%26doi%3D10.1016%2Fj.mrfmmm.2004.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref54"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref54'); return false;" data-citation="" class="refNumLink">54</a></strong><div class="NLM_citation" id="cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Awadallah, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell Nash, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentz, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shroyer, K. R.</span></span> <span> </span><span class="NLM_article-title">NQO1 expression in pancreatic cancer and its potential use as a biomarker</span>. <i>Appl. Immunohistochem. Mol. Morphol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1097/PAI.0b013e31802e91d0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1097%2FPAI.0b013e31802e91d0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=18091324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FlsF2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=24-31&author=N.+S.+Awadallahauthor=D.+Dehnauthor=R.+J.+Shahauthor=S.+Russell+Nashauthor=Y.+K.+Chenauthor=D.+Rossauthor=J.+S.+Bentzauthor=K.+R.+Shroyer&title=NQO1+expression+in+pancreatic+cancer+and+its+potential+use+as+a+biomarker&doi=10.1097%2FPAI.0b013e31802e91d0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1 expression in pancreatic cancer and its potential use as a biomarker</span></div><div class="casAuthors">Awadallah Nida S; Dehn Donna; Shah Raj J; Russell Nash S; Chen Yang K; Ross David; Bentz Joel S; Shroyer Kenneth R</div><div class="citationInfo"><span class="NLM_cas:title">Applied immunohistochemistry & molecular morphology : AIMM</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-31</span>
        ISSN:<span class="NLM_cas:issn">1541-2016</span>.
    </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is rarely curable due to regional/metastatic spread at diagnosis.  Identification of molecular markers may enhance diagnosis and early detection of PDA.  The 2-electron reductase, NAD(P)H:quinone oxidoreductase (NQO1) has been found to be overexpressed in many solid tumors including PDA, and may be a useful clinically relevant diagnostic marker of malignancy.  For this study, we used 37 surgical resection cases: 24 PDAs and 13 benign pancreatic tissue specimens.  An additional 16 specimens from pancreatic endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) were included as a pilot series.  NQO1 was detected by avidin-biotin based immunohistochemical and immunocytochemical methods.  Both staining intensity and proportion of NQO1 positive tumor cells were scored.  Moderate to strong (2 to 3+) staining for NQO1 was detected in 22/24 (92%) surgically resected PDAs, 9/9 (100%) EUS-FNAs with malignant diagnoses, one cytologically atypical but not diagnostic for malignancy EUS-FNA, and 1/6 (17%) EUS-FNAs initially diagnosed as negative for malignancy.  Subsequent histologic assessment confirmed malignancy in all 9 cytologically positive EUS-FNAs and in the atypical case.  The NQO1 positive case initially diagnosed as negative for malignancy showed no evidence of carcinoma on subsequent tissue biopsy.  NQO1 staining was also observed in some benign ducts/cells; however, correlation of NQO1 expression with cellular morphology assessment minimizes the risk of false positive diagnosis.  NQO1 is consistently overexpressed in PDA.  Although NQO1 is observed in some benign tissue components, this marker may be a clinically useful diagnostic adjunct for detection of PDA, independent of tumor grade/stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhxgbKcVaHKy6Ufuk_1xoTfW6udTcc2eaKDgLtc2KAo7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FlsF2msA%253D%253D&md5=f1117fb75ec0de6638489607d82a2603</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1097%2FPAI.0b013e31802e91d0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FPAI.0b013e31802e91d0%26sid%3Dliteratum%253Aachs%26aulast%3DAwadallah%26aufirst%3DN.%2BS.%26aulast%3DDehn%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DR.%2BJ.%26aulast%3DRussell%2BNash%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBentz%26aufirst%3DJ.%2BS.%26aulast%3DShroyer%26aufirst%3DK.%2BR.%26atitle%3DNQO1%2520expression%2520in%2520pancreatic%2520cancer%2520and%2520its%2520potential%2520use%2520as%2520a%2520biomarker%26jtitle%3DAppl.%2520Immunohistochem.%2520Mol.%2520Morphol.%26date%3D2008%26volume%3D16%26spage%3D24%26epage%3D31%26doi%3D10.1097%2FPAI.0b013e31802e91d0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref55"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref55'); return false;" data-citation="" class="refNumLink">55</a></strong><div class="NLM_citation" id="cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madajewski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span> <span> </span><span class="NLM_article-title">Depleting tumor-NQO1 potentiates anoikis and inhibits growth of NSCLC</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-15-0207-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1541-7786.MCR-15-0207-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26553038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=14-25&author=B.+Madajewskiauthor=M.+A.+Boatmanauthor=G.+Chakrabartiauthor=D.+A.+Boothmanauthor=E.+A.+Bey&title=Depleting+tumor-NQO1+potentiates+anoikis+and+inhibits+growth+of+NSCLC&doi=10.1158%2F1541-7786.MCR-15-0207-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC</span></div><div class="casAuthors">Madajewski, Brian; Boatman, Michael A.; Chakrabarti, Gaurab; Boothman, David A.; Bey, Erik A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-25</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fundamental role that NAD(P)H/quinone oxidoreductase 1 (NQO1) plays, in normal cells, as a cytoprotective enzyme guarding against stress induced by reactive oxygen species (ROS) is well documented.  However, what is not known is whether the obsd. overexpression of NQO1 in neoplastic cells contributes to their survival.  The current study discovered that depleting NQO1 expression in A549 and H292 lung adenocarcinoma cells caused an increase in ROS formation, inhibited anchorage-independent growth, increased anoikis sensitization, and decreased three-dimensional tumor spheroid invasion.  These in vivo data further implicate tumor-NQO1 expression in a protumor survival role, because its depletion suppressed cell proliferation and decreased lung tumor xenograft growth.  Finally, these data reveal an exploitable link between tumor-NQO1 expression and the survival of lung tumors because NQO1 depletion significantly decreased the percentage of ALDH(high) cancer cells within the tumor population.  Implications: Loss of tumor-NQO1 expression inhibits tumor growth and suggests that novel therapeutics directed at tumor-NQO1 may have clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG23XWx6fObLVg90H21EOLACvtfcHk0lhZYEdgmzk2pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFOqsg%253D%253D&md5=79ec188e9d2ff4583ef1c9849f6f03ff</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-15-0207-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-15-0207-T%26sid%3Dliteratum%253Aachs%26aulast%3DMadajewski%26aufirst%3DB.%26aulast%3DBoatman%26aufirst%3DM.%2BA.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DBey%26aufirst%3DE.%2BA.%26atitle%3DDepleting%2520tumor-NQO1%2520potentiates%2520anoikis%2520and%2520inhibits%2520growth%2520of%2520NSCLC%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2016%26volume%3D14%26spage%3D14%26epage%3D25%26doi%3D10.1158%2F1541-7786.MCR-15-0207-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref56"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref56'); return false;" data-citation="" class="refNumLink">56</a></strong><div class="NLM_citation" id="cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Columbano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span> <span> </span><span class="NLM_article-title">The dual roles of NRF2 in cancer</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">593</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.molmed.2016.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27263465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=578-593&author=S.+Menegonauthor=A.+Columbanoauthor=S.+Giordano&title=The+dual+roles+of+NRF2+in+cancer&doi=10.1016%2Fj.molmed.2016.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Dual Roles of NRF2 in Cancer</span></div><div class="casAuthors">Menegon, Silvia; Columbano, Amedeo; Giordano, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">578-593</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress.  However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy.  In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6FPL0WZuHbVg90H21EOLACvtfcHk0lhZYEdgmzk2pg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D&md5=88b1ab6ed97e3f249fc5ea9e694b6d75</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DColumbano%26aufirst%3DA.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DThe%2520dual%2520roles%2520of%2520NRF2%2520in%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D578%26epage%3D593%26doi%3D10.1016%2Fj.molmed.2016.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref57"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref57'); return false;" data-citation="" class="refNumLink">57</a></strong><div class="NLM_citation" id="cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leinonen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansanen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinaniemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A. L.</span></span> <span> </span><span class="NLM_article-title">Role of the Keap1-Nrf2 pathway in cancer</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-420117-0.00008-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FB978-0-12-420117-0.00008-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2014&pages=281-320&author=H.+M.+Leinonenauthor=E.+Kansanenauthor=P.+Polonenauthor=M.+Heinaniemiauthor=A.+L.+Levonen&title=Role+of+the+Keap1-Nrf2+pathway+in+cancer&doi=10.1016%2FB978-0-12-420117-0.00008-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420117-0.00008-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420117-0.00008-6%26sid%3Dliteratum%253Aachs%26aulast%3DLeinonen%26aufirst%3DH.%2BM.%26aulast%3DKansanen%26aufirst%3DE.%26aulast%3DPolonen%26aufirst%3DP.%26aulast%3DHeinaniemi%26aufirst%3DM.%26aulast%3DLevonen%26aufirst%3DA.%2BL.%26atitle%3DRole%2520of%2520the%2520Keap1-Nrf2%2520pathway%2520in%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2014%26volume%3D122%26spage%3D281%26epage%3D320%26doi%3D10.1016%2FB978-0-12-420117-0.00008-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref58"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref58'); return false;" data-citation="" class="refNumLink">58</a></strong><div class="NLM_citation" id="cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karreth, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpton, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frese, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrimieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1038/nature10189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fnature10189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21734707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=106-109&author=G.+M.+DeNicolaauthor=F.+A.+Karrethauthor=T.+J.+Humptonauthor=A.+Gopinathanauthor=C.+Weiauthor=K.+Freseauthor=D.+Mangalauthor=K.+H.+Yuauthor=C.+J.+Yeoauthor=E.+S.+Calhounauthor=F.+Scrimieriauthor=J.+M.+Winterauthor=R.+H.+Hrubanauthor=C.+Iacobuzio-Donahueauthor=S.+E.+Kernauthor=I.+A.+Blairauthor=D.+A.+Tuveson&title=Oncogene-induced+Nrf2+transcription+promotes+ROS+detoxification+and+tumorigenesis&doi=10.1038%2Fnature10189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span></div><div class="casAuthors">DeNicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">106-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer.  Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe2l2) and its repressor protein Keap1 (refs. 2-5).  In contrast to the acute physiol. regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2.  Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and addnl. Nrf2 functions may in fact be pro-tumorigenic.  Here, we investigated ROS metab. in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes.  K-RasG12D, B-RafV619E and MycERT2 each increased the transcription of Nrf2 to stably elevate the basal Nrf2 antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment.  Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-RasG12D and B-RafV619E, and in human pancreatic cancer.  Furthermore, genetic targeting of the Nrf2 pathway impairs K-RasG12D-induced proliferation and tumorigenesis in vivo.  Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFpMbvjw2msLVg90H21EOLACvtfcHk0lj5KHUSpN76-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D&md5=54d0e0b5940672a96bde0f8cfd9e7ff9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnature10189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10189%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DKarreth%26aufirst%3DF.%2BA.%26aulast%3DHumpton%26aufirst%3DT.%2BJ.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrese%26aufirst%3DK.%26aulast%3DMangal%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DScrimieri%26aufirst%3DF.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DBlair%26aufirst%3DI.%2BA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DOncogene-induced%2520Nrf2%2520transcription%2520promotes%2520ROS%2520detoxification%2520and%2520tumorigenesis%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D106%26epage%3D109%26doi%3D10.1038%2Fnature10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref59"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref59'); return false;" data-citation="" class="refNumLink">59</a></strong><div class="NLM_citation" id="cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">19798</span>– <span class="NLM_lpage">19808</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601162200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M601162200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=19798-19808&author=K.+S.+Ahnauthor=G.+Sethiauthor=A.+K.+Jainauthor=A.+K.+Jaiswalauthor=B.+B.+Aggarwal&title=Genetic+deletion+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+abrogates+activation+of+nuclear+factor-kappaB%2C+IkappaBalpha+kinase%2C+c-Jun+N-terminal+kinase%2C+Akt%2C+p38%2C+and+p44%2F42+mitogen-activated+protein+kinases+and+potentiates+apoptosis&doi=10.1074%2Fjbc.M601162200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601162200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601162200%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DGenetic%2520deletion%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520abrogates%2520activation%2520of%2520nuclear%2520factor-kappaB%252C%2520IkappaBalpha%2520kinase%252C%2520c-Jun%2520N-terminal%2520kinase%252C%2520Akt%252C%2520p38%252C%2520and%2520p44%252F42%2520mitogen-activated%2520protein%2520kinases%2520and%2520potentiates%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D19798%26epage%3D19808%26doi%3D10.1074%2Fjbc.M601162200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref60"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref60'); return false;" data-citation="" class="refNumLink">60</a></strong><div class="NLM_citation" id="cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruthenborg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span> <span> </span><span class="NLM_article-title">NQO1 inhibits proteasome-mediated degradation of HIF-1α</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13593</span>, <span class="refDoi"> DOI: 10.1038/ncomms13593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fncomms13593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27966538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13593&author=E.+T.+Ohauthor=J.+W.+Kimauthor=J.+M.+Kimauthor=S.+J.+Kimauthor=J.+S.+Leeauthor=S.+S.+Hongauthor=J.+Goodwinauthor=R.+J.+Ruthenborgauthor=M.+G.+Jungauthor=H.+J.+Leeauthor=C.+H.+Leeauthor=E.+S.+Parkauthor=C.+Kimauthor=H.+J.+Park&title=NQO1+inhibits+proteasome-mediated+degradation+of+HIF-1%CE%B1&doi=10.1038%2Fncomms13593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1 inhibits proteasome-mediated degradation of HIF-1α</span></div><div class="casAuthors">Oh, Eun-Taex; Kim, Jung-whan; Kim, Joon Mee; Kim, Soo Jung; Lee, Jae-Seon; Hong, Soon-Sun; Goodwin, Justin; Ruthenborg, Robin J.; Jung, Myung Gu; Lee, Hae-June; Lee, Chul-Ho; Park, Eun Sung; Kim, Chulhee; Park, Heon Joo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13593</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Overexpression of NQO1 is assocd. with poor prognosis in human cancers including breast, colon, cervix, lung and pancreas.  Yet, the mol. mechanisms underlying the pro-tumorigenic capacities of NQO1 have not been fully elucidated.  Here we show a previously undescribed function for NQO1 in stabilizing HIF-1α, a master transcription factor of oxygen homeostasis that has been implicated in the survival, proliferation and malignant progression of cancers.  We demonstrate that NQO1 directly binds to the oxygen-dependent domain of HIF-1α and inhibits the proteasome-mediated degrdn. of HIF-1α by preventing PHDs from interacting with HIF-1α.  NQO1 knockdown in human colorectal and breast cancer cell lines suppresses HIF-1 signalling and tumor growth.  Consistent with this pro-tumorigenic function for NQO1, high NQO1 expression levels correlate with increased HIF-1α expression and poor colorectal cancer patient survival.  These results collectively reveal a function of NQO1 in the oxygen-sensing mechanism that regulates HIF-1α stability in cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1DEnwbSAozbVg90H21EOLACvtfcHk0lj5KHUSpN76-w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamsb3J&md5=1a3f21b8a1c1f64c2f042e159a0be9bc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fncomms13593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13593%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DE.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DGoodwin%26aufirst%3DJ.%26aulast%3DRuthenborg%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%2BG.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DE.%2BS.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26atitle%3DNQO1%2520inhibits%2520proteasome-mediated%2520degradation%2520of%2520HIF-1%25CE%25B1%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13593%26doi%3D10.1038%2Fncomms13593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref61"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref61'); return false;" data-citation="" class="refNumLink">61</a></strong><div class="NLM_citation" id="cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buranrat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongpetch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span> <span> </span><span class="NLM_article-title">Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2362</span>– <span class="NLM_lpage">2370</span>, <span class="refDoi"> DOI: 10.3748/wjg.v16.i19.2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3748%2Fwjg.v16.i19.2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20480521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2362-2370&author=B.+Buranratauthor=A.+Prawanauthor=U.+Kukongviriyapanauthor=S.+Kongpetchauthor=V.+Kukongviriyapan&title=Dicoumarol+enhances+gemcitabine-induced+cytotoxicity+in+high+NQO1-expressing+cholangiocarcinoma+cells&doi=10.3748%2Fwjg.v16.i19.2362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells</span></div><div class="casAuthors">Buranrat, Buranrat; Prawan, Auemduan; Kukongviriyapan, Upa; Kongpetch, Sarinya; Kukongviriyapan, Veerapol</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2362-2370</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">WJG Press and Beijing Baishideng BioMed Scientific Co., Ltd.</span>)
        </div><div class="casAbstract">Aim: To investigate whether dicoumarol, a potent inhibitor of NAD(P)H quinone oxidoreductase-1 (NQO1), potentiates gemcitabine to induce cytotoxicity in cholangiocarcinoma cells (CCA) and the role of reactive oxygen generation in sensitizing the cells.  Methods: Four human cell lines with different NQO1 activity were used; the human CCA cell lines, KKU-100, KKU-OCA17, KKU-M214, and Chang liver cells.  NQO1 activity and mRNA expression were detd.  The cells were pretreated with dicoumarol at relevant concns. before treatment with gemcitabine.  Cytotoxicity was detd. by staining with fluorescent dyes.  Oxidant formation was examd. by assay of cellular glutathione levels and reactive oxygen species prodn. by using dihydrofluorescein diacetate.  Measurement of mitochondrial transmembrane potential was performed by using JC-1 fluorescent probe.  Western blotting anal. was performed to det. levels of survival related proteins.  Results: Dicoumarol markedly enhanced the cytotoxicity of gemcitabine in KKU-100 and KKU-OCA17, the high NQO1 activity and mRNA expressing cells, but not in the other cells with low NQO1 activity.  Dicoumarol induced a marked decrease in cellular redox of glutathione in KKU-100 cells, in contrast to KKU-M214 cells.  Dicoumarol at concns. that inhibited NQO1 activity did not alter mitochondrial transmembrane potential and prodn. of reactive oxygen species.  Gemcitabine alone induced activation of NF-κB and Bcl-XL protein expression.  However, gemcitabine and dicoumarol combination induced increased p53 and decreased Bcl-XL levels in KKU-100, but not in KKU-M214 cells.  Conslusion: NQO1 may be important in sensitizing cells to anticancer drugs and inhibition of NQO1 may be a strategy for the treatment of CCA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreCLcEpizhYrVg90H21EOLACvtfcHk0lhgGQM9gpGgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFCqtL4%253D&md5=febe7e2566ab3d02f4430887f1884bc8</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v16.i19.2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v16.i19.2362%26sid%3Dliteratum%253Aachs%26aulast%3DBuranrat%26aufirst%3DB.%26aulast%3DPrawan%26aufirst%3DA.%26aulast%3DKukongviriyapan%26aufirst%3DU.%26aulast%3DKongpetch%26aufirst%3DS.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26atitle%3DDicoumarol%2520enhances%2520gemcitabine-induced%2520cytotoxicity%2520in%2520high%2520NQO1-expressing%2520cholangiocarcinoma%2520cells%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2010%26volume%3D16%26spage%3D2362%26epage%3D2370%26doi%3D10.3748%2Fwjg.v16.i19.2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref62"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref62'); return false;" data-citation="" class="refNumLink">62</a></strong><div class="NLM_citation" id="cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeekpudsa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senggunprai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sripa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span> <span> </span><span class="NLM_article-title">Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/1756-9966-33-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2F1756-9966-33-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24460787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=11&author=P.+Zeekpudsaauthor=V.+Kukongviriyapanauthor=L.+Senggunpraiauthor=B.+Sripaauthor=A.+Prawan&title=Suppression+of+NAD%28P%29H-quinone+oxidoreductase+1+enhanced+the+susceptibility+of+cholangiocarcinoma+cells+to+chemotherapeutic+agents&doi=10.1186%2F1756-9966-33-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents</span></div><div class="casAuthors">Zeekpudsa, Ponsilp; Kukongviriyapan, Veerapol; Senggunprai, Laddawan; Sripa, Banchob; Prawan, Auemduan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11/1-11/13</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cholangiocarcinoma (CCA) is highly resistant to most of the known chemotherapeutic treatments.  NAD(P)H-quinone oxidoreductase 1 (NQO1) is an antioxidant/detoxifying enzyme recently recognized as an important contributor to chemoresistance in some human cancers.  However, the contribution of NQO1 to chemotherapy resistance in CCA is unknown.  Methods: Two CCA cell lines, KKU-100 and KKU-M214, with high and low NQO1 expression levels, resp., were used to evaluate the sensitivity to chemotherapeutic agents; 5-fluorouracil (5-FU), doxorubicin (Doxo), and gemcitabine (Gem).  NQO1 and/or p53 expression in KKU-100 cells were knocked down by siRNA.  NQO1 was over-expressed in KKU-M214 cells by transfection with pCMV6-XL5-NQO1 expression vector.  CCA cells with modulated NQO1 and/or p53 expression were treated with chemotherapeutic agents, and the cytotoxicity was assessed by SRB assay.  The mechanism of enhanced chemosensitivity was evaluated by Western blot anal.  Results: When NQO1 was knocked down, KKU-100 cells became more susceptible to all chemotherapeutic agents.  Conversely, with over-expression of NQO1 made KKU-M214 cells more resistant to chemotherapeutic agents.  Western blot anal. suggested that enhanced chemosensitivity was probably due to the activation of p53-mediated cell death.  Enhanced susceptibility to chemotherapeutic agents by NQO1 silencing was abolished by knockdown of p53.  Conclusions: These results suggest that inhibition of NQO1 could enhance the susceptibility of CCA to an array of chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWtyzHeX5ebVg90H21EOLACvtfcHk0lhgGQM9gpGgng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFKgtbg%253D&md5=c947cda683ada15e32cf34df1863b55e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-33-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-33-11%26sid%3Dliteratum%253Aachs%26aulast%3DZeekpudsa%26aufirst%3DP.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26aulast%3DSenggunprai%26aufirst%3DL.%26aulast%3DSripa%26aufirst%3DB.%26aulast%3DPrawan%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520NAD%2528P%2529H-quinone%2520oxidoreductase%25201%2520enhanced%2520the%2520susceptibility%2520of%2520cholangiocarcinoma%2520cells%2520to%2520chemotherapeutic%2520agents%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D33%26spage%3D11%26doi%3D10.1186%2F1756-9966-33-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref63"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref63'); return false;" data-citation="" class="refNumLink">63</a></strong><div class="NLM_citation" id="cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butsri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senggunprai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongpetch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeekpudsa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span> <span> </span><span class="NLM_article-title">Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4540</span>– <span class="NLM_lpage">4548</span>, <span class="refDoi"> DOI: 10.3892/ol.2017.5951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3892%2Fol.2017.5951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28599455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmvVSmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=4540-4548&author=S.+Butsriauthor=V.+Kukongviriyapanauthor=L.+Senggunpraiauthor=S.+Kongpetchauthor=P.+Zeekpudsaauthor=A.+Prawan&title=Downregulation+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+inhibits+proliferation%2C+cell+cycle+and+migration+of+cholangiocarcinoma+cells&doi=10.3892%2Fol.2017.5951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells</span></div><div class="casAuthors">Butsri Siriwoot; Kukongviriyapan Veerapol; Senggunprai Laddawan; Kongpetch Sarinya; Prawan Auemduan; Zeekpudsa Ponsilp</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4540-4548</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">We previously reported that upregulation of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cholangiocarcinoma (CCA; a fatal bile duct cancer) was associated with poor prognosis.  It was also demonstrated that the suppression of NQO1 was able to enhance the chemosensitivity of CCA cells.  In the present study, in order to elucidate the biological role of NQO1 in CCA, the effects of small interfering RNA (siRNA)-mediated knockdown of NQO1 on cell proliferation, cell cycle and migration were determined in KKU-100 CCA cells, which notably expressed NQO1.  The cell proliferation ability and cell cycle distribution were identified by clonogenic cell survival assay and flow cytometric analysis, respectively.  Wound healing and Transwell migration assays were performed to evaluate cell migration.  The molecules involved in cell proliferation and migration were determined by western blot analysis and reverse transcription-quantitative polymerase chain reaction analysis.  The results demonstrated that NQO1 siRNA-mediated knockdown effectively impaired colony formation capacity, induced cell cycle arrest at the G1 phase and suppressed migration of KKU-100 cells.  CCA cells transfected with NQO1 siRNA exhibited increased expression levels of p21 and decreased cyclin D1 protein expression levels.  Furthermore, the ratio of matrix metalloproteinase 9/tissue inhibitors of metalloproteinases 1 (TIMP1) mRNA expression level was decreased in the NQO1-knockdown cells.  Therefore, the present study provided evidence supporting the biological role of NQO1 in the regulation of cell proliferation, cell cycle and migration of CCA cells.  Therefore, NQO1 may prove to be a potential molecular target to enhance CCA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTmsNgvUr8LNTiMd2aNQVUfW6udTcc2eZjL2wsoo6DWrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmvVSmsQ%253D%253D&md5=c8ac512aeb4ed14dd225387853e0d106</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.5951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.5951%26sid%3Dliteratum%253Aachs%26aulast%3DButsri%26aufirst%3DS.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26aulast%3DSenggunprai%26aufirst%3DL.%26aulast%3DKongpetch%26aufirst%3DS.%26aulast%3DZeekpudsa%26aufirst%3DP.%26aulast%3DPrawan%26aufirst%3DA.%26atitle%3DDownregulation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520inhibits%2520proliferation%252C%2520cell%2520cycle%2520and%2520migration%2520of%2520cholangiocarcinoma%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D13%26spage%3D4540%26epage%3D4548%26doi%3D10.3892%2Fol.2017.5951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref64"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref64'); return false;" data-citation="" class="refNumLink">64</a></strong><div class="NLM_citation" id="cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(04)82008-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0076-6879%2804%2982008-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15047100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVWksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2004&pages=115-144&author=D.+Rossauthor=D.+Siegel&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%2C+DT-diaphorase%29%2C+functions+and+pharmacogenetics&doi=10.1016%2FS0076-6879%2804%2982008-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics</span></div><div class="casAuthors">Ross, David; Siegel, David</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">Quinones and Quinone Enzymes, Part B</span>),
    <span class="NLM_cas:pages">115-144</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review discussing possible functions of NAD(P)H:quinone oxidoreductase 1 (NQO1) and the relevance of the common NQO polymorphism for chemoprotection, susceptibility to disease and cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFjd2T0Gg33rVg90H21EOLACvtfcHk0lgi638sOnm6Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVWksLY%253D&md5=a744fb90347e782bcc780c0ef9a62b78</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2804%2982008-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252804%252982008-1%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DSiegel%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%252C%2520DT-diaphorase%2529%252C%2520functions%2520and%2520pharmacogenetics%26jtitle%3DMethods%2520Enzymol.%26date%3D2004%26volume%3D382%26spage%3D115%26epage%3D144%26doi%3D10.1016%2FS0076-6879%2804%2982008-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref65"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref65'); return false;" data-citation="" class="refNumLink">65</a></strong><div class="NLM_citation" id="cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1124/mol.59.2.263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.59.2.263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=263-268&author=D.+Siegelauthor=A.+Anwarauthor=S.+L.+Winskiauthor=J.+K.+Kepaauthor=K.+L.+Zolmanauthor=D.+Ross&title=Rapid+polyubiquitination+and+proteasomal+degradation+of+a+mutant+form+of+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1124%2Fmol.59.2.263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.2.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.2.263%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DZolman%26aufirst%3DK.%2BL.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRapid%2520polyubiquitination%2520and%2520proteasomal%2520degradation%2520of%2520a%2520mutant%2520form%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D263%26epage%3D268%26doi%3D10.1124%2Fmol.59.2.263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref66"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref66'); return false;" data-citation="" class="refNumLink">66</a></strong><div class="NLM_citation" id="cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span> <span> </span><span class="NLM_article-title">A functional NQO1 609C > T polymorphism and risk of gastrointestinal cancers: a meta-analysis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e30566</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0030566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1371%2Fjournal.pone.0030566" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30566&author=H.+Yuauthor=H.+Liuauthor=L.+E.+Wangauthor=Q.+Wei&title=A+functional+NQO1+609C+%3E+T+polymorphism+and+risk+of+gastrointestinal+cancers%3A+a+meta-analysis&doi=10.1371%2Fjournal.pone.0030566"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030566%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%2BE.%26aulast%3DWei%26aufirst%3DQ.%26atitle%3DA%2520functional%2520NQO1%2520609C%2520%253E%2520T%2520polymorphism%2520and%2520risk%2520of%2520gastrointestinal%2520cancers%253A%2520a%2520meta-analysis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30566%26doi%3D10.1371%2Fjournal.pone.0030566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref67"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref67'); return false;" data-citation="" class="refNumLink">67</a></strong><div class="NLM_citation" id="cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi-Ishimae, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadakane, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greaves, M.</span></span> <span> </span><span class="NLM_article-title">The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2005&pages=1511-1515&author=M.+Eguchi-Ishimaeauthor=M.+Eguchiauthor=E.+Ishiiauthor=D.+Knightauthor=Y.+Sadakaneauthor=K.+Isoyamaauthor=H.+Yabeauthor=S.+Mizutaniauthor=M.+Greaves&title=The+association+of+a+distinctive+allele+of+NAD%28P%29H%3Aquinone+oxidoreductase+with+pediatric+acute+lymphoblastic+leukemias+with+MLL+fusion+genes+in+Japan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEguchi-Ishimae%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DE.%26aulast%3DKnight%26aufirst%3DD.%26aulast%3DSadakane%26aufirst%3DY.%26aulast%3DIsoyama%26aufirst%3DK.%26aulast%3DYabe%26aufirst%3DH.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DGreaves%26aufirst%3DM.%26atitle%3DThe%2520association%2520of%2520a%2520distinctive%2520allele%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520with%2520pediatric%2520acute%2520lymphoblastic%2520leukemias%2520with%2520MLL%2520fusion%2520genes%2520in%2520Japan%26jtitle%3DHaematologica%26date%3D2005%26volume%3D90%26spage%3D1511%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref68"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref68'); return false;" data-citation="" class="refNumLink">68</a></strong><div class="NLM_citation" id="cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span> <span> </span><span class="NLM_article-title">Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6316</span>– <span class="NLM_lpage">6325</span>, <span class="refDoi"> DOI: 10.1021/jm070472p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070472p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12gs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6316-6325&author=K.+A.+Nolanauthor=H.+Zhaoauthor=P.+F.+Faulderauthor=A.+D.+Frenkelauthor=D.+J.+Timsonauthor=D.+Siegelauthor=D.+Rossauthor=T.+R.+Burkeauthor=I.+J.+Stratfordauthor=R.+A.+Bryce&title=Coumarin-based+inhibitors+of+human+NAD%28P%29H%3Aquinone+oxidoreductase-1.+Identification%2C+structure-activity%2C+off-target+effects+and+in+vitro+human+pancreatic+cancer+toxicity&doi=10.1021%2Fjm070472p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarin-Based Inhibitors of Human NAD(P)H:Quinone Oxidoreductase-1. Identification, Structure-Activity, Off-Target Effects and In Vitro Human Pancreatic Cancer Toxicity</span></div><div class="casAuthors">Nolan, Karen A.; Zhao, He; Faulder, Paul F.; Frenkel, A. David; Timson, David J.; Siegel, David; Ross, David; Burke, Terrence R., Jr.; Stratford, Ian J.; Bryce, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6316-6325</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme human NAD(P)H quinone oxidoreductase-1 (NQO1), which is overexpressed in several types of tumor cell, is considered a design target for cancer therapeutics.  We identify new coumarin-based competitive inhibitors of NQO1, one of which is nanomolar.  Using computational docking and mol. dynamics, we obtain insights into the structural basis of inhibition.  Selected inhibitors were then assessed for off-target effects assocd. with dicoumarol and were found to have differing effects on superoxide formation and mitochondrial respiration.  A comparison of NQO1 inhibition and off-target effects for dicoumarol and its derivs. suggests that the ability of dicoumarol to kill cancer cells is independent of NQO1 inhibition, that cellular superoxide prodn. by dicoumarol does not seem linked to NQO1 inhibition but may be related to mitochondrial decoupling, and that superoxide does not appear to be a major determinant of cytotoxicity.  Implications are discussed for NQO1 inhibition as an anticancer drug design target and superoxide generation as the dicoumarol-mediated mechanism of cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ykpgei7OebVg90H21EOLACvtfcHk0lgi638sOnm6Bw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12gs7rE&md5=c206d6f2d6f676d86f0dbd09ab7a8d4c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm070472p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070472p%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DK.%2BA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DFaulder%26aufirst%3DP.%2BF.%26aulast%3DFrenkel%26aufirst%3DA.%2BD.%26aulast%3DTimson%26aufirst%3DD.%2BJ.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26atitle%3DCoumarin-based%2520inhibitors%2520of%2520human%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase-1.%2520Identification%252C%2520structure-activity%252C%2520off-target%2520effects%2520and%2520in%2520vitro%2520human%2520pancreatic%2520cancer%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6316%26epage%3D6325%26doi%3D10.1021%2Fjm070472p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref69"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref69'); return false;" data-citation="" class="refNumLink">69</a></strong><div class="NLM_citation" id="cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doncaster, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunstan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7142</span>– <span class="NLM_lpage">7156</span>, <span class="refDoi"> DOI: 10.1021/jm9011609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9011609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCku77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7142-7156&author=K.+A.+Nolanauthor=J.+R.+Doncasterauthor=M.+S.+Dunstanauthor=K.+A.+Scottauthor=A.+D.+Frenkelauthor=D.+Siegelauthor=D.+Rossauthor=J.+Barnesauthor=C.+Levyauthor=D.+Leysauthor=R.+C.+Whiteheadauthor=I.+J.+Stratfordauthor=R.+A.+Bryce&title=Synthesis+and+biological+evaluation+of+coumarin-based+inhibitors+of+NAD%28P%29H%3A+quinone+oxidoreductase-1+%28NQO1%29&doi=10.1021%2Fjm9011609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Coumarin-Based Inhibitors of NAD(P)H: Quinone Oxidoreductase-1 (NQO1)</span></div><div class="casAuthors">Nolan, Karen A.; Doncaster, Jeremy R.; Dunstan, Mark S.; Scott, Katherine A.; Frenkel, A. David; Siegel, David; Ross, David; Barnes, John; Levy, Colin; Leys, David; Whitehead, Roger C.; Stratford, Ian J.; Bryce, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7142-7156</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dicoumarol analogs I (R = H, Me, MeO; R1 = H, Me, MeO, F, Cl, Br; R2 = H, Me, MeO, F; R3 = H, Me, Br; R2R3 = benzo; R4 = H, EtCH2, EtO2C) and II (R5 = H; R6 = H, Me; R5R6 = benzo; R7 = H, Me; R8 = H; R7R8 = benzo; R9 = Ph, 1-naphthyl, 2-naphthyl, 3,4-Me2C6H3) are prepd. as inhibitors of human NAD(P)H quinone oxidoreductase-1 (NQO1), an enzyme overexpressed in several types of tumor cell; their calcd. and obsd. binding affinities and energies for NQO1, their antitumor activities in human pancreatic and colon cancer cells, and their calcd. binding modes as detd. by mol. docking calcns. are detd.  Correlation is demonstrated between the inhibition of NQO1 by the dicoumarol analogs and their computed binding affinities.  The structures of I (R = R1 = R2 = R3 = R4 = H) and of II (R5 = H; R6 = R7 = Me; R8 = H; R9 = 1-naphthyl) bound to NQO1 are detd. by X-ray crystallog.  In human pancreatic and colon cancer cells, the parent I (R = R1 = R2 = R3 = R4 = H) is the most active antitumor agent of the compds. tested.  The methodol. provides a computational, synthetic, and biol. platform to generate competitive NQO1 inhibitors with superior pharmacol. properties to dicoumarol and to allow the activities of NQO1 in cells to be detd. more clearly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMXhckZU0ot7Vg90H21EOLACvtfcHk0lgyikUWEjkMFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCku77N&md5=b7cdcf65a1a3beb4d4280ce9d1fff84b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm9011609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9011609%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DK.%2BA.%26aulast%3DDoncaster%26aufirst%3DJ.%2BR.%26aulast%3DDunstan%26aufirst%3DM.%2BS.%26aulast%3DScott%26aufirst%3DK.%2BA.%26aulast%3DFrenkel%26aufirst%3DA.%2BD.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBarnes%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DWhitehead%26aufirst%3DR.%2BC.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520coumarin-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253A%2520quinone%2520oxidoreductase-1%2520%2528NQO1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7142%26epage%3D7156%26doi%3D10.1021%2Fjm9011609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref70"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref70'); return false;" data-citation="" class="refNumLink">70</a></strong><div class="NLM_citation" id="cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">15135</span>– <span class="NLM_lpage">15142</span>, <span class="refDoi"> DOI: 10.1021/bi011324i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011324i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=15135-15142&author=S.+L.+Winskiauthor=M.+Faigauthor=M.+A.+Bianchetauthor=D.+Siegelauthor=E.+Swannauthor=K.+Fungauthor=M.+W.+Duncanauthor=C.+J.+Moodyauthor=L.+M.+Amzelauthor=D.+Ross&title=Characterization+of+a+mechanism-based+inhibitor+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+by+biochemical%2C+X-ray+crystallographic%2C+and+mass+spectrometric+approaches&doi=10.1021%2Fbi011324i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Mechanism-Based Inhibitor of NAD(P)H:Quinone Oxidoreductase 1 by Biochemical, X-ray Crystallographic, and Mass Spectrometric Approaches</span></div><div class="casAuthors">Winski, Shannon L.; Faig, Margarita; Bianchet, Mario A.; Siegel, David; Swann, Elizabeth; Fung, Kim; Duncan, Mark W.; Moody, Christopher J.; Amzel, L. Mario; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">15135-15142</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the characterization of 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione (ES936) as a mechanism-based inhibitor of NQO1.  Inactivation of NQO1 by ES936 was time- and concn.-dependent and required the presence of a pyridine nucleotide cofactor consistent with a need for metabolic activation.  That ES936 was an efficient inhibitor was demonstrated in these studies by the low partition ratio (1.40±0.03).  The orientation of ES936 in the active site of NQO1 was examd. by X-ray crystallog. and found to be opposite to that obsd. for other indolequinones acting as substrates.  ES936 was oriented in such a manner that, after enzymic redn. and loss of a nitrophenol leaving group, a reactive iminium species was located in close proximity to nucleophilic His 162 and Tyr 127 and Tyr 129 residues in the active site.  To det. if ES936 was covalently modifying NQO1, ES936-treated protein was analyzed by electrospray ionization liq. chromatog./mass spectrometry (ESI-LC/MS).  The control NQO1 protein had a mass of 30864 ± 6 Da (n = 20, theor., 30868.6 Da) which increased by 217 Da after ES936 treatment (31081 ± 7 Da, n = 20) in the presence of NADH.  The shift in mass was consistent with adduction of NQO1 by the reactive iminium derived from ES936 (M + 218 Da).  Chymotryptic digestion of the protein followed by LC/MS anal. located a tetrapeptide spanning amino acids 126-129 which was adducted with the reactive iminium species derived from ES936.  LC/MS/MS anal. of the peptide fragment confirmed adduction of either Tyr 127 or Tyr 129 residues.  This work demonstrates that ES936 is a potent mechanism-based inhibitor of NQO1 and may be a useful tool in defining the role of NQO1 in cellular systems and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKFX8Hi1Jtx7Vg90H21EOLACvtfcHk0lgyikUWEjkMFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFCrtLc%253D&md5=bfc6c8271d444668673605c2bcc0d62d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fbi011324i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011324i%26sid%3Dliteratum%253Aachs%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSwann%26aufirst%3DE.%26aulast%3DFung%26aufirst%3DK.%26aulast%3DDuncan%26aufirst%3DM.%2BW.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520a%2520mechanism-based%2520inhibitor%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520by%2520biochemical%252C%2520X-ray%2520crystallographic%252C%2520and%2520mass%2520spectrometric%2520approaches%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D15135%26epage%3D15142%26doi%3D10.1021%2Fbi011324i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref71"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref71'); return false;" data-citation="" class="refNumLink">71</a></strong><div class="NLM_citation" id="cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilloux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">The synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5780</span>– <span class="NLM_lpage">5789</span>, <span class="refDoi"> DOI: 10.1021/jm070396q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070396q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5780-5789&author=M.+A.+Colucciauthor=P.+Reiganauthor=D.+Siegelauthor=A.+Chillouxauthor=D.+Rossauthor=C.+J.+Moody&title=The+synthesis+and+evaluation+of+3-aryloxymethyl-1%2C2-dimethylindole-4%2C7-diones+as+mechanism-based+inhibitors+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+activity&doi=10.1021%2Fjm070396q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm070396q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070396q%26sid%3Dliteratum%253Aachs%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DChilloux%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520synthesis%2520and%2520evaluation%2520of%25203-aryloxymethyl-1%252C2-dimethylindole-4%252C7-diones%2520as%2520mechanism-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5780%26epage%3D5789%26doi%3D10.1021%2Fjm070396q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref72"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref72'); return false;" data-citation="" class="refNumLink">72</a></strong><div class="NLM_citation" id="cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1702</span>– <span class="NLM_lpage">1709</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-06-0105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-06-0105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16891456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslWksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1702-1709&author=D.+L.+Dehnauthor=D.+Siegelauthor=K.+S.+Zafarauthor=P.+Reiganauthor=E.+Swannauthor=C.+J.+Moodyauthor=D.+Ross&title=5-Methoxy-1%2C2-dimethyl-3-%5B%284-nitrophenoxy%29methyl%5Dindole-4%2C7-dione%2C+a+mechanism-based+inhibitor+of+NAD%28P%29H%3Aquinone+oxidoreductase+1%2C+exhibits+activity+against+human+pancreatic+cancer+in+vitro+and+in+vivo&doi=10.1158%2F1535-7163.MCT-06-0105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo</span></div><div class="casAuthors">Dehn, Donna L.; Siegel, David; Zafar, Khan Shoeb; Reigan, Philip; Swann, Elizabeth; Moody, Christopher J.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1702-1709</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1) has been found to be up-regulated in pancreatic cancer as well as many other solid tumors.  A recent study showed that inhibition of NQO1 in pancreatic cancer cells using the nonselective inhibitor dicumarol suppressed the malignant phenotype.  The authors suggested that inhibition of cell growth might result from an increase in intracellular superoxide prodn. due to inhibition of NQO1.  We have recently shown that NQO1 can directly scavenge superoxide and this effect may become physiol. relevant in cells contg. high NQO1 levels.  We therefore tested the hypothesis that 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione (ES936), a specific mechanism-based inhibitor of NQO1, would be an effective agent for the treatment of pancreatic tumors.  The human pancreatic tumor cell lines BxPC-3 and MIA PaCa-2 contain high levels of NQO1 activity and protein as verified by immunoblot and immunocytochem. staining of human pancreatic tumor cells.  ES936 treatment inhibited NQO1 activity by >98% in MIA PaCa-2 and BxPC-3 cells.  In addn., ES936 treatment induced growth inhibition [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay] in MIA PaCa-2 and BxPC-3 cells with an IC50 of 108 and 365 nmol/L, resp.  Treatment of MIA PaCa-2 cells with ES936 also inhibited the ability of these cells to form colonies and grow in soft agar in a dose-dependent manner.  Treatment of mice carrying MIA PaCa-2 xenograft tumors with ES936 resulted in a significant difference in growth rates in ES936-treated and DMSO-treated (control) tumors.  Our data did not show an increase in either intracellular superoxide prodn. or oxygen consumption after treatment of cells with ES936, contrary to the effects seen with dicumarol.  In summary, mechanism-based inhibitors of NQO1, such as ES936, may be useful therapeutic agents for the treatment of pancreatic cancer, although the underlying mechanism seems to be independent of superoxide generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqScnhPVPs3ebVg90H21EOLACvtfcHk0lgyikUWEjkMFA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslWksL0%253D&md5=337f9ca460d5f176b4be9f810caa77ba</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0105%26sid%3Dliteratum%253Aachs%26aulast%3DDehn%26aufirst%3DD.%2BL.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DZafar%26aufirst%3DK.%2BS.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSwann%26aufirst%3DE.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3D5-Methoxy-1%252C2-dimethyl-3-%255B%25284-nitrophenoxy%2529methyl%255Dindole-4%252C7-dione%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%252C%2520exhibits%2520activity%2520against%2520human%2520pancreatic%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1702%26epage%3D1709%26doi%3D10.1158%2F1535-7163.MCT-06-0105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref73"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref73'); return false;" data-citation="" class="refNumLink">73</a></strong><div class="NLM_citation" id="cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilloux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5941</span>– <span class="NLM_lpage">5950</span>, <span class="refDoi"> DOI: 10.1021/bi700008y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi700008y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=5941-5950&author=P.+Reiganauthor=M.+A.+Colucciauthor=D.+Siegelauthor=A.+Chillouxauthor=C.+J.+Moodyauthor=D.+Ross&title=Development+of+indolequinone+mechanism-based+inhibitors+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29%3A+NQO1+inhibition+and+growth+inhibitory+activity+in+human+pancreatic+MIA+PaCa-2+cancer+cells&doi=10.1021%2Fbi700008y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fbi700008y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700008y%26sid%3Dliteratum%253Aachs%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DChilloux%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520indolequinone%2520mechanism-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%253A%2520NQO1%2520inhibition%2520and%2520growth%2520inhibitory%2520activity%2520in%2520human%2520pancreatic%2520MIA%2520PaCa-2%2520cancer%2520cells%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D5941%26epage%3D5950%26doi%3D10.1021%2Fbi700008y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref74"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref74'); return false;" data-citation="" class="refNumLink">74</a></strong><div class="NLM_citation" id="cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newsome, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilloux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1124/mol.111.076091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.111.076091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=401-410&author=C.+Yanauthor=D.+Siegelauthor=J.+Newsomeauthor=A.+Chillouxauthor=C.+J.+Moodyauthor=D.+Ross&title=Antitumor+indolequinones+induced+apoptosis+in+human+pancreatic+cancer+cells+via+inhibition+of+thioredoxin+reductase+and+activation+of+redox+signaling&doi=10.1124%2Fmol.111.076091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.076091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.076091%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DNewsome%26aufirst%3DJ.%26aulast%3DChilloux%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DAntitumor%2520indolequinones%2520induced%2520apoptosis%2520in%2520human%2520pancreatic%2520cancer%2520cells%2520via%2520inhibition%2520of%2520thioredoxin%2520reductase%2520and%2520activation%2520of%2520redox%2520signaling%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D401%26epage%3D410%26doi%3D10.1124%2Fmol.111.076091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref75"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref75'); return false;" data-citation="" class="refNumLink">75</a></strong><div class="NLM_citation" id="cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryatt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardipee, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slawin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1667</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmc.2004.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1667-1687&author=T.+Fryattauthor=H.+I.+Petterssonauthor=W.+T.+Gardipeeauthor=K.+C.+Brayauthor=S.+J.+Greenauthor=A.+M.+Slawinauthor=H.+D.+Beallauthor=C.+J.+Moody&title=Novel+quinolinequinone+antitumor+agents%3A+structure-metabolism+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29&doi=10.1016%2Fj.bmc.2004.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DFryatt%26aufirst%3DT.%26aulast%3DPettersson%26aufirst%3DH.%2BI.%26aulast%3DGardipee%26aufirst%3DW.%2BT.%26aulast%3DBray%26aufirst%3DK.%2BC.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DNovel%2520quinolinequinone%2520antitumor%2520agents%253A%2520structure-metabolism%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D1667%26epage%3D1687%26doi%3D10.1016%2Fj.bmc.2004.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref76"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref76'); return false;" data-citation="" class="refNumLink">76</a></strong><div class="NLM_citation" id="cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of NAD (P) H:quinone oxidoreductase 1 (NQO1) inhibitors with novel chemical scaffolds by shape-based virtual screening combined with cascade docking</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">49471</span>– <span class="NLM_lpage">49479</span>, <span class="refDoi"> DOI: 10.1039/C5RA05919D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2FC5RA05919D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=49471-49479&author=J.+Bianauthor=X.+Qianauthor=B.+Dengauthor=X.+Xuauthor=X.+Guoauthor=Y.+Wangauthor=X.+Liauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+NAD+%28P%29+H%3Aquinone+oxidoreductase+1+%28NQO1%29+inhibitors+with+novel+chemical+scaffolds+by+shape-based+virtual+screening+combined+with+cascade+docking&doi=10.1039%2FC5RA05919D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with novel chemical scaffolds by shape-based virtual screening combined with cascade docking</span></div><div class="casAuthors">Bian, Jinlei; Qian, Xue; Deng, Bang; Xu, Xiaoli; Guo, Xiaoke; Wang, Yalou; Li, Xiang; Sun, Haopeng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">49471-49479</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A no. of novel NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors were discovered from the ChemDiv database via a simple protocol.  Based on two ref. NQO1 inhibitors, dicoumarol (DIC) and ES936, a shape-based similarity search and cascade docking filtering were conducted to identify new NQO1 inhibitors.  Using these techniques, 43 compds. were selected, ordered, and tested.  Among them, 7 compds. with novel chem. scaffolds were confirmed to be active by in vitro assays.  Detn. of the ability for protecting against NQO1-mediated toxicity of β-lapachone (β-lap) confirmed that compds. 8, 10 and 13 may be pharmacol. useful for probing the function of NQO1 in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUC2lbXNdSbVg90H21EOLACvtfcHk0ljFrRdFSmjfeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCksr4%253D&md5=50f96b5c4eed59bdd1ee23c2ae8ff6c8</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1039%2FC5RA05919D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA05919D%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520NAD%2520%2528P%2529%2520H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520inhibitors%2520with%2520novel%2520chemical%2520scaffolds%2520by%2520shape-based%2520virtual%2520screening%2520combined%2520with%2520cascade%2520docking%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D49471%26epage%3D49479%26doi%3D10.1039%2FC5RA05919D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref77"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref77'); return false;" data-citation="" class="refNumLink">77</a></strong><div class="NLM_citation" id="cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Deoxynyboquinones as NQO1-activated cancer therapeutics</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2715</span>– <span class="NLM_lpage">2723</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.5b00365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Wqs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2715-2723&author=E.+I.+Parkinsonauthor=P.+J.+Hergenrother&title=Deoxynyboquinones+as+NQO1-activated+cancer+therapeutics&doi=10.1021%2Facs.accounts.5b00365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Deoxynyboquinones as NQO1-Activated Cancer Therapeutics</span></div><div class="casAuthors">Parkinson, Elizabeth I.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2715-2723</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the major goals of cancer therapy is the selective targeting of cancer cells over normal cells.  Unfortunately, even with recent advances, the majority of chemotherapeutics still indiscriminately kill all rapidly dividing cells.  Although these drugs are effective in certain settings, their inability to specifically target cancer results in significant dose-limiting toxicities.  One way to avoid such toxicities is to target an aspect of the cancer cell that is not shared by normal cells.  A potential cancer-specific target is the enzyme NAD(P)H quinone oxidoreductase 1 (NQO1).  NQO1 is a 2-electron reductase responsible for the detoxification of quinones.  Its expression is typically quite low in normal tissue, but it has been found to be greatly overexpressed in many types of solid tumors, including lung, breast, pancreatic, and colon cancers.  This overexpression is thought to be in response to the higher oxidative stress of the cancer cell, and it is possible that NQO1 contributes to tumor progression.  The overexpression of NQO1 and its correlation with poor patient outcome make it an intriguing target.  Although some have explored inhibiting NQO1 as an anticancer strategy, this has generally been unsuccessful.  A more promising strategy is to utilize NQO1 substrates that are activated upon redn. by NQO1.  For example, in principle, redn. of a quinone can result in a hydroquinone that is a DNA alkylator, protein inhibitor, or redn.-oxidn. cycler.  Although there are many proposed NQO1 substrates, head-to-head assays reveal only two classes of compds. that convincingly induce cancer cell death through NQO1-mediated activation.  The authors describe the discovery and development of one of these compds., the natural product deoxynyboquinone (DNQ), an excellent NQO1 substrate and anticancer agent.  A modular synthesis of DNQ was developed that enabled access to the large compd. quantities needed to conduct extensive mechanistic evaluations and animal expts.  During these evaluations, the authors found that DNQ is an outstanding NQO1 substrate that is processed much more efficiently than other putative NQO1 substrates.  Importantly, its anticancer activity is strictly dependent on the overexpression of active NQO1.  Using previous crystal structures of NQO1, novel DNQ derivs. were designed that are also excellent NQO1 substrates and possess properties that make them more attractive than the parent natural product for translational development.  Given their selectivity, potency, outstanding pharmacokinetic properties, and the ready availability of diagnostics to assess NQO1 in patients, DNQ and its derivs. have considerable potential as personalized medicines for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3MluuGsMA7Vg90H21EOLACvtfcHk0ljFrRdFSmjfeQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Wqs7fI&md5=9395e54798f6a41a31b47a5ad078c9c1</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00365%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DDeoxynyboquinones%2520as%2520NQO1-activated%2520cancer%2520therapeutics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D2715%26epage%3D2723%26doi%3D10.1021%2Facs.accounts.5b00365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref78"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref78'); return false;" data-citation="" class="refNumLink">78</a></strong><div class="NLM_citation" id="cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crooke, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, W. T.</span></span> <span> </span><span class="NLM_article-title">Mitomycin C: a review</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/S0305-7372(76)80019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0305-7372%2876%2980019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=786455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaE2s%252FgtFCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1976&pages=121-139&author=S.+T.+Crookeauthor=W.+T.+Bradner&title=Mitomycin+C%3A+a+review&doi=10.1016%2FS0305-7372%2876%2980019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Mitomycin C: a review</span></div><div class="casAuthors">Crooke S T; Bradner W T</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reviews</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">121-39</span>
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdf41D9V_IIJ6KlWarZTAzfW6udTcc2eZ0fDH6EWmvX7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2s%252FgtFCruw%253D%253D&md5=7e99ce868a2aab0b89751a062903ceaf</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0305-7372%2876%2980019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0305-7372%252876%252980019-9%26sid%3Dliteratum%253Aachs%26aulast%3DCrooke%26aufirst%3DS.%2BT.%26aulast%3DBradner%26aufirst%3DW.%2BT.%26atitle%3DMitomycin%2520C%253A%2520a%2520review%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D1976%26volume%3D3%26spage%3D121%26epage%3D139%26doi%3D10.1016%2FS0305-7372%2876%2980019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref79"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref79'); return false;" data-citation="" class="refNumLink">79</a></strong><div class="NLM_citation" id="cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. D.</span></span> <span> </span><span class="NLM_article-title">Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1039/B715270A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2FB715270A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=18264564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1yksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=637-656&author=M.+A.+Colucciauthor=C.+J.+Moodyauthor=G.+D.+Couch&title=Natural+and+synthetic+quinones+and+their+reduction+by+the+quinone+reductase+enzyme+NQO1%3A+from+synthetic+organic+chemistry+to+compounds+with+anticancer+potential&doi=10.1039%2FB715270A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential</span></div><div class="casAuthors">Colucci, Marie A.; Couch, Gavin D.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">637-656</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The quinone reductase enzyme NAD(P)H: quinone oxidoreductase 1 (NQO1) is a ubiquitous flavoenzyme that catalyzes the two-electron redn. of quinones.  This Perspective briefly reviews the structure and mechanism, physiol. role, and upregulation and induction of the enzyme, but focuses on the synthesis of new heterocyclic quinones and their metab. by recombinant human NQO1.  Thus a range of indolequinones, some of which are novel analogs of mitomycin C, benzimidazolequinones, benzothiazolequinones and quinolinequinones have been prepd. and evaluated, leading to detailed knowledge of the structural requirements for efficient metab. by the enzyme.  Potent mechanism-based inhibitors (suicide substrates) of NQO1 have also been developed.  These indolequinones irreversibly alkylate the protein, preventing its function both in std. enzyme assays and also in cells.  Some of these quinones are also potent inhibitors of growth of human pancreatic cancer cells, suggesting a potential role for such compds. as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPvvIszpepVLVg90H21EOLACvtfcHk0lhksPkGz-nORQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1yksb4%253D&md5=efbef31e39e18c5314ad2c24628254ec</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1039%2FB715270A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB715270A%26sid%3Dliteratum%253Aachs%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DCouch%26aufirst%3DG.%2BD.%26atitle%3DNatural%2520and%2520synthetic%2520quinones%2520and%2520their%2520reduction%2520by%2520the%2520quinone%2520reductase%2520enzyme%2520NQO1%253A%2520from%2520synthetic%2520organic%2520chemistry%2520to%2520compounds%2520with%2520anticancer%2520potential%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D637%26epage%3D656%26doi%3D10.1039%2FB715270A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref80"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref80'); return false;" data-citation="" class="refNumLink">80</a></strong><div class="NLM_citation" id="cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunton, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1124/mol.58.5.1146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.58.5.1146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1146-1155&author=S.+Y.+Sharpauthor=L.+R.+Kellandauthor=M.+R.+Valentiauthor=L.+A.+Bruntonauthor=S.+Hobbsauthor=P.+Workman&title=Establishment+of+an+isogenic+human+colon+tumor+model+for+NQO1+gene+expression%3A+application+to+investigate+the+role+of+DT-diaphorase+in+bioreductive+drug+activation+in+vitro+and+in+vivo&doi=10.1124%2Fmol.58.5.1146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.5.1146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.5.1146%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DValenti%26aufirst%3DM.%2BR.%26aulast%3DBrunton%26aufirst%3DL.%2BA.%26aulast%3DHobbs%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DEstablishment%2520of%2520an%2520isogenic%2520human%2520colon%2520tumor%2520model%2520for%2520NQO1%2520gene%2520expression%253A%2520application%2520to%2520investigate%2520the%2520role%2520of%2520DT-diaphorase%2520in%2520bioreductive%2520drug%2520activation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1146%26epage%3D1155%26doi%3D10.1124%2Fmol.58.5.1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref81"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref81'); return false;" data-citation="" class="refNumLink">81</a></strong><div class="NLM_citation" id="cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=1128-1134&author=D.+Siegelauthor=H.+Beallauthor=M.+Kasaiauthor=H.+Araiauthor=N.+W.+Gibsonauthor=D.+Ross&title=pH-dependent+inactivation+of+DT-diaphorase+by+mitomycin+C+and+porfiromycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBeall%26aufirst%3DH.%26aulast%3DKasai%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DpH-dependent%2520inactivation%2520of%2520DT-diaphorase%2520by%2520mitomycin%2520C%2520and%2520porfiromycin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D44%26spage%3D1128%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref82"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref82'); return false;" data-citation="" class="refNumLink">82</a></strong><div class="NLM_citation" id="cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne-Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myint, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maughan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essapen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadalayil, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebag-Montefiore, D.</span></span> <span> </span><span class="NLM_article-title">Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70086-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS1470-2045%2813%2970086-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23578724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1eqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=516-524&author=R.+D.+Jamesauthor=R.+Glynne-Jonesauthor=H.+M.+Meadowsauthor=D.+Cunninghamauthor=A.+S.+Myintauthor=M.+P.+Saundersauthor=T.+Maughanauthor=A.+McDonaldauthor=S.+Essapenauthor=M.+Leslieauthor=S.+Falkauthor=C.+Wilsonauthor=S.+Gollinsauthor=R.+Begumauthor=J.+Ledermannauthor=L.+Kadalayilauthor=D.+Sebag-Montefiore&title=Mitomycin+or+cisplatin+chemoradiation+with+or+without+maintenance+chemotherapy+for+treatment+of+squamous-cell+carcinoma+of+the+anus+%28ACT+II%29%3A+a+randomised%2C+phase+3%2C+open-label%2C+2+%C3%97+2+factorial+trial&doi=10.1016%2FS1470-2045%2813%2970086-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial</span></div><div class="casAuthors">James, Roger D.; Glynne-Jones, Robert; Meadows, Helen M.; Cunningham, David; Myint, Arthur Sun; Saunders, Mark P.; Maughan, Timothy; McDonald, Alec; Essapen, Sharadah; Leslie, Martin; Falk, Stephen; Wilson, Charles; Gollins, Simon; Begum, Rubina; Ledermann, Jonathan; Kadalayil, Latha; Sebag-Montefiore, David</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">516-524</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chemoradiation became the std. of care for anal cancer after the ACT I trial.  However, only two-thirds of patients achieved local control, with 5-yr survival of 50%; therefore, better treatments are needed.  We investigated whether replacing mitomycin with cisplatin in chemoradiation improves response, and whether maintenance chemotherapy after chemoradiation improves survival.  In this 2×2 factorial trial, we enrolled patients with histol. confirmed squamous-cell carcinoma of the anus without metastatic disease from 59 centers in the UK.  Patients were randomly assigned to one of four groups, to receive either mitomycin (12 mg/m2 on day 1) or cisplatin (60 mg/m2 on days 1 and 29), with fluorouracil (1000 mg/m2 per day on days 1-4 and 29-32) and radiotherapy (50·4 Gy in 28 daily fractions); with or without two courses of maintenance chemotherapy (fluorouracil and cisplatin at weeks 11 and 14).  The random allocation was generated by computer and patients assigned by telephone.  Randomisation was done by minimisation and stratified by tumor site, T and N stage, sex, age, and renal function.  Neither patients nor investigators were masked to assignment.  Primary endpoints were complete response at 26 wk and acute toxic effects (for chemoradiation), and progression-free survival (for maintenance).  The primary analyses were done by intention to treat.  This study is registered at controlled-trials.com, no. 26715889.We enrolled 940 patients: 472 were assigned to mitomycin, of whom 246 were assigned to no maintenance, 226 to maintenance; 468 were assigned to cisplatin, of whom 246 were assigned to no maintenance, 222 to maintenance.  Median follow-up was 5·1 years (IQR 3·9-6·9). 391 of 432 (90·5%) patients in the mitomycin group vs. 386 of 431 (89·6%) in the cisplatin group had a complete response at 26 wk (difference -0·9%, 95% CI -4·9 to 3·1; p=0·64).  Overall, toxic effects were similar in each group (334/472 [71%] for mitomycin vs 337/468 [72%] for cisplatin).  The most common grade 3-4 toxic effects were skin (228/472 [48%] vs 222/468 [47%]), pain (122/472 [26%] vs 135/468 [29%]), haematol. (124/472 [26%] vs 73/468 [16%]), and gastrointestinal (75/472 [16%] vs 85/468 [18%]). 3-yr progression-free survival was 74% (95% CI 69-77; maintenance) vs. 73% (95% CI 68-77; no maintenance; hazard ratio 0·95, 95% CI 0·75-1·21; p=0·70).  The results of our trial-the largest in anal cancer to date-show that fluorouracil and mitomycin with 50·4 Gy radiotherapy in 28 daily fractions should remain std. practice in the UK.Cancer Research UK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4oHp8fLcoV7Vg90H21EOLACvtfcHk0lgQvURcxExsuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1eqsb4%253D&md5=c8f10c2061f41756647817c63f159510</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970086-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970086-X%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DR.%2BD.%26aulast%3DGlynne-Jones%26aufirst%3DR.%26aulast%3DMeadows%26aufirst%3DH.%2BM.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DMyint%26aufirst%3DA.%2BS.%26aulast%3DSaunders%26aufirst%3DM.%2BP.%26aulast%3DMaughan%26aufirst%3DT.%26aulast%3DMcDonald%26aufirst%3DA.%26aulast%3DEssapen%26aufirst%3DS.%26aulast%3DLeslie%26aufirst%3DM.%26aulast%3DFalk%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DGollins%26aufirst%3DS.%26aulast%3DBegum%26aufirst%3DR.%26aulast%3DLedermann%26aufirst%3DJ.%26aulast%3DKadalayil%26aufirst%3DL.%26aulast%3DSebag-Montefiore%26aufirst%3DD.%26atitle%3DMitomycin%2520or%2520cisplatin%2520chemoradiation%2520with%2520or%2520without%2520maintenance%2520chemotherapy%2520for%2520treatment%2520of%2520squamous-cell%2520carcinoma%2520of%2520the%2520anus%2520%2528ACT%2520II%2529%253A%2520a%2520randomised%252C%2520phase%25203%252C%2520open-label%252C%25202%2520%25C3%2597%25202%2520factorial%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3D516%26epage%3D524%26doi%3D10.1016%2FS1470-2045%2813%2970086-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref83"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref83'); return false;" data-citation="" class="refNumLink">83</a></strong><div class="NLM_citation" id="cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amitay, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmeeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La-Beck, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahover, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabizon, A. A.</span></span> <span> </span><span class="NLM_article-title">Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients</span>. <i>Cancer Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1472</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1002/cam4.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fcam4.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26172205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=1472-1483&author=T.+Golanauthor=T.+Grenaderauthor=P.+Ohanaauthor=Y.+Amitayauthor=H.+Shmeedaauthor=N.+M.+La-Beckauthor=E.+Tahoverauthor=R.+Bergerauthor=A.+A.+Gabizon&title=Pegylated+liposomal+mitomycin+C+prodrug+enhances+tolerance+of+mitomycin+C%3A+a+phase+1+study+in+advanced+solid+tumor+patients&doi=10.1002%2Fcam4.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients</span></div><div class="casAuthors">Golan, Talia; Grenader, Tal; Ohana, Patricia; Amitay, Yasmine; Shmeeda, Hilary; La-Beck, Ninh M.; Tahover, Esther; Berger, Raanan; Gabizon, Alberto A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1472-1483</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Mitomycin C (MMC) has potent cytotoxicity but cumulative toxicity limits widespread use.  In animals, pegylated liposomal mitomycin C lipid-based prodrug (PL-MLP) was well tolerated and more effective than free MMC.  We evaluated PL-MLP in patients with advanced cancer.  Twenty-seven patients were treated in escalating dose cohorts of 0.5-3.5 mg/kg (equiv. to 0.15-1.03 mg/kg MMC) every 4 wk for up to 12 cycles, unless disease progression or unacceptable toxicity occurred.  Pharmacokinetics were assessed during cycles 1 and 3.  Per protocol max. tolerated dose was not reached at 3.5 mg/kg.  However, prolonged thrombocytopenia developed after repeated doses of 3 mg/kg or cumulative doses of 10-12 mg/kg.  Dose-related grade 3 or higher adverse events included fatigue, anemia, and decreased platelets.  Cmax and AUC0-∞ increased linearly over the dose range 0.5-2.0 mg/kg, and greater than linearly from 2.5 to 3.5 mg/kg; there were no significant differences in clearance of MLP between cycles 1 and 3.  Median t1/2 was 23 h among dose cohorts, with no trend by dose or cycle.  One patient had a partial response.  Stable disease was obsd. in 10 patients across all dose levels.  PL-MLP has a long circulation time, was well tolerated, and can be administered to heavily pretreated patients at a single dose of 3.0 mg/kg and cumulative dose of 10-12 mg/kg before development of prolonged thrombocytopenia; this is nearly threefold the equiv. dose of MMC tolerated historically.  This formulation may be active in a variety of tumor types and is better tolerated than free MMC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYcERICPvrZrVg90H21EOLACvtfcHk0lgQvURcxExsuQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu7fM&md5=8d4ffff9f8c9a6d23c4acbe8208605c6</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fcam4.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.491%26sid%3Dliteratum%253Aachs%26aulast%3DGolan%26aufirst%3DT.%26aulast%3DGrenader%26aufirst%3DT.%26aulast%3DOhana%26aufirst%3DP.%26aulast%3DAmitay%26aufirst%3DY.%26aulast%3DShmeeda%26aufirst%3DH.%26aulast%3DLa-Beck%26aufirst%3DN.%2BM.%26aulast%3DTahover%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DGabizon%26aufirst%3DA.%2BA.%26atitle%3DPegylated%2520liposomal%2520mitomycin%2520C%2520prodrug%2520enhances%2520tolerance%2520of%2520mitomycin%2520C%253A%2520a%2520phase%25201%2520study%2520in%2520advanced%2520solid%2520tumor%2520patients%26jtitle%3DCancer%2520Med.%26date%3D2015%26volume%3D4%26spage%3D1472%26epage%3D1483%26doi%3D10.1002%2Fcam4.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref84"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref84'); return false;" data-citation="" class="refNumLink">84</a></strong><div class="NLM_citation" id="cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oostveen, E.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speckamp, W. N.</span></span> <span> </span><span class="NLM_article-title">Mitomycin analogs I. Indoloquinones as (potential) bisalkylating agents</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)89952-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0040-4020%2801%2989952-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=255-262&author=E.%0AA.+Oostveenauthor=W.+N.+Speckamp&title=Mitomycin+analogs+I.+Indoloquinones+as+%28potential%29+bisalkylating+agents&doi=10.1016%2FS0040-4020%2801%2989952-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2989952-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252989952-X%26sid%3Dliteratum%253Aachs%26aulast%3DOostveen%26aufirst%3DE.%2BA.%26aulast%3DSpeckamp%26aufirst%3DW.%2BN.%26atitle%3DMitomycin%2520analogs%2520I.%2520Indoloquinones%2520as%2520%2528potential%2529%2520bisalkylating%2520agents%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D255%26epage%3D262%26doi%3D10.1016%2FS0040-4020%2801%2989952-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref85"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref85'); return false;" data-citation="" class="refNumLink">85</a></strong><div class="NLM_citation" id="cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizao, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreef-van
der Meulen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrar, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiebig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornstra, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinedo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartsmann, G.</span></span> <span> </span><span class="NLM_article-title">EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(05)80434-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0959-8049%2805%2980434-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1993&pages=897-906&author=H.+R.+Hendriksauthor=P.+E.+Pizaoauthor=D.+P.+Bergerauthor=K.+L.+Kooistraauthor=M.+C.+Bibbyauthor=E.+Bovenauthor=H.+C.+Dreef-van%0Ader+Meulenauthor=R.+E.+Henrarauthor=H.+H.+Fiebigauthor=J.+A.+Doubleauthor=H.+W.+Hornstraauthor=H.+M.+Pinedoauthor=P.+Workmanauthor=G.+Schwartsmann&title=EO9%3A+a+novel+bioreductive+alkylating+indoloquinone+with+preferential+solid+tumour+activity+and+lack+of+bone+marrow+toxicity+in+preclinical+models&doi=10.1016%2FS0959-8049%2805%2980434-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2805%2980434-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252805%252980434-4%26sid%3Dliteratum%253Aachs%26aulast%3DHendriks%26aufirst%3DH.%2BR.%26aulast%3DPizao%26aufirst%3DP.%2BE.%26aulast%3DBerger%26aufirst%3DD.%2BP.%26aulast%3DKooistra%26aufirst%3DK.%2BL.%26aulast%3DBibby%26aufirst%3DM.%2BC.%26aulast%3DBoven%26aufirst%3DE.%26aulast%3DDreef-van%2Bder%2BMeulen%26aufirst%3DH.%2BC.%26aulast%3DHenrar%26aufirst%3DR.%2BE.%26aulast%3DFiebig%26aufirst%3DH.%2BH.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DHornstra%26aufirst%3DH.%2BW.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DSchwartsmann%26aufirst%3DG.%26atitle%3DEO9%253A%2520a%2520novel%2520bioreductive%2520alkylating%2520indoloquinone%2520with%2520preferential%2520solid%2520tumour%2520activity%2520and%2520lack%2520of%2520bone%2520marrow%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1993%26volume%3D29%26spage%3D897%26epage%3D906%26doi%3D10.1016%2FS0959-8049%2805%2980434-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref86"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref86'); return false;" data-citation="" class="refNumLink">86</a></strong><div class="NLM_citation" id="cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smitskamp-Wilms, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(95)00118-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2F0306-3623%2895%2900118-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=8723519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADyaK28XjtVWjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=421-429&author=E.+Smitskamp-Wilmsauthor=H.+R.+Hendriksauthor=G.+J.+Peters&title=Development%2C+pharmacology%2C+role+of+DT-diaphorase+and+prospects+of+the+indoloquinone+EO9&doi=10.1016%2F0306-3623%2895%2900118-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9</span></div><div class="casAuthors">Smitskamp-Wilms, E.; Hendriks, H. R.; Peters, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with many refs.  The indoloquinone EO9 (3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione)-propenol; E85/053;NSC 382,459) is a synthetic bioreductive alkylating agent that is structurally related to mitomycin C (MMC).  EO9 does, however, show a different mechanism of action and a broader antitumor profile than MMC.  It is also a more potent cytotoxic agent in vitro than MMC, probably because of its impressive efficient activation by reductive enzymes, particularly DT-Diaphorase.  This enzyme is elevated in several tumors compared to normal tissues.  The preferential cytotoxicity of EO9 under hypoxic conditions makes it an interesting compd. to combine with radiation.  In preclin. and the Phase I clin. studies, no myelosuppression was obsd. but reversible proteinuria was dose-limiting.  Phase II clin. studies were started in the summer of 1994.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTSeZGM7i2VbVg90H21EOLACvtfcHk0liP843iJHN12g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVWjt7w%253D&md5=941f3224a8d6b11b12570e43c644f828</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2895%2900118-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252895%252900118-2%26sid%3Dliteratum%253Aachs%26aulast%3DSmitskamp-Wilms%26aufirst%3DE.%26aulast%3DHendriks%26aufirst%3DH.%2BR.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DDevelopment%252C%2520pharmacology%252C%2520role%2520of%2520DT-diaphorase%2520and%2520prospects%2520of%2520the%2520indoloquinone%2520EO9%26jtitle%3DGen.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D421%26epage%3D429%26doi%3D10.1016%2F0306-3623%2895%2900118-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref87"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref87'); return false;" data-citation="" class="refNumLink">87</a></strong><div class="NLM_citation" id="cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirix, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnesen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epelbaum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ten Bokkel
Huinink, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlidis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamucci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Te Velde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, J.</span></span> <span> </span><span class="NLM_article-title">EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2019</span>– <span class="NLM_lpage">2022</span>, <span class="refDoi"> DOI: 10.1016/0959-8049(96)00226-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2F0959-8049%2896%2900226-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1996&pages=2019-2022&author=L.+Y.+Dirixauthor=F.+Tonnesenauthor=J.+Cassidyauthor=R.+Epelbaumauthor=W.+W.+ten+Bokkel%0AHuininkauthor=N.+Pavlidisauthor=R.+Sorioauthor=T.+Gamucciauthor=I.+Wolffauthor=A.+Te+Veldeauthor=J.+Lanauthor=J.+Verweij&title=EO9+phase+II+study+in+advanced+breast%2C+gastric%2C+pancreatic+and+colorectal+carcinoma+by+the+EORTC+Early+Clinical+Studies+Group&doi=10.1016%2F0959-8049%2896%2900226-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2F0959-8049%2896%2900226-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0959-8049%252896%252900226-2%26sid%3Dliteratum%253Aachs%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DTonnesen%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DJ.%26aulast%3DEpelbaum%26aufirst%3DR.%26aulast%3Dten%2BBokkel%2BHuinink%26aufirst%3DW.%2BW.%26aulast%3DPavlidis%26aufirst%3DN.%26aulast%3DSorio%26aufirst%3DR.%26aulast%3DGamucci%26aufirst%3DT.%26aulast%3DWolff%26aufirst%3DI.%26aulast%3DTe%2BVelde%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DEO9%2520phase%2520II%2520study%2520in%2520advanced%2520breast%252C%2520gastric%252C%2520pancreatic%2520and%2520colorectal%2520carcinoma%2520by%2520the%2520EORTC%2520Early%2520Clinical%2520Studies%2520Group%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1996%26volume%3D32%26spage%3D2019%26epage%3D2022%26doi%3D10.1016%2F0959-8049%2896%2900226-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref88"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref88'); return false;" data-citation="" class="refNumLink">88</a></strong><div class="NLM_citation" id="cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavlidis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanauske, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamucci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehnert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">te Velde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, J.</span></span> <span> </span><span class="NLM_article-title">A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG)</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.annonc.a010645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1093%2Foxfordjournals.annonc.a010645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=8839911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaK28vjslSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=529-531&author=N.+Pavlidisauthor=A.+R.+Hanauskeauthor=T.+Gamucciauthor=J.+Smythauthor=M.+Lehnertauthor=A.+te+Veldeauthor=J.+Lanauthor=J.+Verweij&title=A+randomized+phase+II+study+with+two+schedules+of+the+novel+indoloquinone+EO9+in+non-small-cell+lung+cancer%3A+a+study+of+the+EORTC+Early+Clinical+Studies+Group+%28ECSG%29&doi=10.1093%2Foxfordjournals.annonc.a010645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG)</span></div><div class="casAuthors">Pavlidis N; Hanauske A R; Gamucci T; Smyth J; Lehnert M; te Velde A; Lan J; Verweij J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">529-31</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">In a multicentre randomized trial of the EORTC-ECSG, we have treated 38 chemotherapy naive patients with advanced non-small-cell lung cancer (NSCLC) with EO9, a novel bio-reductive alkylating indoloquinone.  The drug was given at two different dose schedules by a single bolus i.v. injection: arm A 12 mg/m2 weekly and arm B 22 mg/m2 every three weeks.  All together 185 courses were administered (145 in arm A and 40 in arm B).  The major toxicity was reversible proteinuria more frequently occurring in the three-weekly schedule (arm A 34.5% vs. arm B 62.5%).  Creatinine elevation, fluid retention and pericardial or pleural effusion were also recorded in a limited number of patients.  Other common toxicities more frequent in the three-weekly administration were asthenia (21% vs. 35% of cycles), nausea (15% vs. 27.5% of cycles) and vomiting (5% vs. 17.5% of cycles).  Toxicities were mainly of grade I and II.  No responses have been observed.  Five patients (26%) on arm A and eight (53%) on arm B experienced stable disease.  These doses and schedules of EO9 do not yield activity in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTahCFcy8GHOb0AGQpJZWpJfW6udTcc2eZqHnIyTG7OI7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vjslSqtQ%253D%253D&md5=3294a215687510a16c9993bc35ea7df7</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.annonc.a010645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.annonc.a010645%26sid%3Dliteratum%253Aachs%26aulast%3DPavlidis%26aufirst%3DN.%26aulast%3DHanauske%26aufirst%3DA.%2BR.%26aulast%3DGamucci%26aufirst%3DT.%26aulast%3DSmyth%26aufirst%3DJ.%26aulast%3DLehnert%26aufirst%3DM.%26aulast%3Dte%2BVelde%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DA%2520randomized%2520phase%2520II%2520study%2520with%2520two%2520schedules%2520of%2520the%2520novel%2520indoloquinone%2520EO9%2520in%2520non-small-cell%2520lung%2520cancer%253A%2520a%2520study%2520of%2520the%2520EORTC%2520Early%2520Clinical%2520Studies%2520Group%2520%2528ECSG%2529%26jtitle%3DAnn.%2520Oncol.%26date%3D1996%26volume%3D7%26spage%3D529%26epage%3D531%26doi%3D10.1093%2Foxfordjournals.annonc.a010645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref89"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref89'); return false;" data-citation="" class="refNumLink">89</a></strong><div class="NLM_citation" id="cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loadman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannigan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudry, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kalken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twelves, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span> <span> </span><span class="NLM_article-title">Phase I/II Pilot study of intravesical apaziquone (EO9) for superficial bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2006.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2006.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16952628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1344-1348&author=R.+Puriauthor=V.+Palitauthor=P.+M.+Loadmanauthor=M.+Flanniganauthor=T.+Shahauthor=G.+A.+Choudryauthor=S.+Basuauthor=J.+A.+Doubleauthor=G.+Lenazauthor=S.+Chawlaauthor=M.+Beerauthor=C.+Van+Kalkenauthor=R.+de+Boerauthor=J.+H.+Beijnenauthor=C.+J.+Twelvesauthor=R.+M.+Phillips&title=Phase+I%2FII+Pilot+study+of+intravesical+apaziquone+%28EO9%29+for+superficial+bladder+cancer&doi=10.1016%2Fj.juro.2006.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer</span></div><div class="casAuthors">Puri, Rajiv; Palit, Victor; Loadman, Paul M.; Flannigan, Michael; Shah, Tariq; Choudry, Guzanfar A.; Basu, Saurajyoti; Double, John A.; Lenaz, Gino; Chawla, Shanta; Beer, Mario; Van Kalken, Coen; de Boer, Richard; Beijnen, Jos H.; Twelves, Christopher J.; Phillips, Roger M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">4, Pt. 1</span>),
    <span class="NLM_cas:pages">1344-1348</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: The quinone based bioreductive drug apaziquone (EO9) failed to demonstrate efficacy in previous phase II studies following i.v. administration.  We detd. the dose of apaziquone that can be safely administered intravesically and explored its activity for superficial bladder transitional cell carcinoma.  Materials and Methods: Six patients with multifocal, Ta/T1 and G1/G2 transitional cell carcinoma of the bladder received escalating doses of apaziquone formulated as EOquin (0.5 mg/40 mL up to 16 mg/40 mL) weekly for 6 wk.  A further 6 patients received weekly apaziquone at the highest nontoxic dose established.  Pharmacokinetic parameters were detd. in urine and blood, and the pharmacodynamic markers NQO1 (reduced NADP: quinone oxidoreductase-1) and glucose transporter 1 were also characterized.  Efficacy was detd. against a marker lesion.  Results: Local toxicity (grades 2 and 3 dysuria, and hematuria) was obsd. at doses of 8 mg/40 mL and above but 4 mg/40 mL was well tolerated with no systemic or local side effects.  Apaziquone in urine increased linearly with the dose but no apaziquone was detected in plasma.  In 8 of 12 patients complete macroscopic and histol. disappearance of the marker lesion occurred.  A correlation between response and NQO1 and/or glucose transporter 1 expression could not be established.  Conclusions: Intravesical administration of 4 mg/40 mL apaziquone was well tolerated and had ablative activity against superficial bladder cancer marker lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDpkglZGigurVg90H21EOLACvtfcHk0lhkfgC7Do8HvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bI&md5=f859e0db22ac8899ebd489bb698dd921</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DR.%26aulast%3DPalit%26aufirst%3DV.%26aulast%3DLoadman%26aufirst%3DP.%2BM.%26aulast%3DFlannigan%26aufirst%3DM.%26aulast%3DShah%26aufirst%3DT.%26aulast%3DChoudry%26aufirst%3DG.%2BA.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DLenaz%26aufirst%3DG.%26aulast%3DChawla%26aufirst%3DS.%26aulast%3DBeer%26aufirst%3DM.%26aulast%3DVan%2BKalken%26aufirst%3DC.%26aulast%3Dde%2BBoer%26aufirst%3DR.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DTwelves%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26atitle%3DPhase%2520I%252FII%2520Pilot%2520study%2520of%2520intravesical%2520apaziquone%2520%2528EO9%2529%2520for%2520superficial%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D1344%26epage%3D1348%26doi%3D10.1016%2Fj.juro.2006.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref90"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref90'); return false;" data-citation="" class="refNumLink">90</a></strong><div class="NLM_citation" id="cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Heijden, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moonen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergunst, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Reijke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Boven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barten, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kalken, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witjes, J. A.</span></span> <span> </span><span class="NLM_article-title">Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1353</span>, discussion 1353 <span class="refDoi"> DOI: 10.1016/j.juro.2006.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2006.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16952629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1349-1353&author=A.+G.+van%0Ader+Heijdenauthor=P.+M.+Moonenauthor=E.+B.+Cornelauthor=H.+Vergunstauthor=T.+M.+de+Reijkeauthor=E.+van+Bovenauthor=E.+J.+Bartenauthor=R.+Puriauthor=C.+K.+van+Kalkenauthor=J.+A.+Witjes&title=Phase+II+marker+lesion+study+with+intravesical+instillation+of+apaziquone+for+superficial+bladder+cancer%3A+toxicity+and+marker+response&doi=10.1016%2Fj.juro.2006.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response</span></div><div class="casAuthors">van der Heijden, Antoine G.; Moonen, Paula M. J.; Cornel, Erik B.; Vergunst, Henk; de Reijke, Theo M.; van Boven, Erika; Barten, Evert J.; Puri, Rajiv; van Kalken, Coenraad K.; Witjes, J. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">4, Pt. 1</span>),
    <span class="NLM_cas:pages">1349-1353</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: We studied the ablative activity of intravesical apaziquone (EOquin) on a papillary marker tumor and detd. the incidence of side effects.  Materials and Methods: A total of 46 patients with multiple pTa or pT1 bladder tumors underwent visible lesion resection except for 1 marker tumor.  Patients were then treated with 6 instillations of apaziquone at weekly intervals.  The response was detd. 2 to 4 wk after the last instillation.  Results: One patient withdrew informed consent and refused the last treatment due to side effects.  A histol. proven complete response was seen in 30 patients.  Progression to invasive stage was not obsd.  Local side effects in this study were comparable to those due to other chemotherapy instillations, such as mitomycin C and epirubicin, but less severe and less frequent compared to those of bacillus Calmette-Guerin instillations.  Conclusions: The histol. complete response rate after 6 consecutive instillations of apaziquone in patients with superficial bladder cancer was 67% (95% CI 51 to 80).  Local side effects were comparable to side effects due to other chemotherapy instillations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhrNtLpiTLvrVg90H21EOLACvtfcHk0lhkfgC7Do8HvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bJ&md5=00592547125b60632b80c740024676cc</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.06.007%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DA.%2BG.%26aulast%3DMoonen%26aufirst%3DP.%2BM.%26aulast%3DCornel%26aufirst%3DE.%2BB.%26aulast%3DVergunst%26aufirst%3DH.%26aulast%3Dde%2BReijke%26aufirst%3DT.%2BM.%26aulast%3Dvan%2BBoven%26aufirst%3DE.%26aulast%3DBarten%26aufirst%3DE.%2BJ.%26aulast%3DPuri%26aufirst%3DR.%26aulast%3Dvan%2BKalken%26aufirst%3DC.%2BK.%26aulast%3DWitjes%26aufirst%3DJ.%2BA.%26atitle%3DPhase%2520II%2520marker%2520lesion%2520study%2520with%2520intravesical%2520instillation%2520of%2520apaziquone%2520for%2520superficial%2520bladder%2520cancer%253A%2520toxicity%2520and%2520marker%2520response%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D1349%26epage%3D1353%26doi%3D10.1016%2Fj.juro.2006.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref91"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref91'); return false;" data-citation="" class="refNumLink">91</a></strong><div class="NLM_citation" id="cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hendricksen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Reijke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arentsen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witjes, J. A.</span></span> <span> </span><span class="NLM_article-title">Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2011.11.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2011.11.101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=22335860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38Xktlelsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2012&pages=1195-1199&author=K.+Hendricksenauthor=E.+B.+Cornelauthor=T.+M.+de+Reijkeauthor=H.+C.+Arentsenauthor=S.+Chawlaauthor=J.+A.+Witjes&title=Phase+2+study+of+adjuvant+intravesical+instillations+of+apaziquone+for+high+risk+nonmuscle+invasive+bladder+cancer&doi=10.1016%2Fj.juro.2011.11.101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer</span></div><div class="casAuthors">Hendricksen, K.; Cornel, E. B.; de Reijke, T. M.; Arentsen, H. C.; Chawla, S.; Witjes, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1195-1199</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We studied the safety and efficacy of multiple adjuvant apaziquone instillations in patients with high risk nonmuscle invasive bladder cancer.  Patients with high risk nonmuscle invasive urothelial carcinoma of the bladder underwent transurethral resection of all bladder tumor(s), and received 6 weekly adjuvant intravesical apaziquone instillations of 4 mg in 40 mL.  Patients with carcinoma in situ received 3 further maintenance instillations at months 3, 6 and 12.  Followup consisted of cystoscopy, urine cytol. and observation of adverse events every 3 mo for 18 mo.  A total of 53 patients were enrolled in the study.  Although all patients were high risk according to the definitions used when the study was initiated, according to most recent guideline criteria, 80% and 20% of these patients would now be considered intermediate and high risk for recurrence, and 50% and 44% would be considered intermediate and high risk for progression, resp.  Intent to treat anal. of 49 patients with papillary tumors showed recurrent tumors in 34.7% and 44.9% at 12 and 18 mo, resp.  One patient had progression to T2 or greater urothelial carcinoma after 9 mo.  There were 4 patients with carcinoma in situ who had complete responses at 3 mo but discontinued treatment due to cystitis, recurrent papillary disease, urinary incontinence and dysuria.  Most other side effects were mild (grade 1 to 2).  Adjuvant intravesical instillations of apaziquone are generally well tolerated.  The recurrence rates of 34.7% after 12 mo and 44.9% after 18 mo in these patients can be considered encouraging, and warrant further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhXCHXSxiSLVg90H21EOLACvtfcHk0lhkfgC7Do8HvQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xktlelsb0%253D&md5=a05e5b4aea326bdad881760058fd472a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2011.11.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2011.11.101%26sid%3Dliteratum%253Aachs%26aulast%3DHendricksen%26aufirst%3DK.%26aulast%3DCornel%26aufirst%3DE.%2BB.%26aulast%3Dde%2BReijke%26aufirst%3DT.%2BM.%26aulast%3DArentsen%26aufirst%3DH.%2BC.%26aulast%3DChawla%26aufirst%3DS.%26aulast%3DWitjes%26aufirst%3DJ.%2BA.%26atitle%3DPhase%25202%2520study%2520of%2520adjuvant%2520intravesical%2520instillations%2520of%2520apaziquone%2520for%2520high%2520risk%2520nonmuscle%2520invasive%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2012%26volume%3D187%26spage%3D1195%26epage%3D1199%26doi%3D10.1016%2Fj.juro.2011.11.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref92"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref92'); return false;" data-citation="" class="refNumLink">92</a></strong><div class="NLM_citation" id="cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karsh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, M.</span></span> <span> </span><span class="NLM_article-title">Integrated results of two multicenter, randomised, placebo controlled, double blind, phase 3 trials (SPI-611/612) of single dose intravesical apaziquone immediately following resection in patients with nonmuscle invasive bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">e290</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2016.02.847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2016.02.847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26235377" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2016&pages=e290&author=L.+Karshauthor=N.+Shoreauthor=D.+Saltzsteinauthor=G.+Bhatauthor=G.+Reddyauthor=L.+F.+Allenauthor=M.+Soloway&title=Integrated+results+of+two+multicenter%2C+randomised%2C+placebo+controlled%2C+double+blind%2C+phase+3+trials+%28SPI-611%2F612%29+of+single+dose+intravesical+apaziquone+immediately+following+resection+in+patients+with+nonmuscle+invasive+bladder+cancer&doi=10.1016%2Fj.juro.2016.02.847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2016.02.847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2016.02.847%26sid%3Dliteratum%253Aachs%26aulast%3DKarsh%26aufirst%3DL.%26aulast%3DShore%26aufirst%3DN.%26aulast%3DSaltzstein%26aufirst%3DD.%26aulast%3DBhat%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DAllen%26aufirst%3DL.%2BF.%26aulast%3DSoloway%26aufirst%3DM.%26atitle%3DIntegrated%2520results%2520of%2520two%2520multicenter%252C%2520randomised%252C%2520placebo%2520controlled%252C%2520double%2520blind%252C%2520phase%25203%2520trials%2520%2528SPI-611%252F612%2529%2520of%2520single%2520dose%2520intravesical%2520apaziquone%2520immediately%2520following%2520resection%2520in%2520patients%2520with%2520nonmuscle%2520invasive%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2016%26volume%3D195%26spage%3De290%26doi%3D10.1016%2Fj.juro.2016.02.847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref93"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref93'); return false;" data-citation="" class="refNumLink">93</a></strong><div class="NLM_citation" id="cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witjes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, N.</span></span> <span> </span><span class="NLM_article-title">Improved efficacy of adjuvant, single dose intravesical apaziquone by timing post-resection in two double blind, randomised, placebo-controlled phase 3 studies in non-muscle invasive bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">e136</span>– <span class="NLM_lpage">e137</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2016.02.2488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2016.02.2488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2016&pages=e136-e137&author=F.+Witjesauthor=L.+Karshauthor=M.+Solowayauthor=G.+Bhatauthor=G.+Reddyauthor=A.+Yangauthor=L.+F.+Allenauthor=N.+Shore&title=Improved+efficacy+of+adjuvant%2C+single+dose+intravesical+apaziquone+by+timing+post-resection+in+two+double+blind%2C+randomised%2C+placebo-controlled+phase+3+studies+in+non-muscle+invasive+bladder+cancer&doi=10.1016%2Fj.juro.2016.02.2488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2016.02.2488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2016.02.2488%26sid%3Dliteratum%253Aachs%26aulast%3DWitjes%26aufirst%3DF.%26aulast%3DKarsh%26aufirst%3DL.%26aulast%3DSoloway%26aufirst%3DM.%26aulast%3DBhat%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DL.%2BF.%26aulast%3DShore%26aufirst%3DN.%26atitle%3DImproved%2520efficacy%2520of%2520adjuvant%252C%2520single%2520dose%2520intravesical%2520apaziquone%2520by%2520timing%2520post-resection%2520in%2520two%2520double%2520blind%252C%2520randomised%252C%2520placebo-controlled%2520phase%25203%2520studies%2520in%2520non-muscle%2520invasive%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2016%26volume%3D195%26spage%3De136%26epage%3De137%26doi%3D10.1016%2Fj.juro.2016.02.2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref94"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref94'); return false;" data-citation="" class="refNumLink">94</a></strong><div class="NLM_citation" id="cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Begleiter, A.</span></span> <span> </span><span class="NLM_article-title">Clinical applications of quinone-containing alkylating agents</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">E153</span>– <span class="NLM_lpage">E171</span>, <span class="refDoi"> DOI: 10.2741/begleit</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2741%2Fbegleit" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11056078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVGqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=E153-E171&author=A.+Begleiter&title=Clinical+applications+of+quinone-containing+alkylating+agents&doi=10.2741%2Fbegleit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical applications of quinone-containing alkylating agents</span></div><div class="casAuthors">Begleiter, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience [Electronic Publication]</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">E153-E171</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review with refs.  Quinone-contg. alkylating agents are a class of chem. agents that have received considerable interest as anticancer drugs.  These agents contain a quinone moiety that can be reduced and an alkylating group that can form covalent bonds with a variety of cellular components.  The oxidn. state of the quinone element can modulate the activity of the alkylating element, and redn. of the quinone is required for activation of the alkylating activity of many of these agents.  The quinone element may also contribute to the cytotoxic activity of quinone-contg. alkylating agents through the formation of reactive oxygen species during redox cycling.  The natural product, mitomycin C, has been the most widely used quinone-contg. alkylating agent in the clinic, but other quinone-contg. alkylating agents like porfiromycin, diaziquone, carbazilquinone, triaziquone and EO9 have also been used in the clinic for the treatment of cancer.  In addn., many other quinone-contg. alkylating agents have been tested in preclin. studies and the development of new agents is being actively pursued.  This chapter describes the current and past clin. uses of these agents in the treatment of cancer and discusses new agents that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO0N2Cf_Ak_bVg90H21EOLACvtfcHk0lj-TkqYtGXJZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVGqtro%253D&md5=62df0b3120d910f03782002284630dd9</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.2741%2Fbegleit&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252Fbegleit%26sid%3Dliteratum%253Aachs%26aulast%3DBegleiter%26aufirst%3DA.%26atitle%3DClinical%2520applications%2520of%2520quinone-containing%2520alkylating%2520agents%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2000%26volume%3D5%26spage%3DE153%26epage%3DE171%26doi%3D10.2741%2Fbegleit" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref95"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref95'); return false;" data-citation="" class="refNumLink">95</a></strong><div class="NLM_citation" id="cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=531-536&author=N.+W.+Gibsonauthor=J.+A.+Hartleyauthor=J.+Butlerauthor=D.+Siegelauthor=D.+Ross&title=Relationship+between+DT-diaphorase-mediated+metabolism+of+a+series+of+aziridinylbenzoquinones+and+DNA+damage+and+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRelationship%2520between%2520DT-diaphorase-mediated%2520metabolism%2520of%2520a%2520series%2520of%2520aziridinylbenzoquinones%2520and%2520DNA%2520damage%2520and%2520cytotoxicity%26jtitle%3DMol.%2520Pharmacol.%26date%3D1992%26volume%3D42%26spage%3D531%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref96"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref96'); return false;" data-citation="" class="refNumLink">96</a></strong><div class="NLM_citation" id="cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inayat-Hussain, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">RH1 induces cellular damage in an NAD(P)H:quinone oxidoreductase 1-dependent manner: relationship between DNA cross-linking, cell cycle perturbations, and apoptosis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1124/jpet.104.081380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fjpet.104.081380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15665137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFemsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=771-779&author=D.+L.+Dehnauthor=S.+H.+Inayat-Hussainauthor=D.+Ross&title=RH1+induces+cellular+damage+in+an+NAD%28P%29H%3Aquinone+oxidoreductase+1-dependent+manner%3A+relationship+between+DNA+cross-linking%2C+cell+cycle+perturbations%2C+and+apoptosis&doi=10.1124%2Fjpet.104.081380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">RH1 induces cellular damage in an NAD(P)H:Quinone oxidoreductase 1-dependent manner: Relationship between DNA cross-linking, cell cycle perturbations, and apoptosis</span></div><div class="casAuthors">Dehn, Donna L.; Inayat-Hussain, Salmaan H.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">771-779</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Structure-based development of NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones resulted in development of RH1 [2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone], a methyl-substituted diaziridinyl quinone.  We conducted expts. to evaluate the mechanism of RH1-induced cytotoxicity and the inter-relation between DNA crosslinking, cell cycle changes, and apoptosis using an isogenic cell line pair developed from the human breast cancer cell line MDA-MB-468 differing only in expression of wtNQO1 (NQ16 cells).  Statistically significant DNA crosslinking was detected using a modified comet assay in cells with wtNQO1 within 1 h of dosing, whereas in parental cells, only marginal DNA crosslinking was obsd. and required a concn. up to 50 times higher.  Crosslinking in NQ16 cells could be abrogated with 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NQO1.  RH1 prolonged S phase and caused a G2/M block.  Cell cycle changes were obsd. up to 10-fold lower in RH1 concns. in NQ16 cells relative to parental cells.  Apoptosis was similarly obsd. morphol. in both cell lines after RH1 treatment but was induced preferentially in NQ16 cells at lower concns. and earlier time points.  Marked cleavage of caspase-3 was obsd. in NQ16 cells relative to parental cells using lower concns. of RH1.  Temporally, low doses of RH1-induced rapid DNA crosslinking in NQ16 cells followed by induction of apoptosis at times when a G2/M block was not obsd.  This suggests that cell cycle arrest is not required for RH1-induced apoptosis and that DNA damage may directly initiate apoptotic events.  In summary, RH1-induced preferential DNA crosslinking, cell cycle changes, and apoptosis in an NQO1-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5pcs4j94ByrVg90H21EOLACvtfcHk0lj-TkqYtGXJZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFemsbo%253D&md5=931768a4fd9a12d979dd270e23c9c3de</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.081380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.081380%26sid%3Dliteratum%253Aachs%26aulast%3DDehn%26aufirst%3DD.%2BL.%26aulast%3DInayat-Hussain%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRH1%2520induces%2520cellular%2520damage%2520in%2520an%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201-dependent%2520manner%253A%2520relationship%2520between%2520DNA%2520cross-linking%252C%2520cell%2520cycle%2520perturbations%252C%2520and%2520apoptosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D771%26epage%3D779%26doi%3D10.1124%2Fjpet.104.081380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref97"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref97'); return false;" data-citation="" class="refNumLink">97</a></strong><div class="NLM_citation" id="cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3147</span>– <span class="NLM_lpage">3155</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-03-0411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-03-0411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15131056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs12lt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3147-3155&author=D.+L.+Dehnauthor=S.+L.+Winskiauthor=D.+Ross&title=Development+of+a+new+isogenic+cell-xenograft+system+for+evaluation+of+NAD%28P%29H%3Aquinone+oxidoreductase-directed+antitumor+quinones%3A+evaluation+of+the+activity+of+RH1&doi=10.1158%2F1078-0432.CCR-03-0411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new isogenic cell-Xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1</span></div><div class="casAuthors">Dehn, Donna L.; Winski, Shannon L.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3147-3155</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of our study was to develop and validate an isogenic cell line pair that differs only in the expression of NAD(P)H:quinone oxidoreductase (NQO1) that can be used to examine the in vitro and in vivo role of NQO1 in the bioactivation of the antitumor quinone RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), a compd. currently in Phase I clin. trials.  MDA-MB-468 (MDA468) human breast adenocarcinoma cells, homozygous for a polymorphism in NQO1 (NQO1*2/*2) and with low levels of NQO1 activity, were stably transfected with human NQO1 to generate a clone (NQ16) expressing very high NQO1 activity.  We examd. levels of other reductases and looked at biochem. systems that might influence response to antitumor quinones to validate that the isogenic cell line pair differed only in the expression of NQO1.  The 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium (MTT) assay was used to det. the differential toxicity of various quinones, including the most recent NQO1-directed antitumor quinone, RH1, between the two cell lines.  Human tumor xenografts were established from both MDA468 and NQ16 cells, and the antitumor activity of RH1 was evaluated.  Levels of cytochrome P 450 reductase, cytochrome b5 reductase, sol. thiols, and superoxide dismutase in the NQ16 line were unchanged from the parental line.  The functional significance of wild-type NQO1 expression was confirmed by measurement of the differential toxicity of compds. activated or deactivated by NQO1 in the two cell lines.  The toxicity of the NQO1-directed antitumor quinones RH1 and streptonigrin were markedly greater and the toxicity of menadione, which is detoxified by NQO1, was ameliorated in the NQ16 line.  High levels of NQO1 expression were obsd. throughout xenograft tumors established from the NQ16 cell line.  RH1 treatment was effective at statistically reducing tumor vol. in NQ16 xenografts at all of the doses tested (0.1, 0.2, 0.4 mg/kg every day for 5 days), whereas only the highest dose of RH1 resulted in a significant redn. in tumor vol. in MDA468 xenografts.  The MDA468/NQ16 isogenic cell line pair is a useful model system for evaluating the role of NQO1 in the bioactivation of antitumor quinones in both cell lines and xenografts.  In addn., our data demonstrate that the novel antitumor quinone RH1, is effectively activated by NQO1 both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR1vAcNs2a37Vg90H21EOLACvtfcHk0ljIVv_2nmJTAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs12lt78%253D&md5=a8fabfa67a288d88b999b98266f1290d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0411%26sid%3Dliteratum%253Aachs%26aulast%3DDehn%26aufirst%3DD.%2BL.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520isogenic%2520cell-xenograft%2520system%2520for%2520evaluation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase-directed%2520antitumor%2520quinones%253A%2520evaluation%2520of%2520the%2520activity%2520of%2520RH1%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D3147%26epage%3D3155%26doi%3D10.1158%2F1078-0432.CCR-03-0411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref98"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref98'); return false;" data-citation="" class="refNumLink">98</a></strong><div class="NLM_citation" id="cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langdon, S.</span></span> <span> </span><span class="NLM_article-title">Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3979</span>– <span class="NLM_lpage">3983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=14666706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFGg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3979-3983&author=J.+Cummingsauthor=A.+Ritchieauthor=J.+Butlerauthor=T.+H.+Wardauthor=S.+Langdon&title=Activity+profile+of+the+novel+aziridinylbenzoquinones+MeDZQ+and+RH1+in+human+tumour+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts</span></div><div class="casAuthors">Cummings, Jeffrey; Ritchie, Alison; Butler, John; Ward, Timothy H.; Langdon, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5A</span>),
    <span class="NLM_cas:pages">3979-3983</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">RH1 and MeDZQ represent novel aziridinylbenzoquinones that can be activated by DT-diaphorase to form unique DNA lesions.  RH1 is due to enter a phase I clin. trial in the United Kingdom in the summer of 2003, where pharmacodynamic monitoring of DT-diaphorase will be performed.  The antitumor efficacy of RH1 and MeDZQ has been studied in 4 human xenografts (3 non-small cell lung cancer and 1 colon cancer), and compared to the level of constitutive DT-Diaphorase activity measured by the DCPIP assay.  The 4 xenografts exhibited a wide range of DT-diaphorase activity (4.8 - 303 nmol/min/mg).  Greater antitumor activity was recorded in the xenografts expressing high levels of DT-diaphorase (e.g. NX002, DT-diaphorase activity, 303 ± 52 nmol/min/mg, T/C to MeDZQ, 33.3% and to RH1, 43.4%).  These data add in vivo support to a role for DT-Diaphorase in the antitumor activity of RH1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMW_a0bkqCA7Vg90H21EOLACvtfcHk0ljIVv_2nmJTAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFGg&md5=e571c319c682e56af271fb8a5e756b81</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DRitchie%26aufirst%3DA.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DT.%2BH.%26aulast%3DLangdon%26aufirst%3DS.%26atitle%3DActivity%2520profile%2520of%2520the%2520novel%2520aziridinylbenzoquinones%2520MeDZQ%2520and%2520RH1%2520in%2520human%2520tumour%2520xenografts%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3979%26epage%3D3983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref99"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref99'); return false;" data-citation="" class="refNumLink">99</a></strong><div class="NLM_citation" id="cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klymenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estlin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makin, G. W.</span></span> <span> </span><span class="NLM_article-title">Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6605100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fsj.bjc.6605100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19491903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVKgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=55-63&author=D.+Husseinauthor=S.+V.+Holtauthor=K.+E.+Brookesauthor=T.+Klymenkoauthor=J.+K.+Adamskiauthor=A.+Hoggauthor=E.+J.+Estlinauthor=T.+Wardauthor=C.+Diveauthor=G.+W.+Makin&title=Preclinical+efficacy+of+the+bioreductive+alkylating+agent+RH1+against+paediatric+tumours&doi=10.1038%2Fsj.bjc.6605100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical efficacy of the bioreductive alkylating agent RH1 against pediatric tumors</span></div><div class="casAuthors">Hussein, D.; Holt, S. V.; Brookes, K. E.; Klymenko, T.; Adamski, J. K.; Hogg, A.; Estlin, E. J.; Ward, T.; Dive, C.; Makin, G. W. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Despite substantial improvements in childhood cancer survival, drug resistance remains problematic for several pediatric tumor types.  The urgent need to access novel agents to treat drug-resistant disease should be expedited by pre-clin. evaluation of pediatric tumor models during the early stages of drug development in adult cancer patients.  Methods/results: The novel cytotoxic RH1 (2,5-diaziridinyl-3-[hydroxymethyl]-6-methyl-1,4-benzoquinone) is activated by the obligate two-electron reductase DT-diaphorase (DTD, widely expressed in adult tumor cells) to a potent DNA interstrand cross-linker.  In acute viability assays against neuroblastoma, osteosarcoma, and Ewing's sarcoma cell lines RH1 IC50 values ranged from 1-200 n and drug potency correlated both with DTD levels and drug-induced apoptosis.  However, synergy between RH1 and cisplatin or doxorubicin was only seen in low DTD expressing cell lines.  In clonogenic assays RH1 IC50 values ranged from 1.5-7.5 n and drug potency did not correlate with DTD level.  In A673 Ewing's sarcoma and 791T osteosarcoma tumor xenografts in mice RH1 induced apoptosis 24 h after a single bolus injection (0.4 mg/kg) and daily dosing for 5 days delayed tumor growth relative to control.  Conclusion: The demonstration of RH1 efficacy against pediatric tumor cell lines, which was performed concurrently with the adult Phase 1 Trial, suggests that this agent may have clin. usefulness in childhood cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLNe86t5klI7Vg90H21EOLACvtfcHk0ljIVv_2nmJTAQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVKgurk%253D&md5=4dbafa0ae2db4636bd17fd7b50e3d779</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605100%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DD.%26aulast%3DHolt%26aufirst%3DS.%2BV.%26aulast%3DBrookes%26aufirst%3DK.%2BE.%26aulast%3DKlymenko%26aufirst%3DT.%26aulast%3DAdamski%26aufirst%3DJ.%2BK.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DEstlin%26aufirst%3DE.%2BJ.%26aulast%3DWard%26aufirst%3DT.%26aulast%3DDive%26aufirst%3DC.%26aulast%3DMakin%26aufirst%3DG.%2BW.%26atitle%3DPreclinical%2520efficacy%2520of%2520the%2520bioreductive%2520alkylating%2520agent%2520RH1%2520against%2520paediatric%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D55%26epage%3D63%26doi%3D10.1038%2Fsj.bjc.6605100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref100"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref100'); return false;" data-citation="" class="refNumLink">100</a></strong><div class="NLM_citation" id="cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denneny, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aarons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jowle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranson</span></span> <span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1653</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdq638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1093%2Fannonc%2Fmdq638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21378203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnjt1CqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1653-1660&author=S.+Dansonauthor=P.+Johnsonauthor=T.+H.+Wardauthor=M.+Dawsonauthor=O.+Dennenyauthor=G.+Dickinsonauthor=L.+Aaronsauthor=A.+Watsonauthor=D.+Jowleauthor=J.+Cummingsauthor=L.+Robsonauthor=G.+Halbertauthor=C.+Diveauthor=+Ranson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+the+bioreductive+drug+RH1&doi=10.1093%2Fannonc%2Fmdq638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1</span></div><div class="casAuthors">Danson S J; Johnson P; Ward T H; Dawson M; Denneny O; Dickinson G; Aarons L; Watson A; Jowle D; Cummings J; Robson L; Halbert G; Dive C; Ranson M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1653-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  This trial describes a first-in-man evaluation of RH1, a novel bioreductive drug activated by DT-diaphorase (DTD), an enzyme overexpressed in many tumours.  PATIENTS AND METHODS:  A dose-escalation phase I trial of RH1 was carried out.  The primary objective was to establish the maximum tolerated dose (MTD) of RH1.  Secondary objectives were assessment of toxicity, pharmacokinetic determination of RH1 and pharmacodynamic assessment of drug effect through measurement of DNA cross linking in peripheral blood mononuclear cells (PBMCs) and tumour, DTD activity in tumour and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism status.  RESULTS:  Eighteen patients of World Health Organization performance status of zero to one with advanced refractory solid malignancies were enrolled.  MTD was 1430 μg/m(2)/day with reversible bone marrow suppression being dose limiting.  Plasma pharmacokinetic analysis showed RH1 is rapidly cleared from blood (t(1/2) = 12.3 min), with AUC increasing proportionately with dose.  The comet-X assay demonstrated dose-related increases in DNA cross linking in PBMCs.  DNA cross linking was demonstrated in tumours, even with low levels of DTD.  Only one patient was homozygous for NQO1 polymorphism precluding any conclusion of its effect.  CONCLUSIONS:  RH1 was well tolerated with predictable and manageable toxicity.  The MTD of 1430 μg/m(2)/day is the dose recommended for phase II trials.  The biomarkers of DNA cross linking, DTD activity and NQO1 status have been validated and clinically developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDwcYCS4u1vCEJCPKhJPuqfW6udTcc2eb0JhswNijkarntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnjt1CqtQ%253D%253D&md5=9ce5b5fd64e831a56ec49497c5743bcd</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdq638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdq638%26sid%3Dliteratum%253Aachs%26aulast%3DDanson%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DT.%2BH.%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DDenneny%26aufirst%3DO.%26aulast%3DDickinson%26aufirst%3DG.%26aulast%3DAarons%26aufirst%3DL.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DJowle%26aufirst%3DD.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DRobson%26aufirst%3DL.%26aulast%3DHalbert%26aufirst%3DG.%26aulast%3DDive%26aufirst%3DC.%26aulast%3DRanson%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%2520the%2520bioreductive%2520drug%2520RH1%26jtitle%3DAnn.%2520Oncol.%26date%3D2011%26volume%3D22%26spage%3D1653%26epage%3D1660%26doi%3D10.1093%2Fannonc%2Fmdq638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref101"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref101'); return false;" data-citation="" class="refNumLink">101</a></strong><div class="NLM_citation" id="cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasinoff, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begleiter, A.</span></span> <span> </span><span class="NLM_article-title">The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">978</span>, <span class="refDoi"> DOI: 10.1080/10715760600833077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1080%2F10715760600833077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=17015278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCjtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=974-978&author=B.+B.+Hasinoffauthor=A.+Begleiter&title=The+reductive+activation+of+the+antitumor+drug+RH1+to+its+semiquinone+free+radical+by+NADPH+cytochrome+P450+reductase+and+by+HCT116+human+colon+cancer+cells&doi=10.1080%2F10715760600833077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells</span></div><div class="casAuthors">Hasinoff, Brian B.; Begleiter, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">974-978</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), which is currently in clin. trials, is a diaziridinyl benzoquinone bioreductive anticancer drug that was designed to be activated by the obligate two-electron reductive enzyme NAD(P)H quinone oxidoreductase 1 (NQO1).  In this ESR study we showed that RH1 was reductively activated by the one-electron reductive enzyme NADPH cytochrome P 450 reductase and by a suspension of HCT116 human colon cancer cells to yield a semiquinone free radical.  As shown by EPR spin trapping expts. RH1 was reductively activated by cytochrome P 450 reductase and underwent redox cycling to produce damaging hydroxyl radicals in reactions that were both H2O2- and iron-dependent.  Thus, reductive activation by cytochrome P 450 reductase or other reductases to produce a semiquinone that can redox cycle to produce damaging hydroxyl radicals and/or DNA-reactive alkylating species may contribute to the potent cell growth inhibitory effects of RH1.  These results also suggest that selection of patients for treatment with RH1 based on their expression levels of NQO1 may be problematic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqESpeJCj4VYLVg90H21EOLACvtfcHk0li0e9837eucCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCjtLzK&md5=d7c4623ed36cba7e63d7e83140024d0c</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1080%2F10715760600833077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760600833077%26sid%3Dliteratum%253Aachs%26aulast%3DHasinoff%26aufirst%3DB.%2BB.%26aulast%3DBegleiter%26aufirst%3DA.%26atitle%3DThe%2520reductive%2520activation%2520of%2520the%2520antitumor%2520drug%2520RH1%2520to%2520its%2520semiquinone%2520free%2520radical%2520by%2520NADPH%2520cytochrome%2520P450%2520reductase%2520and%2520by%2520HCT116%2520human%2520colon%2520cancer%2520cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2006%26volume%3D40%26spage%3D974%26epage%3D978%26doi%3D10.1080%2F10715760600833077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref102"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref102'); return false;" data-citation="" class="refNumLink">102</a></strong><div class="NLM_citation" id="cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Dissecting the role of multiple reductases in bioactivation and cytotoxicity of the antitumor agent RH1</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1665</span>, <span class="refDoi"> DOI: 10.1124/mol.108.050401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.108.050401" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1657-1665&author=C.+Yanauthor=J.+K.+Kepaauthor=D.+Siegelauthor=I.+J.+Stratfordauthor=D.+Ross&title=Dissecting+the+role+of+multiple+reductases+in+bioactivation+and+cytotoxicity+of+the+antitumor+agent+RH1&doi=10.1124%2Fmol.108.050401"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.050401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.050401%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DDissecting%2520the%2520role%2520of%2520multiple%2520reductases%2520in%2520bioactivation%2520and%2520cytotoxicity%2520of%2520the%2520antitumor%2520agent%2520RH1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1657%26epage%3D1665%26doi%3D10.1124%2Fmol.108.050401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref103"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref103'); return false;" data-citation="" class="refNumLink">103</a></strong><div class="NLM_citation" id="cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0li0e9837eucCQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref104"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref104'); return false;" data-citation="" class="refNumLink">104</a></strong><div class="NLM_citation" id="cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zirrolli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">10006</span>– <span class="NLM_lpage">10015</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-05-2029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10006-10015&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=J.+Zirrolliauthor=D.+Gustafsonauthor=D.+Ross&title=Formation+of+17-allylamino-demethoxygeldanamycin+%2817-AAG%29+hydroquinone+by+NAD%28P%29H%3Aquinone+oxidoreductase+1%3A+role+of+17-AAG+hydroquinone+in+heat+shock+protein+90+inhibition&doi=10.1158%2F0008-5472.CAN-05-2029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2029%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DZirrolli%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DFormation%2520of%252017-allylamino-demethoxygeldanamycin%2520%252817-AAG%2529%2520hydroquinone%2520by%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%253A%2520role%2520of%252017-AAG%2520hydroquinone%2520in%2520heat%2520shock%2520protein%252090%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10006%26epage%3D10015%26doi%3D10.1158%2F0008-5472.CAN-05-2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref105"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref105'); return false;" data-citation="" class="refNumLink">105</a></strong><div class="NLM_citation" id="cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zirrolli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1194</span>– <span class="NLM_lpage">1203</span>, <span class="refDoi"> DOI: 10.1124/mol.106.025643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.106.025643" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1194-1203&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=J.+Zirrolliauthor=D.+Gustafsonauthor=D.+Ross&title=The+bioreduction+of+a+series+of+benzoquinone+ansamycins+by+NAD%28P%29H%3Aquinone+oxidoreductase+1+to+more+potent+heat+shock+protein+90+inhibitors%2C+the+hydroquinone+ansamycins&doi=10.1124%2Fmol.106.025643"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025643%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DZirrolli%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DThe%2520bioreduction%2520of%2520a%2520series%2520of%2520benzoquinone%2520ansamycins%2520by%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520to%2520more%2520potent%2520heat%2520shock%2520protein%252090%2520inhibitors%252C%2520the%2520hydroquinone%2520ansamycins%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1194%26epage%3D1203%26doi%3D10.1124%2Fmol.106.025643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref106"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref106'); return false;" data-citation="" class="refNumLink">106</a></strong><div class="NLM_citation" id="cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okubo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeeda, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuhira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maesawa, C.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone Oxidoreductase-1 expression sensitizes malignant melanoma cells to the HSP90 inhibitor 17-AAG</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0153181</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0153181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1371%2Fjournal.pone.0153181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0153181&author=S.+Kasaiauthor=N.+Arakawaauthor=A.+Okuboauthor=W.+Shigeedaauthor=S.+Yasuhiraauthor=T.+Masudaauthor=T.+Akasakaauthor=M.+Shibazakiauthor=C.+Maesawa&title=NAD%28P%29H%3Aquinone+Oxidoreductase-1+expression+sensitizes+malignant+melanoma+cells+to+the+HSP90+inhibitor+17-AAG&doi=10.1371%2Fjournal.pone.0153181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0153181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0153181%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DArakawa%26aufirst%3DN.%26aulast%3DOkubo%26aufirst%3DA.%26aulast%3DShigeeda%26aufirst%3DW.%26aulast%3DYasuhira%26aufirst%3DS.%26aulast%3DMasuda%26aufirst%3DT.%26aulast%3DAkasaka%26aufirst%3DT.%26aulast%3DShibazaki%26aufirst%3DM.%26aulast%3DMaesawa%26aufirst%3DC.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520Oxidoreductase-1%2520expression%2520sensitizes%2520malignant%2520melanoma%2520cells%2520to%2520the%2520HSP90%2520inhibitor%252017-AAG%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0153181%26doi%3D10.1371%2Fjournal.pone.0153181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref107"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref107'); return false;" data-citation="" class="refNumLink">107</a></strong><div class="NLM_citation" id="cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.176438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fjpet.110.176438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21156818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=874-880&author=D.+Siegelauthor=B.+Shiehauthor=C.+Yanauthor=J.+K.+Kepaauthor=D.+Ross&title=Role+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+and+manganese-dependent+superoxide+dismutase+in+17-%28allylamino%29-17-demethoxygeldanamycin-induced+heat+shock+protein+90+inhibition+in+pancreatic+cancer+cells&doi=10.1124%2Fjpet.110.176438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells</span></div><div class="casAuthors">Siegel, David; Shieh, Biehuoy; Yan, Chao; Kepa, Jadwiga K.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-880</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous work demonstrated that NAD(P)H:quinone oxidoreductase 1 (NQO1) metabolized the heat shock protein 90 (Hsp90) inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17AAG) to the corresponding hydroquinone (17AAGH2).  The formation of 17AAGH2 by NQO1 results in a mol. that binds with greater affinity to Hsp90 compared with the parent quinone.  17AAG induced substantial growth inhibition in human pancreatic cancer cell lines expressing NQO1.  Growth inhibition induced by 17AAG could be reduced by pretreatment with 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]-indole-4,7-dione (ES936), a mechanism-based inhibitor of NQO1.  After treatment with 17AAG, biomarkers of Hsp90 inhibition, including markers of cell-cycle arrest, were more pronounced in NQO1-expressing cells compared with NQO1-null cells.  The intracellular concns. of 17AAG and 17AAGH2 were measured in human pancreatic cancer cells, and it was obsd. that larger amts. of 17AAG and 17AAGH2 could be detected in cells with catalytically active NQO1 compared with cells lacking NQO1 activity or cells pretreated with ES936.  These data demonstrate that, in addn. to generating an inhibitor with greater affinity for Hsp90 (17AAGH2), redn. of 17AAG to 17AAGH2 by NQO1 leads to substantially greater intracellular concns. of 17AAG and 17AAGH2.  In addn., oxidn. of 17AAGH2 could be prevented by superoxide dismutase (SOD), demonstrating that 17AAGH2 was sensitive to oxidn. by superoxide.  Stable transfection of manganese-dependent SOD into MiaPaCa-2 cells resulted in a significantly greater intracellular concn. of 17AAGH2 with a corresponding increase in growth inhibitory activity.  These data confirm the role of NQO1 in sensitivity to 17AAG and demonstrate that SOD functions in conjunction with NQO1 to maintain intracellular levels of 17AAGH2, the active Hsp90 inhibitor derived from 17AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwp58rWRMZirVg90H21EOLACvtfcHk0lh6wt8UyjtppQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqt7c%253D&md5=c94b89d8ab2a9bdb6ceee342e94b852a</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.176438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.176438%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DShieh%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRole%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520and%2520manganese-dependent%2520superoxide%2520dismutase%2520in%252017-%2528allylamino%2529-17-demethoxygeldanamycin-induced%2520heat%2520shock%2520protein%252090%2520inhibition%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D874%26epage%3D880%26doi%3D10.1124%2Fjpet.110.176438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref108"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref108'); return false;" data-citation="" class="refNumLink">108</a></strong><div class="NLM_citation" id="cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behrsing, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyson, C. A.</span></span> <span> </span><span class="NLM_article-title">In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin in rats</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1079</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2005.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.tiv.2005.06.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1079-1088&author=H.+P.+Behrsingauthor=K.+Aminauthor=C.+Ipauthor=L.+Jimenezauthor=C.+A.+Tyson&title=In+vitro+detection+of+differential+and+cell-specific+hepatobiliary+toxicity+induced+by+geldanamycin+and+17-allylaminogeldanamycin+in+rats&doi=10.1016%2Fj.tiv.2005.06.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2005.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2005.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DBehrsing%26aufirst%3DH.%2BP.%26aulast%3DAmin%26aufirst%3DK.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DL.%26aulast%3DTyson%26aufirst%3DC.%2BA.%26atitle%3DIn%2520vitro%2520detection%2520of%2520differential%2520and%2520cell-specific%2520hepatobiliary%2520toxicity%2520induced%2520by%2520geldanamycin%2520and%252017-allylaminogeldanamycin%2520in%2520rats%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2005%26volume%3D19%26spage%3D1079%26epage%3D1088%26doi%3D10.1016%2Fj.tiv.2005.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref109"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref109'); return false;" data-citation="" class="refNumLink">109</a></strong><div class="NLM_citation" id="cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: relevance for toxicity and mechanism of action</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2050</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.022004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fdmd.108.022004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2050-2057&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=D.+Ross&title=Enzymatic+reduction+and+glutathione+conjugation+of+benzoquinone+ansamycin+heat+shock+protein+90+inhibitors%3A+relevance+for+toxicity+and+mechanism+of+action&doi=10.1124%2Fdmd.108.022004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.022004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.022004%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DEnzymatic%2520reduction%2520and%2520glutathione%2520conjugation%2520of%2520benzoquinone%2520ansamycin%2520heat%2520shock%2520protein%252090%2520inhibitors%253A%2520relevance%2520for%2520toxicity%2520and%2520mechanism%2520of%2520action%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2050%26epage%3D2057%26doi%3D10.1124%2Fdmd.108.022004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref110"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref110'); return false;" data-citation="" class="refNumLink">110</a></strong><div class="NLM_citation" id="cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samuni, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyodo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuni, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. B.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibiting anti-cancer geldanamycin and its analogs</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.freeradbiomed.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20211249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1559-1563&author=Y.+Samuniauthor=H.+Ishiiauthor=F.+Hyodoauthor=U.+Samuniauthor=M.+C.+Krishnaauthor=S.+Goldsteinauthor=J.+B.+Mitchell&title=Reactive+oxygen+species+mediate+hepatotoxicity+induced+by+the+Hsp90+inhibiting+anti-cancer+geldanamycin+and+its+analogs&doi=10.1016%2Fj.freeradbiomed.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs</span></div><div class="casAuthors">Samuni, Yuval; Ishii, Hisanari; Hyodo, Fuminori; Samuni, Uri; Krishna, Murali C.; Goldstein, Sara; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1559-1563</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Geldanamycin (GM), a benzoquinone ansamycin antibiotic, is a natural product inhibitor of Hsp90 with potent and broad anti-cancer properties.  Because of its adverse effects on liver, its less toxic derivs. 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) are currently being evaluated for the treatment of cancer.  Previously, it was demonstrated that the redox cycling of GM by NADPH-cytochrome P 450 reductase leads to the formation of the GM semiquinone and superoxide radicals, the latter being identified using spin-trapping.  We hypothesized that the different hepatotoxicity induced by GM, 17-AAG, and 17-DMAG reflects the redox active properties of the quinone moiety and possibly the extent of superoxide formation, which may stimulate cellular oxidative injury.  Our data demonstrate that superoxide can be efficiently trapped during the redn. of GM, 17-AAG, and 17-DMAG by NADPH-cytochrome P 450 reductase, and that superoxide formation rate followed the order 17-DMAG > 17-AAG > GM.  In the absence of superoxide scavengers, the rate of NADPH oxidn. followed the order 17-DMAG > GM > 17-AAG.  The half-wave one-electron redn. potentials (E1/2) of GM, 17-AAG, and 17-DMAG in DMSO were detd. to be -0.37, -0.13 and -0.015 V (vs. Ag/AgCl), resp.  If the same order of E1/2 follows in neutral aq. media, thermodn. considerations imply that 17-DMAG is more readily reduced by the P 450 reductase as well as by superoxide.  The order of the drug cytotoxicity toward rat primary hepatocytes, as detd. by their effect on cell viability and on intracellular oxidant level, was opposite to the order of E1/2 of the resp. quinone/semiquinone couples.  These results suggest that hepatotoxicity exhibited by the Hsp90 inhibitors belonging to benzoquinone ansamycins could be attributed to superoxide.  The apparent discrepancy between the order of toxicity and the orders of superoxide formation rate, which is correlated with E1/2, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpruuvDYz3MwbVg90H21EOLACvtfcHk0lh6wt8UyjtppQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D&md5=25d6f75c0c010667a4d9d9be51f67c21</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DSamuni%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DHyodo%26aufirst%3DF.%26aulast%3DSamuni%26aufirst%3DU.%26aulast%3DKrishna%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DS.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520mediate%2520hepatotoxicity%2520induced%2520by%2520the%2520Hsp90%2520inhibiting%2520anti-cancer%2520geldanamycin%2520and%2520its%2520analogs%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1559%26epage%3D1563%26doi%3D10.1016%2Fj.freeradbiomed.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref111"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref111'); return false;" data-citation="" class="refNumLink">111</a></strong><div class="NLM_citation" id="cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.780597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1517%2F13543776.2013.780597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23641970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=919-943&author=T.+Kimauthor=G.+Keumauthor=A.+N.+Pae&title=Discovery+and+development+of+heat+shock+protein+90+inhibitors+as+anticancer+agents%3A+a+review+of+patented+potent+geldanamycin+derivatives&doi=10.1517%2F13543776.2013.780597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives</span></div><div class="casAuthors">Kim, TaeHun; Keum, Gyochang; Pae, Ae Nim</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">919-943</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: There has been research on anticancer strategies which focus on disrupting a single malignant protein.  One of the strategies is the inhibition of one protein, heat shock protein 90 (Hsp90).  There are many reasons why Hsp90 protein is targeted by anticancer agents: maintenance of cellular homeostasis in organisms involves Hsp90 and its client proteins; moreover, Hsp90 complex is involved in regulating several signal transduction pathways and plays an important role in the maturation of lots of tumor-promoting client proteins.  Geldanamycin (GM), the first benzoquinone ansamycin, has shown anticancer activity by binding to Hsp90.  Currently, several GM derivs. such as 17-AAG, 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin, IPI-493, and IPI-504 are being progressively developed toward clin. application.  Areas covered: Several research groups have studied GM and its derivs. to develop novel and potent Hsp90 inhibitors for the treatment of cancer.  The crystal structure of Hsp90 was utilized to undergo structural optimization of GM derivs.  A wide variety of structural modifications were performed and some of the derivs. are now in clin. studies.  The aim of this review was to summarize and analyze the structure-activity relationships of GM derivs. and the focus is on patented novel and pharmaceutically efficacious derivs. published from 1971 to 2012.  Expert opinion: Hsp90 inhibitors offer an effective therapeutic approach for treatment of cancer.  To date, the clin. results of 17-AAG, IPI-493, and IPI-504 suggest that these GM derivs. could be used either alone or in combination with other marketed medications for the treatment of cancer patients.  As there are not any marketed Hsp90 inhibitors, inhibiting Hsp90 chaperone function remains as a promising strategy that still requires further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG3zQbDv_bxrVg90H21EOLACvtfcHk0liGhYgDHALhOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3N&md5=cbfb23877dc1cbc9e26d9916f5f39b0c</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.780597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.780597%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.%26aulast%3DKeum%26aufirst%3DG.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DDiscovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%2520as%2520anticancer%2520agents%253A%2520a%2520review%2520of%2520patented%2520potent%2520geldanamycin%2520derivatives%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D919%26epage%3D943%26doi%3D10.1517%2F13543776.2013.780597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref112"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref112'); return false;" data-citation="" class="refNumLink">112</a></strong><div class="NLM_citation" id="cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glaze, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egorin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiseman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaszewski, J. E.</span></span> <span> </span><span class="NLM_article-title">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1007/s00280-005-1000-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1007%2Fs00280-005-1000-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15986212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=637-647&author=E.+R.+Glazeauthor=A.+L.+Lambertauthor=A.+C.+Smithauthor=J.+G.+Pageauthor=W.+D.+Johnsonauthor=D.+L.+McCormickauthor=A.+P.+Brownauthor=B.+S.+Levineauthor=J.+M.+Coveyauthor=M.+J.+Egorinauthor=J.+L.+Eisemanauthor=J.+L.+Holleranauthor=E.+A.+Sausvilleauthor=J.+E.+Tomaszewski&title=Preclinical+toxicity+of+a+geldanamycin+analog%2C+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin+%2817-DMAG%29%2C+in+rats+and+dogs%3A+potential+clinical+relevance&doi=10.1007%2Fs00280-005-1000-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span></div><div class="casAuthors">Glaze, Elizabeth R.; Lambert, Amy L.; Smith, Adaline C.; Page, John G.; Johnson, William D.; McCormick, David L.; Brown, Alan P.; Levine, Barry S.; Covey, Joseph M.; Egorin, Merrill J.; Eiseman, Julie L.; Holleran, Julianne L.; Sausville, Edward A.; Tomaszewski, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">637-647</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: 17-DMAG is a hydrophilic deriv. of the mol. chaperone inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG; NSC-330507), which is currently being evaluated for the treatment of cancer in clin. trials. 17-DMAG offers a potential advantage over 17-AAG because its aq. soly. eliminates the need for complicated formulations that are currently used for administration of 17-AAG.  In addn., 17-DMAG undergoes only limited metab. compared to 17-AAG.  The present results are from preclin. toxicity studies evaluating 17-DMAG in rats and dogs.  Methods: Doses of 0, 2.4, 12 and 24 mg/m2 per day were administered to rats, while dogs received doses of 0, 8 or 16 mg/m2 per day.  In both species, 17-DMAG was administered i.v. (slow bolus for rats; 1-h infusion for dogs) daily for 5 days.  An addnl. cohort of dogs received 16 mg/m2 per day orally for 5 days.  Clin. observations were noted, and std. hematol. and clin. chem. parameters were monitored.  Selected tissues were evaluated microscopically for drug-related lesions.  Tissue and plasma 17-DMAG concns. were measured by HPLC/MS at selected time-points on days 1 and 5.  Results: Daily i.v. administration of 17-DMAG at doses of 24 mg/m2 per day in rats or 16 mg/m2 per day in dogs produced lethality on day 6, approx. 24 h following the last dose.  Body wt. loss was common in rats and dogs.  Drug-related gastrointestinal, bone marrow and hepatic toxicities were also common in rats and dogs.  Dogs also exhibited signs of renal and gallbladder toxicity.  Plasma concns. of 17-DMAG increased proportionately with dose in rats and disproportionately with dose in dogs.  In rat tissues, however, only fourfold to sixfold increases in 17-DMAG concns. were obsd. with a tenfold increase in dose.  The highest concns. of 17-DMAG were found in the liver of rats, with progressively lower concns. in the spleen, lung, kidney and plasma.  Regardless of the route of administration, higher drug concns. were present in plasma (rat and dog) and tissue (rat) samples obtained on day 5 compared to those obtained on day 1.  Although plasma concns. decreased with time, 17-DMAG was still detected in dog plasma for at least 24 h after drug administration.  Conclusions: With the recent approval of 17-DMAG for clin. use, the data generated from these preclin. studies will provide guidance to clinicians as they administer this drug to their patients.  The MTD of 17-DMAG was 12 mg/m2 per day in rats and 8 mg/m2 per day in dogs; therefore, the recommended starting dose for phase I trial is 1.3 mg/m2 per day for 5 days.  Gastrointestinal and bone marrow toxicity were dose-limiting in rats, and gastrointestinal, renal, gallbladder and bone marrow toxicity were dose-limiting in dogs.  All adverse effects were fully reversible in surviving animals after treatment was complete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWkzP-n-oIFbVg90H21EOLACvtfcHk0liGhYgDHALhOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP&md5=62fe4552e57e6e2b86326d57d4ab8ff2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-1000-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-1000-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlaze%26aufirst%3DE.%2BR.%26aulast%3DLambert%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPage%26aufirst%3DJ.%2BG.%26aulast%3DJohnson%26aufirst%3DW.%2BD.%26aulast%3DMcCormick%26aufirst%3DD.%2BL.%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DLevine%26aufirst%3DB.%2BS.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26aulast%3DHolleran%26aufirst%3DJ.%2BL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26atitle%3DPreclinical%2520toxicity%2520of%2520a%2520geldanamycin%2520analog%252C%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%2520%252817-DMAG%2529%252C%2520in%2520rats%2520and%2520dogs%253A%2520potential%2520clinical%2520relevance%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26spage%3D637%26epage%3D647%26doi%3D10.1007%2Fs00280-005-1000-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref113"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref113'); return false;" data-citation="" class="refNumLink">113</a></strong><div class="NLM_citation" id="cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbits, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span> <span> </span><span class="NLM_article-title">The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3369</span>– <span class="NLM_lpage">3378</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-09-0568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19952119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3369-3378&author=M.+Douglasauthor=A.+R.+Limauthor=J.+R.+Porterauthor=K.+Westauthor=M.+M.+Pinkauthor=J.+Geauthor=A.+A.+Wylieauthor=T.+T.+Tibbitsauthor=K.+Biggsauthor=M.+Curtisauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=C.+C.+Fritzauthor=E.+Normant&title=The+antiproliferative+activity+of+the+heat+shock+protein+90+inhibitor+IPI-504+is+not+dependent+on+NAD%28P%29H%3Aquinone+oxidoreductase+1+activity+in+vivo&doi=10.1158%2F1535-7163.MCT-09-0568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo</span></div><div class="casAuthors">Douglas, Mark; Lim, Alice R.; Porter, James R.; West, Kip; Pink, Melissa M.; Ge, Jie; Wylie, Andrew A.; Tibbits, Thomas T.; Biggs, Kurtis; Curtis, Michael; Palombella, Vito J.; Adams, Julian; Fritz, Christian C.; Normant, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3369-3378</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">IPI-504, a water-sol. ansamycin analog currently being investigated in clin. trials, is a potent inhibitor of the protein chaperone heat shock protein 90 (Hsp90).  Inhibition of Hsp90 by IPI-504 triggers the degrdn. of important oncogenic client proteins.  In cells, the free base of IPI-504 hydroquinone exists in a dynamic redox equil. with its corresponding quinone (17-AAG); the hydroquinone form binding 50 times more tightly to Hsp90.  It has been proposed recently that the NAD(P)H:quinone oxidoreductase NQO1 can produce the active hydroquinone and could be essential for the activity of IPI-504.  Here, we have devised a method to directly measure the intracellular ratio of hydroquinone to quinone (HQ/Q) and have applied this measurement to correlate NQO1 enzyme abundance with HQ/Q ratio and cellular activity of IPI-504 in 30 cancer cell lines.  Interestingly, the intracellular HQ/Q ratio was correlated with NQO1 levels only in a subset of cell lines and overall was poorly correlated with the growth inhibitory activity of IPI-504.  Although artificial overexpression of NQO1 is able to increase the level of hydroquinone and cell sensitivity to IPI-504, it has little effect on the activity of 17-amino-17-demethoxy-geldanamycin, the major active metabolite of IPI-504.  This finding could provide an explanation for the biol. activity of IPI-504 in xenograft models of cell lines that are not sensitive to IPI-504 in vitro.  Our results suggest that NQO1 activity is not a determinant of IPI-504 activity in vivo and, therefore, unlikely to become an important resistance mechanism to IPI-504 in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJ38WfRb4s7Vg90H21EOLACvtfcHk0liGhYgDHALhOg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbrO&md5=d59d0ffb7d0d6dd5a02b84aacc1a8401</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0568%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DA.%2BR.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DWylie%26aufirst%3DA.%2BA.%26aulast%3DTibbits%26aufirst%3DT.%2BT.%26aulast%3DBiggs%26aufirst%3DK.%26aulast%3DCurtis%26aufirst%3DM.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DNormant%26aufirst%3DE.%26atitle%3DThe%2520antiproliferative%2520activity%2520of%2520the%2520heat%2520shock%2520protein%252090%2520inhibitor%2520IPI-504%2520is%2520not%2520dependent%2520on%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520activity%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D3369%26epage%3D3378%26doi%3D10.1158%2F1535-7163.MCT-09-0568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref114"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref114'); return false;" data-citation="" class="refNumLink">114</a></strong><div class="NLM_citation" id="cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesole, D. H.</span></span> <span> </span><span class="NLM_article-title">Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1375</span>– <span class="NLM_lpage">1383</span>, <span class="refDoi"> DOI: 10.1517/13543780903158934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1517%2F13543780903158934" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1375-1383&author=B.+E.+Hansonauthor=D.+H.+Vesole&title=Retaspimycin+hydrochloride+%28IPI-504%29%3A+a+novel+heat+shock+protein+inhibitor+as+an+anticancer+agent&doi=10.1517%2F13543780903158934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1517%2F13543780903158934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780903158934%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DB.%2BE.%26aulast%3DVesole%26aufirst%3DD.%2BH.%26atitle%3DRetaspimycin%2520hydrochloride%2520%2528IPI-504%2529%253A%2520a%2520novel%2520heat%2520shock%2520protein%2520inhibitor%2520as%2520an%2520anticancer%2520agent%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D1375%26epage%3D1383%26doi%3D10.1517%2F13543780903158934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref115"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref115'); return false;" data-citation="" class="refNumLink">115</a></strong><div class="NLM_citation" id="cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span> <span> </span><span class="NLM_article-title">Ansamycin inhibitors of Hsp90: Nature’s prototype for anti-chaperone therapy</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1386</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.2174/156802609789895719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2174%2F156802609789895719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19860734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1386-1418&author=J.+R.+Porterauthor=J.+Geauthor=J.+Leeauthor=E.+Normantauthor=K.+West&title=Ansamycin+inhibitors+of+Hsp90%3A+Nature%E2%80%99s+prototype+for+anti-chaperone+therapy&doi=10.2174%2F156802609789895719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Ansamycin inhibitors of Hsp90: nature's prototype for anti-chaperone therapy</span></div><div class="casAuthors">Porter, James R.; Ge, Jie; Lee, John; Normant, Emmanuel; West, Kip</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1386-1418</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The ansamycin class of natural products is well known for its anti-tumor effects and has been extensively studied by cancer researchers for nearly four decades.  The first description of geldanamycin in the scientific literature appeared in 1970 and nearly thirty years later the semi-synthetic deriv. 17-AAG, or tanespimycin, entered Phase 1 clin. trials.  In the subsequent years, three addnl. geldanamycin derivs. have entered clin. evaluation.  Kosan Biosciences developed 17-DMAG or alvespimycin hydrochloride for clin. evaluation as both an i.v. and oral product.  Infinity Pharmaceuticals is developing IPI-504 or retaspimycin hydrochloride as an i.v. product, which is in several Phase 2 clin. trials; IPI-504 is the hydroquinone hydrochloride salt of 17-AAG.  More recently, Infinity Pharmaceuticals initiated a Phase 1 clin. trial with an oral formulation of 17-AG (IPI-493), the major metabolite of 17-AAG and IPI-504.  Since a vast amt. of scientific literature exists regarding the ansamycin field and Hsp90 inhibition, this review will survey key milestones in the development of the natural product class as anti-cancer drugs including discovery of the compds. and their anti-tumor effects, identification of Hsp90 as their biol. target, the structure-activity relationships that have been identified in this interesting class of compds., and development of clin. candidates for the treatment of cancer patients.  A brief overview of important pre-clin. development data from each clin. lead is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhropKxP9ObVg90H21EOLACvtfcHk0lgLTfep9SWVWQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakuro%253D&md5=9c71a14e77339887c61ecf35924eeafd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.2174%2F156802609789895719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895719%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DWest%26aufirst%3DK.%26atitle%3DAnsamycin%2520inhibitors%2520of%2520Hsp90%253A%2520Nature%25E2%2580%2599s%2520prototype%2520for%2520anti-chaperone%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1386%26epage%3D1418%26doi%3D10.2174%2F156802609789895719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref116"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref116'); return false;" data-citation="" class="refNumLink">116</a></strong><div class="NLM_citation" id="cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, W. P.</span></span> <span> </span><span class="NLM_article-title">Streptonigrin, an antitumor substance. I. Isolation and characterization</span>. <i>Antibiot. Annu.</i> <span class="NLM_year" style="font-weight: bold;">1959</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=14436228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaF3c7ovV2lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1959&pages=950-953&author=K.+V.+Raoauthor=W.+P.+Cullen&title=Streptonigrin%2C+an+antitumor+substance.+I.+Isolation+and+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Streptonigrin, an antitumor substance. I. Isolation and characterization</span></div><div class="casAuthors">RAO K V; CULLEN W P</div><div class="citationInfo"><span class="NLM_cas:title">Antibiotics annual</span>
        (<span class="NLM_cas:date">1959-1960</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">950-3</span>
        ISSN:<span class="NLM_cas:issn">0570-3131</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDjMj1HXEobFm8bhe6roZYfW6udTcc2eaO9nOJ8N35S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c7ovV2lsg%253D%253D&md5=32e9a92caf6defbc6794ac00842dbb68</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DCullen%26aufirst%3DW.%2BP.%26atitle%3DStreptonigrin%252C%2520an%2520antitumor%2520substance.%2520I.%2520Isolation%2520and%2520characterization%26jtitle%3DAntibiot.%2520Annu.%26date%3D1959%26volume%3D7%26spage%3D950%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref117"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref117'); return false;" data-citation="" class="refNumLink">117</a></strong><div class="NLM_citation" id="cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(95)00223-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0006-2952%2895%2900223-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=645-652&author=H.%0AD.+Beallauthor=Y.+Liuauthor=D.+Siegelauthor=E.+M.+Boltonauthor=N.+W.+Gibsonauthor=D.+Ross&title=Role+of+NAD%28P%29H%3Aquinone+oxidoreductase+%28DT-diaphorase%29+in+cytotoxicity+and+induction+of+DNA+damage+by+streptonigrin&doi=10.1016%2FS0006-2952%2895%2900223-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2895%2900223-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252895%252900223-5%26sid%3Dliteratum%253Aachs%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBolton%26aufirst%3DE.%2BM.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRole%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528DT-diaphorase%2529%2520in%2520cytotoxicity%2520and%2520induction%2520of%2520DNA%2520damage%2520by%2520streptonigrin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D51%26spage%3D645%26epage%3D652%26doi%3D10.1016%2FS0006-2952%2895%2900223-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref118"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref118'); return false;" data-citation="" class="refNumLink">118</a></strong><div class="NLM_citation" id="cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yee, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritsos, C. A.</span></span> <span> </span><span class="NLM_article-title">Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1006/abbi.1997.0340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1006%2Fabbi.1997.0340" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1997&pages=235-241&author=S.+B.+Yeeauthor=C.+A.+Pritsos&title=Comparison+of+oxygen+radical+generation+from+the+reductive+activation+of+doxorubicin%2C+streptonigrin%2C+and+menadione+by+xanthine+oxidase+and+xanthine+dehydrogenase&doi=10.1006%2Fabbi.1997.0340"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1997.0340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1997.0340%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DS.%2BB.%26aulast%3DPritsos%26aufirst%3DC.%2BA.%26atitle%3DComparison%2520of%2520oxygen%2520radical%2520generation%2520from%2520the%2520reductive%2520activation%2520of%2520doxorubicin%252C%2520streptonigrin%252C%2520and%2520menadione%2520by%2520xanthine%2520oxidase%2520and%2520xanthine%2520dehydrogenase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D347%26spage%3D235%26epage%3D241%26doi%3D10.1006%2Fabbi.1997.0340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref119"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref119'); return false;" data-citation="" class="refNumLink">119</a></strong><div class="NLM_citation" id="cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackethal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golbey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnofsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchenal, J.</span></span> <span> </span><span class="NLM_article-title">Clinical observations on the effects of streptonigrin in patients with neoplastic disease</span>. <i>Antibiot. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=13710278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaF3c%252FivFyisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1961&pages=178-183&author=C.+Hackethalauthor=R.+Golbeyauthor=C.+Tanauthor=D.+Karnofskyauthor=J.+Burchenal&title=Clinical+observations+on+the+effects+of+streptonigrin+in+patients+with+neoplastic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical observations on the effects of streptonigrin in patients with neoplastic disease</span></div><div class="casAuthors">HACKETHAL C A; GOLBEY R B; TAN C T; KARNOFSKY D A; BURCHENAL J H</div><div class="citationInfo"><span class="NLM_cas:title">Antibiotics & chemotherapy (Northfield, Ill.)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178-83</span>
        ISSN:<span class="NLM_cas:issn">0570-3123</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVmPnvGD5iGu2qxNLjzXe8fW6udTcc2eYGQ3bKvr1T-Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c%252FivFyisQ%253D%253D&md5=7501e7900ece833c522661465cd8c004</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHackethal%26aufirst%3DC.%26aulast%3DGolbey%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DKarnofsky%26aufirst%3DD.%26aulast%3DBurchenal%26aufirst%3DJ.%26atitle%3DClinical%2520observations%2520on%2520the%2520effects%2520of%2520streptonigrin%2520in%2520patients%2520with%2520neoplastic%2520disease%26jtitle%3DAntibiot.%2520Chemother.%26date%3D1961%26volume%3D11%26spage%3D178%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref120"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref120'); return false;" data-citation="" class="refNumLink">120</a></strong><div class="NLM_citation" id="cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’HERRON, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, D.</span></span> <span> </span><span class="NLM_article-title">Isolation of lavendamycin a new antibiotic from <i>Streptomyces lavendulae</i></span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.35.259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.7164%2Fantibiotics.35.259" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1982&pages=259-265&author=D.+Balitzauthor=J.+Bushauthor=W.+Bradnerauthor=T.+Doyleauthor=F.+A.+O%E2%80%99HERRONauthor=D.+Nettleton&title=Isolation+of+lavendamycin+a+new+antibiotic+from+Streptomyces+lavendulae&doi=10.7164%2Fantibiotics.35.259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.35.259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.35.259%26sid%3Dliteratum%253Aachs%26aulast%3DBalitz%26aufirst%3DD.%26aulast%3DBush%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DW.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599HERRON%26aufirst%3DF.%2BA.%26aulast%3DNettleton%26aufirst%3DD.%26atitle%3DIsolation%2520of%2520lavendamycin%2520a%2520new%2520antibiotic%2520from%2520Streptomyces%2520lavendulae%26jtitle%3DJ.%2520Antibiot.%26date%3D1982%26volume%3D35%26spage%3D259%26epage%3D265%26doi%3D10.7164%2Fantibiotics.35.259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref121"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref121'); return false;" data-citation="" class="refNumLink">121</a></strong><div class="NLM_citation" id="cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seradj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedighi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eads, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charkhzarrin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1909</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.01.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmc.2010.01.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1899-1909&author=W.+Caiauthor=M.+Hassaniauthor=R.+Karkiauthor=E.+D.+Walterauthor=K.+H.+Koelschauthor=H.+Seradjauthor=J.+P.+Lineswalaauthor=H.+Mirzaeiauthor=J.+S.+Yorkauthor=F.+Olangauthor=M.+Sedighiauthor=J.+S.+Lucasauthor=T.+J.+Eadsauthor=A.+S.+Roseauthor=S.+Charkhzarrinauthor=N.+G.+Hermannauthor=H.+D.+Beallauthor=M.+Behforouz&title=Synthesis%2C+metabolism+and+in+vitro+cytotoxicity+studies+on+novel+lavendamycin+antitumor+agents&doi=10.1016%2Fj.bmc.2010.01.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DW.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DWalter%26aufirst%3DE.%2BD.%26aulast%3DKoelsch%26aufirst%3DK.%2BH.%26aulast%3DSeradj%26aufirst%3DH.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DMirzaei%26aufirst%3DH.%26aulast%3DYork%26aufirst%3DJ.%2BS.%26aulast%3DOlang%26aufirst%3DF.%26aulast%3DSedighi%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DJ.%2BS.%26aulast%3DEads%26aufirst%3DT.%2BJ.%26aulast%3DRose%26aufirst%3DA.%2BS.%26aulast%3DCharkhzarrin%26aufirst%3DS.%26aulast%3DHermann%26aufirst%3DN.%2BG.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DBehforouz%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520metabolism%2520and%2520in%2520vitro%2520cytotoxicity%2520studies%2520on%2520novel%2520lavendamycin%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D1899%26epage%3D1909%26doi%3D10.1016%2Fj.bmc.2010.01.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref122"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref122'); return false;" data-citation="" class="refNumLink">122</a></strong><div class="NLM_citation" id="cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors</span>. <i>J. Mol. Histol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/s10735-006-9043-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1007%2Fs10735-006-9043-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16868862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1elsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=203-218&author=M.+S.+Bentleauthor=E.+A.+Beyauthor=Y.+Dongauthor=K.+E.+Reinickeauthor=D.+A.+Boothman&title=New+tricks+for+old+drugs%3A+the+anticarcinogenic+potential+of+DNA+repair+inhibitors&doi=10.1007%2Fs10735-006-9043-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors</span></div><div class="casAuthors">Bentle, Melissa S.; Bey, Erik A.; Dong, Ying; Reinicke, Kathryn E.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Histology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">203-218</span>CODEN:
                <span class="NLM_cas:coden">JMHOAO</span>;
        ISSN:<span class="NLM_cas:issn">1567-2379</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Defective or abortive repair of DNA lesions has been assocd. with carcinogenesis.  Therefore it is imperative for a cell to accurately repair its DNA after damage if it is to return to a normal cellular phenotype.  In certain circumstances, if DNA damage cannot be repaired completely and with high fidelity, it is more advantageous for an organism to have some of its more severely damaged cells die rather than survive as neoplastic transformants.  A no. of DNA repair inhibitors have the potential to act as anticarcinogenic compds.  These drugs are capable of modulating DNA repair, thus promoting cell death rather than repair of potentially carcinogenic DNA damage mediated by error-prone DNA repair processes.  In theory, exposure to a DNA repair inhibitor during, or immediately after, carcinogenic exposure should decrease or prevent tumorigenesis.  However, the ability of DNA repair inhibitors to prevent cancer development is difficult to interpret depending upon the system used and the type of genotoxic stress.  Inhibitors may act on multiple aspects of DNA repair as well as the cellular signaling pathways activated in response to the initial damage.  In this review, we summarize basic DNA repair mechanisms and explore the effects of a no. of DNA repair inhibitors that not only potentiate DNA-damaging agents but also decrease carcinogenicity.  In particular, we focus on a novel anti-tumor agent, β-lapachone, and its potential to block transformation by modulating poly(ADP-ribose) polymerase-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcOVYY1omerVg90H21EOLACvtfcHk0lhbFik-mHywxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1elsLjF&md5=1b00e832651db5bd11efc2f5753efc9e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1007%2Fs10735-006-9043-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10735-006-9043-8%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNew%2520tricks%2520for%2520old%2520drugs%253A%2520the%2520anticarcinogenic%2520potential%2520of%2520DNA%2520repair%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Histol.%26date%3D2006%26volume%3D37%26spage%3D203%26epage%3D218%26doi%3D10.1007%2Fs10735-006-9043-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref123"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref123'); return false;" data-citation="" class="refNumLink">123</a></strong><div class="NLM_citation" id="cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trask, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardee, A. B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=605-612&author=D.+A.+Boothmanauthor=D.+K.+Traskauthor=A.+B.+Pardee&title=Inhibition+of+potentially+lethal+DNA+damage+repair+in+human+tumor+cells+by+beta-lapachone%2C+an+activator+of+topoisomerase+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DTrask%26aufirst%3DD.%2BK.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26atitle%3DInhibition%2520of%2520potentially%2520lethal%2520DNA%2520damage%2520repair%2520in%2520human%2520tumor%2520cells%2520by%2520beta-lapachone%252C%2520an%2520activator%2520of%2520topoisomerase%2520I%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D605%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref124"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref124'); return false;" data-citation="" class="refNumLink">124</a></strong><div class="NLM_citation" id="cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planchon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">5416</span>– <span class="NLM_lpage">5424</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.8.5416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.275.8.5416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10681517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFKksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=5416-5424&author=J.+J.+Pinkauthor=S.+M.+Planchonauthor=C.+Tagliarinoauthor=M.+E.+Varnesauthor=D.+Siegelauthor=D.+A.+Boothman&title=NAD%28P%29H%3Aquinone+oxidoreductase+activity+is+the+principal+determinant+of+beta-lapachone+cytotoxicity&doi=10.1074%2Fjbc.275.8.5416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity</span></div><div class="casAuthors">Pink, John J.; Planchon, Sarah M.; Tagliarino, Colleen; Varnes, Marie E.; Siegel, David; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5416-5424</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">β-Lapachone activates a novel apoptotic response in a no. of cell lines.  We demonstrate that the enzyme NAD(P)H:quinone oxidoreductase (NQO1) substantially enhances the toxicity of β-lapachone.  NQO1 expression directly correlated with sensitivity to a 4-h pulse of β-lapachone in a panel of breast cancer cell lines, and the NQO1 inhibitor, dicoumarol, significantly protected NQO1-expressing cells from all aspects of β-lapachone toxicity.  Stable transfection of the NQO1-deficient cell line, MDA-MB-468, with an NQO1 expression plasmid increased apoptotic responses and lethality after β-lapachone exposure.  Dicoumarol blocked both the apoptotic responses and lethality.  Biochem. studies suggest that redn. of β-lapachone by NQO1 leads to a futile cycling between the quinone and hydroquinone forms, with a concomitant loss of reduced NAD(P)H.  In addn., the activation of a cysteine protease, which has characteristics consistent with the neutral calcium-dependent protease, calpain, is obsd. after β-lapachone treatment.  This is the first definitive elucidation of an intracellular target for β-lapachone in tumor cells.  NQO1 could be exploited for gene therapy, radiotherapy, and/or chemopreventive interventions, since the enzyme is elevated in a no. of tumor types (i.e. breast and lung) and during neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmejdtPaHOP7Vg90H21EOLACvtfcHk0lhbFik-mHywxQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFKksL0%253D&md5=3182b82635d926242124dbf0791e22ee</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.8.5416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.8.5416%26sid%3Dliteratum%253Aachs%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DPlanchon%26aufirst%3DS.%2BM.%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DVarnes%26aufirst%3DM.%2BE.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520activity%2520is%2520the%2520principal%2520determinant%2520of%2520beta-lapachone%2520cytotoxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D5416%26epage%3D5424%26doi%3D10.1074%2Fjbc.275.8.5416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref125"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref125'); return false;" data-citation="" class="refNumLink">125</a></strong><div class="NLM_citation" id="cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planchon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D.</span></span> <span> </span><span class="NLM_article-title">A. beta-lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1006/excr.2001.5234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1006%2Fexcr.2001.5234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11412042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVWqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2001&pages=95-106&author=S.+M.+Planchonauthor=J.+J.+Pinkauthor=C.+Tagliarinoauthor=W.+G.+Bornmannauthor=M.+E.+Varnesauthor=D.+Boothman&title=A.+beta-lapachone-induced+apoptosis+in+human+prostate+cancer+cells%3A+involvement+of+NQO1%2Fxip3&doi=10.1006%2Fexcr.2001.5234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3</span></div><div class="casAuthors">Planchon, Sarah M.; Pink, John J.; Tagliarino, Colleen; Bornmann, William G.; Varnes, Marie E.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-106</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">β-Lapachone (β-lap) induces apoptosis in various cancer cells, and its intracellular target has recently been elucidated in breast cancer cells.  Here we show that NAD(P)H:quinone oxidoreductase (NQO1/xip3) expression in human prostate cancer cells is a key determinant for apoptosis and lethality after β-lap exposures.  β-Lap-treated, NQO1-deficient LNCaP cells were significantly more resistant to apoptosis than NQO1-expressing DU-145 or PC-3 cells after drug exposures.  Formation of an atypical 60-kDa PARP cleavage fragment in DU-145 or PC-3 cells was obsd. after 10 μM β-lap treatment and correlated with apoptosis.  In contrast, LNCaP cells required 25 μM β-lap to induce similar responses.  Atypical PARP cleavage in β-lap-treated cells was not affected by 100 μM zVAD-fmk; however, coadministration of dicoumarol, a specific inhibitor of NQO1, reduced β-lap-mediated cytotoxicity, apoptosis, and atypical PARP cleavage in NQO1-expressing cells.  Dicoumarol did not affect the more β-lap-resistant LNCaP cells.  Stable transfection of LNCaP cells with NQO1 increased their sensitivity to β-lap, enhancing apoptosis compared to parental LNCaP cells or vector-alone transfectants.  Dicoumarol increased survival of β-lap-treated NQO1-expressing LNCaP transfectants.  NQO1 activity, therefore, is a key determinant of β-lap-mediated apoptosis and cytotoxicity in prostate cancer cells.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmEt0va0_k07Vg90H21EOLACvtfcHk0ljMF1FElW6Djw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVWqt7g%253D&md5=35e863f0219e0303360fe20879aab356</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1006%2Fexcr.2001.5234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.2001.5234%26sid%3Dliteratum%253Aachs%26aulast%3DPlanchon%26aufirst%3DS.%2BM.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DVarnes%26aufirst%3DM.%2BE.%26aulast%3DBoothman%26aufirst%3DD.%26atitle%3DA.%2520beta-lapachone-induced%2520apoptosis%2520in%2520human%2520prostate%2520cancer%2520cells%253A%2520involvement%2520of%2520NQO1%252Fxip3%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2001%26volume%3D267%26spage%3D95%26epage%3D106%26doi%3D10.1006%2Fexcr.2001.5234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref126"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref126'); return false;" data-citation="" class="refNumLink">126</a></strong><div class="NLM_citation" id="cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C. W.</span></span> <span> </span><span class="NLM_article-title">Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">8866</span>– <span class="NLM_lpage">8871</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-05-0818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16361576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=8866-8871&author=H.+J.+Parkauthor=E.+K.+Choiauthor=J.+Choiauthor=K.+J.+Ahnauthor=E.+J.+Kimauthor=I.+M.+Jiauthor=Y.+H.+Kookauthor=S.+D.+Ahnauthor=B.+Williamsauthor=R.+Griffinauthor=D.+A.+Boothmanauthor=C.+K.+Leeauthor=C.+W.+Song&title=Heat-induced+up-regulation+of+NAD%28P%29H%3Aquinone+oxidoreductase+potentiates+anticancer+effects+of+beta-lapachone&doi=10.1158%2F1078-0432.CCR-05-0818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-Induced Up-Regulation of NAD(P)H:Quinone Oxidoreductase Potentiates Anticancer Effects of β-Lapachone</span></div><div class="casAuthors">Park, Heon Joo; Choi, Eun Kyung; Choi, Jihyung; Ahn, Ki-Jung; Kim, Eun Jung; Ji, In-Mi; Kook, Yeon Hee; Ahn, Seung-Do; Williams, Brent; Griffin, Robert; Boothman, David A.; Lee, Chung K.; Song, Chang W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24, Pt. 1</span>),
    <span class="NLM_cas:pages">8866-8871</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of the present study was to evaluate the efficacy of mild hyperthermia to potentiate the anticancer effects of β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione) by up-regulating NAD(P)H:quinone oxidoreductase (NQO1) in cancer cells.  Effects of β-lapachone alone or in combination with mild heating on the clonogenic survival of FSaII fibrosarcoma cells of C3H mice and A549 human lung tumor cells in vitro was detd.  Effects of heating on the NQO1 level in the cancer cells in vitro were assessed using Western blot anal. for NQO1 expression, biochem. detn. of NQO1 activity, and immunofluorescence microscopy for NQO1 expression.  Growth of FSaII tumors in the hind legs of C3H mice was detd. after treating the host mice with i.p. injection of 45 mg/kg {szligbeta}-lapachone followed by heating the tumors at 42° for 1 h every other day for four times.  Incubation of FSaII tumor cells and A549 tumor cells with β-lapachone at 37° reduced clonogenic survival of the cells in dose-dependent and incubation time-dependent manner.  NQO1 level in the cancer cells in vitro increased within 1 h after heating at 42° for 1 h and remained elevated for >72 h.  The clonogenic cell death caused by β-lapachone increased in parallel with the increase in NQO1 levels in heated cells.  Heating FSaII tumors in the legs of C3H mice enhanced the effect of i.p.-injected β-lapachone in suppressing tumor growth.  We obsd. for the first time that mild heat shock up-regulates NQO1 in tumor cells.  The heat-induced up-regulation of NQO1 enhanced the anticancer effects of β-lapachone in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7LCZgdZOnMLVg90H21EOLACvtfcHk0ljMF1FElW6Djw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsbfP&md5=bd213ea002cc1ce93f3595850acac450</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0818%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DE.%2BK.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DK.%2BJ.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DJi%26aufirst%3DI.%2BM.%26aulast%3DKook%26aufirst%3DY.%2BH.%26aulast%3DAhn%26aufirst%3DS.%2BD.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DGriffin%26aufirst%3DR.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DSong%26aufirst%3DC.%2BW.%26atitle%3DHeat-induced%2520up-regulation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520potentiates%2520anticancer%2520effects%2520of%2520beta-lapachone%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D8866%26epage%3D8871%26doi%3D10.1158%2F1078-0432.CCR-05-0818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref127"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref127'); return false;" data-citation="" class="refNumLink">127</a></strong><div class="NLM_citation" id="cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, B. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span> <span> </span><span class="NLM_article-title">Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive β-lapachone on cancer cells</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1593/neo.07397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1593%2Fneo.07397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=634-642&author=E.+K.+Choiauthor=K.+Teraiauthor=I.+M.+Jiauthor=Y.+H.+Kookauthor=K.+H.+Parkauthor=E.+T.+Ohauthor=R.+J.+Griffinauthor=B.+U.+Limauthor=J.+S.+Kimauthor=D.+S.+Leeauthor=D.+A.+Boothmanauthor=M.+Lorenauthor=C.+W.+Songauthor=H.+J.+Park&title=Upregulation+of+NAD%28P%29H%3Aquinone+oxidoreductase+by+radiation+potentiates+the+effect+of+bioreductive+%CE%B2-lapachone+on+cancer+cells&doi=10.1593%2Fneo.07397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1593%2Fneo.07397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.07397%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.%2BK.%26aulast%3DTerai%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DI.%2BM.%26aulast%3DKook%26aufirst%3DY.%2BH.%26aulast%3DPark%26aufirst%3DK.%2BH.%26aulast%3DOh%26aufirst%3DE.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DLim%26aufirst%3DB.%2BU.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DLoren%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DC.%2BW.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26atitle%3DUpregulation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520by%2520radiation%2520potentiates%2520the%2520effect%2520of%2520bioreductive%2520%25CE%25B2-lapachone%2520on%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2007%26volume%3D9%26spage%3D634%26epage%3D642%26doi%3D10.1593%2Fneo.07397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref128"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref128'); return false;" data-citation="" class="refNumLink">128</a></strong><div class="NLM_citation" id="cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C. W.</span></span> <span> </span><span class="NLM_article-title">Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2004.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ijrobp.2004.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15629614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVGj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=212-219&author=H.+J.+Parkauthor=K.+J.+Ahnauthor=S.+D.+Ahnauthor=E.+Choiauthor=S.+W.+Leeauthor=B.+Williamsauthor=E.+J.+Kimauthor=R.+Griffinauthor=E.+A.+Beyauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=H.+J.+Parkauthor=D.+A.+Boothmanauthor=C.+W.+Song&title=Susceptibility+of+cancer+cells+to+beta-lapachone+is+enhanced+by+ionizing+radiation&doi=10.1016%2Fj.ijrobp.2004.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of cancer cells to β-lapachone is enhanced by ionizing radiation</span></div><div class="casAuthors">Park, Heon Joo; Ahn, Ki-Jung; Ahn, Seung-Do; Choi, Eunkyung; Lee, Sang Wook; Williams, Brent; Kim, Eun Jung; Griffin, Robert; Bey, Erik A.; Bornmann, William G.; Gao, Jinming; Park, Heon Jin; Boothman, David A.; Song, Chang W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-219</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: To reveal the interaction between β-lapachone (β-lap) and ionizing radiation (IR) in causing clonogenic death in cancer cells and to elucidate the potential usefulness of β-lap treatment in combination with radiotherapy of cancer.  Materials and Methods: FSaII tumor cells of C3H mice were used.  The cytotoxicity of β-lap alone or in combination with IR in vitro was detd. using clonogenic survival assay method.  The IR-induced changes in the expression and the enzymic activity of NAD(P)H:quinone oxidoreductase (NQO1), a mediator of β-lap cytotoxicity, were elucidated and the relationship between the NQO1 level and the sensitivity of cells to β-lap was investigated.  The combined effect of IR and β-lap to suppress tumor growth was studied using FSaII tumors grown s.c. in the thigh of C3H mice.  Results: β-Lap caused clonogenic death of FSaII tumor cells in vitro in a dose- and time-dependent manner.  When cells were treated first with β-lap and then exposed to IR in vitro, the resultant cell death was only additive.  On the contrary, exposing cells to IR at 2.5 Gy first and then treating the cells with β-lap killed the cells in a synergistic manner.  Importantly, the 2.5 Gy cells were sensitive to β-lap as long as 10 h after irradn., which was long after the sublethal radiation damage was repaired.  Irradn. of FSaII cells in vitro with 2.5 Gy significantly increased the expression and enzymic activity of NQO1.  The growth delay of FSaII tumors caused by an i.p. injection of β-lap in combination with 20 Gy irradn. of tumor was significantly greater than that caused by β-lap or 20 Gy irradn. alone.  Conclusion: The sensitivity of cells to β-lap is dependent on NQO1 activity.  IR caused a long-lasting increase in NQO1 activity in cancer cells, thereby sensitizing cells to β-lap and treatment of exptl. mouse tumors with IR and β-lap suppressed tumor growth in a synergistic manner.  The combination of β-lap and radiotherapy is a potentially effective regimen for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQhLvMaqOJbVg90H21EOLACvtfcHk0lgUowcxv9g61A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVGj&md5=f7253b79dcf9eac433123ef7cd67889d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2004.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2004.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DAhn%26aufirst%3DK.%2BJ.%26aulast%3DAhn%26aufirst%3DS.%2BD.%26aulast%3DChoi%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DGriffin%26aufirst%3DR.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DSong%26aufirst%3DC.%2BW.%26atitle%3DSusceptibility%2520of%2520cancer%2520cells%2520to%2520beta-lapachone%2520is%2520enhanced%2520by%2520ionizing%2520radiation%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2005%26volume%3D61%26spage%3D212%26epage%3D219%26doi%3D10.1016%2Fj.ijrobp.2004.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref129"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref129'); return false;" data-citation="" class="refNumLink">129</a></strong><div class="NLM_citation" id="cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srougi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euhus, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchsbaum, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Catalase abrogates beta-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2120</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-12-0962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23883585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOhurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=2110-2120&author=E.+A.+Beyauthor=K.+E.+Reinickeauthor=M.+C.+Srougiauthor=M.+Varnesauthor=V.+E.+Andersonauthor=J.+J.+Pinkauthor=L.+S.+Liauthor=M.+Patelauthor=L.+Caoauthor=Z.+Mooreauthor=A.+Rommelauthor=M.+Boatmanauthor=C.+Lewisauthor=D.+M.+Euhusauthor=W.+G.+Bornmannauthor=D.+J.+Buchsbaumauthor=D.+R.+Spitzauthor=J.+Gaoauthor=D.+A.+Boothman&title=Catalase+abrogates+beta-lapachone-induced+PARP1+hyperactivation-directed+programmed+necrosis+in+NQO1-positive+breast+cancers&doi=10.1158%2F1535-7163.MCT-12-0962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Catalase Abrogates β-Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers</span></div><div class="casAuthors">Bey, Erik A.; Reinicke, Kathryn E.; Srougi, Melissa C.; Varnes, Marie; Anderson, Vernon E.; Pink, John J.; Li, Long Shan; Patel, Malina; Cao, Lifen; Moore, Zachary; Rommel, Amy; Boatman, Michael; Lewis, Cheryl; Euhus, David M.; Bornmann, William G.; Buchsbaum, Donald J.; Spitz, Douglas R.; Gao, Jinming; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2110-2120</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Improving patient outcome by personalized therapy involves a thorough understanding of an agent's mechanism of action. β-Lapachone (clin. forms, Arq501/Arq761) has been developed to exploit dramatic cancer-specific elevations in the phase II detoxifying enzyme NAD(P)H:quinone oxidoreductase (NQO1).  NQO1 is dramatically elevated in solid cancers, including primary and metastatic [e.g., triple-neg. (ER-, PR-, Her2/Neu-)] breast cancers.  To define cellular factors that influence the efficacy of β-lapachone using knowledge of its mechanism of action, we confirmed that NQO1 was required for lethality and mediated a futile redox cycle where ∼120 mol of superoxide were formed per mol of β-lapachone in 2 min. β-Lapachone induced reactive oxygen species (ROS), stimulated DNA single-strand break-dependent poly(ADP-ribose) polymerase-1 (PARP1) hyperactivation, caused dramatic loss of essential nucleotides (NAD+/ATP), and elicited programmed necrosis in breast cancer cells.  Although PARP1 hyperactivation and NQO1 expression were major determinants of β-lapachone-induced lethality, alterations in catalase expression, including treatment with exogenous enzyme, caused marked cytoprotection.  Thus, catalase is an important resistance factor and highlights H2O2 as an obligate ROS for cell death from this agent.  Exogenous superoxide dismutase enhanced catalase-induced cytoprotection. β-Lapachone-induced cell death included apoptosis-inducing factor (AIF) translocation from mitochondria to nuclei, TUNEL+ staining, atypical PARP1 cleavage, and glyceraldehyde 3-phosphate dehydrogenase S-nitrosylation, which were abrogated by catalase.  We predict that the ratio of NQO1:catalase activities in breast cancer vs. assocd. normal tissue are likely to be the major determinants affecting the therapeutic window of β-lapachone and other NQO1 bioactivatable drugs.  Mol Cancer Ther; 12(10); 2110-20. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmcAmBm9B5CLVg90H21EOLACvtfcHk0lgUowcxv9g61A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOhurvI&md5=7e6d291985715c425fe3b6db7d85e549</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0962%26sid%3Dliteratum%253Aachs%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DSrougi%26aufirst%3DM.%2BC.%26aulast%3DVarnes%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DV.%2BE.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DRommel%26aufirst%3DA.%26aulast%3DBoatman%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DEuhus%26aufirst%3DD.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBuchsbaum%26aufirst%3DD.%2BJ.%26aulast%3DSpitz%26aufirst%3DD.%2BR.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCatalase%2520abrogates%2520beta-lapachone-induced%2520PARP1%2520hyperactivation-directed%2520programmed%2520necrosis%2520in%2520NQO1-positive%2520breast%2520cancers%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D2110%26epage%3D2120%26doi%3D10.1158%2F1535-7163.MCT-12-0962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref130"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref130'); return false;" data-citation="" class="refNumLink">130</a></strong><div class="NLM_citation" id="cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spruell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srougi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabbani, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motea, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordy, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1089/ars.2013.5462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1089%2Fars.2013.5462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24512128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=237-250&author=L.+Caoauthor=L.+S.+Liauthor=C.+Spruellauthor=L.+Xiaoauthor=G.+Chakrabartiauthor=E.+A.+Beyauthor=K.+E.+Reinickeauthor=M.+C.+Srougiauthor=Z.+Mooreauthor=Y.+Dongauthor=P.+Voauthor=W.+Kabbaniauthor=C.+R.+Yangauthor=X.+Wangauthor=F.+Fattahauthor=J.+C.+Moralesauthor=E.+A.+Moteaauthor=W.+G.+Bornmannauthor=J.+S.+Yordyauthor=D.+A.+Boothman&title=Tumor-selective%2C+futile+redox+cycle-induced+bystander+effects+elicited+by+NQO1+bioactivatable+radiosensitizing+drugs+in+triple-negative+breast+cancers&doi=10.1089%2Fars.2013.5462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers</span></div><div class="casAuthors">Cao, Lifen; Li, Long Shan; Spruell, Christopher; Xiao, Ling; Chakrabarti, Gaurab; Bey, Erik A.; Reinicke, Kathryn E.; Srougi, Melissa C.; Moore, Zachary; Dong, Ying; Vo, Peggy; Kabbani, Wareef; Yang, Chin-Rang; Wang, Xiaoyu; Fattah, Farjana; Morales, Julio C.; Motea, Edward A.; Bornmann, William G.; Yordy, John S.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-250</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: β-Lapachone (β-lap), a novel radiosensitizer with potent antitumor efficacy alone, selectively kills solid cancers that over-express NAD(P)H:quinone oxidoreductase 1 (NQO1).  Since breast or other solid cancers have heterogeneous NQO1 expression, therapies that reduce the resistance (e.g., NQO1low) of tumor cells will have significant clin. advantages.  We tested whether NQO1-proficient (NQO1+) cells generated sufficient hydrogen peroxide (H2O2) after β-lap treatment to elicit bystander effects, DNA damage, and cell death in neighboring NQO1low cells.  Results: β-Lap showed NQO1-dependent efficacy against two triple-neg. breast cancer (TNBC) xenografts.  NQO1 expression variations in human breast cancer patient samples were noted, where ∼60% cancers over-expressed NQO1, with little or no expression in assocd. normal tissue.  Differential DNA damage and lethality were noted in NQO1+ vs. NQO1-deficient (NQO1-) TNBC cells and xenografts after β-lap treatment. β-Lap-treated NQO1+ cells died by programmed necrosis, whereas co-cultured NQO1- TNBC cells exhibited DNA damage and caspase-dependent apoptosis.  NQO1 inhibition (dicoumarol) or H2O2 scavenging (catalase [CAT]) blocked all responses.  Only NQO1- cells neighboring NQO1+ TNBC cells responded to β-lap in vitro, and bystander effects correlated well with H2O2 diffusion.  Bystander effects in NQO1- cells in vivo within mixed 50:50 co-cultured xenografts were dramatic and depended on NQO1+ cells.  However, normal human cells in vitro or in vivo did not show bystander effects, due to elevated endogenous CAT levels.  Innovation and Conclusions: NQO1-dependent bystander effects elicited by NQO1 bioactivatable drugs (β-lap or deoxynyboquinone [DNQ]) likely contribute to their efficacies, killing NQO1+ solid cancer cells and eliminating surrounding heterogeneous NQO1low cancer cells.  Normal cells/tissue are protected by low NQO1:CAT ratios.  Antioxid. Redox Signal. 21, 237-250.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphMoZtdZjlmbVg90H21EOLACvtfcHk0lgUowcxv9g61A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWmu7o%253D&md5=1598ba93f40c7ed764f22d7d0d407205</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1089%2Fars.2013.5462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2013.5462%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DSpruell%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DSrougi%26aufirst%3DM.%2BC.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVo%26aufirst%3DP.%26aulast%3DKabbani%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DMorales%26aufirst%3DJ.%2BC.%26aulast%3DMotea%26aufirst%3DE.%2BA.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DYordy%26aufirst%3DJ.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DTumor-selective%252C%2520futile%2520redox%2520cycle-induced%2520bystander%2520effects%2520elicited%2520by%2520NQO1%2520bioactivatable%2520radiosensitizing%2520drugs%2520in%2520triple-negative%2520breast%2520cancers%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D21%26spage%3D237%26epage%3D250%26doi%3D10.1089%2Fars.2013.5462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref131"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref131'); return false;" data-citation="" class="refNumLink">131</a></strong><div class="NLM_citation" id="cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahanda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWilliams, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slinker, J. D.</span></span> <span> </span><span class="NLM_article-title">Using DNA devices to track anticancer drug activity</span>. <i>Biosens. Bioelectron.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.bios.2016.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bios.2016.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=647-653&author=D.+Kahandaauthor=G.+Chakrabartiauthor=M.+A.+McWilliamsauthor=D.+A.+Boothmanauthor=J.+D.+Slinker&title=Using+DNA+devices+to+track+anticancer+drug+activity&doi=10.1016%2Fj.bios.2016.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bios.2016.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bios.2016.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DKahanda%26aufirst%3DD.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DMcWilliams%26aufirst%3DM.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DSlinker%26aufirst%3DJ.%2BD.%26atitle%3DUsing%2520DNA%2520devices%2520to%2520track%2520anticancer%2520drug%2520activity%26jtitle%3DBiosens.%2520Bioelectron.%26date%3D2016%26volume%3D80%26spage%3D647%26epage%3D653%26doi%3D10.1016%2Fj.bios.2016.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref132"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref132'); return false;" data-citation="" class="refNumLink">132</a></strong><div class="NLM_citation" id="cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolluyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deberardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer</span>. <i>J. Surg. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1002/jso.24624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fjso.24624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28346693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVygurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=83-88&author=M.+S.+Begauthor=X.+Huangauthor=M.+A.+Silversauthor=D.+E.+Gerberauthor=J.+Bolluytauthor=V.+Sarodeauthor=F.+Fattahauthor=R.+J.+Deberardinisauthor=M.+E.+Merrittauthor=X.+J.+Xieauthor=R.+Leffauthor=D.+Laheruauthor=D.+A.+Boothman&title=Using+a+novel+NQO1+bioactivatable+drug%2C+beta-lapachone+%28ARQ761%29%2C+to+enhance+chemotherapeutic+effects+by+metabolic+modulation+in+pancreatic+cancer&doi=10.1002%2Fjso.24624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer</span></div><div class="casAuthors">Beg, Muhammad Shaalan; Huang, Xiumei; Silvers, Molly A.; Gerber, David E.; Bolluyt, Joyce; Sarode, Venetia; Fattah, Farjana; Deberardinis, Ralph J.; Merritt, Matthew E.; Xie, Xian-Jin; Leff, Richard; Laheru, Daniel; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-88</span>CODEN:
                <span class="NLM_cas:coden">JSONAU</span>;
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Novel, tumor-selective therapies are needed to increase the survival rate of pancreatic cancer patients.  K-Ras-mutant-driven NAD(P)H:quinone oxidoreductase 1 (NQO1) is over-expressed in pancreatic tumor vs. assocd. normal tissue, while catalase expression is lowered compared to levels in assocd. normal pancreas tissue.  ARQ761 undergoes a robust, futile redox cycle in NQO1+ cancer cells, producing massive hydrogen peroxide (H2O2) levels; normal tissues are spared by low NQO1 and high catalase expression.  DNA damage created by ARQ761 in pancreatic cancer cells "hyperactivates" PARP1, causing metabolic catastrophe and NAD ± keresis cell death.  NQO1: catalase levels (high in tumor, low in normal tissue) are an attractive therapeutic window to treat pancreatic cancer.  Based on a growing body of literature, we are leading a clin. trial to evaluate the combination of ARQ761 and chemotherapy in patients with pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaBal4wQsDvrVg90H21EOLACvtfcHk0liWop1OHmIRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVygurnO&md5=112175579bfd4fee03af28ec69ee0ffa</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1002%2Fjso.24624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.24624%26sid%3Dliteratum%253Aachs%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBolluyt%26aufirst%3DJ.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DDeberardinis%26aufirst%3DR.%2BJ.%26aulast%3DMerritt%26aufirst%3DM.%2BE.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DLeff%26aufirst%3DR.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DUsing%2520a%2520novel%2520NQO1%2520bioactivatable%2520drug%252C%2520beta-lapachone%2520%2528ARQ761%2529%252C%2520to%2520enhance%2520chemotherapeutic%2520effects%2520by%2520metabolic%2520modulation%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D2017%26volume%3D116%26spage%3D83%26epage%3D88%26doi%3D10.1002%2Fjso.24624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref133"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref133'); return false;" data-citation="" class="refNumLink">133</a></strong><div class="NLM_citation" id="cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubyak, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieminen, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Calcium is a key signaling molecule in beta-lapachone-mediated cell death</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">19150</span>– <span class="NLM_lpage">19159</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100730200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M100730200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=19150-19159&author=C.+Tagliarinoauthor=J.+J.+Pinkauthor=G.+R.+Dubyakauthor=A.+L.+Nieminenauthor=D.+A.+Boothman&title=Calcium+is+a+key+signaling+molecule+in+beta-lapachone-mediated+cell+death&doi=10.1074%2Fjbc.M100730200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100730200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100730200%26sid%3Dliteratum%253Aachs%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DDubyak%26aufirst%3DG.%2BR.%26aulast%3DNieminen%26aufirst%3DA.%2BL.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCalcium%2520is%2520a%2520key%2520signaling%2520molecule%2520in%2520beta-lapachone-mediated%2520cell%2520death%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D19150%26epage%3D19159%26doi%3D10.1074%2Fjbc.M100730200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref134"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref134'); return false;" data-citation="" class="refNumLink">134</a></strong><div class="NLM_citation" id="cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">33684</span>– <span class="NLM_lpage">33696</span>, <span class="refDoi"> DOI: 10.1074/jbc.M603678200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M603678200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=33684-33696&author=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=E.+A.+Beyauthor=D.+R.+Spitzauthor=D.+A.+Boothman&title=Calcium-dependent+modulation+of+poly%28ADP-ribose%29+polymerase-1+alters+cellular+metabolism+and+DNA+repair&doi=10.1074%2Fjbc.M603678200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M603678200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M603678200%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DSpitz%26aufirst%3DD.%2BR.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCalcium-dependent%2520modulation%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520alters%2520cellular%2520metabolism%2520and%2520DNA%2520repair%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D33684%26epage%3D33696%26doi%3D10.1074%2Fjbc.M603678200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref135"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref135'); return false;" data-citation="" class="refNumLink">135</a></strong><div class="NLM_citation" id="cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilcheva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">17066</span>, <span class="refDoi"> DOI: 10.1038/srep17066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fsrep17066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26602448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFentL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17066&author=G.+Chakrabartiauthor=M.+A.+Silversauthor=M.+Ilchevaauthor=Y.+Liuauthor=Z.+R.+Mooreauthor=X.+Luoauthor=J.+Gaoauthor=G.+Andersonauthor=L.+Liuauthor=V.+Sarodeauthor=D.+E.+Gerberauthor=S.+Burmaauthor=R.+J.+DeBerardinisauthor=S.+L.+Gersonauthor=D.+A.+Boothman&title=Tumor-selective+use+of+DNA+base+excision+repair+inhibition+in+pancreatic+cancer+using+the+NQO1+bioactivatable+drug%2C+%CE%B2-lapachone&doi=10.1038%2Fsrep17066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone</span></div><div class="casAuthors">Chakrabarti, Gaurab; Silvers, Molly A.; Ilcheva, Mariya; Liu, Yuliang; Moore, Zachary R.; Luo, Xiuquan; Gao, Jinming; Anderson, Glenda; Liu, Lili; Sarode, Venetia; Gerber, David E.; Burma, Sandeep; DeBerardinis, Ralph J.; Gerson, Stanton L.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17066</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Base excision repair (BER) is an essential pathway for pancreatic ductal adenocarcinoma (PDA) survival.  Attempts to target this repair pathway have failed due to lack of tumor-selectivity and very limited efficacy.  The NAD(P)H:Quinone Oxidoreductase 1 (NQO1) bioactivatable drug, β-lapachone (ARQ761 in clin. form), can provide tumor-selective and enhanced synergy with BER inhibition.  β-Lapachone undergoes NQO1-dependent futile redox cycling, generating massive intracellular hydrogen peroxide levels and oxidative DNA lesions that stimulate poly(ADP-ribose) polymerase 1 (PARP1) hyperactivation.  Rapid NAD+/ATP depletion and programmed necrosis results.  To identify BER modulators essential for repair of β-lapachone-induced DNA base damage, a focused synthetic lethal RNAi screen demonstrated that silencing the BER scaffolding protein, XRCC1, sensitized PDA cells.  In contrast, depleting OGG1 N-glycosylase spared cells from ss-lap-induced lethality and blunted PARP1 hyperactivation.  Combining ss-lapachone with XRCC1 knockdown or methoxyamine (MeOX), an apyrimidinic/apurinic (AP)-modifying agent, led to NQO1-dependent synergistic killing in PDA, NSCLC, breast and head and neck cancers.  OGG1 knockdown, dicoumarol-treatment or NQO1- cancer cells were spared.  MeOX + ss-lapachone exposure resulted in elevated DNA double-strand breaks, PARP1 hyperactivation and TUNEL+ programmed necrosis.  Combination treatment caused dramatic antitumor activity, enhanced PARP1-hyperactivation in tumor tissue, and improved survival of mice bearing MiaPaca2-derived xenografts, with 33% apparent cures.  Significance: Targeting base excision repair (BER) alone has limited therapeutic potential for pancreatic or other cancers due to a general lack of tumor-selectivity.  Here, we present a treatment strategy that makes BER inhibition tumor-selective and NQO1-dependent for therapy of most solid neoplasms, particularly for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsbAMtgoNMBbVg90H21EOLACvtfcHk0liWop1OHmIRvg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFentL7L&md5=368535061421af6bb824d2c2ed3ab645</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fsrep17066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17066%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DIlcheva%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBurma%26aufirst%3DS.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DTumor-selective%2520use%2520of%2520DNA%2520base%2520excision%2520repair%2520inhibition%2520in%2520pancreatic%2520cancer%2520using%2520the%2520NQO1%2520bioactivatable%2520drug%252C%2520%25CE%25B2-lapachone%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17066%26doi%3D10.1038%2Fsrep17066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref136"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref136'); return false;" data-citation="" class="refNumLink">136</a></strong><div class="NLM_citation" id="cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemireddy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by beta-lapachone</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1599</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fcddis.2014.564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25590809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e1599&author=Z.+Mooreauthor=G.+Chakrabartiauthor=X.+Luoauthor=A.+Aliauthor=Z.+Huauthor=F.+J.+Fattahauthor=R.+Vemireddyauthor=R.+J.+DeBerardinisauthor=R.+A.+Brekkenauthor=D.+A.+Boothman&title=NAMPT+inhibition+sensitizes+pancreatic+adenocarcinoma+cells+to+tumor-selective%2C+PAR-independent+metabolic+catastrophe+and+cell+death+induced+by+beta-lapachone&doi=10.1038%2Fcddis.2014.564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone</span></div><div class="casAuthors">Moore, Z.; Chakrabarti, G.; Luo, X.; Ali, A.; Hu, Z.; Fattah, F. J.; Vemireddy, R.; DeBerardinis, R. J.; Brekken, R. A.; Boothman, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1599</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors (e.g., FK866) target the most active pathway of NAD+ synthesis in tumor cells, but lack tumor-selectivity for use as a single agent.  Reducing NAD+ pools by inhibiting NAMPT primed pancreatic ductal adenocarcinoma (PDA) cells for poly(ADP ribose) polymerase (PARP1)-dependent cell death induced by the targeted cancer therapeutic, β-lapachone (β-lap, ARQ761), independent of poly(ADP ribose) (PAR) accumulation.  β-Lap is bioactivated by NADPH:quinone oxidoreductase 1 (NQO1) in a futile redox cycle that consumes oxygen and generates high levels of reactive oxygen species (ROS) that cause extensive DNA damage and rapid PARP1-mediated NAD+ consumption.  Synergy with FK866+β-lap was tumor-selective, only occurring in NQO1-overexpressing cancer cells, which is noted in a majority (∼85%) of PDA cases.  This treatment strategy simultaneously decreases NAD+ synthesis while increasing NAD+ consumption, reducing required doses and treatment times for both drugs and increasing potency.  These complementary mechanisms caused profound NAD(P)+ depletion and inhibited glycolysis, driving down ATP levels and preventing recovery normally obsd. with either agent alone.  Cancer cells died through an ROS-induced, μ-calpain-mediated programmed cell death process that kills independent of caspase activation and is not driven by PAR accumulation, which we call NAD+-Keresis.  Non-overlapping specificities of FK866 for PDA tumors that rely heavily on NAMPT-catalyzed NAD+ synthesis and β-lap for cancer cells with elevated NQO1 levels affords high tumor-selectivity.  The concept of reducing NAD+ pools in cancer cells to sensitize them to ROS-mediated cell death by β-lap is a novel strategy with potential application for pancreatic and other types of NQO1+ solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYojGOGGFv8rVg90H21EOLACvtfcHk0lhCTMPVkFuktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOiur4%253D&md5=ce78c1abbc5c0cd84fd7f843e4eb6e94</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.564%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DFattah%26aufirst%3DF.%2BJ.%26aulast%3DVemireddy%26aufirst%3DR.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNAMPT%2520inhibition%2520sensitizes%2520pancreatic%2520adenocarcinoma%2520cells%2520to%2520tumor-selective%252C%2520PAR-independent%2520metabolic%2520catastrophe%2520and%2520cell%2520death%2520induced%2520by%2520beta-lapachone%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26spage%3De1599%26doi%3D10.1038%2Fcddis.2014.564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref137"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref137'); return false;" data-citation="" class="refNumLink">137</a></strong><div class="NLM_citation" id="cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motea, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patidar, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusko, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ccell.2016.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27960087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyisb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=940-952&author=X.+Huangauthor=E.+A.+Moteaauthor=Z.+R.+Mooreauthor=J.+Yaoauthor=Y.+Dongauthor=G.+Chakrabartiauthor=J.+A.+Kilgoreauthor=M.+A.+Silversauthor=P.+L.+Patidarauthor=A.+Cholkaauthor=F.+Fattahauthor=Y.+Chaauthor=G.+G.+Andersonauthor=R.+Kuskoauthor=M.+Peytonauthor=J.+Yanauthor=X.+J.+Xieauthor=V.+Sarodeauthor=N.+S.+Williamsauthor=J.+D.+Minnaauthor=M.+Begauthor=D.+E.+Gerberauthor=E.+A.+Beyauthor=D.+A.+Boothman&title=Leveraging+an+NQO1+bioactivatable+drug+for+tumor-selective+use+of+poly%28ADP-ribose%29+polymerase+inhibitors&doi=10.1016%2Fj.ccell.2016.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors</span></div><div class="casAuthors">Huang, Xiumei; Motea, Edward A.; Moore, Zachary R.; Yao, Jun; Dong, Ying; Chakrabarti, Gaurab; Kilgore, Jessica A.; Silvers, Molly A.; Patidar, Praveen L.; Cholka, Agnieszka; Fattah, Farjana; Cha, Yoonjeong; Anderson, Glenda G.; Kusko, Rebecca; Peyton, Michael; Yan, Jingsheng; Xie, Xian-Jin; Sarode, Venetia; Williams, Noelle S.; Minna, John D.; Beg, Muhammad; Gerber, David E.; Bey, Erik A.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">940-952</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Therapeutic drugs that block DNA repair, including poly(ADP-ribose) polymerase (PARP) inhibitors, fail due to lack of tumor-selectivity.  When PARP inhibitors and β-lapachone are combined, synergistic antitumor activity results from sustained NAD(P)H levels that refuel NQO1-dependent futile redox drug recycling.  Significant oxygen-consumption-rate/reactive oxygen species cause dramatic DNA lesion increases that are not repaired due to PARP inhibition.  In NQO1+ cancers, such as non-small-cell lung, pancreatic, and breast cancers, cell death mechanism switches from PARP1 hyperactivation-mediated programmed necrosis with β-lapachone monotherapy to synergistic tumor-selective, caspase-dependent apoptosis with PARP inhibitors and β-lapachone.  Synergistic antitumor efficacy and prolonged survival were noted in human orthotopic pancreatic and non-small-cell lung xenograft models, expanding use and efficacy of PARP inhibitors for human cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWh__hezw3bVg90H21EOLACvtfcHk0lhCTMPVkFuktA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyisb%252FP&md5=2de166b47e9886eb784c54e5bd9d85f1</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMotea%26aufirst%3DE.%2BA.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DPatidar%26aufirst%3DP.%2BL.%26aulast%3DCholka%26aufirst%3DA.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DCha%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DG.%2BG.%26aulast%3DKusko%26aufirst%3DR.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DBeg%26aufirst%3DM.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DLeveraging%2520an%2520NQO1%2520bioactivatable%2520drug%2520for%2520tumor-selective%2520use%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitors%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D30%26spage%3D940%26epage%3D952%26doi%3D10.1016%2Fj.ccell.2016.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref138"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref138'); return false;" data-citation="" class="refNumLink">138</a></strong><div class="NLM_citation" id="cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways</span>. <i>Clin. Pharmacol.: Adv. Appl.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.2147/CPAA.S79760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2147%2FCPAA.S79760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25870517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=57-68&author=G.+Chakrabartiauthor=D.+E.+Gerberauthor=D.+A.+Boothman&title=Expanding+antitumor+therapeutic+windows+by+targeting+cancer-specific+nicotinamide+adenine+dinucleotide+phosphate-biogenesis+pathways&doi=10.2147%2FCPAA.S79760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways</span></div><div class="casAuthors">Chakrabarti, Gaurab; Gerber, David E.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology: Advances and Applications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-68</span>CODEN:
                <span class="NLM_cas:coden">CPAAGX</span>;
        ISSN:<span class="NLM_cas:issn">1179-1438</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">NADP (NADPH) biogenesis is an essential mechanism by which both normal and cancer cells maintain redox balance.  While antitumor approaches to treat cancers through elevated reactive oxygen species (ROS) are not new ideas, depleting specific NADPH-biogenesis pathways that control recovery and repair pathways are novel, viable approaches to enhance cancer therapy.  However, to elicit efficacious therapies exploiting NADPH-biogenic pathways, it is crucial to understand and specifically define the roles of NADPH-biogenesis pathways used by cancer cells for survival or recovery from cell stress.  It is equally important to select NADPH-biogenic pathways that are expendable or not utilized in normal tissue to avoid unwanted toxicity.  Here, we address recent literature that demonstrates specific tumor-selective NADPH-biogenesis pathways that can be exploited using agents that target specific cancer cell pathways normally not utilized in normal cells.  Defining NADPH-biogenesis profiles of specific cancer-types should enable novel strategies to exploit these therapeutic windows for increased efficacy against recalcitrant neoplastic disease, such as pancreatic cancers.  Accomplishing the goal of using ROS as a weapon against cancer cells will also require agents, such as NQO1 bioactivatable drugs, that selectively induce elevated ROS levels in cancer cells, while normal cells are protected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZG2MBvGkPbVg90H21EOLACvtfcHk0lia0TpdXsw58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVCnsrs%253D&md5=181547261dba18299cc40670c9d91fed</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.2147%2FCPAA.S79760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCPAA.S79760%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DExpanding%2520antitumor%2520therapeutic%2520windows%2520by%2520targeting%2520cancer-specific%2520nicotinamide%2520adenine%2520dinucleotide%2520phosphate-biogenesis%2520pathways%26jtitle%3DClin.%2520Pharmacol.%253A%2520Adv.%2520Appl.%26date%3D2015%26volume%3D7%26spage%3D57%26epage%3D68%26doi%3D10.2147%2FCPAA.S79760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref139"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref139'); return false;" data-citation="" class="refNumLink">139</a></strong><div class="NLM_citation" id="cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, T. K.</span></span> <span> </span><span class="NLM_article-title">beta-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1230</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fcddis.2014.202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24832602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2ns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1230&author=E.+J.+Parkauthor=K.+J.+Minauthor=T.+J.+Leeauthor=Y.+H.+Yooauthor=Y.+S.+Kimauthor=T.+K.+Kwon&title=beta-Lapachone+induces+programmed+necrosis+through+the+RIP1-PARP-AIF-dependent+pathway+in+human+hepatocellular+carcinoma+SK-Hep1+cells&doi=10.1038%2Fcddis.2014.202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells</span></div><div class="casAuthors">Park, E. J.; Min, K.-J.; Lee, T.-J.; Yoo, Y. H.; Kim, Y.-S.; Kwon, T. K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1230</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Lapachone activates multiple cell death mechanisms including apoptosis, autophagy and necrotic cell death in cancer cells.  In this study, we investigated β-lapachone-induced cell death and the underlying mechanisms in human hepatocellular carcinoma SK-Hep1 cells. β-Lapachone markedly induced cell death without caspase activation. β-Lapachone increased PI uptake and HMGB-1 release to extracellular space, which are markers of necrotic cell death.  Necrostatin-1 (a RIP1 kinase inhibitor) markedly inhibited β-lapachone-induced cell death and HMGB-1 release.  In addn., β-lapachone activated poly (ADP-ribosyl) polymerase-1(PARP-1) and promoted AIF release, and DPQ (a PARP-1 specific inhibitor) or AIF siRNA blocked β-lapachone-induced cell death.  Furthermore, necrostatin-1 blocked PARP-1 activation and cytosolic AIF translocation.  We also found that β-lapachone-induced reactive oxygen species (ROS) prodn. has an important role in the activation of the RIP1-PARP1-AIF pathway.  Finally, β-lapachone-induced cell death was inhibited by dicoumarol (a NQO-1 inhibitor), and NQO1 expression was correlated with sensitivity to β-lapachone.  Taken together, our results demonstrate that β-lapachone induces programmed necrosis through the NQO1-dependent ROS-mediated RIP1-PARP1-AIF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGCvN1XjVf2LVg90H21EOLACvtfcHk0lia0TpdXsw58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2ns7k%253D&md5=ba547ecf27b4ce19e808ae7805908edf</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.202%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DMin%26aufirst%3DK.%2BJ.%26aulast%3DLee%26aufirst%3DT.%2BJ.%26aulast%3DYoo%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKwon%26aufirst%3DT.%2BK.%26atitle%3Dbeta-Lapachone%2520induces%2520programmed%2520necrosis%2520through%2520the%2520RIP1-PARP-AIF-dependent%2520pathway%2520in%2520human%2520hepatocellular%2520carcinoma%2520SK-Hep1%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1230%26doi%3D10.1038%2Fcddis.2014.202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref140"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref140'); return false;" data-citation="" class="refNumLink">140</a></strong><div class="NLM_citation" id="cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Mu-calpain activation in beta-lapachone-mediated apoptosis</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.4161/cbt.2.2.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.4161%2Fcbt.2.2.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=12750552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=141-152&author=C.+Tagliarinoauthor=J.+J.+Pinkauthor=K.+E.+Reinickeauthor=S.+M.+Simmersauthor=D.+A.+Boothman&title=Mu-calpain+activation+in+beta-lapachone-mediated+apoptosis&doi=10.4161%2Fcbt.2.2.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">μ-Calpain Activation in β-Lapachone-Mediated Apoptosis</span></div><div class="casAuthors">Tagliarino, Colleen; Pink, John J.; Reinicke, Kathryn E.; Simmers, Sara M.; Wuerzberger-Davis, Shelly M.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-152</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">β-Lapachone (β-lap) triggers apoptosis in a no. of human breast and prostate cancer cell lines through a unique apoptotic pathway that is dependent upon NQO1, a two-electron reductase.  Recently, our lab. showed that β-lap-exposed MCF-7 cells exhibited an early increase in intracellular cytosolic Ca2+ from endoplasmic reticulum stores, and that BAPTA-AM (an intracellular Ca2+ chelator) blocked these early increases and partially inhibited all aspects of β-lap-induced apoptosis.  We now show that exposure of NQO1-expressing breast cancer cells to β-lap stimulates a unique proteolytic apoptotic pathway involving μ-calpain activation.  No apparent activation of m-calpain was noted.  Upon activation, μ-calpain translocated to the nucleus concomitant with specific nuclear proteolytic events.  Apoptotic responses in β-lap-exposed NQO1-expressing cells were significantly delayed and survival was enhanced by exogenous over-expression of calpastatin, a natural inhibitor of μ- and m-calpains.  Furthermore, purified μ-calpain cleaved PARP to a unique fragment (∼60 kDa), not previously reported for calpains.  We provide evidence that β-lap-induced, μ-calpain-stimulated apoptosis does not involve any known apoptotic caspases; the activated fragments of caspases were not obsd. after β-lap exposures, nor were there any changes in the pro-enzyme forms as measured by Western blot analyses.  The ability of β-lap to trigger an apparently novel, p53-independent, calpain-mediated apoptotic cell death further support the development of this drug for improved breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozakC3ar1up7Vg90H21EOLACvtfcHk0lia0TpdXsw58A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGhsLo%253D&md5=4f47c840086fa27f9568bc24256df3ed</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.4161%2Fcbt.2.2.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.2.2.237%26sid%3Dliteratum%253Aachs%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DSimmers%26aufirst%3DS.%2BM.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DMu-calpain%2520activation%2520in%2520beta-lapachone-mediated%2520apoptosis%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D141%26epage%3D152%26doi%3D10.4161%2Fcbt.2.2.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref141"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref141'); return false;" data-citation="" class="refNumLink">141</a></strong><div class="NLM_citation" id="cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egnatchik, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, M. E.</span></span> <span> </span><span class="NLM_article-title">The NQO1 bioactivatable drug, beta-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">18203</span>– <span class="NLM_lpage">18216</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.813923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M117.813923" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=18203-18216&author=M.+A.+Silversauthor=S.+Dejaauthor=N.+Singhauthor=R.+A.+Egnatchikauthor=J.+Sudderthauthor=X.+Luoauthor=M.+S.+Begauthor=S.+C.+Burgessauthor=R.+J.+DeBerardinisauthor=D.+A.+Boothmanauthor=M.+E.+Merritt&title=The+NQO1+bioactivatable+drug%2C+beta-lapachone%2C+alters+the+redox+state+of+NQO1%2B+pancreatic+cancer+cells%2C+causing+perturbation+in+central+carbon+metabolism&doi=10.1074%2Fjbc.M117.813923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.813923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.813923%26sid%3Dliteratum%253Aachs%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DDeja%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DEgnatchik%26aufirst%3DR.%2BA.%26aulast%3DSudderth%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DBurgess%26aufirst%3DS.%2BC.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DMerritt%26aufirst%3DM.%2BE.%26atitle%3DThe%2520NQO1%2520bioactivatable%2520drug%252C%2520beta-lapachone%252C%2520alters%2520the%2520redox%2520state%2520of%2520NQO1%252B%2520pancreatic%2520cancer%2520cells%252C%2520causing%2520perturbation%2520in%2520central%2520carbon%2520metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D18203%26epage%3D18216%26doi%3D10.1074%2Fjbc.M117.813923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref142"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref142'); return false;" data-citation="" class="refNumLink">142</a></strong><div class="NLM_citation" id="cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planchon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuerzberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witiak, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">β-Lapachone-mediated apoptosis in human promyelocytic Leukemia (HL-60) and human prostate cancer cells: A p53-independent response</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3706</span>– <span class="NLM_lpage">3711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=3706-3711&author=S.+M.+Planchonauthor=S.+Wuerzbergerauthor=B.+Frydmanauthor=D.+T.+Witiakauthor=P.+Hutsonauthor=D.+R.+Churchauthor=G.+Wildingauthor=D.+A.+Boothman&title=%CE%B2-Lapachone-mediated+apoptosis+in+human+promyelocytic+Leukemia+%28HL-60%29+and+human+prostate+cancer+cells%3A+A+p53-independent+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanchon%26aufirst%3DS.%2BM.%26aulast%3DWuerzberger%26aufirst%3DS.%26aulast%3DFrydman%26aufirst%3DB.%26aulast%3DWitiak%26aufirst%3DD.%2BT.%26aulast%3DHutson%26aufirst%3DP.%26aulast%3DChurch%26aufirst%3DD.%2BR.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3D%25CE%25B2-Lapachone-mediated%2520apoptosis%2520in%2520human%2520promyelocytic%2520Leukemia%2520%2528HL-60%2529%2520and%2520human%2520prostate%2520cancer%2520cells%253A%2520A%2520p53-independent%2520response%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D3706%26epage%3D3711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref143"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref143'); return false;" data-citation="" class="refNumLink">143</a></strong><div class="NLM_citation" id="cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of beta-lapachone for pancreatic cancer therapy</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-1983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-10-1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21224367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=275-285&author=L.+S.+Liauthor=E.+A.+Beyauthor=Y.+Dongauthor=J.+Mengauthor=B.+Patraauthor=J.+Yanauthor=X.+J.+Xieauthor=R.+A.+Brekkenauthor=C.+C.+Barnettauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=D.+A.+Boothman&title=Modulating+endogenous+NQO1+levels+identifies+key+regulatory+mechanisms+of+action+of+beta-lapachone+for+pancreatic+cancer+therapy&doi=10.1158%2F1078-0432.CCR-10-1983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy</span></div><div class="casAuthors">Li, Long Shan; Bey, Erik A.; Dong, Ying; Meng, Jieru; Patra, Biswanath; Yan, Jingsheng; Xie, Xian-Jin; Brekken, Rolf A.; Barnett, Carlton C.; Bornmann, William G.; Gao, Jinming; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-285</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Pancreatic cancer is the fourth leading cause of cancer-related deaths, in which the 5-yr survival rate is less than 5%.  Current std. of care therapies offer little selectivity and high toxicity.  Novel, tumor-selective approaches are desperately needed.  Although prior work suggested that β-lapachone (β-lap) could be used for the treatment of pancreatic cancers, the lack of knowledge of the compd.'s mechanism of action prevented optimal use of this agent.  Exptl. Design: We examd. the role of NAD(P)H:quinone oxidoreductase-1 (NQO1) in β-lap-mediated antitumor activity, using a series of MIA PaCa-2 pancreatic cancer clones varying in NQO1 levels by stable shRNA knockdown.  The antitumor efficacy of β-lap was detd. using an optimal hydroxypropyl-β-cyclodextran (HPβ-CD) vehicle formulation in metastatic pancreatic cancer models.  Results: β-Lap-mediated cell death required ∼90 enzymic units of NQO1.  Essential downstream mediators of lethality were as follows: (i) reactive oxygen species (ROS); (ii) single-strand DNA breaks induced by ROS; (iii) poly(ADP-ribose)polymerase-1 (PARP1) hyperactivation; (iv) dramatic NAD+/ATP depletion; and (v) programmed necrosis.  We showed that 1 regimen of β-lap therapy (5 treatments every other day) efficaciously regressed and reduced human pancreatic tumor burden and dramatically extended the survival of athymic mice, using metastatic pancreatic cancer models.  Conclusions: Because NQO1 enzyme activities are easily measured and commonly overexpressed (i.e., >70%) in pancreatic cancers 5- to 10-fold above normal tissue, strategies using β-lap to efficaciously treat pancreatic cancers are indicated.  On the basis of optimal drug formulation and efficacious antitumor efficacy, such a therapy should be extremely safe and not accompanied with normal tissue toxicity or hemolytic anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKcNAcs474ebVg90H21EOLACvtfcHk0lg7ptCaKVNUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslyrtQ%253D%253D&md5=aa9ffc640f55161e6d68598748d7a316</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-1983%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DPatra%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DBarnett%26aufirst%3DC.%2BC.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DModulating%2520endogenous%2520NQO1%2520levels%2520identifies%2520key%2520regulatory%2520mechanisms%2520of%2520action%2520of%2520beta-lapachone%2520for%2520pancreatic%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D275%26epage%3D285%26doi%3D10.1158%2F1078-0432.CCR-10-1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref144"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref144'); return false;" data-citation="" class="refNumLink">144</a></strong><div class="NLM_citation" id="cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span> <span> </span><span class="NLM_article-title">Metabolic profile, enzyme kinetics, and reaction phenotyping of beta-lapachone metabolism in human liver and intestine in vitro</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3476</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1021/mp300296m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300296m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eitL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=3476-3485&author=X.+Chengauthor=F.+Liuauthor=T.+Yanauthor=X.+Zhouauthor=L.+Wuauthor=K.+Liaoauthor=G.+Wangauthor=H.+Hao&title=Metabolic+profile%2C+enzyme+kinetics%2C+and+reaction+phenotyping+of+beta-lapachone+metabolism+in+human+liver+and+intestine+in+vitro&doi=10.1021%2Fmp300296m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Profile, Enzyme Kinetics, and Reaction Phenotyping of β-Lapachone Metabolism in Human Liver and Intestine in Vitro</span></div><div class="casAuthors">Cheng, Xuefang; Liu, Fang; Yan, Tingting; Zhou, Xueyan; Wu, Liang; Liao, Ke; Wang, Guangji; Hao, Haiping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3476-3485</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Lapachone (β-Lap) is an NAD(P)H:quinone oxidoreductase 1 (NQO1) target antitumor drug candidate in phase II clin. trials.  The present study aimed to uncover the metabolic profile, enzyme kinetics, and enzyme isoforms for the metab. of β-Lap in human liver and intestine in vitro.  NQO1-mediated quinone redn. and subsequent glucuronidation is the predominant metabolic pathway for β-Lap in humans; a pair of regioisomers (M1 and M2) of reduced β-Lap glucuronides were the major metabolites found from human S9 incubations.  The overall glucuronidation clearance of β-Lap in human liver S9 was 4754.90 μL/min/mg of protein and was 8.1-fold of that in human intestinal S9.  Recombinant UDP-glucuronosyltransferase (UGT) screening, correlation anal., enzyme kinetics, and chem. inhibition study were performed to det. the UGT isoforms involved in β-Lap metab.  UGT1A7, UGT1A8, and UGT1A9 are the predominant isoforms responsible for the formation of M2 while UGT2B7 is the main isoform for M1, suggesting a regioselective glucuronidation of reduced quinone by UGTs.  It was of interest to find that β-Lap underwent nonenzymic two-electron redn., providing a novel explanation for the toxicities of β-Lap to NQO1-neg. cells at high concn. and with long-time incubation.  In conclusion, this study contributes to a better understanding of not only β-Lap metab. but its antitumor property as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy06KS6EKVTrVg90H21EOLACvtfcHk0lg7ptCaKVNUwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eitL7L&md5=395697aadf832fb428891d388de2b191</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fmp300296m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300296m%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DH.%26atitle%3DMetabolic%2520profile%252C%2520enzyme%2520kinetics%252C%2520and%2520reaction%2520phenotyping%2520of%2520beta-lapachone%2520metabolism%2520in%2520human%2520liver%2520and%2520intestine%2520in%2520vitro%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D3476%26epage%3D3485%26doi%3D10.1021%2Fmp300296m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref145"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref145'); return false;" data-citation="" class="refNumLink">145</a></strong><div class="NLM_citation" id="cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemtong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setti-Guthi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessinger, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnevale, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3896</span>– <span class="NLM_lpage">3904</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-09-3995" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3896-3904&author=E.+Blancoauthor=E.+A.+Beyauthor=C.+Khemtongauthor=S.+G.+Yangauthor=J.+Setti-Guthiauthor=H.+Chenauthor=C.+W.+Kessingerauthor=K.+A.+Carnevaleauthor=W.+G.+Bornmannauthor=D.+A.+Boothmanauthor=J.+Gao&title=Beta-lapachone+micellar+nanotherapeutics+for+non-small+cell+lung+cancer+therapy&doi=10.1158%2F0008-5472.CAN-09-3995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3995%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DKhemtong%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%2BG.%26aulast%3DSetti-Guthi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKessinger%26aufirst%3DC.%2BW.%26aulast%3DCarnevale%26aufirst%3DK.%2BA.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DBeta-lapachone%2520micellar%2520nanotherapeutics%2520for%2520non-small%2520cell%2520lung%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3896%26epage%3D3904%26doi%3D10.1158%2F0008-5472.CAN-09-3995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref146"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref146'); return false;" data-citation="" class="refNumLink">146</a></strong><div class="NLM_citation" id="cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasongkla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruening, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1626</span>– <span class="NLM_lpage">1633</span>, <span class="refDoi"> DOI: 10.1023/A:1026143519395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1023%2FA%3A1026143519395" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1626-1633&author=N.+Nasongklaauthor=A.+F.+Wiedmannauthor=A.+Brueningauthor=M.+Bemanauthor=D.+Rayauthor=W.+G.+Bornmannauthor=D.+A.+Boothmanauthor=J.+Gao&title=Enhancement+of+solubility+and+bioavailability+of+beta-lapachone+using+cyclodextrin+inclusion+complexes&doi=10.1023%2FA%3A1026143519395"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1023%2FA%3A1026143519395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1026143519395%26sid%3Dliteratum%253Aachs%26aulast%3DNasongkla%26aufirst%3DN.%26aulast%3DWiedmann%26aufirst%3DA.%2BF.%26aulast%3DBruening%26aufirst%3DA.%26aulast%3DBeman%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DEnhancement%2520of%2520solubility%2520and%2520bioavailability%2520of%2520beta-lapachone%2520using%2520cyclodextrin%2520inclusion%2520complexes%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26spage%3D1626%26epage%3D1633%26doi%3D10.1023%2FA%3A1026143519395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref147"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref147'); return false;" data-citation="" class="refNumLink">147</a></strong><div class="NLM_citation" id="cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2309</span>– <span class="NLM_lpage">2319</span>, <span class="refDoi"> DOI: 10.1002/jps.20721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fjps.20721" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=2309-2319&author=F.+Wangauthor=E.+Blancoauthor=H.+Aiauthor=D.+A.+Boothmanauthor=J.+Gao&title=Modulating+beta-lapachone+release+from+polymer+millirods+through+cyclodextrin+complexation&doi=10.1002%2Fjps.20721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fjps.20721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20721%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DAi%26aufirst%3DH.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DModulating%2520beta-lapachone%2520release%2520from%2520polymer%2520millirods%2520through%2520cyclodextrin%2520complexation%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D2309%26epage%3D2319%26doi%3D10.1002%2Fjps.20721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref148"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref148'); return false;" data-citation="" class="refNumLink">148</a></strong><div class="NLM_citation" id="cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">672</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.3109/1061186X.2015.1073296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3109%2F1061186X.2015.1073296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26453163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=672-680&author=X.+Maauthor=Z.+R.+Mooreauthor=G.+Huangauthor=X.+Huangauthor=D.+A.+Boothmanauthor=J.+Gao&title=Nanotechnology-enabled+delivery+of+NQO1+bioactivatable+drugs&doi=10.3109%2F1061186X.2015.1073296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span></div><div class="casAuthors">Ma, Xinpeng; Moore, Zachary R.; Huang, Gang; Huang, Xiumei; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">672-680</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Current cancer chemotherapy lacks specificity and is limited by undesirable toxic side-effects, as well as a high rate of recurrence.  Nanotechnol. has the potential to offer paradigm-shifting solns. to improve the outcome of cancer diagnosis and therapy. β-Lapachone (β-lap) is a novel anticancer agent whose mechanism of action is highly dependent on NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II detoxifying enzyme overexpressed in solid tumors from a variety of cancer types.  However, the poor water soly. of β-lap limits its clin. potential.  A series of drug formulations were developed for systemic administration in preclin. evaluations.  Encapsulation of β-lap into polymeric micelles showed less side-effects and higher max. tolerated dose (MTD), prolonged blood circulation time and preferential accumulation in tumors with greatly improved safety and antitumor efficacy.  The prodrug strategy of β-lap further decreases the crystn. of β-lap by introducing esterase degradable side chains to the rigid fused ring structure. β-Lap prodrugs considerably increased the stability, drug-loading content and delivery efficiency of nanoparticles.  The optimized formulation of β-lap-dC3 prodrug micelles showed excellent antitumor efficacy in treating orthotopic non-small cell lung tumors that overexpress NQO1, with target validation using pharmacodynamic endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQWALPeBqdHLVg90H21EOLACvtfcHk0lic9AOv9I95CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ&md5=29ef8202d9d76ad0c55136da17093ac9</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2015.1073296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2015.1073296%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DNanotechnology-enabled%2520delivery%2520of%2520NQO1%2520bioactivatable%2520drugs%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2015%26volume%3D23%26spage%3D672%26epage%3D680%26doi%3D10.3109%2F1061186X.2015.1073296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref149"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref149'); return false;" data-citation="" class="refNumLink">149</a></strong><div class="NLM_citation" id="cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingalls, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misico, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzac, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span> <span> </span><span class="NLM_article-title">Development of B-lapachone prodrugs for therapy against human cancer cells with elevated NAD (P) H: quinone oxidoreductase1 levels</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3055</span>– <span class="NLM_lpage">3064</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-2185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-04-2185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15837761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3055-3064&author=K.+E.+Reinickeauthor=E.+A.+Beyauthor=M.+S.+Bentleauthor=J.+J.+Pinkauthor=S.+T.+Ingallsauthor=C.+L.+Hoppelauthor=R.+I.+Misicoauthor=G.+M.+Arzacauthor=G.+Burtonauthor=W.+G.+Bornmann&title=Development+of+B-lapachone+prodrugs+for+therapy+against+human+cancer+cells+with+elevated+NAD+%28P%29+H%3A+quinone+oxidoreductase1+levels&doi=10.1158%2F1078-0432.CCR-04-2185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Development of β-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels</span></div><div class="casAuthors">Reinicke, Kathryn E.; Bey, Erik A.; Bentle, Melissa S.; Pink, John J.; Ingalls, Stephen T.; Hoppel, Charles L.; Misico, Rosana I.; Arzac, Gisela M.; Burton, Gerardo; Bornmann, William G.; Sutton, Damon; Gao, Jinming; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3055-3064</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">β-Lapachone, an o-naphthoquinone, induces a novel caspase- and p53-independent apoptotic pathway dependent on NAD(P)H:quinone oxidoreductase 1 (NQO1).  NQO1 reduces β-lapachone to an unstable hydroquinone that rapidly undergoes a two-step oxidn. back to the parent compd., perpetuating a futile redox cycle.  A deficiency or inhibition of NQO1 rendered cells resistant to β-lapachone.  Thus, β-lapachone has great potential for the treatment of specific cancers with elevated NQO1 levels (e.g., breast, non-small cell lung, pancreatic, colon, and prostate cancers).  We report the development of mono(arylimino) derivs. of β-lapachone as potential prodrugs.  These derivs. are relatively nontoxic and not substrates for NQO1 when initially dild. in water.  In soln., however, they undergo hydrolytic conversion to β-lapachone at rates dependent on the electron-withdrawing strength of their substituent groups and pH of the diluent.  NQO1 enzyme assays, UV-visible spectrophotometry, high-performance liq. chromatog.-electrospray ionization-mass spectrometry, and NMR analyses confirmed and monitored conversion of each deriv. to β-lapachone.  Once converted, β-lapachone derivs. caused NQO1-dependent, μ-calpain-mediated cell death in human cancer cells identical to that caused by β-lapachone.  Interestingly, coadministration of N-acetyl-L-cysteine, prevented deriv.-induced cytotoxicity but did not affect β-lapachone lethality.  NMR analyses indicated that prevention of β-lapachone deriv. cytotoxicity was the result of direct modification of these derivs. by N-acetyl-L-cysteine, preventing their conversion to β-lapachone.  The use of β-lapachone mono(arylimino) prodrug derivs., or more specifically a deriv. converted in a tumor-specific manner (i.e., in the acidic local environment of the tumor tissue), should reduce normal tissue toxicity while eliciting tumor-selective cell killing by NQO1 bioactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPg3WMhVKl7Vg90H21EOLACvtfcHk0lic9AOv9I95CA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejtbw%253D&md5=c0f7f522fe210d37d58b5b27c3ff1f20</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2185%26sid%3Dliteratum%253Aachs%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DIngalls%26aufirst%3DS.%2BT.%26aulast%3DHoppel%26aufirst%3DC.%2BL.%26aulast%3DMisico%26aufirst%3DR.%2BI.%26aulast%3DArzac%26aufirst%3DG.%2BM.%26aulast%3DBurton%26aufirst%3DG.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26atitle%3DDevelopment%2520of%2520B-lapachone%2520prodrugs%2520for%2520therapy%2520against%2520human%2520cancer%2520cells%2520with%2520elevated%2520NAD%2520%2528P%2529%2520H%253A%2520quinone%2520oxidoreductase1%2520levels%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D3055%26epage%3D3064%26doi%3D10.1158%2F1078-0432.CCR-04-2185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref150"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref150'); return false;" data-citation="" class="refNumLink">150</a></strong><div class="NLM_citation" id="cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkenblit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagovane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span> <span> </span><span class="NLM_article-title">Phase I trial of ARQ 501, an activated checkpoint therapy (ACT) agent, in patients with advanced solid tumors</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3042</span>– <span class="NLM_lpage">3042</span>, <span class="refDoi"> DOI: 10.1200/jco.2005.23.16_suppl.3042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1200%2Fjco.2005.23.16_suppl.3042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3042-3042&author=G.+Shapiroauthor=J.+Supkoauthor=D.+Ryanauthor=L.+Appelmanauthor=A.+Berkenblitauthor=A.+Craigauthor=S.+Jonesauthor=D.+Yagovaneauthor=C.+Liauthor=J.+Eder&title=Phase+I+trial+of+ARQ+501%2C+an+activated+checkpoint+therapy+%28ACT%29+agent%2C+in+patients+with+advanced+solid+tumors&doi=10.1200%2Fjco.2005.23.16_suppl.3042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1200%2Fjco.2005.23.16_suppl.3042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252Fjco.2005.23.16_suppl.3042%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DAppelman%26aufirst%3DL.%26aulast%3DBerkenblit%26aufirst%3DA.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DYagovane%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DEder%26aufirst%3DJ.%26atitle%3DPhase%2520I%2520trial%2520of%2520ARQ%2520501%252C%2520an%2520activated%2520checkpoint%2520therapy%2520%2528ACT%2529%2520agent%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3042%26epage%3D3042%26doi%3D10.1200%2Fjco.2005.23.16_suppl.3042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref151"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref151'); return false;" data-citation="" class="refNumLink">151</a></strong><div class="NLM_citation" id="cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawecki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adkins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vokes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagovane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koralewski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vladimirov, V.</span></span> <span> </span><span class="NLM_article-title">A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">16509</span>– <span class="NLM_lpage">16509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=16509-16509&author=A.+Kaweckiauthor=D.+Adkinsauthor=C.+Cunninghamauthor=E.+Vokesauthor=D.+Yagovaneauthor=G.+Dombalauthor=P.+Koralewskiauthor=Y.+Hotkoauthor=V.+Vladimirov&title=A+phase+II+study+of+ARQ+501+in+patients+with+advanced+squamous+cell+carcinoma+of+the+head+and+neck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawecki%26aufirst%3DA.%26aulast%3DAdkins%26aufirst%3DD.%26aulast%3DCunningham%26aufirst%3DC.%26aulast%3DVokes%26aufirst%3DE.%26aulast%3DYagovane%26aufirst%3DD.%26aulast%3DDombal%26aufirst%3DG.%26aulast%3DKoralewski%26aufirst%3DP.%26aulast%3DHotko%26aufirst%3DY.%26aulast%3DVladimirov%26aufirst%3DV.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520ARQ%2520501%2520in%2520patients%2520with%2520advanced%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520head%2520and%2520neck%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D16509%26epage%3D16509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref152"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref152'); return false;" data-citation="" class="refNumLink">152</a></strong><div class="NLM_citation" id="cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreisbach, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeziorski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonderenko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiela, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagovane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombal, G.</span></span> <span> </span><span class="NLM_article-title">A phase 2 study of ARQ 501 in combination with gemcitabine in adult patients with treatment naive, unresectable pancreatic adenocarcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">15017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=15017&author=H.+Khongauthor=L.+Dreisbachauthor=H.+Kindlerauthor=D.+Trentauthor=K.+Jeziorskiauthor=I.+Bonderenkoauthor=T.+Popielaauthor=D.+Yagovaneauthor=G.+Dombal&title=A+phase+2+study+of+ARQ+501+in+combination+with+gemcitabine+in+adult+patients+with+treatment+naive%2C+unresectable+pancreatic+adenocarcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhong%26aufirst%3DH.%26aulast%3DDreisbach%26aufirst%3DL.%26aulast%3DKindler%26aufirst%3DH.%26aulast%3DTrent%26aufirst%3DD.%26aulast%3DJeziorski%26aufirst%3DK.%26aulast%3DBonderenko%26aufirst%3DI.%26aulast%3DPopiela%26aufirst%3DT.%26aulast%3DYagovane%26aufirst%3DD.%26aulast%3DDombal%26aufirst%3DG.%26atitle%3DA%2520phase%25202%2520study%2520of%2520ARQ%2520501%2520in%2520combination%2520with%2520gemcitabine%2520in%2520adult%2520patients%2520with%2520treatment%2520naive%252C%2520unresectable%2520pancreatic%2520adenocarcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D15017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref153"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref153'); return false;" data-citation="" class="refNumLink">153</a></strong><div class="NLM_citation" id="cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolluyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatunde, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Phase 1 correlative study of ARQ761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70379-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0959-8049%2814%2970379-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=84-85&author=D.+Gerberauthor=Y.+Arriagaauthor=M.+S.+Begauthor=J.+E.+Dowellauthor=J.+H.+Schillerauthor=A.+E.+Frankelauthor=R.+Leffauthor=C.+Meekauthor=J.+Bolluytauthor=O.+Fatundeauthor=R.+T.+Martinezauthor=P.+Voauthor=F.+Fattahauthor=V.+Sarodeauthor=Y.+Zhouauthor=Y.+Xieauthor=M.+McLeodauthor=B.+Schwartzauthor=D.+A.+Boothman&title=Phase+1+correlative+study+of+ARQ761%2C+a+%CE%B2-lapachone+analogue+that+promotes+NQO1-mediated+programmed+cancer+cell+necrosis&doi=10.1016%2FS0959-8049%2814%2970379-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970379-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970379-X%26sid%3Dliteratum%253Aachs%26aulast%3DGerber%26aufirst%3DD.%26aulast%3DArriaga%26aufirst%3DY.%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DDowell%26aufirst%3DJ.%2BE.%26aulast%3DSchiller%26aufirst%3DJ.%2BH.%26aulast%3DFrankel%26aufirst%3DA.%2BE.%26aulast%3DLeff%26aufirst%3DR.%26aulast%3DMeek%26aufirst%3DC.%26aulast%3DBolluyt%26aufirst%3DJ.%26aulast%3DFatunde%26aufirst%3DO.%26aulast%3DMartinez%26aufirst%3DR.%2BT.%26aulast%3DVo%26aufirst%3DP.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DMcLeod%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DPhase%25201%2520correlative%2520study%2520of%2520ARQ761%252C%2520a%2520%25CE%25B2-lapachone%2520analogue%2520that%2520promotes%2520NQO1-mediated%2520programmed%2520cancer%2520cell%2520necrosis%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D84%26epage%3D85%26doi%3D10.1016%2FS0959-8049%2814%2970379-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref154"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref154'); return false;" data-citation="" class="refNumLink">154</a></strong><div class="NLM_citation" id="cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">β-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2007.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.jconrel.2007.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=17574288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2007&pages=365-374&author=E.+Blancoauthor=E.+A.+Beyauthor=Y.+Dongauthor=B.+D.+Weinbergauthor=D.+M.+Suttonauthor=D.+A.+Boothmanauthor=J.+Gao&title=%CE%B2-Lapachone-containing+PEG-PLA+polymer+micelles+as+novel+nanotherapeutics+against+NQO1-overexpressing+tumor+cells&doi=10.1016%2Fj.jconrel.2007.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells</span></div><div class="casAuthors">Blanco, Elvin; Bey, Erik A.; Dong, Ying; Weinberg, Brent D.; Sutton, Damon M.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-374</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">β-Lapachone (β-lap) is a novel anticancer agent that is bioactivated by NADP(H): quinone oxidoreductase 1 (NQO1), an enzyme overexpressed in a variety of tumors.  Despite its therapeutic promise, the poor aq. soly. of β-lap hinders its preclin. evaluation and clin. translation.  The objective was to develop β-lap-contg. poly(ethylene glycol)-block-poly(-lactide) (PEG-PLA) polymer micelles for the treatment of NQO1-overexpressing tumors.  Several micelle fabrication strategies were examd. to maximize drug loading.  A film sonication method yielded β-lap micelles with relatively high loading d. (4.7±1.0% to 6.5±1.0%) and optimal size (29.6±1.5 nm).  Release studies in phosphate-buffered saline (pH 7.4) showed the time (t1/2) for 50% of drug release at 18 h.  In vitro cytotoxicity assays were performed in NQO1-overexpressing (NQO1+) and NQO1-null (NQO1-) H596 lung, DU-145 prostate, and MDA-MB-231 breast cancer cells.  Cytotoxicity data showed that after a 2 h incubation with β-lap micelles, a marked increase in toxicity was shown in NQO1+ cells over NQO1- cells, resembling free drug both in efficacy and mechanism of cell death.  In summary, these data demonstrate the potential of β-lap micelles as an effective therapeutic strategy against NQO1-overexpressing tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNMyJa0BnzXbVg90H21EOLACvtfcHk0lg_l1-nDCc8hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKrsLrJ&md5=521c7a6a49c4c2e38b1adcc6c27b223c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2007.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2007.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWeinberg%26aufirst%3DB.%2BD.%26aulast%3DSutton%26aufirst%3DD.%2BM.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Lapachone-containing%2520PEG-PLA%2520polymer%2520micelles%2520as%2520novel%2520nanotherapeutics%2520against%2520NQO1-overexpressing%2520tumor%2520cells%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2007%26volume%3D122%26spage%3D365%26epage%3D374%26doi%3D10.1016%2Fj.jconrel.2007.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref155"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref155'); return false;" data-citation="" class="refNumLink">155</a></strong><div class="NLM_citation" id="cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Esterase-activatable beta-lapachone prodrug micelles for NQO1-targeted lung cancer therapy</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.jconrel.2014.12.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2015&pages=201-211&author=X.+Maauthor=X.+Huangauthor=Z.+Mooreauthor=G.+Huangauthor=J.+A.+Kilgoreauthor=Y.+Wangauthor=S.+Hammerauthor=N.+S.+Williamsauthor=D.+A.+Boothmanauthor=J.+Gao&title=Esterase-activatable+beta-lapachone+prodrug+micelles+for+NQO1-targeted+lung+cancer+therapy&doi=10.1016%2Fj.jconrel.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHammer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DEsterase-activatable%2520beta-lapachone%2520prodrug%2520micelles%2520for%2520NQO1-targeted%2520lung%2520cancer%2520therapy%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D200%26spage%3D201%26epage%3D211%26doi%3D10.1016%2Fj.jconrel.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref156"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref156'); return false;" data-citation="" class="refNumLink">156</a></strong><div class="NLM_citation" id="cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span> <span> </span><span class="NLM_article-title">Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug</span>. <i>J. Mater. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2310</span>– <span class="NLM_lpage">2315</span>, <span class="refDoi"> DOI: 10.1039/b816209c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2Fb816209c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2hu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2310-2315&author=C.+Parkauthor=H.+Younauthor=H.+Kimauthor=T.+Nohauthor=Y.+H.+Kookauthor=E.+T.+Ohauthor=H.+J.+Parkauthor=C.+Kim&title=Cyclodextrin-covered+gold+nanoparticles+for+targeted+delivery+of+an+anti-cancer+drug&doi=10.1039%2Fb816209c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug</span></div><div class="casAuthors">Park, Chiyoung; Youn, Hyewon; Kim, Hana; Noh, Taiho; Kook, Yeon Hee; Oh, Eun Tax; Park, Heon Joo; Kim, Chulhee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2310-2315</span>CODEN:
                <span class="NLM_cas:coden">JMACEP</span>;
        ISSN:<span class="NLM_cas:issn">0959-9428</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report on the therapeutic ability of a novel cyclodextrin-covered gold nanoparticle (AuNP) carrier for noncovalent encapsulation of an anti-cancer drug.  The surface of the AuNPs was functionalized with cyclodextrin as a drug pocket, anti-epidermal growth factor receptor (anti-EGFR) antibody as a targeting moiety, and poly(ethyleneglycol) (PEG) as an anti-fouling shell.  β-Lapachone, an anti-cancer drug, was efficiently encapsulated into the hydrophobic cavity of cyclodextrin on the surface of the AuNP carriers (AuNP-1).  The glutathione-mediated release of β-lapachone from the surface of AuNP-1 was demonstrated by an expt. with MCF-7 (low glutathione concn.) and A549 cells (high glutathione concn.).  We also show that the introduction of an anti-EGFR antibody onto the AuNP carriers (AuNP-2) increased the intracellular uptake of AuNP carriers as compared with AuNP-1, which does not contain a targeting ligand.  In the in vitro cytotoxicity study, AuNP-2 with β-lapachone exhibited a higher apoptosis effect than that caused by AuNP-1 with β-lapachone.  This work suggests that AuNPs covered with cyclodextrin and tumor-targeting ligands may find useful applications for the development of nanoparticles with therapeutic and diagnostic modalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpj2Qvt9eEU7Vg90H21EOLACvtfcHk0lg_l1-nDCc8hg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2hu7Y%253D&md5=e80e1a41e67990ffdf2b0cefb3427a77</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1039%2Fb816209c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb816209c%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%26aulast%3DYoun%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DNoh%26aufirst%3DT.%26aulast%3DKook%26aufirst%3DY.%2BH.%26aulast%3DOh%26aufirst%3DE.%2BT.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DC.%26atitle%3DCyclodextrin-covered%2520gold%2520nanoparticles%2520for%2520targeted%2520delivery%2520of%2520an%2520anti-cancer%2520drug%26jtitle%3DJ.%2520Mater.%2520Chem.%26date%3D2009%26volume%3D19%26spage%3D2310%26epage%3D2315%26doi%3D10.1039%2Fb816209c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref157"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref157'); return false;" data-citation="" class="refNumLink">157</a></strong><div class="NLM_citation" id="cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabbani, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Intratumoral delivery of β-lapachone via polymer implants for prostate cancer therapy</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-08-1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19118040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1eltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=131-139&author=Y.+Dongauthor=S.+F.+Chinauthor=E.+Blancoauthor=E.+A.+Beyauthor=W.+Kabbaniauthor=X.+J.+Xieauthor=W.+G.+Bornmannauthor=D.+A.+Boothmanauthor=J.+Gao&title=Intratumoral+delivery+of+%CE%B2-lapachone+via+polymer+implants+for+prostate+cancer+therapy&doi=10.1158%2F1078-0432.CCR-08-1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Intratumoral Delivery of β-Lapachone via Polymer Implants for Prostate Cancer Therapy</span></div><div class="casAuthors">Dong, Ying; Chin, Shook-Fong; Blanco, Elvin; Bey, Erik A.; Kabbani, Wareef; Xie, Xian-Jin; Bornmann, William G.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: β-Lapachone (ARQ 501, a formulation of β-lapachone complexed with hydroxypropyl-β-cyclodextrin) is a novel anticancer agent with selectivity against prostate cancer cells overexpressing the NAD(P)H:quinone oxidoreductase-1 enzyme.  Lack of soly. and an efficient drug delivery strategy limits this compd. in clin. applications.  In this study, we aimed to develop β-lapachone-contg. polymer implants (millirods) for direct implantation into prostate tumors to test the hypothesis that the combination of a tumor-specific anticancer agent with site-specific release of the agent will lead to significant antitumor efficacy.  Exptl. Design: Survival assays in vitro were used to test the killing effect of β-lapachone in different prostate cancer cells. β-Lapachone release kinetics from millirods was detd. in vitro and in vivo.  PC-3 prostate tumor xenografts in athymic nude mice were used for antitumor efficacy studies in vivo.  RESULTS: β-Lapachone killed three different prostate cancer cell lines in an NAD(P)H:quinone oxidoreductase-1-dependent manner.  Upon incorporation of solid-state inclusion complexes of β-lapachone with hydroxypropyl-β-cyclodextrin into poly(D,L-lactide-co-glycolide) millirods, β-lapachone release kinetics in vivo showed a burst release of ∼0.5 mg within 12 h and a subsequently sustained release of the drug (∼0.4 mg/kg/d) comparable with that obsd. in vitro.  Antitumor efficacy studies showed significant tumor growth inhibition by β-lapachone millirods compared with controls (P < 0.0001; n = 10 per group).  Kaplan-Meier survival curves showed that tumor-bearing mice treated with β-lapachone millirods survived nearly 2-fold longer than controls, without observable systemic toxicity.  CONCLUSIONS: Intratumoral delivery of β-lapachone using polymer millirods showed the promising therapeutic potential for human prostate tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5oCFMMu_EMrVg90H21EOLACvtfcHk0lizGPIYHPgyPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1eltA%253D%253D&md5=35604dabef56a9706e9bf022d42de128</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1691%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DKabbani%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DIntratumoral%2520delivery%2520of%2520%25CE%25B2-lapachone%2520via%2520polymer%2520implants%2520for%2520prostate%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D131%26epage%3D139%26doi%3D10.1158%2F1078-0432.CCR-08-1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref158"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref158'); return false;" data-citation="" class="refNumLink">158</a></strong><div class="NLM_citation" id="cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Superparamagnetic iron oxide nanoparticles: Amplifying ROS stress to improve anticancer drug efficacy</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.7150/thno.5411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.7150%2Fthno.5411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23423156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=116-126&author=G.+Huangauthor=H.+Chenauthor=Y.+Dongauthor=X.+Luoauthor=H.+Yuauthor=Z.+Mooreauthor=E.+A.+Beyauthor=D.+A.+Boothmanauthor=J.+Gao&title=Superparamagnetic+iron+oxide+nanoparticles%3A+Amplifying+ROS+stress+to+improve+anticancer+drug+efficacy&doi=10.7150%2Fthno.5411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy</span></div><div class="casAuthors">Huang, Gang; Chen, Huabing; Luo, Xiuquan; Yu, Haijun; Moore, Zachary; Bey, Erik A.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Superparamagnetic iron oxide nanoparticles (SPION) are an important and versatile nano-platform with broad biol. applications.  Despite extensive studies, the biol. and pharmacol. activities of SPION have not been exploited in therapeutic applications.  Recently, β-lapachone (β-lap), a novel anticancer drug, has shown considerable cancer specificity by selectively increasing reactive oxygen species (ROS) stress in cancer cells.  In this study, we report that pH-responsive SPION-micelles can synergize with β-lap for improved cancer therapy.  These SPION-micelles selectively release iron ions inside cancer cells, which interact with hydrogen peroxide (H2O2) generated from β-lap in a tumor-specific, NQO1-dependent manner.  Through Fenton reactions, these iron ions escalate the ROS stress in β-lap-exposed cancer cells, thereby greatly enhancing the therapeutic index of β-lap.  More specifically, a 10-fold increase in ROS stress was detected in β-lap-exposed cells pretreated with SPION-micelles over those treated with β-lap alone, which also correlates with significantly increased cell death.  Catalase treatment of cells or administration of an iron chelator can block the therapeutic synergy.  Our data suggest that incorporation of SPION-micelles with ROS-generating drugs can potentially improve drug efficacy during cancer treatment, thereby provides a synergistic strategy to integrate imaging and therapeutic functions in the development of theranostic nanomedicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruVlAUzHeaQrVg90H21EOLACvtfcHk0lizGPIYHPgyPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7g%253D&md5=cb028a8721f7476776a3ad264a547565</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.7150%2Fthno.5411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.5411%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DSuperparamagnetic%2520iron%2520oxide%2520nanoparticles%253A%2520Amplifying%2520ROS%2520stress%2520to%2520improve%2520anticancer%2520drug%2520efficacy%26jtitle%3DTheranostics%26date%3D2013%26volume%3D3%26spage%3D116%26epage%3D126%26doi%3D10.7150%2Fthno.5411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref159"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref159'); return false;" data-citation="" class="refNumLink">159</a></strong><div class="NLM_citation" id="cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, Paul J.</span>; <span class="NLM_string-name">Boothman</span>; , <span class="NLM_string-name">David, A.</span>; <span class="NLM_string-name">Bair</span>; , <span class="NLM_string-name">Joseph, S.</span>; <span class="NLM_string-name">Cao, L. F.</span>; <span class="NLM_string-name">Gao, J.</span>; <span class="NLM_string-name">Huang, X.</span>; <span class="NLM_string-name">Luo, X.</span>; <span class="NLM_string-name">Ma, X.</span>; <span class="NLM_string-name">Moore</span>; , <span class="NLM_string-name">Zachary, R.</span>; <span class="NLM_string-name">Parkinson</span>; , <span class="NLM_string-name">Elizabeth, I.</span></span> <span> </span><span class="NLM_article-title">Tumor Selective Combination Therapy</span>. PCT Int Appl. <span class="NLM_patent">WO2014168991A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Paul+J.+Hergenrother&author=+Boothman&author=A.+David&author=+Bair&author=S.+Joseph&author=L.+F.+Cao&author=J.+Gao&author=X.+Huang&author=X.+Luo&author=X.+Ma&author=+Moore&author=R.+Zachary&author=+Parkinson&author=I.+Elizabeth&title=Tumor+Selective+Combination+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHergenrother%26aufirst%3DPaul%2BJ.%26atitle%3DTumor%2520Selective%2520Combination%2520Therapy%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref160"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref160'); return false;" data-citation="" class="refNumLink">160</a></strong><div class="NLM_citation" id="cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. P.</span></span> <span> </span><span class="NLM_article-title">NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells</span>. <i>Chin. J. Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/S1875-5364(16)30068-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS1875-5364%2816%2930068-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27608947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC2szptVWrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=582-589&author=H.+Y.+Liuauthor=Q.+R.+Liauthor=X.+F.+Chengauthor=G.+J.+Wangauthor=H.+P.+Hao&title=NAMPT+inhibition+synergizes+with+NQO1-targeting+agents+in+inducing+apoptotic+cell+death+in+non-small+cell+lung+cancer+cells&doi=10.1016%2FS1875-5364%2816%2930068-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells</span></div><div class="casAuthors">Liu Hui-Ying; Li Qing-Ran; Cheng Xue-Fang; Wang Guang-Ji; Hao Hai-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Chinese journal of natural medicines</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">582-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the first rate-limiting step in converting nicotinamide to NAD(+), essential for a number of enzymes and regulatory proteins involved in a variety of cellular processes, including deacetylation enzyme SIRT1 which modulates several tumor suppressors such as p53 and FOXO.  Herein we report that NQO1 substrates Tanshione IIA (TSA) and β-lapachone (β-lap) induced a rapid depletion of NAD(+) pool but adaptively a significant upregulation of NAMPT.  NAMPT inhibition by FK866 at a nontoxic dose significantly enhanced NQO1-targeting agent-induced apoptotic cell death.  Compared with TSA or β-lap treatment alone, co-treatment with FK866 induced a more dramatic depletion of NAD(+), repression of SIRT1 activity, and thereby the increased accumulation of acetylated FOXO1 and the activation of apoptotic pathway.  In conclusion, the results from the present study support that NAMPT inhibition can synergize with NQO1 activation to induce apoptotic cell death, thereby providing a new rationale for the development of combinative therapeutic drugs in combating non-small lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxCq2KIoPxdr0AGQpJZWpJfW6udTcc2eb7c8FmLXruLrntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szptVWrtw%253D%253D&md5=61db6b64ccb886624badd85e35b19be6</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2FS1875-5364%2816%2930068-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1875-5364%252816%252930068-1%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%2BR.%26aulast%3DCheng%26aufirst%3DX.%2BF.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DHao%26aufirst%3DH.%2BP.%26atitle%3DNAMPT%2520inhibition%2520synergizes%2520with%2520NQO1-targeting%2520agents%2520in%2520inducing%2520apoptotic%2520cell%2520death%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DChin.%2520J.%2520Nat.%2520Med.%26date%3D2016%26volume%3D14%26spage%3D582%26epage%3D589%26doi%3D10.1016%2FS1875-5364%2816%2930068-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref161"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref161'); return false;" data-citation="" class="refNumLink">161</a></strong><div class="NLM_citation" id="cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilcheva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padanad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglioni, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by β-lapachone</span>. <i>Cancer Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.1186/s40170-015-0137-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2Fs40170-015-0137-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26462257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC28zht1OhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=12&author=G.+Chakrabartiauthor=Z.+R.+Mooreauthor=X.+Luoauthor=M.+Ilchevaauthor=A.+Aliauthor=M.+Padanadauthor=Y.+Zhouauthor=Y.+Xieauthor=S.+Burmaauthor=P.+P.+Scaglioniauthor=L.+C.+Cantleyauthor=R.+J.+DeBerardinisauthor=A.+C.+Kimmelmanauthor=C.+A.+Lyssiotisauthor=D.+A.+Boothman&title=Targeting+glutamine+metabolism+sensitizes+pancreatic+cancer+to+PARP-driven+metabolic+catastrophe+induced+by+%CE%B2-lapachone&doi=10.1186%2Fs40170-015-0137-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ss-lapachone</span></div><div class="casAuthors">Chakrabarti Gaurab; Moore Zachary R; Luo Xiuquan; Boothman David A; Ilcheva Mariya; Burma Sandeep; Ali Aktar; Padanad Mahesh; Scaglioni Pier P; Zhou Yunyun; Xie Yang; Cantley Lewis C; DeBerardinis Ralph J; Kimmelman Alec C; Lyssiotis Costas A</div><div class="citationInfo"><span class="NLM_cas:title">Cancer & metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12</span>
        ISSN:<span class="NLM_cas:issn">2049-3002</span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic ductal adenocarcinomas (PDA) activate a glutamine-dependent pathway of cytosolic nicotinamide adenine dinucleotide phosphate (NADPH) production to maintain redox homeostasis and support proliferation.  Enzymes involved in this pathway (GLS1 (mitochondrial glutaminase 1), GOT1 (cytoplasmic glutamate oxaloacetate transaminase 1), and GOT2 (mitochondrial glutamate oxaloacetate transaminase 2)) are highly upregulated in PDA, and among these, inhibitors of GLS1 were recently deployed in clinical trials to target anabolic glutamine metabolism.  However, single-agent inhibition of this pathway is cytostatic and unlikely to provide durable benefit in controlling advanced disease.  RESULTS:  Here, we report that reducing NADPH pools by genetically or pharmacologically (bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) or CB-839) inhibiting glutamine metabolism in mutant Kirsten rat sarcoma viral oncogene homolog (KRAS) PDA sensitizes cell lines and tumors to ss-lapachone (ss-lap, clinical form ARQ761). ss-Lap is an NADPH:quinone oxidoreductase (NQO1)-bioactivatable drug that leads to NADPH depletion through high levels of reactive oxygen species (ROS) from the futile redox cycling of the drug and subsequently nicotinamide adenine dinucleotide (NAD)+ depletion through poly(ADP ribose) polymerase (PARP) hyperactivation.  NQO1 expression is highly activated by mutant KRAS signaling.  As such, ss-lap treatment concurrent with inhibition of glutamine metabolism in mutant KRAS, NQO1 overexpressing PDA leads to massive redox imbalance, extensive DNA damage, rapid PARP-mediated NAD+ consumption, and PDA cell death-features not observed in NQO1-low, wild-type KRAS expressing cells.  CONCLUSIONS:  This treatment strategy illustrates proof of principle that simultaneously decreasing glutamine metabolism-dependent tumor anti-oxidant defenses and inducing supra-physiological ROS formation are tumoricidal and that this rationally designed combination strategy lowers the required doses of both agents in vitro and in vivo.  The non-overlapping specificities of GLS1 inhibitors and ss-lap for PDA tumors afford high tumor selectivity, while sparing normal tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRy9_YD1cmANNTrvPZP1IpfW6udTcc2eaXSoNE8jLiRbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zht1OhtQ%253D%253D&md5=6c125ace3cbf06d4702d8ba5f2f9f21a</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1186%2Fs40170-015-0137-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40170-015-0137-1%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DIlcheva%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DPadanad%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DBurma%26aufirst%3DS.%26aulast%3DScaglioni%26aufirst%3DP.%2BP.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DTargeting%2520glutamine%2520metabolism%2520sensitizes%2520pancreatic%2520cancer%2520to%2520PARP-driven%2520metabolic%2520catastrophe%2520induced%2520by%2520%25CE%25B2-lapachone%26jtitle%3DCancer%2520Metab.%26date%3D2015%26volume%3D3%26spage%3D12%26doi%3D10.1186%2Fs40170-015-0137-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref162"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref162'); return false;" data-citation="" class="refNumLink">162</a></strong><div class="NLM_citation" id="cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span> <span> </span><span class="NLM_article-title">NQO1-mediated biotransformation determines the cytotoxicity of tanshinone IIA</span>. <i>Chin. J. Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/S1875-5364(12)60070-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS1875-5364%2812%2960070-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=353-357&author=F.+Liuauthor=H.+P.+Haoauthor=G.+J.+Wang&title=NQO1-mediated+biotransformation+determines+the+cytotoxicity+of+tanshinone+IIA&doi=10.1016%2FS1875-5364%2812%2960070-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2FS1875-5364%2812%2960070-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1875-5364%252812%252960070-3%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DHao%26aufirst%3DH.%2BP.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26atitle%3DNQO1-mediated%2520biotransformation%2520determines%2520the%2520cytotoxicity%2520of%2520tanshinone%2520IIA%26jtitle%3DChin.%2520J.%2520Nat.%2520Med.%26date%3D2012%26volume%3D10%26spage%3D353%26epage%3D357%26doi%3D10.1016%2FS1875-5364%2812%2960070-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref163"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref163'); return false;" data-citation="" class="refNumLink">163</a></strong><div class="NLM_citation" id="cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2014.05.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=56-67&author=J.+Bianauthor=B.+Dengauthor=L.+Xuauthor=X.+Xuauthor=N.+Wangauthor=T.+Huauthor=Z.+Yaoauthor=J.+Duauthor=L.+Yangauthor=Y.+Leiauthor=X.+Liauthor=H.+Sunauthor=X.+Zhangauthor=Q.+You&title=2-Substituted+3-methylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+novel+L-shaped+ortho-quinone+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29&doi=10.1016%2Fj.ejmech.2014.05.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.041%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203-methylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520novel%2520L-shaped%2520ortho-quinone%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D56%26epage%3D67%26doi%3D10.1016%2Fj.ejmech.2014.05.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref164"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref164'); return false;" data-citation="" class="refNumLink">164</a></strong><div class="NLM_citation" id="cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1006</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmc.2016.01.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1006-1013&author=X.+Liauthor=J.+Bianauthor=N.+Wangauthor=X.+Qianauthor=J.+Guauthor=T.+Muauthor=J.+Fanauthor=X.+Yangauthor=S.+Liauthor=T.+Yangauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Novel+naphtho%5B2%2C1-d%5Doxazole-4%2C5-diones+as+NQO1+substrates+with+improved+aqueous+solubility%3A+Design%2C+synthesis%2C+and+in+vivo+antitumor+evaluation&doi=10.1016%2Fj.bmc.2016.01.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DNovel%2520naphtho%255B2%252C1-d%255Doxazole-4%252C5-diones%2520as%2520NQO1%2520substrates%2520with%2520improved%2520aqueous%2520solubility%253A%2520Design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520antitumor%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1006%26epage%3D1013%26doi%3D10.1016%2Fj.bmc.2016.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref165"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref165'); return false;" data-citation="" class="refNumLink">165</a></strong><div class="NLM_citation" id="cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2017.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28214631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=27-40&author=J.+Bianauthor=X.+Liauthor=N.+Wangauthor=X.+Wuauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+quinone-directed+antitumor+agents+selectively+bioactivated+by+NQO1+over+CPR+with+improved+safety+profile&doi=10.1016%2Fj.ejmech.2017.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span></div><div class="casAuthors">Bian, Jinlei; Li, Xiang; Wang, Nan; Wu, Xingsen; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The authors mainly focused on discovering compds. with good selectivity for NQO1 over CPR.  The NQO1-mediated two-electron redn. of compds. would kill cancer cells selectively, while CPR-mediated one-electron redn. would induce potential hepatotoxicity.  Several novel quinone-directed antitumor agents were discovered as specific NQO1 substrates through structure-activity relationship studies.  Among them, compd. 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione (12b) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by CPR.  It afforded the highest selectivity between NQO1/CPR (selectivity ratio = 6.37), much higher than the control β-lapachone (selectivity ratio = 1.36), indicated 12b may possess superior safety profile.  The electrochem. studies provided a reasonable explanation to the good selectivity toward NQO1.  Mol. docking studies supported that 12b was capable of forming addnl. C-H... π interactions with Trp 105 and Phe 178 residues compared to the control β-lap.  In addn., compd. 12b was shown to kill cancer cells efficiently both in vitro and in vivo model.  This work gave the authors a promising and novel scaffold for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRMIKxcCSGLVg90H21EOLACvtfcHk0ljnX00wFnqibw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D&md5=18c03007ddfea2f3165662912048ff3b</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520quinone-directed%2520antitumor%2520agents%2520selectively%2520bioactivated%2520by%2520NQO1%2520over%2520CPR%2520with%2520improved%2520safety%2520profile%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D27%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2017.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref166"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref166'); return false;" data-citation="" class="refNumLink">166</a></strong><div class="NLM_citation" id="cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2017.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28710963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=616-629&author=X.+Zhangauthor=J.+Bianauthor=X.+Liauthor=X.+Wuauthor=Y.+Dongauthor=Q.+You&title=2-Substituted+3%2C7%2C8-trimethylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+specific+L-shaped+NQO1-mediated+redox+modulators+for+the+treatment+of+non-small+cell+lung+cancer&doi=10.1016%2Fj.ejmech.2017.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Zhang, Xiaojin; Bian, Jinlei; Li, Xiang; Wu, Xingsen; Dong, Yanan; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">616-629</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Based on the scaffold of 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione, a series of L-shaped derivs. with substituted side chains at the position of C2 were designed by analyzing the binding mode with NQO1.  The drug-like compd. I (named as DDO-7178) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by one-electron oxidoreductases CPR (NQO1/CPR = 20.8).  In addn., compd. 6q showed much improved physicochem. properties such as water soly. than the control β-lap.  The follow-up studies indicated that I showed a NQO1-expressing cancer-cell-selective killing property.  Preliminary mechanism studies on the anticancer effect indicated that I induced ROS prodn. in an NQO1 dependent manner and activated Akt/MAPK pathways in a ROS-dependent fashion, thereby inducing apoptosis.  In addn., emphasized compd. I showed more significant antitumor efficacy than β-lap without producing obvious toxic effects in vivo, which gave us a new tool for further investigation of NQO1-mediated redox modulators as anticancer drugs for the treatment of NQO1-overexpressed NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHJLGgGWnp6bVg90H21EOLACvtfcHk0lgLLmw2Q7kmwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L&md5=00c0fbd05ce4d28225430439dc820303</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203%252C7%252C8-trimethylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520specific%2520L-shaped%2520NQO1-mediated%2520redox%2520modulators%2520for%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D616%26epage%3D629%26doi%3D10.1016%2Fj.ejmech.2017.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref167"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref167'); return false;" data-citation="" class="refNumLink">167</a></strong><div class="NLM_citation" id="cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmcl.2015.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1244-1248&author=J.+Bianauthor=L.+Xuauthor=B.+Dengauthor=X.+Qianauthor=J.+Fanauthor=X.+Yangauthor=F.+Liuauthor=X.+Xuauthor=X.+Guoauthor=X.+Liauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Synthesis+and+evaluation+of+%28%C2%B1%29-dunnione+and+its+ortho-quinone+analogues+as+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29&doi=10.1016%2Fj.bmcl.2015.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%2528%25C2%25B1%2529-dunnione%2520and%2520its%2520ortho-quinone%2520analogues%2520as%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1244%26epage%3D1248%26doi%3D10.1016%2Fj.bmcl.2015.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref168"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref168'); return false;" data-citation="" class="refNumLink">168</a></strong><div class="NLM_citation" id="cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">Pseudonocardians A–C, new diazaanthraquinone derivatives from a deap-sea <i>Actinomycete Pseudonocardia</i> sp. SCSIO 01299</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1428</span>, <span class="refDoi"> DOI: 10.3390/md9081428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3390%2Fmd9081428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21892356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1entbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1428&author=S.+Liauthor=X.+Tianauthor=S.+Niuauthor=W.+Zhangauthor=Y.+Chenauthor=H.+Zhangauthor=X.+Yangauthor=W.+Zhangauthor=W.+Liauthor=S.+Zhangauthor=J.+Juauthor=C.+Zhang&title=Pseudonocardians+A%E2%80%93C%2C+new+diazaanthraquinone+derivatives+from+a+deap-sea+Actinomycete+Pseudonocardia+sp.+SCSIO+01299&doi=10.3390%2Fmd9081428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudonocardians A-C, new diazaanthraquinone derivatives from a deap-sea actinomycete Pseudonocardia sp. SCSIO 01299</span></div><div class="casAuthors">Li, Sumei; Tian, Xinpeng; Niu, Siwen; Zhang, Wenjun; Chen, Yuchan; Zhang, Haibo; Yang, Xianwen; Zhang, Weimin; Li, Wenjun; Zhang, Si; Ju, Jianhua; Zhang, Changsheng</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1428-1439</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">Pseudonocardians A-C (2-4), three new diazaanthraquinone derivs., along with a previously synthesized compd. deoxynyboquinone (1), were produced by the strain SCSIO 01299, a marine actinomycete member of the genus Pseudonocardia, isolated from deep-sea sediment of the South China Sea.  The structures of compds. 1-4 were detd. by mass spectrometry and NMR expts. (1H, 13C, HSQC, and HMBC).  The structure of compd. 1, which was obtained for the first time from a natural source, was confirmed by x-ray anal.  Compds. 1-3 exhibited potent cytotoxic activities against three tumor cell lines of SF-268, MCF-7 and NCI-H460 with IC50 values between 0.01 and 0.21 μm, and also showed antibacterial activities on Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 and Bacillus thuringensis SCSIO BT01, with MIC values of 1-4 μg mL-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp329iKHpyT17Vg90H21EOLACvtfcHk0lgLLmw2Q7kmwQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1entbvK&md5=a87100375aa99aca57a169e6b9369803</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3390%2Fmd9081428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd9081428%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DPseudonocardians%2520A%25E2%2580%2593C%252C%2520new%2520diazaanthraquinone%2520derivatives%2520from%2520a%2520deap-sea%2520Actinomycete%2520Pseudonocardia%2520sp.%2520SCSIO%252001299%26jtitle%3DMar.%2520Drugs%26date%3D2011%26volume%3D9%26spage%3D1428%26doi%3D10.3390%2Fmd9081428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref169"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref169'); return false;" data-citation="" class="refNumLink">169</a></strong><div class="NLM_citation" id="cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">3038</span>– <span class="NLM_lpage">3047</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-11-3135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=22532167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1yisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=3038-3047&author=X.+Huangauthor=Y.+Dongauthor=E.+A.+Beyauthor=J.+A.+Kilgoreauthor=J.+S.+Bairauthor=L.+S.+Liauthor=M.+Patelauthor=E.+I.+Parkinsonauthor=Y.+Wangauthor=N.+S.+Williamsauthor=J.+Gaoauthor=P.+J.+Hergenrotherauthor=D.+A.+Boothman&title=An+NQO1+substrate+with+potent+antitumor+activity+that+selectively+kills+by+PARP1-induced+programmed+necrosis&doi=10.1158%2F0008-5472.CAN-11-3135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis</span></div><div class="casAuthors">Huang, Xiumei; Dong, Ying; Bey, Erik A.; Kilgore, Jessica A.; Bair, Joseph S.; Li, Long-Shan; Patel, Malina; Parkinson, Elizabeth I.; Wang, Yiguang; Williams, Noelle S.; Gao, Jinming; Hergenrother, Paul J.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3038-3047</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Therapeutic programmed necrosis can be achieved in tumors using bioactive substrates of the cytosolic NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme that is overexpressed in most solid cancers and can create extensive tumor-selective ROS bursts, damaging tumor cell DNA and rapidly killing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu3BZY_1Ty4LVg90H21EOLACvtfcHk0lhpfmttODHRIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1yisr4%253D&md5=10b0c945c03f3af3cdc88df6dda639d9</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3135%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DAn%2520NQO1%2520substrate%2520with%2520potent%2520antitumor%2520activity%2520that%2520selectively%2520kills%2520by%2520PARP1-induced%2520programmed%2520necrosis%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D3038%26epage%3D3047%26doi%3D10.1158%2F0008-5472.CAN-11-3135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref170"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref170'); return false;" data-citation="" class="refNumLink">170</a></strong><div class="NLM_citation" id="cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wycislo, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosol, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirikolu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1007/s10637-016-0414-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1007%2Fs10637-016-0414-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27975234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2rsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=134-144&author=A.+P.+Lundbergauthor=J.+M.+Francisauthor=M.+Pajakauthor=E.+I.+Parkinsonauthor=K.+L.+Wycisloauthor=T.+J.+Rosolauthor=M.+E.+Brownauthor=C.+A.+Londonauthor=L.+Dirikoluauthor=P.+J.+Hergenrotherauthor=T.+M.+Fan&title=Pharmacokinetics+and+derivation+of+an+anticancer+dosing+regimen+for+the+novel+anti-cancer+agent+isobutyl-deoxynyboquinone+%28IB-DNQ%29%2C+a+NQO1+bioactivatable+molecule%2C+in+the+domestic+felid+species&doi=10.1007%2Fs10637-016-0414-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species</span></div><div class="casAuthors">Lundberg, Alycen P.; Francis, Joshua M.; Pajak, Malgorzata; Parkinson, Elizabeth I.; Wycislo, Kathryn L.; Rosol, Thomas J.; Brown, Megan E.; London, Cheryl A.; Dirikolu, Levent; Hergenrother, Paul J.; Fan, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Isobutyl-deoxynyboquinone (IB-DNQ) is a selective substrate for NAD(P)H:quinone oxidoreductase (NQO1), an enzyme overexpressed in many solid tumors.  Following activation by NQO1, IB-DNQ participates in a catalytic futile redn./reoxidn. cycle with consequent toxic reactive oxygen species generation within the tumor microenvironment.  To elucidate the potential of IB-DNQ to serve as a novel anticancer agent, in vitro studies coupled with in vivo pharmacokinetic and toxicol. investigations in the domestic felid species were conducted to investigate the tractability of IB-DNQ as a translationally applicable anticancer agent.  First, using feline oral squamous cell carcinoma (OSCC) as a comparative cancer model, expressions of NQO1 were characterized in not only human, but also feline OSCC tissue microarrays.  Second, IB-DNQ mediated cytotoxicity in three immortalized feline OSCC cell lines were studied under dose-dependent and sequential exposure conditions.  Third, the feasibility of administering IB-DNQ at doses predicted to achieve cytotoxic plasma concns. and biol. relevant durations of exposure were investigated through pharmacokinetic and tolerability studies in healthy research felines.  I.v. administration of IB-DNQ at 1.0-2.0 mg/kg achieved peak plasma concns. and durations of exposure reaching or exceeding predicted in vitro cytotoxic concns.  Clin. adverse side effects including ptyalism and tachypnea exhibited during and post-IV infusion of IB-DNQ were transient and tolerable.  Addnl., IB-DNQ administration did not produce acute or delayed-onset unacceptable hematol., non-hematol., or off-target oxidative toxicities.  Collectively, the findings reported here within provide important safety and pharmacokinetic data to support the continued development of IB-DNQ as a novel anticancer strategy for NQO1 expressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox4s6v1-rKrrVg90H21EOLACvtfcHk0lhpfmttODHRIA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2rsrrE&md5=fa005edff1699aa11cdff7d480239e06</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0414-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0414-z%26sid%3Dliteratum%253Aachs%26aulast%3DLundberg%26aufirst%3DA.%2BP.%26aulast%3DFrancis%26aufirst%3DJ.%2BM.%26aulast%3DPajak%26aufirst%3DM.%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DWycislo%26aufirst%3DK.%2BL.%26aulast%3DRosol%26aufirst%3DT.%2BJ.%26aulast%3DBrown%26aufirst%3DM.%2BE.%26aulast%3DLondon%26aufirst%3DC.%2BA.%26aulast%3DDirikolu%26aufirst%3DL.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26aulast%3DFan%26aufirst%3DT.%2BM.%26atitle%3DPharmacokinetics%2520and%2520derivation%2520of%2520an%2520anticancer%2520dosing%2520regimen%2520for%2520the%2520novel%2520anti-cancer%2520agent%2520isobutyl-deoxynyboquinone%2520%2528IB-DNQ%2529%252C%2520a%2520NQO1%2520bioactivatable%2520molecule%252C%2520in%2520the%2520domestic%2520felid%2520species%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2017%26volume%3D35%26spage%3D134%26epage%3D144%26doi%3D10.1007%2Fs10637-016-0414-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref171"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref171'); return false;" data-citation="" class="refNumLink">171</a></strong><div class="NLM_citation" id="cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimoto, S.</span></span> <span> </span><span class="NLM_article-title">Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1905</span>– <span class="NLM_lpage">1910</span>, <span class="refDoi"> DOI: 10.1039/b502813b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2Fb502813b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1905-1910&author=Z.+Zhangauthor=K.+Tanabeauthor=H.+Hattaauthor=S.+Nishimoto&title=Bioreduction+activated+prodrugs+of+camptothecin%3A+molecular+design%2C+synthesis%2C+activation+mechanism+and+hypoxia+selective+cytotoxicity&doi=10.1039%2Fb502813b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1039%2Fb502813b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb502813b%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DHatta%26aufirst%3DH.%26aulast%3DNishimoto%26aufirst%3DS.%26atitle%3DBioreduction%2520activated%2520prodrugs%2520of%2520camptothecin%253A%2520molecular%2520design%252C%2520synthesis%252C%2520activation%2520mechanism%2520and%2520hypoxia%2520selective%2520cytotoxicity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D1905%26epage%3D1910%26doi%3D10.1039%2Fb502813b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref172"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref172'); return false;" data-citation="" class="refNumLink">172</a></strong><div class="NLM_citation" id="cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2017.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28395199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVCrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2017&pages=310-321&author=S.+Xuauthor=H.+Yaoauthor=L.+Peiauthor=M.+Huauthor=D.+Liauthor=Y.+Qiuauthor=G.+Wangauthor=L.+Wuauthor=H.+Yaoauthor=Z.+Zhuauthor=J.+Xu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+NAD%28P%29H%3A+Quinone+oxidoreductase+%28NQO1%29-targeted+oridonin+prodrugs+possessing+indolequinone+moiety+for+hypoxia-selective+activation&doi=10.1016%2Fj.ejmech.2017.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation</span></div><div class="casAuthors">Xu, Shengtao; Yao, Hong; Pei, Lingling; Hu, Mei; Li, Dahong; Qiu, Yangyi; Wang, Guangyu; Wu, Liang; Yao, Hequan; Zhu, Zheying; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">310-321</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The enzyme NQO1 is a potential target for selective cancer therapy due to its overexpression in certain hypoxic tumors.  A series of prodrugs possessing a variety of cytotoxic diterpenoids (oridonin and its analogs) as the leaving groups activated by NQO1 were synthesized by functionalization of 3-(hydroxymethyl)indolequinone, which is a good substrate of NQO1.  The target compds. exhibited relatively higher antiproliferative activities against NQO1-rich human colon carcinoma cells (HT-29) and human lung carcinoma (A549) cells (IC50 = 0.263-2.904 μM), while NQO1-deficient lung adenosquamous carcinoma cells (H596) were less sensitive to these compds., among which, compd. I exhibited the most potent antiproliferative activity against both A549 and HT-29 cells, with IC50 values of 0.386 and 0.263 μM, resp.  Further HPLC and docking studies demonstrated that I is a good substrate of NQO1.  Moreover, the investigation of anticancer mechanism showed that the representative compd. I affected cell cycle and induced NQO1 dependent apoptosis through an oxidative stress triggered mitochondria-related pathway in A549 cells.  Besides, the antitumor activity of I was also verified in a liver cancer xenograft mouse model.  Biol. evaluation of these compds. concludes that there is a strong correlation between NQO1 enzyme and induction of cancer cell death.  Thus, this suggests that some of the target compds. activated by NQO1 are novel prodrug candidates potential for selective anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUnJI_Q_X6ErVg90H21EOLACvtfcHk0ljHDa6diV0eDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVCrurc%253D&md5=5436e872c6b9f388096a8c76488f9767</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520NAD%2528P%2529H%253A%2520Quinone%2520oxidoreductase%2520%2528NQO1%2529-targeted%2520oridonin%2520prodrugs%2520possessing%2520indolequinone%2520moiety%2520for%2520hypoxia-selective%2520activation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D132%26spage%3D310%26epage%3D321%26doi%3D10.1016%2Fj.ejmech.2017.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref173"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref173'); return false;" data-citation="" class="refNumLink">173</a></strong><div class="NLM_citation" id="cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrapani, H.</span></span> <span> </span><span class="NLM_article-title">INDQ/NO, a bioreductively activated nitric oxide prodrug</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2636</span>– <span class="NLM_lpage">2639</span>, <span class="refDoi"> DOI: 10.1021/ol400884v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol400884v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2636-2639&author=K.+Sharmaauthor=A.+Iyerauthor=K.+Senguptaauthor=H.+Chakrapani&title=INDQ%2FNO%2C+a+bioreductively+activated+nitric+oxide+prodrug&doi=10.1021%2Fol400884v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug</span></div><div class="casAuthors">Sharma, Kavita; Iyer, Aishwarya; Sengupta, Kundan; Chakrapani, Harinath</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2636-2639</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and development of INDQ/NO (I), a novel nitric oxide (NO) prodrug targeted by a bioreductive trigger, are described.  INDQ/NO, an indolequinone-diazeniumdiolate is found to be metabolized to produce NO by DT-diaphorase, a bioreductive enzyme that is overexpressed in certain cancers and hypoxic tumors.  Cell-based assays revealed that INDQ/NO induces DNA damage and is a potent inhibitor of cancer cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRYc6gjSC-QLVg90H21EOLACvtfcHk0ljHDa6diV0eDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D&md5=3ccdb7f8bc30a84663f69eacae91b506</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fol400884v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol400884v%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DSengupta%26aufirst%3DK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DINDQ%252FNO%252C%2520a%2520bioreductively%2520activated%2520nitric%2520oxide%2520prodrug%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D2636%26epage%3D2639%26doi%3D10.1021%2Fol400884v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref174"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref174'); return false;" data-citation="" class="refNumLink">174</a></strong><div class="NLM_citation" id="cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1384</span>– <span class="NLM_lpage">1387</span>, <span class="refDoi"> DOI: 10.1021/ol1002626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol1002626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1384-1387&author=B.+Huangauthor=A.+Desaiauthor=S.+Tangauthor=T.+P.+Thomasauthor=J.+R.+Baker&title=The+synthesis+of+a+c%28RGDyK%29+targeted+SN38+prodrug+with+an+indolequinone+structure+for+bioreductive+drug+release&doi=10.1021%2Fol1002626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release</span></div><div class="casAuthors">Huang, Baohua; Desai, Ankur; Tang, Shengzhuang; Thomas, Thommey P.; Baker, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1384-1387</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prepn. of a novel c(RGDyK) targeted SN38 prodrug incorporating an indolequinone structure for bioreductively triggered drug release is described.  This design yields a prodrug that targets surface mols. on tumor cells (αvβ3 integrins) and releases drug under bioreductive conditions.  There are three moieties in the prodrug design, namely a therapeutic drug SN38, an indolequinone structure serving as a drug releasing trigger, and an αvβ3 integrin targeting peptide c(RGDyK).  Preliminary studies showed that SN38 is released in the presence of a bioreductive enzyme (DT-diaphorase).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMclRawXbgtLVg90H21EOLACvtfcHk0ljHDa6diV0eDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D&md5=36b6b14c51b9834b7f656e3cc72fce2f</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fol1002626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1002626%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DDesai%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DT.%2BP.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520synthesis%2520of%2520a%2520c%2528RGDyK%2529%2520targeted%2520SN38%2520prodrug%2520with%2520an%2520indolequinone%2520structure%2520for%2520bioreductive%2520drug%2520release%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1384%26epage%3D1387%26doi%3D10.1021%2Fol1002626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref175"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref175'); return false;" data-citation="" class="refNumLink">175</a></strong><div class="NLM_citation" id="cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Shedding light by cancer redox-human NAD(P)H:quinone oxidoreductase 1 activation of a cloaked fluorescent dye</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">11264</span>– <span class="NLM_lpage">11266</span>, <span class="refDoi"> DOI: 10.1039/c1cc14578a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2Fc1cc14578a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21927746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=11264-11266&author=W.+C.+Silversauthor=A.+S.+Payneauthor=R.+L.+McCarley&title=Shedding+light+by+cancer+redox-human+NAD%28P%29H%3Aquinone+oxidoreductase+1+activation+of+a+cloaked+fluorescent+dye&doi=10.1039%2Fc1cc14578a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Shedding light by cancer redox-human NAD(P)H:quinone oxidoreductase 1 activation of a cloaked fluorescent dye</span></div><div class="casAuthors">Silvers, William C.; Payne, Alex S.; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">11264-11266</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new quinone propionic acid-cloaked rhodamine fluorophore has its fluorescence revealed (de-cloaked) upon activation by human NAD(P)H:quinone oxidoreductase 1 (hNQO1), an upregulated enzyme in cancer cells and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq6-HY833WMrVg90H21EOLACvtfcHk0ljHDa6diV0eDw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GhurrJ&md5=bb64f080bde80124965ac363cac197e6</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1039%2Fc1cc14578a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc14578a%26sid%3Dliteratum%253Aachs%26aulast%3DSilvers%26aufirst%3DW.%2BC.%26aulast%3DPayne%26aufirst%3DA.%2BS.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DShedding%2520light%2520by%2520cancer%2520redox-human%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520activation%2520of%2520a%2520cloaked%2520fluorescent%2520dye%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D11264%26epage%3D11266%26doi%3D10.1039%2Fc1cc14578a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref176"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref176'); return false;" data-citation="" class="refNumLink">176</a></strong><div class="NLM_citation" id="cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouillere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Environmentally robust rhodamine reporters for probe-based cellular detection of the cancer-linked oxidoreductase hNQO1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00792</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00792" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2ht7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=231-240&author=Q.+A.+Bestauthor=A.+E.+Johnsonauthor=B.+Prasaiauthor=A.+Rouillereauthor=R.+L.+McCarley&title=Environmentally+robust+rhodamine+reporters+for+probe-based+cellular+detection+of+the+cancer-linked+oxidoreductase+hNQO1&doi=10.1021%2Facschembio.5b00792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Environmentally Robust Rhodamine Reporters for Probe-based Cellular Detection of the Cancer-linked Oxidoreductase hNQO1</span></div><div class="casAuthors">Best, Quinn A.; Johnson, Amanda E.; Prasai, Bijeta; Rouillere, Alexandra; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">231-240</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We successfully synthesized a fluorescent probe capable of detecting the cancer-assocd. NAD(P)H:quinoneoxidoreductase isoenzyme-1 within human cells, based on results from an investigation of the stability of various rhodamines and seminaphthorhodamines toward the biol. reductant NADH, present at ∼100-200 μM within cells.  While rhodamines are generally known for their chem. stability, we observe that NADH causes significant and sometimes rapid modification of numerous rhodamine analogs, including those oftentimes used in imaging applications.  Results from mechanistic studies lead us to rule out a radical-based redn. pathway, suggesting rhodamine redn. by NADH proceeds by a hydride transfer process to yield the reduced leuco form of the rhodamine and oxidized NAD+.  A relationship between the structural features of the rhodamines and their reactivity with NADH is obsd.  Rhodamines with increased alkylation on the N3- and N6-nitrogens, as well as the xanthene core, react the least with NADH; whereas, nonalkylated variants or analogs with electron-withdrawing substituents have the fastest rates of reaction.  These outcomes allowed us to judiciously construct a seminaphthorhodamine-based, turn-on fluorescent probe that is capable of selectively detecting the cancer-assocd., NADH-dependent enzyme NAD(P)H:quinoneoxidoreductase isoenzyme-1 in human cancer cells, without the issue of NADH-induced deactivation of the seminaphthorhodamine reporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq4QwwW7xj2rVg90H21EOLACvtfcHk0libgQcwITc5PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2ht7%252FP&md5=a379a97804b59435d91a03fa72a3995c</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00792%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DQ.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%2BE.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DRouillere%26aufirst%3DA.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DEnvironmentally%2520robust%2520rhodamine%2520reporters%2520for%2520probe-based%2520cellular%2520detection%2520of%2520the%2520cancer-linked%2520oxidoreductase%2520hNQO1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D231%26epage%3D240%26doi%3D10.1021%2Facschembio.5b00792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref177"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref177'); return false;" data-citation="" class="refNumLink">177</a></strong><div class="NLM_citation" id="cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">oxidoreductase-facilitated visualization and detection of human cancer cells</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">6411</span>– <span class="NLM_lpage">6418</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.5b01615</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.5b01615" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFKktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=6411-6418&author=B.+Prasaiauthor=W.+C.+Silversauthor=R.+L.+McCarley&title=oxidoreductase-facilitated+visualization+and+detection+of+human+cancer+cells&doi=10.1021%2Facs.analchem.5b01615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidoreductase-Facilitated Visualization and Detection of Human Cancer Cells</span></div><div class="casAuthors">Prasai, Bijeta; Silvers, William C.; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6411-6418</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Achieving highly selective and sensitive detection/visualization of intracellular biol. events through the use of cell-penetrable, bioanalyte-activatable, turn-on probes is dependent on the presence of specific event-linked cellular biomarkers, if and only if there exist activatable probes that appropriately respond to the biomarker analyte.  Here is described the evaluation of, and use in cellular imaging studies, a previously undisclosed naphthalimide probe QMeNN (I), whose fluorescence is deactivated by photoinduced electron transfer (PeT) quenching that results from the presence of a covalently linked biomarker-specific quinone trigger group.  Highly selective and rapid activation of the quinone group by the human cancer tumor-linked NAD(P)H:quinone oxido-reductase isoenzyme 1 (hNQO1) results in fast trigger group removal to yield a highly fluorescent green-energy-range reporter that possesses a high molar absorptivity; there is a 136-fold increase in brightness for the enzymically produced reporter vs. probe precursor, a value 4 times greater than previously reported for the hNQO1 analyte.  The novel probe is taken up and activated rapidly within only hNQO1-pos. human cancer cells; addn. of an hNQO1 inhibitor prevents the selective activation of the probe.  Comparison of cytosolic fluorescence intensity in pos. cells vs. background in neg. cells yields a quant. metric (pos.-to-neg. ratio, PNR) for judging hNQO1 activity.  The authors show it is possible to det. hNQO1 presence in previously studied colorectal cancer cells and the unexplored ovarian cancer cell line NIH:OVCAR-3, with resp. PNR values of 926 and 34 being obtained.  Even with 10 min probe incubation, ready discrimination of pos. cells from neg. cells is achieved.  Cell viability is unaffected by probe presence, thereby highlighting the practicality of probe use in live-cell imaging applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVG_Acrf1QirVg90H21EOLACvtfcHk0libgQcwITc5PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFKktrc%253D&md5=46b3a988742b3060af0d20afc15468cb</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.5b01615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.5b01615%26sid%3Dliteratum%253Aachs%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DSilvers%26aufirst%3DW.%2BC.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3Doxidoreductase-facilitated%2520visualization%2520and%2520detection%2520of%2520human%2520cancer%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2015%26volume%3D87%26spage%3D6411%26epage%3D6418%26doi%3D10.1021%2Facs.analchem.5b01615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref178"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref178'); return false;" data-citation="" class="refNumLink">178</a></strong><div class="NLM_citation" id="cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span> <span> </span><span class="NLM_article-title">Rational construction of probes rendering ratiometric response to the cancer-specific enzyme NQO1</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2016.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.dyepig.2016.09.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=846-851&author=Q.+Feiauthor=L.+Zhouauthor=F.+Wangauthor=B.+Shiauthor=C.+Liauthor=R.+Wangauthor=C.+Zhao&title=Rational+construction+of+probes+rendering+ratiometric+response+to+the+cancer-specific+enzyme+NQO1&doi=10.1016%2Fj.dyepig.2016.09.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Rational construction of probes rendering ratiometric response to the cancer-specific enzyme NQO1</span></div><div class="casAuthors">Fei, Qiang; Zhou, Li; Wang, Feiyi; Shi, Ben; Li, Chunbao; Wang, Rui; Zhao, Chunchang</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">846-851</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pursuit of fluorescent probes for identification of cancer biomarkers benefits reliable predictions of early cancer detection.  Here, a strategy employing polymeric micelle assembly for encapsulation of a new enzyme (NQO1)-responsive small mol. (I) was established for facile access to nanoprobes with favorable features in bioimaging, such as good aq. soly., enhanced photo-stability and biocompatibility.  In the presence of the enzyme NQO1, these nanoprobes underwent ratiometric fluorescence changes from yellow-green fluorescence signals to red fluorescence signals.  By exploiting this favorable ratiometric response to NQO1, the authors explored these nanoprobes for evaluation of enzyme activity in living cells, which showed distinct differentiation between NQO1-pos. cancer cells and NQO1-neg. cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtuYXC9_Rx1rVg90H21EOLACvtfcHk0libgQcwITc5PQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsrfI&md5=eeff081729c16c23bccf7008e374914b</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2016.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2016.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DRational%2520construction%2520of%2520probes%2520rendering%2520ratiometric%2520response%2520to%2520the%2520cancer-specific%2520enzyme%2520NQO1%26jtitle%3DDyes%2520Pigm.%26date%3D2017%26volume%3D136%26spage%3D846%26epage%3D851%26doi%3D10.1016%2Fj.dyepig.2016.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref179"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref179'); return false;" data-citation="" class="refNumLink">179</a></strong><div class="NLM_citation" id="cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span> <span> </span><span class="NLM_article-title">A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">9567</span>– <span class="NLM_lpage">9570</span>, <span class="refDoi"> DOI: 10.1039/C5CC02149A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2FC5CC02149A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25971544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=9567-9570&author=P.+Liuauthor=J.+Xuauthor=D.+Yanauthor=P.+Zhangauthor=F.+Zengauthor=B.+Liauthor=S.+Wu&title=A+DT-diaphorase+responsive+theranostic+prodrug+for+diagnosis%2C+drug+release+monitoring+and+therapy&doi=10.1039%2FC5CC02149A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy</span></div><div class="casAuthors">Liu, Peilian; Xu, Jiangsheng; Yan, Donghang; Zhang, Peisheng; Zeng, Fang; Li, Bowen; Wu, Shuizhu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">9567-9570</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A DT-diaphorase-activatable theranostic prodrug, which contains camptothecin, a self-immolative linker and a trigger group, has been developed for the detection of DT-diaphorase, tracking of drug release and selectively killing cancer cells over-expressed with DT-diaphorase.  This strategy may offer a new approach for the development of enzyme-catalyzed theranostic anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbbvOBaYSmELVg90H21EOLACvtfcHk0lhK9bzSQ5-n2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOms7k%253D&md5=d8d35e29b2ade23dfb15dd972a31afd2</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1039%2FC5CC02149A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC02149A%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DS.%26atitle%3DA%2520DT-diaphorase%2520responsive%2520theranostic%2520prodrug%2520for%2520diagnosis%252C%2520drug%2520release%2520monitoring%2520and%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D9567%26epage%3D9570%26doi%3D10.1039%2FC5CC02149A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref180"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref180'); return false;" data-citation="" class="refNumLink">180</a></strong><div class="NLM_citation" id="cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verwilst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Cancer targeted enzymatic theranostic prodrug: precise diagnosis and chemotherapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1419</span>– <span class="NLM_lpage">1426</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.6b00184</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00184" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFKrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1419-1426&author=W.+S.+Shinauthor=J.+Hanauthor=P.+Verwilstauthor=R.+Kumarauthor=J.+H.+Kimauthor=J.+S.+Kim&title=Cancer+targeted+enzymatic+theranostic+prodrug%3A+precise+diagnosis+and+chemotherapy&doi=10.1021%2Facs.bioconjchem.6b00184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy</span></div><div class="casAuthors">Shin, Weon Sup; Han, Jiyou; Verwilst, Peter; Kumar, Rajesh; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1419-1426</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of targeted and effective theranostic (therapeutic and diagnostic) chemotherapeutic agents is highly desirable for precise diagnosis and treatment of cancer.  To realize this goal, the authors developed a cancer-targeting and enzyme-triggered theranostic prodrug (I), contg. 7-ethyl-10-hydroxycamptothecin (SN-38), a well-known anticancer drug, which inhibits topoisomerase I in the cell nucleus; hydroquinone as an enzyme-triggered moiety; and biotin as a cancer targeting unit.  Enzyme-triggered theranostic prodrug (I) selectively targets cancer cells and is subsequently activated in the presence of NAD(P)H: quinone oxidoreductase-1 (NQO1), a cytosolic flavoprotein that catalyzes the two-electron redn. of quinone moieties with the concomitant consumption of NADH or NADPH as electron donors.  High levels of NQO1 were found in a variety of cancer cell lines compared to healthy cells, and therefore, it is an excellent target for the development of cancer targeted drug delivery systems.  Upon preferential cancer cell delivery and uptake, aided by biotin, the enzyme-triggered theranostic prodrug (I) is cleaved by NQO1, with the subsequent release of SN-38, inhibiting topoisomerase I, leading to apoptosis.  The drug release and induced apoptosis of cancer cells expressing both biotin receptors and high levels of NQO1 was simultaneously monitored via the innate fluorescence of the released SN-38 by confocal microscopy.  In vitro and in vivo studies showed an effective inhibition of cancer growth by the enzyme-triggered theranostic prodrug (I).  Thus, this type of enzyme-triggered targeted prodrug therapy is an interesting and promising approach for future cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5BTe_hqwZ8rVg90H21EOLACvtfcHk0lhK9bzSQ5-n2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFKrtbk%253D&md5=3edbe0fe166e198a7e31da85d2e9b19d</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00184%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DW.%2BS.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DVerwilst%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DCancer%2520targeted%2520enzymatic%2520theranostic%2520prodrug%253A%2520precise%2520diagnosis%2520and%2520chemotherapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26spage%3D1419%26epage%3D1426%26doi%3D10.1021%2Facs.bioconjchem.6b00184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1'],'ref2':['cit2'],'ref3':['cit3'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21'],'ref22':['cit22'],'ref23':['cit23'],'ref24':['cit24'],'ref25':['cit25'],'ref26':['cit26'],'ref27':['cit27'],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33'],'ref34':['cit34'],'ref35':['cit35'],'ref36':['cit36'],'ref37':['cit37'],'ref38':['cit38'],'ref39':['cit39'],'ref40':['cit40'],'ref41':['cit41'],'ref42':['cit42'],'ref43':['cit43'],'ref44':['cit44'],'ref45':['cit45'],'ref46':['cit46'],'ref47':['cit47'],'ref48':['cit48'],'ref49':['cit49'],'ref50':['cit50'],'ref51':['cit51'],'ref52':['cit52'],'ref53':['cit53'],'ref54':['cit54'],'ref55':['cit55'],'ref56':['cit56'],'ref57':['cit57'],'ref58':['cit58'],'ref59':['cit59'],'ref60':['cit60'],'ref61':['cit61'],'ref62':['cit62'],'ref63':['cit63'],'ref64':['cit64'],'ref65':['cit65'],'ref66':['cit66'],'ref67':['cit67'],'ref68':['cit68'],'ref69':['cit69'],'ref70':['cit70'],'ref71':['cit71'],'ref72':['cit72'],'ref73':['cit73'],'ref74':['cit74'],'ref75':['cit75'],'ref76':['cit76'],'ref77':['cit77'],'ref78':['cit78'],'ref79':['cit79'],'ref80':['cit80'],'ref81':['cit81'],'ref82':['cit82'],'ref83':['cit83'],'ref84':['cit84'],'ref85':['cit85'],'ref86':['cit86'],'ref87':['cit87'],'ref88':['cit88'],'ref89':['cit89'],'ref90':['cit90'],'ref91':['cit91'],'ref92':['cit92'],'ref93':['cit93'],'ref94':['cit94'],'ref95':['cit95'],'ref96':['cit96'],'ref97':['cit97'],'ref98':['cit98'],'ref99':['cit99'],'ref100':['cit100'],'ref101':['cit101'],'ref102':['cit102'],'ref103':['cit103'],'ref104':['cit104'],'ref105':['cit105'],'ref106':['cit106'],'ref107':['cit107'],'ref108':['cit108'],'ref109':['cit109'],'ref110':['cit110'],'ref111':['cit111'],'ref112':['cit112'],'ref113':['cit113'],'ref114':['cit114'],'ref115':['cit115'],'ref116':['cit116'],'ref117':['cit117'],'ref118':['cit118'],'ref119':['cit119'],'ref120':['cit120'],'ref121':['cit121'],'ref122':['cit122'],'ref123':['cit123'],'ref124':['cit124'],'ref125':['cit125'],'ref126':['cit126'],'ref127':['cit127'],'ref128':['cit128'],'ref129':['cit129'],'ref130':['cit130'],'ref131':['cit131'],'ref132':['cit132'],'ref133':['cit133'],'ref134':['cit134'],'ref135':['cit135'],'ref136':['cit136'],'ref137':['cit137'],'ref138':['cit138'],'ref139':['cit139'],'ref140':['cit140'],'ref141':['cit141'],'ref142':['cit142'],'ref143':['cit143'],'ref144':['cit144'],'ref145':['cit145'],'ref146':['cit146'],'ref147':['cit147'],'ref148':['cit148'],'ref149':['cit149'],'ref150':['cit150'],'ref151':['cit151'],'ref152':['cit152'],'ref153':['cit153'],'ref154':['cit154'],'ref155':['cit155'],'ref156':['cit156'],'ref157':['cit157'],'ref158':['cit158'],'ref159':['cit159'],'ref160':['cit160'],'ref161':['cit161'],'ref162':['cit162'],'ref163':['cit163'],'ref164':['cit164'],'ref165':['cit165'],'ref166':['cit166'],'ref167':['cit167'],'ref168':['cit168'],'ref169':['cit169'],'ref170':['cit170'],'ref171':['cit171'],'ref172':['cit172'],'ref173':['cit173'],'ref174':['cit174'],'ref175':['cit175'],'ref176':['cit176'],'ref177':['cit177'],'ref178':['cit178'],'ref179':['cit179'],'ref180':['cit180']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 54 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Zengrui Wu, Qiaohui Wang, Hongbin Yang, Jiye Wang, Weihua Li, Guixia Liu, Yi Yang, Yuzheng Zhao, <span class="NLM_string-name hlFld-ContribAuthor">Yun Tang</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Natural Products Targeting NQO1 via an Approach Combining Network-Based Inference and Identification of Privileged Substructures. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (5)
                                     , 2486-2498. <a href="https://doi.org/10.1021/acs.jcim.1c00260" title="DOI URL">https://doi.org/10.1021/acs.jcim.1c00260</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.1c00260&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.1c00260%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BNatural%252BProducts%252BTargeting%252BNQO1%252Bvia%252Ban%252BApproach%252BCombining%252BNetwork-Based%252BInference%252Band%252BIdentification%252Bof%252BPrivileged%252BSubstructures%26aulast%3DWu%26aufirst%3DZengrui%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D04032021%26date%3D06052021%26volume%3D61%26issue%3D5%26spage%3D2486%26epage%3D2498" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Yong-Peng Yang, Fu-Jian Qi, Yi-Ping Qian, Xia-Zhen Bao, Han-Chen Zhang, Bin Ma, Fang Dai, Sheng-Xiang Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Bo Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Developing Push–Pull Hydroxylphenylpolyenylpyridinium Chromophores as Ratiometric Two-Photon Fluorescent Probes for Cellular and Intravital Imaging of Mitochondrial NQO1. </span><span class="cited-content_cbyCitation_journal-name">Analytical Chemistry</span><span> <strong>2021,</strong> <em>93 </em>
                                    (4)
                                     , 2385-2393. <a href="https://doi.org/10.1021/acs.analchem.0c04279" title="DOI URL">https://doi.org/10.1021/acs.analchem.0c04279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.analchem.0c04279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.analchem.0c04279%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytical%2520Chemistry%26atitle%3DDeveloping%252BPush%2525E2%252580%252593Pull%252BHydroxylphenylpolyenylpyridinium%252BChromophores%252Bas%252BRatiometric%252BTwo-Photon%252BFluorescent%252BProbes%252Bfor%252BCellular%252Band%252BIntravital%252BImaging%252Bof%252BMitochondrial%252BNQO1%26aulast%3DYang%26aufirst%3DYong-Peng%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D11102020%26date%3D04012021%26date%3D13012021%26volume%3D93%26issue%3D4%26spage%3D2385%26epage%3D2393" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Darren Conboy, Styliana I. Mirallai, Austin Craig, Patrick McArdle, Ali A. Al-Kinani, Stephen Barton, <span class="NLM_string-name hlFld-ContribAuthor">Fawaz Aldabbagh</span>. </span><span class="cited-content_cbyCitation_article-title">Incorporating Morpholine and Oxetane into Benzimidazolequinone Antitumor Agents: The Discovery of 1,4,6,9-Tetramethoxyphenazine from Hydrogen Peroxide and Hydroiodic Acid-Mediated Oxidative Cyclizations. </span><span class="cited-content_cbyCitation_journal-name">The Journal of Organic Chemistry</span><span> <strong>2019,</strong> <em>84 </em>
                                    (15)
                                     , 9811-9818. <a href="https://doi.org/10.1021/acs.joc.9b01427" title="DOI URL">https://doi.org/10.1021/acs.joc.9b01427</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.joc.9b01427&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.joc.9b01427%26sid%3Dliteratum%253Aachs%26jtitle%3DThe%2520Journal%2520of%2520Organic%2520Chemistry%26atitle%3DIncorporating%252BMorpholine%252Band%252BOxetane%252Binto%252BBenzimidazolequinone%252BAntitumor%252BAgents%25253A%252BThe%252BDiscovery%252Bof%252B1%25252C4%25252C6%25252C9-Tetramethoxyphenazine%252Bfrom%252BHydrogen%252BPeroxide%252Band%252BHydroiodic%252BAcid-Mediated%252BOxidative%252BCyclizations%26aulast%3DConboy%26aufirst%3DDarren%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D30052019%26date%3D24072019%26date%3D11072019%26volume%3D84%26issue%3D15%26spage%3D9811%26epage%3D9818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kaiyuan Wang, Bin Yang, Hao Ye, Xuanbo Zhang, Hang Song, Xia Wang, Na Li, Lin Wei, Yu Wang, Haotian Zhang, Qiming Kan, Zhonggui He, Dun Wang, <span class="NLM_string-name hlFld-ContribAuthor">Jin Sun</span>. </span><span class="cited-content_cbyCitation_article-title">Self-Strengthened Oxidation-Responsive Bioactivating Prodrug Nanosystem with Sequential and Synergistically Facilitated Drug Release for Treatment of Breast Cancer. </span><span class="cited-content_cbyCitation_journal-name">ACS Applied Materials & Interfaces</span><span> <strong>2019,</strong> <em>11 </em>
                                    (21)
                                     , 18914-18922. <a href="https://doi.org/10.1021/acsami.9b03056" title="DOI URL">https://doi.org/10.1021/acsami.9b03056</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsami.9b03056&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsami.9b03056%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Applied%2520Materials%2520%2526%2520Interfaces%26atitle%3DSelf-Strengthened%252BOxidation-Responsive%252BBioactivating%252BProdrug%252BNanosystem%252Bwith%252BSequential%252Band%252BSynergistically%252BFacilitated%252BDrug%252BRelease%252Bfor%252BTreatment%252Bof%252BBreast%252BCancer%26aulast%3DWang%26aufirst%3DKaiyuan%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D18022019%26date%3D06052019%26date%3D15052019%26date%3D06052019%26volume%3D11%26issue%3D21%26spage%3D18914%26epage%3D18922" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li  Zhang</span>, <span class="hlFld-ContribAuthor ">Guiying  Zhang</span>, <span class="hlFld-ContribAuthor ">Shujing  Xu</span>, <span class="hlFld-ContribAuthor ">Yuning  Song</span>. </span><span class="cited-content_cbyCitation_article-title">Recent advances of quinones as a privileged structure in drug discovery. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>223 </em>, 113632. <a href="https://doi.org/10.1016/j.ejmech.2021.113632" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113632</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113632&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113632%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRecent%252Badvances%252Bof%252Bquinones%252Bas%252Ba%252Bprivileged%252Bstructure%252Bin%252Bdrug%252Bdiscovery%26aulast%3DZhang%26aufirst%3DLi%26date%3D2021%26volume%3D223%26spage%3D113632" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jagpreet Singh  Sidhu</span>, <span class="hlFld-ContribAuthor ">Navneet  Kaur</span>, <span class="hlFld-ContribAuthor ">Narinder  Singh</span>. </span><span class="cited-content_cbyCitation_article-title">Trends in small organic fluorescent scaffolds for detection of oxidoreductase. </span><span class="cited-content_cbyCitation_journal-name">Biosensors and Bioelectronics</span><span> <strong>2021,</strong> <em>191 </em>, 113441. <a href="https://doi.org/10.1016/j.bios.2021.113441" title="DOI URL">https://doi.org/10.1016/j.bios.2021.113441</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bios.2021.113441&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bios.2021.113441%26sid%3Dliteratum%253Aachs%26jtitle%3DBiosensors%2520and%2520Bioelectronics%26atitle%3DTrends%252Bin%252Bsmall%252Borganic%252Bfluorescent%252Bscaffolds%252Bfor%252Bdetection%252Bof%252Boxidoreductase%26aulast%3DSidhu%26aufirst%3DJagpreet%2BSingh%26date%3D2021%26volume%3D191%26spage%3D113441" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qijie  Gong</span>, <span class="hlFld-ContribAuthor ">Fulai  Yang</span>, <span class="hlFld-ContribAuthor ">Jiabao  Hu</span>, <span class="hlFld-ContribAuthor ">Tian  Li</span>, <span class="hlFld-ContribAuthor ">Pengfei  Wang</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Rational designed highly sensitive NQO1-activated near-infrared fluorescent probe combined with NQO1 substrates in vivo: An innovative strategy for NQO1-overexpressing cancer theranostics. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>224 </em>, 113707. <a href="https://doi.org/10.1016/j.ejmech.2021.113707" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113707</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113707%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DRational%252Bdesigned%252Bhighly%252Bsensitive%252BNQO1-activated%252Bnear-infrared%252Bfluorescent%252Bprobe%252Bcombined%252Bwith%252BNQO1%252Bsubstrates%252Bin%2525C2%2525A0vivo%25253A%252BAn%252Binnovative%252Bstrategy%252Bfor%252BNQO1-overexpressing%252Bcancer%252Btheranostics%26aulast%3DGong%26aufirst%3DQijie%26date%3D2021%26volume%3D224%26spage%3D113707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Qijie  Gong</span>, <span class="hlFld-ContribAuthor ">Quanwei  Yu</span>, <span class="hlFld-ContribAuthor ">Nan  Wang</span>, <span class="hlFld-ContribAuthor ">Jiabao  Hu</span>, <span class="hlFld-ContribAuthor ">Pengfei  Wang</span>, <span class="hlFld-ContribAuthor ">Fulai  Yang</span>, <span class="hlFld-ContribAuthor ">Tian  Li</span>, <span class="hlFld-ContribAuthor ">Qidong  You</span>, <span class="hlFld-ContribAuthor ">Xiang  Li</span>, <span class="hlFld-ContribAuthor ">Xiaojin  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Application of cation-π interactions in enzyme-substrate binding: Design, synthesis, biological evaluation, and molecular dynamics insights of novel hydrophilic substrates for NQO1. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>221 </em>, 113515. <a href="https://doi.org/10.1016/j.ejmech.2021.113515" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113515</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113515&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113515%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252Bcation-%2525CF%252580%252Binteractions%252Bin%252Benzyme-substrate%252Bbinding%25253A%252BDesign%25252C%252Bsynthesis%25252C%252Bbiological%252Bevaluation%25252C%252Band%252Bmolecular%252Bdynamics%252Binsights%252Bof%252Bnovel%252Bhydrophilic%252Bsubstrates%252Bfor%252BNQO1%26aulast%3DGong%26aufirst%3DQijie%26date%3D2021%26volume%3D221%26spage%3D113515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jie  Yu</span>, <span class="hlFld-ContribAuthor ">Bingling  Zhong</span>, <span class="hlFld-ContribAuthor ">Lin  Zhao</span>, <span class="hlFld-ContribAuthor ">Ying  Hou</span>, <span class="hlFld-ContribAuthor ">Xianzhe  Wang</span>, <span class="hlFld-ContribAuthor ">Xiuping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Receptor-interacting serine/threonine-protein kinase 1 (RIPK1) inhibitors Necrostatin-1 (Nec-1) and 7-Cl-O-Nec-1 (Nec-1s) are potent inhibitors of NAD(P)H: Quinone oxidoreductase 1 (NQO1). </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2021,</strong> <em>173 </em>, 64-69. <a href="https://doi.org/10.1016/j.freeradbiomed.2021.07.017" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2021.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2021.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2021.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DReceptor-interacting%252Bserine%25252Fthreonine-protein%252Bkinase%252B1%252B%252528RIPK1%252529%252Binhibitors%252BNecrostatin-1%252B%252528Nec-1%252529%252Band%252B7-Cl-O-Nec-1%252B%252528Nec-1s%252529%252Bare%252Bpotent%252Binhibitors%252Bof%252BNAD%252528P%252529H%25253A%252BQuinone%252Boxidoreductase%252B1%252B%252528NQO1%252529%26aulast%3DYu%26aufirst%3DJie%26date%3D2021%26volume%3D173%26spage%3D64%26epage%3D69" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Xin  Ma</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 3-(1-benzotriazole)-nor-β-lapachones as NQO1-directed antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2021,</strong> <em>113 </em>, 104995. <a href="https://doi.org/10.1016/j.bioorg.2021.104995" title="DOI URL">https://doi.org/10.1016/j.bioorg.2021.104995</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2021.104995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2021.104995%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B3-%2525281-benzotriazole%252529-nor-%2525CE%2525B2-lapachones%252Bas%252BNQO1-directed%252Bantitumor%252Bagents%26aulast%3DWu%26aufirst%3DLi-Qiang%26date%3D2021%26volume%3D113%26spage%3D104995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alycen P.  Lundberg</span>, <span class="hlFld-ContribAuthor ">Matthew W.  Boudreau</span>, <span class="hlFld-ContribAuthor ">Kim A.  Selting</span>, <span class="hlFld-ContribAuthor ">Lindsay E.  Chatkewitz</span>, <span class="hlFld-ContribAuthor ">Jonathan  Samuelson</span>, <span class="hlFld-ContribAuthor ">Joshua M.  Francis</span>, <span class="hlFld-ContribAuthor ">Elizabeth I.  Parkinson</span>, <span class="hlFld-ContribAuthor ">Anne M.  Barger</span>, <span class="hlFld-ContribAuthor ">Paul J.  Hergenrother</span>, <span class="hlFld-ContribAuthor ">Timothy M.  Fan</span>. </span><span class="cited-content_cbyCitation_article-title">Utilizing feline oral squamous cell carcinoma patients to develop NQO1-targeted therapy. </span><span class="cited-content_cbyCitation_journal-name">Neoplasia</span><span> <strong>2021,</strong> <em>23 </em>
                                    (8)
                                     , 811-822. <a href="https://doi.org/10.1016/j.neo.2021.06.008" title="DOI URL">https://doi.org/10.1016/j.neo.2021.06.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.neo.2021.06.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.neo.2021.06.008%26sid%3Dliteratum%253Aachs%26jtitle%3DNeoplasia%26atitle%3DUtilizing%252Bfeline%252Boral%252Bsquamous%252Bcell%252Bcarcinoma%252Bpatients%252Bto%252Bdevelop%252BNQO1-targeted%252Btherapy%26aulast%3DLundberg%26aufirst%3DAlycen%2BP.%26date%3D2021%26volume%3D23%26issue%3D8%26spage%3D811%26epage%3D822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jakub  Modranka</span>, <span class="hlFld-ContribAuthor ">Joanna  Drogosz-Stachowicz</span>, <span class="hlFld-ContribAuthor ">Anna  Pietrzak</span>, <span class="hlFld-ContribAuthor ">Anna  Janecka</span>, <span class="hlFld-ContribAuthor ">Tomasz  Janecki</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and structure–activity relationship study of novel 3-diethoxyphosphorylfuroquinoline-4,9-diones with potent antitumor efficacy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>219 </em>, 113429. <a href="https://doi.org/10.1016/j.ejmech.2021.113429" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113429</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113429&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113429%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bstructure%2525E2%252580%252593activity%252Brelationship%252Bstudy%252Bof%252Bnovel%252B3-diethoxyphosphorylfuroquinoline-4%25252C9-diones%252Bwith%252Bpotent%252Bantitumor%252Befficacy%26aulast%3DModranka%26aufirst%3DJakub%26date%3D2021%26volume%3D219%26spage%3D113429" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Harleen Kaur  Walia</span>, <span class="hlFld-ContribAuthor ">Navneet  Singh</span>, <span class="hlFld-ContribAuthor ">Siddharth  Sharma</span>. </span><span class="cited-content_cbyCitation_article-title">Association of
              NQO1Pro187Ser
              polymorphism with clinical outcomes and survival of lung cancer patients treated with platinum chemotherapy. </span><span class="cited-content_cbyCitation_journal-name">Personalized Medicine</span><span> <strong>2021,</strong> <em>18 </em>
                                    (4)
                                     , 333-346. <a href="https://doi.org/10.2217/pme-2020-0119" title="DOI URL">https://doi.org/10.2217/pme-2020-0119</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.2217/pme-2020-0119&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.2217%2Fpme-2020-0119%26sid%3Dliteratum%253Aachs%26jtitle%3DPersonalized%2520Medicine%26atitle%3DAssociation%252Bof%252BNQO1Pro187Ser%252Bpolymorphism%252Bwith%252Bclinical%252Boutcomes%252Band%252Bsurvival%252Bof%252Blung%252Bcancer%252Bpatients%252Btreated%252Bwith%252Bplatinum%252Bchemotherapy%26aulast%3DWalia%26aufirst%3DHarleen%2BKaur%26date%3D2021%26volume%3D18%26issue%3D4%26spage%3D333%26epage%3D346" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hong  Yu</span>, <span class="hlFld-ContribAuthor ">Hong-ying  Gao</span>, <span class="hlFld-ContribAuthor ">Hua  Guo</span>, <span class="hlFld-ContribAuthor ">Gui-zhen  Wang</span>, <span class="hlFld-ContribAuthor ">Yi-qing  Yang</span>, <span class="hlFld-ContribAuthor ">Qian  Hu</span>, <span class="hlFld-ContribAuthor ">Li-jun  Liang</span>, <span class="hlFld-ContribAuthor ">Qun  Zhao</span>, <span class="hlFld-ContribAuthor ">Da-wei  Xie</span>, <span class="hlFld-ContribAuthor ">Yu  Rao</span>, <span class="hlFld-ContribAuthor ">Guang-biao  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">Upregulation of wild-type p53 by small molecule-induced elevation of NQO1 in non-small cell lung cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmacologica Sinica</span><span> <strong>2021,</strong> <em>71 </em><a href="https://doi.org/10.1038/s41401-021-00691-8" title="DOI URL">https://doi.org/10.1038/s41401-021-00691-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/s41401-021-00691-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fs41401-021-00691-8%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmacologica%2520Sinica%26atitle%3DUpregulation%252Bof%252Bwild-type%252Bp53%252Bby%252Bsmall%252Bmolecule-induced%252Belevation%252Bof%252BNQO1%252Bin%252Bnon-small%252Bcell%252Blung%252Bcancer%252Bcells%26aulast%3DYu%26aufirst%3DHong%26date%3D2021%26date%3D2021%26volume%3D71" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Monivan  Chhour</span>, <span class="hlFld-ContribAuthor ">Pierre  Perio</span>, <span class="hlFld-ContribAuthor ">Regis  Gayon</span>, <span class="hlFld-ContribAuthor ">Hélène  Ternet-Fontebasso</span>, <span class="hlFld-ContribAuthor ">Gilles  Ferry</span>, <span class="hlFld-ContribAuthor ">Françoise  Nepveu</span>, <span class="hlFld-ContribAuthor ">Jean A.  Boutin</span>, <span class="hlFld-ContribAuthor ">Jan  Sudor</span>, <span class="hlFld-ContribAuthor ">Karine  Reybier</span>. </span><span class="cited-content_cbyCitation_article-title">Association of NQO2 With UDP-Glucuronosyltransferases Reduces Menadione Toxicity in Neuroblastoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2021,</strong> <em>12 </em><a href="https://doi.org/10.3389/fphar.2021.660641" title="DOI URL">https://doi.org/10.3389/fphar.2021.660641</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2021.660641&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2021.660641%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DAssociation%252Bof%252BNQO2%252BWith%252BUDP-Glucuronosyltransferases%252BReduces%252BMenadione%252BToxicity%252Bin%252BNeuroblastoma%252BCells%26aulast%3DChhour%26aufirst%3DMonivan%26date%3D2021%26date%3D2021%26volume%3D12" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yingchao  Chen</span>, <span class="hlFld-ContribAuthor ">Xueze  Zhao</span>, <span class="hlFld-ContribAuthor ">Tao  Xiong</span>, <span class="hlFld-ContribAuthor ">Jianjun  Du</span>, <span class="hlFld-ContribAuthor ">Wen  Sun</span>, <span class="hlFld-ContribAuthor ">Jiangli  Fan</span>, <span class="hlFld-ContribAuthor ">Xiaojun  Peng</span>. </span><span class="cited-content_cbyCitation_article-title">NIR photosensitizers activated by γ-glutamyl transpeptidase for precise tumor fluorescence imaging and photodynamic therapy. </span><span class="cited-content_cbyCitation_journal-name">Science China Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (5)
                                     , 808-816. <a href="https://doi.org/10.1007/s11426-020-9947-4" title="DOI URL">https://doi.org/10.1007/s11426-020-9947-4</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s11426-020-9947-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs11426-020-9947-4%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520China%2520Chemistry%26atitle%3DNIR%252Bphotosensitizers%252Bactivated%252Bby%252B%2525CE%2525B3-glutamyl%252Btranspeptidase%252Bfor%252Bprecise%252Btumor%252Bfluorescence%252Bimaging%252Band%252Bphotodynamic%252Btherapy%26aulast%3DChen%26aufirst%3DYingchao%26date%3D2021%26date%3D2021%26volume%3D64%26issue%3D5%26spage%3D808%26epage%3D816" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Martin  Sweeney</span>, <span class="hlFld-ContribAuthor ">Darren  Conboy</span>, <span class="hlFld-ContribAuthor ">Styliana I.  Mirallai</span>, <span class="hlFld-ContribAuthor ">Fawaz  Aldabbagh</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in the Synthesis of Ring-Fused Benzimidazoles and Imidazobenzimidazoles. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2021,</strong> <em>26 </em>
                                    (9)
                                     , 2684. <a href="https://doi.org/10.3390/molecules26092684" title="DOI URL">https://doi.org/10.3390/molecules26092684</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules26092684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules26092684%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DAdvances%252Bin%252Bthe%252BSynthesis%252Bof%252BRing-Fused%252BBenzimidazoles%252Band%252BImidazobenzimidazoles%26aulast%3DSweeney%26aufirst%3DMartin%26date%3D2021%26date%3D2021%26volume%3D26%26issue%3D9%26spage%3D2684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Fuli  Xin</span>, <span class="hlFld-ContribAuthor ">Ming  Wu</span>, <span class="hlFld-ContribAuthor ">Zhixiong  Cai</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zuwu  Wei</span>, <span class="hlFld-ContribAuthor ">Xiaolong  Liu</span>, <span class="hlFld-ContribAuthor ">Jingfeng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Tumor Microenvironment Triggered Cascade‐Activation Nanoplatform for Synergistic and Precise Treatment of Hepatocellular Carcinoma. </span><span class="cited-content_cbyCitation_journal-name">Advanced Healthcare Materials</span><span> <strong>2021,</strong> <em>10 </em>
                                    (10)
                                     , 2002036. <a href="https://doi.org/10.1002/adhm.202002036" title="DOI URL">https://doi.org/10.1002/adhm.202002036</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/adhm.202002036&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fadhm.202002036%26sid%3Dliteratum%253Aachs%26jtitle%3DAdvanced%2520Healthcare%2520Materials%26atitle%3DTumor%252BMicroenvironment%252BTriggered%252BCascade%2525E2%252580%252590Activation%252BNanoplatform%252Bfor%252BSynergistic%252Band%252BPrecise%252BTreatment%252Bof%252BHepatocellular%252BCarcinoma%26aulast%3DXin%26aufirst%3DFuli%26date%3D2021%26date%3D2021%26volume%3D10%26issue%3D10%26spage%3D2002036" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Bingling  Zhong</span>, <span class="hlFld-ContribAuthor ">Jie  Yu</span>, <span class="hlFld-ContribAuthor ">Ying  Hou</span>, <span class="hlFld-ContribAuthor ">Nana  Ai</span>, <span class="hlFld-ContribAuthor ">Wei  Ge</span>, <span class="hlFld-ContribAuthor ">Jin-Jian  Lu</span>, <span class="hlFld-ContribAuthor ">Xiuping  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">A novel strategy for glioblastoma treatment by induction of noptosis, an NQO1-dependent necrosis. </span><span class="cited-content_cbyCitation_journal-name">Free Radical Biology and Medicine</span><span> <strong>2021,</strong> <em>166 </em>, 104-115. <a href="https://doi.org/10.1016/j.freeradbiomed.2021.02.014" title="DOI URL">https://doi.org/10.1016/j.freeradbiomed.2021.02.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.freeradbiomed.2021.02.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.freeradbiomed.2021.02.014%26sid%3Dliteratum%253Aachs%26jtitle%3DFree%2520Radical%2520Biology%2520and%2520Medicine%26atitle%3DA%252Bnovel%252Bstrategy%252Bfor%252Bglioblastoma%252Btreatment%252Bby%252Binduction%252Bof%252Bnoptosis%25252C%252Ban%252BNQO1-dependent%252Bnecrosis%26aulast%3DZhong%26aufirst%3DBingling%26date%3D2021%26volume%3D166%26spage%3D104%26epage%3D115" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Maryam  Gholampour</span>, <span class="hlFld-ContribAuthor ">Amirhossein  Sakhteman</span>, <span class="hlFld-ContribAuthor ">Somayeh  Pirhadi</span>, <span class="hlFld-ContribAuthor ">Hassan  Seradj</span>. </span><span class="cited-content_cbyCitation_article-title">In silico design of novel diamino-quinoline-5,8‑dione derivatives as putative inhibitors of NAD(P)H:Quinone oxidoreductase 1 based on docking studies and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2021,</strong> <em>1230 </em>, 129906. <a href="https://doi.org/10.1016/j.molstruc.2021.129906" title="DOI URL">https://doi.org/10.1016/j.molstruc.2021.129906</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2021.129906&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2021.129906%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DIn%252Bsilico%252Bdesign%252Bof%252Bnovel%252Bdiamino-quinoline-5%25252C8%2525E2%252580%252591dione%252Bderivatives%252Bas%252Bputative%252Binhibitors%252Bof%252BNAD%252528P%252529H%25253AQuinone%252Boxidoreductase%252B1%252Bbased%252Bon%252Bdocking%252Bstudies%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DGholampour%26aufirst%3DMaryam%26date%3D2021%26volume%3D1230%26spage%3D129906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dan  Yan</span>, <span class="hlFld-ContribAuthor ">Xiao  Xu</span>, <span class="hlFld-ContribAuthor ">Chunling  Ren</span>, <span class="hlFld-ContribAuthor ">Chen  Chen</span>, <span class="hlFld-ContribAuthor ">Jianguang  Luo</span>, <span class="hlFld-ContribAuthor ">Chao  Han</span>, <span class="hlFld-ContribAuthor ">Lingyi  Kong</span>. </span><span class="cited-content_cbyCitation_article-title">DT-diaphorase triggered theranostic nanoparticles induce the self-burst of reactive oxygen species for tumor diagnosis and treatment. </span><span class="cited-content_cbyCitation_journal-name">Acta Biomaterialia</span><span> <strong>2021,</strong> <em>125 </em>, 267-279. <a href="https://doi.org/10.1016/j.actbio.2021.02.033" title="DOI URL">https://doi.org/10.1016/j.actbio.2021.02.033</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.actbio.2021.02.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.actbio.2021.02.033%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Biomaterialia%26atitle%3DDT-diaphorase%252Btriggered%252Btheranostic%252Bnanoparticles%252Binduce%252Bthe%252Bself-burst%252Bof%252Breactive%252Boxygen%252Bspecies%252Bfor%252Btumor%252Bdiagnosis%252Band%252Btreatment%26aulast%3DYan%26aufirst%3DDan%26date%3D2021%26volume%3D125%26spage%3D267%26epage%3D279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Glaucia Noeli Maroso  Hajj</span>, <span class="hlFld-ContribAuthor ">Paula Borzino Cordeiro  Nunes</span>, <span class="hlFld-ContribAuthor ">Martin  Roffe</span>. </span><span class="cited-content_cbyCitation_article-title">Genome-wide translation patterns in gliomas: An integrative view. </span><span class="cited-content_cbyCitation_journal-name">Cellular Signalling</span><span> <strong>2021,</strong> <em>79 </em>, 109883. <a href="https://doi.org/10.1016/j.cellsig.2020.109883" title="DOI URL">https://doi.org/10.1016/j.cellsig.2020.109883</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.cellsig.2020.109883&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.cellsig.2020.109883%26sid%3Dliteratum%253Aachs%26jtitle%3DCellular%2520Signalling%26atitle%3DGenome-wide%252Btranslation%252Bpatterns%252Bin%252Bgliomas%25253A%252BAn%252Bintegrative%252Bview%26aulast%3DHajj%26aufirst%3DGlaucia%2BNoeli%2BMaroso%26date%3D2021%26volume%3D79%26spage%3D109883" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sheng-Tao  Cheng</span>, <span class="hlFld-ContribAuthor ">Jie-Li  Hu</span>, <span class="hlFld-ContribAuthor ">Ji-Hua  Ren</span>, <span class="hlFld-ContribAuthor ">Hai-Bo  Yu</span>, <span class="hlFld-ContribAuthor ">Shan  Zhong</span>, <span class="hlFld-ContribAuthor ">Vincent Kam  Wai Wong</span>, <span class="hlFld-ContribAuthor ">Betty Yuen  Kwan Law</span>, <span class="hlFld-ContribAuthor ">Wei-Xian  Chen</span>, <span class="hlFld-ContribAuthor ">Hong-Mei  Xu</span>, <span class="hlFld-ContribAuthor ">Zhen-Zhen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xue-Fei  Cai</span>, <span class="hlFld-ContribAuthor ">Yuan  Hu</span>, <span class="hlFld-ContribAuthor ">Wen-Lu  Zhang</span>, <span class="hlFld-ContribAuthor ">Quan-Xin  Long</span>, <span class="hlFld-ContribAuthor ">Fang  Ren</span>, <span class="hlFld-ContribAuthor ">Hong-Zhong  Zhou</span>, <span class="hlFld-ContribAuthor ">Ai-Long  Huang</span>, <span class="hlFld-ContribAuthor ">Juan  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Dicoumarol, an NQO1 inhibitor, blocks cccDNA transcription by promoting degradation of HBx. </span><span class="cited-content_cbyCitation_journal-name">Journal of Hepatology</span><span> <strong>2021,</strong> <em>74 </em>
                                    (3)
                                     , 522-534. <a href="https://doi.org/10.1016/j.jhep.2020.09.019" title="DOI URL">https://doi.org/10.1016/j.jhep.2020.09.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jhep.2020.09.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jhep.2020.09.019%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Hepatology%26atitle%3DDicoumarol%25252C%252Ban%252BNQO1%252Binhibitor%25252C%252Bblocks%252BcccDNA%252Btranscription%252Bby%252Bpromoting%252Bdegradation%252Bof%252BHBx%26aulast%3DCheng%26aufirst%3DSheng-Tao%26date%3D2021%26volume%3D74%26issue%3D3%26spage%3D522%26epage%3D534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rui  Zhang</span>, <span class="hlFld-ContribAuthor ">Juchuanli  Tu</span>, <span class="hlFld-ContribAuthor ">Suling  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Novel molecular regulators of breast cancer stem cell plasticity and heterogeneity. </span><span class="cited-content_cbyCitation_journal-name">Seminars in Cancer Biology</span><span> <strong>2021,</strong> <em>5 </em><a href="https://doi.org/10.1016/j.semcancer.2021.03.008" title="DOI URL">https://doi.org/10.1016/j.semcancer.2021.03.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.semcancer.2021.03.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.semcancer.2021.03.008%26sid%3Dliteratum%253Aachs%26jtitle%3DSeminars%2520in%2520Cancer%2520Biology%26atitle%3DNovel%252Bmolecular%252Bregulators%252Bof%252Bbreast%252Bcancer%252Bstem%252Bcell%252Bplasticity%252Band%252Bheterogeneity%26aulast%3DZhang%26aufirst%3DRui%26date%3D2021%26volume%3D5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mingchong  Dai</span>, <span class="hlFld-ContribAuthor ">Chang Wook  Song</span>, <span class="hlFld-ContribAuthor ">Yun Jae  Yang</span>, <span class="hlFld-ContribAuthor ">Hye Rim  Kim</span>, <span class="hlFld-ContribAuthor ">Ye Jin  Reo</span>, <span class="hlFld-ContribAuthor ">Kyo Han  Ahn</span>. </span><span class="cited-content_cbyCitation_article-title">Toward Ratiometric Detection of NAD(P)H Quinone Oxidoreductase-1: Benzocoumarin-Based Fluorescent Probes. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2021,</strong> <em>330 </em>, 129277. <a href="https://doi.org/10.1016/j.snb.2020.129277" title="DOI URL">https://doi.org/10.1016/j.snb.2020.129277</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2020.129277&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2020.129277%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DToward%252BRatiometric%252BDetection%252Bof%252BNAD%252528P%252529H%252BQuinone%252BOxidoreductase-1%25253A%252BBenzocoumarin-Based%252BFluorescent%252BProbes%26aulast%3DDai%26aufirst%3DMingchong%26date%3D2021%26volume%3D330%26spage%3D129277" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yun  Yang</span>, <span class="hlFld-ContribAuthor ">Jie  Zheng</span>, <span class="hlFld-ContribAuthor ">Mengchao  Wang</span>, <span class="hlFld-ContribAuthor ">Jin  Zhang</span>, <span class="hlFld-ContribAuthor ">Tao  Tian</span>, <span class="hlFld-ContribAuthor ">Zhiheng  Wang</span>, <span class="hlFld-ContribAuthor ">Shengxian  Yuan</span>, <span class="hlFld-ContribAuthor ">Lei  Liu</span>, <span class="hlFld-ContribAuthor ">Peng  Zhu</span>, <span class="hlFld-ContribAuthor ">Fangming  Gu</span>, <span class="hlFld-ContribAuthor ">Siyuan  Fu</span>, <span class="hlFld-ContribAuthor ">Yunfeng  Shan</span>, <span class="hlFld-ContribAuthor ">Zeya  Pan</span>, <span class="hlFld-ContribAuthor ">Weiping  Zhou</span>. </span><span class="cited-content_cbyCitation_article-title">NQO1 promotes an aggressive phenotype in hepatocellular carcinoma
              via
              amplifying ERK‐NRF2 signaling. </span><span class="cited-content_cbyCitation_journal-name">Cancer Science</span><span> <strong>2021,</strong> <em>112 </em>
                                    (2)
                                     , 641-654. <a href="https://doi.org/10.1111/cas.14744" title="DOI URL">https://doi.org/10.1111/cas.14744</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cas.14744&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcas.14744%26sid%3Dliteratum%253Aachs%26jtitle%3DCancer%2520Science%26atitle%3DNQO1%252Bpromotes%252Ban%252Baggressive%252Bphenotype%252Bin%252Bhepatocellular%252Bcarcinoma%252Bvia%252Bamplifying%252BERK%2525E2%252580%252590NRF2%252Bsignaling%26aulast%3DYang%26aufirst%3DYun%26date%3D2021%26date%3D2020%26volume%3D112%26issue%3D2%26spage%3D641%26epage%3D654" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Takuo  Ogiso</span>, <span class="hlFld-ContribAuthor ">Tatsuki  Fukami</span>, <span class="hlFld-ContribAuthor ">Cheng  Zhongzhe</span>, <span class="hlFld-ContribAuthor ">Keigo  Konishi</span>, <span class="hlFld-ContribAuthor ">Masataka  Nakano</span>, <span class="hlFld-ContribAuthor ">Miki  Nakajima</span>. </span><span class="cited-content_cbyCitation_article-title">Human superoxide dismutase 1 attenuates quinoneimine metabolite formation from mefenamic acid. </span><span class="cited-content_cbyCitation_journal-name">Toxicology</span><span> <strong>2021,</strong> <em>448 </em>, 152648. <a href="https://doi.org/10.1016/j.tox.2020.152648" title="DOI URL">https://doi.org/10.1016/j.tox.2020.152648</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.tox.2020.152648&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.tox.2020.152648%26sid%3Dliteratum%253Aachs%26jtitle%3DToxicology%26atitle%3DHuman%252Bsuperoxide%252Bdismutase%252B1%252Battenuates%252Bquinoneimine%252Bmetabolite%252Bformation%252Bfrom%252Bmefenamic%252Bacid%26aulast%3DOgiso%26aufirst%3DTakuo%26date%3D2021%26volume%3D448%26spage%3D152648" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan  Qu</span>, <span class="hlFld-ContribAuthor ">Chong  Zhang</span>, <span class="hlFld-ContribAuthor ">Xin  Ma</span>, <span class="hlFld-ContribAuthor ">Yunhui  Gao</span>, <span class="hlFld-ContribAuthor ">Jing  Liu</span>, <span class="hlFld-ContribAuthor ">Liqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of NQO1-activated prodrugs of podophyllotoxin as antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2020,</strong> <em>28 </em>
                                    (24)
                                     , 115821. <a href="https://doi.org/10.1016/j.bmc.2020.115821" title="DOI URL">https://doi.org/10.1016/j.bmc.2020.115821</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2020.115821&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2020.115821%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252BNQO1-activated%252Bprodrugs%252Bof%252Bpodophyllotoxin%252Bas%252Bantitumor%252Bagents%26aulast%3DQu%26aufirst%3DYan%26date%3D2020%26volume%3D28%26issue%3D24%26spage%3D115821" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Rumiana  Bakalova</span>, <span class="hlFld-ContribAuthor ">Severina  Semkova</span>, <span class="hlFld-ContribAuthor ">Donika  Ivanova</span>, <span class="hlFld-ContribAuthor ">Zhivko  Zhelev</span>, <span class="hlFld-ContribAuthor ">Thomas  Miller</span>, <span class="hlFld-ContribAuthor ">Tsuguhide  Takeshima</span>, <span class="hlFld-ContribAuthor ">Sayaka  Shibata</span>, <span class="hlFld-ContribAuthor ">Dessislava  Lazarova</span>, <span class="hlFld-ContribAuthor ">Ichio  Aoki</span>, <span class="hlFld-ContribAuthor ">Tatsuya  Higashi</span>, . </span><span class="cited-content_cbyCitation_article-title">Selective Targeting of Cancerous Mitochondria and Suppression of Tumor Growth Using Redox-Active Treatment Adjuvant. </span><span class="cited-content_cbyCitation_journal-name">Oxidative Medicine and Cellular Longevity</span><span> <strong>2020,</strong> <em>2020 </em>, 1-30. <a href="https://doi.org/10.1155/2020/6212935" title="DOI URL">https://doi.org/10.1155/2020/6212935</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1155/2020/6212935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1155%2F2020%2F6212935%26sid%3Dliteratum%253Aachs%26jtitle%3DOxidative%2520Medicine%2520and%2520Cellular%2520Longevity%26atitle%3DSelective%252BTargeting%252Bof%252BCancerous%252BMitochondria%252Band%252BSuppression%252Bof%252BTumor%252BGrowth%252BUsing%252BRedox-Active%252BTreatment%252BAdjuvant%26aulast%3DBakalova%26aufirst%3DRumiana%26date%3D2020%26volume%3D2020%26spage%3D1%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chong  Zhang</span>, <span class="hlFld-ContribAuthor ">Yan  Qu</span>, <span class="hlFld-ContribAuthor ">Xin  Ma</span>, <span class="hlFld-ContribAuthor ">Manping  Li</span>, <span class="hlFld-ContribAuthor ">Sen  Li</span>, <span class="hlFld-ContribAuthor ">Yue  Li</span>, <span class="hlFld-ContribAuthor ">Liqiang  Wu</span>. </span><span class="cited-content_cbyCitation_article-title">NQO1-selective activated prodrugs of combretastatin A-4: Synthesis and biological evaluation. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2020,</strong> <em>103 </em>, 104200. <a href="https://doi.org/10.1016/j.bioorg.2020.104200" title="DOI URL">https://doi.org/10.1016/j.bioorg.2020.104200</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2020.104200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2020.104200%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DNQO1-selective%252Bactivated%252Bprodrugs%252Bof%252Bcombretastatin%252BA-4%25253A%252BSynthesis%252Band%252Bbiological%252Bevaluation%26aulast%3DZhang%26aufirst%3DChong%26date%3D2020%26volume%3D103%26spage%3D104200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Liqiang  Wu</span>, <span class="hlFld-ContribAuthor ">Xin  Ma</span>, <span class="hlFld-ContribAuthor ">Xiaojuan  Yang</span>, <span class="hlFld-ContribAuthor ">Chong  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of β-lapachone-monastrol hybrids as potential anticancer agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>203 </em>, 112594. <a href="https://doi.org/10.1016/j.ejmech.2020.112594" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112594</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112594&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112594%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252B%2525CE%2525B2-lapachone-monastrol%252Bhybrids%252Bas%252Bpotential%252Banticancer%252Bagents%26aulast%3DWu%26aufirst%3DLiqiang%26date%3D2020%26volume%3D203%26spage%3D112594" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Oladipupo A.  Aregbesola</span>, <span class="hlFld-ContribAuthor ">Ajit  Kumar</span>, <span class="hlFld-ContribAuthor ">Mduduzi P.  Mokoena</span>, <span class="hlFld-ContribAuthor ">Ademola O.  Olaniran</span>. </span><span class="cited-content_cbyCitation_article-title">Role of tetrachloro-1,4-benzoquinone reductase in phenylalanine hydroxylation system and pentachlorophenol degradation in Bacillus cereus AOA-CPS1. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Biological Macromolecules</span><span> <strong>2020,</strong> <em>161 </em>, 875-890. <a href="https://doi.org/10.1016/j.ijbiomac.2020.06.083" title="DOI URL">https://doi.org/10.1016/j.ijbiomac.2020.06.083</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ijbiomac.2020.06.083&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ijbiomac.2020.06.083%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Biological%2520Macromolecules%26atitle%3DRole%252Bof%252Btetrachloro-1%25252C4-benzoquinone%252Breductase%252Bin%252Bphenylalanine%252Bhydroxylation%252Bsystem%252Band%252Bpentachlorophenol%252Bdegradation%252Bin%252BBacillus%252Bcereus%252BAOA-CPS1%26aulast%3DAregbesola%26aufirst%3DOladipupo%2BA.%26date%3D2020%26volume%3D161%26spage%3D875%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjun  Zheng</span>, <span class="hlFld-ContribAuthor ">Zhenqiang  Ning</span>, <span class="hlFld-ContribAuthor ">Deng  Pan</span>, <span class="hlFld-ContribAuthor ">Dan  Han</span>, <span class="hlFld-ContribAuthor ">Yuan  Xu</span>, <span class="hlFld-ContribAuthor ">Songqin  Liu</span>, <span class="hlFld-ContribAuthor ">Yuanjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanfei  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Electrochemiluminescent detection of hNQO1 and associated drug screening enabled by futile redox cycle reaction. </span><span class="cited-content_cbyCitation_journal-name">Sensors and Actuators B: Chemical</span><span> <strong>2020,</strong> <em>321 </em>, 128557. <a href="https://doi.org/10.1016/j.snb.2020.128557" title="DOI URL">https://doi.org/10.1016/j.snb.2020.128557</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.snb.2020.128557&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.snb.2020.128557%26sid%3Dliteratum%253Aachs%26jtitle%3DSensors%2520and%2520Actuators%2520B%253A%2520Chemical%26atitle%3DElectrochemiluminescent%252Bdetection%252Bof%252BhNQO1%252Band%252Bassociated%252Bdrug%252Bscreening%252Benabled%252Bby%252Bfutile%252Bredox%252Bcycle%252Breaction%26aulast%3DZheng%26aufirst%3DYongjun%26date%3D2020%26volume%3D321%26spage%3D128557" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jialing  Han</span>, <span class="hlFld-ContribAuthor ">Longhao  Cheng</span>, <span class="hlFld-ContribAuthor ">Ya  Zhu</span>, <span class="hlFld-ContribAuthor ">Xiaowei  Xu</span>, <span class="hlFld-ContribAuthor ">Chaoliang  Ge</span>. </span><span class="cited-content_cbyCitation_article-title">Covalent-Assembly Based Fluorescent Probes for Detection of hNQO1 and Imaging in Living Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Chemistry</span><span> <strong>2020,</strong> <em>8 </em><a href="https://doi.org/10.3389/fchem.2020.00756" title="DOI URL">https://doi.org/10.3389/fchem.2020.00756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fchem.2020.00756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffchem.2020.00756%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Chemistry%26atitle%3DCovalent-Assembly%252BBased%252BFluorescent%252BProbes%252Bfor%252BDetection%252Bof%252BhNQO1%252Band%252BImaging%252Bin%252BLiving%252BCells%26aulast%3DHan%26aufirst%3DJialing%26date%3D2020%26date%3D2020%26volume%3D8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ling  Chen</span>, <span class="hlFld-ContribAuthor ">Yuan-Zhu  Xie</span>, <span class="hlFld-ContribAuthor ">Zhi-Yong  Luo</span>, <span class="hlFld-ContribAuthor ">Li-Jun  Liu</span>, <span class="hlFld-ContribAuthor ">Zi-Zheng  Zou</span>, <span class="hlFld-ContribAuthor ">Hong-Dou  Liu</span>, <span class="hlFld-ContribAuthor ">Fan-Rong  Kong</span>, <span class="hlFld-ContribAuthor ">Ying  Hao</span>, <span class="hlFld-ContribAuthor ">Jin-Lei  Gao</span>, <span class="hlFld-ContribAuthor ">Liu-Liu  Wang</span>, <span class="hlFld-ContribAuthor ">Da-You  Ma</span>, <span class="hlFld-ContribAuthor ">Su-You  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and biological evaluation of novel isothiazoloquinoline quinone analogues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (16)
                                     , 127286. <a href="https://doi.org/10.1016/j.bmcl.2020.127286" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127286</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127286%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSynthesis%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bisothiazoloquinoline%252Bquinone%252Banalogues%26aulast%3DChen%26aufirst%3DLing%26date%3D2020%26volume%3D30%26issue%3D16%26spage%3D127286" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Li-Qiang  Wu</span>, <span class="hlFld-ContribAuthor ">Xin  Ma</span>, <span class="hlFld-ContribAuthor ">Chong  Zhang</span>, <span class="hlFld-ContribAuthor ">Zhao-Peng  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis, and biological evaluation of 4-substituted-3,4-dihydrobenzo[h]quinoline-2,5,6(1H)-triones as NQO1-directed antitumor agents. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>198 </em>, 112396. <a href="https://doi.org/10.1016/j.ejmech.2020.112396" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112396</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112396&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112396%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252B4-substituted-3%25252C4-dihydrobenzo%25255Bh%25255Dquinoline-2%25252C5%25252C6%2525281H%252529-triones%252Bas%252BNQO1-directed%252Bantitumor%252Bagents%26aulast%3DWu%26aufirst%3DLi-Qiang%26date%3D2020%26volume%3D198%26spage%3D112396" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mengjiao  Zhou</span>, <span class="hlFld-ContribAuthor ">Yuqi  Xie</span>, <span class="hlFld-ContribAuthor ">Shujun  Xu</span>, <span class="hlFld-ContribAuthor ">Jingqi  Xin</span>, <span class="hlFld-ContribAuthor ">Jin  Wang</span>, <span class="hlFld-ContribAuthor ">Tao  Han</span>, <span class="hlFld-ContribAuthor ">Richard  Ting</span>, <span class="hlFld-ContribAuthor ">Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Feifei  An</span>. </span><span class="cited-content_cbyCitation_article-title">Hypoxia-activated nanomedicines for effective cancer therapy. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>195 </em>, 112274. <a href="https://doi.org/10.1016/j.ejmech.2020.112274" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112274</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112274&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112274%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DHypoxia-activated%252Bnanomedicines%252Bfor%252Beffective%252Bcancer%252Btherapy%26aulast%3DZhou%26aufirst%3DMengjiao%26date%3D2020%26volume%3D195%26spage%3D112274" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yen-Chi  Tsao</span>, <span class="hlFld-ContribAuthor ">Yu-Jung  Chang</span>, <span class="hlFld-ContribAuthor ">Chun-Hsien  Wang</span>, <span class="hlFld-ContribAuthor ">Linyi  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Isoplumbagin as a Novel NQO1 Substrate and Anti-Cancer Quinone. </span><span class="cited-content_cbyCitation_journal-name">International Journal of Molecular Sciences</span><span> <strong>2020,</strong> <em>21 </em>
                                    (12)
                                     , 4378. <a href="https://doi.org/10.3390/ijms21124378" title="DOI URL">https://doi.org/10.3390/ijms21124378</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/ijms21124378&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fijms21124378%26sid%3Dliteratum%253Aachs%26jtitle%3DInternational%2520Journal%2520of%2520Molecular%2520Sciences%26atitle%3DDiscovery%252Bof%252BIsoplumbagin%252Bas%252Ba%252BNovel%252BNQO1%252BSubstrate%252Band%252BAnti-Cancer%252BQuinone%26aulast%3DTsao%26aufirst%3DYen-Chi%26date%3D2020%26date%3D2020%26volume%3D21%26issue%3D12%26spage%3D4378" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Balachandran  Karpaga Raja Sundari</span>, <span class="hlFld-ContribAuthor ">Roli  Budhwar</span>, <span class="hlFld-ContribAuthor ">Bilikere S.  Dwarakanath</span>, <span class="hlFld-ContribAuthor ">S. P.  Thyagarajan</span>. </span><span class="cited-content_cbyCitation_article-title">De novo transcriptome analysis unravels tissue-specific expression of candidate genes involved in major secondary metabolite biosynthetic pathways of Plumbago zeylanica: implication for pharmacological potential. </span><span class="cited-content_cbyCitation_journal-name">3 Biotech</span><span> <strong>2020,</strong> <em>10 </em>
                                    (6)
                                     <a href="https://doi.org/10.1007/s13205-020-02263-9" title="DOI URL">https://doi.org/10.1007/s13205-020-02263-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s13205-020-02263-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs13205-020-02263-9%26sid%3Dliteratum%253Aachs%26jtitle%3D3%2520Biotech%26atitle%3DDe%252Bnovo%252Btranscriptome%252Banalysis%252Bunravels%252Btissue-specific%252Bexpression%252Bof%252Bcandidate%252Bgenes%252Binvolved%252Bin%252Bmajor%252Bsecondary%252Bmetabolite%252Bbiosynthetic%252Bpathways%252Bof%252BPlumbago%252Bzeylanica%25253A%252Bimplication%252Bfor%252Bpharmacological%252Bpotential%26aulast%3DKarpaga%2BRaja%2BSundari%26aufirst%3DBalachandran%26date%3D2020%26date%3D2020%26volume%3D10%26issue%3D6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Varlet</span>, <span class="hlFld-ContribAuthor ">Coralie  Gelis</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bernadat</span>, <span class="hlFld-ContribAuthor ">Luc  Neuville</span>, <span class="hlFld-ContribAuthor ">Géraldine  Masson</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Redox‐Divergent Chiral Phosphoric Acid Catalyzed Quinone Diels–Alder Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (22)
                                     , 8569-8574. <a href="https://doi.org/10.1002/ange.202000838" title="DOI URL">https://doi.org/10.1002/ange.202000838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202000838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202000838%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3DEnantioselective%252BRedox%2525E2%252580%252590Divergent%252BChiral%252BPhosphoric%252BAcid%252BCatalyzed%252BQuinone%252BDiels%2525E2%252580%252593Alder%252BReactions%26aulast%3DVarlet%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D22%26spage%3D8569%26epage%3D8574" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Thomas  Varlet</span>, <span class="hlFld-ContribAuthor ">Coralie  Gelis</span>, <span class="hlFld-ContribAuthor ">Pascal  Retailleau</span>, <span class="hlFld-ContribAuthor ">Guillaume  Bernadat</span>, <span class="hlFld-ContribAuthor ">Luc  Neuville</span>, <span class="hlFld-ContribAuthor ">Géraldine  Masson</span>. </span><span class="cited-content_cbyCitation_article-title">Enantioselective Redox‐Divergent Chiral Phosphoric Acid Catalyzed Quinone Diels–Alder Reactions. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (22)
                                     , 8491-8496. <a href="https://doi.org/10.1002/anie.202000838" title="DOI URL">https://doi.org/10.1002/anie.202000838</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202000838&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202000838%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3DEnantioselective%252BRedox%2525E2%252580%252590Divergent%252BChiral%252BPhosphoric%252BAcid%252BCatalyzed%252BQuinone%252BDiels%2525E2%252580%252593Alder%252BReactions%26aulast%3DVarlet%26aufirst%3DThomas%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D22%26spage%3D8491%26epage%3D8496" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Naveen  Singh</span>, <span class="hlFld-ContribAuthor ">S. Louise  Pay</span>, <span class="hlFld-ContribAuthor ">Snehal B.  Bhandare</span>, <span class="hlFld-ContribAuthor ">Udhaya  Arimpur</span>, <span class="hlFld-ContribAuthor ">Edward A.  Motea</span>. </span><span class="cited-content_cbyCitation_article-title">Therapeutic Strategies and Biomarkers to Modulate PARP Activity for Targeted Cancer Therapy. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2020,</strong> <em>12 </em>
                                    (4)
                                     , 972. <a href="https://doi.org/10.3390/cancers12040972" title="DOI URL">https://doi.org/10.3390/cancers12040972</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers12040972&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers12040972%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DTherapeutic%252BStrategies%252Band%252BBiomarkers%252Bto%252BModulate%252BPARP%252BActivity%252Bfor%252BTargeted%252BCancer%252BTherapy%26aulast%3DSingh%26aufirst%3DNaveen%26date%3D2020%26date%3D2020%26volume%3D12%26issue%3D4%26spage%3D972" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Darren  Conboy</span>, <span class="hlFld-ContribAuthor ">Fawaz  Aldabbagh</span>. </span><span class="cited-content_cbyCitation_article-title">6-Imino-1,2,3,4,8,9,10,11-octahydropyrido[1,2-a]pyrido[1′,2′:1,2]imidazo[4,5-f]benzimidazole-13-one: Synthesis and Cytotoxicity Evaluation. </span><span class="cited-content_cbyCitation_journal-name">Molbank</span><span> <strong>2020,</strong> <em>2020 </em>
                                    (1)
                                     , M1118. <a href="https://doi.org/10.3390/M1118" title="DOI URL">https://doi.org/10.3390/M1118</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/M1118&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2FM1118%26sid%3Dliteratum%253Aachs%26jtitle%3DMolbank%26atitle%3D6-Imino-1%25252C2%25252C3%25252C4%25252C8%25252C9%25252C10%25252C11-octahydropyrido%25255B1%25252C2-a%25255Dpyrido%25255B1%2525E2%252580%2525B2%25252C2%2525E2%252580%2525B2%25253A1%25252C2%25255Dimidazo%25255B4%25252C5-f%25255Dbenzimidazole-13-one%25253A%252BSynthesis%252Band%252BCytotoxicity%252BEvaluation%26aulast%3DConboy%26aufirst%3DDarren%26date%3D2020%26date%3D2020%26volume%3D2020%26issue%3D1%26spage%3DM1118" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Elyse M.  Digby</span>, <span class="hlFld-ContribAuthor ">Oleg  Sadovski</span>, <span class="hlFld-ContribAuthor ">Andrew A.  Beharry</span>. </span><span class="cited-content_cbyCitation_article-title">An Activatable Photosensitizer Targeting Human NAD(P)H: Quinone Oxidoreductase 1. </span><span class="cited-content_cbyCitation_journal-name">Chemistry – A European Journal</span><span> <strong>2020,</strong> <em>26 </em>
                                    (12)
                                     , 2713-2718. <a href="https://doi.org/10.1002/chem.201904607" title="DOI URL">https://doi.org/10.1002/chem.201904607</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/chem.201904607&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fchem.201904607%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%25E2%2580%2593%2520A%2520European%2520Journal%26atitle%3DAn%252BActivatable%252BPhotosensitizer%252BTargeting%252BHuman%252BNAD%252528P%252529H%25253A%2525E2%252580%252589Quinone%252BOxidoreductase%2525E2%252580%2525851%26aulast%3DDigby%26aufirst%3DElyse%2BM.%26date%3D2020%26date%3D2020%26volume%3D26%26issue%3D12%26spage%3D2713%26epage%3D2718" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yongjun  Zheng</span>, <span class="hlFld-ContribAuthor ">Deng  Pan</span>, <span class="hlFld-ContribAuthor ">Yue  Zhang</span>, <span class="hlFld-ContribAuthor ">Yuanjian  Zhang</span>, <span class="hlFld-ContribAuthor ">Yanfei  Shen</span>. </span><span class="cited-content_cbyCitation_article-title">Hemicyanine-based near-infrared fluorescent probe for the ultrasensitive detection of hNQO1 activity and discrimination of human cancer cells. </span><span class="cited-content_cbyCitation_journal-name">Analytica Chimica Acta</span><span> <strong>2019,</strong> <em>1090 </em>, 125-132. <a href="https://doi.org/10.1016/j.aca.2019.09.012" title="DOI URL">https://doi.org/10.1016/j.aca.2019.09.012</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.aca.2019.09.012&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.aca.2019.09.012%26sid%3Dliteratum%253Aachs%26jtitle%3DAnalytica%2520Chimica%2520Acta%26atitle%3DHemicyanine-based%252Bnear-infrared%252Bfluorescent%252Bprobe%252Bfor%252Bthe%252Bultrasensitive%252Bdetection%252Bof%252BhNQO1%252Bactivity%252Band%252Bdiscrimination%252Bof%2525C2%2525A0human%252Bcancer%252Bcells%26aulast%3DZheng%26aufirst%3DYongjun%26date%3D2019%26volume%3D1090%26spage%3D125%26epage%3D132" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yuhua  Li</span>, <span class="hlFld-ContribAuthor ">Qiang  Meng</span>, <span class="hlFld-ContribAuthor ">Mengbi  Yang</span>, <span class="hlFld-ContribAuthor ">Dongyang  Liu</span>, <span class="hlFld-ContribAuthor ">Xiangyu  Hou</span>, <span class="hlFld-ContribAuthor ">Lan  Tang</span>, <span class="hlFld-ContribAuthor ">Xin  Wang</span>, <span class="hlFld-ContribAuthor ">Yuanfeng  Lyu</span>, <span class="hlFld-ContribAuthor ">Xiaoyan  Chen</span>, <span class="hlFld-ContribAuthor ">Kexin  Liu</span>, <span class="hlFld-ContribAuthor ">Ai-Ming  Yu</span>, <span class="hlFld-ContribAuthor ">Zhong  Zuo</span>, <span class="hlFld-ContribAuthor ">Huichang  Bi</span>. </span><span class="cited-content_cbyCitation_article-title">Current trends in drug metabolism and pharmacokinetics. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2019,</strong> <em>9 </em>
                                    (6)
                                     , 1113-1144. <a href="https://doi.org/10.1016/j.apsb.2019.10.001" title="DOI URL">https://doi.org/10.1016/j.apsb.2019.10.001</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2019.10.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2019.10.001%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DCurrent%252Btrends%252Bin%252Bdrug%252Bmetabolism%252Band%252Bpharmacokinetics%26aulast%3DLi%26aufirst%3DYuhua%26date%3D2019%26volume%3D9%26issue%3D6%26spage%3D1113%26epage%3D1144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao-wan  Wang</span>, <span class="hlFld-ContribAuthor ">Rui-min  Tian</span>, <span class="hlFld-ContribAuthor ">Yi-qi  Yang</span>, <span class="hlFld-ContribAuthor ">Zhao-Yu  Lu</span>, <span class="hlFld-ContribAuthor ">Xiao-dong  Han</span>, <span class="hlFld-ContribAuthor ">Xu-sheng  Liu</span>, <span class="hlFld-ContribAuthor ">Wei  Mao</span>, <span class="hlFld-ContribAuthor ">Peng  Xu</span>, <span class="hlFld-ContribAuthor ">Hong-tao  Xu</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>. </span><span class="cited-content_cbyCitation_article-title">Triptriolide antagonizes triptolide-induced nephrocyte apoptosis via inhibiting oxidative stress in vitro and in vivo. </span><span class="cited-content_cbyCitation_journal-name">Biomedicine & Pharmacotherapy</span><span> <strong>2019,</strong> <em>118 </em>, 109232. <a href="https://doi.org/10.1016/j.biopha.2019.109232" title="DOI URL">https://doi.org/10.1016/j.biopha.2019.109232</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.biopha.2019.109232&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.biopha.2019.109232%26sid%3Dliteratum%253Aachs%26jtitle%3DBiomedicine%2520%2526%2520Pharmacotherapy%26atitle%3DTriptriolide%252Bantagonizes%252Btriptolide-induced%252Bnephrocyte%252Bapoptosis%252Bvia%252Binhibiting%252Boxidative%252Bstress%252Bin%252Bvitro%252Band%252Bin%252Bvivo%26aulast%3DWang%26aufirst%3DXiao-wan%26date%3D2019%26volume%3D118%26spage%3D109232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhiming  Cheng</span>, <span class="hlFld-ContribAuthor ">Wagner O.  Valença</span>, <span class="hlFld-ContribAuthor ">Gleiston G.  Dias</span>, <span class="hlFld-ContribAuthor ">Jamie  Scott</span>, <span class="hlFld-ContribAuthor ">Nicole D.  Barth</span>, <span class="hlFld-ContribAuthor ">Fabio  de Moliner</span>, <span class="hlFld-ContribAuthor ">Gabriela B.P.  Souza</span>, <span class="hlFld-ContribAuthor ">Richard J.  Mellanby</span>, <span class="hlFld-ContribAuthor ">Marc  Vendrell</span>, <span class="hlFld-ContribAuthor ">Eufrânio N.  da Silva Júnior</span>. </span><span class="cited-content_cbyCitation_article-title">Natural product-inspired profluorophores for imaging NQO1 activity in tumour tissues. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2019,</strong> <em>27 </em>
                                    (17)
                                     , 3938-3946. <a href="https://doi.org/10.1016/j.bmc.2019.07.017" title="DOI URL">https://doi.org/10.1016/j.bmc.2019.07.017</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2019.07.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2019.07.017%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DNatural%252Bproduct-inspired%252Bprofluorophores%252Bfor%252Bimaging%252BNQO1%252Bactivity%252Bin%252Btumour%252Btissues%26aulast%3DCheng%26aufirst%3DZhiming%26date%3D2019%26volume%3D27%26issue%3D17%26spage%3D3938%26epage%3D3946" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Wei  Hou</span>, <span class="hlFld-ContribAuthor ">Bo  Liu</span>, <span class="hlFld-ContribAuthor ">Hongtao  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">Triptolide: Medicinal chemistry, chemical biology and clinical progress. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2019,</strong> <em>176 </em>, 378-392. <a href="https://doi.org/10.1016/j.ejmech.2019.05.032" title="DOI URL">https://doi.org/10.1016/j.ejmech.2019.05.032</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2019.05.032&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2019.05.032%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriptolide%25253A%252BMedicinal%252Bchemistry%25252C%252Bchemical%252Bbiology%252Band%252Bclinical%252Bprogress%26aulast%3DHou%26aufirst%3DWei%26date%3D2019%26volume%3D176%26spage%3D378%26epage%3D392" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">An-Yun  Chang</span>, <span class="hlFld-ContribAuthor ">Eric  Hsu</span>, <span class="hlFld-ContribAuthor ">Jaimin  Patel</span>, <span class="hlFld-ContribAuthor ">Yiqun  Li</span>, <span class="hlFld-ContribAuthor ">Minjie  Zhang</span>, <span class="hlFld-ContribAuthor ">Haruhisa  Iguchi</span>, <span class="hlFld-ContribAuthor ">Harry A.  Rogoff</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of Tumor Cell–Tumor Microenvironment Component Interactions as Potential Predictors of Patient Response to Napabucasin. </span><span class="cited-content_cbyCitation_journal-name">Molecular Cancer Research</span><span> <strong>2019,</strong> <em>17 </em>
                                    (7)
                                     , 1429-1434. <a href="https://doi.org/10.1158/1541-7786.MCR-18-1242" title="DOI URL">https://doi.org/10.1158/1541-7786.MCR-18-1242</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1158/1541-7786.MCR-18-1242&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1158%2F1541-7786.MCR-18-1242%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Cancer%2520Research%26atitle%3DEvaluation%252Bof%252BTumor%252BCell%2525E2%252580%252593Tumor%252BMicroenvironment%252BComponent%252BInteractions%252Bas%252BPotential%252BPredictors%252Bof%252BPatient%252BResponse%252Bto%252BNapabucasin%26aulast%3DChang%26aufirst%3DAn-Yun%26date%3D2019%26date%3D2019%26volume%3D17%26issue%3D7%26spage%3D1429%26epage%3D1434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nadezhda R.  Khasiyatullina</span>, <span class="hlFld-ContribAuthor ">Vladimir F.  Mironov</span>, <span class="hlFld-ContribAuthor ">Alexandra D.  Voloshina</span>, <span class="hlFld-ContribAuthor ">Anastasiya S.  Sapunova</span>. </span><span class="cited-content_cbyCitation_article-title">Synthesis and Antimicrobial Properties of Novel Phosphonium Salts Bearing 1,4‐Dihydroxyaryl Fragment. </span><span class="cited-content_cbyCitation_journal-name">Chemistry & Biodiversity</span><span> <strong>2019,</strong> <em>16 </em>
                                    (5)
                                     , e1900039. <a href="https://doi.org/10.1002/cbdv.201900039" title="DOI URL">https://doi.org/10.1002/cbdv.201900039</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cbdv.201900039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcbdv.201900039%26sid%3Dliteratum%253Aachs%26jtitle%3DChemistry%2520%2526%2520Biodiversity%26atitle%3DSynthesis%252Band%252BAntimicrobial%252BProperties%252Bof%252BNovel%252BPhosphonium%252BSalts%252BBearing%252B1%25252C4%2525E2%252580%252590Dihydroxyaryl%252BFragment%26aulast%3DKhasiyatullina%26aufirst%3DNadezhda%2BR.%26date%3D2019%26date%3D2019%26volume%3D16%26issue%3D5%26spage%3De1900039" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Sandip  Mondal</span>, <span class="hlFld-ContribAuthor ">Suvendu  Maity</span>, <span class="hlFld-ContribAuthor ">Prasanta  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Orthopalladated 1,4-iminonaphthoquinone derivative: Syntheses, redox series, molecular and electronic structures. </span><span class="cited-content_cbyCitation_journal-name">Inorganica Chimica Acta</span><span> <strong>2019,</strong> <em>487 </em>, 240-246. <a href="https://doi.org/10.1016/j.ica.2018.12.003" title="DOI URL">https://doi.org/10.1016/j.ica.2018.12.003</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ica.2018.12.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ica.2018.12.003%26sid%3Dliteratum%253Aachs%26jtitle%3DInorganica%2520Chimica%2520Acta%26atitle%3DOrthopalladated%252B1%25252C4-iminonaphthoquinone%252Bderivative%25253A%252BSyntheses%25252C%252Bredox%252Bseries%25252C%252Bmolecular%252Band%252Belectronic%252Bstructures%26aulast%3DMondal%26aufirst%3DSandip%26date%3D2019%26volume%3D487%26spage%3D240%26epage%3D246" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tueanjai  Khunluck</span>, <span class="hlFld-ContribAuthor ">Veerapol  Kukongviriyapan</span>, <span class="hlFld-ContribAuthor ">Laddawan  Senggunprai</span>, <span class="hlFld-ContribAuthor ">Wutthipong  Duangarsong</span>, <span class="hlFld-ContribAuthor ">Auemduan  Prawan</span>. </span><span class="cited-content_cbyCitation_article-title">The Inhibition Kinetics and Potential Anti-Migration Activity of NQO1 Inhibitory Coumarins on Cholangiocarcinoma Cells. </span><span class="cited-content_cbyCitation_journal-name">Integrative Cancer Therapies</span><span> <strong>2019,</strong> <em>18 </em>, 153473541882044. <a href="https://doi.org/10.1177/1534735418820444" title="DOI URL">https://doi.org/10.1177/1534735418820444</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1177/1534735418820444&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1177%2F1534735418820444%26sid%3Dliteratum%253Aachs%26jtitle%3DIntegrative%2520Cancer%2520Therapies%26atitle%3DThe%252BInhibition%252BKinetics%252Band%252BPotential%252BAnti-Migration%252BActivity%252Bof%252BNQO1%252BInhibitory%252BCoumarins%252Bon%252BCholangiocarcinoma%252BCells%26aulast%3DKhunluck%26aufirst%3DTueanjai%26date%3D2019%26date%3D2018%26volume%3D18%26spage%3D153473541882044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Surendra  Punganuru</span>, <span class="hlFld-ContribAuthor ">Hanumantha  Madala</span>, <span class="hlFld-ContribAuthor ">Viswanath  Arutla</span>, <span class="hlFld-ContribAuthor ">Kalkunte  Srivenugopal</span>. </span><span class="cited-content_cbyCitation_article-title">Cancer-Specific Biomarker hNQO1-Activatable Fluorescent Probe for Imaging Cancer Cells In Vitro and In Vivo. </span><span class="cited-content_cbyCitation_journal-name">Cancers</span><span> <strong>2018,</strong> <em>10 </em>
                                    (12)
                                     , 470. <a href="https://doi.org/10.3390/cancers10120470" title="DOI URL">https://doi.org/10.3390/cancers10120470</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/cancers10120470&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fcancers10120470%26sid%3Dliteratum%253Aachs%26jtitle%3DCancers%26atitle%3DCancer-Specific%252BBiomarker%252BhNQO1-Activatable%252BFluorescent%252BProbe%252Bfor%252BImaging%252BCancer%252BCells%252BIn%252BVitro%252Band%252BIn%252BVivo%26aulast%3DPunganuru%26aufirst%3DSurendra%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D12%26spage%3D470" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="_i1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0016.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0016.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=_i1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure of human NQO1 in complex with FAD (apoenzyme) (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1D4A">1D4A</a>). (A) Overall structure of NQO1 apoenzyme. One monomer is shown in green and the other in orange. Carbon atoms of FAD are shown in purple. (B) One monomer of NQO1 apoenzyme. The catalytic domain is shown in purple and the C-terminal domain in blue. Carbon atoms of FAD are shown in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Co-crystal structure of NQO1 apoenzyme with <b>1</b> bound to the active site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DXO">1DXO</a>). (A) Binding surface of <b>1</b> to the active site. (B) Detailed binding mode of <b>1</b>. (C) Chemical structure of <b>1</b>. Carbon atoms of FAD are shown in purple and <b>1</b> in yellow. Hydrogen bonds are represented by green dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0003.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. NQO1’s biological role in cancer. NQO1 can provide normal cells with multiple layers of protection to resist carcinogenesis. On the other hand, NQO1 is overexpressed in cancer cells, where it promotes cell proliferation, malignant transformation, and drug resistance.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0004.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Chemical structures of the most studied NQO1 inhibitors.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0005.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Co-crystal structure of NQO1 apoenzyme with <b>2</b> bound to the active site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F1O">2F1O</a>). (A) Binding surface of <b>2</b> to the active site. (B) Detailed binding mode of <b>2</b>. Carbon atoms of FAD are shown in purple and <b>2</b> in yellow. Hydrogen bonds are represented by green dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0006.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. Proposed mechanism for irreversible inhibition of NQO1 by ES936.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0007.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Cocrystal structure of NQO1 apoenzyme with <b>6</b> bound to the active site (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KBQ">1KBQ</a>). (A) Binding surface of <b>6</b> to the active site. (B) Detailed binding mode of <b>6</b>. Carbon atoms of FAD are shown in purple and <b>2</b> in yellow. Hydrogen bonds are represented by green dashed lines.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0008.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. Detoxification and activation pathways of quinones upon reduction by NQO1. ROS = reactive oxygen species; Hsp90 = heat shock protein 90.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig9" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0009.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Chemical structures of NQO1-bioreductive agents that are converted into DNA alkylators upon reduction by NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0010.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Chemical structures of NQO1-bioreductive agents that are converted into Hsp90 inhibitors more potent than the parent compounds upon reduction by NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0011.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. Chemical structures of NQO1-bioreductive agents that are converted into redox cyclers upon reduction by NQO1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0012.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. NQO1-activated prodrugs. The trigger group that can be activated by NQO1 is shown in red, the linker in blue, and the parent drug in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig13" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Figure 13</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0013.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 13. NQO1-activated fluorescent probes. The trigger group is present in red, the linker in blue, and the dye in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig13"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig14" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 14</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0014.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 14. NQO1-activated theranostic prodrugs. The trigger group is present in red, the linker in blue, and the dye in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig14"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig15" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 15</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/medium/jm-2018-00124v_0015.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0015.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 15. An affinity-based probe. The trigger group is present in red, the linker in blue and the dye in green.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2018/jmcmar.2018.61.issue-16/acs.jmedchem.8b00124/20180816/images/large/jm-2018-00124v_0015.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/acs.jmedchem.8b00124&amp;id=fig15"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i32">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_88031" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_88031" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 180 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, R. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Miller, K. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jemal, A.</span></span> <span> </span><span class="NLM_article-title">Cancer statistics, 2017</span>. <i>Ca-Cancer J. Clin.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">7</span>– <span class="NLM_lpage">30</span>, <span class="refDoi"> DOI: 10.3322/caac.21387</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3322%2Fcaac.21387" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28055103" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2017&pages=7-30&author=R.+L.+Siegelauthor=K.+D.+Millerauthor=A.+Jemal&title=Cancer+statistics%2C+2017&doi=10.3322%2Fcaac.21387"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1R"><div class="casContent"><span class="casTitleNuber">1</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Statistics, 2017</span></div><div class="casAuthors">Siegel Rebecca L; Miller Kimberly D; Jemal Ahmedin</div><div class="citationInfo"><span class="NLM_cas:title">CA: a cancer journal for clinicians</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">67</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">7-30</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Each year, the American Cancer Society estimates the numbers of new cancer cases and deaths that will occur in the United States in the current year and compiles the most recent data on cancer incidence, mortality, and survival.  Incidence data were collected by the Surveillance, Epidemiology, and End Results Program; the National Program of Cancer Registries; and the North American Association of Central Cancer Registries.  Mortality data were collected by the National Center for Health Statistics.  In 2017, 1,688,780 new cancer cases and 600,920 cancer deaths are projected to occur in the United States.  For all sites combined, the cancer incidence rate is 20% higher in men than in women, while the cancer death rate is 40% higher.  However, sex disparities vary by cancer type.  For example, thyroid cancer incidence rates are 3-fold higher in women than in men (21 vs 7 per 100,000 population), despite equivalent death rates (0.5 per 100,000 population), largely reflecting sex differences in the "epidemic of diagnosis." Over the past decade of available data, the overall cancer incidence rate (2004-2013) was stable in women and declined by approximately 2% annually in men, while the cancer death rate (2005-2014) declined by about 1.5% annually in both men and women.  From 1991 to 2014, the overall cancer death rate dropped 25%, translating to approximately 2,143,200 fewer cancer deaths than would have been expected if death rates had remained at their peak.  Although the cancer death rate was 15% higher in blacks than in whites in 2014, increasing access to care as a result of the Patient Protection and Affordable Care Act may expedite the narrowing racial gap; from 2010 to 2015, the proportion of blacks who were uninsured halved, from 21% to 11%, as it did for Hispanics (31% to 16%).  Gains in coverage for traditionally underserved Americans will facilitate the broader application of existing cancer control knowledge across every segment of the population.  CA Cancer J Clin 2017;67:7-30. © 2017 American Cancer Society.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSB4oj7vNRTIb5oR8RchjrrfW6udTcc2eaYJtSWEYHxTLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1c7isFWgtA%253D%253D&md5=e439f3424d5a773e4ae289c392236ad6</span></div><a href="/servlet/linkout?suffix=cit1&amp;dbid=16384&amp;doi=10.3322%2Fcaac.21387&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3322%252Fcaac.21387%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DR.%2BL.%26aulast%3DMiller%26aufirst%3DK.%2BD.%26aulast%3DJemal%26aufirst%3DA.%26atitle%3DCancer%2520statistics%252C%25202017%26jtitle%3DCa-Cancer%2520J.%2520Clin.%26date%3D2017%26volume%3D67%26spage%3D7%26epage%3D30%26doi%3D10.3322%2Fcaac.21387" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eranster, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Navazio, F.</span></span> <span> </span><span class="NLM_article-title">Soluble diaphorase in animal tissues</span>. <i>Acta Chem. Scand.</i> <span class="NLM_year" style="font-weight: bold;">1958</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">595</span>– <span class="NLM_lpage">602</span>, <span class="refDoi"> DOI: 10.3891/acta.chem.scand.12-0595</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3891%2Facta.chem.scand.12-0595" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=1958&pages=595-602&author=L.+Eransterauthor=F.+Navazio&title=Soluble+diaphorase+in+animal+tissues&doi=10.3891%2Facta.chem.scand.12-0595"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=10.3891%2Facta.chem.scand.12-0595&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3891%252Facta.chem.scand.12-0595%26sid%3Dliteratum%253Aachs%26aulast%3DEranster%26aufirst%3DL.%26aulast%3DNavazio%26aufirst%3DF.%26atitle%3DSoluble%2520diaphorase%2520in%2520animal%2520tissues%26jtitle%3DActa%2520Chem.%2520Scand.%26date%3D1958%26volume%3D12%26spage%3D595%26epage%3D602%26doi%3D10.3891%2Facta.chem.scand.12-0595" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">77</span>– <span class="NLM_lpage">97</span>, <span class="refDoi"> DOI: 10.1016/S0009-2797(00)00199-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0009-2797%2800%2900199-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11154736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=77-97&author=D.+Rossauthor=J.+K.+Kepaauthor=S.+L.+Winskiauthor=H.+D.+Beallauthor=A.+Anwarauthor=D.+Siegel&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29%3A+chemoprotection%2C+bioactivation%2C+gene+regulation+and+genetic+polymorphisms&doi=10.1016%2FS0009-2797%2800%2900199-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3R"><div class="casContent"><span class="casTitleNuber">3</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphisms</span></div><div class="casAuthors">Ross, D.; Kepa, J. K.; Winski, S. L.; Beall, H. D.; Anwar, A.; Siegel, D.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">77-97</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review, with 155 refs.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is an obligate two-electron reductase that is involved in chemoprotection and can also bioactivate certain antitumor quinones.  This review focuses on detoxification reactions catalyzed by NQO1 and its role in antioxidant defense via the generation of antioxidant forms of ubiquinone and vitamin E.  Bioactivation reactions catalyzed by NQO1 are also summarized and the development of new antitumor agents for the therapy of solid tumors with marked NQO1 content is reviewed.  NQO1 gene regulation and the role of the antioxidant response element and the xenobiotic response element in transcriptional regulation is summarized.  An overview of genetic polymorphisms in NQO1 is presented and biol. significance for chemoprotection, cancer susceptibility and antitumor drug action is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqXdLgkTvlewbVg90H21EOLACvtfcHk0lhttQiQXS-Yvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOntQ%253D%253D&md5=800e91c28ad691db2ab9cd749011f8c2</span></div><a href="/servlet/linkout?suffix=cit3&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900199-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900199-X%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DSiegel%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%253A%2520chemoprotection%252C%2520bioactivation%252C%2520gene%2520regulation%2520and%2520genetic%2520polymorphisms%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D77%26epage%3D97%26doi%3D10.1016%2FS0009-2797%2800%2900199-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span> <span> </span><span class="NLM_article-title">Role of nicotinamide quinone oxidoreductase 1 (NQO1) in protection against toxicity of electrophiles and reactive oxygen intermediates</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">355</span>– <span class="NLM_lpage">364</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(04)82019-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0076-6879%2804%2982019-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2004&pages=355-364&author=P.+Talalayauthor=A.+T.+Dinkova-Kostova&title=Role+of+nicotinamide+quinone+oxidoreductase+1+%28NQO1%29+in+protection+against+toxicity+of+electrophiles+and+reactive+oxygen+intermediates&doi=10.1016%2FS0076-6879%2804%2982019-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2804%2982019-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252804%252982019-6%26sid%3Dliteratum%253Aachs%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26atitle%3DRole%2520of%2520nicotinamide%2520quinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520in%2520protection%2520against%2520toxicity%2520of%2520electrophiles%2520and%2520reactive%2520oxygen%2520intermediates%26jtitle%3DMethods%2520Enzymol.%26date%3D2004%26volume%3D382%26spage%3D355%26epage%3D364%26doi%3D10.1016%2FS0076-6879%2804%2982019-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Erdemli, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structure, function, and mechanism of cytosolic quinone reductases</span>. <i>Vitam. Horm.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>78</i></span>,  <span class="NLM_fpage">63</span>– <span class="NLM_lpage">84</span>, <span class="refDoi"> DOI: 10.1016/S0083-6729(07)00004-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0083-6729%2807%2900004-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=18374190" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1cXltVKnu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=78&publication_year=2008&pages=63-84&author=M.+A.+Bianchetauthor=S.+B.+Erdemliauthor=L.+M.+Amzel&title=Structure%2C+function%2C+and+mechanism+of+cytosolic+quinone+reductases&doi=10.1016%2FS0083-6729%2807%2900004-0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Structure, function, and mechanism of cytosolic quinone reductases</span></div><div class="casAuthors">Bianchet, Mario A.; Erdemli, Sabri Bora; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Vitamins and Hormones (San Diego, CA, United States)</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">78</span>
        (<span class="NLM_cas:issue">Vitamin K</span>),
    <span class="NLM_cas:pages">63-84, 453-455, (color plates)</span>CODEN:
                <span class="NLM_cas:coden">VIHOAQ</span>;
        ISSN:<span class="NLM_cas:issn">0083-6729</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review.  Quinone reductases type 1 (QR1) are FAD-contg. enzymes that catalyze the redn. of many quinones, including menadione (vitamin K3), to hydroquinones using reducing equiv. provided by NAD(P)H.  The reaction proceeds with a ping-pong mechanism in which the NAD(P)H and the substrate occupy alternatively overlapping regions of the same binding site and participate in a double hydride transfer: one from NAD(P)H to the FAD of the enzyme, and one from the FADH2 of the enzyme to the quinone substrate.  The main function of QR1 is probably the detoxification of dietary quinones but it may also contribute to the redn. of vitamin K for its involvement in blood coagulation.  In addn., the same reaction that QR1 uses in the detoxification of quinones, activates some compds. making them cytotoxic.  Since QR1 is elevated in many tumors, this property has encouraged the development of chemotherapeutic compds. that become cytotoxic after redn. by QR1.  The structures of QR1 alone, and in complexes with substrates, inhibitors, and chemotherapeutic prodrugs, combined with biochem. and mechanistic studies have provided invaluable insight into the mechanism of the enzyme as well as suggestions for the improvements of the chemotherapeutic prodrugs.  Similar information is beginning to accumulate about another related enzyme, QR2.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGonlqRfBgGYELVg90H21EOLACvtfcHk0lhttQiQXS-Yvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXltVKnu70%253D&md5=7dda6283158c91a092ef2d4f18f7057a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1016%2FS0083-6729%2807%2900004-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0083-6729%252807%252900004-0%26sid%3Dliteratum%253Aachs%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DErdemli%26aufirst%3DS.%2BB.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructure%252C%2520function%252C%2520and%2520mechanism%2520of%2520cytosolic%2520quinone%2520reductases%26jtitle%3DVitam.%2520Horm.%26date%3D2008%26volume%3D78%26spage%3D63%26epage%3D84%26doi%3D10.1016%2FS0083-6729%2807%2900004-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>83</i></span>,  <span class="NLM_fpage">1033</span>– <span class="NLM_lpage">1040</span>, <span class="refDoi"> DOI: 10.1016/j.bcp.2011.12.017</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bcp.2011.12.017" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=22209713" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref6/cit6&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38XjsFOhsbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=83&publication_year=2012&pages=1033-1040&author=D.+Siegelauthor=C.+Yanauthor=D.+Ross&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+in+the+sensitivity+and+resistance+to+antitumor+quinones&doi=10.1016%2Fj.bcp.2011.12.017"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6R"><div class="casContent"><span class="casTitleNuber">6</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1) in the sensitivity and resistance to antitumor quinones</span></div><div class="casAuthors">Siegel, David; Yan, Chao; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemical Pharmacology</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">83</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">1033-1040</span>CODEN:
                <span class="NLM_cas:coden">BCPCA6</span>;
        ISSN:<span class="NLM_cas:issn">0006-2952</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  Quinones represent a large and diverse class of antitumor drugs and many quinones are approved for clin. use or are currently undergoing evaluation in clin. trials.  For many quinones redn. to the hydroquinone has been shown to play a key role in their antitumor activity.  The two-electron redn. of quinones by NQO1 has been shown to be an efficient pathway to hydroquinone formation.  NQO1 is expressed at high levels in many human solid tumors making this enzyme ideally suited for intracellular drug activation.  Cellular levels of NQO1 are influenced by the NQO1*2 polymorphism.  Individuals homozygous for the NQO1*2 allele are NQO1 null and homozygous NQO1*2*2 cell lines have been shown to be more resistant to antitumor quinones when compared to isogenic cell lines overexpressing NQO1.  In this review we will discuss the role of NQO1 in the sensitivity and resistance of human cancers to the quinone antitumor drugs mitomycin C, β-lapachone and the benzoquinone ansamycin class of Hsp90 inhibitors including 17-AAG.  The role of NQO1 in the bioreductive activation of mitomycin C remains controversial but pre-clin. data strongly suggests a role for NQO1 in the activation of β-lapachone and the benzoquinone ansamycin class of Hsp90 inhibitors.  Despite a large vol. of preclin. data demonstrating that NQO1 is an important determinant of sensitivity to these antitumor quinones there is little information on whether the clin. response to these agents is influenced by the NQO1*2 polymorphism.  The availability of simple assays for the detn. of the NQO1*2 polymorphism should facilitate clin. testing of this hypothesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEAHcbPaHFBbVg90H21EOLACvtfcHk0lhttQiQXS-Yvw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XjsFOhsbk%253D&md5=076c2caa6ec32484de8451218d5fa199</span></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=10.1016%2Fj.bcp.2011.12.017&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bcp.2011.12.017%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520in%2520the%2520sensitivity%2520and%2520resistance%2520to%2520antitumor%2520quinones%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D2012%26volume%3D83%26spage%3D1033%26epage%3D1040%26doi%3D10.1016%2Fj.bcp.2011.12.017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vredenburg, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Elias, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Venkataraman, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, D. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, J. C.</span></span> <span> </span><span class="NLM_article-title">Human NAD(P)H:quinone oxidoreductase 1 (NQO1)-mediated inactivation of reactive quinoneimine metabolites of diclofenac and mefenamic acid</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">576</span>– <span class="NLM_lpage">586</span>, <span class="refDoi"> DOI: 10.1021/tx400431k</span> </span><div class="citationLinks">[<a href="/doi/10.1021/tx400431k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2014&pages=576-586&author=G.+Vredenburgauthor=N.+S.+Eliasauthor=H.+Venkataramanauthor=D.+F.+Hendriksauthor=N.+P.+Vermeulenauthor=J.+N.+Commandeurauthor=J.+C.+Vos&title=Human+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29-mediated+inactivation+of+reactive+quinoneimine+metabolites+of+diclofenac+and+mefenamic+acid&doi=10.1021%2Ftx400431k"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Ftx400431k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Ftx400431k%26sid%3Dliteratum%253Aachs%26aulast%3DVredenburg%26aufirst%3DG.%26aulast%3DElias%26aufirst%3DN.%2BS.%26aulast%3DVenkataraman%26aufirst%3DH.%26aulast%3DHendriks%26aufirst%3DD.%2BF.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%26aulast%3DVos%26aufirst%3DJ.%2BC.%26atitle%3DHuman%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529-mediated%2520inactivation%2520of%2520reactive%2520quinoneimine%2520metabolites%2520of%2520diclofenac%2520and%2520mefenamic%2520acid%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2014%26volume%3D27%26spage%3D576%26epage%3D586%26doi%3D10.1021%2Ftx400431k" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group"><span class="NLM_string-name">den
Braver-Sewradj, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Braver, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Toorneman, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Leeuwen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vos, J. C.</span></span> <span> </span><span class="NLM_article-title">Reduction and scavenging of chemically reactive drug metabolites by NAD(P)H:quinone oxidoreductase 1 and NRH:quinone oxidoreductase 2 and variability in hepatic concentrations</span>. <i>Chem. Res. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>,  <span class="NLM_volume"><i>31</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.1021/acs.chemrestox.7b00289</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.chemrestox.7b00289" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=31&publication_year=2018&pages=116-126&author=S.+P.+den%0ABraver-Sewradjauthor=M.+W.+den+Braverauthor=R.+M.+Toornemanauthor=S.+van+Leeuwenauthor=Y.+Zhangauthor=S.+J.+Dekkerauthor=N.+P.+E.+Vermeulenauthor=J.+N.+M.+Commandeurauthor=J.+C.+Vos&title=Reduction+and+scavenging+of+chemically+reactive+drug+metabolites+by+NAD%28P%29H%3Aquinone+oxidoreductase+1+and+NRH%3Aquinone+oxidoreductase+2+and+variability+in+hepatic+concentrations&doi=10.1021%2Facs.chemrestox.7b00289"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1021%2Facs.chemrestox.7b00289&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.chemrestox.7b00289%26sid%3Dliteratum%253Aachs%26aulast%3Dden%2BBraver-Sewradj%26aufirst%3DS.%2BP.%26aulast%3Dden%2BBraver%26aufirst%3DM.%2BW.%26aulast%3DToorneman%26aufirst%3DR.%2BM.%26aulast%3Dvan%2BLeeuwen%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDekker%26aufirst%3DS.%2BJ.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%2BM.%26aulast%3DVos%26aufirst%3DJ.%2BC.%26atitle%3DReduction%2520and%2520scavenging%2520of%2520chemically%2520reactive%2520drug%2520metabolites%2520by%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520and%2520NRH%253Aquinone%2520oxidoreductase%25202%2520and%2520variability%2520in%2520hepatic%2520concentrations%26jtitle%3DChem.%2520Res.%2520Toxicol.%26date%3D2018%26volume%3D31%26spage%3D116%26epage%3D126%26doi%3D10.1021%2Facs.chemrestox.7b00289" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dinkova-Kostova, A. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>501</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">123</span>, <span class="refDoi"> DOI: 10.1016/j.abb.2010.03.019</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.abb.2010.03.019" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20361926" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhtV2jur7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=501&publication_year=2010&pages=116-123&author=A.+T.+Dinkova-Kostovaauthor=P.+Talalay&title=NAD%28P%29H%3Aquinone+acceptor+oxidoreductase+1+%28NQO1%29%2C+a+multifunctional+antioxidant+enzyme+and+exceptionally+versatile+cytoprotector&doi=10.1016%2Fj.abb.2010.03.019"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1), a multifunctional antioxidant enzyme and exceptionally versatile cytoprotector</span></div><div class="casAuthors">Dinkova-Kostova, Albena T.; Talalay, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Archives of Biochemistry and Biophysics</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">501</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">116-123</span>CODEN:
                <span class="NLM_cas:coden">ABBIA4</span>;
        ISSN:<span class="NLM_cas:issn">0003-9861</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NAD(P)H:quinone acceptor oxidoreductase 1 (NQO1) is a widely-distributed FAD-dependent flavoprotein that promotes obligatory 2-electron redns. of quinones, quinoneimines, nitroaroms., and azo dyes, at rates that are comparable with NADH or NADPH.  These redns. depress quinone levels and thereby minimize opportunities for generation of reactive oxygen intermediates by redox cycling, and for depletion of intracellular thiol pools.  NQO1 is a highly-inducible enzyme that is regulated by the Keap1/Nrf2/ARE pathway.  Evidence for the importance of the antioxidant functions of NQO1 in combating oxidative stress is provided by demonstrations that induction of NQO1 levels or their depletion (knockout, or knockdown) are assocd. with decreased and increased susceptibilities to oxidative stress, resp.  Furthermore, benzene genotoxicity is markedly enhanced when NQO1 activity is compromised.  Not surprisingly, human polymorphisms that suppress NQO1 activities are assocd. with increased predisposition to disease.  Recent studies have uncovered protective roles for NQO1 that apparently are unrelated to its enzymic activities.  NQO1 binds to and thereby stabilizes the important tumor suppressor p53 against proteasomal degrdn.  Indeed, NQO1 appears to regulate the degradative fate of other proteins.  These findings suggest that NQO1 may exercise a selective gatekeeping role in regulating the proteasomal degrdn. of specific proteins, thereby broadening the cytoprotective role of NQO1 far beyond its highly effective antioxidant functions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpSJ6D5dmXsrVg90H21EOLACvtfcHk0lhI5ks4CY_jDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhtV2jur7L&md5=fdca92a7699b006532ac6334ee79e709</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1016%2Fj.abb.2010.03.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.abb.2010.03.019%26sid%3Dliteratum%253Aachs%26aulast%3DDinkova-Kostova%26aufirst%3DA.%2BT.%26aulast%3DTalalay%26aufirst%3DP.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520acceptor%2520oxidoreductase%25201%2520%2528NQO1%2529%252C%2520a%2520multifunctional%2520antioxidant%2520enzyme%2520and%2520exceptionally%2520versatile%2520cytoprotector%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D2010%26volume%3D501%26spage%3D116%26epage%3D123%26doi%3D10.1016%2Fj.abb.2010.03.019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, L.</span></span> <span> </span><span class="NLM_article-title">Clinical implications of high NQO1 expression in breast cancers</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">14</span>, <span class="refDoi"> DOI: 10.1186/1756-9966-33-14</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2F1756-9966-33-14" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24499631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjtl2gtrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=14-14&author=Y.+Yangauthor=Y.+Zhangauthor=Q.+Wuauthor=X.+Cuiauthor=Z.+Linauthor=S.+Liuauthor=L.+Chen&title=Clinical+implications+of+high+NQO1+expression+in+breast+cancers&doi=10.1186%2F1756-9966-33-14"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical implications of high NQO1 expression in breast cancers</span></div><div class="casAuthors">Yang, Yang; Zhang, Yan; Wu, Qunying; Cui, Xuelian; Lin, Zhenhua; Liu, Shuangping; Chen, Liyan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">14/1-14/9, 9 pp.</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: NAD (P) H: quinone oxidoreductase 1 (NQO1) is a xenobiotic metabolizing enzyme that detoxifies chem. stressors and antioxidants, providing cytoprotection in normal tissues.  However, high-level expression of NQO1 has been correlated with numerous human malignancies, suggesting a role in carcinogenesis and tumor progression.  This study aimed to explore the clinicopathol. significance of NQO1 and as a prognostic determinant in breast cancer.  Methods: A total of 176 breast cancer patients with strict follow-up, 45 ductal carcinoma in situ (DCIS), 22 hyperplasia and 52 adjacent non-tumor breast tissues were selected for immunohistochem. staining of NQO1 protein.  Immunofluorescence staining was also performed to detect the subcellular localization of NQO1 protein in MCF-7 breast cancer cells.  Eight fresh breast cancers paired with adjacent non-tumor tissues were quantified using real time RT-PCR (qRT-PCR) and western blot.  The correlations between NQO1 overexpression and the clin. features of breast cancer were evaluated using chi-square test and Fisher's exact tests.  The survival rate was calcd. using the Kaplan-Meier method, and the relationship between prognostic factors and patient survival was also analyzed by the Cox proportional hazards models.  Results: NQO1 protein showed a mainly cytoplasmic staining pattern in breast cancer.  The strongly pos. rate of NQO1 protein was 61.9% (109/176) in breast cancer, and was significantly higher than in DCIS (31.1%, 14/45), hyperplasia tissues (13.6%, 3/22) and adjacent non-tumor tissues (13.5%, 7/52).  High-level expression of NQO1 protein was correlated with late clin. stage, poor differentiation, lymph node metastasis, Her2 expression and disease-free and 10-yr overall survival rates in breast cancer.  Moreover, multivariate anal. suggested that NQO1 emerged as a significant independent prognostic factor along with clin. stage nd Her2 expression status in patients with breast cancer.  Conclusions: High-level expression of NQO1 appears to be assocd. with breast cancer progression, and may be a potential biomarker for poor prognostic evaluation of breast cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr_ZR_Aw-dUrrVg90H21EOLACvtfcHk0lhI5ks4CY_jDA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjtl2gtrc%253D&md5=deb02775d7dd7c50017839c92e00a463</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-33-14&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-33-14%26sid%3Dliteratum%253Aachs%26aulast%3DYang%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DWu%26aufirst%3DQ.%26aulast%3DCui%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DL.%26atitle%3DClinical%2520implications%2520of%2520high%2520NQO1%2520expression%2520in%2520breast%2520cancers%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D33%26spage%3D14%26epage%3D14%26doi%3D10.1186%2F1756-9966-33-14" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Marin, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lopez de Cerain, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hamilton, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez-Penuela, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Idoate, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bello, J.</span></span> <span> </span><span class="NLM_article-title">DT-diaphorase and cytochrome B5 reductase in human lung and breast tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>76</i></span>,  <span class="NLM_fpage">923</span>– <span class="NLM_lpage">929</span>, <span class="refDoi"> DOI: 10.1038/bjc.1997.485</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fbjc.1997.485" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=9328153" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADyaK2sXmvVGqur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=76&publication_year=1997&pages=923-929&author=A.+Marinauthor=A.+Lopez+de+Cerainauthor=E.+Hamiltonauthor=A.+D.+Lewisauthor=J.+M.+Martinez-Penuelaauthor=M.+A.+Idoateauthor=J.+Bello&title=DT-diaphorase+and+cytochrome+B5+reductase+in+human+lung+and+breast+tumours&doi=10.1038%2Fbjc.1997.485"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11R"><div class="casContent"><span class="casTitleNuber">11</span><div class="casTitle"><span class="NLM_cas:atitle">DT-diaphorase and cytochrome b5 reductase in human lung and breast tumors</span></div><div class="casAuthors">Marin, A.; De Cerain, A. Lopez; Hamilton, E.; Lewis, A. D.; Martinez-Penuela, J. M.; Idoate, M. A.; Bello, J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">76</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">923-929</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Churchill Livingstone</span>)
        </div><div class="casAbstract">The level of expression of enzymes that can activate or detoxify bioreductive agents within tumors has emerged as an important feature in the development of these anti-tumor compds.  The levels of two such reductase enzymes have been detd. in 19 human non-small-cell lung tumors and 20 human breast tumors, together with the corresponding normal tissue.  DT-diaphorase (DTD) enzyme levels (both expression and activity) were detd. in these samples.  Cytochrome b5 reductase (Cytb5R) activity was also assessed.  With the exception of six patients, the levels of DTD activity were below 45 nmol min-1 mg-1 in the normal tissues assayed.  DTD tumor activity was extremely variable, distinguishing two different groups of patients, one with DTD activity above 79 nmol min-1 mg-1 and the other with levels that were in the same range as found for the normal tissues.  In 53% of the lung tumor samples, DTD activity was increased with respect to the normal tissue by a factor of 2.4-90.3 (range 79-965 nmol min-1 mg-1).  In 70% of the breast tumor samples, DTD activity was over 80 nmol min-1 mg-1 (range 83-267 nmol min-1 mg-1).  DTD expression measured by Western blot correlated well with the enzyme activity measured in both tumor and normal tissues.  The levels of the other reductase enzyme, Cytb5R, were not as variable as those for DTD, being in the same range in both tumor and normal tissue or slightly higher in the normal tissues.  The heterogeneous nature of DTD activity and expression reinforces the need to measure enzyme levels in individual patients before therapy with DTD-activated bioreductive drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrdxUZUHFex87Vg90H21EOLACvtfcHk0lgnFz_hYSiEag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXmvVGqur8%253D&md5=e23411ec0a602243217380212f109117</span></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1038%2Fbjc.1997.485&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fbjc.1997.485%26sid%3Dliteratum%253Aachs%26aulast%3DMarin%26aufirst%3DA.%26aulast%3DLopez%2Bde%2BCerain%26aufirst%3DA.%26aulast%3DHamilton%26aufirst%3DE.%26aulast%3DLewis%26aufirst%3DA.%2BD.%26aulast%3DMartinez-Penuela%26aufirst%3DJ.%2BM.%26aulast%3DIdoate%26aufirst%3DM.%2BA.%26aulast%3DBello%26aufirst%3DJ.%26atitle%3DDT-diaphorase%2520and%2520cytochrome%2520B5%2520reductase%2520in%2520human%2520lung%2520and%2520breast%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D1997%26volume%3D76%26spage%3D923%26epage%3D929%26doi%3D10.1038%2Fbjc.1997.485" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Nonhomologous end joining is essential for cellular resistance to the novel antitumor agent, beta-lapachone</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>67</i></span>,  <span class="NLM_fpage">6936</span>– <span class="NLM_lpage">6945</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-07-0935</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-07-0935" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=67&publication_year=2007&pages=6936-6945&author=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=Y.+Dongauthor=E.+A.+Beyauthor=D.+A.+Boothman&title=Nonhomologous+end+joining+is+essential+for+cellular+resistance+to+the+novel+antitumor+agent%2C+beta-lapachone&doi=10.1158%2F0008-5472.CAN-07-0935"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-07-0935&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-07-0935%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNonhomologous%2520end%2520joining%2520is%2520essential%2520for%2520cellular%2520resistance%2520to%2520the%2520novel%2520antitumor%2520agent%252C%2520beta-lapachone%26jtitle%3DCancer%2520Res.%26date%3D2007%26volume%3D67%26spage%3D6936%26epage%3D6945%26doi%3D10.1158%2F0008-5472.CAN-07-0935" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer</span>. <i>Oncol. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2589</span>– <span class="NLM_lpage">2595</span>, <span class="refDoi"> DOI: 10.3892/or.2014.3494</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3892%2For.2014.3494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25231218" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXitVGktL7F" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=2014&pages=2589-2595&author=X.+Cuiauthor=T.+Jinauthor=X.+Wangauthor=G.+Jinauthor=Z.+Liauthor=L.+Lin&title=NAD%28P%29H%3Aquinone+oxidoreductase-1+overexpression+predicts+poor+prognosis+in+small+cell+lung+cancer&doi=10.3892%2For.2014.3494"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase-1 overexpression predicts poor prognosis in small cell lung cancer</span></div><div class="casAuthors">Cui, Xuelian; Jin, Tiefeng; Wang, Xiaoyan; Jin, Guang; Li, Zhuhu; Lin, Lijuan</div><div class="citationInfo"><span class="NLM_cas:title">Oncology Reports</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">32</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2589-2595</span>CODEN:
                <span class="NLM_cas:coden">OCRPEW</span>;
        ISSN:<span class="NLM_cas:issn">1021-335X</span>.
    
            (<span class="NLM_cas:orgname">Spandidos Publications Ltd.</span>)
        </div><div class="casAbstract">NAD(P)H:quinone oxidoreductase-1 (NQO1) is commonly elevated in various types of human cancers, including pancreatic, breast and thyroid cancer, as well as others.  However, little is known concerning the status of NQO1 in small cell lung cancer (SCLC).  To investigate the clinicopathol. significance of NQO1 expression and evaluate its role as a potential prognostic marker in SCLC, protein and mRNA expression levels of NQO1 were detd. in four fresh tissue samples of SCLC and paired adjacent non-cancerous tissues using western blotting and real-time qRT-PCR, resp., and 115 cases of SCLC with strict follow-up were selected for immunohistochem. (IHC) staining of NQO1 protein.  The correlation between NQO1 expression and the clinicopathol. features of SCLC was evaluated using the Chi-square (χ2) and Fisher's exact tests, survival rates were calcd. using the Kaplan-Meier method, and univariate and multivariate analyses were performed using the Cox proportional hazards regression model.  In regards to the results, levels of NQO1 protein and mRNA were significantly elevated in the four fresh tissue samples of SCLC compared with levels in the paired adjacent non-cancerous tissues, resp.  IHC anal. showed that the rate of strong pos. NQO1 protein expression was significantly higher (48.70%) in SCLC when compared with the rate in either adjacent non-cancerous or normal lung tissues (both P<0.001).  The rate of strong pos. NQO1 protein expression was correlated with large tumor size (P = 0.019), late pathol. stage (P = 0.001) and the presence of lymph node metastasis (P = 0.001).  Moreover, high-level expression of NQO1 protein was significantly correlated with lower disease-free survival (P = 0.001) and 5-yr survival rates (P<0.001) in SCLC patients, particularly early-stage patients (P = 0.045 and P = 0.033, resp.).  Further Cox anal. revealed that NQO1 expression emerged as a significantly independent hazard factor for the 5-yr survival rate of patients with SCLC (P = 0.042).  In conclusion, NQO1 plays an important role in the progression of SCLC, and it may potentially be used as a biomarker and therapeutic target of SCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrfTZv2w1bkkbVg90H21EOLACvtfcHk0lgnFz_hYSiEag"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXitVGktL7F&md5=6f70a1c514fac8b8ebfac85dea7a7981</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.3892%2For.2014.3494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252For.2014.3494%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DLin%26aufirst%3DL.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase-1%2520overexpression%2520predicts%2520poor%2520prognosis%2520in%2520small%2520cell%2520lung%2520cancer%26jtitle%3DOncol.%2520Rep.%26date%3D2014%26volume%3D32%26spage%3D2589%26epage%3D2595%26doi%3D10.3892%2For.2014.3494" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Men, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Piao, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span> <span> </span><span class="NLM_article-title">NQO1 protein expression predicts poor prognosis of non-small cell lung cancers</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">207</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1227-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2Fs12885-015-1227-8" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=207&author=Z.+Liauthor=Y.+Zhangauthor=T.+Jinauthor=J.+Menauthor=Z.+Linauthor=P.+Qiauthor=Y.+Piaoauthor=G.+Yan&title=NQO1+protein+expression+predicts+poor+prognosis+of+non-small+cell+lung+cancers&doi=10.1186%2Fs12885-015-1227-8"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1227-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1227-8%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DZ.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DMen%26aufirst%3DJ.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DQi%26aufirst%3DP.%26aulast%3DPiao%26aufirst%3DY.%26aulast%3DYan%26aufirst%3DG.%26atitle%3DNQO1%2520protein%2520expression%2520predicts%2520poor%2520prognosis%2520of%2520non-small%2520cell%2520lung%2520cancers%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D207%26doi%3D10.1186%2Fs12885-015-1227-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Girard, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by beta-lapachone</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>104</i></span>,  <span class="NLM_fpage">11832</span>– <span class="NLM_lpage">11837</span>, <span class="refDoi"> DOI: 10.1073/pnas.0702176104</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1073%2Fpnas.0702176104" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=17609380" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXotVakt74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=104&publication_year=2007&pages=11832-11837&author=E.+A.+Beyauthor=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=Y.+Dongauthor=C.+R.+Yangauthor=L.+Girardauthor=J.+D.+Minnaauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=D.+A.+Boothman&title=An+NQO1-+and+PARP-1-mediated+cell+death+pathway+induced+in+non-small-cell+lung+cancer+cells+by+beta-lapachone&doi=10.1073%2Fpnas.0702176104"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">An NQO1- and PARP-1-mediated cell death pathway induced in non-small-cell lung cancer cells by β-lapachone</span></div><div class="casAuthors">Bey, Erik A.; Bentle, Melissa S.; Reinicke, Kathryn E.; Dong, Ying; Yang, Chin-Rang; Girard, Luc; Minna, John D.; Bornmann, William G.; Gao, Jinming; Boothman, Avid A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">104</span>
        (<span class="NLM_cas:issue">28</span>),
    <span class="NLM_cas:pages">11832-11837, S11832/1-S11832/17</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">Lung cancer is the no. one cause of cancer-related deaths in the world.  Patients treated with current chemotherapies for non-small-cell lung cancers (NSCLCs) have a survival rate of ≈15% after 5 years.  Novel approaches are needed to treat this disease.  We show elevated NAD(P)H:quinone oxidoreductase-1 (NQO1) levels in tumors from NSCLC patients.  β-Lapachone, an effective chemotherapeutic and radiosensitizing agent, selectively killed NSCLC cells that expressed high levels of NQO1.  Isogenic H596 NSCLC cells that lacked or expressed NQO1 along with A549 NSCLC cells treated with or without dicoumarol, were used to elucidate the mechanism of action and optimal therapeutic window of P3-lapachone.  NSCLC cells were killed in an NQO1-dependent manner by 3-lapachone (LD50, ≈4 μM) with a min. 2-h exposure.  Kinetically, β-lapachone-induced cell death was characterized by the following: (i) dramatic reactive oxygen species (ROS) formation, eliciting extensive DNA damage; (ii) hyperactivation of poly(ADP-ribose)polymerase-1 (PARP-1); (iii) depletion of NAD+/ATP levels; and (iv) proteolytic cleavage of p53/PARP-1, indicating μ-calpain activation and apoptosis.  β-Lapachone-induced PARP-1 hyperactivation, nucleotide depletion, and apoptosis were blocked by 3-aminobenzamide, a PARP-1 inhibitor, and BAPTA acetoxymethyl ester (BAPTA-AM), a Ca2+ chelator.  NQO1- cells (H596, IMR-90) or dicoumarol-exposed NQO1 + A549 cells were resistant (LD50, > 40 μM) to ROS formation and all cytotoxic effects of /-lapachone.  Our data indicate that the most efficacious strategy using β-lapachone in chemotherapy was to deliver the drug in short pulses, greatly reducing cytotoxicity to NQO1- "normal" cells.  β-Lapachone killed cells in a tumor-selective manner and is indicated for use against NQO1+ NSCLC cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGot6pYpTh-Qp7Vg90H21EOLACvtfcHk0lgA49C-XqvBbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXotVakt74%253D&md5=3468a6d9a091d4379eec7f362099ee47</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1073%2Fpnas.0702176104&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.0702176104%26sid%3Dliteratum%253Aachs%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYang%26aufirst%3DC.%2BR.%26aulast%3DGirard%26aufirst%3DL.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DAn%2520NQO1-%2520and%2520PARP-1-mediated%2520cell%2520death%2520pathway%2520induced%2520in%2520non-small-cell%2520lung%2520cancer%2520cells%2520by%2520beta-lapachone%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2007%26volume%3D104%26spage%3D11832%26epage%3D11837%26doi%3D10.1073%2Fpnas.0702176104" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabbani, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hsieh, J. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Prostate cancer radiosensitization through poly(ADP-Ribose) polymerase-1 hyperactivation</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">8088</span>– <span class="NLM_lpage">8096</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-10-1418</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-10-1418" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=8088-8096&author=Y.+Dongauthor=E.+A.+Beyauthor=L.+S.+Liauthor=W.+Kabbaniauthor=J.+Yanauthor=X.+J.+Xieauthor=J.+T.+Hsiehauthor=J.+Gaoauthor=D.+A.+Boothman&title=Prostate+cancer+radiosensitization+through+poly%28ADP-Ribose%29+polymerase-1+hyperactivation&doi=10.1158%2F0008-5472.CAN-10-1418"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-10-1418&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-10-1418%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DKabbani%26aufirst%3DW.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DHsieh%26aufirst%3DJ.%2BT.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DProstate%2520cancer%2520radiosensitization%2520through%2520poly%2528ADP-Ribose%2529%2520polymerase-1%2520hyperactivation%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D8088%26epage%3D8096%26doi%3D10.1158%2F0008-5472.CAN-10-1418" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qin, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span> <span> </span><span class="NLM_article-title">Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma</span>. <i>Exp. Mol. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>96</i></span>,  <span class="NLM_fpage">200</span>– <span class="NLM_lpage">205</span>, <span class="refDoi"> DOI: 10.1016/j.yexmp.2013.12.008</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.yexmp.2013.12.008" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24384455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXlvVWnsL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=2014&pages=200-205&author=L.+Linauthor=Y.+Qinauthor=T.+Jinauthor=S.+Liuauthor=S.+Zhangauthor=X.+Shenauthor=Z.+Lin&title=Significance+of+NQO1+overexpression+for+prognostic+evaluation+of+gastric+adenocarcinoma&doi=10.1016%2Fj.yexmp.2013.12.008"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17R"><div class="casContent"><span class="casTitleNuber">17</span><div class="casTitle"><span class="NLM_cas:atitle">Significance of NQO1 overexpression for prognostic evaluation of gastric adenocarcinoma</span></div><div class="casAuthors">Lin, Lijuan; Qin, Yunzhi; Jin, Tiefeng; Liu, Shuangping; Zhang, Songnan; Shen, Xionghu; Lin, Zhenhua</div><div class="citationInfo"><span class="NLM_cas:title">Experimental and Molecular Pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">200-205</span>CODEN:
                <span class="NLM_cas:coden">EXMPA6</span>;
        ISSN:<span class="NLM_cas:issn">0014-4800</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">NQO1 (NAD(P)H: quinone oxidoreductase, also known as DT-diaphorase) plays a prominent role in maintaining cellular homeostasis.  NQO1 is abnormally elevated in many solid cancer types, including those of the adrenal gland, breast, colon, lung, ovary, and thyroid.  However, little is known about the status of NQO1 in gastric adenocarcinoma (GAC).  To investigate the clinicopathol. significance of NQO1 expression in GAC, and thus evaluate its role as a potential prognostic marker, 203 cases of primary GAC, 31 of gastric dysplasia, and 53 of adjacent non-tumor tissues were selected for immunohistochem. staining of NQO1 protein.  Correlations between NQO1 overexpression and clinicopathol. characteristics were evaluated by χ2 test and Fisher's exact test, while survival rates were calcd. by Kaplan-Meier method.  The relationship between prognostic factors and patient survival was analyzed by Cox proportional hazards model.  Through these analyses it was found that the strongly pos. rate of NQO1 protein in GAC was significantly higher than that in gastric dysplasia and adjacent non-tumor tissues.  Anal. by qRT-PCR also confirmed that NQO1 mRNA levels were increased in GAC compared with those detected in either adjacent non-tumor tissues or normal gastric mucosa.  Addnl., the NQO1 expression rate was pos. correlated with tumor size, serosal invasion, tumor stage, and both disease-free survival and 5-yr survival rates.  Further anal. showed that although NQO1 was not an independent predictor of GAC, elevated expression of NQO1 could predict lower disease-free survival and 5-yr survival times in late-stage patients.  In conclusion, NQO1 plays an important role in the progression of GAC, and might be a potential, but not an independent, poor prognostic biomarker and therapeutic target of GAC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpOezXLNrgOI7Vg90H21EOLACvtfcHk0lgA49C-XqvBbA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXlvVWnsL4%253D&md5=b0477890872ddbce9d0a556f3f1eb004</span></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=10.1016%2Fj.yexmp.2013.12.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.yexmp.2013.12.008%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DL.%26aulast%3DQin%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DShen%26aufirst%3DX.%26aulast%3DLin%26aufirst%3DZ.%26atitle%3DSignificance%2520of%2520NQO1%2520overexpression%2520for%2520prognostic%2520evaluation%2520of%2520gastric%2520adenocarcinoma%26jtitle%3DExp.%2520Mol.%2520Pathol.%26date%3D2014%26volume%3D96%26spage%3D200%26epage%3D205%26doi%3D10.1016%2Fj.yexmp.2013.12.008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ji, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jiang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, S.</span></span> <span> </span><span class="NLM_article-title">Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">1124</span>– <span class="NLM_lpage">1131</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24695690" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC2cngtFGruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2014&pages=1124-1131&author=L.+Jiauthor=Y.+Weiauthor=T.+Jiangauthor=S.+Wang&title=Correlation+of+Nrf2%2C+NQO1%2C+MRP1%2C+cmyc+and+p53+in+colorectal+cancer+and+their+relationships+to+clinicopathologic+features+and+survival"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Correlation of Nrf2, NQO1, MRP1, cmyc and p53 in colorectal cancer and their relationships to clinicopathologic features and survival</span></div><div class="casAuthors">Ji Lili; Wei Yingze; Wang Shuyang; Jiang Tao</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">1124-31</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Due to emergence of resistant tumor populations, prognosis for metastatic colorectal cancer (CRC) patients remains poor and five-year survival rate is still very low.  To guide clinicians in selecting treatment option for CRC patients, reliable markers predictive of poor clinical outcome are desirable.  This study analyzed the correlation of NF-E2-related factor 2 (Nrf2), NAD(P)H quinine oxidoreductase 1 (NQO1), multidrug resistant protein 1 (MRP1), cmyc and p53 in CRC and their relationships to Duke's stage and clinical prognosis. 76 specimens of CRC tissues were immunohistochemically investigated using Nrf2, NQO1, MRP1, cmyc and p53 antibodies.  IHC stain showed that Nrf2, NQO1, MRP1, cmyc and p53 were highly expressed in CRC tissues compared with adjacent non-tumor tissues.  Significant positive correlations were found between the expression of Nrf2 and that of NQO1, MRP1, cmyc and p53.  Moreover, there was significant correlation between the high level of Nrf2, NQO1, MRP1, p53 expression and Duke's stage, as well as poor clinical prognosis.  We confirmed that Nrf2, NQO1, MRP1, and p53 expression exhibits considerable heterogeneity according to CRC clinical stage and prognosis.  Nrf2 is the most promising biomarker in identifying a poor prognostic group of CRC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTzJ6OiEeVF0e2qxNLjzXe8fW6udTcc2eaSbD1HENpADLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2cngtFGruw%253D%253D&md5=135cdebf7b8d1304e274cba8ebb58eb8</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DJi%26aufirst%3DL.%26aulast%3DWei%26aufirst%3DY.%26aulast%3DJiang%26aufirst%3DT.%26aulast%3DWang%26aufirst%3DS.%26atitle%3DCorrelation%2520of%2520Nrf2%252C%2520NQO1%252C%2520MRP1%252C%2520cmyc%2520and%2520p53%2520in%2520colorectal%2520cancer%2520and%2520their%2520relationships%2520to%2520clinicopathologic%2520features%2520and%2520survival%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2014%26volume%3D7%26spage%3D1124%26epage%3D1131" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ough, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberley, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, J. J.</span></span> <span> </span><span class="NLM_article-title">Efficacy of beta-lapachone in pancreatic cancer treatment: exploiting the novel, therapeutic target NQO1</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">102</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.4161/cbt.4.1.1382</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.4161%2Fcbt.4.1.1382" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2005&pages=102-109&author=M.+Oughauthor=A.+Lewisauthor=E.+A.+Beyauthor=J.+Gaoauthor=J.+M.+Ritchieauthor=W.+Bornmannauthor=D.+A.+Boothmanauthor=L.+W.+Oberleyauthor=J.+J.+Cullen&title=Efficacy+of+beta-lapachone+in+pancreatic+cancer+treatment%3A+exploiting+the+novel%2C+therapeutic+target+NQO1&doi=10.4161%2Fcbt.4.1.1382"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.4161%2Fcbt.4.1.1382&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.4.1.1382%26sid%3Dliteratum%253Aachs%26aulast%3DOugh%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DA.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DRitchie%26aufirst%3DJ.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DOberley%26aufirst%3DL.%2BW.%26aulast%3DCullen%26aufirst%3DJ.%2BJ.%26atitle%3DEfficacy%2520of%2520beta-lapachone%2520in%2520pancreatic%2520cancer%2520treatment%253A%2520exploiting%2520the%2520novel%252C%2520therapeutic%2520target%2520NQO1%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2005%26volume%3D4%26spage%3D102%26epage%3D109%26doi%3D10.4161%2Fcbt.4.1.1382" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ough, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsao, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oberley, L. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, J. J.</span></span> <span> </span><span class="NLM_article-title">Targeting NAD(P)H:quinone oxidoreductase (NQO1) in pancreatic cancer</span>. <i>Mol. Carcinog.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">1825</span>– <span class="NLM_lpage">1834</span>, <span class="refDoi"> DOI: 10.1002/mc.20199</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fmc.20199" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28639725" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref20/cit20&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7rK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2017&pages=1825-1834&author=A.+M.+Lewisauthor=M.+Oughauthor=J.+Duauthor=M.+S.+Tsaoauthor=L.+W.+Oberleyauthor=J.+J.+Cullen&title=Targeting+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29+in+pancreatic+cancer&doi=10.1002%2Fmc.20199"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit20R"><div class="casContent"><span class="casTitleNuber">20</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting NAD(P)H:Quinone Oxidoreductase (NQO1) in Pancreatic Cancer</span></div><div class="casAuthors">Lewis, Anne M.; Ough, Matthew; Du, Juan; Tsao, Ming-Sound; Oberley, Larry W.; Cullen, Joseph J.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Carcinogenesis</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1825-1834</span>CODEN:
                <span class="NLM_cas:coden">MOCAE8</span>;
        ISSN:<span class="NLM_cas:issn">0899-1987</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">NAD(P)H:Quinone oxidoreductase (NQO1) functions as an important part of cellular antioxidant defense by detoxifying quinones, thus preventing the formation of reactive oxygen species.  The aims of our study were to det. if NQO1 is elevated in pancreatic cancer specimens and pancreatic cancer cell lines and if so, would compds. previously demonstrated to redox cycle with NQO1 be effective in killing pancreatic cancer cells.  Immunohistochem. of resected pancreatic specimens demonstrated an increased immunoreactivity for NQO1 in pancreatic cancer and pancreatic intraepithelial neoplasia (PanIN) specimens vs. normal human pancreas.  Immunocytochem. and Western immunoblots demonstrated inceased immunoreactivity in pancreatic cancer cells when compared to a near normal immortalized human pancreatic ductal epithelial cell line and a colonic epithelial cell line.  Streptonigrin, a compd. known to cause redox cycling in the presence of NQO1, decreased clonogenic survival and decreased anchorage-independent growth in soft agar.  Streptonigrin had little effect on cell lines with absent or reduced levels of NQO1.  The effects of streptonigrin were reversed in pancreatic cancer cells pretreated with dicumarol, a known inhibitor of NQO1.  NQO1 may be a therapeutic target in pancreatic cancer where survival is measured in months.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo3VRHeDUDUa7Vg90H21EOLACvtfcHk0liujijK9P6_Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVanu7rK&md5=6d49f7cbc682ebca05b1fe5b4767f791</span></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=10.1002%2Fmc.20199&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fmc.20199%26sid%3Dliteratum%253Aachs%26aulast%3DLewis%26aufirst%3DA.%2BM.%26aulast%3DOugh%26aufirst%3DM.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DTsao%26aufirst%3DM.%2BS.%26aulast%3DOberley%26aufirst%3DL.%2BW.%26aulast%3DCullen%26aufirst%3DJ.%2BJ.%26atitle%3DTargeting%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%2520in%2520pancreatic%2520cancer%26jtitle%3DMol.%2520Carcinog.%26date%3D2017%26volume%3D56%26spage%3D1825%26epage%3D1834%26doi%3D10.1002%2Fmc.20199" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chun, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thibodeaux, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sumer, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordy, J. S.</span></span> <span> </span><span class="NLM_article-title">NQO1-mediated tumor-selective lethality and radiosensitization for head and neck cancer</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">1757</span>– <span class="NLM_lpage">1767</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-15-0765</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-15-0765" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27196777" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref21/cit21&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XhtFSrur%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2016&pages=1757-1767&author=L.+S.+Liauthor=S.+Reddyauthor=Z.+H.+Linauthor=S.+Liuauthor=H.+Parkauthor=S.+G.+Chunauthor=W.+G.+Bornmannauthor=J.+Thibodeauxauthor=J.+Yanauthor=G.+Chakrabartiauthor=X.+J.+Xieauthor=B.+D.+Sumerauthor=D.+A.+Boothmanauthor=J.+S.+Yordy&title=NQO1-mediated+tumor-selective+lethality+and+radiosensitization+for+head+and+neck+cancer&doi=10.1158%2F1535-7163.MCT-15-0765"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit21R"><div class="casContent"><span class="casTitleNuber">21</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1-Mediated Tumor-Selective Lethality and Radiosensitization for Head and Neck Cancer</span></div><div class="casAuthors">Li, Long-Shan; Reddy, Srilakshmi; Lin, Zhen-Hua; Liu, Shuangping; Park, Hyunsil; Chun, Stephen G.; Bornmann, William G.; Thibodeaux, Joel; Yan, Jingsheng; Chakrabarti, Gaurab; Xie, Xian-Jin; Sumer, Baran D.; Boothman, David A.; Yordy, John S.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1757-1767</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Ionizing radiation (IR) is a key therapeutic regimen for many head and neck cancers (HNC).  However, the 5-yr overall survival rate for locally advanced HNCs is approx. 50% and better therapeutic efficacy is needed.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is overexpressed in many cancers, and β-lapachone (β-lap), a unique NQO1 bioactivatable drug, exploits this enzyme to release massive reactive oxygen species (ROS) that synergize with IR to kill by programmed necrosis. β-Lap represents a novel therapeutic opportunity in HNC leading to tumor-selective lethality that will enhance the efficacy of IR.  Immunohistochem. staining and Western blot assays were used to assess the expression levels of NQO1 in HNC cells and tumors.  Forty-five percent of endogenous HNCs expressed elevated NQO1 levels.  In addn., multiple HNC cell lines and tumors demonstrated elevated levels of NQO1 expression and activity and were tested for anticancer lethality and radiosensitization by β-lap using long-term survival assays.  The combination of nontoxic β-lap doses and IR significantly enhanced NQO1-dependent tumor cell lethality, increased ROS, TUNEL-pos. cells, DNA damage, NAD+, and ATP consumption, and resulted in significant antitumor efficacy and prolonged survival in two xenograft murine HNC models, demonstrating β-lap radiosensitization of HNCs through a NQO1-dependent mechanism.  This translational study offers a potential biomarker-driven strategy using NQO1 expression to select tumors susceptible to β-lap-induced radiosensitization.  Mol Cancer Ther; 15(7); 1757-67. ©2016 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRs3bMowb77LVg90H21EOLACvtfcHk0liujijK9P6_Rg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhtFSrur%252FN&md5=34a4232d03e6dee61e8074f3c918e521</span></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-15-0765&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-15-0765%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DReddy%26aufirst%3DS.%26aulast%3DLin%26aufirst%3DZ.%2BH.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DPark%26aufirst%3DH.%26aulast%3DChun%26aufirst%3DS.%2BG.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DThibodeaux%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DSumer%26aufirst%3DB.%2BD.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DYordy%26aufirst%3DJ.%2BS.%26atitle%3DNQO1-mediated%2520tumor-selective%2520lethality%2520and%2520radiosensitization%2520for%2520head%2520and%2520neck%2520cancer%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2016%26volume%3D15%26spage%3D1757%26epage%3D1767%26doi%3D10.1158%2F1535-7163.MCT-15-0765" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wakai, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shirai, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sakata, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Matsuda, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Korita, P. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Takamura, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ajioka, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatakeyama, K.</span></span> <span> </span><span class="NLM_article-title">Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma</span>. <i>Int. J. Clin. Exp. Pathol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">363</span>– <span class="NLM_lpage">370</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21577322" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref22/cit22&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC3Mrhs1KqtA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2011&pages=363-370&author=T.+Wakaiauthor=Y.+Shiraiauthor=J.+Sakataauthor=Y.+Matsudaauthor=P.+V.+Koritaauthor=M.+Takamuraauthor=Y.+Ajiokaauthor=K.+Hatakeyama&title=Prognostic+significance+of+NQO1+expression+in+intrahepatic+cholangiocarcinoma"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit22R"><div class="casContent"><span class="casTitleNuber">22</span><div class="casTitle"><span class="NLM_cas:atitle">Prognostic significance of NQO1 expression in intrahepatic cholangiocarcinoma</span></div><div class="casAuthors">Wakai Toshifumi; Shirai Yoshio; Sakata Jun; Matsuda Yasunobu; Korita Pavel V; Takamura Masaaki; Ajioka Yoichi; Hatakeyama Katsuyoshi</div><div class="citationInfo"><span class="NLM_cas:title">International journal of clinical and experimental pathology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">363-70</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">This study aimed to evaluate the association between the immunohistochemical expression of NAD(P) H:quinone oxidoreductase-1 (NQO1) and nuclear factor erythroid 2-related factor 2 (Nrf2) in resected specimens of intrahepatic cholangiocarcinoma (ICC) and to elucidate the prognostic value of NQO1 and Nrf2 expression.  A retrospective analysis was conducted of 34 consecutive patients who underwent surgical resection for ICC.  Immunohistochemistry of the resected specimens was conducted using each of the following primary monoclonal antibodies against NQO1 and Nrf2.  Of the 34 patients, 23 were classified as having tumors with NQO1-positive expression and 11 had tumors with loss of NQO1 expression, whereas 22 patients had tumors with Nrf2-positive expression and 12 had tumors with loss of Nrf2 expression.  NQO1 expression showed a positive association with Nrf2 expression (p=0.005).  Loss of NQO1 expression was more frequent in tumor specimens that were moderately or poorly differentiated (11/26; 42%) than in well-differentiated tumors (0/8; 0%; p=0.034).  Post-resection survival was significantly worse in patients with tumors with loss of NQO1 expression than in patients with NQO1-positive tumors (cumulative 5 -year survival rate of 0% and 51%, respectively; p=0.005).  Nrf2 expression was not associated with survival after resection (p=0.287).  The Cox proportional hazards regression analysis revealed that lymph node involvement (p<0.001) and loss of NQO1 expression (p<0.001) had an independent adverse effect on survival.  Loss of NQO1 expression reflects dedifferentiation and thus indicates a poor prognosis for patients undergoing resection for ICC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRlyqtZJd_lev3jf77P2BG3fW6udTcc2eaSsVFxgbB_S7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mrhs1KqtA%253D%253D&md5=833ec78d5f395c8f361dc0d168f11295</span></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWakai%26aufirst%3DT.%26aulast%3DShirai%26aufirst%3DY.%26aulast%3DSakata%26aufirst%3DJ.%26aulast%3DMatsuda%26aufirst%3DY.%26aulast%3DKorita%26aufirst%3DP.%2BV.%26aulast%3DTakamura%26aufirst%3DM.%26aulast%3DAjioka%26aufirst%3DY.%26aulast%3DHatakeyama%26aufirst%3DK.%26atitle%3DPrognostic%2520significance%2520of%2520NQO1%2520expression%2520in%2520intrahepatic%2520cholangiocarcinoma%26jtitle%3DInt.%2520J.%2520Clin.%2520Exp.%2520Pathol.%26date%3D2011%26volume%3D4%26spage%3D363%26epage%3D370" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buranrat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chau-in, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puapairoj, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeekpudsa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span> <span> </span><span class="NLM_article-title">NQO1 expression correlates with cholangiocarcinoma prognosis</span>. <i>Asian Pac. J. Cancer Prev</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>13</i></span> (<span class="NLM_issue">Suppl</span>),  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">136</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23480754" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref23/cit23&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC3svps1Gmtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2012&pages=131-136&issue=Suppl&author=B.+Buranratauthor=S.+Chau-inauthor=A.+Prawanauthor=A.+Puapairojauthor=P.+Zeekpudsaauthor=V.+Kukongviriyapan&title=NQO1+expression+correlates+with+cholangiocarcinoma+prognosis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23R"><div class="casContent"><span class="casTitleNuber">23</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1 expression correlates with cholangiocarcinoma prognosis</span></div><div class="casAuthors">Buranrat Benjaporn; Chau-in Siri; Prawan Auemduan; Puapairoj Anucha; Zeekpudsa Pornsilp; Kukongviriyapan Veerapol</div><div class="citationInfo"><span class="NLM_cas:title">Asian Pacific journal of cancer prevention : APJCP</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">13 Suppl</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">131-6</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Cholangiocarcinoma (CCA) is a rare type of liver cancer with a very poor prognosis.  The prevalence of CCA is markedly variable with the highest incidence in the northeast Thailand, followed by other parts of Southeast Asia and China.  Currently, there is still no reliable biomarker for diagnosis or treatment.  NADPH-quinone oxidoreductase 1 (NQO1) is a xenobiotic metabolizing enzyme detoxifying chemical stressors and antioxidants, thereby providing cytoprotection in normal tissues.  However, NQO1 is over-expressed in some cancers, suggesting roles in carcinogenesis and tumor progression.  In this study, we examined NQO1 activity in surgical specimens from CCA patients and found much higher values than in the adjacent normal tissues.  Immunohistochemical analysis revealed strong staining in tumor epithelial elements, whereas the non-tumor bile ducts and liver parenchyma were weakly stained.  NQO1 mRNA expression in tumor tissues was widely varied among 43 patients.  A significant association was observed between high level of NQO1 expression and short overall survival time by the Cox proportional hazard ratio of 2.40, p<0.05.  By histological classification, non-papillary adenocarcinoma was an independent predictor for poor prognosis with the hazard ratio of 2.79, p<0.05.  NQO1 expression may serve as a prognostic biomarker for the CCA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTNfoZsjPp4hv6BottYdIAWfW6udTcc2eY63qgZr93qerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3svps1Gmtw%253D%253D&md5=c8691b8b6dbb5aa3b0e096b344374fac</span></div><a href="/servlet/linkout?suffix=cit23&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBuranrat%26aufirst%3DB.%26aulast%3DChau-in%26aufirst%3DS.%26aulast%3DPrawan%26aufirst%3DA.%26aulast%3DPuapairoj%26aufirst%3DA.%26aulast%3DZeekpudsa%26aufirst%3DP.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26atitle%3DNQO1%2520expression%2520correlates%2520with%2520cholangiocarcinoma%2520prognosis%26jtitle%3DAsian%2520Pac.%2520J.%2520Cancer%2520Prev%26date%3D2012%26volume%3D13%26issue%3DSuppl%26spage%3D131%26epage%3D136" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Garate, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wani, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, G.</span></span> <span> </span><span class="NLM_article-title">The NAD(P)H:quinone qxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1601</span>– <span class="NLM_lpage">1609</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.03.003</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.freeradbiomed.2010.03.003" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20226854" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlvVeitrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1601-1609&author=M.+Garateauthor=A.+A.+Waniauthor=G.+Li&title=The+NAD%28P%29H%3Aquinone+qxidoreductase+1+induces+cell+cycle+progression+and+proliferation+of+melanoma+cells&doi=10.1016%2Fj.freeradbiomed.2010.03.003"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">The NAD(P)H:Quinone Oxidoreductase 1 induces cell cycle progression and proliferation of melanoma cells</span></div><div class="casAuthors">Garate, Marco; Wani, Aijaz A.; Li, Gang</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1601-1609</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">The oxidoreductase NQO1 plays a prominent role in maintaining the cellular homeostasis.  NQO1 is mainly a cytosolic enzyme which catalyzes the metab. of quinones and is present in almost all tissue types providing protection against different stresses including xenobiotics, oxidants, UV light, and ionizing radiation.  This enzyme is overexpressed in many cancerous tissues and its function in carcinogenesis remains unclear.  Due to the relative lack of information on the role of NQO1 in melanoma pathogenesis, we attempted to det. the expression and basic function of NQO1 in melanoma cell proliferation.  We found that NQO1 is overexpressed in most melanoma cell lines with respect to melanocytes.  Furthermore, the expression of this oxidoreductase significantly induces cell cycle progression by upregulating the expression of cyclins A2, B1 and D1, leading to the proliferation of melanoma cells.  Our results also indicate that NQO1 is an upstream regulator of NF-κB p50, a factor linked to melanoma progression and poor patient prognosis.  Interestingly, we found that NQO1 stabilizes the transactivator BCL3, which in turn upregulates NF-κB p50.  More importantly, our results also indicate that NF-κB p50 correlates with the expression of NQO1 and mediates its role in the proliferation of melanoma cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpN76lpLZ-knrVg90H21EOLACvtfcHk0lj2ezUIU42-HQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlvVeitrc%253D&md5=c9c6157ed02494427ea6c2fce2ab1866</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.003&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.003%26sid%3Dliteratum%253Aachs%26aulast%3DGarate%26aufirst%3DM.%26aulast%3DWani%26aufirst%3DA.%2BA.%26aulast%3DLi%26aufirst%3DG.%26atitle%3DThe%2520NAD%2528P%2529H%253Aquinone%2520qxidoreductase%25201%2520induces%2520cell%2520cycle%2520progression%2520and%2520proliferation%2520of%2520melanoma%2520cells%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1601%26epage%3D1609%26doi%3D10.1016%2Fj.freeradbiomed.2010.03.003" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="NLM_citation" id="rightTab-cit25"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cui, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nan, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span> <span> </span><span class="NLM_article-title">High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">244</span>, <span class="refDoi"> DOI: 10.1186/s12885-015-1271-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2Fs12885-015-1271-4" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25885439" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref25/cit25&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC2Mjls1WjsA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2015&pages=244&author=X.+Cuiauthor=L.+Liauthor=G.+Yanauthor=K.+Mengauthor=Z.+Linauthor=Y.+Nanauthor=G.+Jinauthor=C.+Li&title=High+expression+of+NQO1+is+associated+with+poor+prognosis+in+serous+ovarian+carcinoma&doi=10.1186%2Fs12885-015-1271-4"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit25R"><div class="casContent"><span class="casTitleNuber">25</span><div class="casTitle"><span class="NLM_cas:atitle">High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma</span></div><div class="casAuthors">Cui Xuelian; Lin Zhenhua; Jin Guang; Cui Xuelian; Yan Guanghai; Meng Kai; Lin Zhenhua; Li Chunyu; Li Lianhua; Nan Yunze</div><div class="citationInfo"><span class="NLM_cas:title">BMC cancer</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">244</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  NAD(P)H:  quinone oxidoreductase (NQO1) is a flavoprotein that catalyzes two-electron reduction and detoxification of quinones and its derivatives.  NQO1 catalyzes reactions that have a protective effect against redox cycling, oxidative stress and neoplasia.  High expression of NQO1 is associated with many solid tumors including those affecting the colon, breast and pancreas; however, its role in the progression of ovarian carcinoma is largely undefined.  This study aimed to investigate the clinicopathological significance of high NQO1 expression in serous ovarian carcinoma.  METHODS:  NQO1 protein expression was assessed using immunohistochemical (IHC) staining in 160 patients with serous ovarian carcinoma, 62 patients with ovarian borderline tumors and 53 patients with benign ovarian tumors.  Quantitative real-time polymerase chain reaction (qRT-PCR) was performed to detect NQO1 mRNA expression levels.  The correlation between high NQO1 expression and clinicopathological features of ovarian carcinoma was evaluated by Chi-square and Fisher's exact test.  Overall survival (OS) rates of all of ovarian carcinoma patients were calculated using the Kaplan-Meier method, and univariate and multivariate analyses were performed using the Cox proportional hazards regression model.  RESULTS:  NQO1 protein expression in ovarian carcinoma cells was predominantly cytoplasmic.  Strong, positive expression of NQO1 protein was observed in 63.8% (102/160) of ovarian carcinomas, which was significantly higher than in borderline serous tumors (32.3%, 20/62) or benign serous tumors (11.3%, 6/53).  Importantly, the rate of strong, positive NQO1 expression in borderline serous tumors was also higher than in benign serous tumors.  High expression of NQO1 protein was closely associated with higher histological grade, advanced clinical stage and lower OS rates in ovarian carcinomas.  Moreover, multivariate analysis indicated that NQO1 was a significant independent prognostic factor, in addition to clinical stage, in patients with ovarian carcinoma.  CONCLUSIONS:  NQO1 is frequently upregulated in ovarian carcinoma.  High expressin of NQO1 protein may be an effective biomarker for poor prognostic evaluation of patients with serous ovarian carcinomas.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTWO10RlPN5-u2mnZh2OgS0fW6udTcc2eY63qgZr93qerntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2Mjls1WjsA%253D%253D&md5=8356b0110e8b153176db8ea8095238fa</span></div><a href="/servlet/linkout?suffix=cit25&amp;dbid=16384&amp;doi=10.1186%2Fs12885-015-1271-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs12885-015-1271-4%26sid%3Dliteratum%253Aachs%26aulast%3DCui%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DL.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DMeng%26aufirst%3DK.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DNan%26aufirst%3DY.%26aulast%3DJin%26aufirst%3DG.%26aulast%3DLi%26aufirst%3DC.%26atitle%3DHigh%2520expression%2520of%2520NQO1%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520serous%2520ovarian%2520carcinoma%26jtitle%3DBMC%2520Cancer%26date%3D2015%26volume%3D15%26spage%3D244%26doi%3D10.1186%2Fs12885-015-1271-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kong, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ren, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jin, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lin, Z.</span></span> <span> </span><span class="NLM_article-title">NQO1 overexpression is associated with poor prognosis in squamous cell carcinoma of the uterine cervix</span>. <i>BMC Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">414</span>, <span class="refDoi"> DOI: 10.1186/1471-2407-14-414</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref26/cit26&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2F1471-2407-14-414" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2014&pages=414&author=Y.+Maauthor=J.+Kongauthor=G.+Yanauthor=X.+Renauthor=D.+Jinauthor=T.+Jinauthor=L.+Linauthor=Z.+Lin&title=NQO1+overexpression+is+associated+with+poor+prognosis+in+squamous+cell+carcinoma+of+the+uterine+cervix&doi=10.1186%2F1471-2407-14-414"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=10.1186%2F1471-2407-14-414&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1471-2407-14-414%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DY.%26aulast%3DKong%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DG.%26aulast%3DRen%26aufirst%3DX.%26aulast%3DJin%26aufirst%3DD.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DLin%26aufirst%3DL.%26aulast%3DLin%26aufirst%3DZ.%26atitle%3DNQO1%2520overexpression%2520is%2520associated%2520with%2520poor%2520prognosis%2520in%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520uterine%2520cervix%26jtitle%3DBMC%2520Cancer%26date%3D2014%26volume%3D14%26spage%3D414%26doi%3D10.1186%2F1471-2407-14-414" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="NLM_citation" id="rightTab-cit27"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sweeney, J. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer</span>. <i>Expert Opin. Drug Metab. Toxicol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">783</span>– <span class="NLM_lpage">791</span>, <span class="refDoi"> DOI: 10.1080/17425255.2017.1341490</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1080%2F17425255.2017.1341490" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28637373" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref27/cit27&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKiu7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=783-791&author=R.+M.+Phillipsauthor=H.+R.+Hendriksauthor=J.+B.+Sweeneyauthor=G.+Reddyauthor=G.+J.+Peters&title=Efficacy%2C+pharmacokinetic+and+pharmacodynamic+evaluation+of+apaziquone+in+the+treatment+of+non-muscle+invasive+bladder+cancer&doi=10.1080%2F17425255.2017.1341490"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit27R"><div class="casContent"><span class="casTitleNuber">27</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy, pharmacokinetic and pharmacodynamic evaluation of apaziquone in the treatment of non-muscle invasive bladder cancer</span></div><div class="casAuthors">Phillips, R. M.; Hendriks, H. R.; Sweeney, J. B.; Reddy, G.; Peters, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Drug Metabolism & Toxicology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">783-791</span>CODEN:
                <span class="NLM_cas:coden">EODMAP</span>;
        ISSN:<span class="NLM_cas:issn">1742-5255</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">: Apaziquone (also known as EO9 and QapzolaTM) is a prodrug that is activated to DNA damaging species by oxidoreductases (particularly NQO1) and has the ability to kill aerobic and/or hypoxic cancer cells.: While its poor pharmacokinetic properties contributed to its failure in phase II clin. trials when administered i.v., these properties were ideal for loco-regional therapies.  Apaziquone demonstrated good anti-cancer activity against non-muscle invasive bladder cancer (NMIBC) when administered intravesically to marker lesions and was well tolerated with no systemic side effects.  However, phase III clin. trials did not reach statistical significance for the primary endpoint of 2-yr recurrence in apaziquone over placebo although improvements were obsd.  Post-hoc anal. of the combined study data did indicate a significant benefit for patients treated with apaziquone, esp. when the instillation of apaziquone was given 30 min or more after surgery.  A further phase III study is ongoing to test the hypotheses generated in the unsuccessful phase III studies conducted to date.: Because of its specific pharmacol. properties, Apaziquone is excellently suited for local therapy such as NMIBC.  Future studies should include proper biomarkers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpxlj4YY60Ej7Vg90H21EOLACvtfcHk0lgtZC0PZhejuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKiu7vP&md5=27956c11232190cdbf7a8847427c0ed4</span></div><a href="/servlet/linkout?suffix=cit27&amp;dbid=16384&amp;doi=10.1080%2F17425255.2017.1341490&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F17425255.2017.1341490%26sid%3Dliteratum%253Aachs%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26aulast%3DHendriks%26aufirst%3DH.%2BR.%26aulast%3DSweeney%26aufirst%3DJ.%2BB.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DEfficacy%252C%2520pharmacokinetic%2520and%2520pharmacodynamic%2520evaluation%2520of%2520apaziquone%2520in%2520the%2520treatment%2520of%2520non-muscle%2520invasive%2520bladder%2520cancer%26jtitle%3DExpert%2520Opin.%2520Drug%2520Metab.%2520Toxicol.%26date%3D2017%26volume%3D13%26spage%3D783%26epage%3D791%26doi%3D10.1080%2F17425255.2017.1341490" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burk, D. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Pro-fluorogenic reductase substrate for rapid, selective, and sensitive visualization and detection of human cancer cells that overexpress NQO1</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>135</i></span>,  <span class="NLM_fpage">309</span>– <span class="NLM_lpage">314</span>, <span class="refDoi"> DOI: 10.1021/ja309346f</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja309346f" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=135&publication_year=2013&pages=309-314&author=W.+C.+Silversauthor=B.+Prasaiauthor=D.+H.+Burkauthor=M.+L.+Brownauthor=R.+L.+McCarley&title=Pro-fluorogenic+reductase+substrate+for+rapid%2C+selective%2C+and+sensitive+visualization+and+detection+of+human+cancer+cells+that+overexpress+NQO1&doi=10.1021%2Fja309346f"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=10.1021%2Fja309346f&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja309346f%26sid%3Dliteratum%253Aachs%26aulast%3DSilvers%26aufirst%3DW.%2BC.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DBurk%26aufirst%3DD.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BL.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DPro-fluorogenic%2520reductase%2520substrate%2520for%2520rapid%252C%2520selective%252C%2520and%2520sensitive%2520visualization%2520and%2520detection%2520of%2520human%2520cancer%2520cells%2520that%2520overexpress%2520NQO1%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2013%26volume%3D135%26spage%3D309%26epage%3D314%26doi%3D10.1021%2Fja309346f" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Detection and cellular imaging of human cancer enzyme using a turn-on, wavelength-shiftable, self-immolative Profluorophore</span>. <i>J. Am. Chem. Soc.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">7575</span>– <span class="NLM_lpage">7578</span>, <span class="refDoi"> DOI: 10.1021/ja5030707</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ja5030707" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref29/cit29&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnvVSnsLk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2014&pages=7575-7578&author=S.+U.+Hettiarachchiauthor=B.+Prasaiauthor=R.+L.+McCarley&title=Detection+and+cellular+imaging+of+human+cancer+enzyme+using+a+turn-on%2C+wavelength-shiftable%2C+self-immolative+Profluorophore&doi=10.1021%2Fja5030707"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit29R"><div class="casContent"><span class="casTitleNuber">29</span><div class="casTitle"><span class="NLM_cas:atitle">Detection and Cellular Imaging of Human Cancer Enzyme Using a Turn-On, Wavelength-Shiftable, Self-Immolative Profluorophore</span></div><div class="casAuthors">Hettiarachchi, Suraj U.; Prasai, Bijeta; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of the American Chemical Society</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue">21</span>),
    <span class="NLM_cas:pages">7575-7578</span>CODEN:
                <span class="NLM_cas:coden">JACSAT</span>;
        ISSN:<span class="NLM_cas:issn">0002-7863</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A frontier area in the development of activatable (turn-on) fluorescence-based probes is concerned with rapid and selective stimulus triggering of probe activation so as to allow biomarker identification and cellular imaging.  The work here is concerned with a cloaked fluorophore composed of a reporter whose fluorescence is efficiently quenched by its attachment to an activatable trigger group via a novel self-immolative linker.  Highly selective and rapid activation of the trigger group is achieved by chem. and enzymic means that result in activated trigger group detachment from the self-immolative linker, with the latter subsequently cleaved from the reporter autonomously, thereby unmasking intense, red-shifted fluorescence emission.  To achieve this success, we used a tripartite probe comprised of a trimethyl-locked quinone propionic acid (Q3PA) trigger group and a fluorescently-masked naphthalimide reporter connected by an N-methyl-p-aminobenzyl alc. (NMPABA) self-immolative linker.  Delineated here are the synthesis and characterization of this cloaked fluorophore and the evaluation of its triggered turning on in the presence of an up-regulated enzyme in human cancer cells, NAD(P)H:quinone oxidoreductase-1 (NQO1, DT-diaphorase, EC 1.6.99.2).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrQG-vT5UnaibVg90H21EOLACvtfcHk0lgtZC0PZhejuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnvVSnsLk%253D&md5=a3777b5e4faf5a78d8edaba98be794c4</span></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fja5030707&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fja5030707%26sid%3Dliteratum%253Aachs%26aulast%3DHettiarachchi%26aufirst%3DS.%2BU.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DDetection%2520and%2520cellular%2520imaging%2520of%2520human%2520cancer%2520enzyme%2520using%2520a%2520turn-on%252C%2520wavelength-shiftable%252C%2520self-immolative%2520Profluorophore%26jtitle%3DJ.%2520Am.%2520Chem.%2520Soc.%26date%3D2014%26volume%3D136%26spage%3D7575%26epage%3D7578%26doi%3D10.1021%2Fja5030707" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jackson, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">A near-infrared, wavelength-shiftable, turn-on fluorescent probe for the detection and imaging of cancer tumor cells</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1121</span>– <span class="NLM_lpage">1132</span>, <span class="refDoi"> DOI: 10.1021/acschembio.6b01094</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.6b01094" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref30/cit30&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtlyjur8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2017&pages=1121-1132&author=Z.+Shenauthor=B.+Prasaiauthor=Y.+Nakamuraauthor=H.+Kobayashiauthor=M.+S.+Jacksonauthor=R.+L.+McCarley&title=A+near-infrared%2C+wavelength-shiftable%2C+turn-on+fluorescent+probe+for+the+detection+and+imaging+of+cancer+tumor+cells&doi=10.1021%2Facschembio.6b01094"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit30R"><div class="casContent"><span class="casTitleNuber">30</span><div class="casTitle"><span class="NLM_cas:atitle">A Near-Infrared, Wavelength-Shiftable, Turn-on Fluorescent Probe for the Detection and Imaging of Cancer Tumor Cells</span></div><div class="casAuthors">Shen, Zhenhua; Prasai, Bijeta; Nakamura, Yuko; Kobayashi, Hisataka; Jackson, Milcah S.; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1121-1132</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Fast, selective, and noninvasive reporting of intracellular cancer-assocd. events and species will lead to a better understanding of tumorigenesis at the mol. level and development of precision medicine approaches in oncol.  Overexpressed reductase presence in solid tumor cells is key to cancer progression and protection of those diseased cells from the oxidative effects of therapeutics meant to kill them.  Human NAD(P)H:quinone oxidoreductase isoenzyme I (hNQO1), a cytoprotective 2-electron-specific reductase found at unusually high activity levels in cancer cells of multiple origins, has attracted significant attention due to its major role in metastatic pathways and its link to low survival rates in patients, as well as its ability to effectively activate quinone-based, anticancer drugs.  Accurate assessment of hNQO1 activities in living tumor models and ready differentiation of metastases from healthy tissue by fluorescent light-based protocols requires creation of hNQO1-responsive, near-IR probes that offer deep tissue penetration and low background fluorescence.  Herein, we disclose a quinone-trigger-based, near-IR probe whose fluorescence is effectively turned on several hundred-fold through highly selective redn. of the quinone trigger group by hNQO1, with unprecedented, catalytically efficient formation of a fluorescent reporter. hNQO1 activity-specific prodn. of a fluorescence signal in two-dimensional cultures of respiring human cancer cells that harbor the reductase enzyme allows for their quick (30 min) high-integrity recognition.  The characteristics of the near-IR probe make possible the imaging of clin. relevant three-dimensional colorectal tumor models possessing spatially heterogeneous hNQO1 activities and provide for fluorescence-assisted identification of submillimeter dimension metastases in a preclin. mouse model of human ovarian serous adenocarcinoma.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrEPpZS_DxlpLVg90H21EOLACvtfcHk0lgtZC0PZhejuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtlyjur8%253D&md5=180febd56039c1d2ed43fc9410563a7c</span></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=10.1021%2Facschembio.6b01094&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.6b01094%26sid%3Dliteratum%253Aachs%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DKobayashi%26aufirst%3DH.%26aulast%3DJackson%26aufirst%3DM.%2BS.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DA%2520near-infrared%252C%2520wavelength-shiftable%252C%2520turn-on%2520fluorescent%2520probe%2520for%2520the%2520detection%2520and%2520imaging%2520of%2520cancer%2520tumor%2520cells%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2017%26volume%3D12%26spage%3D1121%26epage%3D1132%26doi%3D10.1021%2Facschembio.6b01094" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nakamura, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shen, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Harada, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nagaya, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sato, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okuyama, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ogata, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choyke, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kobayashi, H.</span></span> <span> </span><span class="NLM_article-title">Characteristics of ovarian cancer detection by a near-infrared fluorescent probe activated by human NAD (P) H: quinone oxidoreductase isozyme 1 (hNQO1)</span>. <i>Oncotarget</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">61181</span>– <span class="NLM_lpage">61192</span>, <span class="refDoi"> DOI: 10.18632/oncotarget.18044</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref31/cit31&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.18632%2Foncotarget.18044" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2017&pages=61181-61192&author=Y.+Nakamuraauthor=Z.+Shenauthor=T.+Haradaauthor=T.+Nagayaauthor=K.+Satoauthor=S.+Okuyamaauthor=F.+Ogataauthor=P.+Choykeauthor=R.+McCarleyauthor=H.+Kobayashi&title=Characteristics+of+ovarian+cancer+detection+by+a+near-infrared+fluorescent+probe+activated+by+human+NAD+%28P%29+H%3A+quinone+oxidoreductase+isozyme+1+%28hNQO1%29&doi=10.18632%2Foncotarget.18044"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=10.18632%2Foncotarget.18044&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.18632%252Foncotarget.18044%26sid%3Dliteratum%253Aachs%26aulast%3DNakamura%26aufirst%3DY.%26aulast%3DShen%26aufirst%3DZ.%26aulast%3DHarada%26aufirst%3DT.%26aulast%3DNagaya%26aufirst%3DT.%26aulast%3DSato%26aufirst%3DK.%26aulast%3DOkuyama%26aufirst%3DS.%26aulast%3DOgata%26aufirst%3DF.%26aulast%3DChoyke%26aufirst%3DP.%26aulast%3DMcCarley%26aufirst%3DR.%26aulast%3DKobayashi%26aufirst%3DH.%26atitle%3DCharacteristics%2520of%2520ovarian%2520cancer%2520detection%2520by%2520a%2520near-infrared%2520fluorescent%2520probe%2520activated%2520by%2520human%2520NAD%2520%2528P%2529%2520H%253A%2520quinone%2520oxidoreductase%2520isozyme%25201%2520%2528hNQO1%2529%26jtitle%3DOncotarget%26date%3D2017%26volume%3D8%26spage%3D61181%26epage%3D61192%26doi%3D10.18632%2Foncotarget.18044" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">246</span>– <span class="NLM_lpage">253</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(00)00310-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0891-5849%2800%2900310-5" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11035253" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref32/cit32&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=246-253&author=D.+Siegelauthor=D.+Ross&title=Immunodetection+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+in+human+tissues&doi=10.1016%2FS0891-5849%2800%2900310-5"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit32R"><div class="casContent"><span class="casTitleNuber">32</span><div class="casTitle"><span class="NLM_cas:atitle">Immunodetection of NAD(P)H:quinone oxidoreductase 1 (NQO1) in human tissues</span></div><div class="casAuthors">Siegel, David; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">246-253</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">Despite the extensive interest in NADPH:quinone oxidoreductase (NQO1, DT-diaphorase), there is little immunohistochem. information regarding its distribution in either normal human tissues or in human tumors.  Using immunohistochem. (IHC), we have examd. cell-specific expression of NQO1 in many normal tissues and tumors as a step toward defining the distribution of NQO1 in humans.  NQO1 was detected by IHC in respiratory, breast duct, thyroid follicle, and colonic epithelium, as well as in the corneal and lens epithelium of the eye.  NQO1 was also detected by IHC in vascular endothelium in all tissues examd.  NQO1 could also readily be detected in the endothelial lining of the aorta but was not detected using immunoblot anal. in the myocardium.  Adipocytes stained pos. for NQO1, and the enzyme was also detected by both IHC and immunoblot anal. in parasympathetic ganglia in the small intestine and in the optic nerve and nerve fibers.  NQO1 was not highly expressed in five different human liver samples using immunoblot anal., whereas studies using IHC demonstrated only trace NQO1 staining in isolated bile duct epithelium.  NQO1 expression was also examd. by IHC in a variety of solid tumors.  Marked NQO1 staining was detected in solid tumors from thyroid, adrenal, breast, ovarian, colon, and cornea and in non-small cell lung cancers.  The NQO1 content of many solid tumors supports the use of NQO1-directed anticancer agents for therapeutic purposes, but the distribution of NQO1 in normal tissues suggests that potential adverse effects of such agents need to be carefully monitored in preclin. studies.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYni1QJFl4J7Vg90H21EOLACvtfcHk0liyoz2ycTqKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrk%253D&md5=e990cc91825486b72d24c848b5d4a819</span></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900310-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900310-5%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DImmunodetection%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520in%2520human%2520tissues%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D246%26epage%3D253%26doi%3D10.1016%2FS0891-5849%2800%2900310-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Vos, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Braver-Sewradj, S. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">den Braver, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Dijk, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dekker, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wijaya, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vermeulen, N. P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Richert, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Commandeur, J. N. M.</span></span> <span> </span><span class="NLM_article-title">Inter-individual variability in activity of the major drug metabolizing enzymes in liver homogenates of 20 individuals</span>. <i>Curr. Drug Metab.</i> <span class="NLM_year" style="font-weight: bold;">2018</span>, <span class="refDoi"> DOI: 10.2174/1389200219666180108160046</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2174%2F1389200219666180108160046" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref33/cit33&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=29318967" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2018&author=J.+C.+Vosauthor=S.+P.+den+Braver-Sewradjauthor=M.+W.+den+Braverauthor=M.+van+Dijkauthor=Y.+Zhangauthor=S.+J.+Dekkerauthor=L.+Wijayaauthor=N.+P.+E.+Vermeulenauthor=L.+Richertauthor=J.+N.+M.+Commandeur&title=Inter-individual+variability+in+activity+of+the+major+drug+metabolizing+enzymes+in+liver+homogenates+of+20+individuals&doi=10.2174%2F1389200219666180108160046"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=10.2174%2F1389200219666180108160046&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F1389200219666180108160046%26sid%3Dliteratum%253Aachs%26aulast%3DVos%26aufirst%3DJ.%2BC.%26aulast%3Dden%2BBraver-Sewradj%26aufirst%3DS.%2BP.%26aulast%3Dden%2BBraver%26aufirst%3DM.%2BW.%26aulast%3Dvan%2BDijk%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DY.%26aulast%3DDekker%26aufirst%3DS.%2BJ.%26aulast%3DWijaya%26aufirst%3DL.%26aulast%3DVermeulen%26aufirst%3DN.%2BP.%2BE.%26aulast%3DRichert%26aufirst%3DL.%26aulast%3DCommandeur%26aufirst%3DJ.%2BN.%2BM.%26atitle%3DInter-individual%2520variability%2520in%2520activity%2520of%2520the%2520major%2520drug%2520metabolizing%2520enzymes%2520in%2520liver%2520homogenates%2520of%252020%2520individuals%26jtitle%3DCurr.%2520Drug%2520Metab.%26date%3D2018%26doi%3D10.2174%2F1389200219666180108160046" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref34"><div class="reference"><strong class="refLabel"><a href="#ref34" class="rightTabRefNumLink">34</a></strong><div class="NLM_citation" id="rightTab-cit34"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rougee, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Riches, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berman, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Collier, A. C.</span></span> <span> </span><span class="NLM_article-title">The ontogeny and population variability of human hepatic NADPH dehydrogenase quinone oxido-reductase 1 (NQO1)</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">967</span>– <span class="NLM_lpage">974</span>, <span class="refDoi"> DOI: 10.1124/dmd.115.068650</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref34/cit34&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fdmd.115.068650" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=2016&pages=967-974&author=L.+R.+Rougeeauthor=Z.+Richesauthor=J.+M.+Bermanauthor=A.+C.+Collier&title=The+ontogeny+and+population+variability+of+human+hepatic+NADPH+dehydrogenase+quinone+oxido-reductase+1+%28NQO1%29&doi=10.1124%2Fdmd.115.068650"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit34&amp;dbid=16384&amp;doi=10.1124%2Fdmd.115.068650&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.115.068650%26sid%3Dliteratum%253Aachs%26aulast%3DRougee%26aufirst%3DL.%2BR.%26aulast%3DRiches%26aufirst%3DZ.%26aulast%3DBerman%26aufirst%3DJ.%2BM.%26aulast%3DCollier%26aufirst%3DA.%2BC.%26atitle%3DThe%2520ontogeny%2520and%2520population%2520variability%2520of%2520human%2520hepatic%2520NADPH%2520dehydrogenase%2520quinone%2520oxido-reductase%25201%2520%2528NQO1%2529%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2016%26volume%3D44%26spage%3D967%26epage%3D974%26doi%3D10.1124%2Fdmd.115.068650" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref35"><div class="reference"><strong class="refLabel"><a href="#ref35" class="rightTabRefNumLink">35</a></strong><div class="NLM_citation" id="rightTab-cit35"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Aleksunes, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goedken, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manautou, J. E.</span></span> <span> </span><span class="NLM_article-title">Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1937</span>– <span class="NLM_lpage">1940</span>, <span class="refDoi"> DOI: 10.3748/wjg.v12.i12.1937</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3748%2Fwjg.v12.i12.1937" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16610002" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref35/cit35&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28Xksl2ntbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2006&pages=1937-1940&author=L.+M.+Aleksunesauthor=M.+Goedkenauthor=J.+E.+Manautou&title=Up-regulation+of+NAD%28P%29H+quinone+oxidoreductase+1+during+human+liver+injury&doi=10.3748%2Fwjg.v12.i12.1937"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit35R"><div class="casContent"><span class="casTitleNuber">35</span><div class="casTitle"><span class="NLM_cas:atitle">Up-regulation of NAD(P)H quinone oxidoreductase 1 during human liver injury</span></div><div class="casAuthors">Aleksunes, Lauren M.; Goedken, Michael; Manautou, Jose E.</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">1937-1940</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">World Journal of Gastroenterology</span>)
        </div><div class="casAbstract">AIM: To investigate the expression and activity of NAD(P)H quinone oxidoreductase 1 (NQO1) in human liver specimens obtained from patients with liver damage due to acetaminophen (APAP) overdose or primary biliary cirrhosis (PBC).  METHODS: NQO1 activity was detd. in cytosol from normal, APAP and PBC liver specimens.  Western blot and immunohistochem. staining were used to det. patterns of NQO1 expression using a specific antibody against NQO1.  RESULTS: NQO1 protein was very low in normal human livers.  In both APAP and PBC livers, there was strong induction of NQO1 protein levels on Western blot.  Correspondingly, significant up-regulation of enzyme activity (16- and 22-fold, P < 0.05) was also obsd. in APAP and PBC livers, resp.  Immunohistochem. anal. highlighted injury-specific patterns of NQO1 staining in both APAP and PBC livers.  CONCLUSION: These data demonstrate that NQO1 protein and activity are markedly induced in human livers during both APAP overdose and PBC.  Up-regulation of this cytoprotective enzyme may represent an adaptive stress response to limit further disease progression by detoxifying reactive species.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMZN7WGnnwLLVg90H21EOLACvtfcHk0liyoz2ycTqKtg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xksl2ntbk%253D&md5=518fff81404a13bab637fc25cbdeaea2</span></div><a href="/servlet/linkout?suffix=cit35&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v12.i12.1937&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v12.i12.1937%26sid%3Dliteratum%253Aachs%26aulast%3DAleksunes%26aufirst%3DL.%2BM.%26aulast%3DGoedken%26aufirst%3DM.%26aulast%3DManautou%26aufirst%3DJ.%2BE.%26atitle%3DUp-regulation%2520of%2520NAD%2528P%2529H%2520quinone%2520oxidoreductase%25201%2520during%2520human%2520liver%2520injury%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2006%26volume%3D12%26spage%3D1937%26epage%3D1940%26doi%3D10.3748%2Fwjg.v12.i12.1937" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref36"><div class="reference"><strong class="refLabel"><a href="#ref36" class="rightTabRefNumLink">36</a></strong><div class="NLM_citation" id="rightTab-cit36"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Strassburg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Strassburg, C. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Manns, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tukey, R. H.</span></span> <span> </span><span class="NLM_article-title">Differential gene expression of NAD(P)H:quinone oxidoreductase and NRH:quinone oxidoreductase in human hepatocellular and biliary tissue</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2002</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">320</span>– <span class="NLM_lpage">325</span>, <span class="refDoi"> DOI: 10.1124/mol.61.2.320</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref36/cit36&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.61.2.320" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2002&pages=320-325&author=A.+Strassburgauthor=C.+P.+Strassburgauthor=M.+P.+Mannsauthor=R.+H.+Tukey&title=Differential+gene+expression+of+NAD%28P%29H%3Aquinone+oxidoreductase+and+NRH%3Aquinone+oxidoreductase+in+human+hepatocellular+and+biliary+tissue&doi=10.1124%2Fmol.61.2.320"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit36&amp;dbid=16384&amp;doi=10.1124%2Fmol.61.2.320&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.61.2.320%26sid%3Dliteratum%253Aachs%26aulast%3DStrassburg%26aufirst%3DA.%26aulast%3DStrassburg%26aufirst%3DC.%2BP.%26aulast%3DManns%26aufirst%3DM.%2BP.%26aulast%3DTukey%26aufirst%3DR.%2BH.%26atitle%3DDifferential%2520gene%2520expression%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520and%2520NRH%253Aquinone%2520oxidoreductase%2520in%2520human%2520hepatocellular%2520and%2520biliary%2520tissue%26jtitle%3DMol.%2520Pharmacol.%26date%3D2002%26volume%3D61%26spage%3D320%26epage%3D325%26doi%3D10.1124%2Fmol.61.2.320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref37"><div class="reference"><strong class="refLabel"><a href="#ref37" class="rightTabRefNumLink">37</a></strong><div class="NLM_citation" id="rightTab-cit37"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Covarrubias, V. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lakhman, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Forrest, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Relling, M. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, J. G.</span></span> <span> </span><span class="NLM_article-title">Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites</span>. <i>Toxicol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>164</i></span>,  <span class="NLM_fpage">249</span>– <span class="NLM_lpage">258</span>, <span class="refDoi"> DOI: 10.1016/j.toxlet.2006.01.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.toxlet.2006.01.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16478651" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref37/cit37&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XltFOrtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=164&publication_year=2006&pages=249-258&author=V.+G.+Covarrubiasauthor=S.+S.+Lakhmanauthor=A.+Forrestauthor=M.+V.+Rellingauthor=J.+G.+Blanco&title=Higher+activity+of+polymorphic+NAD%28P%29H%3Aquinone+oxidoreductase+in+liver+cytosols+from+blacks+compared+to+whites&doi=10.1016%2Fj.toxlet.2006.01.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit37R"><div class="casContent"><span class="casTitleNuber">37</span><div class="casTitle"><span class="NLM_cas:atitle">Higher activity of polymorphic NAD(P)H:quinone oxidoreductase in liver cytosols from blacks compared to whites</span></div><div class="casAuthors">Covarrubias, Vanessa Gonzalez; Lakhman, Sukhwinder S.; Forrest, Alan; Relling, Mary V.; Blanco, Javier G.</div><div class="citationInfo"><span class="NLM_cas:title">Toxicology Letters</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">164</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">249-258</span>CODEN:
                <span class="NLM_cas:coden">TOLED5</span>;
        ISSN:<span class="NLM_cas:issn">0378-4274</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">In human liver, the 2-electron redn. of quinone compds., such as menadione is catalyzed by cytosolic carbonyl reductase (CBR) and NAD(P)H:quinone oxidoreductase (NQO1) activities.  We assessed the relative contributions of CBR and NQO1 activities to the total menadione reducing capacity in liver cytosols from black (n = 31) and white donors (n = 63).  Maximal menadione reductase activities did not differ between black (13.0 ± 5.0 nmol/min mg), and white donors (11.4 ± 6.6 nmol/min mg; p = 0.208).  In addn., both groups presented similar levels of CBR activities (CBRblacks = 10.9 ± 4.1 nmol/min mg vs. CBRwhites = 10.5 ± 5.8 nmol/min mg; p = 0.708).  In contrast, blacks showed higher NQO1 activities (2-fold) than whites (NQO1blacks = 2.1 ± 3.0 nmol/min mg vs. NQO1whites = 0.9 ± 1.6 nmol/min mg, p < 0.01).  To further explore this disparity, we tested whether NQO1 activity was assocd. with the common NQO1 * 2 genetic polymorphism by paired DNA samples for genotyping.  Cytosolic NQO1 activities differed significantly by NQO1 genotype status in whites (NQO1whites[NQO1*1/*1] = 1.3 ± 1.7 nmol/min mg vs. NQO1whites[NQO1*1/*2+NQO1*2/*2] = 0.5 ± 0.7 nmol/min mg, p < 0.01), but not in blacks (NQO1blacks[NQO1*1/*1] = 2.6 ± 3.4 nmol/min mg vs. NQO1blacks[NQO1*1/*2] = 1.1 ± 1.2 nmol/min mg, p = 0.134).  Our findings pinpoint the presence of significant interethnic differences in polymorphic hepatic NQO1 activity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5L7Zq1ydGWLVg90H21EOLACvtfcHk0lh3IXygj2s2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XltFOrtL4%253D&md5=4e2793398368040c75dd0c8d42652d45</span></div><a href="/servlet/linkout?suffix=cit37&amp;dbid=16384&amp;doi=10.1016%2Fj.toxlet.2006.01.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.toxlet.2006.01.004%26sid%3Dliteratum%253Aachs%26aulast%3DCovarrubias%26aufirst%3DV.%2BG.%26aulast%3DLakhman%26aufirst%3DS.%2BS.%26aulast%3DForrest%26aufirst%3DA.%26aulast%3DRelling%26aufirst%3DM.%2BV.%26aulast%3DBlanco%26aufirst%3DJ.%2BG.%26atitle%3DHigher%2520activity%2520of%2520polymorphic%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520in%2520liver%2520cytosols%2520from%2520blacks%2520compared%2520to%2520whites%26jtitle%3DToxicol.%2520Lett.%26date%3D2006%26volume%3D164%26spage%3D249%26epage%3D258%26doi%3D10.1016%2Fj.toxlet.2006.01.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref38"><div class="reference"><strong class="refLabel"><a href="#ref38" class="rightTabRefNumLink">38</a></strong><div class="NLM_citation" id="rightTab-cit38"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Mendoza, M. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hollabaugh, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hettiarachchi, S. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Human NAD(P)H:quinone oxidoreductase type I (hNQO1) activation of quinone propionic acid trigger groups</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">8014</span>– <span class="NLM_lpage">8026</span>, <span class="refDoi"> DOI: 10.1021/bi300760u</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi300760u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2012&pages=8014-8026&author=M.+F.+Mendozaauthor=N.+M.+Hollabaughauthor=S.+U.+Hettiarachchiauthor=R.+L.+McCarley&title=Human+NAD%28P%29H%3Aquinone+oxidoreductase+type+I+%28hNQO1%29+activation+of+quinone+propionic+acid+trigger+groups&doi=10.1021%2Fbi300760u"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit38&amp;dbid=16384&amp;doi=10.1021%2Fbi300760u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi300760u%26sid%3Dliteratum%253Aachs%26aulast%3DMendoza%26aufirst%3DM.%2BF.%26aulast%3DHollabaugh%26aufirst%3DN.%2BM.%26aulast%3DHettiarachchi%26aufirst%3DS.%2BU.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DHuman%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520type%2520I%2520%2528hNQO1%2529%2520activation%2520of%2520quinone%2520propionic%2520acid%2520trigger%2520groups%26jtitle%3DBiochemistry%26date%3D2012%26volume%3D51%26spage%3D8014%26epage%3D8026%26doi%3D10.1021%2Fbi300760u" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref39"><div class="reference"><strong class="refLabel"><a href="#ref39" class="rightTabRefNumLink">39</a></strong><div class="NLM_citation" id="rightTab-cit39"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1) localizes to the mitotic spindle in human cells</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e44861</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0044861</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref39/cit39&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1371%2Fjournal.pone.0044861" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e44861&author=D.+Siegelauthor=J.+K.+Kepaauthor=D.+Ross&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+localizes+to+the+mitotic+spindle+in+human+cells&doi=10.1371%2Fjournal.pone.0044861"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit39&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0044861&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0044861%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520localizes%2520to%2520the%2520mitotic%2520spindle%2520in%2520human%2520cells%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De44861%26doi%3D10.1371%2Fjournal.pone.0044861" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref40"><div class="reference"><strong class="refLabel"><a href="#ref40" class="rightTabRefNumLink">40</a></strong><div class="NLM_citation" id="rightTab-cit40"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Skelly, J. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Suter, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knox, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Garman, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stuart, D. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sanderson, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Roberts, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neidle, S.</span></span> <span> </span><span class="NLM_article-title">Preliminary crystallographic data for NAD(P)H quinone reductase isolated from the Walker 256 rat carcinoma cell line</span>. <i>J. Mol. Biol.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>205</i></span>,  <span class="NLM_fpage">623</span>– <span class="NLM_lpage">624</span>, <span class="refDoi"> DOI: 10.1016/0022-2836(89)90233-7</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref40/cit40&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2F0022-2836%2889%2990233-7" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=205&publication_year=1989&pages=623-624&author=J.+V.+Skellyauthor=D.+A.+Suterauthor=R.+J.+Knoxauthor=E.+Garmanauthor=D.+I.+Stuartauthor=M.+R.+Sandersonauthor=J.+J.+Robertsauthor=S.+Neidle&title=Preliminary+crystallographic+data+for+NAD%28P%29H+quinone+reductase+isolated+from+the+Walker+256+rat+carcinoma+cell+line&doi=10.1016%2F0022-2836%2889%2990233-7"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit40&amp;dbid=16384&amp;doi=10.1016%2F0022-2836%2889%2990233-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0022-2836%252889%252990233-7%26sid%3Dliteratum%253Aachs%26aulast%3DSkelly%26aufirst%3DJ.%2BV.%26aulast%3DSuter%26aufirst%3DD.%2BA.%26aulast%3DKnox%26aufirst%3DR.%2BJ.%26aulast%3DGarman%26aufirst%3DE.%26aulast%3DStuart%26aufirst%3DD.%2BI.%26aulast%3DSanderson%26aufirst%3DM.%2BR.%26aulast%3DRoberts%26aufirst%3DJ.%2BJ.%26aulast%3DNeidle%26aufirst%3DS.%26atitle%3DPreliminary%2520crystallographic%2520data%2520for%2520NAD%2528P%2529H%2520quinone%2520reductase%2520isolated%2520from%2520the%2520Walker%2520256%2520rat%2520carcinoma%2520cell%2520line%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D1989%26volume%3D205%26spage%3D623%26epage%3D624%26doi%3D10.1016%2F0022-2836%2889%2990233-7" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref41"><div class="reference"><strong class="refLabel"><a href="#ref41" class="rightTabRefNumLink">41</a></strong><div class="NLM_citation" id="rightTab-cit41"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>92</i></span>,  <span class="NLM_fpage">8846</span>– <span class="NLM_lpage">8850</span>, <span class="refDoi"> DOI: 10.1073/pnas.92.19.8846</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1073%2Fpnas.92.19.8846" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=7568029" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref41/cit41&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADyaK2MXotVGqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=92&publication_year=1995&pages=8846-8850&author=R.+Liauthor=M.+A.+Bianchetauthor=P.+Talalayauthor=L.+M.+Amzel&title=The+three-dimensional+structure+of+NAD%28P%29H%3Aquinone+reductase%2C+a+flavoprotein+involved+in+cancer+chemoprotection+and+chemotherapy%3A+mechanism+of+the+two-electron+reduction&doi=10.1073%2Fpnas.92.19.8846"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit41R"><div class="casContent"><span class="casTitleNuber">41</span><div class="casTitle"><span class="NLM_cas:atitle">The three-dimensional structure of NAD(P)H:quinone reductase, a flavoprotein involved in cancer chemoprotection and chemotherapy: mechanism of the two-electron reduction</span></div><div class="casAuthors">Li, Rongbao; Bianchet, Mario A.; Talalay, Paul; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">92</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">8846-50</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">NAD(P)H-quinone reductase (EC 1.6.99.2; DT-diaphorase) (I) is a homodimeric FAD-contg. enzyme that catalyzes obligatory NAD(P)H-dependent 2-electron redns. of quinones and protects cells against the toxic and neoplastic effects of free radicals and reactive O species arising from 1-electron redns.  These 2-electron redns. participate in the reductive bioactivation of cancer chemotherapeutic agents, such as mitomycin C, in tumor cells.  Thus, surprisingly, the same enzymic reaction that protects normal cells activates cytotoxic drugs used in cancer chemotherapy.  The 2.1-Å crystal structure of rat liver I reveals that the folding of a portion of each monomer is similar to that of flavodoxin, a bacterial FMN-contg. protein.  Two addnl. portions of the polypeptide chains are involved in dimerization and in formation of the 2 identical catalytic sites to which both monomers contribute.  The crystallog. structures of 2 FAD-contg. enzyme complexes (one contg. NADP, the other contg. duroquinone) suggest that direct hydride transfers from NAD(P)H to FAD and from FADH2 to the quinone [which occupies the site vacated by NAD(P)H] provide a simple rationale for the obligatory 2-electron redns. involving a ping-pong mechanism.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8odSAC4zmXrVg90H21EOLACvtfcHk0lh3IXygj2s2Ww"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXotVGqsb4%253D&md5=02011e74bffe95b5148f3edcf8c5255f</span></div><a href="/servlet/linkout?suffix=cit41&amp;dbid=16384&amp;doi=10.1073%2Fpnas.92.19.8846&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.92.19.8846%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DR.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DThe%2520three-dimensional%2520structure%2520of%2520NAD%2528P%2529H%253Aquinone%2520reductase%252C%2520a%2520flavoprotein%2520involved%2520in%2520cancer%2520chemoprotection%2520and%2520chemotherapy%253A%2520mechanism%2520of%2520the%2520two-electron%2520reduction%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D1995%26volume%3D92%26spage%3D8846%26epage%3D8850%26doi%3D10.1073%2Fpnas.92.19.8846" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref42"><div class="reference"><strong class="refLabel"><a href="#ref42" class="rightTabRefNumLink">42</a></strong><div class="NLM_citation" id="rightTab-cit42"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release</span>. <i>Proc. Natl. Acad. Sci. U. S. A.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>97</i></span>,  <span class="NLM_fpage">3177</span>– <span class="NLM_lpage">3182</span>, <span class="refDoi"> DOI: 10.1073/pnas.97.7.3177</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1073%2Fpnas.97.7.3177" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10706635" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref42/cit42&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitlWqsrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=97&publication_year=2000&pages=3177-3182&author=M.+Faigauthor=M.+A.+Bianchetauthor=P.+Talalayauthor=S.+Chenauthor=S.+Winskiauthor=D.+Rossauthor=L.+M.+Amzel&title=Structures+of+recombinant+human+and+mouse+NAD%28P%29H%3Aquinone+oxidoreductases%3A+species+comparison+and+structural+changes+with+substrate+binding+and+release&doi=10.1073%2Fpnas.97.7.3177"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit42R"><div class="casContent"><span class="casTitleNuber">42</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of recombinant human and mouse NAD(P)H:quinone oxidoreductases: species comparison and structural changes with substrate binding and release</span></div><div class="casAuthors">Faig, Margarita; Bianchet, Mario A.; Talalay, Paul; Chen, Shiuan; Winski, Shannon; Ross, David; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">97</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">3177-3182</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">NAD(P)H/quinone acceptor oxidoreductase (QR1, NQO1, formerly DT-diaphorase; EC 1.6.99.2) protects animal cells from the deleterious and carcinogenic effects of quinones and other electrophiles.  In this paper we report the apoenzyme structures of human (at 1.7-Å resoln.) and mouse (2.8 Å) QR1 and the complex of the human enzyme with the substrate duroquinone (2.5 Å) (2,3,5,6-tetramethyl-p-benzoquinone).  In addn. to providing a description and rationale of the structural and catalytic differences among several species, these structures reveal the changes that accompany substrate or cofactor (NAD) binding and release.  Tyrosine-128 and the loop spanning residues 232-236 close the binding site, partially occupying the space left vacant by the departing mol. (substrate or cofactor).  These changes highlight the exquisite control of access to the catalytic site that is required by the ping-pong mechanism in which, after reducing the flavin, NAD(P)+ leaves the catalytic site and allows substrate to bind at the vacated position.  In the human QR1-duroquinone structure one ring carbon is significantly closer to the flavin N5, suggesting a direct hydride transfer to this atom.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNsGZ7S3xBmbVg90H21EOLACvtfcHk0lgXl19lqg2OCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitlWqsrc%253D&md5=ea05115386364d758bc56f4cb248df86</span></div><a href="/servlet/linkout?suffix=cit42&amp;dbid=16384&amp;doi=10.1073%2Fpnas.97.7.3177&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.97.7.3177%26sid%3Dliteratum%253Aachs%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DChen%26aufirst%3DS.%26aulast%3DWinski%26aufirst%3DS.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructures%2520of%2520recombinant%2520human%2520and%2520mouse%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductases%253A%2520species%2520comparison%2520and%2520structural%2520changes%2520with%2520substrate%2520binding%2520and%2520release%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci.%2520U.%2520S.%2520A.%26date%3D2000%26volume%3D97%26spage%3D3177%26epage%3D3182%26doi%3D10.1073%2Fpnas.97.7.3177" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref43"><div class="reference"><strong class="refLabel"><a href="#ref43" class="rightTabRefNumLink">43</a></strong><div class="NLM_citation" id="rightTab-cit43"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Asher, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dym, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tsvetkov, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shaul, Y.</span></span> <span> </span><span class="NLM_article-title">The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>45</i></span>,  <span class="NLM_fpage">6372</span>– <span class="NLM_lpage">6378</span>, <span class="refDoi"> DOI: 10.1021/bi0600087</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi0600087" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref43/cit43&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XjvVSnsbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2006&pages=6372-6378&author=G.+Asherauthor=O.+Dymauthor=P.+Tsvetkovauthor=J.+Adlerauthor=Y.+Shaul&title=The+crystal+structure+of+NAD%28P%29H+quinone+oxidoreductase+1+in+complex+with+its+potent+inhibitor+dicoumarol&doi=10.1021%2Fbi0600087"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit43R"><div class="casContent"><span class="casTitleNuber">43</span><div class="casTitle"><span class="NLM_cas:atitle">The crystal structure of NAD(P)H quinone oxidoreductase 1 in complex with its potent inhibitor dicoumarol</span></div><div class="casAuthors">Asher, Gad; Dym, Orly; Tsvetkov, Peter; Adler, Julia; Shaul, Yosef</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">6372-6378</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">NAD(P)H-quinone oxidoreductase 1 (NQO1) is a ubiquitous flavoenzyme that catalyzes 2-electron redn. of quinones to hydroquinones utilizing NAD(P)H as an electron donor.  NQO1 binds and stabilizes several short-lived proteins including tumor suppressors p53 and p73 and the enzyme, ornithine decarboxylase (ODC).  Dicoumarol (I) is a widely used potent competitive inhibitor of NQO1 activity, which competes with NAD(P)H for binding to NQO1.  I also disrupts the binding of NQO1 to p53, p73, and ODC, and induces their ubiquitin-independent proteasomal degrdn.  Here, the authors report the crystal structure of human NQO1 in complex with I at 2.75 Å resoln.  The authors identified the interactions of I with different residues of NQO1 and the conformational changes imposed upon I binding.  The most prominent conformational changes that occurred in the presence of I involved Tyr-128 and Phe-232 that were present on the surface of the NQO1 catalytic pocket.  On the basis of the comparison of the NQO1 structure in complex with different NQO1 inhibitors and the authors' previous anal. of NQO1 mutants, it was proposed that the specific conformations of Tyr-128 and Phe-232 are important for NQO1 interaction with p53 and other client proteins.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrkSa4EYFO7G7Vg90H21EOLACvtfcHk0lgXl19lqg2OCg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XjvVSnsbw%253D&md5=518fc56112b1093246f8d41ff6bbcc9e</span></div><a href="/servlet/linkout?suffix=cit43&amp;dbid=16384&amp;doi=10.1021%2Fbi0600087&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi0600087%26sid%3Dliteratum%253Aachs%26aulast%3DAsher%26aufirst%3DG.%26aulast%3DDym%26aufirst%3DO.%26aulast%3DTsvetkov%26aufirst%3DP.%26aulast%3DAdler%26aufirst%3DJ.%26aulast%3DShaul%26aufirst%3DY.%26atitle%3DThe%2520crystal%2520structure%2520of%2520NAD%2528P%2529H%2520quinone%2520oxidoreductase%25201%2520in%2520complex%2520with%2520its%2520potent%2520inhibitor%2520dicoumarol%26jtitle%3DBiochemistry%26date%3D2006%26volume%3D45%26spage%3D6372%26epage%3D6378%26doi%3D10.1021%2Fbi0600087" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref44"><div class="reference"><strong class="refLabel"><a href="#ref44" class="rightTabRefNumLink">44</a></strong><div class="NLM_citation" id="rightTab-cit44"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hargreaves, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hudnott, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structure-based development of anticancer drugs: complexes of NAD(P)H:quinone oxidoreductase 1 with chemotherapeutic quinones</span>. <i>Structure</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">659</span>– <span class="NLM_lpage">667</span>, <span class="refDoi"> DOI: 10.1016/S0969-2126(01)00636-0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref44/cit44&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0969-2126%2801%2900636-0" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2001&pages=659-667&author=M.+Faigauthor=M.+A.+Bianchetauthor=S.+Winskiauthor=R.+Hargreavesauthor=C.+J.+Moodyauthor=A.+R.+Hudnottauthor=D.+Rossauthor=L.+M.+Amzel&title=Structure-based+development+of+anticancer+drugs%3A+complexes+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+with+chemotherapeutic+quinones&doi=10.1016%2FS0969-2126%2801%2900636-0"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit44&amp;dbid=16384&amp;doi=10.1016%2FS0969-2126%2801%2900636-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0969-2126%252801%252900636-0%26sid%3Dliteratum%253Aachs%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DWinski%26aufirst%3DS.%26aulast%3DHargreaves%26aufirst%3DR.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DHudnott%26aufirst%3DA.%2BR.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructure-based%2520development%2520of%2520anticancer%2520drugs%253A%2520complexes%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520with%2520chemotherapeutic%2520quinones%26jtitle%3DStructure%26date%3D2001%26volume%3D9%26spage%3D659%26epage%3D667%26doi%3D10.1016%2FS0969-2126%2801%2900636-0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref45"><div class="reference"><strong class="refLabel"><a href="#ref45" class="rightTabRefNumLink">45</a></strong><div class="NLM_citation" id="rightTab-cit45"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maharjan, B. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ebrahimian, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seradj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stocksdale, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mohammadi, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Marvin, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span> <span> </span><span class="NLM_article-title">Novel lavendamycin analogues as antitumor agents: synthesis, in vitro cytotoxicity, structure-metabolism, and computational molecular modeling studies with NAD(P)H:quinone oxidoreductase 1</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">7733</span>– <span class="NLM_lpage">774946</span>, <span class="refDoi"> DOI: 10.1021/jm050758z</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm050758z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2005&pages=7733-774946&author=M.+Hassaniauthor=W.+Caiauthor=D.+C.+Holleyauthor=J.+P.+Lineswalaauthor=B.+R.+Maharjanauthor=G.+R.+Ebrahimianauthor=H.+Seradjauthor=M.+G.+Stocksdaleauthor=F.+Mohammadiauthor=C.+C.+Marvinauthor=J.+M.+Gerdesauthor=H.+D.+Beallauthor=M.+Behforouz&title=Novel+lavendamycin+analogues+as+antitumor+agents%3A+synthesis%2C+in+vitro+cytotoxicity%2C+structure-metabolism%2C+and+computational+molecular+modeling+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1021%2Fjm050758z"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit45&amp;dbid=16384&amp;doi=10.1021%2Fjm050758z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm050758z%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DMaharjan%26aufirst%3DB.%2BR.%26aulast%3DEbrahimian%26aufirst%3DG.%2BR.%26aulast%3DSeradj%26aufirst%3DH.%26aulast%3DStocksdale%26aufirst%3DM.%2BG.%26aulast%3DMohammadi%26aufirst%3DF.%26aulast%3DMarvin%26aufirst%3DC.%2BC.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DBehforouz%26aufirst%3DM.%26atitle%3DNovel%2520lavendamycin%2520analogues%2520as%2520antitumor%2520agents%253A%2520synthesis%252C%2520in%2520vitro%2520cytotoxicity%252C%2520structure-metabolism%252C%2520and%2520computational%2520molecular%2520modeling%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2005%26volume%3D48%26spage%3D7733%26epage%3D774946%26doi%3D10.1021%2Fjm050758z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref46"><div class="reference"><strong class="refLabel"><a href="#ref46" class="rightTabRefNumLink">46</a></strong><div class="NLM_citation" id="rightTab-cit46"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Alcaín, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Villalba, J. M.</span></span> <span> </span><span class="NLM_article-title">NQO1-directed antitumour quinones</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">649</span>– <span class="NLM_lpage">665</span>, <span class="refDoi"> DOI: 10.1517/13543776.17.6.649</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1517%2F13543776.17.6.649" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref46/cit46&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXntFWqt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=649-665&author=F.+J.+Alca%C3%ADnauthor=J.+M.+Villalba&title=NQO1-directed+antitumour+quinones&doi=10.1517%2F13543776.17.6.649"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit46R"><div class="casContent"><span class="casTitleNuber">46</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1-directed antitumour quinones</span></div><div class="casAuthors">Alcain, Francisco J.; Villalba, Jose M.</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">649-665</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  NAD(P)H:(quinone acceptor) oxidoreductase 1 (NQO1) is a cytosolic flavoenzyme that catalyzes the obligatory two-electron redn. of several quinones to their corresponding hydroquinones by using both NADH and NADPH.  NQO1 has relevance in chemotherapy because bioreductive drugs require enzymic activation prior to conversion into cytotoxic compds.  Because levels of NQO1 are elevated in some tumors, the enzyme provides an opportunity to develop improved new chemotherapeutic drugs that are bioactivated by this enzyme.  The classical NQO1-directed drugs are quinone-contg. alkylating agents, such as the prototypical bioreductive agent mitomycin C, and different azirinidylbenzoquinones, such as 2,5 bis-[1-aziridyl]-1,4 benzoquinone, that target DNA crosslinks and strand breaks after redn.  New analogs of those quinones, such as EO9 and RH1, have been developed to overcome the poor substrate specificity and poor soly. in aq. soln. to improve its therapeutic utilization.  Also, NQO1 is implied in the activation of new drugs that act as inhibitors of different proteins. β-Lapachone is not a DNA damaging agent and preclin. studies have shown very promising results.  The benzoquinone ansamycins, 17-allylamino,17-demethoxygeldanamycin and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin, which exhibit anticancer activity by binding to heat-shock protein 90 (Hsp90), are also in clin. trials.  NQO1 activity needs a threshold value to induce cytotoxicity.  As a polymorphism in NQO1, known as NQO1*2, results in dramatically decreased NQO1 enzyme activity, NQO1 polymorphism should be carefully monitored in the patients before the use of NQO1-directed drugs.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKqsFzr5qNvbVg90H21EOLACvtfcHk0liZyevK_QKCiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXntFWqt78%253D&md5=62fa440c64accbd447a61dc504721e5e</span></div><a href="/servlet/linkout?suffix=cit46&amp;dbid=16384&amp;doi=10.1517%2F13543776.17.6.649&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.17.6.649%26sid%3Dliteratum%253Aachs%26aulast%3DAlca%25C3%25ADn%26aufirst%3DF.%2BJ.%26aulast%3DVillalba%26aufirst%3DJ.%2BM.%26atitle%3DNQO1-directed%2520antitumour%2520quinones%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2007%26volume%3D17%26spage%3D649%26epage%3D665%26doi%3D10.1517%2F13543776.17.6.649" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref47"><div class="reference"><strong class="refLabel"><a href="#ref47" class="rightTabRefNumLink">47</a></strong><div class="NLM_citation" id="rightTab-cit47"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cismesia, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Efficient NQO1 substrates are potent and selective anticancer agents</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">2173</span>– <span class="NLM_lpage">2183</span>, <span class="refDoi"> DOI: 10.1021/cb4005832</span> </span><div class="citationLinks">[<a href="/doi/10.1021/cb4005832" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref47/cit47&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXht1Cqtb7M" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2013&pages=2173-2183&author=E.+I.+Parkinsonauthor=J.+S.+Bairauthor=M.+Cismesiaauthor=P.+J.+Hergenrother&title=Efficient+NQO1+substrates+are+potent+and+selective+anticancer+agents&doi=10.1021%2Fcb4005832"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit47R"><div class="casContent"><span class="casTitleNuber">47</span><div class="casTitle"><span class="NLM_cas:atitle">Efficient NQO1 Substrates are Potent and Selective Anticancer Agents</span></div><div class="casAuthors">Parkinson, Elizabeth I.; Bair, Joseph S.; Cismesia, Megan; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2173-2183</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A major goal of personalized medicine in oncol. is the identification of drugs with predictable efficacy based on a specific trait of the cancer cell, as has been demonstrated with gleevec (presence of Bcr-Abl protein), herceptin (Her2 overexpression), and iressa (presence of a specific EGFR mutation).  This is a challenging task, as it requires identifying a cellular component that is altered in cancer, but not normal cells, and discovering a compd. that specifically interacts with it.  The enzyme NQO1 is a potential target for personalized medicine, as it is overexpressed in many solid tumors.  In normal cells NQO1 is inducibly expressed, and its major role is to detoxify quinones via bioredn.; however, certain quinones become more toxic after redn. by NQO1, and these compds. have potential as selective anticancer agents.  Several quinones of this type have been reported, including mitomycin C, RH1, EO9, streptonigrin, β-lapachone, and deoxynyboquinone (DNQ, I).  However, no unified picture has emerged from these studies, and the key question regarding the relationship between NQO1 processing and anticancer activity remains unanswered.  Here, we directly compare these quinones as substrates for NQO1 in vitro, and for their ability to kill cancer cells in culture in an NQO1-dependent manner.  We show that DNQ is a superior NQO1 substrate, and we use computationally guided design to create DNQ analogs that have a spectrum of activities with NQO1.  Assessment of these compds. definitively establishes a strong relationship between in vitro NQO1 processing and induction of cancer cell death and suggests these compds. are outstanding candidates for selective anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1kk91zQCbDrVg90H21EOLACvtfcHk0liZyevK_QKCiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXht1Cqtb7M&md5=589e4483d77ac0534e4098ae8c9c4760</span></div><a href="/servlet/linkout?suffix=cit47&amp;dbid=16384&amp;doi=10.1021%2Fcb4005832&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcb4005832%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DCismesia%26aufirst%3DM.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DEfficient%2520NQO1%2520substrates%2520are%2520potent%2520and%2520selective%2520anticancer%2520agents%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2013%26volume%3D8%26spage%3D2173%26epage%3D2183%26doi%3D10.1021%2Fcb4005832" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref48"><div class="reference"><strong class="refLabel"><a href="#ref48" class="rightTabRefNumLink">48</a></strong><div class="NLM_citation" id="rightTab-cit48"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holley, D. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holloway, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerdes, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span> <span> </span><span class="NLM_article-title">Lavendamycin antitumor agents: structure-based design, synthesis, and NAD(P)H:quinone oxidoreductase 1 (NQO1) model validation with molecular docking and biological studies</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">3104</span>– <span class="NLM_lpage">3115</span>, <span class="refDoi"> DOI: 10.1021/jm701066a</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm701066a" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref48/cit48&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1cXlsVKmur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=3104-3115&author=M.+Hassaniauthor=W.+Caiauthor=K.+H.+Koelschauthor=D.+C.+Holleyauthor=A.+S.+Roseauthor=F.+Olangauthor=J.+P.+Lineswalaauthor=W.+G.+Hollowayauthor=J.+M.+Gerdesauthor=M.+Behforouzauthor=H.+D.+Beall&title=Lavendamycin+antitumor+agents%3A+structure-based+design%2C+synthesis%2C+and+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+model+validation+with+molecular+docking+and+biological+studies&doi=10.1021%2Fjm701066a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit48R"><div class="casContent"><span class="casTitleNuber">48</span><div class="casTitle"><span class="NLM_cas:atitle">Lavendamycin Antitumor Agents: Structure-Based Design, Synthesis, and NAD(P)H:Quinone Oxidoreductase 1 (NQO1) Model Validation with Molecular Docking and Biological Studies</span></div><div class="casAuthors">Hassani, Mary; Cai, Wen; Koelsch, Katherine H.; Holley, David C.; Rose, Anthony S.; Olang, Fatemeh; Lineswala, Jayana P.; Holloway, William G.; Gerdes, John M.; Behforouz, Mohammad; Beall, Howard D.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">3104-3115</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A 1H69 crystal structure-based in silico model of the NAD(P)H:quinone oxidoreductase 1 (NQO1) active site has been developed to facilitate NQO1-directed lavendamycin antitumor agent development.  Lavendamycin analogs, e.g. I, were designed as NQO1 substrates utilizing structure-based design criteria.  Computational docking studies were performed using the model to predict NQO1 substrate specificity.  Designed N-acyllavendamycin esters and amides were synthesized by Pictet-Spengler condensation.  Metab. and cytotoxicity studies were performed on the analogs with recombinant human NQO1 and human colon adenocarcinoma cells (NQO1-deficient BE and NQO1-rich BE-NQ).  Docking and biol. data were found to be correlated where analogs were categorized as good, poor, poor, poor, and good NQO1 substrates, resp.  Our results demonstrated that the ligand design criteria were valid, resulting in the discovery of two good NQO1 substrates.  The obsd. consistency between the docking and biol. data suggests that the model possesses practical predictive power.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUcaMyIPjnRrVg90H21EOLACvtfcHk0liZyevK_QKCiA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXlsVKmur4%253D&md5=993bc0a63b2e61cc7a190788c655eb7e</span></div><a href="/servlet/linkout?suffix=cit48&amp;dbid=16384&amp;doi=10.1021%2Fjm701066a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701066a%26sid%3Dliteratum%253Aachs%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DCai%26aufirst%3DW.%26aulast%3DKoelsch%26aufirst%3DK.%2BH.%26aulast%3DHolley%26aufirst%3DD.%2BC.%26aulast%3DRose%26aufirst%3DA.%2BS.%26aulast%3DOlang%26aufirst%3DF.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DHolloway%26aufirst%3DW.%2BG.%26aulast%3DGerdes%26aufirst%3DJ.%2BM.%26aulast%3DBehforouz%26aufirst%3DM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26atitle%3DLavendamycin%2520antitumor%2520agents%253A%2520structure-based%2520design%252C%2520synthesis%252C%2520and%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520model%2520validation%2520with%2520molecular%2520docking%2520and%2520biological%2520studies%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D3104%26epage%3D3115%26doi%3D10.1021%2Fjm701066a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref49"><div class="reference"><strong class="refLabel"><a href="#ref49" class="rightTabRefNumLink">49</a></strong><div class="NLM_citation" id="rightTab-cit49"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Affinity-based small fluorescent probe for NAD(P)H:quinone oxidoreductase 1 (NQO1). Design, synthesis and pharmacological evaluation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>127</i></span>,  <span class="NLM_fpage">828</span>– <span class="NLM_lpage">839</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2016.10.062</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref49/cit49&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2016.10.062" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=127&publication_year=2017&pages=828-839&author=J.+Bianauthor=X.+Liauthor=L.+Xuauthor=N.+Wangauthor=X.+Qianauthor=Q.+Youauthor=X.+Zhang&title=Affinity-based+small+fluorescent+probe+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29.+Design%2C+synthesis+and+pharmacological+evaluation&doi=10.1016%2Fj.ejmech.2016.10.062"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit49&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2016.10.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2016.10.062%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DAffinity-based%2520small%2520fluorescent%2520probe%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529.%2520Design%252C%2520synthesis%2520and%2520pharmacological%2520evaluation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D127%26spage%3D828%26epage%3D839%26doi%3D10.1016%2Fj.ejmech.2016.10.062" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref50"><div class="reference"><strong class="refLabel"><a href="#ref50" class="rightTabRefNumLink">50</a></strong><div class="NLM_citation" id="rightTab-cit50"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Foster, C. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Talalay, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span> <span> </span><span class="NLM_article-title">Structures of mammalian cytosolic quinone reductases</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">241</span>– <span class="NLM_lpage">245</span>, <span class="refDoi"> DOI: 10.1016/S0891-5849(00)00299-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0891-5849%2800%2900299-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11035252" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref50/cit50&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=2000&pages=241-245&author=C.+E.+Fosterauthor=M.+A.+Bianchetauthor=P.+Talalayauthor=M.+Faigauthor=L.+M.+Amzel&title=Structures+of+mammalian+cytosolic+quinone+reductases&doi=10.1016%2FS0891-5849%2800%2900299-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit50R"><div class="casContent"><span class="casTitleNuber">50</span><div class="casTitle"><span class="NLM_cas:atitle">Structures of mammalian cytosolic quinone reductases</span></div><div class="casAuthors">Foster, Christine E.; Bianchet, Mario A.; Talalay, Paul; Faig, Margarita; Amzel, L. Mario</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">29</span>
        (<span class="NLM_cas:issue">3/4</span>),
    <span class="NLM_cas:pages">241-245</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Inc.</span>)
        </div><div class="casAbstract">A review with 14 refs.  The metab. of quinone compds. presents one source of oxidative stress in mammals, as many pathways proceed by mechanisms that generate reactive oxygen species as byproducts.  One defense against quinone toxicity is the enzyme NAD(P)H:quinone oxidoreductase type 1 (QR1), which metabolizes quinones by a two-electron redn. mechanism, thus averting prodn. of radicals.  QR1 is expressed in the cytoplasm of many tissues, and is highly inducible.  A closely related homolog, quinone reductase type 2 (QR2), has been identified in several mammalian species.  QR2 is also capable of reducing quinones to hydroquinones, but unlike QR1, cannot use NAD(P)H.  X-ray crystallog. studies of QR1 and QR2 illustrate that despite their different biochem. properties, these enzymes have very similar three-dimensional structures.  In particular, conserved features of the active sites point to the close relationship between these two enzymes.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqv8qE1WvdS7Vg90H21EOLACvtfcHk0ljjA6gNAQg_jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXnslWmtrg%253D&md5=dec7a440e344046491917934f56f5313</span></div><a href="/servlet/linkout?suffix=cit50&amp;dbid=16384&amp;doi=10.1016%2FS0891-5849%2800%2900299-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0891-5849%252800%252900299-9%26sid%3Dliteratum%253Aachs%26aulast%3DFoster%26aufirst%3DC.%2BE.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DTalalay%26aufirst%3DP.%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26atitle%3DStructures%2520of%2520mammalian%2520cytosolic%2520quinone%2520reductases%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2000%26volume%3D29%26spage%3D241%26epage%3D245%26doi%3D10.1016%2FS0891-5849%2800%2900299-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref51"><div class="reference"><strong class="refLabel"><a href="#ref51" class="rightTabRefNumLink">51</a></strong><div class="NLM_citation" id="rightTab-cit51"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dufour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gomez, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Indolequinone inhibitors of NRH:quinone oxidoreductase 2. Characterization of the mechanism of inhibition in both cell-free and cellular systems</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6678</span>– <span class="NLM_lpage">6688</span>, <span class="refDoi"> DOI: 10.1021/bi2002967</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi2002967" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2011&pages=6678-6688&author=C.+Yanauthor=M.+Dufourauthor=D.+Siegelauthor=P.+Reiganauthor=J.+Gomezauthor=B.+Shiehauthor=C.+J.+Moodyauthor=D.+Ross&title=Indolequinone+inhibitors+of+NRH%3Aquinone+oxidoreductase+2.+Characterization+of+the+mechanism+of+inhibition+in+both+cell-free+and+cellular+systems&doi=10.1021%2Fbi2002967"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit51&amp;dbid=16384&amp;doi=10.1021%2Fbi2002967&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi2002967%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%26aulast%3DDufour%26aufirst%3DM.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DGomez%26aufirst%3DJ.%26aulast%3DShieh%26aufirst%3DB.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DIndolequinone%2520inhibitors%2520of%2520NRH%253Aquinone%2520oxidoreductase%25202.%2520Characterization%2520of%2520the%2520mechanism%2520of%2520inhibition%2520in%2520both%2520cell-free%2520and%2520cellular%2520systems%26jtitle%3DBiochemistry%26date%3D2011%26volume%3D50%26spage%3D6678%26epage%3D6688%26doi%3D10.1021%2Fbi2002967" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref52"><div class="reference"><strong class="refLabel"><a href="#ref52" class="rightTabRefNumLink">52</a></strong><div class="NLM_citation" id="rightTab-cit52"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Long, D. J.,  2nd</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, A. K.</span></span> <span> </span><span class="NLM_article-title">NRH:quinone oxidoreductase2 (NQO2)</span>. <i>Chem.-Biol. Interact.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">99</span>– <span class="NLM_lpage">112</span>, <span class="refDoi"> DOI: 10.1016/S0009-2797(00)00200-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0009-2797%2800%2900200-3" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11154737" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref52/cit52&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXitlOnug%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2000&pages=99-112&author=D.+J.+Longauthor=A.+K.+Jaiswal&title=NRH%3Aquinone+oxidoreductase2+%28NQO2%29&doi=10.1016%2FS0009-2797%2800%2900200-3"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit52R"><div class="casContent"><span class="casTitleNuber">52</span><div class="casTitle"><span class="NLM_cas:atitle">NRH:quinone oxidoreductase2 (NQO2)</span></div><div class="casAuthors">Long, D. J.; Jaiswal, A. K.</div><div class="citationInfo"><span class="NLM_cas:title">Chemico-Biological Interactions</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">99-112</span>CODEN:
                <span class="NLM_cas:coden">CBINA8</span>;
        ISSN:<span class="NLM_cas:issn">0009-2797</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review, with 73 refs.  The quinone oxidoreductases [NAD(P)H:quinone oxidoreductase1 (NQO1) and NRH:quinone oxidoreductase2 (NQO2)] are flavoproteins.  NQO1 is known to catalyze metabolic detoxification of quinones and protect cells from redox cycling, oxidative stress and neoplasia.  NQO2 is a 231 amino acid protein (25956 mw) that is 43 amino acids shorter than NQO1 at its C-terminus.  The human NQO2 cDNA and protein are 54 and 49% similar to the human liver cytosolic NQO1 cDNA and protein.  Recent studies have revealed that NQO2 differs from NQO1 in its cofactor requirement.  NQO2 uses dihydronicotinamide riboside (NRH) rather than NAD(P)H as an electron donor.  Another difference between NQO1 and NQO2 is that NQO2 is resistant to typical inhibitors of NQO1, such as dicoumarol, Cibacron blue and phenindone.  Flavones, including quercetin and benzo(a)pyrene, are known inhibitors of NQO2.  Even though overlapping substrate specificities have been obsd. for NQO1 and NQO2, significant differences exist in relative affinities for the various substrates.  Anal. of the crystal structure of NQO2 revealed that NQO2 contains a specific metal binding site, which is not present in NQO1.  The human NQO2 gene has been precisely localized to chromosome 6p25.  The human NQO2 gene locus is highly polymorphic.  The NQO2 gene is ubiquitously expressed and induced in response to TCDD.  Nucleotide sequence anal. of the NQO2 gene promoter revealed the presence of several cis-elements, including SP1 binding sites, CCAAT box, xenobiotic response element (XRE) and an antioxidant response element (ARE).  The complement of these elements regulates tissue specific expression and induction of the NQO2 gene in response to xenobiotics and antioxidants.  The in vivo role of NQO2 and its role in quinone detoxification remains unknown.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq-3DSF4CJxcLVg90H21EOLACvtfcHk0ljjA6gNAQg_jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXitlOnug%253D%253D&md5=6180e990aec3b7754653993364e52159</span></div><a href="/servlet/linkout?suffix=cit52&amp;dbid=16384&amp;doi=10.1016%2FS0009-2797%2800%2900200-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0009-2797%252800%252900200-3%26sid%3Dliteratum%253Aachs%26aulast%3DLong%26aufirst%3DD.%2BJ.%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26atitle%3DNRH%253Aquinone%2520oxidoreductase2%2520%2528NQO2%2529%26jtitle%3DChem.-Biol.%2520Interact.%26date%3D2000%26volume%3D129%26spage%3D99%26epage%3D112%26doi%3D10.1016%2FS0009-2797%2800%2900200-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref53"><div class="reference"><strong class="refLabel"><a href="#ref53" class="rightTabRefNumLink">53</a></strong><div class="NLM_citation" id="rightTab-cit53"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nioi, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hayes, J. D.</span></span> <span> </span><span class="NLM_article-title">Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors</span>. <i>Mutat. Res., Fundam. Mol. Mech. Mutagen.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>555</i></span>,  <span class="NLM_fpage">149</span>– <span class="NLM_lpage">171</span>, <span class="refDoi"> DOI: 10.1016/j.mrfmmm.2004.05.023</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.mrfmmm.2004.05.023" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15476858" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref53/cit53&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXot12gs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=555&publication_year=2004&pages=149-171&author=P.+Nioiauthor=J.+D.+Hayes&title=Contribution+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+to+protection+against+carcinogenesis%2C+and+regulation+of+its+gene+by+the+Nrf2+basic-region+leucine+zipper+and+the+arylhydrocarbon+receptor+basic+helix-loop-helix+transcription+factors&doi=10.1016%2Fj.mrfmmm.2004.05.023"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit53R"><div class="casContent"><span class="casTitleNuber">53</span><div class="casTitle"><span class="NLM_cas:atitle">Contribution of NAD(P)H:quinone oxidoreductase 1 to protection against carcinogenesis, and regulation of its gene by the Nrf2 basic-region leucine zipper and the arylhydrocarbon receptor basic helix-loop-helix transcription factors</span></div><div class="casAuthors">Nioi, Paul; Hayes, John D.</div><div class="citationInfo"><span class="NLM_cas:title">Mutation Research, Fundamental and Molecular Mechanisms of Mutagenesis</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">555</span>
        (<span class="NLM_cas:issue">1-2</span>),
    <span class="NLM_cas:pages">149-171</span>CODEN:
                <span class="NLM_cas:coden">MUREAV</span>;
        ISSN:<span class="NLM_cas:issn">0027-5107</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A review.  NAD(P)H:quinone oxidoreductase 1 (NQO1) is a key enzyme involved in defense against reactive forms of oxygen and inhibition of neoplasia.  Under conditions of oxidative stress, expression of NQO1 is induced, and the resulting increase in oxidoreductase protein provides the cell with multiple layers of protection against environmental insults.  Firstly, the catalytic activity of NQO1 is directed towards the complete redn. and detoxication of highly reactive quinones.  Secondly, the oxidoreductase maintains the endogenous lipid-sol. antioxidants, α-tocopherol-hydroquinone and ubiquinol in their reduced and active forms.  Thirdly, NQO1 is required for the stabilization of p53 protein in response to DNA-damaging stimuli, and it thereby influences cell fate decisions.  In view of the anticarcinogenic actions of NQO1, an understanding of the mechanisms that govern its expression is desirable.  The redox sensitivity of NQO1 transcription occurs through a cis-acting antioxidant response element (ARE) located within the regulatory region of the mouse, rat and human genes.  This element recruits the pos. acting basic leucine zipper (bZip) transcription factor NF-E2 p45-related factor 2 (Nrf2).  Under normal constitutive conditions, Nrf2 assocs. with the cytoskeletal-binding protein Keap1, which regulates the subcellular distribution of the bZip factor and also targets it for proteasome-dependent degrdn.  Oxidative stress inhibits the Nrf2-Keap1 interaction, thus promoting nuclear accumulation of the transcription factor and transactivation of NQO1 and other ARE-driven genes.  Mouse, rat and human NQO1 can also be induced by planar arom. hydrocarbons through a cis-acting xenobiotic response element (XRE) located in their gene promoters.  The XRE recruits the arylhydrocarbon receptor (AhR) and AhR nuclear translocator.  Cross-talk may occur between Nrf2 and AhR, but the details of this process remain to be elucidated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7W-E8vNF8ALVg90H21EOLACvtfcHk0ljjA6gNAQg_jA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXot12gs7w%253D&md5=e57ca8beda945db8d929c3bfbb9472a0</span></div><a href="/servlet/linkout?suffix=cit53&amp;dbid=16384&amp;doi=10.1016%2Fj.mrfmmm.2004.05.023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.mrfmmm.2004.05.023%26sid%3Dliteratum%253Aachs%26aulast%3DNioi%26aufirst%3DP.%26aulast%3DHayes%26aufirst%3DJ.%2BD.%26atitle%3DContribution%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520to%2520protection%2520against%2520carcinogenesis%252C%2520and%2520regulation%2520of%2520its%2520gene%2520by%2520the%2520Nrf2%2520basic-region%2520leucine%2520zipper%2520and%2520the%2520arylhydrocarbon%2520receptor%2520basic%2520helix-loop-helix%2520transcription%2520factors%26jtitle%3DMutat.%2520Res.%252C%2520Fundam.%2520Mol.%2520Mech.%2520Mutagen.%26date%3D2004%26volume%3D555%26spage%3D149%26epage%3D171%26doi%3D10.1016%2Fj.mrfmmm.2004.05.023" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref54"><div class="reference"><strong class="refLabel"><a href="#ref54" class="rightTabRefNumLink">54</a></strong><div class="NLM_citation" id="rightTab-cit54"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Awadallah, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Russell Nash, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentz, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shroyer, K. R.</span></span> <span> </span><span class="NLM_article-title">NQO1 expression in pancreatic cancer and its potential use as a biomarker</span>. <i>Appl. Immunohistochem. Mol. Morphol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">24</span>– <span class="NLM_lpage">31</span>, <span class="refDoi"> DOI: 10.1097/PAI.0b013e31802e91d0</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1097%2FPAI.0b013e31802e91d0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=18091324" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref54/cit54&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BD1c%252FlsF2msA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2008&pages=24-31&author=N.+S.+Awadallahauthor=D.+Dehnauthor=R.+J.+Shahauthor=S.+Russell+Nashauthor=Y.+K.+Chenauthor=D.+Rossauthor=J.+S.+Bentzauthor=K.+R.+Shroyer&title=NQO1+expression+in+pancreatic+cancer+and+its+potential+use+as+a+biomarker&doi=10.1097%2FPAI.0b013e31802e91d0"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit54R"><div class="casContent"><span class="casTitleNuber">54</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1 expression in pancreatic cancer and its potential use as a biomarker</span></div><div class="casAuthors">Awadallah Nida S; Dehn Donna; Shah Raj J; Russell Nash S; Chen Yang K; Ross David; Bentz Joel S; Shroyer Kenneth R</div><div class="citationInfo"><span class="NLM_cas:title">Applied immunohistochemistry & molecular morphology : AIMM</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">24-31</span>
        ISSN:<span class="NLM_cas:issn">1541-2016</span>.
    </div><div class="casAbstract">Pancreatic ductal adenocarcinoma (PDA) is rarely curable due to regional/metastatic spread at diagnosis.  Identification of molecular markers may enhance diagnosis and early detection of PDA.  The 2-electron reductase, NAD(P)H:quinone oxidoreductase (NQO1) has been found to be overexpressed in many solid tumors including PDA, and may be a useful clinically relevant diagnostic marker of malignancy.  For this study, we used 37 surgical resection cases: 24 PDAs and 13 benign pancreatic tissue specimens.  An additional 16 specimens from pancreatic endoscopic ultrasound-guided fine needle aspiration (EUS-FNA) were included as a pilot series.  NQO1 was detected by avidin-biotin based immunohistochemical and immunocytochemical methods.  Both staining intensity and proportion of NQO1 positive tumor cells were scored.  Moderate to strong (2 to 3+) staining for NQO1 was detected in 22/24 (92%) surgically resected PDAs, 9/9 (100%) EUS-FNAs with malignant diagnoses, one cytologically atypical but not diagnostic for malignancy EUS-FNA, and 1/6 (17%) EUS-FNAs initially diagnosed as negative for malignancy.  Subsequent histologic assessment confirmed malignancy in all 9 cytologically positive EUS-FNAs and in the atypical case.  The NQO1 positive case initially diagnosed as negative for malignancy showed no evidence of carcinoma on subsequent tissue biopsy.  NQO1 staining was also observed in some benign ducts/cells; however, correlation of NQO1 expression with cellular morphology assessment minimizes the risk of false positive diagnosis.  NQO1 is consistently overexpressed in PDA.  Although NQO1 is observed in some benign tissue components, this marker may be a clinically useful diagnostic adjunct for detection of PDA, independent of tumor grade/stage.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQhxgbKcVaHKy6Ufuk_1xoTfW6udTcc2ebjdsloP0K8SLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD1c%252FlsF2msA%253D%253D&md5=f1117fb75ec0de6638489607d82a2603</span></div><a href="/servlet/linkout?suffix=cit54&amp;dbid=16384&amp;doi=10.1097%2FPAI.0b013e31802e91d0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1097%252FPAI.0b013e31802e91d0%26sid%3Dliteratum%253Aachs%26aulast%3DAwadallah%26aufirst%3DN.%2BS.%26aulast%3DDehn%26aufirst%3DD.%26aulast%3DShah%26aufirst%3DR.%2BJ.%26aulast%3DRussell%2BNash%26aufirst%3DS.%26aulast%3DChen%26aufirst%3DY.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBentz%26aufirst%3DJ.%2BS.%26aulast%3DShroyer%26aufirst%3DK.%2BR.%26atitle%3DNQO1%2520expression%2520in%2520pancreatic%2520cancer%2520and%2520its%2520potential%2520use%2520as%2520a%2520biomarker%26jtitle%3DAppl.%2520Immunohistochem.%2520Mol.%2520Morphol.%26date%3D2008%26volume%3D16%26spage%3D24%26epage%3D31%26doi%3D10.1097%2FPAI.0b013e31802e91d0" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref55"><div class="reference"><strong class="refLabel"><a href="#ref55" class="rightTabRefNumLink">55</a></strong><div class="NLM_citation" id="rightTab-cit55"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Madajewski, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span> <span> </span><span class="NLM_article-title">Depleting tumor-NQO1 potentiates anoikis and inhibits growth of NSCLC</span>. <i>Mol. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">14</span>– <span class="NLM_lpage">25</span>, <span class="refDoi"> DOI: 10.1158/1541-7786.MCR-15-0207-T</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1541-7786.MCR-15-0207-T" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26553038" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref55/cit55&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XpsFOqsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=14-25&author=B.+Madajewskiauthor=M.+A.+Boatmanauthor=G.+Chakrabartiauthor=D.+A.+Boothmanauthor=E.+A.+Bey&title=Depleting+tumor-NQO1+potentiates+anoikis+and+inhibits+growth+of+NSCLC&doi=10.1158%2F1541-7786.MCR-15-0207-T"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit55R"><div class="casContent"><span class="casTitleNuber">55</span><div class="casTitle"><span class="NLM_cas:atitle">Depleting Tumor-NQO1 Potentiates Anoikis and Inhibits Growth of NSCLC</span></div><div class="casAuthors">Madajewski, Brian; Boatman, Michael A.; Chakrabarti, Gaurab; Boothman, David A.; Bey, Erik A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Research</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">14-25</span>CODEN:
                <span class="NLM_cas:coden">MCROC5</span>;
        ISSN:<span class="NLM_cas:issn">1541-7786</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The fundamental role that NAD(P)H/quinone oxidoreductase 1 (NQO1) plays, in normal cells, as a cytoprotective enzyme guarding against stress induced by reactive oxygen species (ROS) is well documented.  However, what is not known is whether the obsd. overexpression of NQO1 in neoplastic cells contributes to their survival.  The current study discovered that depleting NQO1 expression in A549 and H292 lung adenocarcinoma cells caused an increase in ROS formation, inhibited anchorage-independent growth, increased anoikis sensitization, and decreased three-dimensional tumor spheroid invasion.  These in vivo data further implicate tumor-NQO1 expression in a protumor survival role, because its depletion suppressed cell proliferation and decreased lung tumor xenograft growth.  Finally, these data reveal an exploitable link between tumor-NQO1 expression and the survival of lung tumors because NQO1 depletion significantly decreased the percentage of ALDH(high) cancer cells within the tumor population.  Implications: Loss of tumor-NQO1 expression inhibits tumor growth and suggests that novel therapeutics directed at tumor-NQO1 may have clin. benefit.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoG23XWx6fObLVg90H21EOLACvtfcHk0ljGbYZDBttQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XpsFOqsg%253D%253D&md5=79ec188e9d2ff4583ef1c9849f6f03ff</span></div><a href="/servlet/linkout?suffix=cit55&amp;dbid=16384&amp;doi=10.1158%2F1541-7786.MCR-15-0207-T&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1541-7786.MCR-15-0207-T%26sid%3Dliteratum%253Aachs%26aulast%3DMadajewski%26aufirst%3DB.%26aulast%3DBoatman%26aufirst%3DM.%2BA.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DBey%26aufirst%3DE.%2BA.%26atitle%3DDepleting%2520tumor-NQO1%2520potentiates%2520anoikis%2520and%2520inhibits%2520growth%2520of%2520NSCLC%26jtitle%3DMol.%2520Cancer%2520Res.%26date%3D2016%26volume%3D14%26spage%3D14%26epage%3D25%26doi%3D10.1158%2F1541-7786.MCR-15-0207-T" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref56"><div class="reference"><strong class="refLabel"><a href="#ref56" class="rightTabRefNumLink">56</a></strong><div class="NLM_citation" id="rightTab-cit56"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Menegon, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Columbano, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giordano, S.</span></span> <span> </span><span class="NLM_article-title">The dual roles of NRF2 in cancer</span>. <i>Trends Mol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">578</span>– <span class="NLM_lpage">593</span>, <span class="refDoi"> DOI: 10.1016/j.molmed.2016.05.002</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.molmed.2016.05.002" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27263465" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref56/cit56&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2016&pages=578-593&author=S.+Menegonauthor=A.+Columbanoauthor=S.+Giordano&title=The+dual+roles+of+NRF2+in+cancer&doi=10.1016%2Fj.molmed.2016.05.002"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit56R"><div class="casContent"><span class="casTitleNuber">56</span><div class="casTitle"><span class="NLM_cas:atitle">The Dual Roles of NRF2 in Cancer</span></div><div class="casAuthors">Menegon, Silvia; Columbano, Amedeo; Giordano, Silvia</div><div class="citationInfo"><span class="NLM_cas:title">Trends in Molecular Medicine</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">578-593</span>CODEN:
                <span class="NLM_cas:coden">TMMRCY</span>;
        ISSN:<span class="NLM_cas:issn">1471-4914</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">A review.  NRF2 has been traditionally considered as a tumor suppressor because its cytoprotective functions are deemed to be the main cellular defense mechanism against exogenous and endogenous insults, including xenobiotics and oxidative stress.  However, several recent studies demonstrate that hyperactivation of the NRF2 pathway creates an environment that favors the survival of normal as well as malignant cells, protecting them against oxidative stress, chemotherapeutic agents, and radiotherapy.  In a rapidly advancing field, this review summarizes some of the known mechanisms by which NRF2 can exert its oncogenic functions, and describes the current status of NRF2 inhibitors, providing a clear rationale for the consideration of NRF2 as a powerful putative therapeutic target in cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpw6FPL0WZuHbVg90H21EOLACvtfcHk0ljGbYZDBttQ2Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVSnsL0%253D&md5=88b1ab6ed97e3f249fc5ea9e694b6d75</span></div><a href="/servlet/linkout?suffix=cit56&amp;dbid=16384&amp;doi=10.1016%2Fj.molmed.2016.05.002&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.molmed.2016.05.002%26sid%3Dliteratum%253Aachs%26aulast%3DMenegon%26aufirst%3DS.%26aulast%3DColumbano%26aufirst%3DA.%26aulast%3DGiordano%26aufirst%3DS.%26atitle%3DThe%2520dual%2520roles%2520of%2520NRF2%2520in%2520cancer%26jtitle%3DTrends%2520Mol.%2520Med.%26date%3D2016%26volume%3D22%26spage%3D578%26epage%3D593%26doi%3D10.1016%2Fj.molmed.2016.05.002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref57"><div class="reference"><strong class="refLabel"><a href="#ref57" class="rightTabRefNumLink">57</a></strong><div class="NLM_citation" id="rightTab-cit57"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Leinonen, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kansanen, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Polonen, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Heinaniemi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levonen, A. L.</span></span> <span> </span><span class="NLM_article-title">Role of the Keap1-Nrf2 pathway in cancer</span>. <i>Adv. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">281</span>– <span class="NLM_lpage">320</span>, <span class="refDoi"> DOI: 10.1016/B978-0-12-420117-0.00008-6</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref57/cit57&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FB978-0-12-420117-0.00008-6" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2014&pages=281-320&author=H.+M.+Leinonenauthor=E.+Kansanenauthor=P.+Polonenauthor=M.+Heinaniemiauthor=A.+L.+Levonen&title=Role+of+the+Keap1-Nrf2+pathway+in+cancer&doi=10.1016%2FB978-0-12-420117-0.00008-6"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit57&amp;dbid=16384&amp;doi=10.1016%2FB978-0-12-420117-0.00008-6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FB978-0-12-420117-0.00008-6%26sid%3Dliteratum%253Aachs%26aulast%3DLeinonen%26aufirst%3DH.%2BM.%26aulast%3DKansanen%26aufirst%3DE.%26aulast%3DPolonen%26aufirst%3DP.%26aulast%3DHeinaniemi%26aufirst%3DM.%26aulast%3DLevonen%26aufirst%3DA.%2BL.%26atitle%3DRole%2520of%2520the%2520Keap1-Nrf2%2520pathway%2520in%2520cancer%26jtitle%3DAdv.%2520Cancer%2520Res.%26date%3D2014%26volume%3D122%26spage%3D281%26epage%3D320%26doi%3D10.1016%2FB978-0-12-420117-0.00008-6" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref58"><div class="reference"><strong class="refLabel"><a href="#ref58" class="rightTabRefNumLink">58</a></strong><div class="NLM_citation" id="rightTab-cit58"><span><span class="NLM_contrib-group"><span class="NLM_string-name">DeNicola, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karreth, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Humpton, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gopinathan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frese, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mangal, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yeo, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Calhoun, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scrimieri, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winter, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hruban, R. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iacobuzio-Donahue, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kern, S. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blair, I. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tuveson, D. A.</span></span> <span> </span><span class="NLM_article-title">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span>. <i>Nature</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>475</i></span>,  <span class="NLM_fpage">106</span>– <span class="NLM_lpage">109</span>, <span class="refDoi"> DOI: 10.1038/nature10189</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fnature10189" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21734707" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref58/cit58&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=475&publication_year=2011&pages=106-109&author=G.+M.+DeNicolaauthor=F.+A.+Karrethauthor=T.+J.+Humptonauthor=A.+Gopinathanauthor=C.+Weiauthor=K.+Freseauthor=D.+Mangalauthor=K.+H.+Yuauthor=C.+J.+Yeoauthor=E.+S.+Calhounauthor=F.+Scrimieriauthor=J.+M.+Winterauthor=R.+H.+Hrubanauthor=C.+Iacobuzio-Donahueauthor=S.+E.+Kernauthor=I.+A.+Blairauthor=D.+A.+Tuveson&title=Oncogene-induced+Nrf2+transcription+promotes+ROS+detoxification+and+tumorigenesis&doi=10.1038%2Fnature10189"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit58R"><div class="casContent"><span class="casTitleNuber">58</span><div class="casTitle"><span class="NLM_cas:atitle">Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis</span></div><div class="casAuthors">DeNicola, Gina M.; Karreth, Florian A.; Humpton, Timothy J.; Gopinathan, Aarthi; Wei, Cong; Frese, Kristopher; Mangal, Dipti; Yu, Kenneth H.; Yeo, Charles J.; Calhoun, Eric S.; Scrimieri, Francesca; Winter, Jordan M.; Hruban, Ralph H.; Iacobuzio-Donahue, Christine; Kern, Scott E.; Blair, Ian A.; Tuveson, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Nature (London, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">475</span>
        (<span class="NLM_cas:issue">7354</span>),
    <span class="NLM_cas:pages">106-109</span>CODEN:
                <span class="NLM_cas:coden">NATUAS</span>;
        ISSN:<span class="NLM_cas:issn">0028-0836</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Reactive oxygen species (ROS) are mutagenic and may thereby promote cancer.  Normally, ROS levels are tightly controlled by an inducible antioxidant program that responds to cellular stressors and is predominantly regulated by the transcription factor Nrf2 (also known as Nfe2l2) and its repressor protein Keap1 (refs. 2-5).  In contrast to the acute physiol. regulation of Nrf2, in neoplasia there is evidence for increased basal activation of Nrf2.  Indeed, somatic mutations that disrupt the Nrf2-Keap1 interaction to stabilize Nrf2 and increase the constitutive transcription of Nrf2 target genes were recently identified, indicating that enhanced ROS detoxification and addnl. Nrf2 functions may in fact be pro-tumorigenic.  Here, we investigated ROS metab. in primary murine cells following the expression of endogenous oncogenic alleles of Kras, Braf and Myc, and found that ROS are actively suppressed by these oncogenes.  K-RasG12D, B-RafV619E and MycERT2 each increased the transcription of Nrf2 to stably elevate the basal Nrf2 antioxidant program and thereby lower intracellular ROS and confer a more reduced intracellular environment.  Oncogene-directed increased expression of Nrf2 is a new mechanism for the activation of the Nrf2 antioxidant program, and is evident in primary cells and tissues of mice expressing K-RasG12D and B-RafV619E, and in human pancreatic cancer.  Furthermore, genetic targeting of the Nrf2 pathway impairs K-RasG12D-induced proliferation and tumorigenesis in vivo.  Thus, the Nrf2 antioxidant and cellular detoxification program represents a previously unappreciated mediator of oncogenesis.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFpMbvjw2msLVg90H21EOLACvtfcHk0ljUni84KWSn0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXosFemtr0%253D&md5=54d0e0b5940672a96bde0f8cfd9e7ff9</span></div><a href="/servlet/linkout?suffix=cit58&amp;dbid=16384&amp;doi=10.1038%2Fnature10189&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnature10189%26sid%3Dliteratum%253Aachs%26aulast%3DDeNicola%26aufirst%3DG.%2BM.%26aulast%3DKarreth%26aufirst%3DF.%2BA.%26aulast%3DHumpton%26aufirst%3DT.%2BJ.%26aulast%3DGopinathan%26aufirst%3DA.%26aulast%3DWei%26aufirst%3DC.%26aulast%3DFrese%26aufirst%3DK.%26aulast%3DMangal%26aufirst%3DD.%26aulast%3DYu%26aufirst%3DK.%2BH.%26aulast%3DYeo%26aufirst%3DC.%2BJ.%26aulast%3DCalhoun%26aufirst%3DE.%2BS.%26aulast%3DScrimieri%26aufirst%3DF.%26aulast%3DWinter%26aufirst%3DJ.%2BM.%26aulast%3DHruban%26aufirst%3DR.%2BH.%26aulast%3DIacobuzio-Donahue%26aufirst%3DC.%26aulast%3DKern%26aufirst%3DS.%2BE.%26aulast%3DBlair%26aufirst%3DI.%2BA.%26aulast%3DTuveson%26aufirst%3DD.%2BA.%26atitle%3DOncogene-induced%2520Nrf2%2520transcription%2520promotes%2520ROS%2520detoxification%2520and%2520tumorigenesis%26jtitle%3DNature%26date%3D2011%26volume%3D475%26spage%3D106%26epage%3D109%26doi%3D10.1038%2Fnature10189" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref59"><div class="reference"><strong class="refLabel"><a href="#ref59" class="rightTabRefNumLink">59</a></strong><div class="NLM_citation" id="rightTab-cit59"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sethi, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jain, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jaiswal, A. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aggarwal, B. B.</span></span> <span> </span><span class="NLM_article-title">Genetic deletion of NAD(P)H:quinone oxidoreductase 1 abrogates activation of nuclear factor-kappaB, IkappaBalpha kinase, c-Jun N-terminal kinase, Akt, p38, and p44/42 mitogen-activated protein kinases and potentiates apoptosis</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">19798</span>– <span class="NLM_lpage">19808</span>, <span class="refDoi"> DOI: 10.1074/jbc.M601162200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref59/cit59&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M601162200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=19798-19808&author=K.+S.+Ahnauthor=G.+Sethiauthor=A.+K.+Jainauthor=A.+K.+Jaiswalauthor=B.+B.+Aggarwal&title=Genetic+deletion+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+abrogates+activation+of+nuclear+factor-kappaB%2C+IkappaBalpha+kinase%2C+c-Jun+N-terminal+kinase%2C+Akt%2C+p38%2C+and+p44%2F42+mitogen-activated+protein+kinases+and+potentiates+apoptosis&doi=10.1074%2Fjbc.M601162200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit59&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M601162200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M601162200%26sid%3Dliteratum%253Aachs%26aulast%3DAhn%26aufirst%3DK.%2BS.%26aulast%3DSethi%26aufirst%3DG.%26aulast%3DJain%26aufirst%3DA.%2BK.%26aulast%3DJaiswal%26aufirst%3DA.%2BK.%26aulast%3DAggarwal%26aufirst%3DB.%2BB.%26atitle%3DGenetic%2520deletion%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520abrogates%2520activation%2520of%2520nuclear%2520factor-kappaB%252C%2520IkappaBalpha%2520kinase%252C%2520c-Jun%2520N-terminal%2520kinase%252C%2520Akt%252C%2520p38%252C%2520and%2520p44%252F42%2520mitogen-activated%2520protein%2520kinases%2520and%2520potentiates%2520apoptosis%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D19798%26epage%3D19808%26doi%3D10.1074%2Fjbc.M601162200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref60"><div class="reference"><strong class="refLabel"><a href="#ref60" class="rightTabRefNumLink">60</a></strong><div class="NLM_citation" id="rightTab-cit60"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hong, S. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goodwin, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ruthenborg, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jung, M. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span> <span> </span><span class="NLM_article-title">NQO1 inhibits proteasome-mediated degradation of HIF-1α</span>. <i>Nat. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">13593</span>, <span class="refDoi"> DOI: 10.1038/ncomms13593</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fncomms13593" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27966538" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref60/cit60&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XitFamsb3J" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2016&pages=13593&author=E.+T.+Ohauthor=J.+W.+Kimauthor=J.+M.+Kimauthor=S.+J.+Kimauthor=J.+S.+Leeauthor=S.+S.+Hongauthor=J.+Goodwinauthor=R.+J.+Ruthenborgauthor=M.+G.+Jungauthor=H.+J.+Leeauthor=C.+H.+Leeauthor=E.+S.+Parkauthor=C.+Kimauthor=H.+J.+Park&title=NQO1+inhibits+proteasome-mediated+degradation+of+HIF-1%CE%B1&doi=10.1038%2Fncomms13593"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit60R"><div class="casContent"><span class="casTitleNuber">60</span><div class="casTitle"><span class="NLM_cas:atitle">NQO1 inhibits proteasome-mediated degradation of HIF-1α</span></div><div class="casAuthors">Oh, Eun-Taex; Kim, Jung-whan; Kim, Joon Mee; Kim, Soo Jung; Lee, Jae-Seon; Hong, Soon-Sun; Goodwin, Justin; Ruthenborg, Robin J.; Jung, Myung Gu; Lee, Hae-June; Lee, Chul-Ho; Park, Eun Sung; Kim, Chulhee; Park, Heon Joo</div><div class="citationInfo"><span class="NLM_cas:title">Nature Communications</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">13593</span>CODEN:
                <span class="NLM_cas:coden">NCAOBW</span>;
        ISSN:<span class="NLM_cas:issn">2041-1723</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Overexpression of NQO1 is assocd. with poor prognosis in human cancers including breast, colon, cervix, lung and pancreas.  Yet, the mol. mechanisms underlying the pro-tumorigenic capacities of NQO1 have not been fully elucidated.  Here we show a previously undescribed function for NQO1 in stabilizing HIF-1α, a master transcription factor of oxygen homeostasis that has been implicated in the survival, proliferation and malignant progression of cancers.  We demonstrate that NQO1 directly binds to the oxygen-dependent domain of HIF-1α and inhibits the proteasome-mediated degrdn. of HIF-1α by preventing PHDs from interacting with HIF-1α.  NQO1 knockdown in human colorectal and breast cancer cell lines suppresses HIF-1 signalling and tumor growth.  Consistent with this pro-tumorigenic function for NQO1, high NQO1 expression levels correlate with increased HIF-1α expression and poor colorectal cancer patient survival.  These results collectively reveal a function of NQO1 in the oxygen-sensing mechanism that regulates HIF-1α stability in cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr1DEnwbSAozbVg90H21EOLACvtfcHk0ljUni84KWSn0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitFamsb3J&md5=1a3f21b8a1c1f64c2f042e159a0be9bc</span></div><a href="/servlet/linkout?suffix=cit60&amp;dbid=16384&amp;doi=10.1038%2Fncomms13593&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fncomms13593%26sid%3Dliteratum%253Aachs%26aulast%3DOh%26aufirst%3DE.%2BT.%26aulast%3DKim%26aufirst%3DJ.%2BW.%26aulast%3DKim%26aufirst%3DJ.%2BM.%26aulast%3DKim%26aufirst%3DS.%2BJ.%26aulast%3DLee%26aufirst%3DJ.%2BS.%26aulast%3DHong%26aufirst%3DS.%2BS.%26aulast%3DGoodwin%26aufirst%3DJ.%26aulast%3DRuthenborg%26aufirst%3DR.%2BJ.%26aulast%3DJung%26aufirst%3DM.%2BG.%26aulast%3DLee%26aufirst%3DH.%2BJ.%26aulast%3DLee%26aufirst%3DC.%2BH.%26aulast%3DPark%26aufirst%3DE.%2BS.%26aulast%3DKim%26aufirst%3DC.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26atitle%3DNQO1%2520inhibits%2520proteasome-mediated%2520degradation%2520of%2520HIF-1%25CE%25B1%26jtitle%3DNat.%2520Commun.%26date%3D2016%26volume%3D7%26spage%3D13593%26doi%3D10.1038%2Fncomms13593" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref61"><div class="reference"><strong class="refLabel"><a href="#ref61" class="rightTabRefNumLink">61</a></strong><div class="NLM_citation" id="rightTab-cit61"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Buranrat, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongpetch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span> <span> </span><span class="NLM_article-title">Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells</span>. <i>World J. Gastroenterol.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>16</i></span>,  <span class="NLM_fpage">2362</span>– <span class="NLM_lpage">2370</span>, <span class="refDoi"> DOI: 10.3748/wjg.v16.i19.2362</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3748%2Fwjg.v16.i19.2362" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20480521" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref61/cit61&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXmsFCqtL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=16&publication_year=2010&pages=2362-2370&author=B.+Buranratauthor=A.+Prawanauthor=U.+Kukongviriyapanauthor=S.+Kongpetchauthor=V.+Kukongviriyapan&title=Dicoumarol+enhances+gemcitabine-induced+cytotoxicity+in+high+NQO1-expressing+cholangiocarcinoma+cells&doi=10.3748%2Fwjg.v16.i19.2362"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit61R"><div class="casContent"><span class="casTitleNuber">61</span><div class="casTitle"><span class="NLM_cas:atitle">Dicoumarol enhances gemcitabine-induced cytotoxicity in high NQO1-expressing cholangiocarcinoma cells</span></div><div class="casAuthors">Buranrat, Buranrat; Prawan, Auemduan; Kukongviriyapan, Upa; Kongpetch, Sarinya; Kukongviriyapan, Veerapol</div><div class="citationInfo"><span class="NLM_cas:title">World Journal of Gastroenterology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">16</span>
        (<span class="NLM_cas:issue">19</span>),
    <span class="NLM_cas:pages">2362-2370</span>CODEN:
                <span class="NLM_cas:coden">WJGAF2</span>;
        ISSN:<span class="NLM_cas:issn">1007-9327</span>.
    
            (<span class="NLM_cas:orgname">WJG Press and Beijing Baishideng BioMed Scientific Co., Ltd.</span>)
        </div><div class="casAbstract">Aim: To investigate whether dicoumarol, a potent inhibitor of NAD(P)H quinone oxidoreductase-1 (NQO1), potentiates gemcitabine to induce cytotoxicity in cholangiocarcinoma cells (CCA) and the role of reactive oxygen generation in sensitizing the cells.  Methods: Four human cell lines with different NQO1 activity were used; the human CCA cell lines, KKU-100, KKU-OCA17, KKU-M214, and Chang liver cells.  NQO1 activity and mRNA expression were detd.  The cells were pretreated with dicoumarol at relevant concns. before treatment with gemcitabine.  Cytotoxicity was detd. by staining with fluorescent dyes.  Oxidant formation was examd. by assay of cellular glutathione levels and reactive oxygen species prodn. by using dihydrofluorescein diacetate.  Measurement of mitochondrial transmembrane potential was performed by using JC-1 fluorescent probe.  Western blotting anal. was performed to det. levels of survival related proteins.  Results: Dicoumarol markedly enhanced the cytotoxicity of gemcitabine in KKU-100 and KKU-OCA17, the high NQO1 activity and mRNA expressing cells, but not in the other cells with low NQO1 activity.  Dicoumarol induced a marked decrease in cellular redox of glutathione in KKU-100 cells, in contrast to KKU-M214 cells.  Dicoumarol at concns. that inhibited NQO1 activity did not alter mitochondrial transmembrane potential and prodn. of reactive oxygen species.  Gemcitabine alone induced activation of NF-κB and Bcl-XL protein expression.  However, gemcitabine and dicoumarol combination induced increased p53 and decreased Bcl-XL levels in KKU-100, but not in KKU-M214 cells.  Conslusion: NQO1 may be important in sensitizing cells to anticancer drugs and inhibition of NQO1 may be a strategy for the treatment of CCA.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGreCLcEpizhYrVg90H21EOLACvtfcHk0ljUni84KWSn0Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXmsFCqtL4%253D&md5=febe7e2566ab3d02f4430887f1884bc8</span></div><a href="/servlet/linkout?suffix=cit61&amp;dbid=16384&amp;doi=10.3748%2Fwjg.v16.i19.2362&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3748%252Fwjg.v16.i19.2362%26sid%3Dliteratum%253Aachs%26aulast%3DBuranrat%26aufirst%3DB.%26aulast%3DPrawan%26aufirst%3DA.%26aulast%3DKukongviriyapan%26aufirst%3DU.%26aulast%3DKongpetch%26aufirst%3DS.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26atitle%3DDicoumarol%2520enhances%2520gemcitabine-induced%2520cytotoxicity%2520in%2520high%2520NQO1-expressing%2520cholangiocarcinoma%2520cells%26jtitle%3DWorld%2520J.%2520Gastroenterol.%26date%3D2010%26volume%3D16%26spage%3D2362%26epage%3D2370%26doi%3D10.3748%2Fwjg.v16.i19.2362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref62"><div class="reference"><strong class="refLabel"><a href="#ref62" class="rightTabRefNumLink">62</a></strong><div class="NLM_citation" id="rightTab-cit62"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zeekpudsa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senggunprai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sripa, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span> <span> </span><span class="NLM_article-title">Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents</span>. <i>J. Exp. Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>33</i></span>,  <span class="NLM_fpage">11</span>, <span class="refDoi"> DOI: 10.1186/1756-9966-33-11</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2F1756-9966-33-11" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24460787" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref62/cit62&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXjsFKgtbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=33&publication_year=2014&pages=11&author=P.+Zeekpudsaauthor=V.+Kukongviriyapanauthor=L.+Senggunpraiauthor=B.+Sripaauthor=A.+Prawan&title=Suppression+of+NAD%28P%29H-quinone+oxidoreductase+1+enhanced+the+susceptibility+of+cholangiocarcinoma+cells+to+chemotherapeutic+agents&doi=10.1186%2F1756-9966-33-11"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit62R"><div class="casContent"><span class="casTitleNuber">62</span><div class="casTitle"><span class="NLM_cas:atitle">Suppression of NAD(P)H-quinone oxidoreductase 1 enhanced the susceptibility of cholangiocarcinoma cells to chemotherapeutic agents</span></div><div class="casAuthors">Zeekpudsa, Ponsilp; Kukongviriyapan, Veerapol; Senggunprai, Laddawan; Sripa, Banchob; Prawan, Auemduan</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Experimental & Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">33</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">11/1-11/13</span>CODEN:
                <span class="NLM_cas:coden">JECRDN</span>;
        ISSN:<span class="NLM_cas:issn">1756-9966</span>.
    
            (<span class="NLM_cas:orgname">BioMed Central Ltd.</span>)
        </div><div class="casAbstract">Background: Cholangiocarcinoma (CCA) is highly resistant to most of the known chemotherapeutic treatments.  NAD(P)H-quinone oxidoreductase 1 (NQO1) is an antioxidant/detoxifying enzyme recently recognized as an important contributor to chemoresistance in some human cancers.  However, the contribution of NQO1 to chemotherapy resistance in CCA is unknown.  Methods: Two CCA cell lines, KKU-100 and KKU-M214, with high and low NQO1 expression levels, resp., were used to evaluate the sensitivity to chemotherapeutic agents; 5-fluorouracil (5-FU), doxorubicin (Doxo), and gemcitabine (Gem).  NQO1 and/or p53 expression in KKU-100 cells were knocked down by siRNA.  NQO1 was over-expressed in KKU-M214 cells by transfection with pCMV6-XL5-NQO1 expression vector.  CCA cells with modulated NQO1 and/or p53 expression were treated with chemotherapeutic agents, and the cytotoxicity was assessed by SRB assay.  The mechanism of enhanced chemosensitivity was evaluated by Western blot anal.  Results: When NQO1 was knocked down, KKU-100 cells became more susceptible to all chemotherapeutic agents.  Conversely, with over-expression of NQO1 made KKU-M214 cells more resistant to chemotherapeutic agents.  Western blot anal. suggested that enhanced chemosensitivity was probably due to the activation of p53-mediated cell death.  Enhanced susceptibility to chemotherapeutic agents by NQO1 silencing was abolished by knockdown of p53.  Conclusions: These results suggest that inhibition of NQO1 could enhance the susceptibility of CCA to an array of chemotherapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGriWtyzHeX5ebVg90H21EOLACvtfcHk0lgdkf40LIwLZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXjsFKgtbg%253D&md5=c947cda683ada15e32cf34df1863b55e</span></div><a href="/servlet/linkout?suffix=cit62&amp;dbid=16384&amp;doi=10.1186%2F1756-9966-33-11&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252F1756-9966-33-11%26sid%3Dliteratum%253Aachs%26aulast%3DZeekpudsa%26aufirst%3DP.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26aulast%3DSenggunprai%26aufirst%3DL.%26aulast%3DSripa%26aufirst%3DB.%26aulast%3DPrawan%26aufirst%3DA.%26atitle%3DSuppression%2520of%2520NAD%2528P%2529H-quinone%2520oxidoreductase%25201%2520enhanced%2520the%2520susceptibility%2520of%2520cholangiocarcinoma%2520cells%2520to%2520chemotherapeutic%2520agents%26jtitle%3DJ.%2520Exp.%2520Clin.%2520Cancer%2520Res.%26date%3D2014%26volume%3D33%26spage%3D11%26doi%3D10.1186%2F1756-9966-33-11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref63"><div class="reference"><strong class="refLabel"><a href="#ref63" class="rightTabRefNumLink">63</a></strong><div class="NLM_citation" id="rightTab-cit63"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Butsri, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kukongviriyapan, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Senggunprai, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kongpetch, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeekpudsa, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prawan, A.</span></span> <span> </span><span class="NLM_article-title">Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells</span>. <i>Oncol. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>13</i></span>,  <span class="NLM_fpage">4540</span>– <span class="NLM_lpage">4548</span>, <span class="refDoi"> DOI: 10.3892/ol.2017.5951</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3892%2Fol.2017.5951" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28599455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref63/cit63&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC1cnmvVSmsQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2017&pages=4540-4548&author=S.+Butsriauthor=V.+Kukongviriyapanauthor=L.+Senggunpraiauthor=S.+Kongpetchauthor=P.+Zeekpudsaauthor=A.+Prawan&title=Downregulation+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+inhibits+proliferation%2C+cell+cycle+and+migration+of+cholangiocarcinoma+cells&doi=10.3892%2Fol.2017.5951"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit63R"><div class="casContent"><span class="casTitleNuber">63</span><div class="casTitle"><span class="NLM_cas:atitle">Downregulation of NAD(P)H:quinone oxidoreductase 1 inhibits proliferation, cell cycle and migration of cholangiocarcinoma cells</span></div><div class="casAuthors">Butsri Siriwoot; Kukongviriyapan Veerapol; Senggunprai Laddawan; Kongpetch Sarinya; Prawan Auemduan; Zeekpudsa Ponsilp</div><div class="citationInfo"><span class="NLM_cas:title">Oncology letters</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">4540-4548</span>
        ISSN:<span class="NLM_cas:issn">1792-1074</span>.
    </div><div class="casAbstract">We previously reported that upregulation of NAD(P)H:quinone oxidoreductase 1 (NQO1) in cholangiocarcinoma (CCA; a fatal bile duct cancer) was associated with poor prognosis.  It was also demonstrated that the suppression of NQO1 was able to enhance the chemosensitivity of CCA cells.  In the present study, in order to elucidate the biological role of NQO1 in CCA, the effects of small interfering RNA (siRNA)-mediated knockdown of NQO1 on cell proliferation, cell cycle and migration were determined in KKU-100 CCA cells, which notably expressed NQO1.  The cell proliferation ability and cell cycle distribution were identified by clonogenic cell survival assay and flow cytometric analysis, respectively.  Wound healing and Transwell migration assays were performed to evaluate cell migration.  The molecules involved in cell proliferation and migration were determined by western blot analysis and reverse transcription-quantitative polymerase chain reaction analysis.  The results demonstrated that NQO1 siRNA-mediated knockdown effectively impaired colony formation capacity, induced cell cycle arrest at the G1 phase and suppressed migration of KKU-100 cells.  CCA cells transfected with NQO1 siRNA exhibited increased expression levels of p21 and decreased cyclin D1 protein expression levels.  Furthermore, the ratio of matrix metalloproteinase 9/tissue inhibitors of metalloproteinases 1 (TIMP1) mRNA expression level was decreased in the NQO1-knockdown cells.  Therefore, the present study provided evidence supporting the biological role of NQO1 in the regulation of cell proliferation, cell cycle and migration of CCA cells.  Therefore, NQO1 may prove to be a potential molecular target to enhance CCA treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQTmsNgvUr8LNTiMd2aNQVUfW6udTcc2eavQB7shapUE7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC1cnmvVSmsQ%253D%253D&md5=c8ac512aeb4ed14dd225387853e0d106</span></div><a href="/servlet/linkout?suffix=cit63&amp;dbid=16384&amp;doi=10.3892%2Fol.2017.5951&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3892%252Fol.2017.5951%26sid%3Dliteratum%253Aachs%26aulast%3DButsri%26aufirst%3DS.%26aulast%3DKukongviriyapan%26aufirst%3DV.%26aulast%3DSenggunprai%26aufirst%3DL.%26aulast%3DKongpetch%26aufirst%3DS.%26aulast%3DZeekpudsa%26aufirst%3DP.%26aulast%3DPrawan%26aufirst%3DA.%26atitle%3DDownregulation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520inhibits%2520proliferation%252C%2520cell%2520cycle%2520and%2520migration%2520of%2520cholangiocarcinoma%2520cells%26jtitle%3DOncol.%2520Lett.%26date%3D2017%26volume%3D13%26spage%3D4540%26epage%3D4548%26doi%3D10.3892%2Fol.2017.5951" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref64"><div class="reference"><strong class="refLabel"><a href="#ref64" class="rightTabRefNumLink">64</a></strong><div class="NLM_citation" id="rightTab-cit64"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics</span>. <i>Methods Enzymol.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>382</i></span>,  <span class="NLM_fpage">115</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1016/S0076-6879(04)82008-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0076-6879%2804%2982008-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15047100" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref64/cit64&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjtVWksLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=382&publication_year=2004&pages=115-144&author=D.+Rossauthor=D.+Siegel&title=NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%2C+DT-diaphorase%29%2C+functions+and+pharmacogenetics&doi=10.1016%2FS0076-6879%2804%2982008-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit64R"><div class="casContent"><span class="casTitleNuber">64</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase 1 (NQO1, DT-diaphorase), functions and pharmacogenetics</span></div><div class="casAuthors">Ross, David; Siegel, David</div><div class="citationInfo"><span class="NLM_cas:title">Methods in Enzymology</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">382</span>
        (<span class="NLM_cas:issue">Quinones and Quinone Enzymes, Part B</span>),
    <span class="NLM_cas:pages">115-144</span>CODEN:
                <span class="NLM_cas:coden">MENZAU</span>;
        ISSN:<span class="NLM_cas:issn">0076-6879</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review discussing possible functions of NAD(P)H:quinone oxidoreductase 1 (NQO1) and the relevance of the common NQO polymorphism for chemoprotection, susceptibility to disease and cancer chemotherapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrFjd2T0Gg33rVg90H21EOLACvtfcHk0lgdkf40LIwLZg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjtVWksLY%253D&md5=a744fb90347e782bcc780c0ef9a62b78</span></div><a href="/servlet/linkout?suffix=cit64&amp;dbid=16384&amp;doi=10.1016%2FS0076-6879%2804%2982008-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0076-6879%252804%252982008-1%26sid%3Dliteratum%253Aachs%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DSiegel%26aufirst%3DD.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%252C%2520DT-diaphorase%2529%252C%2520functions%2520and%2520pharmacogenetics%26jtitle%3DMethods%2520Enzymol.%26date%3D2004%26volume%3D382%26spage%3D115%26epage%3D144%26doi%3D10.1016%2FS0076-6879%2804%2982008-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref65"><div class="reference"><strong class="refLabel"><a href="#ref65" class="rightTabRefNumLink">65</a></strong><div class="NLM_citation" id="rightTab-cit65"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anwar, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zolman, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H:quinone oxidoreductase 1</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>59</i></span>,  <span class="NLM_fpage">263</span>– <span class="NLM_lpage">268</span>, <span class="refDoi"> DOI: 10.1124/mol.59.2.263</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref65/cit65&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.59.2.263" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=59&publication_year=2001&pages=263-268&author=D.+Siegelauthor=A.+Anwarauthor=S.+L.+Winskiauthor=J.+K.+Kepaauthor=K.+L.+Zolmanauthor=D.+Ross&title=Rapid+polyubiquitination+and+proteasomal+degradation+of+a+mutant+form+of+NAD%28P%29H%3Aquinone+oxidoreductase+1&doi=10.1124%2Fmol.59.2.263"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit65&amp;dbid=16384&amp;doi=10.1124%2Fmol.59.2.263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.59.2.263%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DAnwar%26aufirst%3DA.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DZolman%26aufirst%3DK.%2BL.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRapid%2520polyubiquitination%2520and%2520proteasomal%2520degradation%2520of%2520a%2520mutant%2520form%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%26jtitle%3DMol.%2520Pharmacol.%26date%3D2001%26volume%3D59%26spage%3D263%26epage%3D268%26doi%3D10.1124%2Fmol.59.2.263" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref66"><div class="reference"><strong class="refLabel"><a href="#ref66" class="rightTabRefNumLink">66</a></strong><div class="NLM_citation" id="rightTab-cit66"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, L. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wei, Q.</span></span> <span> </span><span class="NLM_article-title">A functional NQO1 609C > T polymorphism and risk of gastrointestinal cancers: a meta-analysis</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">e30566</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0030566</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref66/cit66&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1371%2Fjournal.pone.0030566" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2012&pages=e30566&author=H.+Yuauthor=H.+Liuauthor=L.+E.+Wangauthor=Q.+Wei&title=A+functional+NQO1+609C+%3E+T+polymorphism+and+risk+of+gastrointestinal+cancers%3A+a+meta-analysis&doi=10.1371%2Fjournal.pone.0030566"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit66&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0030566&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0030566%26sid%3Dliteratum%253Aachs%26aulast%3DYu%26aufirst%3DH.%26aulast%3DLiu%26aufirst%3DH.%26aulast%3DWang%26aufirst%3DL.%2BE.%26aulast%3DWei%26aufirst%3DQ.%26atitle%3DA%2520functional%2520NQO1%2520609C%2520%253E%2520T%2520polymorphism%2520and%2520risk%2520of%2520gastrointestinal%2520cancers%253A%2520a%2520meta-analysis%26jtitle%3DPLoS%2520One%26date%3D2012%26volume%3D7%26spage%3De30566%26doi%3D10.1371%2Fjournal.pone.0030566" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref67"><div class="reference"><strong class="refLabel"><a href="#ref67" class="rightTabRefNumLink">67</a></strong><div class="NLM_citation" id="rightTab-cit67"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi-Ishimae, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eguchi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Knight, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sadakane, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Isoyama, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yabe, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mizutani, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Greaves, M.</span></span> <span> </span><span class="NLM_article-title">The association of a distinctive allele of NAD(P)H:quinone oxidoreductase with pediatric acute lymphoblastic leukemias with MLL fusion genes in Japan</span>. <i>Haematologica</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>90</i></span>,  <span class="NLM_fpage">1511</span>– <span class="NLM_lpage">1515</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=90&publication_year=2005&pages=1511-1515&author=M.+Eguchi-Ishimaeauthor=M.+Eguchiauthor=E.+Ishiiauthor=D.+Knightauthor=Y.+Sadakaneauthor=K.+Isoyamaauthor=H.+Yabeauthor=S.+Mizutaniauthor=M.+Greaves&title=The+association+of+a+distinctive+allele+of+NAD%28P%29H%3Aquinone+oxidoreductase+with+pediatric+acute+lymphoblastic+leukemias+with+MLL+fusion+genes+in+Japan"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit67&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEguchi-Ishimae%26aufirst%3DM.%26aulast%3DEguchi%26aufirst%3DM.%26aulast%3DIshii%26aufirst%3DE.%26aulast%3DKnight%26aufirst%3DD.%26aulast%3DSadakane%26aufirst%3DY.%26aulast%3DIsoyama%26aufirst%3DK.%26aulast%3DYabe%26aufirst%3DH.%26aulast%3DMizutani%26aufirst%3DS.%26aulast%3DGreaves%26aufirst%3DM.%26atitle%3DThe%2520association%2520of%2520a%2520distinctive%2520allele%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520with%2520pediatric%2520acute%2520lymphoblastic%2520leukemias%2520with%2520MLL%2520fusion%2520genes%2520in%2520Japan%26jtitle%3DHaematologica%26date%3D2005%26volume%3D90%26spage%3D1511%26epage%3D1515" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref68"><div class="reference"><strong class="refLabel"><a href="#ref68" class="rightTabRefNumLink">68</a></strong><div class="NLM_citation" id="rightTab-cit68"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faulder, P. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Timson, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burke, T. R.,  Jr.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span> <span> </span><span class="NLM_article-title">Coumarin-based inhibitors of human NAD(P)H:quinone oxidoreductase-1. Identification, structure-activity, off-target effects and in vitro human pancreatic cancer toxicity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">6316</span>– <span class="NLM_lpage">6325</span>, <span class="refDoi"> DOI: 10.1021/jm070472p</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070472p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref68/cit68&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht12gs7rE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=6316-6325&author=K.+A.+Nolanauthor=H.+Zhaoauthor=P.+F.+Faulderauthor=A.+D.+Frenkelauthor=D.+J.+Timsonauthor=D.+Siegelauthor=D.+Rossauthor=T.+R.+Burkeauthor=I.+J.+Stratfordauthor=R.+A.+Bryce&title=Coumarin-based+inhibitors+of+human+NAD%28P%29H%3Aquinone+oxidoreductase-1.+Identification%2C+structure-activity%2C+off-target+effects+and+in+vitro+human+pancreatic+cancer+toxicity&doi=10.1021%2Fjm070472p"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit68R"><div class="casContent"><span class="casTitleNuber">68</span><div class="casTitle"><span class="NLM_cas:atitle">Coumarin-Based Inhibitors of Human NAD(P)H:Quinone Oxidoreductase-1. Identification, Structure-Activity, Off-Target Effects and In Vitro Human Pancreatic Cancer Toxicity</span></div><div class="casAuthors">Nolan, Karen A.; Zhao, He; Faulder, Paul F.; Frenkel, A. David; Timson, David J.; Siegel, David; Ross, David; Burke, Terrence R., Jr.; Stratford, Ian J.; Bryce, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">25</span>),
    <span class="NLM_cas:pages">6316-6325</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The enzyme human NAD(P)H quinone oxidoreductase-1 (NQO1), which is overexpressed in several types of tumor cell, is considered a design target for cancer therapeutics.  We identify new coumarin-based competitive inhibitors of NQO1, one of which is nanomolar.  Using computational docking and mol. dynamics, we obtain insights into the structural basis of inhibition.  Selected inhibitors were then assessed for off-target effects assocd. with dicoumarol and were found to have differing effects on superoxide formation and mitochondrial respiration.  A comparison of NQO1 inhibition and off-target effects for dicoumarol and its derivs. suggests that the ability of dicoumarol to kill cancer cells is independent of NQO1 inhibition, that cellular superoxide prodn. by dicoumarol does not seem linked to NQO1 inhibition but may be related to mitochondrial decoupling, and that superoxide does not appear to be a major determinant of cytotoxicity.  Implications are discussed for NQO1 inhibition as an anticancer drug design target and superoxide generation as the dicoumarol-mediated mechanism of cytotoxicity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr2ykpgei7OebVg90H21EOLACvtfcHk0lisqrwl2uYMsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht12gs7rE&md5=c206d6f2d6f676d86f0dbd09ab7a8d4c</span></div><a href="/servlet/linkout?suffix=cit68&amp;dbid=16384&amp;doi=10.1021%2Fjm070472p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070472p%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DK.%2BA.%26aulast%3DZhao%26aufirst%3DH.%26aulast%3DFaulder%26aufirst%3DP.%2BF.%26aulast%3DFrenkel%26aufirst%3DA.%2BD.%26aulast%3DTimson%26aufirst%3DD.%2BJ.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBurke%26aufirst%3DT.%2BR.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26atitle%3DCoumarin-based%2520inhibitors%2520of%2520human%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase-1.%2520Identification%252C%2520structure-activity%252C%2520off-target%2520effects%2520and%2520in%2520vitro%2520human%2520pancreatic%2520cancer%2520toxicity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D6316%26epage%3D6325%26doi%3D10.1021%2Fjm070472p" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref69"><div class="reference"><strong class="refLabel"><a href="#ref69" class="rightTabRefNumLink">69</a></strong><div class="NLM_citation" id="rightTab-cit69"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nolan, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doncaster, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dunstan, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scott, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frenkel, A. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnes, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levy, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leys, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Whitehead, R. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bryce, R. A.</span></span> <span> </span><span class="NLM_article-title">Synthesis and biological evaluation of coumarin-based inhibitors of NAD(P)H: quinone oxidoreductase-1 (NQO1)</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>52</i></span>,  <span class="NLM_fpage">7142</span>– <span class="NLM_lpage">7156</span>, <span class="refDoi"> DOI: 10.1021/jm9011609</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm9011609" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref69/cit69&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhtlCku77N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7142-7156&author=K.+A.+Nolanauthor=J.+R.+Doncasterauthor=M.+S.+Dunstanauthor=K.+A.+Scottauthor=A.+D.+Frenkelauthor=D.+Siegelauthor=D.+Rossauthor=J.+Barnesauthor=C.+Levyauthor=D.+Leysauthor=R.+C.+Whiteheadauthor=I.+J.+Stratfordauthor=R.+A.+Bryce&title=Synthesis+and+biological+evaluation+of+coumarin-based+inhibitors+of+NAD%28P%29H%3A+quinone+oxidoreductase-1+%28NQO1%29&doi=10.1021%2Fjm9011609"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit69R"><div class="casContent"><span class="casTitleNuber">69</span><div class="casTitle"><span class="NLM_cas:atitle">Synthesis and Biological Evaluation of Coumarin-Based Inhibitors of NAD(P)H: Quinone Oxidoreductase-1 (NQO1)</span></div><div class="casAuthors">Nolan, Karen A.; Doncaster, Jeremy R.; Dunstan, Mark S.; Scott, Katherine A.; Frenkel, A. David; Siegel, David; Ross, David; Barnes, John; Levy, Colin; Leys, David; Whitehead, Roger C.; Stratford, Ian J.; Bryce, Richard A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">7142-7156</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Dicoumarol analogs I (R = H, Me, MeO; R1 = H, Me, MeO, F, Cl, Br; R2 = H, Me, MeO, F; R3 = H, Me, Br; R2R3 = benzo; R4 = H, EtCH2, EtO2C) and II (R5 = H; R6 = H, Me; R5R6 = benzo; R7 = H, Me; R8 = H; R7R8 = benzo; R9 = Ph, 1-naphthyl, 2-naphthyl, 3,4-Me2C6H3) are prepd. as inhibitors of human NAD(P)H quinone oxidoreductase-1 (NQO1), an enzyme overexpressed in several types of tumor cell; their calcd. and obsd. binding affinities and energies for NQO1, their antitumor activities in human pancreatic and colon cancer cells, and their calcd. binding modes as detd. by mol. docking calcns. are detd.  Correlation is demonstrated between the inhibition of NQO1 by the dicoumarol analogs and their computed binding affinities.  The structures of I (R = R1 = R2 = R3 = R4 = H) and of II (R5 = H; R6 = R7 = Me; R8 = H; R9 = 1-naphthyl) bound to NQO1 are detd. by X-ray crystallog.  In human pancreatic and colon cancer cells, the parent I (R = R1 = R2 = R3 = R4 = H) is the most active antitumor agent of the compds. tested.  The methodol. provides a computational, synthetic, and biol. platform to generate competitive NQO1 inhibitors with superior pharmacol. properties to dicoumarol and to allow the activities of NQO1 in cells to be detd. more clearly.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMXhckZU0ot7Vg90H21EOLACvtfcHk0lisqrwl2uYMsg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhtlCku77N&md5=b7cdcf65a1a3beb4d4280ce9d1fff84b</span></div><a href="/servlet/linkout?suffix=cit69&amp;dbid=16384&amp;doi=10.1021%2Fjm9011609&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9011609%26sid%3Dliteratum%253Aachs%26aulast%3DNolan%26aufirst%3DK.%2BA.%26aulast%3DDoncaster%26aufirst%3DJ.%2BR.%26aulast%3DDunstan%26aufirst%3DM.%2BS.%26aulast%3DScott%26aufirst%3DK.%2BA.%26aulast%3DFrenkel%26aufirst%3DA.%2BD.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DBarnes%26aufirst%3DJ.%26aulast%3DLevy%26aufirst%3DC.%26aulast%3DLeys%26aufirst%3DD.%26aulast%3DWhitehead%26aufirst%3DR.%2BC.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DBryce%26aufirst%3DR.%2BA.%26atitle%3DSynthesis%2520and%2520biological%2520evaluation%2520of%2520coumarin-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253A%2520quinone%2520oxidoreductase-1%2520%2528NQO1%2529%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7142%26epage%3D7156%26doi%3D10.1021%2Fjm9011609" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref70"><div class="reference"><strong class="refLabel"><a href="#ref70" class="rightTabRefNumLink">70</a></strong><div class="NLM_citation" id="rightTab-cit70"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Faig, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bianchet, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fung, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Duncan, M. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amzel, L. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Characterization of a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1 by biochemical, X-ray crystallographic, and mass spectrometric approaches</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">15135</span>– <span class="NLM_lpage">15142</span>, <span class="refDoi"> DOI: 10.1021/bi011324i</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi011324i" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref70/cit70&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosFCrtLc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2001&pages=15135-15142&author=S.+L.+Winskiauthor=M.+Faigauthor=M.+A.+Bianchetauthor=D.+Siegelauthor=E.+Swannauthor=K.+Fungauthor=M.+W.+Duncanauthor=C.+J.+Moodyauthor=L.+M.+Amzelauthor=D.+Ross&title=Characterization+of+a+mechanism-based+inhibitor+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+by+biochemical%2C+X-ray+crystallographic%2C+and+mass+spectrometric+approaches&doi=10.1021%2Fbi011324i"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit70R"><div class="casContent"><span class="casTitleNuber">70</span><div class="casTitle"><span class="NLM_cas:atitle">Characterization of a Mechanism-Based Inhibitor of NAD(P)H:Quinone Oxidoreductase 1 by Biochemical, X-ray Crystallographic, and Mass Spectrometric Approaches</span></div><div class="casAuthors">Winski, Shannon L.; Faig, Margarita; Bianchet, Mario A.; Siegel, David; Swann, Elizabeth; Fung, Kim; Duncan, Mark W.; Moody, Christopher J.; Amzel, L. Mario; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Biochemistry</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">50</span>),
    <span class="NLM_cas:pages">15135-15142</span>CODEN:
                <span class="NLM_cas:coden">BICHAW</span>;
        ISSN:<span class="NLM_cas:issn">0006-2960</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We report the characterization of 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione (ES936) as a mechanism-based inhibitor of NQO1.  Inactivation of NQO1 by ES936 was time- and concn.-dependent and required the presence of a pyridine nucleotide cofactor consistent with a need for metabolic activation.  That ES936 was an efficient inhibitor was demonstrated in these studies by the low partition ratio (1.40±0.03).  The orientation of ES936 in the active site of NQO1 was examd. by X-ray crystallog. and found to be opposite to that obsd. for other indolequinones acting as substrates.  ES936 was oriented in such a manner that, after enzymic redn. and loss of a nitrophenol leaving group, a reactive iminium species was located in close proximity to nucleophilic His 162 and Tyr 127 and Tyr 129 residues in the active site.  To det. if ES936 was covalently modifying NQO1, ES936-treated protein was analyzed by electrospray ionization liq. chromatog./mass spectrometry (ESI-LC/MS).  The control NQO1 protein had a mass of 30864 ± 6 Da (n = 20, theor., 30868.6 Da) which increased by 217 Da after ES936 treatment (31081 ± 7 Da, n = 20) in the presence of NADH.  The shift in mass was consistent with adduction of NQO1 by the reactive iminium derived from ES936 (M + 218 Da).  Chymotryptic digestion of the protein followed by LC/MS anal. located a tetrapeptide spanning amino acids 126-129 which was adducted with the reactive iminium species derived from ES936.  LC/MS/MS anal. of the peptide fragment confirmed adduction of either Tyr 127 or Tyr 129 residues.  This work demonstrates that ES936 is a potent mechanism-based inhibitor of NQO1 and may be a useful tool in defining the role of NQO1 in cellular systems and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKFX8Hi1Jtx7Vg90H21EOLACvtfcHk0lgG28Ycsf15dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosFCrtLc%253D&md5=bfc6c8271d444668673605c2bcc0d62d</span></div><a href="/servlet/linkout?suffix=cit70&amp;dbid=16384&amp;doi=10.1021%2Fbi011324i&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi011324i%26sid%3Dliteratum%253Aachs%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DFaig%26aufirst%3DM.%26aulast%3DBianchet%26aufirst%3DM.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DSwann%26aufirst%3DE.%26aulast%3DFung%26aufirst%3DK.%26aulast%3DDuncan%26aufirst%3DM.%2BW.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DAmzel%26aufirst%3DL.%2BM.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DCharacterization%2520of%2520a%2520mechanism-based%2520inhibitor%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520by%2520biochemical%252C%2520X-ray%2520crystallographic%252C%2520and%2520mass%2520spectrometric%2520approaches%26jtitle%3DBiochemistry%26date%3D2001%26volume%3D40%26spage%3D15135%26epage%3D15142%26doi%3D10.1021%2Fbi011324i" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref71"><div class="reference"><strong class="refLabel"><a href="#ref71" class="rightTabRefNumLink">71</a></strong><div class="NLM_citation" id="rightTab-cit71"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilloux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">The synthesis and evaluation of 3-aryloxymethyl-1,2-dimethylindole-4,7-diones as mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1) activity</span>. <i>J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">5780</span>– <span class="NLM_lpage">5789</span>, <span class="refDoi"> DOI: 10.1021/jm070396q</span> </span><div class="citationLinks">[<a href="/doi/10.1021/jm070396q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=5780-5789&author=M.+A.+Colucciauthor=P.+Reiganauthor=D.+Siegelauthor=A.+Chillouxauthor=D.+Rossauthor=C.+J.+Moody&title=The+synthesis+and+evaluation+of+3-aryloxymethyl-1%2C2-dimethylindole-4%2C7-diones+as+mechanism-based+inhibitors+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29+activity&doi=10.1021%2Fjm070396q"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit71&amp;dbid=16384&amp;doi=10.1021%2Fjm070396q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm070396q%26sid%3Dliteratum%253Aachs%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DChilloux%26aufirst%3DA.%26aulast%3DRoss%26aufirst%3DD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DThe%2520synthesis%2520and%2520evaluation%2520of%25203-aryloxymethyl-1%252C2-dimethylindole-4%252C7-diones%2520as%2520mechanism-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520activity%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D5780%26epage%3D5789%26doi%3D10.1021%2Fjm070396q" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref72"><div class="reference"><strong class="refLabel"><a href="#ref72" class="rightTabRefNumLink">72</a></strong><div class="NLM_citation" id="rightTab-cit72"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zafar, K. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Swann, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">1702</span>– <span class="NLM_lpage">1709</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-06-0105</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-06-0105" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16891456" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref72/cit72&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XnslWksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2006&pages=1702-1709&author=D.+L.+Dehnauthor=D.+Siegelauthor=K.+S.+Zafarauthor=P.+Reiganauthor=E.+Swannauthor=C.+J.+Moodyauthor=D.+Ross&title=5-Methoxy-1%2C2-dimethyl-3-%5B%284-nitrophenoxy%29methyl%5Dindole-4%2C7-dione%2C+a+mechanism-based+inhibitor+of+NAD%28P%29H%3Aquinone+oxidoreductase+1%2C+exhibits+activity+against+human+pancreatic+cancer+in+vitro+and+in+vivo&doi=10.1158%2F1535-7163.MCT-06-0105"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit72R"><div class="casContent"><span class="casTitleNuber">72</span><div class="casTitle"><span class="NLM_cas:atitle">5-Methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NAD(P)H:quinone oxidoreductase 1, exhibits activity against human pancreatic cancer in vitro and in vivo</span></div><div class="casAuthors">Dehn, Donna L.; Siegel, David; Zafar, Khan Shoeb; Reigan, Philip; Swann, Elizabeth; Moody, Christopher J.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1702-1709</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The enzyme NAD(P)H:quinone oxidoreductase 1 (NQO1) has been found to be up-regulated in pancreatic cancer as well as many other solid tumors.  A recent study showed that inhibition of NQO1 in pancreatic cancer cells using the nonselective inhibitor dicumarol suppressed the malignant phenotype.  The authors suggested that inhibition of cell growth might result from an increase in intracellular superoxide prodn. due to inhibition of NQO1.  We have recently shown that NQO1 can directly scavenge superoxide and this effect may become physiol. relevant in cells contg. high NQO1 levels.  We therefore tested the hypothesis that 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione (ES936), a specific mechanism-based inhibitor of NQO1, would be an effective agent for the treatment of pancreatic tumors.  The human pancreatic tumor cell lines BxPC-3 and MIA PaCa-2 contain high levels of NQO1 activity and protein as verified by immunoblot and immunocytochem. staining of human pancreatic tumor cells.  ES936 treatment inhibited NQO1 activity by >98% in MIA PaCa-2 and BxPC-3 cells.  In addn., ES936 treatment induced growth inhibition [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide assay] in MIA PaCa-2 and BxPC-3 cells with an IC50 of 108 and 365 nmol/L, resp.  Treatment of MIA PaCa-2 cells with ES936 also inhibited the ability of these cells to form colonies and grow in soft agar in a dose-dependent manner.  Treatment of mice carrying MIA PaCa-2 xenograft tumors with ES936 resulted in a significant difference in growth rates in ES936-treated and DMSO-treated (control) tumors.  Our data did not show an increase in either intracellular superoxide prodn. or oxygen consumption after treatment of cells with ES936, contrary to the effects seen with dicumarol.  In summary, mechanism-based inhibitors of NQO1, such as ES936, may be useful therapeutic agents for the treatment of pancreatic cancer, although the underlying mechanism seems to be independent of superoxide generation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqScnhPVPs3ebVg90H21EOLACvtfcHk0lgG28Ycsf15dg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XnslWksL0%253D&md5=337f9ca460d5f176b4be9f810caa77ba</span></div><a href="/servlet/linkout?suffix=cit72&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-06-0105&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-06-0105%26sid%3Dliteratum%253Aachs%26aulast%3DDehn%26aufirst%3DD.%2BL.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DZafar%26aufirst%3DK.%2BS.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSwann%26aufirst%3DE.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3D5-Methoxy-1%252C2-dimethyl-3-%255B%25284-nitrophenoxy%2529methyl%255Dindole-4%252C7-dione%252C%2520a%2520mechanism-based%2520inhibitor%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%252C%2520exhibits%2520activity%2520against%2520human%2520pancreatic%2520cancer%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2006%26volume%3D5%26spage%3D1702%26epage%3D1709%26doi%3D10.1158%2F1535-7163.MCT-06-0105" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref73"><div class="reference"><strong class="refLabel"><a href="#ref73" class="rightTabRefNumLink">73</a></strong><div class="NLM_citation" id="rightTab-cit73"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilloux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Development of indolequinone mechanism-based inhibitors of NAD(P)H:quinone oxidoreductase 1 (NQO1): NQO1 inhibition and growth inhibitory activity in human pancreatic MIA PaCa-2 cancer cells</span>. <i>Biochemistry</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>46</i></span>,  <span class="NLM_fpage">5941</span>– <span class="NLM_lpage">5950</span>, <span class="refDoi"> DOI: 10.1021/bi700008y</span> </span><div class="citationLinks">[<a href="/doi/10.1021/bi700008y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=5941-5950&author=P.+Reiganauthor=M.+A.+Colucciauthor=D.+Siegelauthor=A.+Chillouxauthor=C.+J.+Moodyauthor=D.+Ross&title=Development+of+indolequinone+mechanism-based+inhibitors+of+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29%3A+NQO1+inhibition+and+growth+inhibitory+activity+in+human+pancreatic+MIA+PaCa-2+cancer+cells&doi=10.1021%2Fbi700008y"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit73&amp;dbid=16384&amp;doi=10.1021%2Fbi700008y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbi700008y%26sid%3Dliteratum%253Aachs%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DChilloux%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520indolequinone%2520mechanism-based%2520inhibitors%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%253A%2520NQO1%2520inhibition%2520and%2520growth%2520inhibitory%2520activity%2520in%2520human%2520pancreatic%2520MIA%2520PaCa-2%2520cancer%2520cells%26jtitle%3DBiochemistry%26date%3D2007%26volume%3D46%26spage%3D5941%26epage%3D5950%26doi%3D10.1021%2Fbi700008y" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref74"><div class="reference"><strong class="refLabel"><a href="#ref74" class="rightTabRefNumLink">74</a></strong><div class="NLM_citation" id="rightTab-cit74"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Newsome, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chilloux, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Antitumor indolequinones induced apoptosis in human pancreatic cancer cells via inhibition of thioredoxin reductase and activation of redox signaling</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>81</i></span>,  <span class="NLM_fpage">401</span>– <span class="NLM_lpage">410</span>, <span class="refDoi"> DOI: 10.1124/mol.111.076091</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref74/cit74&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.111.076091" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=81&publication_year=2012&pages=401-410&author=C.+Yanauthor=D.+Siegelauthor=J.+Newsomeauthor=A.+Chillouxauthor=C.+J.+Moodyauthor=D.+Ross&title=Antitumor+indolequinones+induced+apoptosis+in+human+pancreatic+cancer+cells+via+inhibition+of+thioredoxin+reductase+and+activation+of+redox+signaling&doi=10.1124%2Fmol.111.076091"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit74&amp;dbid=16384&amp;doi=10.1124%2Fmol.111.076091&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.111.076091%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DNewsome%26aufirst%3DJ.%26aulast%3DChilloux%26aufirst%3DA.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DAntitumor%2520indolequinones%2520induced%2520apoptosis%2520in%2520human%2520pancreatic%2520cancer%2520cells%2520via%2520inhibition%2520of%2520thioredoxin%2520reductase%2520and%2520activation%2520of%2520redox%2520signaling%26jtitle%3DMol.%2520Pharmacol.%26date%3D2012%26volume%3D81%26spage%3D401%26epage%3D410%26doi%3D10.1124%2Fmol.111.076091" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref75"><div class="reference"><strong class="refLabel"><a href="#ref75" class="rightTabRefNumLink">75</a></strong><div class="NLM_citation" id="rightTab-cit75"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fryatt, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pettersson, H. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gardipee, W. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bray, K. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Green, S. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slawin, A. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span> <span> </span><span class="NLM_article-title">Novel quinolinequinone antitumor agents: structure-metabolism studies with NAD(P)H:quinone oxidoreductase (NQO1)</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1667</span>– <span class="NLM_lpage">1687</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2004.01.021</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref75/cit75&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmc.2004.01.021" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2004&pages=1667-1687&author=T.+Fryattauthor=H.+I.+Petterssonauthor=W.+T.+Gardipeeauthor=K.+C.+Brayauthor=S.+J.+Greenauthor=A.+M.+Slawinauthor=H.+D.+Beallauthor=C.+J.+Moody&title=Novel+quinolinequinone+antitumor+agents%3A+structure-metabolism+studies+with+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29&doi=10.1016%2Fj.bmc.2004.01.021"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit75&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2004.01.021&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2004.01.021%26sid%3Dliteratum%253Aachs%26aulast%3DFryatt%26aufirst%3DT.%26aulast%3DPettersson%26aufirst%3DH.%2BI.%26aulast%3DGardipee%26aufirst%3DW.%2BT.%26aulast%3DBray%26aufirst%3DK.%2BC.%26aulast%3DGreen%26aufirst%3DS.%2BJ.%26aulast%3DSlawin%26aufirst%3DA.%2BM.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26atitle%3DNovel%2520quinolinequinone%2520antitumor%2520agents%253A%2520structure-metabolism%2520studies%2520with%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2004%26volume%3D12%26spage%3D1667%26epage%3D1687%26doi%3D10.1016%2Fj.bmc.2004.01.021" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref76"><div class="reference"><strong class="refLabel"><a href="#ref76" class="rightTabRefNumLink">76</a></strong><div class="NLM_citation" id="rightTab-cit76"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of NAD (P) H:quinone oxidoreductase 1 (NQO1) inhibitors with novel chemical scaffolds by shape-based virtual screening combined with cascade docking</span>. <i>RSC Adv.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">49471</span>– <span class="NLM_lpage">49479</span>, <span class="refDoi"> DOI: 10.1039/C5RA05919D</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2FC5RA05919D" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref76/cit76&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXptFCksr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=49471-49479&author=J.+Bianauthor=X.+Qianauthor=B.+Dengauthor=X.+Xuauthor=X.+Guoauthor=Y.+Wangauthor=X.+Liauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+NAD+%28P%29+H%3Aquinone+oxidoreductase+1+%28NQO1%29+inhibitors+with+novel+chemical+scaffolds+by+shape-based+virtual+screening+combined+with+cascade+docking&doi=10.1039%2FC5RA05919D"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit76R"><div class="casContent"><span class="casTitleNuber">76</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors with novel chemical scaffolds by shape-based virtual screening combined with cascade docking</span></div><div class="casAuthors">Bian, Jinlei; Qian, Xue; Deng, Bang; Xu, Xiaoli; Guo, Xiaoke; Wang, Yalou; Li, Xiang; Sun, Haopeng; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">RSC Advances</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">61</span>),
    <span class="NLM_cas:pages">49471-49479</span>CODEN:
                <span class="NLM_cas:coden">RSCACL</span>;
        ISSN:<span class="NLM_cas:issn">2046-2069</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A no. of novel NAD(P)H:quinone oxidoreductase 1 (NQO1) inhibitors were discovered from the ChemDiv database via a simple protocol.  Based on two ref. NQO1 inhibitors, dicoumarol (DIC) and ES936, a shape-based similarity search and cascade docking filtering were conducted to identify new NQO1 inhibitors.  Using these techniques, 43 compds. were selected, ordered, and tested.  Among them, 7 compds. with novel chem. scaffolds were confirmed to be active by in vitro assays.  Detn. of the ability for protecting against NQO1-mediated toxicity of β-lapachone (β-lap) confirmed that compds. 8, 10 and 13 may be pharmacol. useful for probing the function of NQO1 in cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqjUC2lbXNdSbVg90H21EOLACvtfcHk0ljPszhE-3luCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXptFCksr4%253D&md5=50f96b5c4eed59bdd1ee23c2ae8ff6c8</span></div><a href="/servlet/linkout?suffix=cit76&amp;dbid=16384&amp;doi=10.1039%2FC5RA05919D&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5RA05919D%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520NAD%2520%2528P%2529%2520H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%2520inhibitors%2520with%2520novel%2520chemical%2520scaffolds%2520by%2520shape-based%2520virtual%2520screening%2520combined%2520with%2520cascade%2520docking%26jtitle%3DRSC%2520Adv.%26date%3D2015%26volume%3D5%26spage%3D49471%26epage%3D49479%26doi%3D10.1039%2FC5RA05919D" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref77"><div class="reference"><strong class="refLabel"><a href="#ref77" class="rightTabRefNumLink">77</a></strong><div class="NLM_citation" id="rightTab-cit77"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span> <span> </span><span class="NLM_article-title">Deoxynyboquinones as NQO1-activated cancer therapeutics</span>. <i>Acc. Chem. Res.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">2715</span>– <span class="NLM_lpage">2723</span>, <span class="refDoi"> DOI: 10.1021/acs.accounts.5b00365</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.accounts.5b00365" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref77/cit77&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Wqs7fI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2015&pages=2715-2723&author=E.+I.+Parkinsonauthor=P.+J.+Hergenrother&title=Deoxynyboquinones+as+NQO1-activated+cancer+therapeutics&doi=10.1021%2Facs.accounts.5b00365"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit77R"><div class="casContent"><span class="casTitleNuber">77</span><div class="casTitle"><span class="NLM_cas:atitle">Deoxynyboquinones as NQO1-Activated Cancer Therapeutics</span></div><div class="casAuthors">Parkinson, Elizabeth I.; Hergenrother, Paul J.</div><div class="citationInfo"><span class="NLM_cas:title">Accounts of Chemical Research</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2715-2723</span>CODEN:
                <span class="NLM_cas:coden">ACHRE4</span>;
        ISSN:<span class="NLM_cas:issn">0001-4842</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the major goals of cancer therapy is the selective targeting of cancer cells over normal cells.  Unfortunately, even with recent advances, the majority of chemotherapeutics still indiscriminately kill all rapidly dividing cells.  Although these drugs are effective in certain settings, their inability to specifically target cancer results in significant dose-limiting toxicities.  One way to avoid such toxicities is to target an aspect of the cancer cell that is not shared by normal cells.  A potential cancer-specific target is the enzyme NAD(P)H quinone oxidoreductase 1 (NQO1).  NQO1 is a 2-electron reductase responsible for the detoxification of quinones.  Its expression is typically quite low in normal tissue, but it has been found to be greatly overexpressed in many types of solid tumors, including lung, breast, pancreatic, and colon cancers.  This overexpression is thought to be in response to the higher oxidative stress of the cancer cell, and it is possible that NQO1 contributes to tumor progression.  The overexpression of NQO1 and its correlation with poor patient outcome make it an intriguing target.  Although some have explored inhibiting NQO1 as an anticancer strategy, this has generally been unsuccessful.  A more promising strategy is to utilize NQO1 substrates that are activated upon redn. by NQO1.  For example, in principle, redn. of a quinone can result in a hydroquinone that is a DNA alkylator, protein inhibitor, or redn.-oxidn. cycler.  Although there are many proposed NQO1 substrates, head-to-head assays reveal only two classes of compds. that convincingly induce cancer cell death through NQO1-mediated activation.  The authors describe the discovery and development of one of these compds., the natural product deoxynyboquinone (DNQ), an excellent NQO1 substrate and anticancer agent.  A modular synthesis of DNQ was developed that enabled access to the large compd. quantities needed to conduct extensive mechanistic evaluations and animal expts.  During these evaluations, the authors found that DNQ is an outstanding NQO1 substrate that is processed much more efficiently than other putative NQO1 substrates.  Importantly, its anticancer activity is strictly dependent on the overexpression of active NQO1.  Using previous crystal structures of NQO1, novel DNQ derivs. were designed that are also excellent NQO1 substrates and possess properties that make them more attractive than the parent natural product for translational development.  Given their selectivity, potency, outstanding pharmacokinetic properties, and the ready availability of diagnostics to assess NQO1 in patients, DNQ and its derivs. have considerable potential as personalized medicines for the treatment of cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrW3MluuGsMA7Vg90H21EOLACvtfcHk0ljPszhE-3luCw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Wqs7fI&md5=9395e54798f6a41a31b47a5ad078c9c1</span></div><a href="/servlet/linkout?suffix=cit77&amp;dbid=16384&amp;doi=10.1021%2Facs.accounts.5b00365&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.accounts.5b00365%26sid%3Dliteratum%253Aachs%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26atitle%3DDeoxynyboquinones%2520as%2520NQO1-activated%2520cancer%2520therapeutics%26jtitle%3DAcc.%2520Chem.%2520Res.%26date%3D2015%26volume%3D48%26spage%3D2715%26epage%3D2723%26doi%3D10.1021%2Facs.accounts.5b00365" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref78"><div class="reference"><strong class="refLabel"><a href="#ref78" class="rightTabRefNumLink">78</a></strong><div class="NLM_citation" id="rightTab-cit78"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Crooke, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, W. T.</span></span> <span> </span><span class="NLM_article-title">Mitomycin C: a review</span>. <i>Cancer Treat. Rev.</i> <span class="NLM_year" style="font-weight: bold;">1976</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">121</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1016/S0305-7372(76)80019-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0305-7372%2876%2980019-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=786455" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref78/cit78&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaE2s%252FgtFCruw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=1976&pages=121-139&author=S.+T.+Crookeauthor=W.+T.+Bradner&title=Mitomycin+C%3A+a+review&doi=10.1016%2FS0305-7372%2876%2980019-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit78R"><div class="casContent"><span class="casTitleNuber">78</span><div class="casTitle"><span class="NLM_cas:atitle">Mitomycin C: a review</span></div><div class="casAuthors">Crooke S T; Bradner W T</div><div class="citationInfo"><span class="NLM_cas:title">Cancer treatment reviews</span>
        (<span class="NLM_cas:date">1976</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">121-39</span>
        ISSN:<span class="NLM_cas:issn">0305-7372</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRdf41D9V_IIJ6KlWarZTAzfW6udTcc2eaNcSQsgDAny7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaE2s%252FgtFCruw%253D%253D&md5=7e99ce868a2aab0b89751a062903ceaf</span></div><a href="/servlet/linkout?suffix=cit78&amp;dbid=16384&amp;doi=10.1016%2FS0305-7372%2876%2980019-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0305-7372%252876%252980019-9%26sid%3Dliteratum%253Aachs%26aulast%3DCrooke%26aufirst%3DS.%2BT.%26aulast%3DBradner%26aufirst%3DW.%2BT.%26atitle%3DMitomycin%2520C%253A%2520a%2520review%26jtitle%3DCancer%2520Treat.%2520Rev.%26date%3D1976%26volume%3D3%26spage%3D121%26epage%3D139%26doi%3D10.1016%2FS0305-7372%2876%2980019-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref79"><div class="reference"><strong class="refLabel"><a href="#ref79" class="rightTabRefNumLink">79</a></strong><div class="NLM_citation" id="rightTab-cit79"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Colucci, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moody, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Couch, G. D.</span></span> <span> </span><span class="NLM_article-title">Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">656</span>, <span class="refDoi"> DOI: 10.1039/B715270A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2FB715270A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=18264564" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref79/cit79&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhs1yksb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2008&pages=637-656&author=M.+A.+Colucciauthor=C.+J.+Moodyauthor=G.+D.+Couch&title=Natural+and+synthetic+quinones+and+their+reduction+by+the+quinone+reductase+enzyme+NQO1%3A+from+synthetic+organic+chemistry+to+compounds+with+anticancer+potential&doi=10.1039%2FB715270A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit79R"><div class="casContent"><span class="casTitleNuber">79</span><div class="casTitle"><span class="NLM_cas:atitle">Natural and synthetic quinones and their reduction by the quinone reductase enzyme NQO1: from synthetic organic chemistry to compounds with anticancer potential</span></div><div class="casAuthors">Colucci, Marie A.; Couch, Gavin D.; Moody, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Organic & Biomolecular Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">637-656</span>CODEN:
                <span class="NLM_cas:coden">OBCRAK</span>;
        ISSN:<span class="NLM_cas:issn">1477-0520</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A review.  The quinone reductase enzyme NAD(P)H: quinone oxidoreductase 1 (NQO1) is a ubiquitous flavoenzyme that catalyzes the two-electron redn. of quinones.  This Perspective briefly reviews the structure and mechanism, physiol. role, and upregulation and induction of the enzyme, but focuses on the synthesis of new heterocyclic quinones and their metab. by recombinant human NQO1.  Thus a range of indolequinones, some of which are novel analogs of mitomycin C, benzimidazolequinones, benzothiazolequinones and quinolinequinones have been prepd. and evaluated, leading to detailed knowledge of the structural requirements for efficient metab. by the enzyme.  Potent mechanism-based inhibitors (suicide substrates) of NQO1 have also been developed.  These indolequinones irreversibly alkylate the protein, preventing its function both in std. enzyme assays and also in cells.  Some of these quinones are also potent inhibitors of growth of human pancreatic cancer cells, suggesting a potential role for such compds. as therapeutic agents.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPvvIszpepVLVg90H21EOLACvtfcHk0lgFqtEjP4wChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhs1yksb4%253D&md5=efbef31e39e18c5314ad2c24628254ec</span></div><a href="/servlet/linkout?suffix=cit79&amp;dbid=16384&amp;doi=10.1039%2FB715270A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FB715270A%26sid%3Dliteratum%253Aachs%26aulast%3DColucci%26aufirst%3DM.%2BA.%26aulast%3DMoody%26aufirst%3DC.%2BJ.%26aulast%3DCouch%26aufirst%3DG.%2BD.%26atitle%3DNatural%2520and%2520synthetic%2520quinones%2520and%2520their%2520reduction%2520by%2520the%2520quinone%2520reductase%2520enzyme%2520NQO1%253A%2520from%2520synthetic%2520organic%2520chemistry%2520to%2520compounds%2520with%2520anticancer%2520potential%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2008%26volume%3D6%26spage%3D637%26epage%3D656%26doi%3D10.1039%2FB715270A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref80"><div class="reference"><strong class="refLabel"><a href="#ref80" class="rightTabRefNumLink">80</a></strong><div class="NLM_citation" id="rightTab-cit80"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharp, S. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kelland, L. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Valenti, M. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brunton, L. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hobbs, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span> <span> </span><span class="NLM_article-title">Establishment of an isogenic human colon tumor model for NQO1 gene expression: application to investigate the role of DT-diaphorase in bioreductive drug activation in vitro and in vivo</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>58</i></span>,  <span class="NLM_fpage">1146</span>– <span class="NLM_lpage">1155</span>, <span class="refDoi"> DOI: 10.1124/mol.58.5.1146</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref80/cit80&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.58.5.1146" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=58&publication_year=2000&pages=1146-1155&author=S.+Y.+Sharpauthor=L.+R.+Kellandauthor=M.+R.+Valentiauthor=L.+A.+Bruntonauthor=S.+Hobbsauthor=P.+Workman&title=Establishment+of+an+isogenic+human+colon+tumor+model+for+NQO1+gene+expression%3A+application+to+investigate+the+role+of+DT-diaphorase+in+bioreductive+drug+activation+in+vitro+and+in+vivo&doi=10.1124%2Fmol.58.5.1146"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit80&amp;dbid=16384&amp;doi=10.1124%2Fmol.58.5.1146&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.58.5.1146%26sid%3Dliteratum%253Aachs%26aulast%3DSharp%26aufirst%3DS.%2BY.%26aulast%3DKelland%26aufirst%3DL.%2BR.%26aulast%3DValenti%26aufirst%3DM.%2BR.%26aulast%3DBrunton%26aufirst%3DL.%2BA.%26aulast%3DHobbs%26aufirst%3DS.%26aulast%3DWorkman%26aufirst%3DP.%26atitle%3DEstablishment%2520of%2520an%2520isogenic%2520human%2520colon%2520tumor%2520model%2520for%2520NQO1%2520gene%2520expression%253A%2520application%2520to%2520investigate%2520the%2520role%2520of%2520DT-diaphorase%2520in%2520bioreductive%2520drug%2520activation%2520in%2520vitro%2520and%2520in%2520vivo%26jtitle%3DMol.%2520Pharmacol.%26date%3D2000%26volume%3D58%26spage%3D1146%26epage%3D1155%26doi%3D10.1124%2Fmol.58.5.1146" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref81"><div class="reference"><strong class="refLabel"><a href="#ref81" class="rightTabRefNumLink">81</a></strong><div class="NLM_citation" id="rightTab-cit81"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">pH-dependent inactivation of DT-diaphorase by mitomycin C and porfiromycin</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>44</i></span>,  <span class="NLM_fpage">1128</span>– <span class="NLM_lpage">1134</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=44&publication_year=1993&pages=1128-1134&author=D.+Siegelauthor=H.+Beallauthor=M.+Kasaiauthor=H.+Araiauthor=N.+W.+Gibsonauthor=D.+Ross&title=pH-dependent+inactivation+of+DT-diaphorase+by+mitomycin+C+and+porfiromycin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit81&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBeall%26aufirst%3DH.%26aulast%3DKasai%26aufirst%3DM.%26aulast%3DArai%26aufirst%3DH.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DpH-dependent%2520inactivation%2520of%2520DT-diaphorase%2520by%2520mitomycin%2520C%2520and%2520porfiromycin%26jtitle%3DMol.%2520Pharmacol.%26date%3D1993%26volume%3D44%26spage%3D1128%26epage%3D1134" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref82"><div class="reference"><strong class="refLabel"><a href="#ref82" class="rightTabRefNumLink">82</a></strong><div class="NLM_citation" id="rightTab-cit82"><span><span class="NLM_contrib-group"><span class="NLM_string-name">James, R. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Glynne-Jones, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meadows, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Myint, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saunders, M. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maughan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McDonald, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Essapen, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leslie, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Falk, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilson, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gollins, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ledermann, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kadalayil, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sebag-Montefiore, D.</span></span> <span> </span><span class="NLM_article-title">Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2 × 2 factorial trial</span>. <i>Lancet Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">516</span>– <span class="NLM_lpage">524</span>, <span class="refDoi"> DOI: 10.1016/S1470-2045(13)70086-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS1470-2045%2813%2970086-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23578724" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref82/cit82&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXls1eqsb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2013&pages=516-524&author=R.+D.+Jamesauthor=R.+Glynne-Jonesauthor=H.+M.+Meadowsauthor=D.+Cunninghamauthor=A.+S.+Myintauthor=M.+P.+Saundersauthor=T.+Maughanauthor=A.+McDonaldauthor=S.+Essapenauthor=M.+Leslieauthor=S.+Falkauthor=C.+Wilsonauthor=S.+Gollinsauthor=R.+Begumauthor=J.+Ledermannauthor=L.+Kadalayilauthor=D.+Sebag-Montefiore&title=Mitomycin+or+cisplatin+chemoradiation+with+or+without+maintenance+chemotherapy+for+treatment+of+squamous-cell+carcinoma+of+the+anus+%28ACT+II%29%3A+a+randomised%2C+phase+3%2C+open-label%2C+2+%C3%97+2+factorial+trial&doi=10.1016%2FS1470-2045%2813%2970086-X"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit82R"><div class="casContent"><span class="casTitleNuber">82</span><div class="casTitle"><span class="NLM_cas:atitle">Mitomycin or cisplatin chemoradiation with or without maintenance chemotherapy for treatment of squamous-cell carcinoma of the anus (ACT II): a randomised, phase 3, open-label, 2×2 factorial trial</span></div><div class="casAuthors">James, Roger D.; Glynne-Jones, Robert; Meadows, Helen M.; Cunningham, David; Myint, Arthur Sun; Saunders, Mark P.; Maughan, Timothy; McDonald, Alec; Essapen, Sharadah; Leslie, Martin; Falk, Stephen; Wilson, Charles; Gollins, Simon; Begum, Rubina; Ledermann, Jonathan; Kadalayil, Latha; Sebag-Montefiore, David</div><div class="citationInfo"><span class="NLM_cas:title">Lancet Oncology</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">516-524</span>CODEN:
                <span class="NLM_cas:coden">LOANBN</span>;
        ISSN:<span class="NLM_cas:issn">1470-2045</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Chemoradiation became the std. of care for anal cancer after the ACT I trial.  However, only two-thirds of patients achieved local control, with 5-yr survival of 50%; therefore, better treatments are needed.  We investigated whether replacing mitomycin with cisplatin in chemoradiation improves response, and whether maintenance chemotherapy after chemoradiation improves survival.  In this 2×2 factorial trial, we enrolled patients with histol. confirmed squamous-cell carcinoma of the anus without metastatic disease from 59 centers in the UK.  Patients were randomly assigned to one of four groups, to receive either mitomycin (12 mg/m2 on day 1) or cisplatin (60 mg/m2 on days 1 and 29), with fluorouracil (1000 mg/m2 per day on days 1-4 and 29-32) and radiotherapy (50·4 Gy in 28 daily fractions); with or without two courses of maintenance chemotherapy (fluorouracil and cisplatin at weeks 11 and 14).  The random allocation was generated by computer and patients assigned by telephone.  Randomisation was done by minimisation and stratified by tumor site, T and N stage, sex, age, and renal function.  Neither patients nor investigators were masked to assignment.  Primary endpoints were complete response at 26 wk and acute toxic effects (for chemoradiation), and progression-free survival (for maintenance).  The primary analyses were done by intention to treat.  This study is registered at controlled-trials.com, no. 26715889.We enrolled 940 patients: 472 were assigned to mitomycin, of whom 246 were assigned to no maintenance, 226 to maintenance; 468 were assigned to cisplatin, of whom 246 were assigned to no maintenance, 222 to maintenance.  Median follow-up was 5·1 years (IQR 3·9-6·9). 391 of 432 (90·5%) patients in the mitomycin group vs. 386 of 431 (89·6%) in the cisplatin group had a complete response at 26 wk (difference -0·9%, 95% CI -4·9 to 3·1; p=0·64).  Overall, toxic effects were similar in each group (334/472 [71%] for mitomycin vs 337/468 [72%] for cisplatin).  The most common grade 3-4 toxic effects were skin (228/472 [48%] vs 222/468 [47%]), pain (122/472 [26%] vs 135/468 [29%]), haematol. (124/472 [26%] vs 73/468 [16%]), and gastrointestinal (75/472 [16%] vs 85/468 [18%]). 3-yr progression-free survival was 74% (95% CI 69-77; maintenance) vs. 73% (95% CI 68-77; no maintenance; hazard ratio 0·95, 95% CI 0·75-1·21; p=0·70).  The results of our trial-the largest in anal cancer to date-show that fluorouracil and mitomycin with 50·4 Gy radiotherapy in 28 daily fractions should remain std. practice in the UK.Cancer Research UK.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp4oHp8fLcoV7Vg90H21EOLACvtfcHk0lgFqtEjP4wChQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXls1eqsb4%253D&md5=c8f10c2061f41756647817c63f159510</span></div><a href="/servlet/linkout?suffix=cit82&amp;dbid=16384&amp;doi=10.1016%2FS1470-2045%2813%2970086-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1470-2045%252813%252970086-X%26sid%3Dliteratum%253Aachs%26aulast%3DJames%26aufirst%3DR.%2BD.%26aulast%3DGlynne-Jones%26aufirst%3DR.%26aulast%3DMeadows%26aufirst%3DH.%2BM.%26aulast%3DCunningham%26aufirst%3DD.%26aulast%3DMyint%26aufirst%3DA.%2BS.%26aulast%3DSaunders%26aufirst%3DM.%2BP.%26aulast%3DMaughan%26aufirst%3DT.%26aulast%3DMcDonald%26aufirst%3DA.%26aulast%3DEssapen%26aufirst%3DS.%26aulast%3DLeslie%26aufirst%3DM.%26aulast%3DFalk%26aufirst%3DS.%26aulast%3DWilson%26aufirst%3DC.%26aulast%3DGollins%26aufirst%3DS.%26aulast%3DBegum%26aufirst%3DR.%26aulast%3DLedermann%26aufirst%3DJ.%26aulast%3DKadalayil%26aufirst%3DL.%26aulast%3DSebag-Montefiore%26aufirst%3DD.%26atitle%3DMitomycin%2520or%2520cisplatin%2520chemoradiation%2520with%2520or%2520without%2520maintenance%2520chemotherapy%2520for%2520treatment%2520of%2520squamous-cell%2520carcinoma%2520of%2520the%2520anus%2520%2528ACT%2520II%2529%253A%2520a%2520randomised%252C%2520phase%25203%252C%2520open-label%252C%25202%2520%25C3%2597%25202%2520factorial%2520trial%26jtitle%3DLancet%2520Oncol.%26date%3D2013%26volume%3D14%26spage%3D516%26epage%3D524%26doi%3D10.1016%2FS1470-2045%2813%2970086-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref83"><div class="reference"><strong class="refLabel"><a href="#ref83" class="rightTabRefNumLink">83</a></strong><div class="NLM_citation" id="rightTab-cit83"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Golan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Grenader, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ohana, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amitay, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shmeeda, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">La-Beck, N. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tahover, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gabizon, A. A.</span></span> <span> </span><span class="NLM_article-title">Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients</span>. <i>Cancer Med.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>4</i></span>,  <span class="NLM_fpage">1472</span>– <span class="NLM_lpage">1483</span>, <span class="refDoi"> DOI: 10.1002/cam4.491</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fcam4.491" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26172205" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref83/cit83&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu7fM" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=4&publication_year=2015&pages=1472-1483&author=T.+Golanauthor=T.+Grenaderauthor=P.+Ohanaauthor=Y.+Amitayauthor=H.+Shmeedaauthor=N.+M.+La-Beckauthor=E.+Tahoverauthor=R.+Bergerauthor=A.+A.+Gabizon&title=Pegylated+liposomal+mitomycin+C+prodrug+enhances+tolerance+of+mitomycin+C%3A+a+phase+1+study+in+advanced+solid+tumor+patients&doi=10.1002%2Fcam4.491"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit83R"><div class="casContent"><span class="casTitleNuber">83</span><div class="casTitle"><span class="NLM_cas:atitle">Pegylated liposomal mitomycin C prodrug enhances tolerance of mitomycin C: a phase 1 study in advanced solid tumor patients</span></div><div class="casAuthors">Golan, Talia; Grenader, Tal; Ohana, Patricia; Amitay, Yasmine; Shmeeda, Hilary; La-Beck, Ninh M.; Tahover, Esther; Berger, Raanan; Gabizon, Alberto A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Medicine</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">4</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">1472-1483</span>CODEN:
                <span class="NLM_cas:coden">CMAEDL</span>;
        ISSN:<span class="NLM_cas:issn">2045-7634</span>.
    
            (<span class="NLM_cas:orgname">John Wiley & Sons Ltd.</span>)
        </div><div class="casAbstract">Mitomycin C (MMC) has potent cytotoxicity but cumulative toxicity limits widespread use.  In animals, pegylated liposomal mitomycin C lipid-based prodrug (PL-MLP) was well tolerated and more effective than free MMC.  We evaluated PL-MLP in patients with advanced cancer.  Twenty-seven patients were treated in escalating dose cohorts of 0.5-3.5 mg/kg (equiv. to 0.15-1.03 mg/kg MMC) every 4 wk for up to 12 cycles, unless disease progression or unacceptable toxicity occurred.  Pharmacokinetics were assessed during cycles 1 and 3.  Per protocol max. tolerated dose was not reached at 3.5 mg/kg.  However, prolonged thrombocytopenia developed after repeated doses of 3 mg/kg or cumulative doses of 10-12 mg/kg.  Dose-related grade 3 or higher adverse events included fatigue, anemia, and decreased platelets.  Cmax and AUC0-∞ increased linearly over the dose range 0.5-2.0 mg/kg, and greater than linearly from 2.5 to 3.5 mg/kg; there were no significant differences in clearance of MLP between cycles 1 and 3.  Median t1/2 was 23 h among dose cohorts, with no trend by dose or cycle.  One patient had a partial response.  Stable disease was obsd. in 10 patients across all dose levels.  PL-MLP has a long circulation time, was well tolerated, and can be administered to heavily pretreated patients at a single dose of 3.0 mg/kg and cumulative dose of 10-12 mg/kg before development of prolonged thrombocytopenia; this is nearly threefold the equiv. dose of MMC tolerated historically.  This formulation may be active in a variety of tumor types and is better tolerated than free MMC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqYcERICPvrZrVg90H21EOLACvtfcHk0li0rbsEpVIIVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhs1Ohu7fM&md5=8d4ffff9f8c9a6d23c4acbe8208605c6</span></div><a href="/servlet/linkout?suffix=cit83&amp;dbid=16384&amp;doi=10.1002%2Fcam4.491&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fcam4.491%26sid%3Dliteratum%253Aachs%26aulast%3DGolan%26aufirst%3DT.%26aulast%3DGrenader%26aufirst%3DT.%26aulast%3DOhana%26aufirst%3DP.%26aulast%3DAmitay%26aufirst%3DY.%26aulast%3DShmeeda%26aufirst%3DH.%26aulast%3DLa-Beck%26aufirst%3DN.%2BM.%26aulast%3DTahover%26aufirst%3DE.%26aulast%3DBerger%26aufirst%3DR.%26aulast%3DGabizon%26aufirst%3DA.%2BA.%26atitle%3DPegylated%2520liposomal%2520mitomycin%2520C%2520prodrug%2520enhances%2520tolerance%2520of%2520mitomycin%2520C%253A%2520a%2520phase%25201%2520study%2520in%2520advanced%2520solid%2520tumor%2520patients%26jtitle%3DCancer%2520Med.%26date%3D2015%26volume%3D4%26spage%3D1472%26epage%3D1483%26doi%3D10.1002%2Fcam4.491" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref84"><div class="reference"><strong class="refLabel"><a href="#ref84" class="rightTabRefNumLink">84</a></strong><div class="NLM_citation" id="rightTab-cit84"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Oostveen, E.
A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Speckamp, W. N.</span></span> <span> </span><span class="NLM_article-title">Mitomycin analogs I. Indoloquinones as (potential) bisalkylating agents</span>. <i>Tetrahedron</i> <span class="NLM_year" style="font-weight: bold;">1987</span>,  <span class="NLM_volume"><i>43</i></span>,  <span class="NLM_fpage">255</span>– <span class="NLM_lpage">262</span>, <span class="refDoi"> DOI: 10.1016/S0040-4020(01)89952-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref84/cit84&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0040-4020%2801%2989952-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=1987&pages=255-262&author=E.%0AA.+Oostveenauthor=W.+N.+Speckamp&title=Mitomycin+analogs+I.+Indoloquinones+as+%28potential%29+bisalkylating+agents&doi=10.1016%2FS0040-4020%2801%2989952-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit84&amp;dbid=16384&amp;doi=10.1016%2FS0040-4020%2801%2989952-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0040-4020%252801%252989952-X%26sid%3Dliteratum%253Aachs%26aulast%3DOostveen%26aufirst%3DE.%2BA.%26aulast%3DSpeckamp%26aufirst%3DW.%2BN.%26atitle%3DMitomycin%2520analogs%2520I.%2520Indoloquinones%2520as%2520%2528potential%2529%2520bisalkylating%2520agents%26jtitle%3DTetrahedron%26date%3D1987%26volume%3D43%26spage%3D255%26epage%3D262%26doi%3D10.1016%2FS0040-4020%2801%2989952-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref85"><div class="reference"><strong class="refLabel"><a href="#ref85" class="rightTabRefNumLink">85</a></strong><div class="NLM_citation" id="rightTab-cit85"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pizao, P. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berger, D. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kooistra, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bibby, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreef-van
der Meulen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Henrar, R. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fiebig, H. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hornstra, H. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pinedo, H. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Workman, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartsmann, G.</span></span> <span> </span><span class="NLM_article-title">EO9: a novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1993</span>,  <span class="NLM_volume"><i>29</i></span>,  <span class="NLM_fpage">897</span>– <span class="NLM_lpage">906</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(05)80434-4</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref85/cit85&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0959-8049%2805%2980434-4" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=29&publication_year=1993&pages=897-906&author=H.+R.+Hendriksauthor=P.+E.+Pizaoauthor=D.+P.+Bergerauthor=K.+L.+Kooistraauthor=M.+C.+Bibbyauthor=E.+Bovenauthor=H.+C.+Dreef-van%0Ader+Meulenauthor=R.+E.+Henrarauthor=H.+H.+Fiebigauthor=J.+A.+Doubleauthor=H.+W.+Hornstraauthor=H.+M.+Pinedoauthor=P.+Workmanauthor=G.+Schwartsmann&title=EO9%3A+a+novel+bioreductive+alkylating+indoloquinone+with+preferential+solid+tumour+activity+and+lack+of+bone+marrow+toxicity+in+preclinical+models&doi=10.1016%2FS0959-8049%2805%2980434-4"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit85&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2805%2980434-4&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252805%252980434-4%26sid%3Dliteratum%253Aachs%26aulast%3DHendriks%26aufirst%3DH.%2BR.%26aulast%3DPizao%26aufirst%3DP.%2BE.%26aulast%3DBerger%26aufirst%3DD.%2BP.%26aulast%3DKooistra%26aufirst%3DK.%2BL.%26aulast%3DBibby%26aufirst%3DM.%2BC.%26aulast%3DBoven%26aufirst%3DE.%26aulast%3DDreef-van%2Bder%2BMeulen%26aufirst%3DH.%2BC.%26aulast%3DHenrar%26aufirst%3DR.%2BE.%26aulast%3DFiebig%26aufirst%3DH.%2BH.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DHornstra%26aufirst%3DH.%2BW.%26aulast%3DPinedo%26aufirst%3DH.%2BM.%26aulast%3DWorkman%26aufirst%3DP.%26aulast%3DSchwartsmann%26aufirst%3DG.%26atitle%3DEO9%253A%2520a%2520novel%2520bioreductive%2520alkylating%2520indoloquinone%2520with%2520preferential%2520solid%2520tumour%2520activity%2520and%2520lack%2520of%2520bone%2520marrow%2520toxicity%2520in%2520preclinical%2520models%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1993%26volume%3D29%26spage%3D897%26epage%3D906%26doi%3D10.1016%2FS0959-8049%2805%2980434-4" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref86"><div class="reference"><strong class="refLabel"><a href="#ref86" class="rightTabRefNumLink">86</a></strong><div class="NLM_citation" id="rightTab-cit86"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Smitskamp-Wilms, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hendriks, H. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peters, G. J.</span></span> <span> </span><span class="NLM_article-title">Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9</span>. <i>Gen. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">421</span>– <span class="NLM_lpage">429</span>, <span class="refDoi"> DOI: 10.1016/0306-3623(95)00118-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2F0306-3623%2895%2900118-2" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=8723519" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref86/cit86&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADyaK28XjtVWjt7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=1996&pages=421-429&author=E.+Smitskamp-Wilmsauthor=H.+R.+Hendriksauthor=G.+J.+Peters&title=Development%2C+pharmacology%2C+role+of+DT-diaphorase+and+prospects+of+the+indoloquinone+EO9&doi=10.1016%2F0306-3623%2895%2900118-2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit86R"><div class="casContent"><span class="casTitleNuber">86</span><div class="casTitle"><span class="NLM_cas:atitle">Development, pharmacology, role of DT-diaphorase and prospects of the indoloquinone EO9</span></div><div class="casAuthors">Smitskamp-Wilms, E.; Hendriks, H. R.; Peters, G. J.</div><div class="citationInfo"><span class="NLM_cas:title">General Pharmacology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">421-429</span>CODEN:
                <span class="NLM_cas:coden">GEPHDP</span>;
        ISSN:<span class="NLM_cas:issn">0306-3623</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">A review with many refs.  The indoloquinone EO9 (3-hydroxymethyl-5-aziridinyl-1-methyl-2-(1H-indole-4,7-dione)-propenol; E85/053;NSC 382,459) is a synthetic bioreductive alkylating agent that is structurally related to mitomycin C (MMC).  EO9 does, however, show a different mechanism of action and a broader antitumor profile than MMC.  It is also a more potent cytotoxic agent in vitro than MMC, probably because of its impressive efficient activation by reductive enzymes, particularly DT-Diaphorase.  This enzyme is elevated in several tumors compared to normal tissues.  The preferential cytotoxicity of EO9 under hypoxic conditions makes it an interesting compd. to combine with radiation.  In preclin. and the Phase I clin. studies, no myelosuppression was obsd. but reversible proteinuria was dose-limiting.  Phase II clin. studies were started in the summer of 1994.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrTSeZGM7i2VbVg90H21EOLACvtfcHk0li0rbsEpVIIVw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK28XjtVWjt7w%253D&md5=941f3224a8d6b11b12570e43c644f828</span></div><a href="/servlet/linkout?suffix=cit86&amp;dbid=16384&amp;doi=10.1016%2F0306-3623%2895%2900118-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0306-3623%252895%252900118-2%26sid%3Dliteratum%253Aachs%26aulast%3DSmitskamp-Wilms%26aufirst%3DE.%26aulast%3DHendriks%26aufirst%3DH.%2BR.%26aulast%3DPeters%26aufirst%3DG.%2BJ.%26atitle%3DDevelopment%252C%2520pharmacology%252C%2520role%2520of%2520DT-diaphorase%2520and%2520prospects%2520of%2520the%2520indoloquinone%2520EO9%26jtitle%3DGen.%2520Pharmacol.%26date%3D1996%26volume%3D27%26spage%3D421%26epage%3D429%26doi%3D10.1016%2F0306-3623%2895%2900118-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref87"><div class="reference"><strong class="refLabel"><a href="#ref87" class="rightTabRefNumLink">87</a></strong><div class="NLM_citation" id="rightTab-cit87"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dirix, L. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tonnesen, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cassidy, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Epelbaum, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">ten Bokkel
Huinink, W. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pavlidis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sorio, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamucci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wolff, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Te Velde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, J.</span></span> <span> </span><span class="NLM_article-title">EO9 phase II study in advanced breast, gastric, pancreatic and colorectal carcinoma by the EORTC Early Clinical Studies Group</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>32</i></span>,  <span class="NLM_fpage">2019</span>– <span class="NLM_lpage">2022</span>, <span class="refDoi"> DOI: 10.1016/0959-8049(96)00226-2</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref87/cit87&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2F0959-8049%2896%2900226-2" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=32&publication_year=1996&pages=2019-2022&author=L.+Y.+Dirixauthor=F.+Tonnesenauthor=J.+Cassidyauthor=R.+Epelbaumauthor=W.+W.+ten+Bokkel%0AHuininkauthor=N.+Pavlidisauthor=R.+Sorioauthor=T.+Gamucciauthor=I.+Wolffauthor=A.+Te+Veldeauthor=J.+Lanauthor=J.+Verweij&title=EO9+phase+II+study+in+advanced+breast%2C+gastric%2C+pancreatic+and+colorectal+carcinoma+by+the+EORTC+Early+Clinical+Studies+Group&doi=10.1016%2F0959-8049%2896%2900226-2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit87&amp;dbid=16384&amp;doi=10.1016%2F0959-8049%2896%2900226-2&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F0959-8049%252896%252900226-2%26sid%3Dliteratum%253Aachs%26aulast%3DDirix%26aufirst%3DL.%2BY.%26aulast%3DTonnesen%26aufirst%3DF.%26aulast%3DCassidy%26aufirst%3DJ.%26aulast%3DEpelbaum%26aufirst%3DR.%26aulast%3Dten%2BBokkel%2BHuinink%26aufirst%3DW.%2BW.%26aulast%3DPavlidis%26aufirst%3DN.%26aulast%3DSorio%26aufirst%3DR.%26aulast%3DGamucci%26aufirst%3DT.%26aulast%3DWolff%26aufirst%3DI.%26aulast%3DTe%2BVelde%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DEO9%2520phase%2520II%2520study%2520in%2520advanced%2520breast%252C%2520gastric%252C%2520pancreatic%2520and%2520colorectal%2520carcinoma%2520by%2520the%2520EORTC%2520Early%2520Clinical%2520Studies%2520Group%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D1996%26volume%3D32%26spage%3D2019%26epage%3D2022%26doi%3D10.1016%2F0959-8049%2896%2900226-2" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref88"><div class="reference"><strong class="refLabel"><a href="#ref88" class="rightTabRefNumLink">88</a></strong><div class="NLM_citation" id="rightTab-cit88"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pavlidis, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hanauske, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gamucci, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smyth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lehnert, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">te Velde, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verweij, J.</span></span> <span> </span><span class="NLM_article-title">A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG)</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">529</span>– <span class="NLM_lpage">531</span>, <span class="refDoi"> DOI: 10.1093/oxfordjournals.annonc.a010645</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1093%2Foxfordjournals.annonc.a010645" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=8839911" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref88/cit88&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaK28vjslSqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1996&pages=529-531&author=N.+Pavlidisauthor=A.+R.+Hanauskeauthor=T.+Gamucciauthor=J.+Smythauthor=M.+Lehnertauthor=A.+te+Veldeauthor=J.+Lanauthor=J.+Verweij&title=A+randomized+phase+II+study+with+two+schedules+of+the+novel+indoloquinone+EO9+in+non-small-cell+lung+cancer%3A+a+study+of+the+EORTC+Early+Clinical+Studies+Group+%28ECSG%29&doi=10.1093%2Foxfordjournals.annonc.a010645"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit88R"><div class="casContent"><span class="casTitleNuber">88</span><div class="casTitle"><span class="NLM_cas:atitle">A randomized phase II study with two schedules of the novel indoloquinone EO9 in non-small-cell lung cancer: a study of the EORTC Early Clinical Studies Group (ECSG)</span></div><div class="casAuthors">Pavlidis N; Hanauske A R; Gamucci T; Smyth J; Lehnert M; te Velde A; Lan J; Verweij J</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">1996</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">529-31</span>
        ISSN:<span class="NLM_cas:issn">0923-7534</span>.
    </div><div class="casAbstract">In a multicentre randomized trial of the EORTC-ECSG, we have treated 38 chemotherapy naive patients with advanced non-small-cell lung cancer (NSCLC) with EO9, a novel bio-reductive alkylating indoloquinone.  The drug was given at two different dose schedules by a single bolus i.v. injection: arm A 12 mg/m2 weekly and arm B 22 mg/m2 every three weeks.  All together 185 courses were administered (145 in arm A and 40 in arm B).  The major toxicity was reversible proteinuria more frequently occurring in the three-weekly schedule (arm A 34.5% vs. arm B 62.5%).  Creatinine elevation, fluid retention and pericardial or pleural effusion were also recorded in a limited number of patients.  Other common toxicities more frequent in the three-weekly administration were asthenia (21% vs. 35% of cycles), nausea (15% vs. 27.5% of cycles) and vomiting (5% vs. 17.5% of cycles).  Toxicities were mainly of grade I and II.  No responses have been observed.  Five patients (26%) on arm A and eight (53%) on arm B experienced stable disease.  These doses and schedules of EO9 do not yield activity in NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTahCFcy8GHOb0AGQpJZWpJfW6udTcc2eY1G9PgEVPH7Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaK28vjslSqtQ%253D%253D&md5=3294a215687510a16c9993bc35ea7df7</span></div><a href="/servlet/linkout?suffix=cit88&amp;dbid=16384&amp;doi=10.1093%2Foxfordjournals.annonc.a010645&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Foxfordjournals.annonc.a010645%26sid%3Dliteratum%253Aachs%26aulast%3DPavlidis%26aufirst%3DN.%26aulast%3DHanauske%26aufirst%3DA.%2BR.%26aulast%3DGamucci%26aufirst%3DT.%26aulast%3DSmyth%26aufirst%3DJ.%26aulast%3DLehnert%26aufirst%3DM.%26aulast%3Dte%2BVelde%26aufirst%3DA.%26aulast%3DLan%26aufirst%3DJ.%26aulast%3DVerweij%26aufirst%3DJ.%26atitle%3DA%2520randomized%2520phase%2520II%2520study%2520with%2520two%2520schedules%2520of%2520the%2520novel%2520indoloquinone%2520EO9%2520in%2520non-small-cell%2520lung%2520cancer%253A%2520a%2520study%2520of%2520the%2520EORTC%2520Early%2520Clinical%2520Studies%2520Group%2520%2528ECSG%2529%26jtitle%3DAnn.%2520Oncol.%26date%3D1996%26volume%3D7%26spage%3D529%26epage%3D531%26doi%3D10.1093%2Foxfordjournals.annonc.a010645" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref89"><div class="reference"><strong class="refLabel"><a href="#ref89" class="rightTabRefNumLink">89</a></strong><div class="NLM_citation" id="rightTab-cit89"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Puri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palit, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loadman, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Flannigan, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shah, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choudry, G. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Basu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Double, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lenaz, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beer, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Van Kalken, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Boer, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beijnen, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Twelves, C. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Phillips, R. M.</span></span> <span> </span><span class="NLM_article-title">Phase I/II Pilot study of intravesical apaziquone (EO9) for superficial bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">1344</span>– <span class="NLM_lpage">1348</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2006.06.047</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2006.06.047" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16952628" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref89/cit89&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1344-1348&author=R.+Puriauthor=V.+Palitauthor=P.+M.+Loadmanauthor=M.+Flanniganauthor=T.+Shahauthor=G.+A.+Choudryauthor=S.+Basuauthor=J.+A.+Doubleauthor=G.+Lenazauthor=S.+Chawlaauthor=M.+Beerauthor=C.+Van+Kalkenauthor=R.+de+Boerauthor=J.+H.+Beijnenauthor=C.+J.+Twelvesauthor=R.+M.+Phillips&title=Phase+I%2FII+Pilot+study+of+intravesical+apaziquone+%28EO9%29+for+superficial+bladder+cancer&doi=10.1016%2Fj.juro.2006.06.047"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit89R"><div class="casContent"><span class="casTitleNuber">89</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I/II pilot study of intravesical apaziquone (EO9) for superficial bladder cancer</span></div><div class="casAuthors">Puri, Rajiv; Palit, Victor; Loadman, Paul M.; Flannigan, Michael; Shah, Tariq; Choudry, Guzanfar A.; Basu, Saurajyoti; Double, John A.; Lenaz, Gino; Chawla, Shanta; Beer, Mario; Van Kalken, Coen; de Boer, Richard; Beijnen, Jos H.; Twelves, Christopher J.; Phillips, Roger M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">4, Pt. 1</span>),
    <span class="NLM_cas:pages">1344-1348</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: The quinone based bioreductive drug apaziquone (EO9) failed to demonstrate efficacy in previous phase II studies following i.v. administration.  We detd. the dose of apaziquone that can be safely administered intravesically and explored its activity for superficial bladder transitional cell carcinoma.  Materials and Methods: Six patients with multifocal, Ta/T1 and G1/G2 transitional cell carcinoma of the bladder received escalating doses of apaziquone formulated as EOquin (0.5 mg/40 mL up to 16 mg/40 mL) weekly for 6 wk.  A further 6 patients received weekly apaziquone at the highest nontoxic dose established.  Pharmacokinetic parameters were detd. in urine and blood, and the pharmacodynamic markers NQO1 (reduced NADP: quinone oxidoreductase-1) and glucose transporter 1 were also characterized.  Efficacy was detd. against a marker lesion.  Results: Local toxicity (grades 2 and 3 dysuria, and hematuria) was obsd. at doses of 8 mg/40 mL and above but 4 mg/40 mL was well tolerated with no systemic or local side effects.  Apaziquone in urine increased linearly with the dose but no apaziquone was detected in plasma.  In 8 of 12 patients complete macroscopic and histol. disappearance of the marker lesion occurred.  A correlation between response and NQO1 and/or glucose transporter 1 expression could not be established.  Conclusions: Intravesical administration of 4 mg/40 mL apaziquone was well tolerated and had ablative activity against superficial bladder cancer marker lesions.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqDpkglZGigurVg90H21EOLACvtfcHk0ljRtlgJmFRxBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bI&md5=f859e0db22ac8899ebd489bb698dd921</span></div><a href="/servlet/linkout?suffix=cit89&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.06.047&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.06.047%26sid%3Dliteratum%253Aachs%26aulast%3DPuri%26aufirst%3DR.%26aulast%3DPalit%26aufirst%3DV.%26aulast%3DLoadman%26aufirst%3DP.%2BM.%26aulast%3DFlannigan%26aufirst%3DM.%26aulast%3DShah%26aufirst%3DT.%26aulast%3DChoudry%26aufirst%3DG.%2BA.%26aulast%3DBasu%26aufirst%3DS.%26aulast%3DDouble%26aufirst%3DJ.%2BA.%26aulast%3DLenaz%26aufirst%3DG.%26aulast%3DChawla%26aufirst%3DS.%26aulast%3DBeer%26aufirst%3DM.%26aulast%3DVan%2BKalken%26aufirst%3DC.%26aulast%3Dde%2BBoer%26aufirst%3DR.%26aulast%3DBeijnen%26aufirst%3DJ.%2BH.%26aulast%3DTwelves%26aufirst%3DC.%2BJ.%26aulast%3DPhillips%26aufirst%3DR.%2BM.%26atitle%3DPhase%2520I%252FII%2520Pilot%2520study%2520of%2520intravesical%2520apaziquone%2520%2528EO9%2529%2520for%2520superficial%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D1344%26epage%3D1348%26doi%3D10.1016%2Fj.juro.2006.06.047" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref90"><div class="reference"><strong class="refLabel"><a href="#ref90" class="rightTabRefNumLink">90</a></strong><div class="NLM_citation" id="rightTab-cit90"><span><span class="NLM_contrib-group"><span class="NLM_string-name">van
der Heijden, A. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moonen, P. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vergunst, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Reijke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Boven, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barten, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Puri, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">van Kalken, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witjes, J. A.</span></span> <span> </span><span class="NLM_article-title">Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>176</i></span>,  <span class="NLM_fpage">1349</span>– <span class="NLM_lpage">1353</span>, discussion 1353 <span class="refDoi"> DOI: 10.1016/j.juro.2006.06.007</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2006.06.007" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16952629" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref90/cit90&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=176&publication_year=2006&pages=1349-1353&author=A.+G.+van%0Ader+Heijdenauthor=P.+M.+Moonenauthor=E.+B.+Cornelauthor=H.+Vergunstauthor=T.+M.+de+Reijkeauthor=E.+van+Bovenauthor=E.+J.+Bartenauthor=R.+Puriauthor=C.+K.+van+Kalkenauthor=J.+A.+Witjes&title=Phase+II+marker+lesion+study+with+intravesical+instillation+of+apaziquone+for+superficial+bladder+cancer%3A+toxicity+and+marker+response&doi=10.1016%2Fj.juro.2006.06.007"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit90R"><div class="casContent"><span class="casTitleNuber">90</span><div class="casTitle"><span class="NLM_cas:atitle">Phase II marker lesion study with intravesical instillation of apaziquone for superficial bladder cancer: toxicity and marker response</span></div><div class="casAuthors">van der Heijden, Antoine G.; Moonen, Paula M. J.; Cornel, Erik B.; Vergunst, Henk; de Reijke, Theo M.; van Boven, Erika; Barten, Evert J.; Puri, Rajiv; van Kalken, Coenraad K.; Witjes, J. Alfred</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">176</span>
        (<span class="NLM_cas:issue">4, Pt. 1</span>),
    <span class="NLM_cas:pages">1349-1353</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">Purpose: We studied the ablative activity of intravesical apaziquone (EOquin) on a papillary marker tumor and detd. the incidence of side effects.  Materials and Methods: A total of 46 patients with multiple pTa or pT1 bladder tumors underwent visible lesion resection except for 1 marker tumor.  Patients were then treated with 6 instillations of apaziquone at weekly intervals.  The response was detd. 2 to 4 wk after the last instillation.  Results: One patient withdrew informed consent and refused the last treatment due to side effects.  A histol. proven complete response was seen in 30 patients.  Progression to invasive stage was not obsd.  Local side effects in this study were comparable to those due to other chemotherapy instillations, such as mitomycin C and epirubicin, but less severe and less frequent compared to those of bacillus Calmette-Guerin instillations.  Conclusions: The histol. complete response rate after 6 consecutive instillations of apaziquone in patients with superficial bladder cancer was 67% (95% CI 51 to 80).  Local side effects were comparable to side effects due to other chemotherapy instillations.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhrNtLpiTLvrVg90H21EOLACvtfcHk0ljRtlgJmFRxBQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCht7bJ&md5=00592547125b60632b80c740024676cc</span></div><a href="/servlet/linkout?suffix=cit90&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2006.06.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2006.06.007%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BHeijden%26aufirst%3DA.%2BG.%26aulast%3DMoonen%26aufirst%3DP.%2BM.%26aulast%3DCornel%26aufirst%3DE.%2BB.%26aulast%3DVergunst%26aufirst%3DH.%26aulast%3Dde%2BReijke%26aufirst%3DT.%2BM.%26aulast%3Dvan%2BBoven%26aufirst%3DE.%26aulast%3DBarten%26aufirst%3DE.%2BJ.%26aulast%3DPuri%26aufirst%3DR.%26aulast%3Dvan%2BKalken%26aufirst%3DC.%2BK.%26aulast%3DWitjes%26aufirst%3DJ.%2BA.%26atitle%3DPhase%2520II%2520marker%2520lesion%2520study%2520with%2520intravesical%2520instillation%2520of%2520apaziquone%2520for%2520superficial%2520bladder%2520cancer%253A%2520toxicity%2520and%2520marker%2520response%26jtitle%3DJ.%2520Urol.%26date%3D2006%26volume%3D176%26spage%3D1349%26epage%3D1353%26doi%3D10.1016%2Fj.juro.2006.06.007" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref91"><div class="reference"><strong class="refLabel"><a href="#ref91" class="rightTabRefNumLink">91</a></strong><div class="NLM_citation" id="rightTab-cit91"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hendricksen, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cornel, E. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">de Reijke, T. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arentsen, H. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chawla, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witjes, J. A.</span></span> <span> </span><span class="NLM_article-title">Phase 2 study of adjuvant intravesical instillations of apaziquone for high risk nonmuscle invasive bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>187</i></span>,  <span class="NLM_fpage">1195</span>– <span class="NLM_lpage">1199</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2011.11.101</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2011.11.101" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=22335860" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref91/cit91&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38Xktlelsb0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=187&publication_year=2012&pages=1195-1199&author=K.+Hendricksenauthor=E.+B.+Cornelauthor=T.+M.+de+Reijkeauthor=H.+C.+Arentsenauthor=S.+Chawlaauthor=J.+A.+Witjes&title=Phase+2+study+of+adjuvant+intravesical+instillations+of+apaziquone+for+high+risk+nonmuscle+invasive+bladder+cancer&doi=10.1016%2Fj.juro.2011.11.101"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit91R"><div class="casContent"><span class="casTitleNuber">91</span><div class="casTitle"><span class="NLM_cas:atitle">Phase 2 Study of Adjuvant Intravesical Instillations of Apaziquone for High Risk Nonmuscle Invasive Bladder Cancer</span></div><div class="casAuthors">Hendricksen, K.; Cornel, E. B.; de Reijke, T. M.; Arentsen, H. C.; Chawla, S.; Witjes, J. A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Urology (New York, NY, United States)</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">187</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1195-1199</span>CODEN:
                <span class="NLM_cas:coden">JOURAA</span>;
        ISSN:<span class="NLM_cas:issn">0022-5347</span>.
    
            (<span class="NLM_cas:orgname">Elsevier</span>)
        </div><div class="casAbstract">We studied the safety and efficacy of multiple adjuvant apaziquone instillations in patients with high risk nonmuscle invasive bladder cancer.  Patients with high risk nonmuscle invasive urothelial carcinoma of the bladder underwent transurethral resection of all bladder tumor(s), and received 6 weekly adjuvant intravesical apaziquone instillations of 4 mg in 40 mL.  Patients with carcinoma in situ received 3 further maintenance instillations at months 3, 6 and 12.  Followup consisted of cystoscopy, urine cytol. and observation of adverse events every 3 mo for 18 mo.  A total of 53 patients were enrolled in the study.  Although all patients were high risk according to the definitions used when the study was initiated, according to most recent guideline criteria, 80% and 20% of these patients would now be considered intermediate and high risk for recurrence, and 50% and 44% would be considered intermediate and high risk for progression, resp.  Intent to treat anal. of 49 patients with papillary tumors showed recurrent tumors in 34.7% and 44.9% at 12 and 18 mo, resp.  One patient had progression to T2 or greater urothelial carcinoma after 9 mo.  There were 4 patients with carcinoma in situ who had complete responses at 3 mo but discontinued treatment due to cystitis, recurrent papillary disease, urinary incontinence and dysuria.  Most other side effects were mild (grade 1 to 2).  Adjuvant intravesical instillations of apaziquone are generally well tolerated.  The recurrence rates of 34.7% after 12 mo and 44.9% after 18 mo in these patients can be considered encouraging, and warrant further study.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhXCHXSxiSLVg90H21EOLACvtfcHk0liMURVF21HLNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xktlelsb0%253D&md5=a05e5b4aea326bdad881760058fd472a</span></div><a href="/servlet/linkout?suffix=cit91&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2011.11.101&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2011.11.101%26sid%3Dliteratum%253Aachs%26aulast%3DHendricksen%26aufirst%3DK.%26aulast%3DCornel%26aufirst%3DE.%2BB.%26aulast%3Dde%2BReijke%26aufirst%3DT.%2BM.%26aulast%3DArentsen%26aufirst%3DH.%2BC.%26aulast%3DChawla%26aufirst%3DS.%26aulast%3DWitjes%26aufirst%3DJ.%2BA.%26atitle%3DPhase%25202%2520study%2520of%2520adjuvant%2520intravesical%2520instillations%2520of%2520apaziquone%2520for%2520high%2520risk%2520nonmuscle%2520invasive%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2012%26volume%3D187%26spage%3D1195%26epage%3D1199%26doi%3D10.1016%2Fj.juro.2011.11.101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref92"><div class="reference"><strong class="refLabel"><a href="#ref92" class="rightTabRefNumLink">92</a></strong><div class="NLM_citation" id="rightTab-cit92"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Karsh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Saltzstein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, M.</span></span> <span> </span><span class="NLM_article-title">Integrated results of two multicenter, randomised, placebo controlled, double blind, phase 3 trials (SPI-611/612) of single dose intravesical apaziquone immediately following resection in patients with nonmuscle invasive bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">e290</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2016.02.847</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2016.02.847" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref92/cit92&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26235377" title="">PubMed</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2016&pages=e290&author=L.+Karshauthor=N.+Shoreauthor=D.+Saltzsteinauthor=G.+Bhatauthor=G.+Reddyauthor=L.+F.+Allenauthor=M.+Soloway&title=Integrated+results+of+two+multicenter%2C+randomised%2C+placebo+controlled%2C+double+blind%2C+phase+3+trials+%28SPI-611%2F612%29+of+single+dose+intravesical+apaziquone+immediately+following+resection+in+patients+with+nonmuscle+invasive+bladder+cancer&doi=10.1016%2Fj.juro.2016.02.847"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit92&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2016.02.847&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2016.02.847%26sid%3Dliteratum%253Aachs%26aulast%3DKarsh%26aufirst%3DL.%26aulast%3DShore%26aufirst%3DN.%26aulast%3DSaltzstein%26aufirst%3DD.%26aulast%3DBhat%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DAllen%26aufirst%3DL.%2BF.%26aulast%3DSoloway%26aufirst%3DM.%26atitle%3DIntegrated%2520results%2520of%2520two%2520multicenter%252C%2520randomised%252C%2520placebo%2520controlled%252C%2520double%2520blind%252C%2520phase%25203%2520trials%2520%2528SPI-611%252F612%2529%2520of%2520single%2520dose%2520intravesical%2520apaziquone%2520immediately%2520following%2520resection%2520in%2520patients%2520with%2520nonmuscle%2520invasive%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2016%26volume%3D195%26spage%3De290%26doi%3D10.1016%2Fj.juro.2016.02.847" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref93"><div class="reference"><strong class="refLabel"><a href="#ref93" class="rightTabRefNumLink">93</a></strong><div class="NLM_citation" id="rightTab-cit93"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Witjes, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karsh, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Soloway, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bhat, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reddy, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Allen, L. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shore, N.</span></span> <span> </span><span class="NLM_article-title">Improved efficacy of adjuvant, single dose intravesical apaziquone by timing post-resection in two double blind, randomised, placebo-controlled phase 3 studies in non-muscle invasive bladder cancer</span>. <i>J. Urol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>195</i></span>,  <span class="NLM_fpage">e136</span>– <span class="NLM_lpage">e137</span>, <span class="refDoi"> DOI: 10.1016/j.juro.2016.02.2488</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref93/cit93&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.juro.2016.02.2488" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=195&publication_year=2016&pages=e136-e137&author=F.+Witjesauthor=L.+Karshauthor=M.+Solowayauthor=G.+Bhatauthor=G.+Reddyauthor=A.+Yangauthor=L.+F.+Allenauthor=N.+Shore&title=Improved+efficacy+of+adjuvant%2C+single+dose+intravesical+apaziquone+by+timing+post-resection+in+two+double+blind%2C+randomised%2C+placebo-controlled+phase+3+studies+in+non-muscle+invasive+bladder+cancer&doi=10.1016%2Fj.juro.2016.02.2488"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit93&amp;dbid=16384&amp;doi=10.1016%2Fj.juro.2016.02.2488&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.juro.2016.02.2488%26sid%3Dliteratum%253Aachs%26aulast%3DWitjes%26aufirst%3DF.%26aulast%3DKarsh%26aufirst%3DL.%26aulast%3DSoloway%26aufirst%3DM.%26aulast%3DBhat%26aufirst%3DG.%26aulast%3DReddy%26aufirst%3DG.%26aulast%3DYang%26aufirst%3DA.%26aulast%3DAllen%26aufirst%3DL.%2BF.%26aulast%3DShore%26aufirst%3DN.%26atitle%3DImproved%2520efficacy%2520of%2520adjuvant%252C%2520single%2520dose%2520intravesical%2520apaziquone%2520by%2520timing%2520post-resection%2520in%2520two%2520double%2520blind%252C%2520randomised%252C%2520placebo-controlled%2520phase%25203%2520studies%2520in%2520non-muscle%2520invasive%2520bladder%2520cancer%26jtitle%3DJ.%2520Urol.%26date%3D2016%26volume%3D195%26spage%3De136%26epage%3De137%26doi%3D10.1016%2Fj.juro.2016.02.2488" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref94"><div class="reference"><strong class="refLabel"><a href="#ref94" class="rightTabRefNumLink">94</a></strong><div class="NLM_citation" id="rightTab-cit94"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Begleiter, A.</span></span> <span> </span><span class="NLM_article-title">Clinical applications of quinone-containing alkylating agents</span>. <i>Front. Biosci., Landmark Ed.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">E153</span>– <span class="NLM_lpage">E171</span>, <span class="refDoi"> DOI: 10.2741/begleit</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2741%2Fbegleit" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11056078" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref94/cit94&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXjsVGqtro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2000&pages=E153-E171&author=A.+Begleiter&title=Clinical+applications+of+quinone-containing+alkylating+agents&doi=10.2741%2Fbegleit"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit94R"><div class="casContent"><span class="casTitleNuber">94</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical applications of quinone-containing alkylating agents</span></div><div class="casAuthors">Begleiter, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Frontiers in Bioscience [Electronic Publication]</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">E153-E171</span>CODEN:
                <span class="NLM_cas:coden">FRBIF6</span>;
        ISSN:<span class="NLM_cas:issn">1093-4715</span>.
    
            (<span class="NLM_cas:orgname">Frontiers in Bioscience</span>)
        </div><div class="casAbstract">A review with refs.  Quinone-contg. alkylating agents are a class of chem. agents that have received considerable interest as anticancer drugs.  These agents contain a quinone moiety that can be reduced and an alkylating group that can form covalent bonds with a variety of cellular components.  The oxidn. state of the quinone element can modulate the activity of the alkylating element, and redn. of the quinone is required for activation of the alkylating activity of many of these agents.  The quinone element may also contribute to the cytotoxic activity of quinone-contg. alkylating agents through the formation of reactive oxygen species during redox cycling.  The natural product, mitomycin C, has been the most widely used quinone-contg. alkylating agent in the clinic, but other quinone-contg. alkylating agents like porfiromycin, diaziquone, carbazilquinone, triaziquone and EO9 have also been used in the clinic for the treatment of cancer.  In addn., many other quinone-contg. alkylating agents have been tested in preclin. studies and the development of new agents is being actively pursued.  This chapter describes the current and past clin. uses of these agents in the treatment of cancer and discusses new agents that are currently in clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqO0N2Cf_Ak_bVg90H21EOLACvtfcHk0liMURVF21HLNw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXjsVGqtro%253D&md5=62df0b3120d910f03782002284630dd9</span></div><a href="/servlet/linkout?suffix=cit94&amp;dbid=16384&amp;doi=10.2741%2Fbegleit&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2741%252Fbegleit%26sid%3Dliteratum%253Aachs%26aulast%3DBegleiter%26aufirst%3DA.%26atitle%3DClinical%2520applications%2520of%2520quinone-containing%2520alkylating%2520agents%26jtitle%3DFront.%2520Biosci.%252C%2520Landmark%2520Ed.%26date%3D2000%26volume%3D5%26spage%3DE153%26epage%3DE171%26doi%3D10.2741%2Fbegleit" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref95"><div class="reference"><strong class="refLabel"><a href="#ref95" class="rightTabRefNumLink">95</a></strong><div class="NLM_citation" id="rightTab-cit95"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hartley, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Relationship between DT-diaphorase-mediated metabolism of a series of aziridinylbenzoquinones and DNA damage and cytotoxicity</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1992</span>,  <span class="NLM_volume"><i>42</i></span>,  <span class="NLM_fpage">531</span>– <span class="NLM_lpage">536</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=1992&pages=531-536&author=N.+W.+Gibsonauthor=J.+A.+Hartleyauthor=J.+Butlerauthor=D.+Siegelauthor=D.+Ross&title=Relationship+between+DT-diaphorase-mediated+metabolism+of+a+series+of+aziridinylbenzoquinones+and+DNA+damage+and+cytotoxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit95&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DHartley%26aufirst%3DJ.%2BA.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRelationship%2520between%2520DT-diaphorase-mediated%2520metabolism%2520of%2520a%2520series%2520of%2520aziridinylbenzoquinones%2520and%2520DNA%2520damage%2520and%2520cytotoxicity%26jtitle%3DMol.%2520Pharmacol.%26date%3D1992%26volume%3D42%26spage%3D531%26epage%3D536" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref96"><div class="reference"><strong class="refLabel"><a href="#ref96" class="rightTabRefNumLink">96</a></strong><div class="NLM_citation" id="rightTab-cit96"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Inayat-Hussain, S. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">RH1 induces cellular damage in an NAD(P)H:quinone oxidoreductase 1-dependent manner: relationship between DNA cross-linking, cell cycle perturbations, and apoptosis</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>313</i></span>,  <span class="NLM_fpage">771</span>– <span class="NLM_lpage">779</span>, <span class="refDoi"> DOI: 10.1124/jpet.104.081380</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fjpet.104.081380" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15665137" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref96/cit96&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXktFemsbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=313&publication_year=2005&pages=771-779&author=D.+L.+Dehnauthor=S.+H.+Inayat-Hussainauthor=D.+Ross&title=RH1+induces+cellular+damage+in+an+NAD%28P%29H%3Aquinone+oxidoreductase+1-dependent+manner%3A+relationship+between+DNA+cross-linking%2C+cell+cycle+perturbations%2C+and+apoptosis&doi=10.1124%2Fjpet.104.081380"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit96R"><div class="casContent"><span class="casTitleNuber">96</span><div class="casTitle"><span class="NLM_cas:atitle">RH1 induces cellular damage in an NAD(P)H:Quinone oxidoreductase 1-dependent manner: Relationship between DNA cross-linking, cell cycle perturbations, and apoptosis</span></div><div class="casAuthors">Dehn, Donna L.; Inayat-Hussain, Salmaan H.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">313</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">771-779</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Structure-based development of NAD(P)H:quinone oxidoreductase (NQO1)-directed antitumor quinones resulted in development of RH1 [2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone], a methyl-substituted diaziridinyl quinone.  We conducted expts. to evaluate the mechanism of RH1-induced cytotoxicity and the inter-relation between DNA crosslinking, cell cycle changes, and apoptosis using an isogenic cell line pair developed from the human breast cancer cell line MDA-MB-468 differing only in expression of wtNQO1 (NQ16 cells).  Statistically significant DNA crosslinking was detected using a modified comet assay in cells with wtNQO1 within 1 h of dosing, whereas in parental cells, only marginal DNA crosslinking was obsd. and required a concn. up to 50 times higher.  Crosslinking in NQ16 cells could be abrogated with 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]indole-4,7-dione, a mechanism-based inhibitor of NQO1.  RH1 prolonged S phase and caused a G2/M block.  Cell cycle changes were obsd. up to 10-fold lower in RH1 concns. in NQ16 cells relative to parental cells.  Apoptosis was similarly obsd. morphol. in both cell lines after RH1 treatment but was induced preferentially in NQ16 cells at lower concns. and earlier time points.  Marked cleavage of caspase-3 was obsd. in NQ16 cells relative to parental cells using lower concns. of RH1.  Temporally, low doses of RH1-induced rapid DNA crosslinking in NQ16 cells followed by induction of apoptosis at times when a G2/M block was not obsd.  This suggests that cell cycle arrest is not required for RH1-induced apoptosis and that DNA damage may directly initiate apoptotic events.  In summary, RH1-induced preferential DNA crosslinking, cell cycle changes, and apoptosis in an NQO1-dependent manner.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo5pcs4j94ByrVg90H21EOLACvtfcHk0lhUbQy3tuEb0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXktFemsbo%253D&md5=931768a4fd9a12d979dd270e23c9c3de</span></div><a href="/servlet/linkout?suffix=cit96&amp;dbid=16384&amp;doi=10.1124%2Fjpet.104.081380&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.104.081380%26sid%3Dliteratum%253Aachs%26aulast%3DDehn%26aufirst%3DD.%2BL.%26aulast%3DInayat-Hussain%26aufirst%3DS.%2BH.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRH1%2520induces%2520cellular%2520damage%2520in%2520an%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201-dependent%2520manner%253A%2520relationship%2520between%2520DNA%2520cross-linking%252C%2520cell%2520cycle%2520perturbations%252C%2520and%2520apoptosis%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2005%26volume%3D313%26spage%3D771%26epage%3D779%26doi%3D10.1124%2Fjpet.104.081380" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref97"><div class="reference"><strong class="refLabel"><a href="#ref97" class="rightTabRefNumLink">97</a></strong><div class="NLM_citation" id="rightTab-cit97"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dehn, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Winski, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Development of a new isogenic cell-xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2004</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">3147</span>– <span class="NLM_lpage">3155</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-03-0411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-03-0411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15131056" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref97/cit97&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXjs12lt78%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2004&pages=3147-3155&author=D.+L.+Dehnauthor=S.+L.+Winskiauthor=D.+Ross&title=Development+of+a+new+isogenic+cell-xenograft+system+for+evaluation+of+NAD%28P%29H%3Aquinone+oxidoreductase-directed+antitumor+quinones%3A+evaluation+of+the+activity+of+RH1&doi=10.1158%2F1078-0432.CCR-03-0411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit97R"><div class="casContent"><span class="casTitleNuber">97</span><div class="casTitle"><span class="NLM_cas:atitle">Development of a new isogenic cell-Xenograft system for evaluation of NAD(P)H:quinone oxidoreductase-directed antitumor quinones: evaluation of the activity of RH1</span></div><div class="casAuthors">Dehn, Donna L.; Winski, Shannon L.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">3147-3155</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of our study was to develop and validate an isogenic cell line pair that differs only in the expression of NAD(P)H:quinone oxidoreductase (NQO1) that can be used to examine the in vitro and in vivo role of NQO1 in the bioactivation of the antitumor quinone RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), a compd. currently in Phase I clin. trials.  MDA-MB-468 (MDA468) human breast adenocarcinoma cells, homozygous for a polymorphism in NQO1 (NQO1*2/*2) and with low levels of NQO1 activity, were stably transfected with human NQO1 to generate a clone (NQ16) expressing very high NQO1 activity.  We examd. levels of other reductases and looked at biochem. systems that might influence response to antitumor quinones to validate that the isogenic cell line pair differed only in the expression of NQO1.  The 3-(4,5-dimethylthiazol-2,5-diphenyl)tetrazolium (MTT) assay was used to det. the differential toxicity of various quinones, including the most recent NQO1-directed antitumor quinone, RH1, between the two cell lines.  Human tumor xenografts were established from both MDA468 and NQ16 cells, and the antitumor activity of RH1 was evaluated.  Levels of cytochrome P 450 reductase, cytochrome b5 reductase, sol. thiols, and superoxide dismutase in the NQ16 line were unchanged from the parental line.  The functional significance of wild-type NQO1 expression was confirmed by measurement of the differential toxicity of compds. activated or deactivated by NQO1 in the two cell lines.  The toxicity of the NQO1-directed antitumor quinones RH1 and streptonigrin were markedly greater and the toxicity of menadione, which is detoxified by NQO1, was ameliorated in the NQ16 line.  High levels of NQO1 expression were obsd. throughout xenograft tumors established from the NQ16 cell line.  RH1 treatment was effective at statistically reducing tumor vol. in NQ16 xenografts at all of the doses tested (0.1, 0.2, 0.4 mg/kg every day for 5 days), whereas only the highest dose of RH1 resulted in a significant redn. in tumor vol. in MDA468 xenografts.  The MDA468/NQ16 isogenic cell line pair is a useful model system for evaluating the role of NQO1 in the bioactivation of antitumor quinones in both cell lines and xenografts.  In addn., our data demonstrate that the novel antitumor quinone RH1, is effectively activated by NQO1 both in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR1vAcNs2a37Vg90H21EOLACvtfcHk0lhUbQy3tuEb0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXjs12lt78%253D&md5=a8fabfa67a288d88b999b98266f1290d</span></div><a href="/servlet/linkout?suffix=cit97&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-03-0411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-03-0411%26sid%3Dliteratum%253Aachs%26aulast%3DDehn%26aufirst%3DD.%2BL.%26aulast%3DWinski%26aufirst%3DS.%2BL.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DDevelopment%2520of%2520a%2520new%2520isogenic%2520cell-xenograft%2520system%2520for%2520evaluation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase-directed%2520antitumor%2520quinones%253A%2520evaluation%2520of%2520the%2520activity%2520of%2520RH1%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2004%26volume%3D10%26spage%3D3147%26epage%3D3155%26doi%3D10.1158%2F1078-0432.CCR-03-0411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref98"><div class="reference"><strong class="refLabel"><a href="#ref98" class="rightTabRefNumLink">98</a></strong><div class="NLM_citation" id="rightTab-cit98"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ritchie, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Butler, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Langdon, S.</span></span> <span> </span><span class="NLM_article-title">Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts</span>. <i>Anticancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3979</span>– <span class="NLM_lpage">3983</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=14666706" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref98/cit98&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2cXkvFGg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2003&pages=3979-3983&author=J.+Cummingsauthor=A.+Ritchieauthor=J.+Butlerauthor=T.+H.+Wardauthor=S.+Langdon&title=Activity+profile+of+the+novel+aziridinylbenzoquinones+MeDZQ+and+RH1+in+human+tumour+xenografts"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit98R"><div class="casContent"><span class="casTitleNuber">98</span><div class="casTitle"><span class="NLM_cas:atitle">Activity profile of the novel aziridinylbenzoquinones MeDZQ and RH1 in human tumour xenografts</span></div><div class="casAuthors">Cummings, Jeffrey; Ritchie, Alison; Butler, John; Ward, Timothy H.; Langdon, Simon</div><div class="citationInfo"><span class="NLM_cas:title">Anticancer Research</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">5A</span>),
    <span class="NLM_cas:pages">3979-3983</span>CODEN:
                <span class="NLM_cas:coden">ANTRD4</span>;
        ISSN:<span class="NLM_cas:issn">0250-7005</span>.
    
            (<span class="NLM_cas:orgname">International Institute of Anticancer Research</span>)
        </div><div class="casAbstract">RH1 and MeDZQ represent novel aziridinylbenzoquinones that can be activated by DT-diaphorase to form unique DNA lesions.  RH1 is due to enter a phase I clin. trial in the United Kingdom in the summer of 2003, where pharmacodynamic monitoring of DT-diaphorase will be performed.  The antitumor efficacy of RH1 and MeDZQ has been studied in 4 human xenografts (3 non-small cell lung cancer and 1 colon cancer), and compared to the level of constitutive DT-Diaphorase activity measured by the DCPIP assay.  The 4 xenografts exhibited a wide range of DT-diaphorase activity (4.8 - 303 nmol/min/mg).  Greater antitumor activity was recorded in the xenografts expressing high levels of DT-diaphorase (e.g. NX002, DT-diaphorase activity, 303 ± 52 nmol/min/mg, T/C to MeDZQ, 33.3% and to RH1, 43.4%).  These data add in vivo support to a role for DT-Diaphorase in the antitumor activity of RH1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMW_a0bkqCA7Vg90H21EOLACvtfcHk0lhUbQy3tuEb0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2cXkvFGg&md5=e571c319c682e56af271fb8a5e756b81</span></div><a href="/servlet/linkout?suffix=cit98&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DRitchie%26aufirst%3DA.%26aulast%3DButler%26aufirst%3DJ.%26aulast%3DWard%26aufirst%3DT.%2BH.%26aulast%3DLangdon%26aufirst%3DS.%26atitle%3DActivity%2520profile%2520of%2520the%2520novel%2520aziridinylbenzoquinones%2520MeDZQ%2520and%2520RH1%2520in%2520human%2520tumour%2520xenografts%26jtitle%3DAnticancer%2520Res.%26date%3D2003%26volume%3D23%26spage%3D3979%26epage%3D3983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref99"><div class="reference"><strong class="refLabel"><a href="#ref99" class="rightTabRefNumLink">99</a></strong><div class="NLM_citation" id="rightTab-cit99"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hussein, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holt, S. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brookes, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Klymenko, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adamski, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hogg, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Estlin, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Makin, G. W.</span></span> <span> </span><span class="NLM_article-title">Preclinical efficacy of the bioreductive alkylating agent RH1 against paediatric tumours</span>. <i>Br. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>101</i></span>,  <span class="NLM_fpage">55</span>– <span class="NLM_lpage">63</span>, <span class="refDoi"> DOI: 10.1038/sj.bjc.6605100</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fsj.bjc.6605100" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19491903" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref99/cit99&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXotVKgurk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=101&publication_year=2009&pages=55-63&author=D.+Husseinauthor=S.+V.+Holtauthor=K.+E.+Brookesauthor=T.+Klymenkoauthor=J.+K.+Adamskiauthor=A.+Hoggauthor=E.+J.+Estlinauthor=T.+Wardauthor=C.+Diveauthor=G.+W.+Makin&title=Preclinical+efficacy+of+the+bioreductive+alkylating+agent+RH1+against+paediatric+tumours&doi=10.1038%2Fsj.bjc.6605100"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit99R"><div class="casContent"><span class="casTitleNuber">99</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical efficacy of the bioreductive alkylating agent RH1 against pediatric tumors</span></div><div class="casAuthors">Hussein, D.; Holt, S. V.; Brookes, K. E.; Klymenko, T.; Adamski, J. K.; Hogg, A.; Estlin, E. J.; Ward, T.; Dive, C.; Makin, G. W. J.</div><div class="citationInfo"><span class="NLM_cas:title">British Journal of Cancer</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">101</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">55-63</span>CODEN:
                <span class="NLM_cas:coden">BJCAAI</span>;
        ISSN:<span class="NLM_cas:issn">0007-0920</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Background: Despite substantial improvements in childhood cancer survival, drug resistance remains problematic for several pediatric tumor types.  The urgent need to access novel agents to treat drug-resistant disease should be expedited by pre-clin. evaluation of pediatric tumor models during the early stages of drug development in adult cancer patients.  Methods/results: The novel cytotoxic RH1 (2,5-diaziridinyl-3-[hydroxymethyl]-6-methyl-1,4-benzoquinone) is activated by the obligate two-electron reductase DT-diaphorase (DTD, widely expressed in adult tumor cells) to a potent DNA interstrand cross-linker.  In acute viability assays against neuroblastoma, osteosarcoma, and Ewing's sarcoma cell lines RH1 IC50 values ranged from 1-200 n and drug potency correlated both with DTD levels and drug-induced apoptosis.  However, synergy between RH1 and cisplatin or doxorubicin was only seen in low DTD expressing cell lines.  In clonogenic assays RH1 IC50 values ranged from 1.5-7.5 n and drug potency did not correlate with DTD level.  In A673 Ewing's sarcoma and 791T osteosarcoma tumor xenografts in mice RH1 induced apoptosis 24 h after a single bolus injection (0.4 mg/kg) and daily dosing for 5 days delayed tumor growth relative to control.  Conclusion: The demonstration of RH1 efficacy against pediatric tumor cell lines, which was performed concurrently with the adult Phase 1 Trial, suggests that this agent may have clin. usefulness in childhood cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpLNe86t5klI7Vg90H21EOLACvtfcHk0liuHwglaIm2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXotVKgurk%253D&md5=4dbafa0ae2db4636bd17fd7b50e3d779</span></div><a href="/servlet/linkout?suffix=cit99&amp;dbid=16384&amp;doi=10.1038%2Fsj.bjc.6605100&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsj.bjc.6605100%26sid%3Dliteratum%253Aachs%26aulast%3DHussein%26aufirst%3DD.%26aulast%3DHolt%26aufirst%3DS.%2BV.%26aulast%3DBrookes%26aufirst%3DK.%2BE.%26aulast%3DKlymenko%26aufirst%3DT.%26aulast%3DAdamski%26aufirst%3DJ.%2BK.%26aulast%3DHogg%26aufirst%3DA.%26aulast%3DEstlin%26aufirst%3DE.%2BJ.%26aulast%3DWard%26aufirst%3DT.%26aulast%3DDive%26aufirst%3DC.%26aulast%3DMakin%26aufirst%3DG.%2BW.%26atitle%3DPreclinical%2520efficacy%2520of%2520the%2520bioreductive%2520alkylating%2520agent%2520RH1%2520against%2520paediatric%2520tumours%26jtitle%3DBr.%2520J.%2520Cancer%26date%3D2009%26volume%3D101%26spage%3D55%26epage%3D63%26doi%3D10.1038%2Fsj.bjc.6605100" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref100"><div class="reference"><strong class="refLabel"><a href="#ref100" class="rightTabRefNumLink">100</a></strong><div class="NLM_citation" id="rightTab-cit100"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Danson, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ward, T. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dawson, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Denneny, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dickinson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Aarons, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Watson, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jowle, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cummings, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Robson, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Halbert, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dive, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ranson</span></span> <span> </span><span class="NLM_article-title">Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1</span>. <i>Ann. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>22</i></span>,  <span class="NLM_fpage">1653</span>– <span class="NLM_lpage">1660</span>, <span class="refDoi"> DOI: 10.1093/annonc/mdq638</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1093%2Fannonc%2Fmdq638" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21378203" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref100/cit100&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC3Mnjt1CqtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2011&pages=1653-1660&author=S.+Dansonauthor=P.+Johnsonauthor=T.+H.+Wardauthor=M.+Dawsonauthor=O.+Dennenyauthor=G.+Dickinsonauthor=L.+Aaronsauthor=A.+Watsonauthor=D.+Jowleauthor=J.+Cummingsauthor=L.+Robsonauthor=G.+Halbertauthor=C.+Diveauthor=+Ranson&title=Phase+I+pharmacokinetic+and+pharmacodynamic+study+of+the+bioreductive+drug+RH1&doi=10.1093%2Fannonc%2Fmdq638"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit100R"><div class="casContent"><span class="casTitleNuber">100</span><div class="casTitle"><span class="NLM_cas:atitle">Phase I pharmacokinetic and pharmacodynamic study of the bioreductive drug RH1</span></div><div class="casAuthors">Danson S J; Johnson P; Ward T H; Dawson M; Denneny O; Dickinson G; Aarons L; Watson A; Jowle D; Cummings J; Robson L; Halbert G; Dive C; Ranson M</div><div class="citationInfo"><span class="NLM_cas:title">Annals of oncology : official journal of the European Society for Medical Oncology</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">22</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1653-60</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">BACKGROUND:  This trial describes a first-in-man evaluation of RH1, a novel bioreductive drug activated by DT-diaphorase (DTD), an enzyme overexpressed in many tumours.  PATIENTS AND METHODS:  A dose-escalation phase I trial of RH1 was carried out.  The primary objective was to establish the maximum tolerated dose (MTD) of RH1.  Secondary objectives were assessment of toxicity, pharmacokinetic determination of RH1 and pharmacodynamic assessment of drug effect through measurement of DNA cross linking in peripheral blood mononuclear cells (PBMCs) and tumour, DTD activity in tumour and NAD(P)H:quinone oxidoreductase 1 (NQO1) polymorphism status.  RESULTS:  Eighteen patients of World Health Organization performance status of zero to one with advanced refractory solid malignancies were enrolled.  MTD was 1430 μg/m(2)/day with reversible bone marrow suppression being dose limiting.  Plasma pharmacokinetic analysis showed RH1 is rapidly cleared from blood (t(1/2) = 12.3 min), with AUC increasing proportionately with dose.  The comet-X assay demonstrated dose-related increases in DNA cross linking in PBMCs.  DNA cross linking was demonstrated in tumours, even with low levels of DTD.  Only one patient was homozygous for NQO1 polymorphism precluding any conclusion of its effect.  CONCLUSIONS:  RH1 was well tolerated with predictable and manageable toxicity.  The MTD of 1430 μg/m(2)/day is the dose recommended for phase II trials.  The biomarkers of DNA cross linking, DTD activity and NQO1 status have been validated and clinically developed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDwcYCS4u1vCEJCPKhJPuqfW6udTcc2ebUJ2CU7VR6Srntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC3Mnjt1CqtQ%253D%253D&md5=9ce5b5fd64e831a56ec49497c5743bcd</span></div><a href="/servlet/linkout?suffix=cit100&amp;dbid=16384&amp;doi=10.1093%2Fannonc%2Fmdq638&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1093%252Fannonc%252Fmdq638%26sid%3Dliteratum%253Aachs%26aulast%3DDanson%26aufirst%3DS.%26aulast%3DJohnson%26aufirst%3DP.%26aulast%3DWard%26aufirst%3DT.%2BH.%26aulast%3DDawson%26aufirst%3DM.%26aulast%3DDenneny%26aufirst%3DO.%26aulast%3DDickinson%26aufirst%3DG.%26aulast%3DAarons%26aufirst%3DL.%26aulast%3DWatson%26aufirst%3DA.%26aulast%3DJowle%26aufirst%3DD.%26aulast%3DCummings%26aufirst%3DJ.%26aulast%3DRobson%26aufirst%3DL.%26aulast%3DHalbert%26aufirst%3DG.%26aulast%3DDive%26aufirst%3DC.%26aulast%3DRanson%26atitle%3DPhase%2520I%2520pharmacokinetic%2520and%2520pharmacodynamic%2520study%2520of%2520the%2520bioreductive%2520drug%2520RH1%26jtitle%3DAnn.%2520Oncol.%26date%3D2011%26volume%3D22%26spage%3D1653%26epage%3D1660%26doi%3D10.1093%2Fannonc%2Fmdq638" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref101"><div class="reference"><strong class="refLabel"><a href="#ref101" class="rightTabRefNumLink">101</a></strong><div class="NLM_citation" id="rightTab-cit101"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hasinoff, B. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Begleiter, A.</span></span> <span> </span><span class="NLM_article-title">The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells</span>. <i>Free Radical Res.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>40</i></span>,  <span class="NLM_fpage">974</span>– <span class="NLM_lpage">978</span>, <span class="refDoi"> DOI: 10.1080/10715760600833077</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1080%2F10715760600833077" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=17015278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref101/cit101&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28XhtVCjtLzK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2006&pages=974-978&author=B.+B.+Hasinoffauthor=A.+Begleiter&title=The+reductive+activation+of+the+antitumor+drug+RH1+to+its+semiquinone+free+radical+by+NADPH+cytochrome+P450+reductase+and+by+HCT116+human+colon+cancer+cells&doi=10.1080%2F10715760600833077"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit101R"><div class="casContent"><span class="casTitleNuber">101</span><div class="casTitle"><span class="NLM_cas:atitle">The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells</span></div><div class="casAuthors">Hasinoff, Brian B.; Begleiter, Asher</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Research</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">974-978</span>CODEN:
                <span class="NLM_cas:coden">FRARER</span>;
        ISSN:<span class="NLM_cas:issn">1071-5762</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">RH1 (2,5-diaziridinyl-3-(hydroxymethyl)-6-methyl-1,4-benzoquinone), which is currently in clin. trials, is a diaziridinyl benzoquinone bioreductive anticancer drug that was designed to be activated by the obligate two-electron reductive enzyme NAD(P)H quinone oxidoreductase 1 (NQO1).  In this ESR study we showed that RH1 was reductively activated by the one-electron reductive enzyme NADPH cytochrome P 450 reductase and by a suspension of HCT116 human colon cancer cells to yield a semiquinone free radical.  As shown by EPR spin trapping expts. RH1 was reductively activated by cytochrome P 450 reductase and underwent redox cycling to produce damaging hydroxyl radicals in reactions that were both H2O2- and iron-dependent.  Thus, reductive activation by cytochrome P 450 reductase or other reductases to produce a semiquinone that can redox cycle to produce damaging hydroxyl radicals and/or DNA-reactive alkylating species may contribute to the potent cell growth inhibitory effects of RH1.  These results also suggest that selection of patients for treatment with RH1 based on their expression levels of NQO1 may be problematic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqESpeJCj4VYLVg90H21EOLACvtfcHk0liuHwglaIm2rQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28XhtVCjtLzK&md5=d7c4623ed36cba7e63d7e83140024d0c</span></div><a href="/servlet/linkout?suffix=cit101&amp;dbid=16384&amp;doi=10.1080%2F10715760600833077&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F10715760600833077%26sid%3Dliteratum%253Aachs%26aulast%3DHasinoff%26aufirst%3DB.%2BB.%26aulast%3DBegleiter%26aufirst%3DA.%26atitle%3DThe%2520reductive%2520activation%2520of%2520the%2520antitumor%2520drug%2520RH1%2520to%2520its%2520semiquinone%2520free%2520radical%2520by%2520NADPH%2520cytochrome%2520P450%2520reductase%2520and%2520by%2520HCT116%2520human%2520colon%2520cancer%2520cells%26jtitle%3DFree%2520Radical%2520Res.%26date%3D2006%26volume%3D40%26spage%3D974%26epage%3D978%26doi%3D10.1080%2F10715760600833077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref102"><div class="reference"><strong class="refLabel"><a href="#ref102" class="rightTabRefNumLink">102</a></strong><div class="NLM_citation" id="rightTab-cit102"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Stratford, I. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Dissecting the role of multiple reductases in bioactivation and cytotoxicity of the antitumor agent RH1</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>74</i></span>,  <span class="NLM_fpage">1657</span>– <span class="NLM_lpage">1665</span>, <span class="refDoi"> DOI: 10.1124/mol.108.050401</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref102/cit102&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.108.050401" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=2008&pages=1657-1665&author=C.+Yanauthor=J.+K.+Kepaauthor=D.+Siegelauthor=I.+J.+Stratfordauthor=D.+Ross&title=Dissecting+the+role+of+multiple+reductases+in+bioactivation+and+cytotoxicity+of+the+antitumor+agent+RH1&doi=10.1124%2Fmol.108.050401"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit102&amp;dbid=16384&amp;doi=10.1124%2Fmol.108.050401&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.108.050401%26sid%3Dliteratum%253Aachs%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DStratford%26aufirst%3DI.%2BJ.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DDissecting%2520the%2520role%2520of%2520multiple%2520reductases%2520in%2520bioactivation%2520and%2520cytotoxicity%2520of%2520the%2520antitumor%2520agent%2520RH1%26jtitle%3DMol.%2520Pharmacol.%26date%3D2008%26volume%3D74%26spage%3D1657%26epage%3D1665%26doi%3D10.1124%2Fmol.108.050401" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref103"><div class="reference"><strong class="refLabel"><a href="#ref103" class="rightTabRefNumLink">103</a></strong><div class="NLM_citation" id="rightTab-cit103"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Trepel, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mollapour, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Giaccone, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Neckers, L.</span></span> <span> </span><span class="NLM_article-title">Targeting the dynamic HSP90 complex in cancer</span>. <i>Nat. Rev. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">537</span>– <span class="NLM_lpage">549</span>, <span class="refDoi"> DOI: 10.1038/nrc2887</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fnrc2887" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20651736" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref103/cit103&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=537-549&author=J.+Trepelauthor=M.+Mollapourauthor=G.+Giacconeauthor=L.+Neckers&title=Targeting+the+dynamic+HSP90+complex+in+cancer&doi=10.1038%2Fnrc2887"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit103R"><div class="casContent"><span class="casTitleNuber">103</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting the dynamic HSP90 complex in cancer</span></div><div class="casAuthors">Trepel, Jane; Mollapour, Mehdi; Giaccone, Giuseppe; Neckers, Len</div><div class="citationInfo"><span class="NLM_cas:title">Nature Reviews Cancer</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">537-549</span>CODEN:
                <span class="NLM_cas:coden">NRCAC4</span>;
        ISSN:<span class="NLM_cas:issn">1474-175X</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">A review.  The mol. chaperone, heat-shock protein 90 (HSP90), has been used by cancer cells to facilitate the function of numerous oncoproteins, and it can be argued that cancer cells are 'addicted' to HSP90.  However, although recent reports of the early clin. efficacy of HSP90 inhibitors are encouraging, the optimal use of HSP90-targeted therapeutics will depend on understanding the complexity of HSP90 regulation and the degree to which HSP90 participates in both neoplastic and normal cellular physiol.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGprGEqkx6m7p7Vg90H21EOLACvtfcHk0lglXscrHZNGmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpt1GjtLs%253D&md5=8acba020073ebb93cf1dee577420dc32</span></div><a href="/servlet/linkout?suffix=cit103&amp;dbid=16384&amp;doi=10.1038%2Fnrc2887&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fnrc2887%26sid%3Dliteratum%253Aachs%26aulast%3DTrepel%26aufirst%3DJ.%26aulast%3DMollapour%26aufirst%3DM.%26aulast%3DGiaccone%26aufirst%3DG.%26aulast%3DNeckers%26aufirst%3DL.%26atitle%3DTargeting%2520the%2520dynamic%2520HSP90%2520complex%2520in%2520cancer%26jtitle%3DNat.%2520Rev.%2520Cancer%26date%3D2010%26volume%3D10%26spage%3D537%26epage%3D549%26doi%3D10.1038%2Fnrc2887" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref104"><div class="reference"><strong class="refLabel"><a href="#ref104" class="rightTabRefNumLink">104</a></strong><div class="NLM_citation" id="rightTab-cit104"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zirrolli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Formation of 17-allylamino-demethoxygeldanamycin (17-AAG) hydroquinone by NAD(P)H:quinone oxidoreductase 1: role of 17-AAG hydroquinone in heat shock protein 90 inhibition</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>65</i></span>,  <span class="NLM_fpage">10006</span>– <span class="NLM_lpage">10015</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-05-2029</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref104/cit104&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-05-2029" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=65&publication_year=2005&pages=10006-10015&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=J.+Zirrolliauthor=D.+Gustafsonauthor=D.+Ross&title=Formation+of+17-allylamino-demethoxygeldanamycin+%2817-AAG%29+hydroquinone+by+NAD%28P%29H%3Aquinone+oxidoreductase+1%3A+role+of+17-AAG+hydroquinone+in+heat+shock+protein+90+inhibition&doi=10.1158%2F0008-5472.CAN-05-2029"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit104&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-05-2029&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-05-2029%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DZirrolli%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DFormation%2520of%252017-allylamino-demethoxygeldanamycin%2520%252817-AAG%2529%2520hydroquinone%2520by%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%253A%2520role%2520of%252017-AAG%2520hydroquinone%2520in%2520heat%2520shock%2520protein%252090%2520inhibition%26jtitle%3DCancer%2520Res.%26date%3D2005%26volume%3D65%26spage%3D10006%26epage%3D10015%26doi%3D10.1158%2F0008-5472.CAN-05-2029" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref105"><div class="reference"><strong class="refLabel"><a href="#ref105" class="rightTabRefNumLink">105</a></strong><div class="NLM_citation" id="rightTab-cit105"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zirrolli, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gustafson, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">The bioreduction of a series of benzoquinone ansamycins by NAD(P)H:quinone oxidoreductase 1 to more potent heat shock protein 90 inhibitors, the hydroquinone ansamycins</span>. <i>Mol. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">1194</span>– <span class="NLM_lpage">1203</span>, <span class="refDoi"> DOI: 10.1124/mol.106.025643</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref105/cit105&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fmol.106.025643" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2006&pages=1194-1203&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=J.+Zirrolliauthor=D.+Gustafsonauthor=D.+Ross&title=The+bioreduction+of+a+series+of+benzoquinone+ansamycins+by+NAD%28P%29H%3Aquinone+oxidoreductase+1+to+more+potent+heat+shock+protein+90+inhibitors%2C+the+hydroquinone+ansamycins&doi=10.1124%2Fmol.106.025643"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit105&amp;dbid=16384&amp;doi=10.1124%2Fmol.106.025643&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fmol.106.025643%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DZirrolli%26aufirst%3DJ.%26aulast%3DGustafson%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DThe%2520bioreduction%2520of%2520a%2520series%2520of%2520benzoquinone%2520ansamycins%2520by%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520to%2520more%2520potent%2520heat%2520shock%2520protein%252090%2520inhibitors%252C%2520the%2520hydroquinone%2520ansamycins%26jtitle%3DMol.%2520Pharmacol.%26date%3D2006%26volume%3D70%26spage%3D1194%26epage%3D1203%26doi%3D10.1124%2Fmol.106.025643" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref106"><div class="reference"><strong class="refLabel"><a href="#ref106" class="rightTabRefNumLink">106</a></strong><div class="NLM_citation" id="rightTab-cit106"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kasai, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arakawa, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Okubo, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shigeeda, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yasuhira, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Masuda, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Akasaka, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shibazaki, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Maesawa, C.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone Oxidoreductase-1 expression sensitizes malignant melanoma cells to the HSP90 inhibitor 17-AAG</span>. <i>PLoS One</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">e0153181</span>, <span class="refDoi"> DOI: 10.1371/journal.pone.0153181</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref106/cit106&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1371%2Fjournal.pone.0153181" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=e0153181&author=S.+Kasaiauthor=N.+Arakawaauthor=A.+Okuboauthor=W.+Shigeedaauthor=S.+Yasuhiraauthor=T.+Masudaauthor=T.+Akasakaauthor=M.+Shibazakiauthor=C.+Maesawa&title=NAD%28P%29H%3Aquinone+Oxidoreductase-1+expression+sensitizes+malignant+melanoma+cells+to+the+HSP90+inhibitor+17-AAG&doi=10.1371%2Fjournal.pone.0153181"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit106&amp;dbid=16384&amp;doi=10.1371%2Fjournal.pone.0153181&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1371%252Fjournal.pone.0153181%26sid%3Dliteratum%253Aachs%26aulast%3DKasai%26aufirst%3DS.%26aulast%3DArakawa%26aufirst%3DN.%26aulast%3DOkubo%26aufirst%3DA.%26aulast%3DShigeeda%26aufirst%3DW.%26aulast%3DYasuhira%26aufirst%3DS.%26aulast%3DMasuda%26aufirst%3DT.%26aulast%3DAkasaka%26aufirst%3DT.%26aulast%3DShibazaki%26aufirst%3DM.%26aulast%3DMaesawa%26aufirst%3DC.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520Oxidoreductase-1%2520expression%2520sensitizes%2520malignant%2520melanoma%2520cells%2520to%2520the%2520HSP90%2520inhibitor%252017-AAG%26jtitle%3DPLoS%2520One%26date%3D2016%26volume%3D11%26spage%3De0153181%26doi%3D10.1371%2Fjournal.pone.0153181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref107"><div class="reference"><strong class="refLabel"><a href="#ref107" class="rightTabRefNumLink">107</a></strong><div class="NLM_citation" id="rightTab-cit107"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shieh, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kepa, J. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells</span>. <i>J. Pharmacol. Exp. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>336</i></span>,  <span class="NLM_fpage">874</span>– <span class="NLM_lpage">880</span>, <span class="refDoi"> DOI: 10.1124/jpet.110.176438</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fjpet.110.176438" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21156818" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref107/cit107&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXivVKqt7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=336&publication_year=2011&pages=874-880&author=D.+Siegelauthor=B.+Shiehauthor=C.+Yanauthor=J.+K.+Kepaauthor=D.+Ross&title=Role+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+and+manganese-dependent+superoxide+dismutase+in+17-%28allylamino%29-17-demethoxygeldanamycin-induced+heat+shock+protein+90+inhibition+in+pancreatic+cancer+cells&doi=10.1124%2Fjpet.110.176438"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit107R"><div class="casContent"><span class="casTitleNuber">107</span><div class="casTitle"><span class="NLM_cas:atitle">Role for NAD(P)H:quinone oxidoreductase 1 and manganese-dependent superoxide dismutase in 17-(allylamino)-17-demethoxygeldanamycin-induced heat shock protein 90 inhibition in pancreatic cancer cells</span></div><div class="casAuthors">Siegel, David; Shieh, Biehuoy; Yan, Chao; Kepa, Jadwiga K.; Ross, David</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">336</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">874-880</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">0022-3565</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Previous work demonstrated that NAD(P)H:quinone oxidoreductase 1 (NQO1) metabolized the heat shock protein 90 (Hsp90) inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17AAG) to the corresponding hydroquinone (17AAGH2).  The formation of 17AAGH2 by NQO1 results in a mol. that binds with greater affinity to Hsp90 compared with the parent quinone.  17AAG induced substantial growth inhibition in human pancreatic cancer cell lines expressing NQO1.  Growth inhibition induced by 17AAG could be reduced by pretreatment with 5-methoxy-1,2-dimethyl-3-[(4-nitrophenoxy)methyl]-indole-4,7-dione (ES936), a mechanism-based inhibitor of NQO1.  After treatment with 17AAG, biomarkers of Hsp90 inhibition, including markers of cell-cycle arrest, were more pronounced in NQO1-expressing cells compared with NQO1-null cells.  The intracellular concns. of 17AAG and 17AAGH2 were measured in human pancreatic cancer cells, and it was obsd. that larger amts. of 17AAG and 17AAGH2 could be detected in cells with catalytically active NQO1 compared with cells lacking NQO1 activity or cells pretreated with ES936.  These data demonstrate that, in addn. to generating an inhibitor with greater affinity for Hsp90 (17AAGH2), redn. of 17AAG to 17AAGH2 by NQO1 leads to substantially greater intracellular concns. of 17AAG and 17AAGH2.  In addn., oxidn. of 17AAGH2 could be prevented by superoxide dismutase (SOD), demonstrating that 17AAGH2 was sensitive to oxidn. by superoxide.  Stable transfection of manganese-dependent SOD into MiaPaCa-2 cells resulted in a significantly greater intracellular concn. of 17AAGH2 with a corresponding increase in growth inhibitory activity.  These data confirm the role of NQO1 in sensitivity to 17AAG and demonstrate that SOD functions in conjunction with NQO1 to maintain intracellular levels of 17AAGH2, the active Hsp90 inhibitor derived from 17AAG.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpwp58rWRMZirVg90H21EOLACvtfcHk0lglXscrHZNGmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXivVKqt7c%253D&md5=c94b89d8ab2a9bdb6ceee342e94b852a</span></div><a href="/servlet/linkout?suffix=cit107&amp;dbid=16384&amp;doi=10.1124%2Fjpet.110.176438&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.110.176438%26sid%3Dliteratum%253Aachs%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DShieh%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DC.%26aulast%3DKepa%26aufirst%3DJ.%2BK.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRole%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520and%2520manganese-dependent%2520superoxide%2520dismutase%2520in%252017-%2528allylamino%2529-17-demethoxygeldanamycin-induced%2520heat%2520shock%2520protein%252090%2520inhibition%2520in%2520pancreatic%2520cancer%2520cells%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2011%26volume%3D336%26spage%3D874%26epage%3D880%26doi%3D10.1124%2Fjpet.110.176438" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref108"><div class="reference"><strong class="refLabel"><a href="#ref108" class="rightTabRefNumLink">108</a></strong><div class="NLM_citation" id="rightTab-cit108"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Behrsing, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Amin, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ip, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jimenez, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tyson, C. A.</span></span> <span> </span><span class="NLM_article-title">In vitro detection of differential and cell-specific hepatobiliary toxicity induced by geldanamycin and 17-allylaminogeldanamycin in rats</span>. <i>Toxicol. In Vitro</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">1079</span>– <span class="NLM_lpage">1088</span>, <span class="refDoi"> DOI: 10.1016/j.tiv.2005.06.033</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref108/cit108&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.tiv.2005.06.033" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2005&pages=1079-1088&author=H.+P.+Behrsingauthor=K.+Aminauthor=C.+Ipauthor=L.+Jimenezauthor=C.+A.+Tyson&title=In+vitro+detection+of+differential+and+cell-specific+hepatobiliary+toxicity+induced+by+geldanamycin+and+17-allylaminogeldanamycin+in+rats&doi=10.1016%2Fj.tiv.2005.06.033"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit108&amp;dbid=16384&amp;doi=10.1016%2Fj.tiv.2005.06.033&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.tiv.2005.06.033%26sid%3Dliteratum%253Aachs%26aulast%3DBehrsing%26aufirst%3DH.%2BP.%26aulast%3DAmin%26aufirst%3DK.%26aulast%3DIp%26aufirst%3DC.%26aulast%3DJimenez%26aufirst%3DL.%26aulast%3DTyson%26aufirst%3DC.%2BA.%26atitle%3DIn%2520vitro%2520detection%2520of%2520differential%2520and%2520cell-specific%2520hepatobiliary%2520toxicity%2520induced%2520by%2520geldanamycin%2520and%252017-allylaminogeldanamycin%2520in%2520rats%26jtitle%3DToxicol.%2520In%2520Vitro%26date%3D2005%26volume%3D19%26spage%3D1079%26epage%3D1088%26doi%3D10.1016%2Fj.tiv.2005.06.033" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref109"><div class="reference"><strong class="refLabel"><a href="#ref109" class="rightTabRefNumLink">109</a></strong><div class="NLM_citation" id="rightTab-cit109"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Guo, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reigan, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Enzymatic reduction and glutathione conjugation of benzoquinone ansamycin heat shock protein 90 inhibitors: relevance for toxicity and mechanism of action</span>. <i>Drug Metab. Dispos.</i> <span class="NLM_year" style="font-weight: bold;">2008</span>,  <span class="NLM_volume"><i>36</i></span>,  <span class="NLM_fpage">2050</span>– <span class="NLM_lpage">2057</span>, <span class="refDoi"> DOI: 10.1124/dmd.108.022004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref109/cit109&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1124%2Fdmd.108.022004" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=2050-2057&author=W.+Guoauthor=P.+Reiganauthor=D.+Siegelauthor=D.+Ross&title=Enzymatic+reduction+and+glutathione+conjugation+of+benzoquinone+ansamycin+heat+shock+protein+90+inhibitors%3A+relevance+for+toxicity+and+mechanism+of+action&doi=10.1124%2Fdmd.108.022004"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit109&amp;dbid=16384&amp;doi=10.1124%2Fdmd.108.022004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.108.022004%26sid%3Dliteratum%253Aachs%26aulast%3DGuo%26aufirst%3DW.%26aulast%3DReigan%26aufirst%3DP.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DEnzymatic%2520reduction%2520and%2520glutathione%2520conjugation%2520of%2520benzoquinone%2520ansamycin%2520heat%2520shock%2520protein%252090%2520inhibitors%253A%2520relevance%2520for%2520toxicity%2520and%2520mechanism%2520of%2520action%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D2050%26epage%3D2057%26doi%3D10.1124%2Fdmd.108.022004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref110"><div class="reference"><strong class="refLabel"><a href="#ref110" class="rightTabRefNumLink">110</a></strong><div class="NLM_citation" id="rightTab-cit110"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Samuni, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ishii, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hyodo, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Samuni, U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Krishna, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Goldstein, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mitchell, J. B.</span></span> <span> </span><span class="NLM_article-title">Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibiting anti-cancer geldanamycin and its analogs</span>. <i>Free Radical Biol. Med.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>48</i></span>,  <span class="NLM_fpage">1559</span>– <span class="NLM_lpage">1563</span>, <span class="refDoi"> DOI: 10.1016/j.freeradbiomed.2010.03.001</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.freeradbiomed.2010.03.001" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=20211249" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref110/cit110&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=48&publication_year=2010&pages=1559-1563&author=Y.+Samuniauthor=H.+Ishiiauthor=F.+Hyodoauthor=U.+Samuniauthor=M.+C.+Krishnaauthor=S.+Goldsteinauthor=J.+B.+Mitchell&title=Reactive+oxygen+species+mediate+hepatotoxicity+induced+by+the+Hsp90+inhibiting+anti-cancer+geldanamycin+and+its+analogs&doi=10.1016%2Fj.freeradbiomed.2010.03.001"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit110R"><div class="casContent"><span class="casTitleNuber">110</span><div class="casTitle"><span class="NLM_cas:atitle">Reactive oxygen species mediate hepatotoxicity induced by the Hsp90 inhibitor geldanamycin and its analogs</span></div><div class="casAuthors">Samuni, Yuval; Ishii, Hisanari; Hyodo, Fuminori; Samuni, Uri; Krishna, Murali C.; Goldstein, Sara; Mitchell, James B.</div><div class="citationInfo"><span class="NLM_cas:title">Free Radical Biology & Medicine</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">48</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">1559-1563</span>CODEN:
                <span class="NLM_cas:coden">FRBMEH</span>;
        ISSN:<span class="NLM_cas:issn">0891-5849</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">Geldanamycin (GM), a benzoquinone ansamycin antibiotic, is a natural product inhibitor of Hsp90 with potent and broad anti-cancer properties.  Because of its adverse effects on liver, its less toxic derivs. 17-(allylamino)-17-demethoxygeldanamycin (17-AAG) and 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG) are currently being evaluated for the treatment of cancer.  Previously, it was demonstrated that the redox cycling of GM by NADPH-cytochrome P 450 reductase leads to the formation of the GM semiquinone and superoxide radicals, the latter being identified using spin-trapping.  We hypothesized that the different hepatotoxicity induced by GM, 17-AAG, and 17-DMAG reflects the redox active properties of the quinone moiety and possibly the extent of superoxide formation, which may stimulate cellular oxidative injury.  Our data demonstrate that superoxide can be efficiently trapped during the redn. of GM, 17-AAG, and 17-DMAG by NADPH-cytochrome P 450 reductase, and that superoxide formation rate followed the order 17-DMAG > 17-AAG > GM.  In the absence of superoxide scavengers, the rate of NADPH oxidn. followed the order 17-DMAG > GM > 17-AAG.  The half-wave one-electron redn. potentials (E1/2) of GM, 17-AAG, and 17-DMAG in DMSO were detd. to be -0.37, -0.13 and -0.015 V (vs. Ag/AgCl), resp.  If the same order of E1/2 follows in neutral aq. media, thermodn. considerations imply that 17-DMAG is more readily reduced by the P 450 reductase as well as by superoxide.  The order of the drug cytotoxicity toward rat primary hepatocytes, as detd. by their effect on cell viability and on intracellular oxidant level, was opposite to the order of E1/2 of the resp. quinone/semiquinone couples.  These results suggest that hepatotoxicity exhibited by the Hsp90 inhibitors belonging to benzoquinone ansamycins could be attributed to superoxide.  The apparent discrepancy between the order of toxicity and the orders of superoxide formation rate, which is correlated with E1/2, is discussed.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpruuvDYz3MwbVg90H21EOLACvtfcHk0li-QjDj1IyEqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlsFGru7Y%253D&md5=25d6f75c0c010667a4d9d9be51f67c21</span></div><a href="/servlet/linkout?suffix=cit110&amp;dbid=16384&amp;doi=10.1016%2Fj.freeradbiomed.2010.03.001&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.freeradbiomed.2010.03.001%26sid%3Dliteratum%253Aachs%26aulast%3DSamuni%26aufirst%3DY.%26aulast%3DIshii%26aufirst%3DH.%26aulast%3DHyodo%26aufirst%3DF.%26aulast%3DSamuni%26aufirst%3DU.%26aulast%3DKrishna%26aufirst%3DM.%2BC.%26aulast%3DGoldstein%26aufirst%3DS.%26aulast%3DMitchell%26aufirst%3DJ.%2BB.%26atitle%3DReactive%2520oxygen%2520species%2520mediate%2520hepatotoxicity%2520induced%2520by%2520the%2520Hsp90%2520inhibiting%2520anti-cancer%2520geldanamycin%2520and%2520its%2520analogs%26jtitle%3DFree%2520Radical%2520Biol.%2520Med.%26date%3D2010%26volume%3D48%26spage%3D1559%26epage%3D1563%26doi%3D10.1016%2Fj.freeradbiomed.2010.03.001" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref111"><div class="reference"><strong class="refLabel"><a href="#ref111" class="rightTabRefNumLink">111</a></strong><div class="NLM_citation" id="rightTab-cit111"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kim, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Keum, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pae, A. N.</span></span> <span> </span><span class="NLM_article-title">Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives</span>. <i>Expert Opin. Ther. Pat.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">919</span>– <span class="NLM_lpage">943</span>, <span class="refDoi"> DOI: 10.1517/13543776.2013.780597</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1517%2F13543776.2013.780597" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23641970" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref111/cit111&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3N" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2013&pages=919-943&author=T.+Kimauthor=G.+Keumauthor=A.+N.+Pae&title=Discovery+and+development+of+heat+shock+protein+90+inhibitors+as+anticancer+agents%3A+a+review+of+patented+potent+geldanamycin+derivatives&doi=10.1517%2F13543776.2013.780597"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit111R"><div class="casContent"><span class="casTitleNuber">111</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and development of heat shock protein 90 inhibitors as anticancer agents: a review of patented potent geldanamycin derivatives</span></div><div class="casAuthors">Kim, TaeHun; Keum, Gyochang; Pae, Ae Nim</div><div class="citationInfo"><span class="NLM_cas:title">Expert Opinion on Therapeutic Patents</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">919-943</span>CODEN:
                <span class="NLM_cas:coden">EOTPEG</span>;
        ISSN:<span class="NLM_cas:issn">1354-3776</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">A review.  Introduction: There has been research on anticancer strategies which focus on disrupting a single malignant protein.  One of the strategies is the inhibition of one protein, heat shock protein 90 (Hsp90).  There are many reasons why Hsp90 protein is targeted by anticancer agents: maintenance of cellular homeostasis in organisms involves Hsp90 and its client proteins; moreover, Hsp90 complex is involved in regulating several signal transduction pathways and plays an important role in the maturation of lots of tumor-promoting client proteins.  Geldanamycin (GM), the first benzoquinone ansamycin, has shown anticancer activity by binding to Hsp90.  Currently, several GM derivs. such as 17-AAG, 17-(2-dimethylaminoethyl)amino-17-demethoxygeldanamycin, IPI-493, and IPI-504 are being progressively developed toward clin. application.  Areas covered: Several research groups have studied GM and its derivs. to develop novel and potent Hsp90 inhibitors for the treatment of cancer.  The crystal structure of Hsp90 was utilized to undergo structural optimization of GM derivs.  A wide variety of structural modifications were performed and some of the derivs. are now in clin. studies.  The aim of this review was to summarize and analyze the structure-activity relationships of GM derivs. and the focus is on patented novel and pharmaceutically efficacious derivs. published from 1971 to 2012.  Expert opinion: Hsp90 inhibitors offer an effective therapeutic approach for treatment of cancer.  To date, the clin. results of 17-AAG, IPI-493, and IPI-504 suggest that these GM derivs. could be used either alone or in combination with other marketed medications for the treatment of cancer patients.  As there are not any marketed Hsp90 inhibitors, inhibiting Hsp90 chaperone function remains as a promising strategy that still requires further research.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrG3zQbDv_bxrVg90H21EOLACvtfcHk0li-QjDj1IyEqQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhtFamsb3N&md5=cbfb23877dc1cbc9e26d9916f5f39b0c</span></div><a href="/servlet/linkout?suffix=cit111&amp;dbid=16384&amp;doi=10.1517%2F13543776.2013.780597&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543776.2013.780597%26sid%3Dliteratum%253Aachs%26aulast%3DKim%26aufirst%3DT.%26aulast%3DKeum%26aufirst%3DG.%26aulast%3DPae%26aufirst%3DA.%2BN.%26atitle%3DDiscovery%2520and%2520development%2520of%2520heat%2520shock%2520protein%252090%2520inhibitors%2520as%2520anticancer%2520agents%253A%2520a%2520review%2520of%2520patented%2520potent%2520geldanamycin%2520derivatives%26jtitle%3DExpert%2520Opin.%2520Ther.%2520Pat.%26date%3D2013%26volume%3D23%26spage%3D919%26epage%3D943%26doi%3D10.1517%2F13543776.2013.780597" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref112"><div class="reference"><strong class="refLabel"><a href="#ref112" class="rightTabRefNumLink">112</a></strong><div class="NLM_citation" id="rightTab-cit112"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Glaze, E. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lambert, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Smith, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Page, J. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, W. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCormick, D. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Levine, B. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Covey, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egorin, M. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eiseman, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Holleran, J. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sausville, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tomaszewski, J. E.</span></span> <span> </span><span class="NLM_article-title">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span>. <i>Cancer Chemother. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>56</i></span>,  <span class="NLM_fpage">637</span>– <span class="NLM_lpage">647</span>, <span class="refDoi"> DOI: 10.1007/s00280-005-1000-9</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1007%2Fs00280-005-1000-9" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15986212" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref112/cit112&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=56&publication_year=2005&pages=637-647&author=E.+R.+Glazeauthor=A.+L.+Lambertauthor=A.+C.+Smithauthor=J.+G.+Pageauthor=W.+D.+Johnsonauthor=D.+L.+McCormickauthor=A.+P.+Brownauthor=B.+S.+Levineauthor=J.+M.+Coveyauthor=M.+J.+Egorinauthor=J.+L.+Eisemanauthor=J.+L.+Holleranauthor=E.+A.+Sausvilleauthor=J.+E.+Tomaszewski&title=Preclinical+toxicity+of+a+geldanamycin+analog%2C+17-%28dimethylaminoethylamino%29-17-demethoxygeldanamycin+%2817-DMAG%29%2C+in+rats+and+dogs%3A+potential+clinical+relevance&doi=10.1007%2Fs00280-005-1000-9"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit112R"><div class="casContent"><span class="casTitleNuber">112</span><div class="casTitle"><span class="NLM_cas:atitle">Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance</span></div><div class="casAuthors">Glaze, Elizabeth R.; Lambert, Amy L.; Smith, Adaline C.; Page, John G.; Johnson, William D.; McCormick, David L.; Brown, Alan P.; Levine, Barry S.; Covey, Joseph M.; Egorin, Merrill J.; Eiseman, Julie L.; Holleran, Julianne L.; Sausville, Edward A.; Tomaszewski, Joseph E.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Chemotherapy and Pharmacology</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">56</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">637-647</span>CODEN:
                <span class="NLM_cas:coden">CCPHDZ</span>;
        ISSN:<span class="NLM_cas:issn">0344-5704</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Purpose: 17-DMAG is a hydrophilic deriv. of the mol. chaperone inhibitor 17-(allylamino)-17-demethoxygeldanamycin (17-AAG; NSC-330507), which is currently being evaluated for the treatment of cancer in clin. trials. 17-DMAG offers a potential advantage over 17-AAG because its aq. soly. eliminates the need for complicated formulations that are currently used for administration of 17-AAG.  In addn., 17-DMAG undergoes only limited metab. compared to 17-AAG.  The present results are from preclin. toxicity studies evaluating 17-DMAG in rats and dogs.  Methods: Doses of 0, 2.4, 12 and 24 mg/m2 per day were administered to rats, while dogs received doses of 0, 8 or 16 mg/m2 per day.  In both species, 17-DMAG was administered i.v. (slow bolus for rats; 1-h infusion for dogs) daily for 5 days.  An addnl. cohort of dogs received 16 mg/m2 per day orally for 5 days.  Clin. observations were noted, and std. hematol. and clin. chem. parameters were monitored.  Selected tissues were evaluated microscopically for drug-related lesions.  Tissue and plasma 17-DMAG concns. were measured by HPLC/MS at selected time-points on days 1 and 5.  Results: Daily i.v. administration of 17-DMAG at doses of 24 mg/m2 per day in rats or 16 mg/m2 per day in dogs produced lethality on day 6, approx. 24 h following the last dose.  Body wt. loss was common in rats and dogs.  Drug-related gastrointestinal, bone marrow and hepatic toxicities were also common in rats and dogs.  Dogs also exhibited signs of renal and gallbladder toxicity.  Plasma concns. of 17-DMAG increased proportionately with dose in rats and disproportionately with dose in dogs.  In rat tissues, however, only fourfold to sixfold increases in 17-DMAG concns. were obsd. with a tenfold increase in dose.  The highest concns. of 17-DMAG were found in the liver of rats, with progressively lower concns. in the spleen, lung, kidney and plasma.  Regardless of the route of administration, higher drug concns. were present in plasma (rat and dog) and tissue (rat) samples obtained on day 5 compared to those obtained on day 1.  Although plasma concns. decreased with time, 17-DMAG was still detected in dog plasma for at least 24 h after drug administration.  Conclusions: With the recent approval of 17-DMAG for clin. use, the data generated from these preclin. studies will provide guidance to clinicians as they administer this drug to their patients.  The MTD of 17-DMAG was 12 mg/m2 per day in rats and 8 mg/m2 per day in dogs; therefore, the recommended starting dose for phase I trial is 1.3 mg/m2 per day for 5 days.  Gastrointestinal and bone marrow toxicity were dose-limiting in rats, and gastrointestinal, renal, gallbladder and bone marrow toxicity were dose-limiting in dogs.  All adverse effects were fully reversible in surviving animals after treatment was complete.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoWkzP-n-oIFbVg90H21EOLACvtfcHk0lhz_BHfGDWvng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtVKqu7bP&md5=62fe4552e57e6e2b86326d57d4ab8ff2</span></div><a href="/servlet/linkout?suffix=cit112&amp;dbid=16384&amp;doi=10.1007%2Fs00280-005-1000-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00280-005-1000-9%26sid%3Dliteratum%253Aachs%26aulast%3DGlaze%26aufirst%3DE.%2BR.%26aulast%3DLambert%26aufirst%3DA.%2BL.%26aulast%3DSmith%26aufirst%3DA.%2BC.%26aulast%3DPage%26aufirst%3DJ.%2BG.%26aulast%3DJohnson%26aufirst%3DW.%2BD.%26aulast%3DMcCormick%26aufirst%3DD.%2BL.%26aulast%3DBrown%26aufirst%3DA.%2BP.%26aulast%3DLevine%26aufirst%3DB.%2BS.%26aulast%3DCovey%26aufirst%3DJ.%2BM.%26aulast%3DEgorin%26aufirst%3DM.%2BJ.%26aulast%3DEiseman%26aufirst%3DJ.%2BL.%26aulast%3DHolleran%26aufirst%3DJ.%2BL.%26aulast%3DSausville%26aufirst%3DE.%2BA.%26aulast%3DTomaszewski%26aufirst%3DJ.%2BE.%26atitle%3DPreclinical%2520toxicity%2520of%2520a%2520geldanamycin%2520analog%252C%252017-%2528dimethylaminoethylamino%2529-17-demethoxygeldanamycin%2520%252817-DMAG%2529%252C%2520in%2520rats%2520and%2520dogs%253A%2520potential%2520clinical%2520relevance%26jtitle%3DCancer%2520Chemother.%2520Pharmacol.%26date%3D2005%26volume%3D56%26spage%3D637%26epage%3D647%26doi%3D10.1007%2Fs00280-005-1000-9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref113"><div class="reference"><strong class="refLabel"><a href="#ref113" class="rightTabRefNumLink">113</a></strong><div class="NLM_citation" id="rightTab-cit113"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Douglas, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, A. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, M. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wylie, A. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tibbits, T. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Biggs, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Curtis, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Palombella, V. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adams, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fritz, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span> <span> </span><span class="NLM_article-title">The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>8</i></span>,  <span class="NLM_fpage">3369</span>– <span class="NLM_lpage">3378</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-09-0568</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-09-0568" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19952119" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref113/cit113&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbrO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=8&publication_year=2009&pages=3369-3378&author=M.+Douglasauthor=A.+R.+Limauthor=J.+R.+Porterauthor=K.+Westauthor=M.+M.+Pinkauthor=J.+Geauthor=A.+A.+Wylieauthor=T.+T.+Tibbitsauthor=K.+Biggsauthor=M.+Curtisauthor=V.+J.+Palombellaauthor=J.+Adamsauthor=C.+C.+Fritzauthor=E.+Normant&title=The+antiproliferative+activity+of+the+heat+shock+protein+90+inhibitor+IPI-504+is+not+dependent+on+NAD%28P%29H%3Aquinone+oxidoreductase+1+activity+in+vivo&doi=10.1158%2F1535-7163.MCT-09-0568"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit113R"><div class="casContent"><span class="casTitleNuber">113</span><div class="casTitle"><span class="NLM_cas:atitle">The antiproliferative activity of the heat shock protein 90 inhibitor IPI-504 is not dependent on NAD(P)H:quinone oxidoreductase 1 activity in vivo</span></div><div class="casAuthors">Douglas, Mark; Lim, Alice R.; Porter, James R.; West, Kip; Pink, Melissa M.; Ge, Jie; Wylie, Andrew A.; Tibbits, Thomas T.; Biggs, Kurtis; Curtis, Michael; Palombella, Vito J.; Adams, Julian; Fritz, Christian C.; Normant, Emmanuel</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">8</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3369-3378</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">IPI-504, a water-sol. ansamycin analog currently being investigated in clin. trials, is a potent inhibitor of the protein chaperone heat shock protein 90 (Hsp90).  Inhibition of Hsp90 by IPI-504 triggers the degrdn. of important oncogenic client proteins.  In cells, the free base of IPI-504 hydroquinone exists in a dynamic redox equil. with its corresponding quinone (17-AAG); the hydroquinone form binding 50 times more tightly to Hsp90.  It has been proposed recently that the NAD(P)H:quinone oxidoreductase NQO1 can produce the active hydroquinone and could be essential for the activity of IPI-504.  Here, we have devised a method to directly measure the intracellular ratio of hydroquinone to quinone (HQ/Q) and have applied this measurement to correlate NQO1 enzyme abundance with HQ/Q ratio and cellular activity of IPI-504 in 30 cancer cell lines.  Interestingly, the intracellular HQ/Q ratio was correlated with NQO1 levels only in a subset of cell lines and overall was poorly correlated with the growth inhibitory activity of IPI-504.  Although artificial overexpression of NQO1 is able to increase the level of hydroquinone and cell sensitivity to IPI-504, it has little effect on the activity of 17-amino-17-demethoxy-geldanamycin, the major active metabolite of IPI-504.  This finding could provide an explanation for the biol. activity of IPI-504 in xenograft models of cell lines that are not sensitive to IPI-504 in vitro.  Our results suggest that NQO1 activity is not a determinant of IPI-504 activity in vivo and, therefore, unlikely to become an important resistance mechanism to IPI-504 in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoDJ38WfRb4s7Vg90H21EOLACvtfcHk0lhz_BHfGDWvng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsFCitbrO&md5=d59d0ffb7d0d6dd5a02b84aacc1a8401</span></div><a href="/servlet/linkout?suffix=cit113&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-09-0568&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-09-0568%26sid%3Dliteratum%253Aachs%26aulast%3DDouglas%26aufirst%3DM.%26aulast%3DLim%26aufirst%3DA.%2BR.%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DWest%26aufirst%3DK.%26aulast%3DPink%26aufirst%3DM.%2BM.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DWylie%26aufirst%3DA.%2BA.%26aulast%3DTibbits%26aufirst%3DT.%2BT.%26aulast%3DBiggs%26aufirst%3DK.%26aulast%3DCurtis%26aufirst%3DM.%26aulast%3DPalombella%26aufirst%3DV.%2BJ.%26aulast%3DAdams%26aufirst%3DJ.%26aulast%3DFritz%26aufirst%3DC.%2BC.%26aulast%3DNormant%26aufirst%3DE.%26atitle%3DThe%2520antiproliferative%2520activity%2520of%2520the%2520heat%2520shock%2520protein%252090%2520inhibitor%2520IPI-504%2520is%2520not%2520dependent%2520on%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520activity%2520in%2520vivo%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2009%26volume%3D8%26spage%3D3369%26epage%3D3378%26doi%3D10.1158%2F1535-7163.MCT-09-0568" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref114"><div class="reference"><strong class="refLabel"><a href="#ref114" class="rightTabRefNumLink">114</a></strong><div class="NLM_citation" id="rightTab-cit114"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hanson, B. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vesole, D. H.</span></span> <span> </span><span class="NLM_article-title">Retaspimycin hydrochloride (IPI-504): a novel heat shock protein inhibitor as an anticancer agent</span>. <i>Expert Opin. Invest. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1375</span>– <span class="NLM_lpage">1383</span>, <span class="refDoi"> DOI: 10.1517/13543780903158934</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref114/cit114&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1517%2F13543780903158934" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2009&pages=1375-1383&author=B.+E.+Hansonauthor=D.+H.+Vesole&title=Retaspimycin+hydrochloride+%28IPI-504%29%3A+a+novel+heat+shock+protein+inhibitor+as+an+anticancer+agent&doi=10.1517%2F13543780903158934"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit114&amp;dbid=16384&amp;doi=10.1517%2F13543780903158934&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1517%252F13543780903158934%26sid%3Dliteratum%253Aachs%26aulast%3DHanson%26aufirst%3DB.%2BE.%26aulast%3DVesole%26aufirst%3DD.%2BH.%26atitle%3DRetaspimycin%2520hydrochloride%2520%2528IPI-504%2529%253A%2520a%2520novel%2520heat%2520shock%2520protein%2520inhibitor%2520as%2520an%2520anticancer%2520agent%26jtitle%3DExpert%2520Opin.%2520Invest.%2520Drugs%26date%3D2009%26volume%3D18%26spage%3D1375%26epage%3D1383%26doi%3D10.1517%2F13543780903158934" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref115"><div class="reference"><strong class="refLabel"><a href="#ref115" class="rightTabRefNumLink">115</a></strong><div class="NLM_citation" id="rightTab-cit115"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Porter, J. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ge, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Normant, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">West, K.</span></span> <span> </span><span class="NLM_article-title">Ansamycin inhibitors of Hsp90: Nature’s prototype for anti-chaperone therapy</span>. <i>Curr. Top. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1386</span>– <span class="NLM_lpage">1418</span>, <span class="refDoi"> DOI: 10.2174/156802609789895719</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2174%2F156802609789895719" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19860734" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref115/cit115&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFakuro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2009&pages=1386-1418&author=J.+R.+Porterauthor=J.+Geauthor=J.+Leeauthor=E.+Normantauthor=K.+West&title=Ansamycin+inhibitors+of+Hsp90%3A+Nature%E2%80%99s+prototype+for+anti-chaperone+therapy&doi=10.2174%2F156802609789895719"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit115R"><div class="casContent"><span class="casTitleNuber">115</span><div class="casTitle"><span class="NLM_cas:atitle">Ansamycin inhibitors of Hsp90: nature's prototype for anti-chaperone therapy</span></div><div class="casAuthors">Porter, James R.; Ge, Jie; Lee, John; Normant, Emmanuel; West, Kip</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">1386-1418</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  The ansamycin class of natural products is well known for its anti-tumor effects and has been extensively studied by cancer researchers for nearly four decades.  The first description of geldanamycin in the scientific literature appeared in 1970 and nearly thirty years later the semi-synthetic deriv. 17-AAG, or tanespimycin, entered Phase 1 clin. trials.  In the subsequent years, three addnl. geldanamycin derivs. have entered clin. evaluation.  Kosan Biosciences developed 17-DMAG or alvespimycin hydrochloride for clin. evaluation as both an i.v. and oral product.  Infinity Pharmaceuticals is developing IPI-504 or retaspimycin hydrochloride as an i.v. product, which is in several Phase 2 clin. trials; IPI-504 is the hydroquinone hydrochloride salt of 17-AAG.  More recently, Infinity Pharmaceuticals initiated a Phase 1 clin. trial with an oral formulation of 17-AG (IPI-493), the major metabolite of 17-AAG and IPI-504.  Since a vast amt. of scientific literature exists regarding the ansamycin field and Hsp90 inhibition, this review will survey key milestones in the development of the natural product class as anti-cancer drugs including discovery of the compds. and their anti-tumor effects, identification of Hsp90 as their biol. target, the structure-activity relationships that have been identified in this interesting class of compds., and development of clin. candidates for the treatment of cancer patients.  A brief overview of important pre-clin. development data from each clin. lead is also provided.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBhropKxP9ObVg90H21EOLACvtfcHk0lhz_BHfGDWvng"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFakuro%253D&md5=9c71a14e77339887c61ecf35924eeafd</span></div><a href="/servlet/linkout?suffix=cit115&amp;dbid=16384&amp;doi=10.2174%2F156802609789895719&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802609789895719%26sid%3Dliteratum%253Aachs%26aulast%3DPorter%26aufirst%3DJ.%2BR.%26aulast%3DGe%26aufirst%3DJ.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DNormant%26aufirst%3DE.%26aulast%3DWest%26aufirst%3DK.%26atitle%3DAnsamycin%2520inhibitors%2520of%2520Hsp90%253A%2520Nature%25E2%2580%2599s%2520prototype%2520for%2520anti-chaperone%2520therapy%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2009%26volume%3D9%26spage%3D1386%26epage%3D1418%26doi%3D10.2174%2F156802609789895719" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref116"><div class="reference"><strong class="refLabel"><a href="#ref116" class="rightTabRefNumLink">116</a></strong><div class="NLM_citation" id="rightTab-cit116"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Rao, K. V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cullen, W. P.</span></span> <span> </span><span class="NLM_article-title">Streptonigrin, an antitumor substance. I. Isolation and characterization</span>. <i>Antibiot. Annu.</i> <span class="NLM_year" style="font-weight: bold;">1959</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">950</span>– <span class="NLM_lpage">953</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=14436228" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref116/cit116&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaF3c7ovV2lsg%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1959&pages=950-953&author=K.+V.+Raoauthor=W.+P.+Cullen&title=Streptonigrin%2C+an+antitumor+substance.+I.+Isolation+and+characterization"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit116R"><div class="casContent"><span class="casTitleNuber">116</span><div class="casTitle"><span class="NLM_cas:atitle">Streptonigrin, an antitumor substance. I. Isolation and characterization</span></div><div class="casAuthors">RAO K V; CULLEN W P</div><div class="citationInfo"><span class="NLM_cas:title">Antibiotics annual</span>
        (<span class="NLM_cas:date">1959-1960</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">950-3</span>
        ISSN:<span class="NLM_cas:issn">0570-3131</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRDjMj1HXEobFm8bhe6roZYfW6udTcc2ebkop_HJ6VNELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c7ovV2lsg%253D%253D&md5=32e9a92caf6defbc6794ac00842dbb68</span></div><a href="/servlet/linkout?suffix=cit116&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRao%26aufirst%3DK.%2BV.%26aulast%3DCullen%26aufirst%3DW.%2BP.%26atitle%3DStreptonigrin%252C%2520an%2520antitumor%2520substance.%2520I.%2520Isolation%2520and%2520characterization%26jtitle%3DAntibiot.%2520Annu.%26date%3D1959%26volume%3D7%26spage%3D950%26epage%3D953" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref117"><div class="reference"><strong class="refLabel"><a href="#ref117" class="rightTabRefNumLink">117</a></strong><div class="NLM_citation" id="rightTab-cit117"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H.
D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolton, E. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gibson, N. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ross, D.</span></span> <span> </span><span class="NLM_article-title">Role of NAD(P)H:quinone oxidoreductase (DT-diaphorase) in cytotoxicity and induction of DNA damage by streptonigrin</span>. <i>Biochem. Pharmacol.</i> <span class="NLM_year" style="font-weight: bold;">1996</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">645</span>– <span class="NLM_lpage">652</span>, <span class="refDoi"> DOI: 10.1016/S0006-2952(95)00223-5</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref117/cit117&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0006-2952%2895%2900223-5" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=1996&pages=645-652&author=H.%0AD.+Beallauthor=Y.+Liuauthor=D.+Siegelauthor=E.+M.+Boltonauthor=N.+W.+Gibsonauthor=D.+Ross&title=Role+of+NAD%28P%29H%3Aquinone+oxidoreductase+%28DT-diaphorase%29+in+cytotoxicity+and+induction+of+DNA+damage+by+streptonigrin&doi=10.1016%2FS0006-2952%2895%2900223-5"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit117&amp;dbid=16384&amp;doi=10.1016%2FS0006-2952%2895%2900223-5&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0006-2952%252895%252900223-5%26sid%3Dliteratum%253Aachs%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBolton%26aufirst%3DE.%2BM.%26aulast%3DGibson%26aufirst%3DN.%2BW.%26aulast%3DRoss%26aufirst%3DD.%26atitle%3DRole%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528DT-diaphorase%2529%2520in%2520cytotoxicity%2520and%2520induction%2520of%2520DNA%2520damage%2520by%2520streptonigrin%26jtitle%3DBiochem.%2520Pharmacol.%26date%3D1996%26volume%3D51%26spage%3D645%26epage%3D652%26doi%3D10.1016%2FS0006-2952%2895%2900223-5" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref118"><div class="reference"><strong class="refLabel"><a href="#ref118" class="rightTabRefNumLink">118</a></strong><div class="NLM_citation" id="rightTab-cit118"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Yee, S. B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pritsos, C. A.</span></span> <span> </span><span class="NLM_article-title">Comparison of oxygen radical generation from the reductive activation of doxorubicin, streptonigrin, and menadione by xanthine oxidase and xanthine dehydrogenase</span>. <i>Arch. Biochem. Biophys.</i> <span class="NLM_year" style="font-weight: bold;">1997</span>,  <span class="NLM_volume"><i>347</i></span>,  <span class="NLM_fpage">235</span>– <span class="NLM_lpage">241</span>, <span class="refDoi"> DOI: 10.1006/abbi.1997.0340</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref118/cit118&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1006%2Fabbi.1997.0340" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=347&publication_year=1997&pages=235-241&author=S.+B.+Yeeauthor=C.+A.+Pritsos&title=Comparison+of+oxygen+radical+generation+from+the+reductive+activation+of+doxorubicin%2C+streptonigrin%2C+and+menadione+by+xanthine+oxidase+and+xanthine+dehydrogenase&doi=10.1006%2Fabbi.1997.0340"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit118&amp;dbid=16384&amp;doi=10.1006%2Fabbi.1997.0340&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fabbi.1997.0340%26sid%3Dliteratum%253Aachs%26aulast%3DYee%26aufirst%3DS.%2BB.%26aulast%3DPritsos%26aufirst%3DC.%2BA.%26atitle%3DComparison%2520of%2520oxygen%2520radical%2520generation%2520from%2520the%2520reductive%2520activation%2520of%2520doxorubicin%252C%2520streptonigrin%252C%2520and%2520menadione%2520by%2520xanthine%2520oxidase%2520and%2520xanthine%2520dehydrogenase%26jtitle%3DArch.%2520Biochem.%2520Biophys.%26date%3D1997%26volume%3D347%26spage%3D235%26epage%3D241%26doi%3D10.1006%2Fabbi.1997.0340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref119"><div class="reference"><strong class="refLabel"><a href="#ref119" class="rightTabRefNumLink">119</a></strong><div class="NLM_citation" id="rightTab-cit119"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hackethal, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Golbey, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tan, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karnofsky, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burchenal, J.</span></span> <span> </span><span class="NLM_article-title">Clinical observations on the effects of streptonigrin in patients with neoplastic disease</span>. <i>Antibiot. Chemother.</i> <span class="NLM_year" style="font-weight: bold;">1961</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">178</span>– <span class="NLM_lpage">183</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=13710278" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref119/cit119&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADyaF3c%252FivFyisQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=1961&pages=178-183&author=C.+Hackethalauthor=R.+Golbeyauthor=C.+Tanauthor=D.+Karnofskyauthor=J.+Burchenal&title=Clinical+observations+on+the+effects+of+streptonigrin+in+patients+with+neoplastic+disease"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit119R"><div class="casContent"><span class="casTitleNuber">119</span><div class="casTitle"><span class="NLM_cas:atitle">Clinical observations on the effects of streptonigrin in patients with neoplastic disease</span></div><div class="casAuthors">HACKETHAL C A; GOLBEY R B; TAN C T; KARNOFSKY D A; BURCHENAL J H</div><div class="citationInfo"><span class="NLM_cas:title">Antibiotics & chemotherapy (Northfield, Ill.)</span>
        (<span class="NLM_cas:date">1961</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">178-83</span>
        ISSN:<span class="NLM_cas:issn">0570-3123</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcQVmPnvGD5iGu2qxNLjzXe8fW6udTcc2ebkop_HJ6VNELntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADyaF3c%252FivFyisQ%253D%253D&md5=7501e7900ece833c522661465cd8c004</span></div><a href="/servlet/linkout?suffix=cit119&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHackethal%26aufirst%3DC.%26aulast%3DGolbey%26aufirst%3DR.%26aulast%3DTan%26aufirst%3DC.%26aulast%3DKarnofsky%26aufirst%3DD.%26aulast%3DBurchenal%26aufirst%3DJ.%26atitle%3DClinical%2520observations%2520on%2520the%2520effects%2520of%2520streptonigrin%2520in%2520patients%2520with%2520neoplastic%2520disease%26jtitle%3DAntibiot.%2520Chemother.%26date%3D1961%26volume%3D11%26spage%3D178%26epage%3D183" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref120"><div class="reference"><strong class="refLabel"><a href="#ref120" class="rightTabRefNumLink">120</a></strong><div class="NLM_citation" id="rightTab-cit120"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Balitz, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bush, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bradner, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Doyle, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">O’HERRON, F. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nettleton, D.</span></span> <span> </span><span class="NLM_article-title">Isolation of lavendamycin a new antibiotic from <i>Streptomyces lavendulae</i></span>. <i>J. Antibiot.</i> <span class="NLM_year" style="font-weight: bold;">1982</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">259</span>– <span class="NLM_lpage">265</span>, <span class="refDoi"> DOI: 10.7164/antibiotics.35.259</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref120/cit120&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.7164%2Fantibiotics.35.259" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=1982&pages=259-265&author=D.+Balitzauthor=J.+Bushauthor=W.+Bradnerauthor=T.+Doyleauthor=F.+A.+O%E2%80%99HERRONauthor=D.+Nettleton&title=Isolation+of+lavendamycin+a+new+antibiotic+from+Streptomyces+lavendulae&doi=10.7164%2Fantibiotics.35.259"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit120&amp;dbid=16384&amp;doi=10.7164%2Fantibiotics.35.259&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7164%252Fantibiotics.35.259%26sid%3Dliteratum%253Aachs%26aulast%3DBalitz%26aufirst%3DD.%26aulast%3DBush%26aufirst%3DJ.%26aulast%3DBradner%26aufirst%3DW.%26aulast%3DDoyle%26aufirst%3DT.%26aulast%3DO%25E2%2580%2599HERRON%26aufirst%3DF.%2BA.%26aulast%3DNettleton%26aufirst%3DD.%26atitle%3DIsolation%2520of%2520lavendamycin%2520a%2520new%2520antibiotic%2520from%2520Streptomyces%2520lavendulae%26jtitle%3DJ.%2520Antibiot.%26date%3D1982%26volume%3D35%26spage%3D259%26epage%3D265%26doi%3D10.7164%2Fantibiotics.35.259" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref121"><div class="reference"><strong class="refLabel"><a href="#ref121" class="rightTabRefNumLink">121</a></strong><div class="NLM_citation" id="rightTab-cit121"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cai, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hassani, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Karki, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Walter, E. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koelsch, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Seradj, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lineswala, J. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mirzaei, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">York, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Olang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sedighi, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lucas, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eads, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rose, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Charkhzarrin, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hermann, N. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beall, H. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Behforouz, M.</span></span> <span> </span><span class="NLM_article-title">Synthesis, metabolism and in vitro cytotoxicity studies on novel lavendamycin antitumor agents</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>18</i></span>,  <span class="NLM_fpage">1899</span>– <span class="NLM_lpage">1909</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2010.01.037</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref121/cit121&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmc.2010.01.037" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2010&pages=1899-1909&author=W.+Caiauthor=M.+Hassaniauthor=R.+Karkiauthor=E.+D.+Walterauthor=K.+H.+Koelschauthor=H.+Seradjauthor=J.+P.+Lineswalaauthor=H.+Mirzaeiauthor=J.+S.+Yorkauthor=F.+Olangauthor=M.+Sedighiauthor=J.+S.+Lucasauthor=T.+J.+Eadsauthor=A.+S.+Roseauthor=S.+Charkhzarrinauthor=N.+G.+Hermannauthor=H.+D.+Beallauthor=M.+Behforouz&title=Synthesis%2C+metabolism+and+in+vitro+cytotoxicity+studies+on+novel+lavendamycin+antitumor+agents&doi=10.1016%2Fj.bmc.2010.01.037"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit121&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2010.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2010.01.037%26sid%3Dliteratum%253Aachs%26aulast%3DCai%26aufirst%3DW.%26aulast%3DHassani%26aufirst%3DM.%26aulast%3DKarki%26aufirst%3DR.%26aulast%3DWalter%26aufirst%3DE.%2BD.%26aulast%3DKoelsch%26aufirst%3DK.%2BH.%26aulast%3DSeradj%26aufirst%3DH.%26aulast%3DLineswala%26aufirst%3DJ.%2BP.%26aulast%3DMirzaei%26aufirst%3DH.%26aulast%3DYork%26aufirst%3DJ.%2BS.%26aulast%3DOlang%26aufirst%3DF.%26aulast%3DSedighi%26aufirst%3DM.%26aulast%3DLucas%26aufirst%3DJ.%2BS.%26aulast%3DEads%26aufirst%3DT.%2BJ.%26aulast%3DRose%26aufirst%3DA.%2BS.%26aulast%3DCharkhzarrin%26aufirst%3DS.%26aulast%3DHermann%26aufirst%3DN.%2BG.%26aulast%3DBeall%26aufirst%3DH.%2BD.%26aulast%3DBehforouz%26aufirst%3DM.%26atitle%3DSynthesis%252C%2520metabolism%2520and%2520in%2520vitro%2520cytotoxicity%2520studies%2520on%2520novel%2520lavendamycin%2520antitumor%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2010%26volume%3D18%26spage%3D1899%26epage%3D1909%26doi%3D10.1016%2Fj.bmc.2010.01.037" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref122"><div class="reference"><strong class="refLabel"><a href="#ref122" class="rightTabRefNumLink">122</a></strong><div class="NLM_citation" id="rightTab-cit122"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors</span>. <i>J. Mol. Histol.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>37</i></span>,  <span class="NLM_fpage">203</span>– <span class="NLM_lpage">218</span>, <span class="refDoi"> DOI: 10.1007/s10735-006-9043-8</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1007%2Fs10735-006-9043-8" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16868862" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref122/cit122&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD28Xht1elsLjF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=37&publication_year=2006&pages=203-218&author=M.+S.+Bentleauthor=E.+A.+Beyauthor=Y.+Dongauthor=K.+E.+Reinickeauthor=D.+A.+Boothman&title=New+tricks+for+old+drugs%3A+the+anticarcinogenic+potential+of+DNA+repair+inhibitors&doi=10.1007%2Fs10735-006-9043-8"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit122R"><div class="casContent"><span class="casTitleNuber">122</span><div class="casTitle"><span class="NLM_cas:atitle">New tricks for old drugs: the anticarcinogenic potential of DNA repair inhibitors</span></div><div class="casAuthors">Bentle, Melissa S.; Bey, Erik A.; Dong, Ying; Reinicke, Kathryn E.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Histology</span>
        (<span class="NLM_cas:date">2006</span>),
    <span class="NLM_cas:volume">37</span>
        (<span class="NLM_cas:issue">5-7</span>),
    <span class="NLM_cas:pages">203-218</span>CODEN:
                <span class="NLM_cas:coden">JMHOAO</span>;
        ISSN:<span class="NLM_cas:issn">1567-2379</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">A review.  Defective or abortive repair of DNA lesions has been assocd. with carcinogenesis.  Therefore it is imperative for a cell to accurately repair its DNA after damage if it is to return to a normal cellular phenotype.  In certain circumstances, if DNA damage cannot be repaired completely and with high fidelity, it is more advantageous for an organism to have some of its more severely damaged cells die rather than survive as neoplastic transformants.  A no. of DNA repair inhibitors have the potential to act as anticarcinogenic compds.  These drugs are capable of modulating DNA repair, thus promoting cell death rather than repair of potentially carcinogenic DNA damage mediated by error-prone DNA repair processes.  In theory, exposure to a DNA repair inhibitor during, or immediately after, carcinogenic exposure should decrease or prevent tumorigenesis.  However, the ability of DNA repair inhibitors to prevent cancer development is difficult to interpret depending upon the system used and the type of genotoxic stress.  Inhibitors may act on multiple aspects of DNA repair as well as the cellular signaling pathways activated in response to the initial damage.  In this review, we summarize basic DNA repair mechanisms and explore the effects of a no. of DNA repair inhibitors that not only potentiate DNA-damaging agents but also decrease carcinogenicity.  In particular, we focus on a novel anti-tumor agent, β-lapachone, and its potential to block transformation by modulating poly(ADP-ribose) polymerase-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGptcOVYY1omerVg90H21EOLACvtfcHk0ljM77illVHSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD28Xht1elsLjF&md5=1b00e832651db5bd11efc2f5753efc9e</span></div><a href="/servlet/linkout?suffix=cit122&amp;dbid=16384&amp;doi=10.1007%2Fs10735-006-9043-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10735-006-9043-8%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNew%2520tricks%2520for%2520old%2520drugs%253A%2520the%2520anticarcinogenic%2520potential%2520of%2520DNA%2520repair%2520inhibitors%26jtitle%3DJ.%2520Mol.%2520Histol.%26date%3D2006%26volume%3D37%26spage%3D203%26epage%3D218%26doi%3D10.1007%2Fs10735-006-9043-8" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref123"><div class="reference"><strong class="refLabel"><a href="#ref123" class="rightTabRefNumLink">123</a></strong><div class="NLM_citation" id="rightTab-cit123"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trask, D. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pardee, A. B.</span></span> <span> </span><span class="NLM_article-title">Inhibition of potentially lethal DNA damage repair in human tumor cells by beta-lapachone, an activator of topoisomerase I</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1989</span>,  <span class="NLM_volume"><i>49</i></span>,  <span class="NLM_fpage">605</span>– <span class="NLM_lpage">612</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=49&publication_year=1989&pages=605-612&author=D.+A.+Boothmanauthor=D.+K.+Traskauthor=A.+B.+Pardee&title=Inhibition+of+potentially+lethal+DNA+damage+repair+in+human+tumor+cells+by+beta-lapachone%2C+an+activator+of+topoisomerase+I"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit123&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DTrask%26aufirst%3DD.%2BK.%26aulast%3DPardee%26aufirst%3DA.%2BB.%26atitle%3DInhibition%2520of%2520potentially%2520lethal%2520DNA%2520damage%2520repair%2520in%2520human%2520tumor%2520cells%2520by%2520beta-lapachone%252C%2520an%2520activator%2520of%2520topoisomerase%2520I%26jtitle%3DCancer%2520Res.%26date%3D1989%26volume%3D49%26spage%3D605%26epage%3D612" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref124"><div class="reference"><strong class="refLabel"><a href="#ref124" class="rightTabRefNumLink">124</a></strong><div class="NLM_citation" id="rightTab-cit124"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Planchon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Siegel, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">NAD(P)H:quinone oxidoreductase activity is the principal determinant of beta-lapachone cytotoxicity</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2000</span>,  <span class="NLM_volume"><i>275</i></span>,  <span class="NLM_fpage">5416</span>– <span class="NLM_lpage">5424</span>, <span class="refDoi"> DOI: 10.1074/jbc.275.8.5416</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.275.8.5416" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10681517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref124/cit124&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3cXhsFKksL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=275&publication_year=2000&pages=5416-5424&author=J.+J.+Pinkauthor=S.+M.+Planchonauthor=C.+Tagliarinoauthor=M.+E.+Varnesauthor=D.+Siegelauthor=D.+A.+Boothman&title=NAD%28P%29H%3Aquinone+oxidoreductase+activity+is+the+principal+determinant+of+beta-lapachone+cytotoxicity&doi=10.1074%2Fjbc.275.8.5416"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit124R"><div class="casContent"><span class="casTitleNuber">124</span><div class="casTitle"><span class="NLM_cas:atitle">NAD(P)H:quinone oxidoreductase activity is the principal determinant of β-lapachone cytotoxicity</span></div><div class="casAuthors">Pink, John J.; Planchon, Sarah M.; Tagliarino, Colleen; Varnes, Marie E.; Siegel, David; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Biological Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">275</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">5416-5424</span>CODEN:
                <span class="NLM_cas:coden">JBCHA3</span>;
        ISSN:<span class="NLM_cas:issn">0021-9258</span>.
    
            (<span class="NLM_cas:orgname">American Society for Biochemistry and Molecular Biology</span>)
        </div><div class="casAbstract">β-Lapachone activates a novel apoptotic response in a no. of cell lines.  We demonstrate that the enzyme NAD(P)H:quinone oxidoreductase (NQO1) substantially enhances the toxicity of β-lapachone.  NQO1 expression directly correlated with sensitivity to a 4-h pulse of β-lapachone in a panel of breast cancer cell lines, and the NQO1 inhibitor, dicoumarol, significantly protected NQO1-expressing cells from all aspects of β-lapachone toxicity.  Stable transfection of the NQO1-deficient cell line, MDA-MB-468, with an NQO1 expression plasmid increased apoptotic responses and lethality after β-lapachone exposure.  Dicoumarol blocked both the apoptotic responses and lethality.  Biochem. studies suggest that redn. of β-lapachone by NQO1 leads to a futile cycling between the quinone and hydroquinone forms, with a concomitant loss of reduced NAD(P)H.  In addn., the activation of a cysteine protease, which has characteristics consistent with the neutral calcium-dependent protease, calpain, is obsd. after β-lapachone treatment.  This is the first definitive elucidation of an intracellular target for β-lapachone in tumor cells.  NQO1 could be exploited for gene therapy, radiotherapy, and/or chemopreventive interventions, since the enzyme is elevated in a no. of tumor types (i.e. breast and lung) and during neoplastic transformation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpmejdtPaHOP7Vg90H21EOLACvtfcHk0ljM77illVHSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXhsFKksL0%253D&md5=3182b82635d926242124dbf0791e22ee</span></div><a href="/servlet/linkout?suffix=cit124&amp;dbid=16384&amp;doi=10.1074%2Fjbc.275.8.5416&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.275.8.5416%26sid%3Dliteratum%253Aachs%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DPlanchon%26aufirst%3DS.%2BM.%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DVarnes%26aufirst%3DM.%2BE.%26aulast%3DSiegel%26aufirst%3DD.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520activity%2520is%2520the%2520principal%2520determinant%2520of%2520beta-lapachone%2520cytotoxicity%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2000%26volume%3D275%26spage%3D5416%26epage%3D5424%26doi%3D10.1074%2Fjbc.275.8.5416" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref125"><div class="reference"><strong class="refLabel"><a href="#ref125" class="rightTabRefNumLink">125</a></strong><div class="NLM_citation" id="rightTab-cit125"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planchon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D.</span></span> <span> </span><span class="NLM_article-title">A. beta-lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3</span>. <i>Exp. Cell Res.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>267</i></span>,  <span class="NLM_fpage">95</span>– <span class="NLM_lpage">106</span>, <span class="refDoi"> DOI: 10.1006/excr.2001.5234</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1006%2Fexcr.2001.5234" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=11412042" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref125/cit125&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3MXksVWqt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=267&publication_year=2001&pages=95-106&author=S.+M.+Planchonauthor=J.+J.+Pinkauthor=C.+Tagliarinoauthor=W.+G.+Bornmannauthor=M.+E.+Varnesauthor=D.+Boothman&title=A.+beta-lapachone-induced+apoptosis+in+human+prostate+cancer+cells%3A+involvement+of+NQO1%2Fxip3&doi=10.1006%2Fexcr.2001.5234"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit125R"><div class="casContent"><span class="casTitleNuber">125</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lapachone-induced apoptosis in human prostate cancer cells: involvement of NQO1/xip3</span></div><div class="casAuthors">Planchon, Sarah M.; Pink, John J.; Tagliarino, Colleen; Bornmann, William G.; Varnes, Marie E.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Experimental Cell Research</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">267</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">95-106</span>CODEN:
                <span class="NLM_cas:coden">ECREAL</span>;
        ISSN:<span class="NLM_cas:issn">0014-4827</span>.
    
            (<span class="NLM_cas:orgname">Academic Press</span>)
        </div><div class="casAbstract">β-Lapachone (β-lap) induces apoptosis in various cancer cells, and its intracellular target has recently been elucidated in breast cancer cells.  Here we show that NAD(P)H:quinone oxidoreductase (NQO1/xip3) expression in human prostate cancer cells is a key determinant for apoptosis and lethality after β-lap exposures.  β-Lap-treated, NQO1-deficient LNCaP cells were significantly more resistant to apoptosis than NQO1-expressing DU-145 or PC-3 cells after drug exposures.  Formation of an atypical 60-kDa PARP cleavage fragment in DU-145 or PC-3 cells was obsd. after 10 μM β-lap treatment and correlated with apoptosis.  In contrast, LNCaP cells required 25 μM β-lap to induce similar responses.  Atypical PARP cleavage in β-lap-treated cells was not affected by 100 μM zVAD-fmk; however, coadministration of dicoumarol, a specific inhibitor of NQO1, reduced β-lap-mediated cytotoxicity, apoptosis, and atypical PARP cleavage in NQO1-expressing cells.  Dicoumarol did not affect the more β-lap-resistant LNCaP cells.  Stable transfection of LNCaP cells with NQO1 increased their sensitivity to β-lap, enhancing apoptosis compared to parental LNCaP cells or vector-alone transfectants.  Dicoumarol increased survival of β-lap-treated NQO1-expressing LNCaP transfectants.  NQO1 activity, therefore, is a key determinant of β-lap-mediated apoptosis and cytotoxicity in prostate cancer cells.  (c) 2001 Academic Press.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqmEt0va0_k07Vg90H21EOLACvtfcHk0ljM77illVHSrg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXksVWqt7g%253D&md5=35e863f0219e0303360fe20879aab356</span></div><a href="/servlet/linkout?suffix=cit125&amp;dbid=16384&amp;doi=10.1006%2Fexcr.2001.5234&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1006%252Fexcr.2001.5234%26sid%3Dliteratum%253Aachs%26aulast%3DPlanchon%26aufirst%3DS.%2BM.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DVarnes%26aufirst%3DM.%2BE.%26aulast%3DBoothman%26aufirst%3DD.%26atitle%3DA.%2520beta-lapachone-induced%2520apoptosis%2520in%2520human%2520prostate%2520cancer%2520cells%253A%2520involvement%2520of%2520NQO1%252Fxip3%26jtitle%3DExp.%2520Cell%2520Res.%26date%3D2001%26volume%3D267%26spage%3D95%26epage%3D106%26doi%3D10.1006%2Fexcr.2001.5234" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref126"><div class="reference"><strong class="refLabel"><a href="#ref126" class="rightTabRefNumLink">126</a></strong><div class="NLM_citation" id="rightTab-cit126"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, C. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C. W.</span></span> <span> </span><span class="NLM_article-title">Heat-induced up-regulation of NAD(P)H:quinone oxidoreductase potentiates anticancer effects of beta-lapachone</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">8866</span>– <span class="NLM_lpage">8871</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-05-0818</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-05-0818" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=16361576" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref126/cit126&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsbfP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=8866-8871&author=H.+J.+Parkauthor=E.+K.+Choiauthor=J.+Choiauthor=K.+J.+Ahnauthor=E.+J.+Kimauthor=I.+M.+Jiauthor=Y.+H.+Kookauthor=S.+D.+Ahnauthor=B.+Williamsauthor=R.+Griffinauthor=D.+A.+Boothmanauthor=C.+K.+Leeauthor=C.+W.+Song&title=Heat-induced+up-regulation+of+NAD%28P%29H%3Aquinone+oxidoreductase+potentiates+anticancer+effects+of+beta-lapachone&doi=10.1158%2F1078-0432.CCR-05-0818"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit126R"><div class="casContent"><span class="casTitleNuber">126</span><div class="casTitle"><span class="NLM_cas:atitle">Heat-Induced Up-Regulation of NAD(P)H:Quinone Oxidoreductase Potentiates Anticancer Effects of β-Lapachone</span></div><div class="casAuthors">Park, Heon Joo; Choi, Eun Kyung; Choi, Jihyung; Ahn, Ki-Jung; Kim, Eun Jung; Ji, In-Mi; Kook, Yeon Hee; Ahn, Seung-Do; Williams, Brent; Griffin, Robert; Boothman, David A.; Lee, Chung K.; Song, Chang W.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">24, Pt. 1</span>),
    <span class="NLM_cas:pages">8866-8871</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">The purpose of the present study was to evaluate the efficacy of mild hyperthermia to potentiate the anticancer effects of β-lapachone (3,4-dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione) by up-regulating NAD(P)H:quinone oxidoreductase (NQO1) in cancer cells.  Effects of β-lapachone alone or in combination with mild heating on the clonogenic survival of FSaII fibrosarcoma cells of C3H mice and A549 human lung tumor cells in vitro was detd.  Effects of heating on the NQO1 level in the cancer cells in vitro were assessed using Western blot anal. for NQO1 expression, biochem. detn. of NQO1 activity, and immunofluorescence microscopy for NQO1 expression.  Growth of FSaII tumors in the hind legs of C3H mice was detd. after treating the host mice with i.p. injection of 45 mg/kg {szligbeta}-lapachone followed by heating the tumors at 42° for 1 h every other day for four times.  Incubation of FSaII tumor cells and A549 tumor cells with β-lapachone at 37° reduced clonogenic survival of the cells in dose-dependent and incubation time-dependent manner.  NQO1 level in the cancer cells in vitro increased within 1 h after heating at 42° for 1 h and remained elevated for >72 h.  The clonogenic cell death caused by β-lapachone increased in parallel with the increase in NQO1 levels in heated cells.  Heating FSaII tumors in the legs of C3H mice enhanced the effect of i.p.-injected β-lapachone in suppressing tumor growth.  We obsd. for the first time that mild heat shock up-regulates NQO1 in tumor cells.  The heat-induced up-regulation of NQO1 enhanced the anticancer effects of β-lapachone in vitro and in vivo.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7LCZgdZOnMLVg90H21EOLACvtfcHk0lgN_7jLB6_e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXhtlWrsbfP&md5=bd213ea002cc1ce93f3595850acac450</span></div><a href="/servlet/linkout?suffix=cit126&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-05-0818&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-05-0818%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DChoi%26aufirst%3DE.%2BK.%26aulast%3DChoi%26aufirst%3DJ.%26aulast%3DAhn%26aufirst%3DK.%2BJ.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DJi%26aufirst%3DI.%2BM.%26aulast%3DKook%26aufirst%3DY.%2BH.%26aulast%3DAhn%26aufirst%3DS.%2BD.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DGriffin%26aufirst%3DR.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DLee%26aufirst%3DC.%2BK.%26aulast%3DSong%26aufirst%3DC.%2BW.%26atitle%3DHeat-induced%2520up-regulation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520potentiates%2520anticancer%2520effects%2520of%2520beta-lapachone%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D8866%26epage%3D8871%26doi%3D10.1158%2F1078-0432.CCR-05-0818" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref127"><div class="reference"><strong class="refLabel"><a href="#ref127" class="rightTabRefNumLink">127</a></strong><div class="NLM_citation" id="rightTab-cit127"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E. K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Terai, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ji, I. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, K. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lim, B. U.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, D. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Loren, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span> <span> </span><span class="NLM_article-title">Upregulation of NAD(P)H:quinone oxidoreductase by radiation potentiates the effect of bioreductive β-lapachone on cancer cells</span>. <i>Neoplasia</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">634</span>– <span class="NLM_lpage">642</span>, <span class="refDoi"> DOI: 10.1593/neo.07397</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref127/cit127&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1593%2Fneo.07397" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2007&pages=634-642&author=E.+K.+Choiauthor=K.+Teraiauthor=I.+M.+Jiauthor=Y.+H.+Kookauthor=K.+H.+Parkauthor=E.+T.+Ohauthor=R.+J.+Griffinauthor=B.+U.+Limauthor=J.+S.+Kimauthor=D.+S.+Leeauthor=D.+A.+Boothmanauthor=M.+Lorenauthor=C.+W.+Songauthor=H.+J.+Park&title=Upregulation+of+NAD%28P%29H%3Aquinone+oxidoreductase+by+radiation+potentiates+the+effect+of+bioreductive+%CE%B2-lapachone+on+cancer+cells&doi=10.1593%2Fneo.07397"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit127&amp;dbid=16384&amp;doi=10.1593%2Fneo.07397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1593%252Fneo.07397%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DE.%2BK.%26aulast%3DTerai%26aufirst%3DK.%26aulast%3DJi%26aufirst%3DI.%2BM.%26aulast%3DKook%26aufirst%3DY.%2BH.%26aulast%3DPark%26aufirst%3DK.%2BH.%26aulast%3DOh%26aufirst%3DE.%2BT.%26aulast%3DGriffin%26aufirst%3DR.%2BJ.%26aulast%3DLim%26aufirst%3DB.%2BU.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26aulast%3DLee%26aufirst%3DD.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DLoren%26aufirst%3DM.%26aulast%3DSong%26aufirst%3DC.%2BW.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26atitle%3DUpregulation%2520of%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520by%2520radiation%2520potentiates%2520the%2520effect%2520of%2520bioreductive%2520%25CE%25B2-lapachone%2520on%2520cancer%2520cells%26jtitle%3DNeoplasia%26date%3D2007%26volume%3D9%26spage%3D634%26epage%3D642%26doi%3D10.1593%2Fneo.07397" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref128"><div class="reference"><strong class="refLabel"><a href="#ref128" class="rightTabRefNumLink">128</a></strong><div class="NLM_citation" id="rightTab-cit128"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ahn, S. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Choi, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, S. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Griffin, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Song, C. W.</span></span> <span> </span><span class="NLM_article-title">Susceptibility of cancer cells to beta-lapachone is enhanced by ionizing radiation</span>. <i>Int. J. Radiat. Oncol., Biol., Phys.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>61</i></span>,  <span class="NLM_fpage">212</span>– <span class="NLM_lpage">219</span>, <span class="refDoi"> DOI: 10.1016/j.ijrobp.2004.09.018</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ijrobp.2004.09.018" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15629614" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref128/cit128&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjsVGj" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2005&pages=212-219&author=H.+J.+Parkauthor=K.+J.+Ahnauthor=S.+D.+Ahnauthor=E.+Choiauthor=S.+W.+Leeauthor=B.+Williamsauthor=E.+J.+Kimauthor=R.+Griffinauthor=E.+A.+Beyauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=H.+J.+Parkauthor=D.+A.+Boothmanauthor=C.+W.+Song&title=Susceptibility+of+cancer+cells+to+beta-lapachone+is+enhanced+by+ionizing+radiation&doi=10.1016%2Fj.ijrobp.2004.09.018"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit128R"><div class="casContent"><span class="casTitleNuber">128</span><div class="casTitle"><span class="NLM_cas:atitle">Susceptibility of cancer cells to β-lapachone is enhanced by ionizing radiation</span></div><div class="casAuthors">Park, Heon Joo; Ahn, Ki-Jung; Ahn, Seung-Do; Choi, Eunkyung; Lee, Sang Wook; Williams, Brent; Kim, Eun Jung; Griffin, Robert; Bey, Erik A.; Bornmann, William G.; Gao, Jinming; Park, Heon Jin; Boothman, David A.; Song, Chang W.</div><div class="citationInfo"><span class="NLM_cas:title">International Journal of Radiation Oncology, Biology, Physics</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">61</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">212-219</span>CODEN:
                <span class="NLM_cas:coden">IOBPD3</span>;
        ISSN:<span class="NLM_cas:issn">0360-3016</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Purpose: To reveal the interaction between β-lapachone (β-lap) and ionizing radiation (IR) in causing clonogenic death in cancer cells and to elucidate the potential usefulness of β-lap treatment in combination with radiotherapy of cancer.  Materials and Methods: FSaII tumor cells of C3H mice were used.  The cytotoxicity of β-lap alone or in combination with IR in vitro was detd. using clonogenic survival assay method.  The IR-induced changes in the expression and the enzymic activity of NAD(P)H:quinone oxidoreductase (NQO1), a mediator of β-lap cytotoxicity, were elucidated and the relationship between the NQO1 level and the sensitivity of cells to β-lap was investigated.  The combined effect of IR and β-lap to suppress tumor growth was studied using FSaII tumors grown s.c. in the thigh of C3H mice.  Results: β-Lap caused clonogenic death of FSaII tumor cells in vitro in a dose- and time-dependent manner.  When cells were treated first with β-lap and then exposed to IR in vitro, the resultant cell death was only additive.  On the contrary, exposing cells to IR at 2.5 Gy first and then treating the cells with β-lap killed the cells in a synergistic manner.  Importantly, the 2.5 Gy cells were sensitive to β-lap as long as 10 h after irradn., which was long after the sublethal radiation damage was repaired.  Irradn. of FSaII cells in vitro with 2.5 Gy significantly increased the expression and enzymic activity of NQO1.  The growth delay of FSaII tumors caused by an i.p. injection of β-lap in combination with 20 Gy irradn. of tumor was significantly greater than that caused by β-lap or 20 Gy irradn. alone.  Conclusion: The sensitivity of cells to β-lap is dependent on NQO1 activity.  IR caused a long-lasting increase in NQO1 activity in cancer cells, thereby sensitizing cells to β-lap and treatment of exptl. mouse tumors with IR and β-lap suppressed tumor growth in a synergistic manner.  The combination of β-lap and radiotherapy is a potentially effective regimen for the treatment of human cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqQhLvMaqOJbVg90H21EOLACvtfcHk0lgN_7jLB6_e7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjsVGj&md5=f7253b79dcf9eac433123ef7cd67889d</span></div><a href="/servlet/linkout?suffix=cit128&amp;dbid=16384&amp;doi=10.1016%2Fj.ijrobp.2004.09.018&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ijrobp.2004.09.018%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DAhn%26aufirst%3DK.%2BJ.%26aulast%3DAhn%26aufirst%3DS.%2BD.%26aulast%3DChoi%26aufirst%3DE.%26aulast%3DLee%26aufirst%3DS.%2BW.%26aulast%3DWilliams%26aufirst%3DB.%26aulast%3DKim%26aufirst%3DE.%2BJ.%26aulast%3DGriffin%26aufirst%3DR.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DSong%26aufirst%3DC.%2BW.%26atitle%3DSusceptibility%2520of%2520cancer%2520cells%2520to%2520beta-lapachone%2520is%2520enhanced%2520by%2520ionizing%2520radiation%26jtitle%3DInt.%2520J.%2520Radiat.%2520Oncol.%252C%2520Biol.%252C%2520Phys.%26date%3D2005%26volume%3D61%26spage%3D212%26epage%3D219%26doi%3D10.1016%2Fj.ijrobp.2004.09.018" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref129"><div class="reference"><strong class="refLabel"><a href="#ref129" class="rightTabRefNumLink">129</a></strong><div class="NLM_citation" id="rightTab-cit129"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srougi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Varnes, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, V. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rommel, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boatman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lewis, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Euhus, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Buchsbaum, D. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Catalase abrogates beta-lapachone-induced PARP1 hyperactivation-directed programmed necrosis in NQO1-positive breast cancers</span>. <i>Mol. Cancer Ther.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">2110</span>– <span class="NLM_lpage">2120</span>, <span class="refDoi"> DOI: 10.1158/1535-7163.MCT-12-0962</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1535-7163.MCT-12-0962" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23883585" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref129/cit129&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXhsFOhurvI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2013&pages=2110-2120&author=E.+A.+Beyauthor=K.+E.+Reinickeauthor=M.+C.+Srougiauthor=M.+Varnesauthor=V.+E.+Andersonauthor=J.+J.+Pinkauthor=L.+S.+Liauthor=M.+Patelauthor=L.+Caoauthor=Z.+Mooreauthor=A.+Rommelauthor=M.+Boatmanauthor=C.+Lewisauthor=D.+M.+Euhusauthor=W.+G.+Bornmannauthor=D.+J.+Buchsbaumauthor=D.+R.+Spitzauthor=J.+Gaoauthor=D.+A.+Boothman&title=Catalase+abrogates+beta-lapachone-induced+PARP1+hyperactivation-directed+programmed+necrosis+in+NQO1-positive+breast+cancers&doi=10.1158%2F1535-7163.MCT-12-0962"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit129R"><div class="casContent"><span class="casTitleNuber">129</span><div class="casTitle"><span class="NLM_cas:atitle">Catalase Abrogates β-Lapachone-Induced PARP1 Hyperactivation-Directed Programmed Necrosis in NQO1-Positive Breast Cancers</span></div><div class="casAuthors">Bey, Erik A.; Reinicke, Kathryn E.; Srougi, Melissa C.; Varnes, Marie; Anderson, Vernon E.; Pink, John J.; Li, Long Shan; Patel, Malina; Cao, Lifen; Moore, Zachary; Rommel, Amy; Boatman, Michael; Lewis, Cheryl; Euhus, David M.; Bornmann, William G.; Buchsbaum, Donald J.; Spitz, Douglas R.; Gao, Jinming; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Cancer Therapeutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">2110-2120</span>CODEN:
                <span class="NLM_cas:coden">MCTOCF</span>;
        ISSN:<span class="NLM_cas:issn">1535-7163</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Improving patient outcome by personalized therapy involves a thorough understanding of an agent's mechanism of action. β-Lapachone (clin. forms, Arq501/Arq761) has been developed to exploit dramatic cancer-specific elevations in the phase II detoxifying enzyme NAD(P)H:quinone oxidoreductase (NQO1).  NQO1 is dramatically elevated in solid cancers, including primary and metastatic [e.g., triple-neg. (ER-, PR-, Her2/Neu-)] breast cancers.  To define cellular factors that influence the efficacy of β-lapachone using knowledge of its mechanism of action, we confirmed that NQO1 was required for lethality and mediated a futile redox cycle where ∼120 mol of superoxide were formed per mol of β-lapachone in 2 min. β-Lapachone induced reactive oxygen species (ROS), stimulated DNA single-strand break-dependent poly(ADP-ribose) polymerase-1 (PARP1) hyperactivation, caused dramatic loss of essential nucleotides (NAD+/ATP), and elicited programmed necrosis in breast cancer cells.  Although PARP1 hyperactivation and NQO1 expression were major determinants of β-lapachone-induced lethality, alterations in catalase expression, including treatment with exogenous enzyme, caused marked cytoprotection.  Thus, catalase is an important resistance factor and highlights H2O2 as an obligate ROS for cell death from this agent.  Exogenous superoxide dismutase enhanced catalase-induced cytoprotection. β-Lapachone-induced cell death included apoptosis-inducing factor (AIF) translocation from mitochondria to nuclei, TUNEL+ staining, atypical PARP1 cleavage, and glyceraldehyde 3-phosphate dehydrogenase S-nitrosylation, which were abrogated by catalase.  We predict that the ratio of NQO1:catalase activities in breast cancer vs. assocd. normal tissue are likely to be the major determinants affecting the therapeutic window of β-lapachone and other NQO1 bioactivatable drugs.  Mol Cancer Ther; 12(10); 2110-20. ©2013 AACR.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrmcAmBm9B5CLVg90H21EOLACvtfcHk0liVX7V8_5NIlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXhsFOhurvI&md5=7e6d291985715c425fe3b6db7d85e549</span></div><a href="/servlet/linkout?suffix=cit129&amp;dbid=16384&amp;doi=10.1158%2F1535-7163.MCT-12-0962&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1535-7163.MCT-12-0962%26sid%3Dliteratum%253Aachs%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DSrougi%26aufirst%3DM.%2BC.%26aulast%3DVarnes%26aufirst%3DM.%26aulast%3DAnderson%26aufirst%3DV.%2BE.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DCao%26aufirst%3DL.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DRommel%26aufirst%3DA.%26aulast%3DBoatman%26aufirst%3DM.%26aulast%3DLewis%26aufirst%3DC.%26aulast%3DEuhus%26aufirst%3DD.%2BM.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBuchsbaum%26aufirst%3DD.%2BJ.%26aulast%3DSpitz%26aufirst%3DD.%2BR.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCatalase%2520abrogates%2520beta-lapachone-induced%2520PARP1%2520hyperactivation-directed%2520programmed%2520necrosis%2520in%2520NQO1-positive%2520breast%2520cancers%26jtitle%3DMol.%2520Cancer%2520Ther.%26date%3D2013%26volume%3D12%26spage%3D2110%26epage%3D2120%26doi%3D10.1158%2F1535-7163.MCT-12-0962" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref130"><div class="reference"><strong class="refLabel"><a href="#ref130" class="rightTabRefNumLink">130</a></strong><div class="NLM_citation" id="rightTab-cit130"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spruell, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xiao, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Srougi, M. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabbani, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, C. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Morales, J. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motea, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yordy, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Tumor-selective, futile redox cycle-induced bystander effects elicited by NQO1 bioactivatable radiosensitizing drugs in triple-negative breast cancers</span>. <i>Antioxid. Redox Signaling</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>21</i></span>,  <span class="NLM_fpage">237</span>– <span class="NLM_lpage">250</span>, <span class="refDoi"> DOI: 10.1089/ars.2013.5462</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1089%2Fars.2013.5462" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24512128" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref130/cit130&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXpvVWmu7o%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2014&pages=237-250&author=L.+Caoauthor=L.+S.+Liauthor=C.+Spruellauthor=L.+Xiaoauthor=G.+Chakrabartiauthor=E.+A.+Beyauthor=K.+E.+Reinickeauthor=M.+C.+Srougiauthor=Z.+Mooreauthor=Y.+Dongauthor=P.+Voauthor=W.+Kabbaniauthor=C.+R.+Yangauthor=X.+Wangauthor=F.+Fattahauthor=J.+C.+Moralesauthor=E.+A.+Moteaauthor=W.+G.+Bornmannauthor=J.+S.+Yordyauthor=D.+A.+Boothman&title=Tumor-selective%2C+futile+redox+cycle-induced+bystander+effects+elicited+by+NQO1+bioactivatable+radiosensitizing+drugs+in+triple-negative+breast+cancers&doi=10.1089%2Fars.2013.5462"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit130R"><div class="casContent"><span class="casTitleNuber">130</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-Selective, Futile Redox Cycle-Induced Bystander Effects Elicited by NQO1 Bioactivatable Radiosensitizing Drugs in Triple-Negative Breast Cancers</span></div><div class="casAuthors">Cao, Lifen; Li, Long Shan; Spruell, Christopher; Xiao, Ling; Chakrabarti, Gaurab; Bey, Erik A.; Reinicke, Kathryn E.; Srougi, Melissa C.; Moore, Zachary; Dong, Ying; Vo, Peggy; Kabbani, Wareef; Yang, Chin-Rang; Wang, Xiaoyu; Fattah, Farjana; Morales, Julio C.; Motea, Edward A.; Bornmann, William G.; Yordy, John S.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Antioxidants & Redox Signaling</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">237-250</span>CODEN:
                <span class="NLM_cas:coden">ARSIF2</span>;
        ISSN:<span class="NLM_cas:issn">1523-0864</span>.
    
            (<span class="NLM_cas:orgname">Mary Ann Liebert, Inc.</span>)
        </div><div class="casAbstract">Aims: β-Lapachone (β-lap), a novel radiosensitizer with potent antitumor efficacy alone, selectively kills solid cancers that over-express NAD(P)H:quinone oxidoreductase 1 (NQO1).  Since breast or other solid cancers have heterogeneous NQO1 expression, therapies that reduce the resistance (e.g., NQO1low) of tumor cells will have significant clin. advantages.  We tested whether NQO1-proficient (NQO1+) cells generated sufficient hydrogen peroxide (H2O2) after β-lap treatment to elicit bystander effects, DNA damage, and cell death in neighboring NQO1low cells.  Results: β-Lap showed NQO1-dependent efficacy against two triple-neg. breast cancer (TNBC) xenografts.  NQO1 expression variations in human breast cancer patient samples were noted, where ∼60% cancers over-expressed NQO1, with little or no expression in assocd. normal tissue.  Differential DNA damage and lethality were noted in NQO1+ vs. NQO1-deficient (NQO1-) TNBC cells and xenografts after β-lap treatment. β-Lap-treated NQO1+ cells died by programmed necrosis, whereas co-cultured NQO1- TNBC cells exhibited DNA damage and caspase-dependent apoptosis.  NQO1 inhibition (dicoumarol) or H2O2 scavenging (catalase [CAT]) blocked all responses.  Only NQO1- cells neighboring NQO1+ TNBC cells responded to β-lap in vitro, and bystander effects correlated well with H2O2 diffusion.  Bystander effects in NQO1- cells in vivo within mixed 50:50 co-cultured xenografts were dramatic and depended on NQO1+ cells.  However, normal human cells in vitro or in vivo did not show bystander effects, due to elevated endogenous CAT levels.  Innovation and Conclusions: NQO1-dependent bystander effects elicited by NQO1 bioactivatable drugs (β-lap or deoxynyboquinone [DNQ]) likely contribute to their efficacies, killing NQO1+ solid cancer cells and eliminating surrounding heterogeneous NQO1low cancer cells.  Normal cells/tissue are protected by low NQO1:CAT ratios.  Antioxid. Redox Signal. 21, 237-250.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGphMoZtdZjlmbVg90H21EOLACvtfcHk0liVX7V8_5NIlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXpvVWmu7o%253D&md5=1598ba93f40c7ed764f22d7d0d407205</span></div><a href="/servlet/linkout?suffix=cit130&amp;dbid=16384&amp;doi=10.1089%2Fars.2013.5462&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1089%252Fars.2013.5462%26sid%3Dliteratum%253Aachs%26aulast%3DCao%26aufirst%3DL.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DSpruell%26aufirst%3DC.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DSrougi%26aufirst%3DM.%2BC.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DVo%26aufirst%3DP.%26aulast%3DKabbani%26aufirst%3DW.%26aulast%3DYang%26aufirst%3DC.%2BR.%26aulast%3DWang%26aufirst%3DX.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DMorales%26aufirst%3DJ.%2BC.%26aulast%3DMotea%26aufirst%3DE.%2BA.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DYordy%26aufirst%3DJ.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DTumor-selective%252C%2520futile%2520redox%2520cycle-induced%2520bystander%2520effects%2520elicited%2520by%2520NQO1%2520bioactivatable%2520radiosensitizing%2520drugs%2520in%2520triple-negative%2520breast%2520cancers%26jtitle%3DAntioxid.%2520Redox%2520Signaling%26date%3D2014%26volume%3D21%26spage%3D237%26epage%3D250%26doi%3D10.1089%2Fars.2013.5462" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref131"><div class="reference"><strong class="refLabel"><a href="#ref131" class="rightTabRefNumLink">131</a></strong><div class="NLM_citation" id="rightTab-cit131"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kahanda, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McWilliams, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Slinker, J. D.</span></span> <span> </span><span class="NLM_article-title">Using DNA devices to track anticancer drug activity</span>. <i>Biosens. Bioelectron.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>80</i></span>,  <span class="NLM_fpage">647</span>– <span class="NLM_lpage">653</span>, <span class="refDoi"> DOI: 10.1016/j.bios.2016.02.026</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref131/cit131&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bios.2016.02.026" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=80&publication_year=2016&pages=647-653&author=D.+Kahandaauthor=G.+Chakrabartiauthor=M.+A.+McWilliamsauthor=D.+A.+Boothmanauthor=J.+D.+Slinker&title=Using+DNA+devices+to+track+anticancer+drug+activity&doi=10.1016%2Fj.bios.2016.02.026"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit131&amp;dbid=16384&amp;doi=10.1016%2Fj.bios.2016.02.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bios.2016.02.026%26sid%3Dliteratum%253Aachs%26aulast%3DKahanda%26aufirst%3DD.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DMcWilliams%26aufirst%3DM.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DSlinker%26aufirst%3DJ.%2BD.%26atitle%3DUsing%2520DNA%2520devices%2520to%2520track%2520anticancer%2520drug%2520activity%26jtitle%3DBiosens.%2520Bioelectron.%26date%3D2016%26volume%3D80%26spage%3D647%26epage%3D653%26doi%3D10.1016%2Fj.bios.2016.02.026" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref132"><div class="reference"><strong class="refLabel"><a href="#ref132" class="rightTabRefNumLink">132</a></strong><div class="NLM_citation" id="rightTab-cit132"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolluyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deberardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Laheru, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer</span>. <i>J. Surg. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>116</i></span>,  <span class="NLM_fpage">83</span>– <span class="NLM_lpage">88</span>, <span class="refDoi"> DOI: 10.1002/jso.24624</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fjso.24624" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28346693" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref132/cit132&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtVygurnO" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=116&publication_year=2017&pages=83-88&author=M.+S.+Begauthor=X.+Huangauthor=M.+A.+Silversauthor=D.+E.+Gerberauthor=J.+Bolluytauthor=V.+Sarodeauthor=F.+Fattahauthor=R.+J.+Deberardinisauthor=M.+E.+Merrittauthor=X.+J.+Xieauthor=R.+Leffauthor=D.+Laheruauthor=D.+A.+Boothman&title=Using+a+novel+NQO1+bioactivatable+drug%2C+beta-lapachone+%28ARQ761%29%2C+to+enhance+chemotherapeutic+effects+by+metabolic+modulation+in+pancreatic+cancer&doi=10.1002%2Fjso.24624"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit132R"><div class="casContent"><span class="casTitleNuber">132</span><div class="casTitle"><span class="NLM_cas:atitle">Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer</span></div><div class="casAuthors">Beg, Muhammad Shaalan; Huang, Xiumei; Silvers, Molly A.; Gerber, David E.; Bolluyt, Joyce; Sarode, Venetia; Fattah, Farjana; Deberardinis, Ralph J.; Merritt, Matthew E.; Xie, Xian-Jin; Leff, Richard; Laheru, Daniel; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Surgical Oncology</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">116</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">83-88</span>CODEN:
                <span class="NLM_cas:coden">JSONAU</span>;
        ISSN:<span class="NLM_cas:issn">0022-4790</span>.
    
            (<span class="NLM_cas:orgname">Wiley-Blackwell</span>)
        </div><div class="casAbstract">Novel, tumor-selective therapies are needed to increase the survival rate of pancreatic cancer patients.  K-Ras-mutant-driven NAD(P)H:quinone oxidoreductase 1 (NQO1) is over-expressed in pancreatic tumor vs. assocd. normal tissue, while catalase expression is lowered compared to levels in assocd. normal pancreas tissue.  ARQ761 undergoes a robust, futile redox cycle in NQO1+ cancer cells, producing massive hydrogen peroxide (H2O2) levels; normal tissues are spared by low NQO1 and high catalase expression.  DNA damage created by ARQ761 in pancreatic cancer cells "hyperactivates" PARP1, causing metabolic catastrophe and NAD ± keresis cell death.  NQO1: catalase levels (high in tumor, low in normal tissue) are an attractive therapeutic window to treat pancreatic cancer.  Based on a growing body of literature, we are leading a clin. trial to evaluate the combination of ARQ761 and chemotherapy in patients with pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoaBal4wQsDvrVg90H21EOLACvtfcHk0liVX7V8_5NIlA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtVygurnO&md5=112175579bfd4fee03af28ec69ee0ffa</span></div><a href="/servlet/linkout?suffix=cit132&amp;dbid=16384&amp;doi=10.1002%2Fjso.24624&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjso.24624%26sid%3Dliteratum%253Aachs%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBolluyt%26aufirst%3DJ.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DDeberardinis%26aufirst%3DR.%2BJ.%26aulast%3DMerritt%26aufirst%3DM.%2BE.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DLeff%26aufirst%3DR.%26aulast%3DLaheru%26aufirst%3DD.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DUsing%2520a%2520novel%2520NQO1%2520bioactivatable%2520drug%252C%2520beta-lapachone%2520%2528ARQ761%2529%252C%2520to%2520enhance%2520chemotherapeutic%2520effects%2520by%2520metabolic%2520modulation%2520in%2520pancreatic%2520cancer%26jtitle%3DJ.%2520Surg.%2520Oncol.%26date%3D2017%26volume%3D116%26spage%3D83%26epage%3D88%26doi%3D10.1002%2Fjso.24624" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref133"><div class="reference"><strong class="refLabel"><a href="#ref133" class="rightTabRefNumLink">133</a></strong><div class="NLM_citation" id="rightTab-cit133"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dubyak, G. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nieminen, A. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Calcium is a key signaling molecule in beta-lapachone-mediated cell death</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2001</span>,  <span class="NLM_volume"><i>276</i></span>,  <span class="NLM_fpage">19150</span>– <span class="NLM_lpage">19159</span>, <span class="refDoi"> DOI: 10.1074/jbc.M100730200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref133/cit133&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M100730200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=276&publication_year=2001&pages=19150-19159&author=C.+Tagliarinoauthor=J.+J.+Pinkauthor=G.+R.+Dubyakauthor=A.+L.+Nieminenauthor=D.+A.+Boothman&title=Calcium+is+a+key+signaling+molecule+in+beta-lapachone-mediated+cell+death&doi=10.1074%2Fjbc.M100730200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit133&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M100730200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M100730200%26sid%3Dliteratum%253Aachs%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DDubyak%26aufirst%3DG.%2BR.%26aulast%3DNieminen%26aufirst%3DA.%2BL.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCalcium%2520is%2520a%2520key%2520signaling%2520molecule%2520in%2520beta-lapachone-mediated%2520cell%2520death%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2001%26volume%3D276%26spage%3D19150%26epage%3D19159%26doi%3D10.1074%2Fjbc.M100730200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref134"><div class="reference"><strong class="refLabel"><a href="#ref134" class="rightTabRefNumLink">134</a></strong><div class="NLM_citation" id="rightTab-cit134"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Spitz, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Calcium-dependent modulation of poly(ADP-ribose) polymerase-1 alters cellular metabolism and DNA repair</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>281</i></span>,  <span class="NLM_fpage">33684</span>– <span class="NLM_lpage">33696</span>, <span class="refDoi"> DOI: 10.1074/jbc.M603678200</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref134/cit134&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M603678200" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=281&publication_year=2006&pages=33684-33696&author=M.+S.+Bentleauthor=K.+E.+Reinickeauthor=E.+A.+Beyauthor=D.+R.+Spitzauthor=D.+A.+Boothman&title=Calcium-dependent+modulation+of+poly%28ADP-ribose%29+polymerase-1+alters+cellular+metabolism+and+DNA+repair&doi=10.1074%2Fjbc.M603678200"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit134&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M603678200&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M603678200%26sid%3Dliteratum%253Aachs%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DSpitz%26aufirst%3DD.%2BR.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DCalcium-dependent%2520modulation%2520of%2520poly%2528ADP-ribose%2529%2520polymerase-1%2520alters%2520cellular%2520metabolism%2520and%2520DNA%2520repair%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2006%26volume%3D281%26spage%3D33684%26epage%3D33696%26doi%3D10.1074%2Fjbc.M603678200" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref135"><div class="reference"><strong class="refLabel"><a href="#ref135" class="rightTabRefNumLink">135</a></strong><div class="NLM_citation" id="rightTab-cit135"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilcheva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerson, S. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone</span>. <i>Sci. Rep.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">17066</span>, <span class="refDoi"> DOI: 10.1038/srep17066</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fsrep17066" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26602448" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref135/cit135&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhvFentL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2015&pages=17066&author=G.+Chakrabartiauthor=M.+A.+Silversauthor=M.+Ilchevaauthor=Y.+Liuauthor=Z.+R.+Mooreauthor=X.+Luoauthor=J.+Gaoauthor=G.+Andersonauthor=L.+Liuauthor=V.+Sarodeauthor=D.+E.+Gerberauthor=S.+Burmaauthor=R.+J.+DeBerardinisauthor=S.+L.+Gersonauthor=D.+A.+Boothman&title=Tumor-selective+use+of+DNA+base+excision+repair+inhibition+in+pancreatic+cancer+using+the+NQO1+bioactivatable+drug%2C+%CE%B2-lapachone&doi=10.1038%2Fsrep17066"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit135R"><div class="casContent"><span class="casTitleNuber">135</span><div class="casTitle"><span class="NLM_cas:atitle">Tumor-selective use of DNA base excision repair inhibition in pancreatic cancer using the NQO1 bioactivatable drug, β-lapachone</span></div><div class="casAuthors">Chakrabarti, Gaurab; Silvers, Molly A.; Ilcheva, Mariya; Liu, Yuliang; Moore, Zachary R.; Luo, Xiuquan; Gao, Jinming; Anderson, Glenda; Liu, Lili; Sarode, Venetia; Gerber, David E.; Burma, Sandeep; DeBerardinis, Ralph J.; Gerson, Stanton L.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Scientific Reports</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">17066</span>CODEN:
                <span class="NLM_cas:coden">SRCEC3</span>;
        ISSN:<span class="NLM_cas:issn">2045-2322</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Base excision repair (BER) is an essential pathway for pancreatic ductal adenocarcinoma (PDA) survival.  Attempts to target this repair pathway have failed due to lack of tumor-selectivity and very limited efficacy.  The NAD(P)H:Quinone Oxidoreductase 1 (NQO1) bioactivatable drug, β-lapachone (ARQ761 in clin. form), can provide tumor-selective and enhanced synergy with BER inhibition.  β-Lapachone undergoes NQO1-dependent futile redox cycling, generating massive intracellular hydrogen peroxide levels and oxidative DNA lesions that stimulate poly(ADP-ribose) polymerase 1 (PARP1) hyperactivation.  Rapid NAD+/ATP depletion and programmed necrosis results.  To identify BER modulators essential for repair of β-lapachone-induced DNA base damage, a focused synthetic lethal RNAi screen demonstrated that silencing the BER scaffolding protein, XRCC1, sensitized PDA cells.  In contrast, depleting OGG1 N-glycosylase spared cells from ss-lap-induced lethality and blunted PARP1 hyperactivation.  Combining ss-lapachone with XRCC1 knockdown or methoxyamine (MeOX), an apyrimidinic/apurinic (AP)-modifying agent, led to NQO1-dependent synergistic killing in PDA, NSCLC, breast and head and neck cancers.  OGG1 knockdown, dicoumarol-treatment or NQO1- cancer cells were spared.  MeOX + ss-lapachone exposure resulted in elevated DNA double-strand breaks, PARP1 hyperactivation and TUNEL+ programmed necrosis.  Combination treatment caused dramatic antitumor activity, enhanced PARP1-hyperactivation in tumor tissue, and improved survival of mice bearing MiaPaca2-derived xenografts, with 33% apparent cures.  Significance: Targeting base excision repair (BER) alone has limited therapeutic potential for pancreatic or other cancers due to a general lack of tumor-selectivity.  Here, we present a treatment strategy that makes BER inhibition tumor-selective and NQO1-dependent for therapy of most solid neoplasms, particularly for pancreatic cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsbAMtgoNMBbVg90H21EOLACvtfcHk0ljFRl2mMN6NrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhvFentL7L&md5=368535061421af6bb824d2c2ed3ab645</span></div><a href="/servlet/linkout?suffix=cit135&amp;dbid=16384&amp;doi=10.1038%2Fsrep17066&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fsrep17066%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DIlcheva%26aufirst%3DM.%26aulast%3DLiu%26aufirst%3DY.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DAnderson%26aufirst%3DG.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBurma%26aufirst%3DS.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DGerson%26aufirst%3DS.%2BL.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DTumor-selective%2520use%2520of%2520DNA%2520base%2520excision%2520repair%2520inhibition%2520in%2520pancreatic%2520cancer%2520using%2520the%2520NQO1%2520bioactivatable%2520drug%252C%2520%25CE%25B2-lapachone%26jtitle%3DSci.%2520Rep.%26date%3D2015%26volume%3D5%26spage%3D17066%26doi%3D10.1038%2Fsrep17066" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref136"><div class="reference"><strong class="refLabel"><a href="#ref136" class="rightTabRefNumLink">136</a></strong><div class="NLM_citation" id="rightTab-cit136"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vemireddy, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by beta-lapachone</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>6</i></span>,  <span class="NLM_fpage">e1599</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.564</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fcddis.2014.564" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25590809" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref136/cit136&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhtFOiur4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2015&pages=e1599&author=Z.+Mooreauthor=G.+Chakrabartiauthor=X.+Luoauthor=A.+Aliauthor=Z.+Huauthor=F.+J.+Fattahauthor=R.+Vemireddyauthor=R.+J.+DeBerardinisauthor=R.+A.+Brekkenauthor=D.+A.+Boothman&title=NAMPT+inhibition+sensitizes+pancreatic+adenocarcinoma+cells+to+tumor-selective%2C+PAR-independent+metabolic+catastrophe+and+cell+death+induced+by+beta-lapachone&doi=10.1038%2Fcddis.2014.564"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit136R"><div class="casContent"><span class="casTitleNuber">136</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT inhibition sensitizes pancreatic adenocarcinoma cells to tumor-selective, PAR-independent metabolic catastrophe and cell death induced by β-lapachone</span></div><div class="casAuthors">Moore, Z.; Chakrabarti, G.; Luo, X.; Ali, A.; Hu, Z.; Fattah, F. J.; Vemireddy, R.; DeBerardinis, R. J.; Brekken, R. A.; Boothman, D. A.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">6</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">e1599</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors (e.g., FK866) target the most active pathway of NAD+ synthesis in tumor cells, but lack tumor-selectivity for use as a single agent.  Reducing NAD+ pools by inhibiting NAMPT primed pancreatic ductal adenocarcinoma (PDA) cells for poly(ADP ribose) polymerase (PARP1)-dependent cell death induced by the targeted cancer therapeutic, β-lapachone (β-lap, ARQ761), independent of poly(ADP ribose) (PAR) accumulation.  β-Lap is bioactivated by NADPH:quinone oxidoreductase 1 (NQO1) in a futile redox cycle that consumes oxygen and generates high levels of reactive oxygen species (ROS) that cause extensive DNA damage and rapid PARP1-mediated NAD+ consumption.  Synergy with FK866+β-lap was tumor-selective, only occurring in NQO1-overexpressing cancer cells, which is noted in a majority (∼85%) of PDA cases.  This treatment strategy simultaneously decreases NAD+ synthesis while increasing NAD+ consumption, reducing required doses and treatment times for both drugs and increasing potency.  These complementary mechanisms caused profound NAD(P)+ depletion and inhibited glycolysis, driving down ATP levels and preventing recovery normally obsd. with either agent alone.  Cancer cells died through an ROS-induced, μ-calpain-mediated programmed cell death process that kills independent of caspase activation and is not driven by PAR accumulation, which we call NAD+-Keresis.  Non-overlapping specificities of FK866 for PDA tumors that rely heavily on NAMPT-catalyzed NAD+ synthesis and β-lap for cancer cells with elevated NQO1 levels affords high tumor-selectivity.  The concept of reducing NAD+ pools in cancer cells to sensitize them to ROS-mediated cell death by β-lap is a novel strategy with potential application for pancreatic and other types of NQO1+ solid tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrYojGOGGFv8rVg90H21EOLACvtfcHk0ljFRl2mMN6NrA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhtFOiur4%253D&md5=ce78c1abbc5c0cd84fd7f843e4eb6e94</span></div><a href="/servlet/linkout?suffix=cit136&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.564&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.564%26sid%3Dliteratum%253Aachs%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DHu%26aufirst%3DZ.%26aulast%3DFattah%26aufirst%3DF.%2BJ.%26aulast%3DVemireddy%26aufirst%3DR.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DNAMPT%2520inhibition%2520sensitizes%2520pancreatic%2520adenocarcinoma%2520cells%2520to%2520tumor-selective%252C%2520PAR-independent%2520metabolic%2520catastrophe%2520and%2520cell%2520death%2520induced%2520by%2520beta-lapachone%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2015%26volume%3D6%26spage%3De1599%26doi%3D10.1038%2Fcddis.2014.564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref137"><div class="reference"><strong class="refLabel"><a href="#ref137" class="rightTabRefNumLink">137</a></strong><div class="NLM_citation" id="rightTab-cit137"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Motea, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patidar, P. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cholka, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cha, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Anderson, G. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kusko, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Peyton, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Minna, J. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Leveraging an NQO1 bioactivatable drug for tumor-selective use of poly(ADP-ribose) polymerase inhibitors</span>. <i>Cancer Cell</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>30</i></span>,  <span class="NLM_fpage">940</span>– <span class="NLM_lpage">952</span>, <span class="refDoi"> DOI: 10.1016/j.ccell.2016.11.006</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ccell.2016.11.006" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27960087" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref137/cit137&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XitVyisb%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=30&publication_year=2016&pages=940-952&author=X.+Huangauthor=E.+A.+Moteaauthor=Z.+R.+Mooreauthor=J.+Yaoauthor=Y.+Dongauthor=G.+Chakrabartiauthor=J.+A.+Kilgoreauthor=M.+A.+Silversauthor=P.+L.+Patidarauthor=A.+Cholkaauthor=F.+Fattahauthor=Y.+Chaauthor=G.+G.+Andersonauthor=R.+Kuskoauthor=M.+Peytonauthor=J.+Yanauthor=X.+J.+Xieauthor=V.+Sarodeauthor=N.+S.+Williamsauthor=J.+D.+Minnaauthor=M.+Begauthor=D.+E.+Gerberauthor=E.+A.+Beyauthor=D.+A.+Boothman&title=Leveraging+an+NQO1+bioactivatable+drug+for+tumor-selective+use+of+poly%28ADP-ribose%29+polymerase+inhibitors&doi=10.1016%2Fj.ccell.2016.11.006"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit137R"><div class="casContent"><span class="casTitleNuber">137</span><div class="casTitle"><span class="NLM_cas:atitle">Leveraging an NQO1 Bioactivatable Drug for Tumor-Selective Use of Poly(ADP-ribose) Polymerase Inhibitors</span></div><div class="casAuthors">Huang, Xiumei; Motea, Edward A.; Moore, Zachary R.; Yao, Jun; Dong, Ying; Chakrabarti, Gaurab; Kilgore, Jessica A.; Silvers, Molly A.; Patidar, Praveen L.; Cholka, Agnieszka; Fattah, Farjana; Cha, Yoonjeong; Anderson, Glenda G.; Kusko, Rebecca; Peyton, Michael; Yan, Jingsheng; Xie, Xian-Jin; Sarode, Venetia; Williams, Noelle S.; Minna, John D.; Beg, Muhammad; Gerber, David E.; Bey, Erik A.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">30</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">940-952</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Inc.</span>)
        </div><div class="casAbstract">Therapeutic drugs that block DNA repair, including poly(ADP-ribose) polymerase (PARP) inhibitors, fail due to lack of tumor-selectivity.  When PARP inhibitors and β-lapachone are combined, synergistic antitumor activity results from sustained NAD(P)H levels that refuel NQO1-dependent futile redox drug recycling.  Significant oxygen-consumption-rate/reactive oxygen species cause dramatic DNA lesion increases that are not repaired due to PARP inhibition.  In NQO1+ cancers, such as non-small-cell lung, pancreatic, and breast cancers, cell death mechanism switches from PARP1 hyperactivation-mediated programmed necrosis with β-lapachone monotherapy to synergistic tumor-selective, caspase-dependent apoptosis with PARP inhibitors and β-lapachone.  Synergistic antitumor efficacy and prolonged survival were noted in human orthotopic pancreatic and non-small-cell lung xenograft models, expanding use and efficacy of PARP inhibitors for human cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpjWh__hezw3bVg90H21EOLACvtfcHk0lhPFkyyhOFOdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitVyisb%252FP&md5=2de166b47e9886eb784c54e5bd9d85f1</span></div><a href="/servlet/linkout?suffix=cit137&amp;dbid=16384&amp;doi=10.1016%2Fj.ccell.2016.11.006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccell.2016.11.006%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMotea%26aufirst%3DE.%2BA.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DYao%26aufirst%3DJ.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DPatidar%26aufirst%3DP.%2BL.%26aulast%3DCholka%26aufirst%3DA.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DCha%26aufirst%3DY.%26aulast%3DAnderson%26aufirst%3DG.%2BG.%26aulast%3DKusko%26aufirst%3DR.%26aulast%3DPeyton%26aufirst%3DM.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DMinna%26aufirst%3DJ.%2BD.%26aulast%3DBeg%26aufirst%3DM.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DLeveraging%2520an%2520NQO1%2520bioactivatable%2520drug%2520for%2520tumor-selective%2520use%2520of%2520poly%2528ADP-ribose%2529%2520polymerase%2520inhibitors%26jtitle%3DCancer%2520Cell%26date%3D2016%26volume%3D30%26spage%3D940%26epage%3D952%26doi%3D10.1016%2Fj.ccell.2016.11.006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref138"><div class="reference"><strong class="refLabel"><a href="#ref138" class="rightTabRefNumLink">138</a></strong><div class="NLM_citation" id="rightTab-cit138"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways</span>. <i>Clin. Pharmacol.: Adv. Appl.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>7</i></span>,  <span class="NLM_fpage">57</span>– <span class="NLM_lpage">68</span>, <span class="refDoi"> DOI: 10.2147/CPAA.S79760</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.2147%2FCPAA.S79760" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25870517" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref138/cit138&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XosVCnsrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2015&pages=57-68&author=G.+Chakrabartiauthor=D.+E.+Gerberauthor=D.+A.+Boothman&title=Expanding+antitumor+therapeutic+windows+by+targeting+cancer-specific+nicotinamide+adenine+dinucleotide+phosphate-biogenesis+pathways&doi=10.2147%2FCPAA.S79760"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit138R"><div class="casContent"><span class="casTitleNuber">138</span><div class="casTitle"><span class="NLM_cas:atitle">Expanding antitumor therapeutic windows by targeting cancer-specific nicotinamide adenine dinucleotide phosphate-biogenesis pathways</span></div><div class="casAuthors">Chakrabarti, Gaurab; Gerber, David E.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Pharmacology: Advances and Applications</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">7</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">57-68</span>CODEN:
                <span class="NLM_cas:coden">CPAAGX</span>;
        ISSN:<span class="NLM_cas:issn">1179-1438</span>.
    
            (<span class="NLM_cas:orgname">Dove Medical Press Ltd.</span>)
        </div><div class="casAbstract">NADP (NADPH) biogenesis is an essential mechanism by which both normal and cancer cells maintain redox balance.  While antitumor approaches to treat cancers through elevated reactive oxygen species (ROS) are not new ideas, depleting specific NADPH-biogenesis pathways that control recovery and repair pathways are novel, viable approaches to enhance cancer therapy.  However, to elicit efficacious therapies exploiting NADPH-biogenic pathways, it is crucial to understand and specifically define the roles of NADPH-biogenesis pathways used by cancer cells for survival or recovery from cell stress.  It is equally important to select NADPH-biogenic pathways that are expendable or not utilized in normal tissue to avoid unwanted toxicity.  Here, we address recent literature that demonstrates specific tumor-selective NADPH-biogenesis pathways that can be exploited using agents that target specific cancer cell pathways normally not utilized in normal cells.  Defining NADPH-biogenesis profiles of specific cancer-types should enable novel strategies to exploit these therapeutic windows for increased efficacy against recalcitrant neoplastic disease, such as pancreatic cancers.  Accomplishing the goal of using ROS as a weapon against cancer cells will also require agents, such as NQO1 bioactivatable drugs, that selectively induce elevated ROS levels in cancer cells, while normal cells are protected.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp7ZG2MBvGkPbVg90H21EOLACvtfcHk0lhPFkyyhOFOdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XosVCnsrs%253D&md5=181547261dba18299cc40670c9d91fed</span></div><a href="/servlet/linkout?suffix=cit138&amp;dbid=16384&amp;doi=10.2147%2FCPAA.S79760&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2147%252FCPAA.S79760%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DGerber%26aufirst%3DD.%2BE.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DExpanding%2520antitumor%2520therapeutic%2520windows%2520by%2520targeting%2520cancer-specific%2520nicotinamide%2520adenine%2520dinucleotide%2520phosphate-biogenesis%2520pathways%26jtitle%3DClin.%2520Pharmacol.%253A%2520Adv.%2520Appl.%26date%3D2015%26volume%3D7%26spage%3D57%26epage%3D68%26doi%3D10.2147%2FCPAA.S79760" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref139"><div class="reference"><strong class="refLabel"><a href="#ref139" class="rightTabRefNumLink">139</a></strong><div class="NLM_citation" id="rightTab-cit139"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, E. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Min, K. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lee, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yoo, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, Y. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kwon, T. K.</span></span> <span> </span><span class="NLM_article-title">beta-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells</span>. <i>Cell Death Dis.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>5</i></span>,  <span class="NLM_fpage">e1230</span>, <span class="refDoi"> DOI: 10.1038/cddis.2014.202</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1038%2Fcddis.2014.202" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=24832602" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref139/cit139&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2cXnsl2ns7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2014&pages=e1230&author=E.+J.+Parkauthor=K.+J.+Minauthor=T.+J.+Leeauthor=Y.+H.+Yooauthor=Y.+S.+Kimauthor=T.+K.+Kwon&title=beta-Lapachone+induces+programmed+necrosis+through+the+RIP1-PARP-AIF-dependent+pathway+in+human+hepatocellular+carcinoma+SK-Hep1+cells&doi=10.1038%2Fcddis.2014.202"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit139R"><div class="casContent"><span class="casTitleNuber">139</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lapachone induces programmed necrosis through the RIP1-PARP-AIF-dependent pathway in human hepatocellular carcinoma SK-Hep1 cells</span></div><div class="casAuthors">Park, E. J.; Min, K.-J.; Lee, T.-J.; Yoo, Y. H.; Kim, Y.-S.; Kwon, T. K.</div><div class="citationInfo"><span class="NLM_cas:title">Cell Death & Disease</span>
        (<span class="NLM_cas:date">2014</span>),
    <span class="NLM_cas:volume">5</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">e1230</span>CODEN:
                <span class="NLM_cas:coden">CDDEA4</span>;
        ISSN:<span class="NLM_cas:issn">2041-4889</span>.
    
            (<span class="NLM_cas:orgname">Nature Publishing Group</span>)
        </div><div class="casAbstract">β-Lapachone activates multiple cell death mechanisms including apoptosis, autophagy and necrotic cell death in cancer cells.  In this study, we investigated β-lapachone-induced cell death and the underlying mechanisms in human hepatocellular carcinoma SK-Hep1 cells. β-Lapachone markedly induced cell death without caspase activation. β-Lapachone increased PI uptake and HMGB-1 release to extracellular space, which are markers of necrotic cell death.  Necrostatin-1 (a RIP1 kinase inhibitor) markedly inhibited β-lapachone-induced cell death and HMGB-1 release.  In addn., β-lapachone activated poly (ADP-ribosyl) polymerase-1(PARP-1) and promoted AIF release, and DPQ (a PARP-1 specific inhibitor) or AIF siRNA blocked β-lapachone-induced cell death.  Furthermore, necrostatin-1 blocked PARP-1 activation and cytosolic AIF translocation.  We also found that β-lapachone-induced reactive oxygen species (ROS) prodn. has an important role in the activation of the RIP1-PARP1-AIF pathway.  Finally, β-lapachone-induced cell death was inhibited by dicoumarol (a NQO-1 inhibitor), and NQO1 expression was correlated with sensitivity to β-lapachone.  Taken together, our results demonstrate that β-lapachone induces programmed necrosis through the NQO1-dependent ROS-mediated RIP1-PARP1-AIF pathway.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrGCvN1XjVf2LVg90H21EOLACvtfcHk0lhPFkyyhOFOdg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2cXnsl2ns7k%253D&md5=ba547ecf27b4ce19e808ae7805908edf</span></div><a href="/servlet/linkout?suffix=cit139&amp;dbid=16384&amp;doi=10.1038%2Fcddis.2014.202&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1038%252Fcddis.2014.202%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DE.%2BJ.%26aulast%3DMin%26aufirst%3DK.%2BJ.%26aulast%3DLee%26aufirst%3DT.%2BJ.%26aulast%3DYoo%26aufirst%3DY.%2BH.%26aulast%3DKim%26aufirst%3DY.%2BS.%26aulast%3DKwon%26aufirst%3DT.%2BK.%26atitle%3Dbeta-Lapachone%2520induces%2520programmed%2520necrosis%2520through%2520the%2520RIP1-PARP-AIF-dependent%2520pathway%2520in%2520human%2520hepatocellular%2520carcinoma%2520SK-Hep1%2520cells%26jtitle%3DCell%2520Death%2520Dis.%26date%3D2014%26volume%3D5%26spage%3De1230%26doi%3D10.1038%2Fcddis.2014.202" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref140"><div class="reference"><strong class="refLabel"><a href="#ref140" class="rightTabRefNumLink">140</a></strong><div class="NLM_citation" id="rightTab-cit140"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Tagliarino, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Simmers, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Mu-calpain activation in beta-lapachone-mediated apoptosis</span>. <i>Cancer Biol. Ther.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>2</i></span>,  <span class="NLM_fpage">141</span>– <span class="NLM_lpage">152</span>, <span class="refDoi"> DOI: 10.4161/cbt.2.2.237</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.4161%2Fcbt.2.2.237" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=12750552" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref140/cit140&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD3sXmvFGhsLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=2003&pages=141-152&author=C.+Tagliarinoauthor=J.+J.+Pinkauthor=K.+E.+Reinickeauthor=S.+M.+Simmersauthor=D.+A.+Boothman&title=Mu-calpain+activation+in+beta-lapachone-mediated+apoptosis&doi=10.4161%2Fcbt.2.2.237"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit140R"><div class="casContent"><span class="casTitleNuber">140</span><div class="casTitle"><span class="NLM_cas:atitle">μ-Calpain Activation in β-Lapachone-Mediated Apoptosis</span></div><div class="casAuthors">Tagliarino, Colleen; Pink, John J.; Reinicke, Kathryn E.; Simmers, Sara M.; Wuerzberger-Davis, Shelly M.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Biology & Therapy</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">141-152</span>CODEN:
                <span class="NLM_cas:coden">CBTAAO</span>;
        ISSN:<span class="NLM_cas:issn">1538-4047</span>.
    
            (<span class="NLM_cas:orgname">Landes Bioscience</span>)
        </div><div class="casAbstract">β-Lapachone (β-lap) triggers apoptosis in a no. of human breast and prostate cancer cell lines through a unique apoptotic pathway that is dependent upon NQO1, a two-electron reductase.  Recently, our lab. showed that β-lap-exposed MCF-7 cells exhibited an early increase in intracellular cytosolic Ca2+ from endoplasmic reticulum stores, and that BAPTA-AM (an intracellular Ca2+ chelator) blocked these early increases and partially inhibited all aspects of β-lap-induced apoptosis.  We now show that exposure of NQO1-expressing breast cancer cells to β-lap stimulates a unique proteolytic apoptotic pathway involving μ-calpain activation.  No apparent activation of m-calpain was noted.  Upon activation, μ-calpain translocated to the nucleus concomitant with specific nuclear proteolytic events.  Apoptotic responses in β-lap-exposed NQO1-expressing cells were significantly delayed and survival was enhanced by exogenous over-expression of calpastatin, a natural inhibitor of μ- and m-calpains.  Furthermore, purified μ-calpain cleaved PARP to a unique fragment (∼60 kDa), not previously reported for calpains.  We provide evidence that β-lap-induced, μ-calpain-stimulated apoptosis does not involve any known apoptotic caspases; the activated fragments of caspases were not obsd. after β-lap exposures, nor were there any changes in the pro-enzyme forms as measured by Western blot analyses.  The ability of β-lap to trigger an apparently novel, p53-independent, calpain-mediated apoptotic cell death further support the development of this drug for improved breast cancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGozakC3ar1up7Vg90H21EOLACvtfcHk0liLpUeT_c_2oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXmvFGhsLo%253D&md5=4f47c840086fa27f9568bc24256df3ed</span></div><a href="/servlet/linkout?suffix=cit140&amp;dbid=16384&amp;doi=10.4161%2Fcbt.2.2.237&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.4161%252Fcbt.2.2.237%26sid%3Dliteratum%253Aachs%26aulast%3DTagliarino%26aufirst%3DC.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DSimmers%26aufirst%3DS.%2BM.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DMu-calpain%2520activation%2520in%2520beta-lapachone-mediated%2520apoptosis%26jtitle%3DCancer%2520Biol.%2520Ther.%26date%3D2003%26volume%3D2%26spage%3D141%26epage%3D152%26doi%3D10.4161%2Fcbt.2.2.237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref141"><div class="reference"><strong class="refLabel"><a href="#ref141" class="rightTabRefNumLink">141</a></strong><div class="NLM_citation" id="rightTab-cit141"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, M. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deja, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Singh, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Egnatchik, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sudderth, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burgess, S. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Merritt, M. E.</span></span> <span> </span><span class="NLM_article-title">The NQO1 bioactivatable drug, beta-lapachone, alters the redox state of NQO1+ pancreatic cancer cells, causing perturbation in central carbon metabolism</span>. <i>J. Biol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>292</i></span>,  <span class="NLM_fpage">18203</span>– <span class="NLM_lpage">18216</span>, <span class="refDoi"> DOI: 10.1074/jbc.M117.813923</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref141/cit141&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1074%2Fjbc.M117.813923" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=292&publication_year=2017&pages=18203-18216&author=M.+A.+Silversauthor=S.+Dejaauthor=N.+Singhauthor=R.+A.+Egnatchikauthor=J.+Sudderthauthor=X.+Luoauthor=M.+S.+Begauthor=S.+C.+Burgessauthor=R.+J.+DeBerardinisauthor=D.+A.+Boothmanauthor=M.+E.+Merritt&title=The+NQO1+bioactivatable+drug%2C+beta-lapachone%2C+alters+the+redox+state+of+NQO1%2B+pancreatic+cancer+cells%2C+causing+perturbation+in+central+carbon+metabolism&doi=10.1074%2Fjbc.M117.813923"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit141&amp;dbid=16384&amp;doi=10.1074%2Fjbc.M117.813923&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1074%252Fjbc.M117.813923%26sid%3Dliteratum%253Aachs%26aulast%3DSilvers%26aufirst%3DM.%2BA.%26aulast%3DDeja%26aufirst%3DS.%26aulast%3DSingh%26aufirst%3DN.%26aulast%3DEgnatchik%26aufirst%3DR.%2BA.%26aulast%3DSudderth%26aufirst%3DJ.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DBurgess%26aufirst%3DS.%2BC.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DMerritt%26aufirst%3DM.%2BE.%26atitle%3DThe%2520NQO1%2520bioactivatable%2520drug%252C%2520beta-lapachone%252C%2520alters%2520the%2520redox%2520state%2520of%2520NQO1%252B%2520pancreatic%2520cancer%2520cells%252C%2520causing%2520perturbation%2520in%2520central%2520carbon%2520metabolism%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D2017%26volume%3D292%26spage%3D18203%26epage%3D18216%26doi%3D10.1074%2Fjbc.M117.813923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref142"><div class="reference"><strong class="refLabel"><a href="#ref142" class="rightTabRefNumLink">142</a></strong><div class="NLM_citation" id="rightTab-cit142"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Planchon, S. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wuerzberger, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frydman, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Witiak, D. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hutson, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Church, D. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wilding, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">β-Lapachone-mediated apoptosis in human promyelocytic Leukemia (HL-60) and human prostate cancer cells: A p53-independent response</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">1995</span>,  <span class="NLM_volume"><i>55</i></span>,  <span class="NLM_fpage">3706</span>– <span class="NLM_lpage">3711</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=1995&pages=3706-3711&author=S.+M.+Planchonauthor=S.+Wuerzbergerauthor=B.+Frydmanauthor=D.+T.+Witiakauthor=P.+Hutsonauthor=D.+R.+Churchauthor=G.+Wildingauthor=D.+A.+Boothman&title=%CE%B2-Lapachone-mediated+apoptosis+in+human+promyelocytic+Leukemia+%28HL-60%29+and+human+prostate+cancer+cells%3A+A+p53-independent+response"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit142&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DPlanchon%26aufirst%3DS.%2BM.%26aulast%3DWuerzberger%26aufirst%3DS.%26aulast%3DFrydman%26aufirst%3DB.%26aulast%3DWitiak%26aufirst%3DD.%2BT.%26aulast%3DHutson%26aufirst%3DP.%26aulast%3DChurch%26aufirst%3DD.%2BR.%26aulast%3DWilding%26aufirst%3DG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3D%25CE%25B2-Lapachone-mediated%2520apoptosis%2520in%2520human%2520promyelocytic%2520Leukemia%2520%2528HL-60%2529%2520and%2520human%2520prostate%2520cancer%2520cells%253A%2520A%2520p53-independent%2520response%26jtitle%3DCancer%2520Res.%26date%3D1995%26volume%3D55%26spage%3D3706%26epage%3D3711" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref143"><div class="reference"><strong class="refLabel"><a href="#ref143" class="rightTabRefNumLink">143</a></strong><div class="NLM_citation" id="rightTab-cit143"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meng, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patra, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brekken, R. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Barnett, C. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Modulating endogenous NQO1 levels identifies key regulatory mechanisms of action of beta-lapachone for pancreatic cancer therapy</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>17</i></span>,  <span class="NLM_fpage">275</span>– <span class="NLM_lpage">285</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-10-1983</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-10-1983" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21224367" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref143/cit143&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXmslyrtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2011&pages=275-285&author=L.+S.+Liauthor=E.+A.+Beyauthor=Y.+Dongauthor=J.+Mengauthor=B.+Patraauthor=J.+Yanauthor=X.+J.+Xieauthor=R.+A.+Brekkenauthor=C.+C.+Barnettauthor=W.+G.+Bornmannauthor=J.+Gaoauthor=D.+A.+Boothman&title=Modulating+endogenous+NQO1+levels+identifies+key+regulatory+mechanisms+of+action+of+beta-lapachone+for+pancreatic+cancer+therapy&doi=10.1158%2F1078-0432.CCR-10-1983"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit143R"><div class="casContent"><span class="casTitleNuber">143</span><div class="casTitle"><span class="NLM_cas:atitle">Modulating Endogenous NQO1 Levels Identifies Key Regulatory Mechanisms of Action of β-Lapachone for Pancreatic Cancer Therapy</span></div><div class="casAuthors">Li, Long Shan; Bey, Erik A.; Dong, Ying; Meng, Jieru; Patra, Biswanath; Yan, Jingsheng; Xie, Xian-Jin; Brekken, Rolf A.; Barnett, Carlton C.; Bornmann, William G.; Gao, Jinming; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">275-285</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Purpose: Pancreatic cancer is the fourth leading cause of cancer-related deaths, in which the 5-yr survival rate is less than 5%.  Current std. of care therapies offer little selectivity and high toxicity.  Novel, tumor-selective approaches are desperately needed.  Although prior work suggested that β-lapachone (β-lap) could be used for the treatment of pancreatic cancers, the lack of knowledge of the compd.'s mechanism of action prevented optimal use of this agent.  Exptl. Design: We examd. the role of NAD(P)H:quinone oxidoreductase-1 (NQO1) in β-lap-mediated antitumor activity, using a series of MIA PaCa-2 pancreatic cancer clones varying in NQO1 levels by stable shRNA knockdown.  The antitumor efficacy of β-lap was detd. using an optimal hydroxypropyl-β-cyclodextran (HPβ-CD) vehicle formulation in metastatic pancreatic cancer models.  Results: β-Lap-mediated cell death required ∼90 enzymic units of NQO1.  Essential downstream mediators of lethality were as follows: (i) reactive oxygen species (ROS); (ii) single-strand DNA breaks induced by ROS; (iii) poly(ADP-ribose)polymerase-1 (PARP1) hyperactivation; (iv) dramatic NAD+/ATP depletion; and (v) programmed necrosis.  We showed that 1 regimen of β-lap therapy (5 treatments every other day) efficaciously regressed and reduced human pancreatic tumor burden and dramatically extended the survival of athymic mice, using metastatic pancreatic cancer models.  Conclusions: Because NQO1 enzyme activities are easily measured and commonly overexpressed (i.e., >70%) in pancreatic cancers 5- to 10-fold above normal tissue, strategies using β-lap to efficaciously treat pancreatic cancers are indicated.  On the basis of optimal drug formulation and efficacious antitumor efficacy, such a therapy should be extremely safe and not accompanied with normal tissue toxicity or hemolytic anemia.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpKcNAcs474ebVg90H21EOLACvtfcHk0liLpUeT_c_2oQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXmslyrtQ%253D%253D&md5=aa9ffc640f55161e6d68598748d7a316</span></div><a href="/servlet/linkout?suffix=cit143&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-10-1983&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-10-1983%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DMeng%26aufirst%3DJ.%26aulast%3DPatra%26aufirst%3DB.%26aulast%3DYan%26aufirst%3DJ.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DBrekken%26aufirst%3DR.%2BA.%26aulast%3DBarnett%26aufirst%3DC.%2BC.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DModulating%2520endogenous%2520NQO1%2520levels%2520identifies%2520key%2520regulatory%2520mechanisms%2520of%2520action%2520of%2520beta-lapachone%2520for%2520pancreatic%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2011%26volume%3D17%26spage%3D275%26epage%3D285%26doi%3D10.1158%2F1078-0432.CCR-10-1983" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref144"><div class="reference"><strong class="refLabel"><a href="#ref144" class="rightTabRefNumLink">144</a></strong><div class="NLM_citation" id="rightTab-cit144"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liao, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H.</span></span> <span> </span><span class="NLM_article-title">Metabolic profile, enzyme kinetics, and reaction phenotyping of beta-lapachone metabolism in human liver and intestine in vitro</span>. <i>Mol. Pharmaceutics</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">3476</span>– <span class="NLM_lpage">3485</span>, <span class="refDoi"> DOI: 10.1021/mp300296m</span> </span><div class="citationLinks">[<a href="/doi/10.1021/mp300296m" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref144/cit144&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38Xhs1eitL7L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2012&pages=3476-3485&author=X.+Chengauthor=F.+Liuauthor=T.+Yanauthor=X.+Zhouauthor=L.+Wuauthor=K.+Liaoauthor=G.+Wangauthor=H.+Hao&title=Metabolic+profile%2C+enzyme+kinetics%2C+and+reaction+phenotyping+of+beta-lapachone+metabolism+in+human+liver+and+intestine+in+vitro&doi=10.1021%2Fmp300296m"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit144R"><div class="casContent"><span class="casTitleNuber">144</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic Profile, Enzyme Kinetics, and Reaction Phenotyping of β-Lapachone Metabolism in Human Liver and Intestine in Vitro</span></div><div class="casAuthors">Cheng, Xuefang; Liu, Fang; Yan, Tingting; Zhou, Xueyan; Wu, Liang; Liao, Ke; Wang, Guangji; Hao, Haiping</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3476-3485</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">β-Lapachone (β-Lap) is an NAD(P)H:quinone oxidoreductase 1 (NQO1) target antitumor drug candidate in phase II clin. trials.  The present study aimed to uncover the metabolic profile, enzyme kinetics, and enzyme isoforms for the metab. of β-Lap in human liver and intestine in vitro.  NQO1-mediated quinone redn. and subsequent glucuronidation is the predominant metabolic pathway for β-Lap in humans; a pair of regioisomers (M1 and M2) of reduced β-Lap glucuronides were the major metabolites found from human S9 incubations.  The overall glucuronidation clearance of β-Lap in human liver S9 was 4754.90 μL/min/mg of protein and was 8.1-fold of that in human intestinal S9.  Recombinant UDP-glucuronosyltransferase (UGT) screening, correlation anal., enzyme kinetics, and chem. inhibition study were performed to det. the UGT isoforms involved in β-Lap metab.  UGT1A7, UGT1A8, and UGT1A9 are the predominant isoforms responsible for the formation of M2 while UGT2B7 is the main isoform for M1, suggesting a regioselective glucuronidation of reduced quinone by UGTs.  It was of interest to find that β-Lap underwent nonenzymic two-electron redn., providing a novel explanation for the toxicities of β-Lap to NQO1-neg. cells at high concn. and with long-time incubation.  In conclusion, this study contributes to a better understanding of not only β-Lap metab. but its antitumor property as well.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqy06KS6EKVTrVg90H21EOLACvtfcHk0liTKdNTtPDz7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xhs1eitL7L&md5=395697aadf832fb428891d388de2b191</span></div><a href="/servlet/linkout?suffix=cit144&amp;dbid=16384&amp;doi=10.1021%2Fmp300296m&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp300296m%26sid%3Dliteratum%253Aachs%26aulast%3DCheng%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DYan%26aufirst%3DT.%26aulast%3DZhou%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DLiao%26aufirst%3DK.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DHao%26aufirst%3DH.%26atitle%3DMetabolic%2520profile%252C%2520enzyme%2520kinetics%252C%2520and%2520reaction%2520phenotyping%2520of%2520beta-lapachone%2520metabolism%2520in%2520human%2520liver%2520and%2520intestine%2520in%2520vitro%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2012%26volume%3D9%26spage%3D3476%26epage%3D3485%26doi%3D10.1021%2Fmp300296m" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref145"><div class="reference"><strong class="refLabel"><a href="#ref145" class="rightTabRefNumLink">145</a></strong><div class="NLM_citation" id="rightTab-cit145"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Khemtong, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, S. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Setti-Guthi, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kessinger, C. W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Carnevale, K. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Beta-lapachone micellar nanotherapeutics for non-small cell lung cancer therapy</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>70</i></span>,  <span class="NLM_fpage">3896</span>– <span class="NLM_lpage">3904</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-09-3995</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref145/cit145&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-09-3995" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=70&publication_year=2010&pages=3896-3904&author=E.+Blancoauthor=E.+A.+Beyauthor=C.+Khemtongauthor=S.+G.+Yangauthor=J.+Setti-Guthiauthor=H.+Chenauthor=C.+W.+Kessingerauthor=K.+A.+Carnevaleauthor=W.+G.+Bornmannauthor=D.+A.+Boothmanauthor=J.+Gao&title=Beta-lapachone+micellar+nanotherapeutics+for+non-small+cell+lung+cancer+therapy&doi=10.1158%2F0008-5472.CAN-09-3995"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit145&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-09-3995&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-09-3995%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DKhemtong%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%2BG.%26aulast%3DSetti-Guthi%26aufirst%3DJ.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DKessinger%26aufirst%3DC.%2BW.%26aulast%3DCarnevale%26aufirst%3DK.%2BA.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DBeta-lapachone%2520micellar%2520nanotherapeutics%2520for%2520non-small%2520cell%2520lung%2520cancer%2520therapy%26jtitle%3DCancer%2520Res.%26date%3D2010%26volume%3D70%26spage%3D3896%26epage%3D3904%26doi%3D10.1158%2F0008-5472.CAN-09-3995" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref146"><div class="reference"><strong class="refLabel"><a href="#ref146" class="rightTabRefNumLink">146</a></strong><div class="NLM_citation" id="rightTab-cit146"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Nasongkla, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wiedmann, A. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bruening, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beman, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ray, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Enhancement of solubility and bioavailability of beta-lapachone using cyclodextrin inclusion complexes</span>. <i>Pharm. Res.</i> <span class="NLM_year" style="font-weight: bold;">2003</span>,  <span class="NLM_volume"><i>20</i></span>,  <span class="NLM_fpage">1626</span>– <span class="NLM_lpage">1633</span>, <span class="refDoi"> DOI: 10.1023/A:1026143519395</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref146/cit146&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1023%2FA%3A1026143519395" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2003&pages=1626-1633&author=N.+Nasongklaauthor=A.+F.+Wiedmannauthor=A.+Brueningauthor=M.+Bemanauthor=D.+Rayauthor=W.+G.+Bornmannauthor=D.+A.+Boothmanauthor=J.+Gao&title=Enhancement+of+solubility+and+bioavailability+of+beta-lapachone+using+cyclodextrin+inclusion+complexes&doi=10.1023%2FA%3A1026143519395"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit146&amp;dbid=16384&amp;doi=10.1023%2FA%3A1026143519395&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1026143519395%26sid%3Dliteratum%253Aachs%26aulast%3DNasongkla%26aufirst%3DN.%26aulast%3DWiedmann%26aufirst%3DA.%2BF.%26aulast%3DBruening%26aufirst%3DA.%26aulast%3DBeman%26aufirst%3DM.%26aulast%3DRay%26aufirst%3DD.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DEnhancement%2520of%2520solubility%2520and%2520bioavailability%2520of%2520beta-lapachone%2520using%2520cyclodextrin%2520inclusion%2520complexes%26jtitle%3DPharm.%2520Res.%26date%3D2003%26volume%3D20%26spage%3D1626%26epage%3D1633%26doi%3D10.1023%2FA%3A1026143519395" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref147"><div class="reference"><strong class="refLabel"><a href="#ref147" class="rightTabRefNumLink">147</a></strong><div class="NLM_citation" id="rightTab-cit147"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ai, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Modulating beta-lapachone release from polymer millirods through cyclodextrin complexation</span>. <i>J. Pharm. Sci.</i> <span class="NLM_year" style="font-weight: bold;">2006</span>,  <span class="NLM_volume"><i>95</i></span>,  <span class="NLM_fpage">2309</span>– <span class="NLM_lpage">2319</span>, <span class="refDoi"> DOI: 10.1002/jps.20721</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref147/cit147&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1002%2Fjps.20721" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=95&publication_year=2006&pages=2309-2319&author=F.+Wangauthor=E.+Blancoauthor=H.+Aiauthor=D.+A.+Boothmanauthor=J.+Gao&title=Modulating+beta-lapachone+release+from+polymer+millirods+through+cyclodextrin+complexation&doi=10.1002%2Fjps.20721"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit147&amp;dbid=16384&amp;doi=10.1002%2Fjps.20721&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fjps.20721%26sid%3Dliteratum%253Aachs%26aulast%3DWang%26aufirst%3DF.%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DAi%26aufirst%3DH.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DModulating%2520beta-lapachone%2520release%2520from%2520polymer%2520millirods%2520through%2520cyclodextrin%2520complexation%26jtitle%3DJ.%2520Pharm.%2520Sci.%26date%3D2006%26volume%3D95%26spage%3D2309%26epage%3D2319%26doi%3D10.1002%2Fjps.20721" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref148"><div class="reference"><strong class="refLabel"><a href="#ref148" class="rightTabRefNumLink">148</a></strong><div class="NLM_citation" id="rightTab-cit148"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span>. <i>J. Drug Target.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">672</span>– <span class="NLM_lpage">680</span>, <span class="refDoi"> DOI: 10.3109/1061186X.2015.1073296</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3109%2F1061186X.2015.1073296" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26453163" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref148/cit148&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2015&pages=672-680&author=X.+Maauthor=Z.+R.+Mooreauthor=G.+Huangauthor=X.+Huangauthor=D.+A.+Boothmanauthor=J.+Gao&title=Nanotechnology-enabled+delivery+of+NQO1+bioactivatable+drugs&doi=10.3109%2F1061186X.2015.1073296"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit148R"><div class="casContent"><span class="casTitleNuber">148</span><div class="casTitle"><span class="NLM_cas:atitle">Nanotechnology-enabled delivery of NQO1 bioactivatable drugs</span></div><div class="casAuthors">Ma, Xinpeng; Moore, Zachary R.; Huang, Gang; Huang, Xiumei; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Drug Targeting</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue">7-8</span>),
    <span class="NLM_cas:pages">672-680</span>CODEN:
                <span class="NLM_cas:coden">JDTAEH</span>;
        ISSN:<span class="NLM_cas:issn">1026-7158</span>.
    
            (<span class="NLM_cas:orgname">Taylor & Francis Ltd.</span>)
        </div><div class="casAbstract">Current cancer chemotherapy lacks specificity and is limited by undesirable toxic side-effects, as well as a high rate of recurrence.  Nanotechnol. has the potential to offer paradigm-shifting solns. to improve the outcome of cancer diagnosis and therapy. β-Lapachone (β-lap) is a novel anticancer agent whose mechanism of action is highly dependent on NAD(P)H:quinone oxidoreductase 1 (NQO1), a phase II detoxifying enzyme overexpressed in solid tumors from a variety of cancer types.  However, the poor water soly. of β-lap limits its clin. potential.  A series of drug formulations were developed for systemic administration in preclin. evaluations.  Encapsulation of β-lap into polymeric micelles showed less side-effects and higher max. tolerated dose (MTD), prolonged blood circulation time and preferential accumulation in tumors with greatly improved safety and antitumor efficacy.  The prodrug strategy of β-lap further decreases the crystn. of β-lap by introducing esterase degradable side chains to the rigid fused ring structure. β-Lap prodrugs considerably increased the stability, drug-loading content and delivery efficiency of nanoparticles.  The optimized formulation of β-lap-dC3 prodrug micelles showed excellent antitumor efficacy in treating orthotopic non-small cell lung tumors that overexpress NQO1, with target validation using pharmacodynamic endpoints.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqQWALPeBqdHLVg90H21EOLACvtfcHk0liTKdNTtPDz7A"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhslWgs7%252FJ&md5=29ef8202d9d76ad0c55136da17093ac9</span></div><a href="/servlet/linkout?suffix=cit148&amp;dbid=16384&amp;doi=10.3109%2F1061186X.2015.1073296&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F1061186X.2015.1073296%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DNanotechnology-enabled%2520delivery%2520of%2520NQO1%2520bioactivatable%2520drugs%26jtitle%3DJ.%2520Drug%2520Target.%26date%3D2015%26volume%3D23%26spage%3D672%26epage%3D680%26doi%3D10.3109%2F1061186X.2015.1073296" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref149"><div class="reference"><strong class="refLabel"><a href="#ref149" class="rightTabRefNumLink">149</a></strong><div class="NLM_citation" id="rightTab-cit149"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Reinicke, K. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bentle, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pink, J. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ingalls, S. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hoppel, C. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Misico, R. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arzac, G. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burton, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span> <span> </span><span class="NLM_article-title">Development of B-lapachone prodrugs for therapy against human cancer cells with elevated NAD (P) H: quinone oxidoreductase1 levels</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">3055</span>– <span class="NLM_lpage">3064</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-04-2185</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-04-2185" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=15837761" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref149/cit149&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2MXjtlejtbw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2005&pages=3055-3064&author=K.+E.+Reinickeauthor=E.+A.+Beyauthor=M.+S.+Bentleauthor=J.+J.+Pinkauthor=S.+T.+Ingallsauthor=C.+L.+Hoppelauthor=R.+I.+Misicoauthor=G.+M.+Arzacauthor=G.+Burtonauthor=W.+G.+Bornmann&title=Development+of+B-lapachone+prodrugs+for+therapy+against+human+cancer+cells+with+elevated+NAD+%28P%29+H%3A+quinone+oxidoreductase1+levels&doi=10.1158%2F1078-0432.CCR-04-2185"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit149R"><div class="casContent"><span class="casTitleNuber">149</span><div class="casTitle"><span class="NLM_cas:atitle">Development of β-lapachone prodrugs for therapy against human cancer cells with elevated NAD(P)H:quinone oxidoreductase 1 levels</span></div><div class="casAuthors">Reinicke, Kathryn E.; Bey, Erik A.; Bentle, Melissa S.; Pink, John J.; Ingalls, Stephen T.; Hoppel, Charles L.; Misico, Rosana I.; Arzac, Gisela M.; Burton, Gerardo; Bornmann, William G.; Sutton, Damon; Gao, Jinming; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2005</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">3055-3064</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">β-Lapachone, an o-naphthoquinone, induces a novel caspase- and p53-independent apoptotic pathway dependent on NAD(P)H:quinone oxidoreductase 1 (NQO1).  NQO1 reduces β-lapachone to an unstable hydroquinone that rapidly undergoes a two-step oxidn. back to the parent compd., perpetuating a futile redox cycle.  A deficiency or inhibition of NQO1 rendered cells resistant to β-lapachone.  Thus, β-lapachone has great potential for the treatment of specific cancers with elevated NQO1 levels (e.g., breast, non-small cell lung, pancreatic, colon, and prostate cancers).  We report the development of mono(arylimino) derivs. of β-lapachone as potential prodrugs.  These derivs. are relatively nontoxic and not substrates for NQO1 when initially dild. in water.  In soln., however, they undergo hydrolytic conversion to β-lapachone at rates dependent on the electron-withdrawing strength of their substituent groups and pH of the diluent.  NQO1 enzyme assays, UV-visible spectrophotometry, high-performance liq. chromatog.-electrospray ionization-mass spectrometry, and NMR analyses confirmed and monitored conversion of each deriv. to β-lapachone.  Once converted, β-lapachone derivs. caused NQO1-dependent, μ-calpain-mediated cell death in human cancer cells identical to that caused by β-lapachone.  Interestingly, coadministration of N-acetyl-L-cysteine, prevented deriv.-induced cytotoxicity but did not affect β-lapachone lethality.  NMR analyses indicated that prevention of β-lapachone deriv. cytotoxicity was the result of direct modification of these derivs. by N-acetyl-L-cysteine, preventing their conversion to β-lapachone.  The use of β-lapachone mono(arylimino) prodrug derivs., or more specifically a deriv. converted in a tumor-specific manner (i.e., in the acidic local environment of the tumor tissue), should reduce normal tissue toxicity while eliciting tumor-selective cell killing by NQO1 bioactivation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGryPg3WMhVKl7Vg90H21EOLACvtfcHk0lhjU3dqMpSKJA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2MXjtlejtbw%253D&md5=c0f7f522fe210d37d58b5b27c3ff1f20</span></div><a href="/servlet/linkout?suffix=cit149&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-04-2185&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-04-2185%26sid%3Dliteratum%253Aachs%26aulast%3DReinicke%26aufirst%3DK.%2BE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBentle%26aufirst%3DM.%2BS.%26aulast%3DPink%26aufirst%3DJ.%2BJ.%26aulast%3DIngalls%26aufirst%3DS.%2BT.%26aulast%3DHoppel%26aufirst%3DC.%2BL.%26aulast%3DMisico%26aufirst%3DR.%2BI.%26aulast%3DArzac%26aufirst%3DG.%2BM.%26aulast%3DBurton%26aufirst%3DG.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26atitle%3DDevelopment%2520of%2520B-lapachone%2520prodrugs%2520for%2520therapy%2520against%2520human%2520cancer%2520cells%2520with%2520elevated%2520NAD%2520%2528P%2529%2520H%253A%2520quinone%2520oxidoreductase1%2520levels%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2005%26volume%3D11%26spage%3D3055%26epage%3D3064%26doi%3D10.1158%2F1078-0432.CCR-04-2185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref150"><div class="reference"><strong class="refLabel"><a href="#ref150" class="rightTabRefNumLink">150</a></strong><div class="NLM_citation" id="rightTab-cit150"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shapiro, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Supko, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ryan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Appelman, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Berkenblit, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Craig, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jones, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagovane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Eder, J.</span></span> <span> </span><span class="NLM_article-title">Phase I trial of ARQ 501, an activated checkpoint therapy (ACT) agent, in patients with advanced solid tumors</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>23</i></span>,  <span class="NLM_fpage">3042</span>– <span class="NLM_lpage">3042</span>, <span class="refDoi"> DOI: 10.1200/jco.2005.23.16_suppl.3042</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref150/cit150&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1200%2Fjco.2005.23.16_suppl.3042" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2005&pages=3042-3042&author=G.+Shapiroauthor=J.+Supkoauthor=D.+Ryanauthor=L.+Appelmanauthor=A.+Berkenblitauthor=A.+Craigauthor=S.+Jonesauthor=D.+Yagovaneauthor=C.+Liauthor=J.+Eder&title=Phase+I+trial+of+ARQ+501%2C+an+activated+checkpoint+therapy+%28ACT%29+agent%2C+in+patients+with+advanced+solid+tumors&doi=10.1200%2Fjco.2005.23.16_suppl.3042"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit150&amp;dbid=16384&amp;doi=10.1200%2Fjco.2005.23.16_suppl.3042&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1200%252Fjco.2005.23.16_suppl.3042%26sid%3Dliteratum%253Aachs%26aulast%3DShapiro%26aufirst%3DG.%26aulast%3DSupko%26aufirst%3DJ.%26aulast%3DRyan%26aufirst%3DD.%26aulast%3DAppelman%26aufirst%3DL.%26aulast%3DBerkenblit%26aufirst%3DA.%26aulast%3DCraig%26aufirst%3DA.%26aulast%3DJones%26aufirst%3DS.%26aulast%3DYagovane%26aufirst%3DD.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DEder%26aufirst%3DJ.%26atitle%3DPhase%2520I%2520trial%2520of%2520ARQ%2520501%252C%2520an%2520activated%2520checkpoint%2520therapy%2520%2528ACT%2529%2520agent%252C%2520in%2520patients%2520with%2520advanced%2520solid%2520tumors%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2005%26volume%3D23%26spage%3D3042%26epage%3D3042%26doi%3D10.1200%2Fjco.2005.23.16_suppl.3042" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref151"><div class="reference"><strong class="refLabel"><a href="#ref151" class="rightTabRefNumLink">151</a></strong><div class="NLM_citation" id="rightTab-cit151"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Kawecki, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Adkins, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cunningham, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vokes, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagovane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombal, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Koralewski, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hotko, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vladimirov, V.</span></span> <span> </span><span class="NLM_article-title">A phase II study of ARQ 501 in patients with advanced squamous cell carcinoma of the head and neck</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">16509</span>– <span class="NLM_lpage">16509</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=16509-16509&author=A.+Kaweckiauthor=D.+Adkinsauthor=C.+Cunninghamauthor=E.+Vokesauthor=D.+Yagovaneauthor=G.+Dombalauthor=P.+Koralewskiauthor=Y.+Hotkoauthor=V.+Vladimirov&title=A+phase+II+study+of+ARQ+501+in+patients+with+advanced+squamous+cell+carcinoma+of+the+head+and+neck"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit151&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKawecki%26aufirst%3DA.%26aulast%3DAdkins%26aufirst%3DD.%26aulast%3DCunningham%26aufirst%3DC.%26aulast%3DVokes%26aufirst%3DE.%26aulast%3DYagovane%26aufirst%3DD.%26aulast%3DDombal%26aufirst%3DG.%26aulast%3DKoralewski%26aufirst%3DP.%26aulast%3DHotko%26aufirst%3DY.%26aulast%3DVladimirov%26aufirst%3DV.%26atitle%3DA%2520phase%2520II%2520study%2520of%2520ARQ%2520501%2520in%2520patients%2520with%2520advanced%2520squamous%2520cell%2520carcinoma%2520of%2520the%2520head%2520and%2520neck%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D16509%26epage%3D16509" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref152"><div class="reference"><strong class="refLabel"><a href="#ref152" class="rightTabRefNumLink">152</a></strong><div class="NLM_citation" id="rightTab-cit152"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Khong, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dreisbach, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kindler, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Trent, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Jeziorski, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bonderenko, I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Popiela, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yagovane, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dombal, G.</span></span> <span> </span><span class="NLM_article-title">A phase 2 study of ARQ 501 in combination with gemcitabine in adult patients with treatment naive, unresectable pancreatic adenocarcinoma</span>. <i>J. Clin. Oncol.</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">15017</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2007&pages=15017&author=H.+Khongauthor=L.+Dreisbachauthor=H.+Kindlerauthor=D.+Trentauthor=K.+Jeziorskiauthor=I.+Bonderenkoauthor=T.+Popielaauthor=D.+Yagovaneauthor=G.+Dombal&title=A+phase+2+study+of+ARQ+501+in+combination+with+gemcitabine+in+adult+patients+with+treatment+naive%2C+unresectable+pancreatic+adenocarcinoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit152&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DKhong%26aufirst%3DH.%26aulast%3DDreisbach%26aufirst%3DL.%26aulast%3DKindler%26aufirst%3DH.%26aulast%3DTrent%26aufirst%3DD.%26aulast%3DJeziorski%26aufirst%3DK.%26aulast%3DBonderenko%26aufirst%3DI.%26aulast%3DPopiela%26aufirst%3DT.%26aulast%3DYagovane%26aufirst%3DD.%26aulast%3DDombal%26aufirst%3DG.%26atitle%3DA%2520phase%25202%2520study%2520of%2520ARQ%2520501%2520in%2520combination%2520with%2520gemcitabine%2520in%2520adult%2520patients%2520with%2520treatment%2520naive%252C%2520unresectable%2520pancreatic%2520adenocarcinoma%26jtitle%3DJ.%2520Clin.%2520Oncol.%26date%3D2007%26volume%3D25%26spage%3D15017" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref153"><div class="reference"><strong class="refLabel"><a href="#ref153" class="rightTabRefNumLink">153</a></strong><div class="NLM_citation" id="rightTab-cit153"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Gerber, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Arriaga, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Beg, M. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dowell, J. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schiller, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Frankel, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Leff, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Meek, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bolluyt, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fatunde, O.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Martinez, R. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Vo, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fattah, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sarode, V.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McLeod, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Schwartz, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Phase 1 correlative study of ARQ761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis</span>. <i>Eur. J. Cancer</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>50</i></span>,  <span class="NLM_fpage">84</span>– <span class="NLM_lpage">85</span>, <span class="refDoi"> DOI: 10.1016/S0959-8049(14)70379-X</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref153/cit153&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS0959-8049%2814%2970379-X" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2014&pages=84-85&author=D.+Gerberauthor=Y.+Arriagaauthor=M.+S.+Begauthor=J.+E.+Dowellauthor=J.+H.+Schillerauthor=A.+E.+Frankelauthor=R.+Leffauthor=C.+Meekauthor=J.+Bolluytauthor=O.+Fatundeauthor=R.+T.+Martinezauthor=P.+Voauthor=F.+Fattahauthor=V.+Sarodeauthor=Y.+Zhouauthor=Y.+Xieauthor=M.+McLeodauthor=B.+Schwartzauthor=D.+A.+Boothman&title=Phase+1+correlative+study+of+ARQ761%2C+a+%CE%B2-lapachone+analogue+that+promotes+NQO1-mediated+programmed+cancer+cell+necrosis&doi=10.1016%2FS0959-8049%2814%2970379-X"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit153&amp;dbid=16384&amp;doi=10.1016%2FS0959-8049%2814%2970379-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0959-8049%252814%252970379-X%26sid%3Dliteratum%253Aachs%26aulast%3DGerber%26aufirst%3DD.%26aulast%3DArriaga%26aufirst%3DY.%26aulast%3DBeg%26aufirst%3DM.%2BS.%26aulast%3DDowell%26aufirst%3DJ.%2BE.%26aulast%3DSchiller%26aufirst%3DJ.%2BH.%26aulast%3DFrankel%26aufirst%3DA.%2BE.%26aulast%3DLeff%26aufirst%3DR.%26aulast%3DMeek%26aufirst%3DC.%26aulast%3DBolluyt%26aufirst%3DJ.%26aulast%3DFatunde%26aufirst%3DO.%26aulast%3DMartinez%26aufirst%3DR.%2BT.%26aulast%3DVo%26aufirst%3DP.%26aulast%3DFattah%26aufirst%3DF.%26aulast%3DSarode%26aufirst%3DV.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DMcLeod%26aufirst%3DM.%26aulast%3DSchwartz%26aufirst%3DB.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DPhase%25201%2520correlative%2520study%2520of%2520ARQ761%252C%2520a%2520%25CE%25B2-lapachone%2520analogue%2520that%2520promotes%2520NQO1-mediated%2520programmed%2520cancer%2520cell%2520necrosis%26jtitle%3DEur.%2520J.%2520Cancer%26date%3D2014%26volume%3D50%26spage%3D84%26epage%3D85%26doi%3D10.1016%2FS0959-8049%2814%2970379-X" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref154"><div class="reference"><strong class="refLabel"><a href="#ref154" class="rightTabRefNumLink">154</a></strong><div class="NLM_citation" id="rightTab-cit154"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Weinberg, B. D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sutton, D. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">β-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2007</span>,  <span class="NLM_volume"><i>122</i></span>,  <span class="NLM_fpage">365</span>– <span class="NLM_lpage">374</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2007.04.014</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.jconrel.2007.04.014" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=17574288" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref154/cit154&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtVKrsLrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=122&publication_year=2007&pages=365-374&author=E.+Blancoauthor=E.+A.+Beyauthor=Y.+Dongauthor=B.+D.+Weinbergauthor=D.+M.+Suttonauthor=D.+A.+Boothmanauthor=J.+Gao&title=%CE%B2-Lapachone-containing+PEG-PLA+polymer+micelles+as+novel+nanotherapeutics+against+NQO1-overexpressing+tumor+cells&doi=10.1016%2Fj.jconrel.2007.04.014"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit154R"><div class="casContent"><span class="casTitleNuber">154</span><div class="casTitle"><span class="NLM_cas:atitle">β-Lapachone-containing PEG-PLA polymer micelles as novel nanotherapeutics against NQO1-overexpressing tumor cells</span></div><div class="casAuthors">Blanco, Elvin; Bey, Erik A.; Dong, Ying; Weinberg, Brent D.; Sutton, Damon M.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Controlled Release</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">122</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">365-374</span>CODEN:
                <span class="NLM_cas:coden">JCREEC</span>;
        ISSN:<span class="NLM_cas:issn">0168-3659</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">β-Lapachone (β-lap) is a novel anticancer agent that is bioactivated by NADP(H): quinone oxidoreductase 1 (NQO1), an enzyme overexpressed in a variety of tumors.  Despite its therapeutic promise, the poor aq. soly. of β-lap hinders its preclin. evaluation and clin. translation.  The objective was to develop β-lap-contg. poly(ethylene glycol)-block-poly(-lactide) (PEG-PLA) polymer micelles for the treatment of NQO1-overexpressing tumors.  Several micelle fabrication strategies were examd. to maximize drug loading.  A film sonication method yielded β-lap micelles with relatively high loading d. (4.7±1.0% to 6.5±1.0%) and optimal size (29.6±1.5 nm).  Release studies in phosphate-buffered saline (pH 7.4) showed the time (t1/2) for 50% of drug release at 18 h.  In vitro cytotoxicity assays were performed in NQO1-overexpressing (NQO1+) and NQO1-null (NQO1-) H596 lung, DU-145 prostate, and MDA-MB-231 breast cancer cells.  Cytotoxicity data showed that after a 2 h incubation with β-lap micelles, a marked increase in toxicity was shown in NQO1+ cells over NQO1- cells, resembling free drug both in efficacy and mechanism of cell death.  In summary, these data demonstrate the potential of β-lap micelles as an effective therapeutic strategy against NQO1-overexpressing tumor cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoNMyJa0BnzXbVg90H21EOLACvtfcHk0lj5_D8xCUj5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtVKrsLrJ&md5=521c7a6a49c4c2e38b1adcc6c27b223c</span></div><a href="/servlet/linkout?suffix=cit154&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2007.04.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2007.04.014%26sid%3Dliteratum%253Aachs%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DWeinberg%26aufirst%3DB.%2BD.%26aulast%3DSutton%26aufirst%3DD.%2BM.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3D%25CE%25B2-Lapachone-containing%2520PEG-PLA%2520polymer%2520micelles%2520as%2520novel%2520nanotherapeutics%2520against%2520NQO1-overexpressing%2520tumor%2520cells%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2007%26volume%3D122%26spage%3D365%26epage%3D374%26doi%3D10.1016%2Fj.jconrel.2007.04.014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref155"><div class="reference"><strong class="refLabel"><a href="#ref155" class="rightTabRefNumLink">155</a></strong><div class="NLM_citation" id="rightTab-cit155"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Ma, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hammer, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Esterase-activatable beta-lapachone prodrug micelles for NQO1-targeted lung cancer therapy</span>. <i>J. Controlled Release</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>200</i></span>,  <span class="NLM_fpage">201</span>– <span class="NLM_lpage">211</span>, <span class="refDoi"> DOI: 10.1016/j.jconrel.2014.12.027</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref155/cit155&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.jconrel.2014.12.027" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=200&publication_year=2015&pages=201-211&author=X.+Maauthor=X.+Huangauthor=Z.+Mooreauthor=G.+Huangauthor=J.+A.+Kilgoreauthor=Y.+Wangauthor=S.+Hammerauthor=N.+S.+Williamsauthor=D.+A.+Boothmanauthor=J.+Gao&title=Esterase-activatable+beta-lapachone+prodrug+micelles+for+NQO1-targeted+lung+cancer+therapy&doi=10.1016%2Fj.jconrel.2014.12.027"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit155&amp;dbid=16384&amp;doi=10.1016%2Fj.jconrel.2014.12.027&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jconrel.2014.12.027%26sid%3Dliteratum%253Aachs%26aulast%3DMa%26aufirst%3DX.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DHammer%26aufirst%3DS.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DEsterase-activatable%2520beta-lapachone%2520prodrug%2520micelles%2520for%2520NQO1-targeted%2520lung%2520cancer%2520therapy%26jtitle%3DJ.%2520Controlled%2520Release%26date%3D2015%26volume%3D200%26spage%3D201%26epage%3D211%26doi%3D10.1016%2Fj.jconrel.2014.12.027" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref156"><div class="reference"><strong class="refLabel"><a href="#ref156" class="rightTabRefNumLink">156</a></strong><div class="NLM_citation" id="rightTab-cit156"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Park, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Youn, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Noh, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kook, Y. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Oh, E. T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Park, H. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, C.</span></span> <span> </span><span class="NLM_article-title">Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug</span>. <i>J. Mater. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>19</i></span>,  <span class="NLM_fpage">2310</span>– <span class="NLM_lpage">2315</span>, <span class="refDoi"> DOI: 10.1039/b816209c</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2Fb816209c" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref156/cit156&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXktV2hu7Y%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=2310-2315&author=C.+Parkauthor=H.+Younauthor=H.+Kimauthor=T.+Nohauthor=Y.+H.+Kookauthor=E.+T.+Ohauthor=H.+J.+Parkauthor=C.+Kim&title=Cyclodextrin-covered+gold+nanoparticles+for+targeted+delivery+of+an+anti-cancer+drug&doi=10.1039%2Fb816209c"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit156R"><div class="casContent"><span class="casTitleNuber">156</span><div class="casTitle"><span class="NLM_cas:atitle">Cyclodextrin-covered gold nanoparticles for targeted delivery of an anti-cancer drug</span></div><div class="casAuthors">Park, Chiyoung; Youn, Hyewon; Kim, Hana; Noh, Taiho; Kook, Yeon Hee; Oh, Eun Tax; Park, Heon Joo; Kim, Chulhee</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Materials Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">16</span>),
    <span class="NLM_cas:pages">2310-2315</span>CODEN:
                <span class="NLM_cas:coden">JMACEP</span>;
        ISSN:<span class="NLM_cas:issn">0959-9428</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">We report on the therapeutic ability of a novel cyclodextrin-covered gold nanoparticle (AuNP) carrier for noncovalent encapsulation of an anti-cancer drug.  The surface of the AuNPs was functionalized with cyclodextrin as a drug pocket, anti-epidermal growth factor receptor (anti-EGFR) antibody as a targeting moiety, and poly(ethyleneglycol) (PEG) as an anti-fouling shell.  β-Lapachone, an anti-cancer drug, was efficiently encapsulated into the hydrophobic cavity of cyclodextrin on the surface of the AuNP carriers (AuNP-1).  The glutathione-mediated release of β-lapachone from the surface of AuNP-1 was demonstrated by an expt. with MCF-7 (low glutathione concn.) and A549 cells (high glutathione concn.).  We also show that the introduction of an anti-EGFR antibody onto the AuNP carriers (AuNP-2) increased the intracellular uptake of AuNP carriers as compared with AuNP-1, which does not contain a targeting ligand.  In the in vitro cytotoxicity study, AuNP-2 with β-lapachone exhibited a higher apoptosis effect than that caused by AuNP-1 with β-lapachone.  This work suggests that AuNPs covered with cyclodextrin and tumor-targeting ligands may find useful applications for the development of nanoparticles with therapeutic and diagnostic modalities.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqpj2Qvt9eEU7Vg90H21EOLACvtfcHk0lj5_D8xCUj5tg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXktV2hu7Y%253D&md5=e80e1a41e67990ffdf2b0cefb3427a77</span></div><a href="/servlet/linkout?suffix=cit156&amp;dbid=16384&amp;doi=10.1039%2Fb816209c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb816209c%26sid%3Dliteratum%253Aachs%26aulast%3DPark%26aufirst%3DC.%26aulast%3DYoun%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DH.%26aulast%3DNoh%26aufirst%3DT.%26aulast%3DKook%26aufirst%3DY.%2BH.%26aulast%3DOh%26aufirst%3DE.%2BT.%26aulast%3DPark%26aufirst%3DH.%2BJ.%26aulast%3DKim%26aufirst%3DC.%26atitle%3DCyclodextrin-covered%2520gold%2520nanoparticles%2520for%2520targeted%2520delivery%2520of%2520an%2520anti-cancer%2520drug%26jtitle%3DJ.%2520Mater.%2520Chem.%26date%3D2009%26volume%3D19%26spage%3D2310%26epage%3D2315%26doi%3D10.1039%2Fb816209c" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref157"><div class="reference"><strong class="refLabel"><a href="#ref157" class="rightTabRefNumLink">157</a></strong><div class="NLM_citation" id="rightTab-cit157"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chin, S. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Blanco, E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kabbani, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, X. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bornmann, W. G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Intratumoral delivery of β-lapachone via polymer implants for prostate cancer therapy</span>. <i>Clin. Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2009</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">131</span>– <span class="NLM_lpage">139</span>, <span class="refDoi"> DOI: 10.1158/1078-0432.CCR-08-1691</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F1078-0432.CCR-08-1691" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=19118040" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref157/cit157&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhs1eltA%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2009&pages=131-139&author=Y.+Dongauthor=S.+F.+Chinauthor=E.+Blancoauthor=E.+A.+Beyauthor=W.+Kabbaniauthor=X.+J.+Xieauthor=W.+G.+Bornmannauthor=D.+A.+Boothmanauthor=J.+Gao&title=Intratumoral+delivery+of+%CE%B2-lapachone+via+polymer+implants+for+prostate+cancer+therapy&doi=10.1158%2F1078-0432.CCR-08-1691"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit157R"><div class="casContent"><span class="casTitleNuber">157</span><div class="casTitle"><span class="NLM_cas:atitle">Intratumoral Delivery of β-Lapachone via Polymer Implants for Prostate Cancer Therapy</span></div><div class="casAuthors">Dong, Ying; Chin, Shook-Fong; Blanco, Elvin; Bey, Erik A.; Kabbani, Wareef; Xie, Xian-Jin; Bornmann, William G.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Clinical Cancer Research</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">131-139</span>CODEN:
                <span class="NLM_cas:coden">CCREF4</span>;
        ISSN:<span class="NLM_cas:issn">1078-0432</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">PURPOSE: β-Lapachone (ARQ 501, a formulation of β-lapachone complexed with hydroxypropyl-β-cyclodextrin) is a novel anticancer agent with selectivity against prostate cancer cells overexpressing the NAD(P)H:quinone oxidoreductase-1 enzyme.  Lack of soly. and an efficient drug delivery strategy limits this compd. in clin. applications.  In this study, we aimed to develop β-lapachone-contg. polymer implants (millirods) for direct implantation into prostate tumors to test the hypothesis that the combination of a tumor-specific anticancer agent with site-specific release of the agent will lead to significant antitumor efficacy.  Exptl. Design: Survival assays in vitro were used to test the killing effect of β-lapachone in different prostate cancer cells. β-Lapachone release kinetics from millirods was detd. in vitro and in vivo.  PC-3 prostate tumor xenografts in athymic nude mice were used for antitumor efficacy studies in vivo.  RESULTS: β-Lapachone killed three different prostate cancer cell lines in an NAD(P)H:quinone oxidoreductase-1-dependent manner.  Upon incorporation of solid-state inclusion complexes of β-lapachone with hydroxypropyl-β-cyclodextrin into poly(D,L-lactide-co-glycolide) millirods, β-lapachone release kinetics in vivo showed a burst release of ∼0.5 mg within 12 h and a subsequently sustained release of the drug (∼0.4 mg/kg/d) comparable with that obsd. in vitro.  Antitumor efficacy studies showed significant tumor growth inhibition by β-lapachone millirods compared with controls (P < 0.0001; n = 10 per group).  Kaplan-Meier survival curves showed that tumor-bearing mice treated with β-lapachone millirods survived nearly 2-fold longer than controls, without observable systemic toxicity.  CONCLUSIONS: Intratumoral delivery of β-lapachone using polymer millirods showed the promising therapeutic potential for human prostate tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq5oCFMMu_EMrVg90H21EOLACvtfcHk0lg3LS4kSVUVkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhs1eltA%253D%253D&md5=35604dabef56a9706e9bf022d42de128</span></div><a href="/servlet/linkout?suffix=cit157&amp;dbid=16384&amp;doi=10.1158%2F1078-0432.CCR-08-1691&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F1078-0432.CCR-08-1691%26sid%3Dliteratum%253Aachs%26aulast%3DDong%26aufirst%3DY.%26aulast%3DChin%26aufirst%3DS.%2BF.%26aulast%3DBlanco%26aufirst%3DE.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DKabbani%26aufirst%3DW.%26aulast%3DXie%26aufirst%3DX.%2BJ.%26aulast%3DBornmann%26aufirst%3DW.%2BG.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DIntratumoral%2520delivery%2520of%2520%25CE%25B2-lapachone%2520via%2520polymer%2520implants%2520for%2520prostate%2520cancer%2520therapy%26jtitle%3DClin.%2520Cancer%2520Res.%26date%3D2009%26volume%3D15%26spage%3D131%26epage%3D139%26doi%3D10.1158%2F1078-0432.CCR-08-1691" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref158"><div class="reference"><strong class="refLabel"><a href="#ref158" class="rightTabRefNumLink">158</a></strong><div class="NLM_citation" id="rightTab-cit158"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yu, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span> <span> </span><span class="NLM_article-title">Superparamagnetic iron oxide nanoparticles: Amplifying ROS stress to improve anticancer drug efficacy</span>. <i>Theranostics</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">116</span>– <span class="NLM_lpage">126</span>, <span class="refDoi"> DOI: 10.7150/thno.5411</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.7150%2Fthno.5411" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=23423156" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref158/cit158&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2013&pages=116-126&author=G.+Huangauthor=H.+Chenauthor=Y.+Dongauthor=X.+Luoauthor=H.+Yuauthor=Z.+Mooreauthor=E.+A.+Beyauthor=D.+A.+Boothmanauthor=J.+Gao&title=Superparamagnetic+iron+oxide+nanoparticles%3A+Amplifying+ROS+stress+to+improve+anticancer+drug+efficacy&doi=10.7150%2Fthno.5411"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit158R"><div class="casContent"><span class="casTitleNuber">158</span><div class="casTitle"><span class="NLM_cas:atitle">Superparamagnetic iron oxide nanoparticles: amplifying ROS stress to improve anticancer drug efficacy</span></div><div class="casAuthors">Huang, Gang; Chen, Huabing; Luo, Xiuquan; Yu, Haijun; Moore, Zachary; Bey, Erik A.; Boothman, David A.; Gao, Jinming</div><div class="citationInfo"><span class="NLM_cas:title">Theranostics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">116-126</span>CODEN:
                <span class="NLM_cas:coden">THERDS</span>;
        ISSN:<span class="NLM_cas:issn">1838-7640</span>.
    
            (<span class="NLM_cas:orgname">Ivyspring International Publisher</span>)
        </div><div class="casAbstract">Superparamagnetic iron oxide nanoparticles (SPION) are an important and versatile nano-platform with broad biol. applications.  Despite extensive studies, the biol. and pharmacol. activities of SPION have not been exploited in therapeutic applications.  Recently, β-lapachone (β-lap), a novel anticancer drug, has shown considerable cancer specificity by selectively increasing reactive oxygen species (ROS) stress in cancer cells.  In this study, we report that pH-responsive SPION-micelles can synergize with β-lap for improved cancer therapy.  These SPION-micelles selectively release iron ions inside cancer cells, which interact with hydrogen peroxide (H2O2) generated from β-lap in a tumor-specific, NQO1-dependent manner.  Through Fenton reactions, these iron ions escalate the ROS stress in β-lap-exposed cancer cells, thereby greatly enhancing the therapeutic index of β-lap.  More specifically, a 10-fold increase in ROS stress was detected in β-lap-exposed cells pretreated with SPION-micelles over those treated with β-lap alone, which also correlates with significantly increased cell death.  Catalase treatment of cells or administration of an iron chelator can block the therapeutic synergy.  Our data suggest that incorporation of SPION-micelles with ROS-generating drugs can potentially improve drug efficacy during cancer treatment, thereby provides a synergistic strategy to integrate imaging and therapeutic functions in the development of theranostic nanomedicine.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGruVlAUzHeaQrVg90H21EOLACvtfcHk0lg3LS4kSVUVkA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXjtFKmu7g%253D&md5=cb028a8721f7476776a3ad264a547565</span></div><a href="/servlet/linkout?suffix=cit158&amp;dbid=16384&amp;doi=10.7150%2Fthno.5411&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.7150%252Fthno.5411%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DG.%26aulast%3DChen%26aufirst%3DH.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DYu%26aufirst%3DH.%26aulast%3DMoore%26aufirst%3DZ.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26aulast%3DGao%26aufirst%3DJ.%26atitle%3DSuperparamagnetic%2520iron%2520oxide%2520nanoparticles%253A%2520Amplifying%2520ROS%2520stress%2520to%2520improve%2520anticancer%2520drug%2520efficacy%26jtitle%3DTheranostics%26date%3D2013%26volume%3D3%26spage%3D116%26epage%3D126%26doi%3D10.7150%2Fthno.5411" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref159"><div class="reference"><strong class="refLabel"><a href="#ref159" class="rightTabRefNumLink">159</a></strong><div class="NLM_citation" id="rightTab-cit159"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, Paul J.</span>; <span class="NLM_string-name">Boothman</span>; , <span class="NLM_string-name">David, A.</span>; <span class="NLM_string-name">Bair</span>; , <span class="NLM_string-name">Joseph, S.</span>; <span class="NLM_string-name">Cao, L. F.</span>; <span class="NLM_string-name">Gao, J.</span>; <span class="NLM_string-name">Huang, X.</span>; <span class="NLM_string-name">Luo, X.</span>; <span class="NLM_string-name">Ma, X.</span>; <span class="NLM_string-name">Moore</span>; , <span class="NLM_string-name">Zachary, R.</span>; <span class="NLM_string-name">Parkinson</span>; , <span class="NLM_string-name">Elizabeth, I.</span></span> <span> </span><span class="NLM_article-title">Tumor Selective Combination Therapy</span>. PCT Int Appl. <span class="NLM_patent">WO2014168991A1</span>, <span class="NLM_year">2014</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2014&author=Paul+J.+Hergenrother&author=+Boothman&author=A.+David&author=+Bair&author=S.+Joseph&author=L.+F.+Cao&author=J.+Gao&author=X.+Huang&author=X.+Luo&author=X.+Ma&author=+Moore&author=R.+Zachary&author=+Parkinson&author=I.+Elizabeth&title=Tumor+Selective+Combination+Therapy"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit159&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DHergenrother%26aufirst%3DPaul%2BJ.%26atitle%3DTumor%2520Selective%2520Combination%2520Therapy%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref160"><div class="reference"><strong class="refLabel"><a href="#ref160" class="rightTabRefNumLink">160</a></strong><div class="NLM_citation" id="rightTab-cit160"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, H. Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, Q. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cheng, X. F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. P.</span></span> <span> </span><span class="NLM_article-title">NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells</span>. <i>Chin. J. Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>14</i></span>,  <span class="NLM_fpage">582</span>– <span class="NLM_lpage">589</span>, <span class="refDoi"> DOI: 10.1016/S1875-5364(16)30068-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS1875-5364%2816%2930068-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27608947" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref160/cit160&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC2szptVWrtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=14&publication_year=2016&pages=582-589&author=H.+Y.+Liuauthor=Q.+R.+Liauthor=X.+F.+Chengauthor=G.+J.+Wangauthor=H.+P.+Hao&title=NAMPT+inhibition+synergizes+with+NQO1-targeting+agents+in+inducing+apoptotic+cell+death+in+non-small+cell+lung+cancer+cells&doi=10.1016%2FS1875-5364%2816%2930068-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit160R"><div class="casContent"><span class="casTitleNuber">160</span><div class="casTitle"><span class="NLM_cas:atitle">NAMPT inhibition synergizes with NQO1-targeting agents in inducing apoptotic cell death in non-small cell lung cancer cells</span></div><div class="casAuthors">Liu Hui-Ying; Li Qing-Ran; Cheng Xue-Fang; Wang Guang-Ji; Hao Hai-Ping</div><div class="citationInfo"><span class="NLM_cas:title">Chinese journal of natural medicines</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">14</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">582-9</span>
        ISSN:<span class="NLM_cas:issn"></span>.
    </div><div class="casAbstract">Nicotinamide phosphoribosyltransferase (NAMPT) catalyzes the first rate-limiting step in converting nicotinamide to NAD(+), essential for a number of enzymes and regulatory proteins involved in a variety of cellular processes, including deacetylation enzyme SIRT1 which modulates several tumor suppressors such as p53 and FOXO.  Herein we report that NQO1 substrates Tanshione IIA (TSA) and β-lapachone (β-lap) induced a rapid depletion of NAD(+) pool but adaptively a significant upregulation of NAMPT.  NAMPT inhibition by FK866 at a nontoxic dose significantly enhanced NQO1-targeting agent-induced apoptotic cell death.  Compared with TSA or β-lap treatment alone, co-treatment with FK866 induced a more dramatic depletion of NAD(+), repression of SIRT1 activity, and thereby the increased accumulation of acetylated FOXO1 and the activation of apoptotic pathway.  In conclusion, the results from the present study support that NAMPT inhibition can synergize with NQO1 activation to induce apoptotic cell death, thereby providing a new rationale for the development of combinative therapeutic drugs in combating non-small lung cancer.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcRxCq2KIoPxdr0AGQpJZWpJfW6udTcc2eYE7w7C6detp7ntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC2szptVWrtw%253D%253D&md5=61db6b64ccb886624badd85e35b19be6</span></div><a href="/servlet/linkout?suffix=cit160&amp;dbid=16384&amp;doi=10.1016%2FS1875-5364%2816%2930068-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1875-5364%252816%252930068-1%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DH.%2BY.%26aulast%3DLi%26aufirst%3DQ.%2BR.%26aulast%3DCheng%26aufirst%3DX.%2BF.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26aulast%3DHao%26aufirst%3DH.%2BP.%26atitle%3DNAMPT%2520inhibition%2520synergizes%2520with%2520NQO1-targeting%2520agents%2520in%2520inducing%2520apoptotic%2520cell%2520death%2520in%2520non-small%2520cell%2520lung%2520cancer%2520cells%26jtitle%3DChin.%2520J.%2520Nat.%2520Med.%26date%3D2016%26volume%3D14%26spage%3D582%26epage%3D589%26doi%3D10.1016%2FS1875-5364%2816%2930068-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref161"><div class="reference"><strong class="refLabel"><a href="#ref161" class="rightTabRefNumLink">161</a></strong><div class="NLM_citation" id="rightTab-cit161"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Chakrabarti, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Moore, Z. R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Luo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ilcheva, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ali, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Padanad, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xie, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Burma, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Scaglioni, P. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Cantley, L. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">DeBerardinis, R. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kimmelman, A. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lyssiotis, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by β-lapachone</span>. <i>Cancer Metab.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">12</span>, <span class="refDoi"> DOI: 10.1186/s40170-015-0137-1</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1186%2Fs40170-015-0137-1" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=26462257" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref161/cit161&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A280%3ADC%252BC28zht1OhtQ%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2015&pages=12&author=G.+Chakrabartiauthor=Z.+R.+Mooreauthor=X.+Luoauthor=M.+Ilchevaauthor=A.+Aliauthor=M.+Padanadauthor=Y.+Zhouauthor=Y.+Xieauthor=S.+Burmaauthor=P.+P.+Scaglioniauthor=L.+C.+Cantleyauthor=R.+J.+DeBerardinisauthor=A.+C.+Kimmelmanauthor=C.+A.+Lyssiotisauthor=D.+A.+Boothman&title=Targeting+glutamine+metabolism+sensitizes+pancreatic+cancer+to+PARP-driven+metabolic+catastrophe+induced+by+%CE%B2-lapachone&doi=10.1186%2Fs40170-015-0137-1"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit161R"><div class="casContent"><span class="casTitleNuber">161</span><div class="casTitle"><span class="NLM_cas:atitle">Targeting glutamine metabolism sensitizes pancreatic cancer to PARP-driven metabolic catastrophe induced by ss-lapachone</span></div><div class="casAuthors">Chakrabarti Gaurab; Moore Zachary R; Luo Xiuquan; Boothman David A; Ilcheva Mariya; Burma Sandeep; Ali Aktar; Padanad Mahesh; Scaglioni Pier P; Zhou Yunyun; Xie Yang; Cantley Lewis C; DeBerardinis Ralph J; Kimmelman Alec C; Lyssiotis Costas A</div><div class="citationInfo"><span class="NLM_cas:title">Cancer & metabolism</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">3</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">12</span>
        ISSN:<span class="NLM_cas:issn">2049-3002</span>.
    </div><div class="casAbstract">BACKGROUND:  Pancreatic ductal adenocarcinomas (PDA) activate a glutamine-dependent pathway of cytosolic nicotinamide adenine dinucleotide phosphate (NADPH) production to maintain redox homeostasis and support proliferation.  Enzymes involved in this pathway (GLS1 (mitochondrial glutaminase 1), GOT1 (cytoplasmic glutamate oxaloacetate transaminase 1), and GOT2 (mitochondrial glutamate oxaloacetate transaminase 2)) are highly upregulated in PDA, and among these, inhibitors of GLS1 were recently deployed in clinical trials to target anabolic glutamine metabolism.  However, single-agent inhibition of this pathway is cytostatic and unlikely to provide durable benefit in controlling advanced disease.  RESULTS:  Here, we report that reducing NADPH pools by genetically or pharmacologically (bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide (BPTES) or CB-839) inhibiting glutamine metabolism in mutant Kirsten rat sarcoma viral oncogene homolog (KRAS) PDA sensitizes cell lines and tumors to ss-lapachone (ss-lap, clinical form ARQ761). ss-Lap is an NADPH:quinone oxidoreductase (NQO1)-bioactivatable drug that leads to NADPH depletion through high levels of reactive oxygen species (ROS) from the futile redox cycling of the drug and subsequently nicotinamide adenine dinucleotide (NAD)+ depletion through poly(ADP ribose) polymerase (PARP) hyperactivation.  NQO1 expression is highly activated by mutant KRAS signaling.  As such, ss-lap treatment concurrent with inhibition of glutamine metabolism in mutant KRAS, NQO1 overexpressing PDA leads to massive redox imbalance, extensive DNA damage, rapid PARP-mediated NAD+ consumption, and PDA cell death-features not observed in NQO1-low, wild-type KRAS expressing cells.  CONCLUSIONS:  This treatment strategy illustrates proof of principle that simultaneously decreasing glutamine metabolism-dependent tumor anti-oxidant defenses and inducing supra-physiological ROS formation are tumoricidal and that this rationally designed combination strategy lowers the required doses of both agents in vitro and in vivo.  The non-overlapping specificities of GLS1 inhibitors and ss-lap for PDA tumors afford high tumor selectivity, while sparing normal tissue.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcTRy9_YD1cmANNTrvPZP1IpfW6udTcc2eZhhbTaqCxR4Lntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BC28zht1OhtQ%253D%253D&md5=6c125ace3cbf06d4702d8ba5f2f9f21a</span></div><a href="/servlet/linkout?suffix=cit161&amp;dbid=16384&amp;doi=10.1186%2Fs40170-015-0137-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1186%252Fs40170-015-0137-1%26sid%3Dliteratum%253Aachs%26aulast%3DChakrabarti%26aufirst%3DG.%26aulast%3DMoore%26aufirst%3DZ.%2BR.%26aulast%3DLuo%26aufirst%3DX.%26aulast%3DIlcheva%26aufirst%3DM.%26aulast%3DAli%26aufirst%3DA.%26aulast%3DPadanad%26aufirst%3DM.%26aulast%3DZhou%26aufirst%3DY.%26aulast%3DXie%26aufirst%3DY.%26aulast%3DBurma%26aufirst%3DS.%26aulast%3DScaglioni%26aufirst%3DP.%2BP.%26aulast%3DCantley%26aufirst%3DL.%2BC.%26aulast%3DDeBerardinis%26aufirst%3DR.%2BJ.%26aulast%3DKimmelman%26aufirst%3DA.%2BC.%26aulast%3DLyssiotis%26aufirst%3DC.%2BA.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DTargeting%2520glutamine%2520metabolism%2520sensitizes%2520pancreatic%2520cancer%2520to%2520PARP-driven%2520metabolic%2520catastrophe%2520induced%2520by%2520%25CE%25B2-lapachone%26jtitle%3DCancer%2520Metab.%26date%3D2015%26volume%3D3%26spage%3D12%26doi%3D10.1186%2Fs40170-015-0137-1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref162"><div class="reference"><strong class="refLabel"><a href="#ref162" class="rightTabRefNumLink">162</a></strong><div class="NLM_citation" id="rightTab-cit162"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hao, H. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G. J.</span></span> <span> </span><span class="NLM_article-title">NQO1-mediated biotransformation determines the cytotoxicity of tanshinone IIA</span>. <i>Chin. J. Nat. Med.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>10</i></span>,  <span class="NLM_fpage">353</span>– <span class="NLM_lpage">357</span>, <span class="refDoi"> DOI: 10.1016/S1875-5364(12)60070-3</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref162/cit162&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2FS1875-5364%2812%2960070-3" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2012&pages=353-357&author=F.+Liuauthor=H.+P.+Haoauthor=G.+J.+Wang&title=NQO1-mediated+biotransformation+determines+the+cytotoxicity+of+tanshinone+IIA&doi=10.1016%2FS1875-5364%2812%2960070-3"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit162&amp;dbid=16384&amp;doi=10.1016%2FS1875-5364%2812%2960070-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1875-5364%252812%252960070-3%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DHao%26aufirst%3DH.%2BP.%26aulast%3DWang%26aufirst%3DG.%2BJ.%26atitle%3DNQO1-mediated%2520biotransformation%2520determines%2520the%2520cytotoxicity%2520of%2520tanshinone%2520IIA%26jtitle%3DChin.%2520J.%2520Nat.%2520Med.%26date%3D2012%26volume%3D10%26spage%3D353%26epage%3D357%26doi%3D10.1016%2FS1875-5364%2812%2960070-3" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref163"><div class="reference"><strong class="refLabel"><a href="#ref163" class="rightTabRefNumLink">163</a></strong><div class="NLM_citation" id="rightTab-cit163"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Du, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Lei, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3-methylnaphtho[1,2-b]furan-4,5-diones as novel L-shaped ortho-quinone substrates for NAD(P)H:quinone oxidoreductase (NQO1)</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2014</span>,  <span class="NLM_volume"><i>82</i></span>,  <span class="NLM_fpage">56</span>– <span class="NLM_lpage">67</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2014.05.041</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref163/cit163&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2014.05.041" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=82&publication_year=2014&pages=56-67&author=J.+Bianauthor=B.+Dengauthor=L.+Xuauthor=X.+Xuauthor=N.+Wangauthor=T.+Huauthor=Z.+Yaoauthor=J.+Duauthor=L.+Yangauthor=Y.+Leiauthor=X.+Liauthor=H.+Sunauthor=X.+Zhangauthor=Q.+You&title=2-Substituted+3-methylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+novel+L-shaped+ortho-quinone+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+%28NQO1%29&doi=10.1016%2Fj.ejmech.2014.05.041"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit163&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2014.05.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2014.05.041%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DHu%26aufirst%3DT.%26aulast%3DYao%26aufirst%3DZ.%26aulast%3DDu%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DL.%26aulast%3DLei%26aufirst%3DY.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203-methylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520novel%2520L-shaped%2520ortho-quinone%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%2520%2528NQO1%2529%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2014%26volume%3D82%26spage%3D56%26epage%3D67%26doi%3D10.1016%2Fj.ejmech.2014.05.041" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref164"><div class="reference"><strong class="refLabel"><a href="#ref164" class="rightTabRefNumLink">164</a></strong><div class="NLM_citation" id="rightTab-cit164"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Mu, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, T.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Novel naphtho[2,1-d]oxazole-4,5-diones as NQO1 substrates with improved aqueous solubility: Design, synthesis, and in vivo antitumor evaluation</span>. <i>Bioorg. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>24</i></span>,  <span class="NLM_fpage">1006</span>– <span class="NLM_lpage">1013</span>, <span class="refDoi"> DOI: 10.1016/j.bmc.2016.01.024</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref164/cit164&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmc.2016.01.024" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2016&pages=1006-1013&author=X.+Liauthor=J.+Bianauthor=N.+Wangauthor=X.+Qianauthor=J.+Guauthor=T.+Muauthor=J.+Fanauthor=X.+Yangauthor=S.+Liauthor=T.+Yangauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Novel+naphtho%5B2%2C1-d%5Doxazole-4%2C5-diones+as+NQO1+substrates+with+improved+aqueous+solubility%3A+Design%2C+synthesis%2C+and+in+vivo+antitumor+evaluation&doi=10.1016%2Fj.bmc.2016.01.024"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit164&amp;dbid=16384&amp;doi=10.1016%2Fj.bmc.2016.01.024&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmc.2016.01.024%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DGu%26aufirst%3DJ.%26aulast%3DMu%26aufirst%3DT.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DS.%26aulast%3DYang%26aufirst%3DT.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DNovel%2520naphtho%255B2%252C1-d%255Doxazole-4%252C5-diones%2520as%2520NQO1%2520substrates%2520with%2520improved%2520aqueous%2520solubility%253A%2520Design%252C%2520synthesis%252C%2520and%2520in%2520vivo%2520antitumor%2520evaluation%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2016%26volume%3D24%26spage%3D1006%26epage%3D1013%26doi%3D10.1016%2Fj.bmc.2016.01.024" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref165"><div class="reference"><strong class="refLabel"><a href="#ref165" class="rightTabRefNumLink">165</a></strong><div class="NLM_citation" id="rightTab-cit165"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, N.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>129</i></span>,  <span class="NLM_fpage">27</span>– <span class="NLM_lpage">40</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.02.004</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2017.02.004" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28214631" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref165/cit165&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=129&publication_year=2017&pages=27-40&author=J.+Bianauthor=X.+Liauthor=N.+Wangauthor=X.+Wuauthor=Q.+Youauthor=X.+Zhang&title=Discovery+of+quinone-directed+antitumor+agents+selectively+bioactivated+by+NQO1+over+CPR+with+improved+safety+profile&doi=10.1016%2Fj.ejmech.2017.02.004"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit165R"><div class="casContent"><span class="casTitleNuber">165</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of quinone-directed antitumor agents selectively bioactivated by NQO1 over CPR with improved safety profile</span></div><div class="casAuthors">Bian, Jinlei; Li, Xiang; Wang, Nan; Wu, Xingsen; You, Qidong; Zhang, Xiaojin</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">129</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">27-40</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The authors mainly focused on discovering compds. with good selectivity for NQO1 over CPR.  The NQO1-mediated two-electron redn. of compds. would kill cancer cells selectively, while CPR-mediated one-electron redn. would induce potential hepatotoxicity.  Several novel quinone-directed antitumor agents were discovered as specific NQO1 substrates through structure-activity relationship studies.  Among them, compd. 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione (12b) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by CPR.  It afforded the highest selectivity between NQO1/CPR (selectivity ratio = 6.37), much higher than the control β-lapachone (selectivity ratio = 1.36), indicated 12b may possess superior safety profile.  The electrochem. studies provided a reasonable explanation to the good selectivity toward NQO1.  Mol. docking studies supported that 12b was capable of forming addnl. C-H... π interactions with Trp 105 and Phe 178 residues compared to the control β-lap.  In addn., compd. 12b was shown to kill cancer cells efficiently both in vitro and in vivo model.  This work gave the authors a promising and novel scaffold for further investigation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqqRMIKxcCSGLVg90H21EOLACvtfcHk0lgf13djR8Y3xA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXjtVehu70%253D&md5=18c03007ddfea2f3165662912048ff3b</span></div><a href="/servlet/linkout?suffix=cit165&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.02.004&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.02.004%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DN.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DDiscovery%2520of%2520quinone-directed%2520antitumor%2520agents%2520selectively%2520bioactivated%2520by%2520NQO1%2520over%2520CPR%2520with%2520improved%2520safety%2520profile%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D129%26spage%3D27%26epage%3D40%26doi%3D10.1016%2Fj.ejmech.2017.02.004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref166"><div class="reference"><strong class="refLabel"><a href="#ref166" class="rightTabRefNumLink">166</a></strong><div class="NLM_citation" id="rightTab-cit166"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span> <span> </span><span class="NLM_article-title">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>138</i></span>,  <span class="NLM_fpage">616</span>– <span class="NLM_lpage">629</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.06.028</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2017.06.028" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28710963" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref166/cit166&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=138&publication_year=2017&pages=616-629&author=X.+Zhangauthor=J.+Bianauthor=X.+Liauthor=X.+Wuauthor=Y.+Dongauthor=Q.+You&title=2-Substituted+3%2C7%2C8-trimethylnaphtho%5B1%2C2-b%5Dfuran-4%2C5-diones+as+specific+L-shaped+NQO1-mediated+redox+modulators+for+the+treatment+of+non-small+cell+lung+cancer&doi=10.1016%2Fj.ejmech.2017.06.028"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit166R"><div class="casContent"><span class="casTitleNuber">166</span><div class="casTitle"><span class="NLM_cas:atitle">2-Substituted 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-diones as specific L-shaped NQO1-mediated redox modulators for the treatment of non-small cell lung cancer</span></div><div class="casAuthors">Zhang, Xiaojin; Bian, Jinlei; Li, Xiang; Wu, Xingsen; Dong, Yanan; You, Qidong</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">138</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">616-629</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">Based on the scaffold of 3,7,8-trimethylnaphtho[1,2-b]furan-4,5-dione, a series of L-shaped derivs. with substituted side chains at the position of C2 were designed by analyzing the binding mode with NQO1.  The drug-like compd. I (named as DDO-7178) emerged as the most specific substrate of the two-electron oxidoreductase NQO1 and could hardly be reduced by one-electron oxidoreductases CPR (NQO1/CPR = 20.8).  In addn., compd. 6q showed much improved physicochem. properties such as water soly. than the control β-lap.  The follow-up studies indicated that I showed a NQO1-expressing cancer-cell-selective killing property.  Preliminary mechanism studies on the anticancer effect indicated that I induced ROS prodn. in an NQO1 dependent manner and activated Akt/MAPK pathways in a ROS-dependent fashion, thereby inducing apoptosis.  In addn., emphasized compd. I showed more significant antitumor efficacy than β-lap without producing obvious toxic effects in vivo, which gave us a new tool for further investigation of NQO1-mediated redox modulators as anticancer drugs for the treatment of NQO1-overexpressed NSCLC.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqHJLGgGWnp6bVg90H21EOLACvtfcHk0li63jRpyGtRPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXhtFKrs77L&md5=00c0fbd05ce4d28225430439dc820303</span></div><a href="/servlet/linkout?suffix=cit166&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.06.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.06.028%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DWu%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DYou%26aufirst%3DQ.%26atitle%3D2-Substituted%25203%252C7%252C8-trimethylnaphtho%255B1%252C2-b%255Dfuran-4%252C5-diones%2520as%2520specific%2520L-shaped%2520NQO1-mediated%2520redox%2520modulators%2520for%2520the%2520treatment%2520of%2520non-small%2520cell%2520lung%2520cancer%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D138%26spage%3D616%26epage%3D629%26doi%3D10.1016%2Fj.ejmech.2017.06.028" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref167"><div class="reference"><strong class="refLabel"><a href="#ref167" class="rightTabRefNumLink">167</a></strong><div class="NLM_citation" id="rightTab-cit167"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Bian, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Deng, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Liu, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Guo, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sun, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">You, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, X.</span></span> <span> </span><span class="NLM_article-title">Synthesis and evaluation of (±)-dunnione and its ortho-quinone analogues as substrates for NAD(P)H:quinone oxidoreductase 1 (NQO1)</span>. <i>Bioorg. Med. Chem. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>25</i></span>,  <span class="NLM_fpage">1244</span>– <span class="NLM_lpage">1248</span>, <span class="refDoi"> DOI: 10.1016/j.bmcl.2015.01.057</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref167/cit167&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.bmcl.2015.01.057" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2015&pages=1244-1248&author=J.+Bianauthor=L.+Xuauthor=B.+Dengauthor=X.+Qianauthor=J.+Fanauthor=X.+Yangauthor=F.+Liuauthor=X.+Xuauthor=X.+Guoauthor=X.+Liauthor=H.+Sunauthor=Q.+Youauthor=X.+Zhang&title=Synthesis+and+evaluation+of+%28%C2%B1%29-dunnione+and+its+ortho-quinone+analogues+as+substrates+for+NAD%28P%29H%3Aquinone+oxidoreductase+1+%28NQO1%29&doi=10.1016%2Fj.bmcl.2015.01.057"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit167&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2015.01.057&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2015.01.057%26sid%3Dliteratum%253Aachs%26aulast%3DBian%26aufirst%3DJ.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DDeng%26aufirst%3DB.%26aulast%3DQian%26aufirst%3DX.%26aulast%3DFan%26aufirst%3DJ.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DLiu%26aufirst%3DF.%26aulast%3DXu%26aufirst%3DX.%26aulast%3DGuo%26aufirst%3DX.%26aulast%3DLi%26aufirst%3DX.%26aulast%3DSun%26aufirst%3DH.%26aulast%3DYou%26aufirst%3DQ.%26aulast%3DZhang%26aufirst%3DX.%26atitle%3DSynthesis%2520and%2520evaluation%2520of%2520%2528%25C2%25B1%2529-dunnione%2520and%2520its%2520ortho-quinone%2520analogues%2520as%2520substrates%2520for%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520%2528NQO1%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2015%26volume%3D25%26spage%3D1244%26epage%3D1248%26doi%3D10.1016%2Fj.bmcl.2015.01.057" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref168"><div class="reference"><strong class="refLabel"><a href="#ref168" class="rightTabRefNumLink">168</a></strong><div class="NLM_citation" id="rightTab-cit168"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Li, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tian, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Niu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chen, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, W.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Ju, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, C.</span></span> <span> </span><span class="NLM_article-title">Pseudonocardians A–C, new diazaanthraquinone derivatives from a deap-sea <i>Actinomycete Pseudonocardia</i> sp. SCSIO 01299</span>. <i>Mar. Drugs</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>9</i></span>,  <span class="NLM_fpage">1428</span>, <span class="refDoi"> DOI: 10.3390/md9081428</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.3390%2Fmd9081428" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21892356" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref168/cit168&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1entbvK" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2011&pages=1428&author=S.+Liauthor=X.+Tianauthor=S.+Niuauthor=W.+Zhangauthor=Y.+Chenauthor=H.+Zhangauthor=X.+Yangauthor=W.+Zhangauthor=W.+Liauthor=S.+Zhangauthor=J.+Juauthor=C.+Zhang&title=Pseudonocardians+A%E2%80%93C%2C+new+diazaanthraquinone+derivatives+from+a+deap-sea+Actinomycete+Pseudonocardia+sp.+SCSIO+01299&doi=10.3390%2Fmd9081428"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit168R"><div class="casContent"><span class="casTitleNuber">168</span><div class="casTitle"><span class="NLM_cas:atitle">Pseudonocardians A-C, new diazaanthraquinone derivatives from a deap-sea actinomycete Pseudonocardia sp. SCSIO 01299</span></div><div class="casAuthors">Li, Sumei; Tian, Xinpeng; Niu, Siwen; Zhang, Wenjun; Chen, Yuchan; Zhang, Haibo; Yang, Xianwen; Zhang, Weimin; Li, Wenjun; Zhang, Si; Ju, Jianhua; Zhang, Changsheng</div><div class="citationInfo"><span class="NLM_cas:title">Marine Drugs</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">1428-1439</span>CODEN:
                <span class="NLM_cas:coden">MDARE6</span>;
        ISSN:<span class="NLM_cas:issn">1660-3397</span>.
    
            (<span class="NLM_cas:orgname">MDPI Center</span>)
        </div><div class="casAbstract">Pseudonocardians A-C (2-4), three new diazaanthraquinone derivs., along with a previously synthesized compd. deoxynyboquinone (1), were produced by the strain SCSIO 01299, a marine actinomycete member of the genus Pseudonocardia, isolated from deep-sea sediment of the South China Sea.  The structures of compds. 1-4 were detd. by mass spectrometry and NMR expts. (1H, 13C, HSQC, and HMBC).  The structure of compd. 1, which was obtained for the first time from a natural source, was confirmed by x-ray anal.  Compds. 1-3 exhibited potent cytotoxic activities against three tumor cell lines of SF-268, MCF-7 and NCI-H460 with IC50 values between 0.01 and 0.21 μm, and also showed antibacterial activities on Staphylococcus aureus ATCC 29213, Enterococcus faecalis ATCC 29212 and Bacillus thuringensis SCSIO BT01, with MIC values of 1-4 μg mL-1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp329iKHpyT17Vg90H21EOLACvtfcHk0li63jRpyGtRPA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1entbvK&md5=a87100375aa99aca57a169e6b9369803</span></div><a href="/servlet/linkout?suffix=cit168&amp;dbid=16384&amp;doi=10.3390%2Fmd9081428&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3390%252Fmd9081428%26sid%3Dliteratum%253Aachs%26aulast%3DLi%26aufirst%3DS.%26aulast%3DTian%26aufirst%3DX.%26aulast%3DNiu%26aufirst%3DS.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DChen%26aufirst%3DY.%26aulast%3DZhang%26aufirst%3DH.%26aulast%3DYang%26aufirst%3DX.%26aulast%3DZhang%26aufirst%3DW.%26aulast%3DLi%26aufirst%3DW.%26aulast%3DZhang%26aufirst%3DS.%26aulast%3DJu%26aufirst%3DJ.%26aulast%3DZhang%26aufirst%3DC.%26atitle%3DPseudonocardians%2520A%25E2%2580%2593C%252C%2520new%2520diazaanthraquinone%2520derivatives%2520from%2520a%2520deap-sea%2520Actinomycete%2520Pseudonocardia%2520sp.%2520SCSIO%252001299%26jtitle%3DMar.%2520Drugs%26date%3D2011%26volume%3D9%26spage%3D1428%26doi%3D10.3390%2Fmd9081428" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref169"><div class="reference"><strong class="refLabel"><a href="#ref169" class="rightTabRefNumLink">169</a></strong><div class="NLM_citation" id="rightTab-cit169"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, X.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dong, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bey, E. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kilgore, J. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Bair, J. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, L. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Patel, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Williams, N. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Gao, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Boothman, D. A.</span></span> <span> </span><span class="NLM_article-title">An NQO1 substrate with potent antitumor activity that selectively kills by PARP1-induced programmed necrosis</span>. <i>Cancer Res.</i> <span class="NLM_year" style="font-weight: bold;">2012</span>,  <span class="NLM_volume"><i>72</i></span>,  <span class="NLM_fpage">3038</span>– <span class="NLM_lpage">3047</span>, <span class="refDoi"> DOI: 10.1158/0008-5472.CAN-11-3135</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1158%2F0008-5472.CAN-11-3135" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=22532167" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref169/cit169&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1yisr4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=72&publication_year=2012&pages=3038-3047&author=X.+Huangauthor=Y.+Dongauthor=E.+A.+Beyauthor=J.+A.+Kilgoreauthor=J.+S.+Bairauthor=L.+S.+Liauthor=M.+Patelauthor=E.+I.+Parkinsonauthor=Y.+Wangauthor=N.+S.+Williamsauthor=J.+Gaoauthor=P.+J.+Hergenrotherauthor=D.+A.+Boothman&title=An+NQO1+substrate+with+potent+antitumor+activity+that+selectively+kills+by+PARP1-induced+programmed+necrosis&doi=10.1158%2F0008-5472.CAN-11-3135"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit169R"><div class="casContent"><span class="casTitleNuber">169</span><div class="casTitle"><span class="NLM_cas:atitle">An NQO1 Substrate with Potent Antitumor Activity That Selectively Kills by PARP1-Induced Programmed Necrosis</span></div><div class="casAuthors">Huang, Xiumei; Dong, Ying; Bey, Erik A.; Kilgore, Jessica A.; Bair, Joseph S.; Li, Long-Shan; Patel, Malina; Parkinson, Elizabeth I.; Wang, Yiguang; Williams, Noelle S.; Gao, Jinming; Hergenrother, Paul J.; Boothman, David A.</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Research</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">72</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">3038-3047</span>CODEN:
                <span class="NLM_cas:coden">CNREA8</span>;
        ISSN:<span class="NLM_cas:issn">0008-5472</span>.
    
            (<span class="NLM_cas:orgname">American Association for Cancer Research</span>)
        </div><div class="casAbstract">Therapeutic programmed necrosis can be achieved in tumors using bioactive substrates of the cytosolic NAD(P)H:quinone oxidoreductase 1 (NQO1) enzyme that is overexpressed in most solid cancers and can create extensive tumor-selective ROS bursts, damaging tumor cell DNA and rapidly killing cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpu3BZY_1Ty4LVg90H21EOLACvtfcHk0ljQX8-YthNUQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1yisr4%253D&md5=10b0c945c03f3af3cdc88df6dda639d9</span></div><a href="/servlet/linkout?suffix=cit169&amp;dbid=16384&amp;doi=10.1158%2F0008-5472.CAN-11-3135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1158%252F0008-5472.CAN-11-3135%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DDong%26aufirst%3DY.%26aulast%3DBey%26aufirst%3DE.%2BA.%26aulast%3DKilgore%26aufirst%3DJ.%2BA.%26aulast%3DBair%26aufirst%3DJ.%2BS.%26aulast%3DLi%26aufirst%3DL.%2BS.%26aulast%3DPatel%26aufirst%3DM.%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DWang%26aufirst%3DY.%26aulast%3DWilliams%26aufirst%3DN.%2BS.%26aulast%3DGao%26aufirst%3DJ.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26aulast%3DBoothman%26aufirst%3DD.%2BA.%26atitle%3DAn%2520NQO1%2520substrate%2520with%2520potent%2520antitumor%2520activity%2520that%2520selectively%2520kills%2520by%2520PARP1-induced%2520programmed%2520necrosis%26jtitle%3DCancer%2520Res.%26date%3D2012%26volume%3D72%26spage%3D3038%26epage%3D3047%26doi%3D10.1158%2F0008-5472.CAN-11-3135" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref170"><div class="reference"><strong class="refLabel"><a href="#ref170" class="rightTabRefNumLink">170</a></strong><div class="NLM_citation" id="rightTab-cit170"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Lundberg, A. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Francis, J. M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pajak, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Parkinson, E. I.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wycislo, K. L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rosol, T. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Brown, M. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">London, C. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Dirikolu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hergenrother, P. J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Fan, T. M.</span></span> <span> </span><span class="NLM_article-title">Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species</span>. <i>Invest. New Drugs</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>35</i></span>,  <span class="NLM_fpage">134</span>– <span class="NLM_lpage">144</span>, <span class="refDoi"> DOI: 10.1007/s10637-016-0414-z</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1007%2Fs10637-016-0414-z" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=27975234" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref170/cit170&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XitV2rsrrE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=35&publication_year=2017&pages=134-144&author=A.+P.+Lundbergauthor=J.+M.+Francisauthor=M.+Pajakauthor=E.+I.+Parkinsonauthor=K.+L.+Wycisloauthor=T.+J.+Rosolauthor=M.+E.+Brownauthor=C.+A.+Londonauthor=L.+Dirikoluauthor=P.+J.+Hergenrotherauthor=T.+M.+Fan&title=Pharmacokinetics+and+derivation+of+an+anticancer+dosing+regimen+for+the+novel+anti-cancer+agent+isobutyl-deoxynyboquinone+%28IB-DNQ%29%2C+a+NQO1+bioactivatable+molecule%2C+in+the+domestic+felid+species&doi=10.1007%2Fs10637-016-0414-z"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit170R"><div class="casContent"><span class="casTitleNuber">170</span><div class="casTitle"><span class="NLM_cas:atitle">Pharmacokinetics and derivation of an anticancer dosing regimen for the novel anti-cancer agent isobutyl-deoxynyboquinone (IB-DNQ), a NQO1 bioactivatable molecule, in the domestic felid species</span></div><div class="casAuthors">Lundberg, Alycen P.; Francis, Joshua M.; Pajak, Malgorzata; Parkinson, Elizabeth I.; Wycislo, Kathryn L.; Rosol, Thomas J.; Brown, Megan E.; London, Cheryl A.; Dirikolu, Levent; Hergenrother, Paul J.; Fan, Timothy M.</div><div class="citationInfo"><span class="NLM_cas:title">Investigational New Drugs</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">35</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">134-144</span>CODEN:
                <span class="NLM_cas:coden">INNDDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-6997</span>.
    
            (<span class="NLM_cas:orgname">Springer</span>)
        </div><div class="casAbstract">Isobutyl-deoxynyboquinone (IB-DNQ) is a selective substrate for NAD(P)H:quinone oxidoreductase (NQO1), an enzyme overexpressed in many solid tumors.  Following activation by NQO1, IB-DNQ participates in a catalytic futile redn./reoxidn. cycle with consequent toxic reactive oxygen species generation within the tumor microenvironment.  To elucidate the potential of IB-DNQ to serve as a novel anticancer agent, in vitro studies coupled with in vivo pharmacokinetic and toxicol. investigations in the domestic felid species were conducted to investigate the tractability of IB-DNQ as a translationally applicable anticancer agent.  First, using feline oral squamous cell carcinoma (OSCC) as a comparative cancer model, expressions of NQO1 were characterized in not only human, but also feline OSCC tissue microarrays.  Second, IB-DNQ mediated cytotoxicity in three immortalized feline OSCC cell lines were studied under dose-dependent and sequential exposure conditions.  Third, the feasibility of administering IB-DNQ at doses predicted to achieve cytotoxic plasma concns. and biol. relevant durations of exposure were investigated through pharmacokinetic and tolerability studies in healthy research felines.  I.v. administration of IB-DNQ at 1.0-2.0 mg/kg achieved peak plasma concns. and durations of exposure reaching or exceeding predicted in vitro cytotoxic concns.  Clin. adverse side effects including ptyalism and tachypnea exhibited during and post-IV infusion of IB-DNQ were transient and tolerable.  Addnl., IB-DNQ administration did not produce acute or delayed-onset unacceptable hematol., non-hematol., or off-target oxidative toxicities.  Collectively, the findings reported here within provide important safety and pharmacokinetic data to support the continued development of IB-DNQ as a novel anticancer strategy for NQO1 expressing cancers.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGox4s6v1-rKrrVg90H21EOLACvtfcHk0ljQX8-YthNUQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XitV2rsrrE&md5=fa005edff1699aa11cdff7d480239e06</span></div><a href="/servlet/linkout?suffix=cit170&amp;dbid=16384&amp;doi=10.1007%2Fs10637-016-0414-z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs10637-016-0414-z%26sid%3Dliteratum%253Aachs%26aulast%3DLundberg%26aufirst%3DA.%2BP.%26aulast%3DFrancis%26aufirst%3DJ.%2BM.%26aulast%3DPajak%26aufirst%3DM.%26aulast%3DParkinson%26aufirst%3DE.%2BI.%26aulast%3DWycislo%26aufirst%3DK.%2BL.%26aulast%3DRosol%26aufirst%3DT.%2BJ.%26aulast%3DBrown%26aufirst%3DM.%2BE.%26aulast%3DLondon%26aufirst%3DC.%2BA.%26aulast%3DDirikolu%26aufirst%3DL.%26aulast%3DHergenrother%26aufirst%3DP.%2BJ.%26aulast%3DFan%26aufirst%3DT.%2BM.%26atitle%3DPharmacokinetics%2520and%2520derivation%2520of%2520an%2520anticancer%2520dosing%2520regimen%2520for%2520the%2520novel%2520anti-cancer%2520agent%2520isobutyl-deoxynyboquinone%2520%2528IB-DNQ%2529%252C%2520a%2520NQO1%2520bioactivatable%2520molecule%252C%2520in%2520the%2520domestic%2520felid%2520species%26jtitle%3DInvest.%2520New%2520Drugs%26date%3D2017%26volume%3D35%26spage%3D134%26epage%3D144%26doi%3D10.1007%2Fs10637-016-0414-z" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref171"><div class="reference"><strong class="refLabel"><a href="#ref171" class="rightTabRefNumLink">171</a></strong><div class="NLM_citation" id="rightTab-cit171"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tanabe, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hatta, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Nishimoto, S.</span></span> <span> </span><span class="NLM_article-title">Bioreduction activated prodrugs of camptothecin: molecular design, synthesis, activation mechanism and hypoxia selective cytotoxicity</span>. <i>Org. Biomol. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2005</span>,  <span class="NLM_volume"><i>3</i></span>,  <span class="NLM_fpage">1905</span>– <span class="NLM_lpage">1910</span>, <span class="refDoi"> DOI: 10.1039/b502813b</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref171/cit171&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2Fb502813b" title="">Crossref</a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2005&pages=1905-1910&author=Z.+Zhangauthor=K.+Tanabeauthor=H.+Hattaauthor=S.+Nishimoto&title=Bioreduction+activated+prodrugs+of+camptothecin%3A+molecular+design%2C+synthesis%2C+activation+mechanism+and+hypoxia+selective+cytotoxicity&doi=10.1039%2Fb502813b"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit171&amp;dbid=16384&amp;doi=10.1039%2Fb502813b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fb502813b%26sid%3Dliteratum%253Aachs%26aulast%3DZhang%26aufirst%3DZ.%26aulast%3DTanabe%26aufirst%3DK.%26aulast%3DHatta%26aufirst%3DH.%26aulast%3DNishimoto%26aufirst%3DS.%26atitle%3DBioreduction%2520activated%2520prodrugs%2520of%2520camptothecin%253A%2520molecular%2520design%252C%2520synthesis%252C%2520activation%2520mechanism%2520and%2520hypoxia%2520selective%2520cytotoxicity%26jtitle%3DOrg.%2520Biomol.%2520Chem.%26date%3D2005%26volume%3D3%26spage%3D1905%26epage%3D1910%26doi%3D10.1039%2Fb502813b" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref172"><div class="reference"><strong class="refLabel"><a href="#ref172" class="rightTabRefNumLink">172</a></strong><div class="NLM_citation" id="rightTab-cit172"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Xu, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Pei, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Hu, M.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Qiu, Y.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, G.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yao, H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhu, Z.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span> <span> </span><span class="NLM_article-title">Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation</span>. <i>Eur. J. Med. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>132</i></span>,  <span class="NLM_fpage">310</span>– <span class="NLM_lpage">321</span>, <span class="refDoi"> DOI: 10.1016/j.ejmech.2017.03.055</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.ejmech.2017.03.055" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=28395199" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref172/cit172&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2sXlvVCrurc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=132&publication_year=2017&pages=310-321&author=S.+Xuauthor=H.+Yaoauthor=L.+Peiauthor=M.+Huauthor=D.+Liauthor=Y.+Qiuauthor=G.+Wangauthor=L.+Wuauthor=H.+Yaoauthor=Z.+Zhuauthor=J.+Xu&title=Design%2C+synthesis%2C+and+biological+evaluation+of+NAD%28P%29H%3A+Quinone+oxidoreductase+%28NQO1%29-targeted+oridonin+prodrugs+possessing+indolequinone+moiety+for+hypoxia-selective+activation&doi=10.1016%2Fj.ejmech.2017.03.055"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit172R"><div class="casContent"><span class="casTitleNuber">172</span><div class="casTitle"><span class="NLM_cas:atitle">Design, synthesis, and biological evaluation of NAD(P)H: Quinone oxidoreductase (NQO1)-targeted oridonin prodrugs possessing indolequinone moiety for hypoxia-selective activation</span></div><div class="casAuthors">Xu, Shengtao; Yao, Hong; Pei, Lingling; Hu, Mei; Li, Dahong; Qiu, Yangyi; Wang, Guangyu; Wu, Liang; Yao, Hequan; Zhu, Zheying; Xu, Jinyi</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">132</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">310-321</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">The enzyme NQO1 is a potential target for selective cancer therapy due to its overexpression in certain hypoxic tumors.  A series of prodrugs possessing a variety of cytotoxic diterpenoids (oridonin and its analogs) as the leaving groups activated by NQO1 were synthesized by functionalization of 3-(hydroxymethyl)indolequinone, which is a good substrate of NQO1.  The target compds. exhibited relatively higher antiproliferative activities against NQO1-rich human colon carcinoma cells (HT-29) and human lung carcinoma (A549) cells (IC50 = 0.263-2.904 μM), while NQO1-deficient lung adenosquamous carcinoma cells (H596) were less sensitive to these compds., among which, compd. I exhibited the most potent antiproliferative activity against both A549 and HT-29 cells, with IC50 values of 0.386 and 0.263 μM, resp.  Further HPLC and docking studies demonstrated that I is a good substrate of NQO1.  Moreover, the investigation of anticancer mechanism showed that the representative compd. I affected cell cycle and induced NQO1 dependent apoptosis through an oxidative stress triggered mitochondria-related pathway in A549 cells.  Besides, the antitumor activity of I was also verified in a liver cancer xenograft mouse model.  Biol. evaluation of these compds. concludes that there is a strong correlation between NQO1 enzyme and induction of cancer cell death.  Thus, this suggests that some of the target compds. activated by NQO1 are novel prodrug candidates potential for selective anticancer therapy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqUnJI_Q_X6ErVg90H21EOLACvtfcHk0ljQX8-YthNUQg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2sXlvVCrurc%253D&md5=5436e872c6b9f388096a8c76488f9767</span></div><a href="/servlet/linkout?suffix=cit172&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2017.03.055&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2017.03.055%26sid%3Dliteratum%253Aachs%26aulast%3DXu%26aufirst%3DS.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DPei%26aufirst%3DL.%26aulast%3DHu%26aufirst%3DM.%26aulast%3DLi%26aufirst%3DD.%26aulast%3DQiu%26aufirst%3DY.%26aulast%3DWang%26aufirst%3DG.%26aulast%3DWu%26aufirst%3DL.%26aulast%3DYao%26aufirst%3DH.%26aulast%3DZhu%26aufirst%3DZ.%26aulast%3DXu%26aufirst%3DJ.%26atitle%3DDesign%252C%2520synthesis%252C%2520and%2520biological%2520evaluation%2520of%2520NAD%2528P%2529H%253A%2520Quinone%2520oxidoreductase%2520%2528NQO1%2529-targeted%2520oridonin%2520prodrugs%2520possessing%2520indolequinone%2520moiety%2520for%2520hypoxia-selective%2520activation%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2017%26volume%3D132%26spage%3D310%26epage%3D321%26doi%3D10.1016%2Fj.ejmech.2017.03.055" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref173"><div class="reference"><strong class="refLabel"><a href="#ref173" class="rightTabRefNumLink">173</a></strong><div class="NLM_citation" id="rightTab-cit173"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Sharma, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Iyer, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Sengupta, K.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Chakrapani, H.</span></span> <span> </span><span class="NLM_article-title">INDQ/NO, a bioreductively activated nitric oxide prodrug</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2013</span>,  <span class="NLM_volume"><i>15</i></span>,  <span class="NLM_fpage">2636</span>– <span class="NLM_lpage">2639</span>, <span class="refDoi"> DOI: 10.1021/ol400884v</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol400884v" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref173/cit173&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2013&pages=2636-2639&author=K.+Sharmaauthor=A.+Iyerauthor=K.+Senguptaauthor=H.+Chakrapani&title=INDQ%2FNO%2C+a+bioreductively+activated+nitric+oxide+prodrug&doi=10.1021%2Fol400884v"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit173R"><div class="casContent"><span class="casTitleNuber">173</span><div class="casTitle"><span class="NLM_cas:atitle">INDQ/NO, a Bioreductively Activated Nitric Oxide Prodrug</span></div><div class="casAuthors">Sharma, Kavita; Iyer, Aishwarya; Sengupta, Kundan; Chakrapani, Harinath</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">15</span>
        (<span class="NLM_cas:issue">11</span>),
    <span class="NLM_cas:pages">2636-2639</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7052</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The design, synthesis, and development of INDQ/NO (I), a novel nitric oxide (NO) prodrug targeted by a bioreductive trigger, are described.  INDQ/NO, an indolequinone-diazeniumdiolate is found to be metabolized to produce NO by DT-diaphorase, a bioreductive enzyme that is overexpressed in certain cancers and hypoxic tumors.  Cell-based assays revealed that INDQ/NO induces DNA damage and is a potent inhibitor of cancer cell proliferation.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpRYc6gjSC-QLVg90H21EOLACvtfcHk0lhEKYELleucPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXnsVWisL8%253D&md5=3ccdb7f8bc30a84663f69eacae91b506</span></div><a href="/servlet/linkout?suffix=cit173&amp;dbid=16384&amp;doi=10.1021%2Fol400884v&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol400884v%26sid%3Dliteratum%253Aachs%26aulast%3DSharma%26aufirst%3DK.%26aulast%3DIyer%26aufirst%3DA.%26aulast%3DSengupta%26aufirst%3DK.%26aulast%3DChakrapani%26aufirst%3DH.%26atitle%3DINDQ%252FNO%252C%2520a%2520bioreductively%2520activated%2520nitric%2520oxide%2520prodrug%26jtitle%3DOrg.%2520Lett.%26date%3D2013%26volume%3D15%26spage%3D2636%26epage%3D2639%26doi%3D10.1021%2Fol400884v" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref174"><div class="reference"><strong class="refLabel"><a href="#ref174" class="rightTabRefNumLink">174</a></strong><div class="NLM_citation" id="rightTab-cit174"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Huang, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Desai, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Tang, S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Thomas, T. P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Baker, J. R.,  Jr.</span></span> <span> </span><span class="NLM_article-title">The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release</span>. <i>Org. Lett.</i> <span class="NLM_year" style="font-weight: bold;">2010</span>,  <span class="NLM_volume"><i>12</i></span>,  <span class="NLM_fpage">1384</span>– <span class="NLM_lpage">1387</span>, <span class="refDoi"> DOI: 10.1021/ol1002626</span> </span><div class="citationLinks">[<a href="/doi/10.1021/ol1002626" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref174/cit174&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2010&pages=1384-1387&author=B.+Huangauthor=A.+Desaiauthor=S.+Tangauthor=T.+P.+Thomasauthor=J.+R.+Baker&title=The+synthesis+of+a+c%28RGDyK%29+targeted+SN38+prodrug+with+an+indolequinone+structure+for+bioreductive+drug+release&doi=10.1021%2Fol1002626"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit174R"><div class="casContent"><span class="casTitleNuber">174</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis of a c(RGDyK) targeted SN38 prodrug with an indolequinone structure for bioreductive drug release</span></div><div class="casAuthors">Huang, Baohua; Desai, Ankur; Tang, Shengzhuang; Thomas, Thommey P.; Baker, James R.</div><div class="citationInfo"><span class="NLM_cas:title">Organic Letters</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">12</span>
        (<span class="NLM_cas:issue">7</span>),
    <span class="NLM_cas:pages">1384-1387</span>CODEN:
                <span class="NLM_cas:coden">ORLEF7</span>;
        ISSN:<span class="NLM_cas:issn">1523-7060</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Prepn. of a novel c(RGDyK) targeted SN38 prodrug incorporating an indolequinone structure for bioreductively triggered drug release is described.  This design yields a prodrug that targets surface mols. on tumor cells (αvβ3 integrins) and releases drug under bioreductive conditions.  There are three moieties in the prodrug design, namely a therapeutic drug SN38, an indolequinone structure serving as a drug releasing trigger, and an αvβ3 integrin targeting peptide c(RGDyK).  Preliminary studies showed that SN38 is released in the presence of a bioreductive enzyme (DT-diaphorase).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqMclRawXbgtLVg90H21EOLACvtfcHk0lhEKYELleucPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXisFGmtLo%253D&md5=36b6b14c51b9834b7f656e3cc72fce2f</span></div><a href="/servlet/linkout?suffix=cit174&amp;dbid=16384&amp;doi=10.1021%2Fol1002626&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol1002626%26sid%3Dliteratum%253Aachs%26aulast%3DHuang%26aufirst%3DB.%26aulast%3DDesai%26aufirst%3DA.%26aulast%3DTang%26aufirst%3DS.%26aulast%3DThomas%26aufirst%3DT.%2BP.%26aulast%3DBaker%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520synthesis%2520of%2520a%2520c%2528RGDyK%2529%2520targeted%2520SN38%2520prodrug%2520with%2520an%2520indolequinone%2520structure%2520for%2520bioreductive%2520drug%2520release%26jtitle%3DOrg.%2520Lett.%26date%3D2010%26volume%3D12%26spage%3D1384%26epage%3D1387%26doi%3D10.1021%2Fol1002626" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref175"><div class="reference"><strong class="refLabel"><a href="#ref175" class="rightTabRefNumLink">175</a></strong><div class="NLM_citation" id="rightTab-cit175"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Payne, A. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Shedding light by cancer redox-human NAD(P)H:quinone oxidoreductase 1 activation of a cloaked fluorescent dye</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2011</span>,  <span class="NLM_volume"><i>47</i></span>,  <span class="NLM_fpage">11264</span>– <span class="NLM_lpage">11266</span>, <span class="refDoi"> DOI: 10.1039/c1cc14578a</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2Fc1cc14578a" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=21927746" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref175/cit175&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC3MXht1GhurrJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2011&pages=11264-11266&author=W.+C.+Silversauthor=A.+S.+Payneauthor=R.+L.+McCarley&title=Shedding+light+by+cancer+redox-human+NAD%28P%29H%3Aquinone+oxidoreductase+1+activation+of+a+cloaked+fluorescent+dye&doi=10.1039%2Fc1cc14578a"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit175R"><div class="casContent"><span class="casTitleNuber">175</span><div class="casTitle"><span class="NLM_cas:atitle">Shedding light by cancer redox-human NAD(P)H:quinone oxidoreductase 1 activation of a cloaked fluorescent dye</span></div><div class="casAuthors">Silvers, William C.; Payne, Alex S.; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">11264-11266</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A new quinone propionic acid-cloaked rhodamine fluorophore has its fluorescence revealed (de-cloaked) upon activation by human NAD(P)H:quinone oxidoreductase 1 (hNQO1), an upregulated enzyme in cancer cells and tumors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrq6-HY833WMrVg90H21EOLACvtfcHk0lhEKYELleucPg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXht1GhurrJ&md5=bb64f080bde80124965ac363cac197e6</span></div><a href="/servlet/linkout?suffix=cit175&amp;dbid=16384&amp;doi=10.1039%2Fc1cc14578a&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252Fc1cc14578a%26sid%3Dliteratum%253Aachs%26aulast%3DSilvers%26aufirst%3DW.%2BC.%26aulast%3DPayne%26aufirst%3DA.%2BS.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DShedding%2520light%2520by%2520cancer%2520redox-human%2520NAD%2528P%2529H%253Aquinone%2520oxidoreductase%25201%2520activation%2520of%2520a%2520cloaked%2520fluorescent%2520dye%26jtitle%3DChem.%2520Commun.%26date%3D2011%26volume%3D47%26spage%3D11264%26epage%3D11266%26doi%3D10.1039%2Fc1cc14578a" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref176"><div class="reference"><strong class="refLabel"><a href="#ref176" class="rightTabRefNumLink">176</a></strong><div class="NLM_citation" id="rightTab-cit176"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Best, Q. A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Johnson, A. E.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Rouillere, A.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">Environmentally robust rhodamine reporters for probe-based cellular detection of the cancer-linked oxidoreductase hNQO1</span>. <i>ACS Chem. Biol.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>11</i></span>,  <span class="NLM_fpage">231</span>– <span class="NLM_lpage">240</span>, <span class="refDoi"> DOI: 10.1021/acschembio.5b00792</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acschembio.5b00792" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref176/cit176&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXhsl2ht7%252FP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2016&pages=231-240&author=Q.+A.+Bestauthor=A.+E.+Johnsonauthor=B.+Prasaiauthor=A.+Rouillereauthor=R.+L.+McCarley&title=Environmentally+robust+rhodamine+reporters+for+probe-based+cellular+detection+of+the+cancer-linked+oxidoreductase+hNQO1&doi=10.1021%2Facschembio.5b00792"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit176R"><div class="casContent"><span class="casTitleNuber">176</span><div class="casTitle"><span class="NLM_cas:atitle">Environmentally Robust Rhodamine Reporters for Probe-based Cellular Detection of the Cancer-linked Oxidoreductase hNQO1</span></div><div class="casAuthors">Best, Quinn A.; Johnson, Amanda E.; Prasai, Bijeta; Rouillere, Alexandra; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Biology</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">11</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">231-240</span>CODEN:
                <span class="NLM_cas:coden">ACBCCT</span>;
        ISSN:<span class="NLM_cas:issn">1554-8929</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We successfully synthesized a fluorescent probe capable of detecting the cancer-assocd. NAD(P)H:quinoneoxidoreductase isoenzyme-1 within human cells, based on results from an investigation of the stability of various rhodamines and seminaphthorhodamines toward the biol. reductant NADH, present at ∼100-200 μM within cells.  While rhodamines are generally known for their chem. stability, we observe that NADH causes significant and sometimes rapid modification of numerous rhodamine analogs, including those oftentimes used in imaging applications.  Results from mechanistic studies lead us to rule out a radical-based redn. pathway, suggesting rhodamine redn. by NADH proceeds by a hydride transfer process to yield the reduced leuco form of the rhodamine and oxidized NAD+.  A relationship between the structural features of the rhodamines and their reactivity with NADH is obsd.  Rhodamines with increased alkylation on the N3- and N6-nitrogens, as well as the xanthene core, react the least with NADH; whereas, nonalkylated variants or analogs with electron-withdrawing substituents have the fastest rates of reaction.  These outcomes allowed us to judiciously construct a seminaphthorhodamine-based, turn-on fluorescent probe that is capable of selectively detecting the cancer-assocd., NADH-dependent enzyme NAD(P)H:quinoneoxidoreductase isoenzyme-1 in human cancer cells, without the issue of NADH-induced deactivation of the seminaphthorhodamine reporter.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqq4QwwW7xj2rVg90H21EOLACvtfcHk0lgyqeHrcE8YQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXhsl2ht7%252FP&md5=a379a97804b59435d91a03fa72a3995c</span></div><a href="/servlet/linkout?suffix=cit176&amp;dbid=16384&amp;doi=10.1021%2Facschembio.5b00792&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facschembio.5b00792%26sid%3Dliteratum%253Aachs%26aulast%3DBest%26aufirst%3DQ.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%2BE.%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DRouillere%26aufirst%3DA.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3DEnvironmentally%2520robust%2520rhodamine%2520reporters%2520for%2520probe-based%2520cellular%2520detection%2520of%2520the%2520cancer-linked%2520oxidoreductase%2520hNQO1%26jtitle%3DACS%2520Chem.%2520Biol.%26date%3D2016%26volume%3D11%26spage%3D231%26epage%3D240%26doi%3D10.1021%2Facschembio.5b00792" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref177"><div class="reference"><strong class="refLabel"><a href="#ref177" class="rightTabRefNumLink">177</a></strong><div class="NLM_citation" id="rightTab-cit177"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Prasai, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Silvers, W. C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">McCarley, R. L.</span></span> <span> </span><span class="NLM_article-title">oxidoreductase-facilitated visualization and detection of human cancer cells</span>. <i>Anal. Chem.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>87</i></span>,  <span class="NLM_fpage">6411</span>– <span class="NLM_lpage">6418</span>, <span class="refDoi"> DOI: 10.1021/acs.analchem.5b01615</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.analchem.5b01615" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref177/cit177&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXovFKktrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=87&publication_year=2015&pages=6411-6418&author=B.+Prasaiauthor=W.+C.+Silversauthor=R.+L.+McCarley&title=oxidoreductase-facilitated+visualization+and+detection+of+human+cancer+cells&doi=10.1021%2Facs.analchem.5b01615"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit177R"><div class="casContent"><span class="casTitleNuber">177</span><div class="casTitle"><span class="NLM_cas:atitle">Oxidoreductase-Facilitated Visualization and Detection of Human Cancer Cells</span></div><div class="casAuthors">Prasai, Bijeta; Silvers, William C.; McCarley, Robin L.</div><div class="citationInfo"><span class="NLM_cas:title">Analytical Chemistry (Washington, DC, United States)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">87</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">6411-6418</span>CODEN:
                <span class="NLM_cas:coden">ANCHAM</span>;
        ISSN:<span class="NLM_cas:issn">0003-2700</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Achieving highly selective and sensitive detection/visualization of intracellular biol. events through the use of cell-penetrable, bioanalyte-activatable, turn-on probes is dependent on the presence of specific event-linked cellular biomarkers, if and only if there exist activatable probes that appropriately respond to the biomarker analyte.  Here is described the evaluation of, and use in cellular imaging studies, a previously undisclosed naphthalimide probe QMeNN (I), whose fluorescence is deactivated by photoinduced electron transfer (PeT) quenching that results from the presence of a covalently linked biomarker-specific quinone trigger group.  Highly selective and rapid activation of the quinone group by the human cancer tumor-linked NAD(P)H:quinone oxido-reductase isoenzyme 1 (hNQO1) results in fast trigger group removal to yield a highly fluorescent green-energy-range reporter that possesses a high molar absorptivity; there is a 136-fold increase in brightness for the enzymically produced reporter vs. probe precursor, a value 4 times greater than previously reported for the hNQO1 analyte.  The novel probe is taken up and activated rapidly within only hNQO1-pos. human cancer cells; addn. of an hNQO1 inhibitor prevents the selective activation of the probe.  Comparison of cytosolic fluorescence intensity in pos. cells vs. background in neg. cells yields a quant. metric (pos.-to-neg. ratio, PNR) for judging hNQO1 activity.  The authors show it is possible to det. hNQO1 presence in previously studied colorectal cancer cells and the unexplored ovarian cancer cell line NIH:OVCAR-3, with resp. PNR values of 926 and 34 being obtained.  Even with 10 min probe incubation, ready discrimination of pos. cells from neg. cells is achieved.  Cell viability is unaffected by probe presence, thereby highlighting the practicality of probe use in live-cell imaging applications.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpVG_Acrf1QirVg90H21EOLACvtfcHk0lgyqeHrcE8YQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXovFKktrc%253D&md5=46b3a988742b3060af0d20afc15468cb</span></div><a href="/servlet/linkout?suffix=cit177&amp;dbid=16384&amp;doi=10.1021%2Facs.analchem.5b01615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.analchem.5b01615%26sid%3Dliteratum%253Aachs%26aulast%3DPrasai%26aufirst%3DB.%26aulast%3DSilvers%26aufirst%3DW.%2BC.%26aulast%3DMcCarley%26aufirst%3DR.%2BL.%26atitle%3Doxidoreductase-facilitated%2520visualization%2520and%2520detection%2520of%2520human%2520cancer%2520cells%26jtitle%3DAnal.%2520Chem.%26date%3D2015%26volume%3D87%26spage%3D6411%26epage%3D6418%26doi%3D10.1021%2Facs.analchem.5b01615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref178"><div class="reference"><strong class="refLabel"><a href="#ref178" class="rightTabRefNumLink">178</a></strong><div class="NLM_citation" id="rightTab-cit178"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Fei, Q.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhou, L.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Shi, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, C.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wang, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhao, C.</span></span> <span> </span><span class="NLM_article-title">Rational construction of probes rendering ratiometric response to the cancer-specific enzyme NQO1</span>. <i>Dyes Pigm.</i> <span class="NLM_year" style="font-weight: bold;">2017</span>,  <span class="NLM_volume"><i>136</i></span>,  <span class="NLM_fpage">846</span>– <span class="NLM_lpage">851</span>, <span class="refDoi"> DOI: 10.1016/j.dyepig.2016.09.031</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1016%2Fj.dyepig.2016.09.031" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref178/cit178&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XhsF2nsrfI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=136&publication_year=2017&pages=846-851&author=Q.+Feiauthor=L.+Zhouauthor=F.+Wangauthor=B.+Shiauthor=C.+Liauthor=R.+Wangauthor=C.+Zhao&title=Rational+construction+of+probes+rendering+ratiometric+response+to+the+cancer-specific+enzyme+NQO1&doi=10.1016%2Fj.dyepig.2016.09.031"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit178R"><div class="casContent"><span class="casTitleNuber">178</span><div class="casTitle"><span class="NLM_cas:atitle">Rational construction of probes rendering ratiometric response to the cancer-specific enzyme NQO1</span></div><div class="casAuthors">Fei, Qiang; Zhou, Li; Wang, Feiyi; Shi, Ben; Li, Chunbao; Wang, Rui; Zhao, Chunchang</div><div class="citationInfo"><span class="NLM_cas:title">Dyes and Pigments</span>
        (<span class="NLM_cas:date">2017</span>),
    <span class="NLM_cas:volume">136</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">846-851</span>CODEN:
                <span class="NLM_cas:coden">DYPIDX</span>;
        ISSN:<span class="NLM_cas:issn">0143-7208</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Pursuit of fluorescent probes for identification of cancer biomarkers benefits reliable predictions of early cancer detection.  Here, a strategy employing polymeric micelle assembly for encapsulation of a new enzyme (NQO1)-responsive small mol. (I) was established for facile access to nanoprobes with favorable features in bioimaging, such as good aq. soly., enhanced photo-stability and biocompatibility.  In the presence of the enzyme NQO1, these nanoprobes underwent ratiometric fluorescence changes from yellow-green fluorescence signals to red fluorescence signals.  By exploiting this favorable ratiometric response to NQO1, the authors explored these nanoprobes for evaluation of enzyme activity in living cells, which showed distinct differentiation between NQO1-pos. cancer cells and NQO1-neg. cells.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqtuYXC9_Rx1rVg90H21EOLACvtfcHk0lgyqeHrcE8YQw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XhsF2nsrfI&md5=eeff081729c16c23bccf7008e374914b</span></div><a href="/servlet/linkout?suffix=cit178&amp;dbid=16384&amp;doi=10.1016%2Fj.dyepig.2016.09.031&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.dyepig.2016.09.031%26sid%3Dliteratum%253Aachs%26aulast%3DFei%26aufirst%3DQ.%26aulast%3DZhou%26aufirst%3DL.%26aulast%3DWang%26aufirst%3DF.%26aulast%3DShi%26aufirst%3DB.%26aulast%3DLi%26aufirst%3DC.%26aulast%3DWang%26aufirst%3DR.%26aulast%3DZhao%26aufirst%3DC.%26atitle%3DRational%2520construction%2520of%2520probes%2520rendering%2520ratiometric%2520response%2520to%2520the%2520cancer-specific%2520enzyme%2520NQO1%26jtitle%3DDyes%2520Pigm.%26date%3D2017%26volume%3D136%26spage%3D846%26epage%3D851%26doi%3D10.1016%2Fj.dyepig.2016.09.031" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref179"><div class="reference"><strong class="refLabel"><a href="#ref179" class="rightTabRefNumLink">179</a></strong><div class="NLM_citation" id="rightTab-cit179"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Liu, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Xu, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Yan, D.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zhang, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Zeng, F.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Li, B.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Wu, S.</span></span> <span> </span><span class="NLM_article-title">A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy</span>. <i>Chem. Commun.</i> <span class="NLM_year" style="font-weight: bold;">2015</span>,  <span class="NLM_volume"><i>51</i></span>,  <span class="NLM_fpage">9567</span>– <span class="NLM_lpage">9570</span>, <span class="refDoi"> DOI: 10.1039/C5CC02149A</span> </span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=16&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=10.1039%2FC5CC02149A" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=8&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=25971544" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref179/cit179&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC2MXnslOms7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2015&pages=9567-9570&author=P.+Liuauthor=J.+Xuauthor=D.+Yanauthor=P.+Zhangauthor=F.+Zengauthor=B.+Liauthor=S.+Wu&title=A+DT-diaphorase+responsive+theranostic+prodrug+for+diagnosis%2C+drug+release+monitoring+and+therapy&doi=10.1039%2FC5CC02149A"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit179R"><div class="casContent"><span class="casTitleNuber">179</span><div class="casTitle"><span class="NLM_cas:atitle">A DT-diaphorase responsive theranostic prodrug for diagnosis, drug release monitoring and therapy</span></div><div class="casAuthors">Liu, Peilian; Xu, Jiangsheng; Yan, Donghang; Zhang, Peisheng; Zeng, Fang; Li, Bowen; Wu, Shuizhu</div><div class="citationInfo"><span class="NLM_cas:title">Chemical Communications (Cambridge, United Kingdom)</span>
        (<span class="NLM_cas:date">2015</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">46</span>),
    <span class="NLM_cas:pages">9567-9570</span>CODEN:
                <span class="NLM_cas:coden">CHCOFS</span>;
        ISSN:<span class="NLM_cas:issn">1359-7345</span>.
    
            (<span class="NLM_cas:orgname">Royal Society of Chemistry</span>)
        </div><div class="casAbstract">A DT-diaphorase-activatable theranostic prodrug, which contains camptothecin, a self-immolative linker and a trigger group, has been developed for the detection of DT-diaphorase, tracking of drug release and selectively killing cancer cells over-expressed with DT-diaphorase.  This strategy may offer a new approach for the development of enzyme-catalyzed theranostic anticancer therapeutics.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbbvOBaYSmELVg90H21EOLACvtfcHk0lgEBO5OJ0MCTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC2MXnslOms7k%253D&md5=d8d35e29b2ade23dfb15dd972a31afd2</span></div><a href="/servlet/linkout?suffix=cit179&amp;dbid=16384&amp;doi=10.1039%2FC5CC02149A&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1039%252FC5CC02149A%26sid%3Dliteratum%253Aachs%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DXu%26aufirst%3DJ.%26aulast%3DYan%26aufirst%3DD.%26aulast%3DZhang%26aufirst%3DP.%26aulast%3DZeng%26aufirst%3DF.%26aulast%3DLi%26aufirst%3DB.%26aulast%3DWu%26aufirst%3DS.%26atitle%3DA%2520DT-diaphorase%2520responsive%2520theranostic%2520prodrug%2520for%2520diagnosis%252C%2520drug%2520release%2520monitoring%2520and%2520therapy%26jtitle%3DChem.%2520Commun.%26date%3D2015%26volume%3D51%26spage%3D9567%26epage%3D9570%26doi%3D10.1039%2FC5CC02149A" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref180"><div class="reference"><strong class="refLabel"><a href="#ref180" class="rightTabRefNumLink">180</a></strong><div class="NLM_citation" id="rightTab-cit180"><span><span class="NLM_contrib-group"><span class="NLM_string-name">Shin, W. S.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Han, J.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Verwilst, P.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kumar, R.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. H.</span></span>; <span class="NLM_contrib-group"><span class="NLM_string-name">Kim, J. S.</span></span> <span> </span><span class="NLM_article-title">Cancer targeted enzymatic theranostic prodrug: precise diagnosis and chemotherapy</span>. <i>Bioconjugate Chem.</i> <span class="NLM_year" style="font-weight: bold;">2016</span>,  <span class="NLM_volume"><i>27</i></span>,  <span class="NLM_fpage">1419</span>– <span class="NLM_lpage">1426</span>, <span class="refDoi"> DOI: 10.1021/acs.bioconjchem.6b00184</span> </span><div class="citationLinks">[<a href="/doi/10.1021/acs.bioconjchem.6b00184" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref180/cit180&amp;dbid=32&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;key=1%3ACAS%3A528%3ADC%252BC28XmvFKrtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=27&publication_year=2016&pages=1419-1426&author=W.+S.+Shinauthor=J.+Hanauthor=P.+Verwilstauthor=R.+Kumarauthor=J.+H.+Kimauthor=J.+S.+Kim&title=Cancer+targeted+enzymatic+theranostic+prodrug%3A+precise+diagnosis+and+chemotherapy&doi=10.1021%2Facs.bioconjchem.6b00184"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit180R"><div class="casContent"><span class="casTitleNuber">180</span><div class="casTitle"><span class="NLM_cas:atitle">Cancer Targeted Enzymatic Theranostic Prodrug: Precise Diagnosis and Chemotherapy</span></div><div class="casAuthors">Shin, Weon Sup; Han, Jiyou; Verwilst, Peter; Kumar, Rajesh; Kim, Jong-Hoon; Kim, Jong Seung</div><div class="citationInfo"><span class="NLM_cas:title">Bioconjugate Chemistry</span>
        (<span class="NLM_cas:date">2016</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">1419-1426</span>CODEN:
                <span class="NLM_cas:coden">BCCHES</span>;
        ISSN:<span class="NLM_cas:issn">1043-1802</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The development of targeted and effective theranostic (therapeutic and diagnostic) chemotherapeutic agents is highly desirable for precise diagnosis and treatment of cancer.  To realize this goal, the authors developed a cancer-targeting and enzyme-triggered theranostic prodrug (I), contg. 7-ethyl-10-hydroxycamptothecin (SN-38), a well-known anticancer drug, which inhibits topoisomerase I in the cell nucleus; hydroquinone as an enzyme-triggered moiety; and biotin as a cancer targeting unit.  Enzyme-triggered theranostic prodrug (I) selectively targets cancer cells and is subsequently activated in the presence of NAD(P)H: quinone oxidoreductase-1 (NQO1), a cytosolic flavoprotein that catalyzes the two-electron redn. of quinone moieties with the concomitant consumption of NADH or NADPH as electron donors.  High levels of NQO1 were found in a variety of cancer cell lines compared to healthy cells, and therefore, it is an excellent target for the development of cancer targeted drug delivery systems.  Upon preferential cancer cell delivery and uptake, aided by biotin, the enzyme-triggered theranostic prodrug (I) is cleaved by NQO1, with the subsequent release of SN-38, inhibiting topoisomerase I, leading to apoptosis.  The drug release and induced apoptosis of cancer cells expressing both biotin receptors and high levels of NQO1 was simultaneously monitored via the innate fluorescence of the released SN-38 by confocal microscopy.  In vitro and in vivo studies showed an effective inhibition of cancer growth by the enzyme-triggered theranostic prodrug (I).  Thus, this type of enzyme-triggered targeted prodrug therapy is an interesting and promising approach for future cancer treatment.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr5BTe_hqwZ8rVg90H21EOLACvtfcHk0lgEBO5OJ0MCTQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC28XmvFKrtbk%253D&md5=3edbe0fe166e198a7e31da85d2e9b19d</span></div><a href="/servlet/linkout?suffix=cit180&amp;dbid=16384&amp;doi=10.1021%2Facs.bioconjchem.6b00184&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Facs.bioconjchem.6b00184%26sid%3Dliteratum%253Aachs%26aulast%3DShin%26aufirst%3DW.%2BS.%26aulast%3DHan%26aufirst%3DJ.%26aulast%3DVerwilst%26aufirst%3DP.%26aulast%3DKumar%26aufirst%3DR.%26aulast%3DKim%26aufirst%3DJ.%2BH.%26aulast%3DKim%26aufirst%3DJ.%2BS.%26atitle%3DCancer%2520targeted%2520enzymatic%2520theranostic%2520prodrug%253A%2520precise%2520diagnosis%2520and%2520chemotherapy%26jtitle%3DBioconjugate%2520Chem.%26date%3D2016%26volume%3D27%26spage%3D1419%26epage%3D1426%26doi%3D10.1021%2Facs.bioconjchem.6b00184" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1D4A" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1D4A','PDB','1D4A'); return false;">PDB: 1D4A</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DXO" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1DXO','PDB','1DXO'); return false;">PDB: 1DXO</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F1O" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=2F1O','PDB','2F1O'); return false;">PDB: 2F1O</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KBQ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=1KBQ','PDB','1KBQ'); return false;">PDB: 1KBQ</a></li></ul></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Facs.jmedchem.8b00124&amp;pbContext=%3Barticle%3Aarticle%3A10.1021%2Facs.jmedchem.8b00124%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2018.61.issue-16%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/acs.jmedchem.8b00124" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                5MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67997cc8e9ab3c2e","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
